data_2hnb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hnb _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.206 0 N-CA-C 109.807 -0.442 . . . . 10.0 109.807 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -114.15 -24.45 8.97 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.859 1.263 . . . . 10.0 110.686 174.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.8 mt -125.94 89.66 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.146 0 N-CA-C 105.793 -1.929 . . . . 10.0 105.793 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.8 m -74.11 115.34 13.47 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.9 mp -77.27 154.0 33.39 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.701 -1.222 . . . . 10.0 107.701 169.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.8 mt -125.62 83.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 103.084 -2.932 . . . . 10.0 103.084 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 m -69.31 147.52 51.02 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.96 1.304 . . . . 10.0 109.272 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.46 81.59 0.15 Allowed Glycine 0 C--N 1.335 0.511 0 N-CA-C 111.119 -0.792 . . . . 10.0 111.119 -172.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.7 p . . . . . 0 C--O 1.232 0.176 0 CA-C-N 117.859 0.83 . . . . 10.0 110.142 165.954 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.99 0 N-CA-C 112.129 -0.389 . . . . 10.0 112.129 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.76 -31.24 70.14 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 117.899 0.849 . . . . 10.0 111.146 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -66.67 -42.37 86.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.099 0.863 . . . . 10.0 109.477 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -59.2 -53.04 62.84 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.133 0.573 . . . . 10.0 110.113 175.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.98 -40.37 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 119.012 -0.518 . . . . 10.0 110.006 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.54 -46.92 86.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.818 0.736 . . . . 10.0 110.433 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.75 -42.86 99.53 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.339 0.518 . . . . 10.0 110.444 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -62.6 -48.97 77.09 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.211 0.604 . . . . 10.0 110.114 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 23.7 mt -60.81 -43.59 98.0 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 124.029 0.932 . . . . 10.0 111.044 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.84 91.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.195 0.598 . . . . 10.0 110.534 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.02 -47.14 87.79 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.699 0.681 . . . . 10.0 110.281 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -61.59 -40.09 93.56 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 121.804 -0.56 . . . . 10.0 110.759 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.1 mt -64.16 -39.96 95.11 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 119.012 -0.518 . . . . 10.0 110.95 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.59 -38.81 92.28 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.847 0.749 . . . . 10.0 110.323 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.83 -33.81 75.5 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.914 0.779 . . . . 10.0 111.197 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.71 -20.58 65.28 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.266 0.626 . . . . 10.0 111.807 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.81 6.47 22.94 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.371 1.463 . . . . 10.0 113.376 171.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -103.28 135.87 44.11 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.196 1.498 . . . . 10.0 108.539 -173.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.8 p -79.69 147.42 31.97 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.024 0.53 . . . . 10.0 110.011 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.8 p -141.97 164.33 30.48 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.776 0.798 . . . . 10.0 111.309 -168.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -151.26 159.59 44.27 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.48 2.312 . . . . 10.0 105.103 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -131.0 61.45 1.63 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.356 1.462 . . . . 10.0 108.446 -171.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 mt -55.64 118.71 4.77 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.759 0.824 . . . . 10.0 108.957 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.21 116.57 16.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.178 -1.415 . . . . 10.0 107.178 171.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.8 50.49 14.78 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.027 -1.43 . . . . 10.0 115.73 167.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -65.3 164.35 26.0 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 CA-C-N 120.352 2.076 . . . . 10.0 110.391 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.7 mt -108.7 163.81 12.92 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.851 0.86 . . . . 10.0 108.754 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -56.75 -39.99 74.98 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.849 0.86 . . . . 10.0 110.356 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.35 2.1 1.36 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.545 1.138 . . . . 10.0 113.705 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -126.33 17.23 7.7 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.691 1.596 . . . . 10.0 111.263 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.6 mt -132.01 123.43 18.96 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.837 1.255 . . . . 10.0 108.558 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.55 159.45 52.77 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 121.926 1.751 . . . . 10.0 110.565 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.74 11.1 1.82 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.664 1.186 . . . . 10.0 113.963 -174.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.0 m -143.71 138.66 29.02 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.114 1.366 . . . . 10.0 107.944 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.42 -177.7 31.64 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.457 -1.057 . . . . 10.0 110.457 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mt -125.6 96.13 3.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 104.699 -2.334 . . . . 10.0 104.699 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -97.14 175.54 6.26 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.17 0.588 . . . . 10.0 110.605 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.9 tp -150.13 99.09 2.78 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 107.812 -1.181 . . . . 10.0 107.812 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.6 t -83.5 130.82 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.751 -1.203 . . . . 10.0 107.751 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.9 mt -132.75 128.35 57.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.321 -2.103 . . . . 10.0 105.321 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.7 m -137.89 133.16 33.51 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.48 0.488 . . . . 10.0 109.936 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.3 m -62.61 160.67 13.53 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.506 0.669 . . . . 10.0 110.024 157.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.1 m -126.7 117.42 22.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 103.82 -2.659 . . . . 10.0 103.82 171.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -74.54 8.7 2.14 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.7 1.0 . . . . 10.0 113.7 -168.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.99 -22.94 26.66 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.766 1.651 . . . . 10.0 112.221 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.02 8.82 8.67 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.447 1.099 . . . . 10.0 112.505 -172.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.32 -2.86 81.61 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 123.534 0.588 . . . . 10.0 112.895 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -68.26 124.35 23.25 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.031 0.916 . . . . 10.0 108.737 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.9 mt -72.73 142.56 83.62 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 106.388 -1.708 . . . . 10.0 106.388 173.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.78 140.38 93.45 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.217 2.612 . . . . 10.0 111.066 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -60.34 -21.79 62.48 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.558 1.143 . . . . 10.0 113.118 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -50.99 -44.18 60.85 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.235 1.414 . . . . 10.0 111.132 169.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.1 tp -122.45 -19.34 6.43 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.745 0.818 . . . . 10.0 112.439 -168.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.9 p -52.78 -35.06 20.46 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 115.131 1.53 . . . . 10.0 115.131 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -54.73 -24.46 37.83 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.365 2.043 . . . . 10.0 114.577 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -62.02 -36.73 82.45 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.427 1.012 . . . . 10.0 111.027 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -61.16 -42.46 98.61 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.513 0.597 . . . . 10.0 110.205 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -72.01 -45.51 60.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.149 0.58 . . . . 10.0 109.732 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.45 -37.09 82.3 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.312 0.645 . . . . 10.0 111.315 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.8 mt -64.75 -59.44 4.23 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 118.726 -0.654 . . . . 10.0 109.529 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -66.99 -29.42 69.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.113 0.869 . . . . 10.0 112.372 -170.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.72 -34.14 76.28 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.226 0.611 . . . . 10.0 111.257 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -105.74 -27.55 11.23 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.417 0.687 . . . . 10.0 111.862 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt 26.73 62.82 0.56 Allowed Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 128.657 2.783 . . . . 10.0 112.858 -169.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.0 166.91 23.14 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.631 2.22 . . . . 10.0 110.364 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -71.53 120.17 16.73 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.533 -0.914 . . . . 10.0 108.533 165.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.2 mt -124.83 24.37 7.68 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.484 1.514 . . . . 10.0 110.255 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.7 m -63.96 10.8 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 115.803 1.779 . . . . 10.0 115.803 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.33 3.01 4.67 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.849 1.26 . . . . 10.0 112.23 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.1 t -74.66 131.8 34.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.752 -1.573 . . . . 10.0 106.752 165.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -105.31 150.81 24.86 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.29 -1.744 . . . . 10.0 106.29 157.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -145.54 159.36 43.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.273 0.559 . . . . 10.0 111.081 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -113.4 163.14 12.17 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 108.445 -1.862 . . . . 10.0 108.445 162.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.54 130.32 21.6 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.492 1.117 . . . . 10.0 108.299 -172.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 mt -134.78 133.21 54.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 105.866 -1.901 . . . . 10.0 105.866 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -108.65 145.04 16.39 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 108.336 -1.906 . . . . 10.0 108.336 166.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.4 mt -130.52 142.67 43.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.331 -2.1 . . . . 10.0 105.331 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.37 174.36 40.34 Favored Glycine 0 N--CA 1.453 -0.209 0 O-C-N 121.374 -0.829 . . . . 10.0 111.532 169.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.0 m -69.06 104.71 2.2 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.064 -1.088 . . . . 10.0 108.064 168.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -75.74 -10.57 59.55 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.321 0.86 . . . . 10.0 113.321 -163.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -76.62 -12.25 59.98 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.573 1.079 . . . . 10.0 112.236 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -64.17 162.59 14.19 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.185 0.902 . . . . 10.0 111.631 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.75 -34.36 74.32 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.92 0.888 . . . . 10.0 111.924 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 108.505 -0.924 . . . . 10.0 108.505 174.734 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.364 0 CA-C-O 120.685 0.279 . . . . 10.0 110.811 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.5 tp -57.1 -32.31 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.636 1.175 . . . . 10.0 111.691 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -54.96 -38.06 67.28 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.72 0.808 . . . . 10.0 111.933 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.92 -42.25 85.69 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.834 0.453 . . . . 10.0 110.98 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.3 mt -67.68 -49.28 63.6 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.163 -0.68 . . . . 10.0 109.163 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -63.77 -37.9 89.11 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 118.595 -0.717 . . . . 10.0 110.443 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.29 99.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.129 0.877 . . . . 10.0 110.643 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -74.09 -30.36 62.31 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 119.557 1.071 . . . . 10.0 112.043 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.2 mt -61.59 -48.25 81.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.826 1.193 . . . . 10.0 109.315 169.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -59.44 -45.93 90.19 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.724 1.21 . . . . 10.0 110.296 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -62.38 -38.62 90.32 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.822 1.649 . . . . 10.0 111.311 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.0 m -71.81 -11.87 61.01 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.427 1.091 . . . . 10.0 112.632 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.72 -12.64 8.76 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.706 1.146 . . . . 10.0 113.264 169.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.15 169.86 3.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.437 1.118 . . . . 10.0 110.585 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -138.32 145.16 40.85 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.441 -0.787 . . . . 10.0 111.009 168.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -63.18 166.79 5.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.403 -1.271 . . . . 10.0 109.19 172.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.3 m -132.61 153.06 51.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 105.606 -1.998 . . . . 10.0 105.606 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.99 -140.98 47.09 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 110.97 -0.852 . . . . 10.0 110.97 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -133.8 167.69 20.1 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.547 1.539 . . . . 10.0 108.147 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.2 m -82.64 123.22 29.05 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.793 0.837 . . . . 10.0 109.59 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.5 tp -85.48 145.95 27.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 122.636 0.374 . . . . 10.0 110.045 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -110.64 145.4 38.0 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.005 1.722 . . . . 10.0 106.956 169.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.5 mt -140.29 102.92 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.429 -1.693 . . . . 10.0 106.429 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -73.93 135.51 43.26 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.411 -0.589 . . . . 10.0 109.411 173.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.1 pp -128.67 7.75 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.109 0.963 . . . . 10.0 112.805 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.2 tp . . . . . 0 N--CA 1.469 0.489 0 CA-C-N 119.07 0.85 . . . . 10.0 111.3 -177.616 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 110.184 -0.302 . . . . 10.0 110.184 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -56.27 -39.84 73.27 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.987 1.715 . . . . 10.0 112.164 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -67.52 -47.18 70.68 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.01 0.823 . . . . 10.0 109.091 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -61.97 -41.02 97.55 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.389 0.676 . . . . 10.0 110.353 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.3 tp -61.58 -38.99 89.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.802 1.241 . . . . 10.0 110.646 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.07 -50.25 62.74 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.862 -0.895 . . . . 10.0 110.862 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.5 m -60.65 -30.27 69.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.007 0.523 . . . . 10.0 111.786 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -52.87 10.74 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.488 0.715 . . . . 10.0 111.852 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.0 -32.04 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -59.96 -23.53 63.66 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.476 1.111 . . . . 10.0 113.622 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.5 mt -102.06 -44.23 5.52 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 120.139 1.336 . . . . 10.0 111.382 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.95 -27.43 62.78 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.786 -1.102 . . . . 10.0 112.244 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm . . . . . 0 C--O 1.252 1.194 0 C-N-CA 128.672 2.789 . . . . 10.0 113.417 -177.296 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 121.063 0.459 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -76.0 -29.48 58.18 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.136 0.975 . . . . 0.0 110.113 -175.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.8 mt -125.15 74.17 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.1 m -74.81 114.83 13.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.94 155.19 37.69 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 172.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.9 mt -116.95 112.06 37.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 103.829 -2.656 . . . . 0.0 103.829 172.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -113.86 155.55 25.53 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.531 1.532 . . . . 0.0 110.84 -169.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.01 131.21 1.28 Allowed Glycine 0 N--CA 1.448 -0.512 0 O-C-N 121.187 -0.945 . . . . 0.0 111.13 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.0 p . . . . . 0 C--N 1.328 -0.33 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 169.433 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.279 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.79 -27.7 68.47 Favored 'General case' 0 C--O 1.228 -0.075 0 CA-C-N 118.108 0.954 . . . . 0.0 110.702 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -60.48 -27.89 67.92 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.921 0.488 . . . . 0.0 111.029 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -95.89 -51.75 4.34 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.631 0.773 . . . . 0.0 110.426 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.61 -39.22 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.741 -171.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.92 89.08 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.414 1.006 . . . . 0.0 111.04 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -68.24 -41.19 81.57 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.637 0.653 . . . . 0.0 110.144 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -60.45 -49.4 77.73 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.927 0.491 . . . . 0.0 110.276 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.5 mt -60.05 -43.43 95.38 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.523 0.729 . . . . 0.0 110.42 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.83 98.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.976 0.511 . . . . 0.0 110.753 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -66.25 -42.55 88.43 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.129 0.571 . . . . 0.0 110.419 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -59.66 -39.85 85.82 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 121.507 -0.746 . . . . 0.0 111.085 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.3 mt -68.28 -29.22 67.96 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.98 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -65.56 -38.26 89.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.713 1.142 . . . . 0.0 109.875 172.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.81 -39.29 93.34 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.948 0.794 . . . . 0.0 110.496 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.07 -21.83 64.96 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.545 0.738 . . . . 0.0 112.259 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.84 31.09 3.25 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 118.651 -1.083 . . . . 0.0 113.58 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -125.29 148.25 48.78 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.026 1.413 . . . . 0.0 110.055 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 p -71.88 146.28 47.99 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.6 p -139.19 160.06 40.68 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.486 0.66 . . . . 0.0 110.956 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -149.64 161.69 41.69 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 p -134.3 81.41 1.91 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -175.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.63 105.57 3.72 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -78.97 102.67 8.44 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.17 56.58 15.03 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-O 118.348 -1.251 . . . . 0.0 114.589 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -69.24 178.3 4.38 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.043 2.495 . . . . 0.0 110.804 171.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.8 mt -125.03 158.08 34.63 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 169.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -53.53 -31.0 44.45 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.237 1.015 . . . . 0.0 111.134 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -62.45 -10.72 12.51 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.353 1.861 . . . . 0.0 112.736 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -133.87 18.67 3.83 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.393 1.077 . . . . 0.0 110.905 -175.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -134.77 106.08 10.68 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.743 1.217 . . . . 0.0 108.881 -169.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.82 161.52 41.4 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.884 2.39 . . . . 0.0 112.969 -170.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.43 7.38 5.47 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.763 1.625 . . . . 0.0 114.934 -171.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.8 m -146.81 129.72 16.29 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.7 -179.86 27.95 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.4 mt -112.94 101.83 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -99.55 168.78 9.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.3 tp -146.83 112.69 5.72 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -98.36 134.45 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -169.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 mp -132.78 125.11 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.8 p -138.6 143.2 39.24 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.945 1.298 . . . . 0.0 107.82 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.1 p -77.04 175.41 9.62 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 169.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.9 m -130.7 123.43 29.29 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 169.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -69.07 -22.2 64.03 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 159.56 -35.53 0.47 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 118.696 0.68 . . . . 0.0 113.37 170.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.78 22.87 8.09 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.124 0.969 . . . . 0.0 112.153 -169.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.75 -1.1 56.67 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 123.936 0.779 . . . . 0.0 113.094 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.5 114.67 8.84 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.301 1.051 . . . . 0.0 109.582 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.7 mt -68.91 147.8 97.86 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 125.643 1.577 . . . . 0.0 107.795 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -56.54 137.61 81.32 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.113 3.209 . . . . 0.0 112.38 175.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -63.93 -22.31 66.86 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -169.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -71.55 -24.42 61.93 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.713 -0.617 . . . . 0.0 111.941 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.6 tp -121.92 -24.76 5.13 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.279 1.032 . . . . 0.0 111.771 -169.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.0 p -55.12 -28.21 3.91 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 116.924 -1.512 . . . . 0.0 114.939 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -53.4 -24.55 28.16 Favored 'Trans proline' 0 C--N 1.354 0.86 0 CA-C-N 122.903 2.073 . . . . 0.0 114.716 169.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -62.02 -43.92 97.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.58 1.082 . . . . 0.0 110.673 175.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -60.96 -40.01 91.7 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.866 0.866 . . . . 0.0 110.101 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -68.77 -48.37 63.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.853 0.461 . . . . 0.0 110.54 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.06 -28.59 67.51 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.464 -0.772 . . . . 0.0 112.37 -176.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.1 mt -67.6 -57.74 5.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.722 -0.656 . . . . 0.0 109.385 171.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -67.25 -29.2 68.77 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.06 0.846 . . . . 0.0 112.071 -171.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.82 -31.0 71.34 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.136 0.574 . . . . 0.0 110.775 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -115.09 -23.21 9.13 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -169.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.4 tttt 37.74 66.11 2.46 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.67 1.588 . . . . 0.0 110.796 -169.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.32 168.82 10.46 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.687 2.258 . . . . 0.0 110.696 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -92.68 107.2 19.04 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 169.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.423 ' C ' ' H ' ' A' ' 82' ' ' ALA . 52.5 mt -120.02 26.15 9.46 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.262 1.825 . . . . 0.0 110.045 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -61.58 18.62 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.318 1.847 . . . . 0.0 115.424 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.423 ' H ' ' C ' ' A' ' 80' ' ' LEU . . . -140.77 3.19 1.84 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.265 1.426 . . . . 0.0 111.855 174.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.7 t -79.53 140.46 16.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.5 mmm-85 -123.79 138.4 54.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 168.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -134.39 170.87 15.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.895 0.378 . . . . 0.0 110.653 -172.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.14 162.86 23.09 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 105.347 -3.101 . . . . 0.0 105.347 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.89 124.55 11.81 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.401 1.101 . . . . 0.0 109.446 -170.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.6 mt -133.73 124.27 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -100.7 156.73 19.34 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.4 mt -134.9 139.11 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.17 -151.42 13.74 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.6 m -126.02 135.36 51.71 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.727 1.211 . . . . 0.0 108.517 -175.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -66.72 -10.25 44.95 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.78 -15.03 58.25 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.979 0.809 . . . . 0.0 112.359 171.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -64.32 148.68 49.76 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.381 0.991 . . . . 0.0 110.847 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.65 -34.22 77.7 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.511 0.725 . . . . 0.0 111.392 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.8 m . . . . . 0 CA--C 1.536 0.42 0 C-N-CA 125.73 1.612 . . . . 0.0 107.467 179.133 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -29.7 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.964 0.905 . . . . 0.0 109.444 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -54.75 -34.18 62.2 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.104 0.962 . . . . 0.0 112.071 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -81.58 -37.83 27.07 Favored 'General case' 0 C--O 1.232 0.14 0 O-C-N 121.731 -0.606 . . . . 0.0 110.189 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.5 mt -57.89 -50.88 71.81 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -70.58 -32.98 70.57 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.394 -174.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.28 80.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.315 0.507 . . . . 0.0 110.103 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -79.79 -28.88 40.23 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.03 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.0 -45.75 84.25 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.379 1.445 . . . . 0.0 109.578 170.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -71.27 -33.66 69.97 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.469 0.577 . . . . 0.0 111.266 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -61.23 -39.66 91.09 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.178 0.591 . . . . 0.0 110.537 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.6 m -72.03 -7.82 50.98 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.221 1.008 . . . . 0.0 113.13 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.24 -14.93 10.15 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.644 1.116 . . . . 0.0 114.102 169.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.19 173.52 1.94 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.573 1.187 . . . . 0.0 111.341 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -143.83 148.1 35.04 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.019 -1.051 . . . . 0.0 112.153 170.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -58.78 158.55 7.94 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.376 1.87 . . . . 0.0 109.851 173.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.8 m -139.88 163.33 32.94 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.465 1.906 . . . . 0.0 106.087 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.35 -135.25 48.07 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -173.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -146.5 150.18 35.07 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 169.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.2 m -61.76 149.48 39.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.125 1.37 . . . . 0.0 111.176 -171.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.3 tp -129.81 151.21 50.64 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.343 1.057 . . . . 0.0 110.388 -173.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -119.87 150.4 40.51 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 23.5 mm -131.68 100.47 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -78.33 126.47 30.83 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 118.682 -0.675 . . . . 0.0 109.363 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.57 9.46 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.768 0.827 . . . . 0.0 112.152 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.1 tp . . . . . 0 N--CA 1.469 0.479 0 C-N-CA 126.067 1.747 . . . . 0.0 113.685 -174.228 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -56.33 -42.76 78.21 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.261 0.937 . . . . 0.0 112.041 -169.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -69.45 -40.3 77.24 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.999 -0.438 . . . . 0.0 110.453 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -72.36 -35.48 68.51 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.642 0.777 . . . . 0.0 110.58 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.97 -35.14 77.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.459 0.704 . . . . 0.0 109.958 170.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.47 -47.18 57.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.387 0.994 . . . . 0.0 111.177 169.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.8 m -62.59 -38.22 89.28 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 122.081 -0.658 . . . . 0.0 111.132 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -53.48 50.22 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.087 175.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.9 m -62.89 -31.25 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 119.799 1.182 . . . . 0.0 111.188 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -62.82 -27.03 69.04 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.593 -0.718 . . . . 0.0 112.669 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.2 mt -106.37 -37.09 6.63 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.216 0.917 . . . . 0.0 112.93 -176.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 pp -73.03 -12.59 60.98 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.465 1.03 . . . . 0.0 112.171 172.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.018 0 C-N-CA 129.451 3.1 . . . . 0.0 112.645 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.246 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -136.97 -25.37 1.08 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.79 1.236 . . . . 0.0 111.085 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.4 mt -130.52 82.38 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.0 m -75.23 121.15 21.72 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.9 mp -85.41 152.19 23.42 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.312 0.645 . . . . 0.0 109.711 174.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.8 mt -123.49 93.28 2.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 126.294 1.837 . . . . 0.0 106.161 -175.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -72.95 155.7 39.6 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.558 1.143 . . . . 0.0 110.862 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.2 65.17 0.26 Allowed Glycine 0 C--N 1.34 0.801 0 N-CA-C 114.239 0.456 . . . . 0.0 114.239 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.455 -0.211 0 C-N-CA 124.52 1.128 . . . . 0.0 110.595 174.029 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.566 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.6 -28.25 68.36 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 117.51 0.655 . . . . 0.0 111.231 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -68.62 -44.8 73.5 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -70.55 -46.02 64.33 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.386 0.675 . . . . 0.0 109.94 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.9 t -62.15 -38.52 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 118.451 -0.785 . . . . 0.0 110.101 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.17 97.82 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.693 1.133 . . . . 0.0 110.777 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -63.49 -41.42 98.56 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.594 0.634 . . . . 0.0 110.551 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -63.85 -43.3 96.55 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.941 -0.474 . . . . 0.0 111.125 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.4 mt -63.78 -43.81 95.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.546 0.738 . . . . 0.0 109.666 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.33 -37.8 78.72 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.422 0.689 . . . . 0.0 111.219 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -52.55 -44.68 66.0 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.847 0.748 . . . . 0.0 110.482 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt -68.33 -37.54 80.63 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.834 -0.541 . . . . 0.0 109.813 -175.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.1 mt -68.09 -38.61 82.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.262 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.83 -38.57 89.26 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.361 0.528 . . . . 0.0 110.329 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.04 -37.05 84.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.599 0.636 . . . . 0.0 110.98 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.27 -26.0 66.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.972 0.509 . . . . 0.0 111.67 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.86 -3.88 10.77 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.32 1.438 . . . . 0.0 113.743 169.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -78.9 146.4 33.58 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.924 1.362 . . . . 0.0 109.981 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 p -83.5 146.6 28.28 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 169.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.2 p -134.43 169.29 17.47 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.806 0.842 . . . . 0.0 109.943 -170.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.1 158.73 44.41 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 169.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.4 m -130.42 81.96 2.03 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.9 mt -75.94 116.41 16.61 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -74.88 94.48 2.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.0 57.2 19.41 Favored Glycine 0 CA--C 1.54 1.635 0 CA-C-O 118.797 -1.001 . . . . 0.0 114.437 172.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.35 179.01 4.33 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.338 2.692 . . . . 0.0 111.297 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.8 mt -114.38 151.16 33.52 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 169.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -61.21 -28.89 69.47 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.348 0.659 . . . . 0.0 111.747 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.99 -21.59 63.68 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 175.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -82.89 -7.02 59.7 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.697 0.799 . . . . 0.0 111.812 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.1 mt -113.91 145.07 32.75 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 124.359 1.063 . . . . 0.0 109.989 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -70.15 162.89 40.57 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.758 2.305 . . . . 0.0 110.725 169.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.37 23.65 0.6 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.179 1.392 . . . . 0.0 112.024 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 m -156.37 142.87 18.48 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.352 1.461 . . . . 0.0 107.832 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 150.33 179.98 26.57 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.7 mt -122.24 101.74 10.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -107.12 170.59 7.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.535 1.134 . . . . 0.0 109.051 -175.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.8 tp -149.45 121.88 8.49 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.0 t -111.6 138.3 40.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -169.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -134.43 138.57 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.9 m -139.75 145.34 38.15 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.507 1.123 . . . . 0.0 109.213 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -99.21 95.72 7.27 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.752 0.786 . . . . 0.0 109.911 174.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.3 m -58.54 135.42 57.31 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 169.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.4 p-80 -136.01 41.59 2.65 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.986 1.314 . . . . 0.0 108.961 -174.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.43 -35.37 2.43 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.765 1.65 . . . . 0.0 113.118 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.61 -21.03 66.13 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.058 1.343 . . . . 0.0 113.975 -171.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.11 33.78 64.95 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -172.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -141.42 149.92 41.66 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.319 1.048 . . . . 0.0 108.482 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.2 mp -69.3 148.2 97.32 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -55.44 153.08 29.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.411 2.741 . . . . 0.0 112.635 169.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.77 -19.14 25.89 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.833 1.253 . . . . 0.0 114.003 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -63.15 -36.63 84.27 Favored 'General case' 0 C--N 1.343 0.289 0 O-C-N 121.801 -0.562 . . . . 0.0 110.591 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.2 tp -127.16 -18.25 4.6 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.883 -169.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.6 p -52.66 -32.43 9.51 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.54 -21.4 18.72 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.131 2.554 . . . . 0.0 115.773 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -56.82 -32.31 65.6 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.187 0.995 . . . . 0.0 110.96 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -62.79 -51.2 68.0 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -62.2 -42.98 99.79 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.027 0.531 . . . . 0.0 109.906 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.11 -27.52 68.43 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.445 0.698 . . . . 0.0 112.591 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 mt -75.94 -20.84 57.62 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.21 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -93.95 -41.78 9.41 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.038 1.29 . . . . 0.0 109.062 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -60.22 -36.54 77.92 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.105 0.962 . . . . 0.0 110.208 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -107.61 -37.11 6.26 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.089 0.555 . . . . 0.0 112.426 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm 27.31 64.3 0.59 Allowed Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 126.853 2.061 . . . . 0.0 113.355 -169.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -59.3 160.52 19.33 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.297 1.998 . . . . 0.0 111.276 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.35 50.72 1.12 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.978 1.311 . . . . 0.0 109.965 173.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 82' ' ' ALA . 3.8 pp -74.66 34.98 0.1 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.279 1.831 . . . . 0.0 114.168 -169.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -61.75 23.42 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 128.699 2.8 . . . . 0.0 114.745 171.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 80' ' ' LEU . . . -140.06 0.07 1.71 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.886 1.675 . . . . 0.0 111.672 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.6 t -82.47 147.97 5.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 169.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -126.29 141.34 51.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 168.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -140.01 175.38 9.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.225 0.536 . . . . 0.0 110.4 -172.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.07 164.92 26.09 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 106.631 -2.588 . . . . 0.0 106.631 169.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.69 124.89 15.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -169.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.8 mt -133.71 128.08 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 -177.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.66 120.33 5.37 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 107.576 -2.21 . . . . 0.0 107.576 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.9 mt -94.67 152.43 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 169.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 169.81 -144.01 8.26 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 172.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.2 m -132.59 127.69 35.57 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.38 -11.13 60.56 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.699 -0.626 . . . . 0.0 112.124 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.08 -28.44 69.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.513 0.725 . . . . 0.0 111.129 169.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -66.1 145.37 55.91 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 118.87 0.759 . . . . 0.0 109.479 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.98 -35.38 80.52 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 168.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 CA--C 1.544 0.736 0 C-N-CA 128.086 2.554 . . . . 0.0 109.138 169.592 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.446 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 tp -56.28 -28.63 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.02 1.728 . . . . 0.0 110.723 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -53.03 -37.46 61.56 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.77 0.828 . . . . 0.0 112.73 -173.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -65.23 -42.19 93.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 118.785 0.72 . . . . 0.0 111.458 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.7 mt -68.76 -50.74 47.95 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -37.06 81.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.729 -170.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.4 -35.48 79.37 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.58 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -72.76 -31.24 64.76 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.471 1.032 . . . . 0.0 111.978 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.2 mt -62.13 -44.8 95.84 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 120.77 1.623 . . . . 0.0 108.749 169.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -61.44 -44.6 96.84 Favored 'General case' 0 C--N 1.335 -0.055 0 C-N-CA 124.037 0.935 . . . . 0.0 110.057 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -65.26 -43.34 91.58 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.917 1.287 . . . . 0.0 110.891 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m -68.07 -27.07 66.18 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 119.204 -0.427 . . . . 0.0 111.286 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.94 -32.69 0.38 Allowed Glycine 0 CA--C 1.529 0.929 0 CA-C-N 118.987 0.812 . . . . 0.0 115.002 169.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.61 177.51 0.52 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.807 1.243 . . . . 0.0 113.498 -171.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -138.49 147.31 43.04 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.689 -0.632 . . . . 0.0 110.687 169.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -64.55 166.45 8.53 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.837 1.255 . . . . 0.0 109.404 175.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 m -137.88 153.06 49.59 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.286 1.834 . . . . 0.0 106.189 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 56.08 -139.1 44.18 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -170.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -137.44 157.02 47.48 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.4 145.98 52.57 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.589 1.156 . . . . 0.0 110.074 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.3 tp -120.42 138.85 53.55 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.563 0.745 . . . . 0.0 109.26 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -101.72 141.3 34.79 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 53.0 mt -130.7 136.21 58.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 175.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -125.78 96.03 4.63 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.567 1.547 . . . . 0.0 109.279 -169.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.4 pp -80.48 -3.98 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 O-C-N 121.433 -0.792 . . . . 0.0 112.668 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.3 tp . . . . . 0 CA--C 1.534 0.361 0 C-N-CA 123.846 0.858 . . . . 0.0 112.124 178.907 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 119.582 -0.247 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.55 -42.07 98.3 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.373 0.669 . . . . 0.0 110.411 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -76.88 -40.94 45.79 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.348 0.659 . . . . 0.0 109.703 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 -64.11 -42.15 96.98 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.928 0.491 . . . . 0.0 110.612 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 15.6 tp -66.57 -27.62 67.87 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.72 -0.612 . . . . 0.0 110.451 174.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.97 -48.37 82.99 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 169.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.6 m -63.68 -35.2 79.77 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.736 -0.861 . . . . 0.0 111.129 175.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 38.4 t90 -63.23 -50.68 69.28 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.211 0.605 . . . . 0.0 110.461 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 32.0 m -68.24 -29.21 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 121.214 -0.929 . . . . 0.0 111.444 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -60.71 -21.6 63.08 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.504 -0.76 . . . . 0.0 112.003 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.2 mt -101.77 -32.01 10.49 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 117.963 -1.018 . . . . 0.0 112.664 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.47 -28.35 66.01 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.471 1.487 . . . . 0.0 111.485 173.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttm . . . . . 0 C--O 1.251 1.167 0 C-N-CA 128.321 2.649 . . . . 0.0 111.596 -177.902 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.222 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -79.36 -31.18 42.87 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.967 0.907 . . . . 0.0 109.898 -172.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.7 mt -122.32 70.02 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.7 m -68.4 116.46 8.99 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.7 mt -86.09 155.09 20.95 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.0 mt -123.14 90.62 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -172.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.6 m -77.62 129.07 35.14 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.153 0.981 . . . . 0.0 110.619 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.0 60.99 0.66 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 124.637 1.113 . . . . 0.0 113.123 -169.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.8 p . . . . . 0 N--CA 1.453 -0.275 0 CA-C-N 117.515 0.658 . . . . 0.0 109.894 169.431 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.915 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.34 -34.01 76.43 Favored 'General case' 0 C--O 1.227 -0.128 0 O-C-N 122.065 -0.667 . . . . 0.0 110.487 175.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.13 -39.84 86.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.676 0.671 . . . . 0.0 110.332 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -66.46 -46.28 76.95 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.996 0.918 . . . . 0.0 109.012 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.99 -49.19 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.88 87.59 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.927 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.57 -44.25 94.64 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.139 0.881 . . . . 0.0 111.101 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -68.91 -41.82 77.68 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.949 -0.469 . . . . 0.0 110.852 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.42 -42.05 98.72 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.66 96.33 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.769 0.828 . . . . 0.0 110.753 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -58.38 -42.87 88.01 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.595 0.634 . . . . 0.0 110.362 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -67.2 -39.61 86.36 Favored 'General case' 0 N--CA 1.461 0.109 0 O-C-N 121.738 -0.601 . . . . 0.0 111.179 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 mt -62.25 -37.64 86.2 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.54 0.609 . . . . 0.0 111.259 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.41 -38.44 87.47 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.092 0.86 . . . . 0.0 110.283 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -66.24 -35.77 81.28 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.609 0.64 . . . . 0.0 110.888 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.6 -26.79 66.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.085 0.554 . . . . 0.0 111.644 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.44 -3.36 10.32 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.269 1.414 . . . . 0.0 113.928 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -81.07 148.31 29.73 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.059 1.43 . . . . 0.0 110.342 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 p -79.05 144.42 34.65 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 169.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.8 p -140.64 163.96 31.48 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.284 0.634 . . . . 0.0 111.036 -176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -150.47 151.62 32.99 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 105.437 -2.06 . . . . 0.0 105.437 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 p -108.81 73.15 0.85 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.32 104.01 6.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -169.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -73.25 121.54 20.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.15 51.85 29.14 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 117.89 -1.505 . . . . 0.0 116.759 169.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -67.23 175.84 5.35 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 CA-C-N 120.735 2.268 . . . . 0.0 111.368 170.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 mt -128.62 168.94 15.03 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.687 1.595 . . . . 0.0 108.659 171.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.38 -37.74 67.95 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.083 0.953 . . . . 0.0 110.902 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.36 -3.46 14.25 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.15 0.98 . . . . 0.0 113.294 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -125.17 9.33 8.0 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.919 1.288 . . . . 0.0 112.332 -170.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.45 149.78 52.29 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 124.127 0.971 . . . . 0.0 110.552 169.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.31 164.28 29.15 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.745 2.297 . . . . 0.0 111.471 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.67 21.19 0.84 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.204 1.402 . . . . 0.0 112.9 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.6 p -153.12 143.66 22.62 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.575 1.15 . . . . 0.0 108.772 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.19 -176.72 27.82 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.22 93.25 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -96.54 169.18 10.07 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.718 0.807 . . . . 0.0 109.796 -172.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.0 tp -135.39 124.14 23.86 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.73 130.48 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.53 121.04 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.4 m -138.4 133.07 32.4 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.307 0.643 . . . . 0.0 109.41 -169.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -77.13 163.85 26.22 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 169.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.0 m -114.35 119.04 35.58 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -66.69 -30.04 70.19 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.402 0.281 . . . . 0.0 110.965 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.49 -35.09 0.34 Allowed Glycine 0 CA--C 1.526 0.777 0 C-N-CA 123.791 0.71 . . . . 0.0 112.81 171.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.09 23.83 7.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.24 1.016 . . . . 0.0 112.192 -173.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.01 -3.62 60.47 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.196 -0.78 . . . . 0.0 113.098 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.29 149.18 47.66 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.448 1.124 . . . . 0.0 109.71 170.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.7 mt -113.71 144.27 31.11 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 126.043 1.737 . . . . 0.0 107.096 -169.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -48.72 139.94 23.46 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 124.223 3.282 . . . . 0.0 114.381 172.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -59.46 -21.56 60.25 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.634 1.574 . . . . 0.0 113.858 -172.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -67.35 -29.63 69.22 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.305 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.0 tp -127.64 -22.11 3.66 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.607 0.763 . . . . 0.0 112.049 -171.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 92.1 p -53.2 -31.66 8.3 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -52.1 -24.05 18.97 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.203 2.602 . . . . 0.0 115.278 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -58.5 -35.58 72.44 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.162 0.892 . . . . 0.0 110.773 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -62.45 -42.76 99.7 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.779 0.718 . . . . 0.0 110.484 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -68.89 -48.05 64.34 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.354 0.662 . . . . 0.0 109.286 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.28 -35.25 79.91 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 118.969 -0.539 . . . . 0.0 111.788 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.0 mt -65.72 -53.07 45.84 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.777 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -70.03 -28.34 65.39 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.337 0.972 . . . . 0.0 112.035 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.01 -35.03 77.63 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.515 0.598 . . . . 0.0 110.825 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -109.25 -33.64 6.8 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -169.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp 30.53 57.22 0.89 Allowed Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 127.385 2.274 . . . . 0.0 113.119 -172.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -69.3 172.0 12.97 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.169 1.913 . . . . 0.0 110.029 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -71.75 106.66 4.21 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.912 -0.493 . . . . 0.0 110.077 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.412 ' C ' ' H ' ' A' ' 82' ' ' ALA . 73.1 mt -113.0 20.43 16.37 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.601 1.56 . . . . 0.0 110.899 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 m -63.31 19.97 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.957 1.703 . . . . 0.0 115.548 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 80' ' ' LEU . . . -135.28 0.1 2.77 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.208 1.403 . . . . 0.0 111.762 173.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 64.5 t -82.13 133.78 28.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -108.99 142.78 39.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 103.444 -2.798 . . . . 0.0 103.444 168.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -136.41 168.35 19.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 119.13 0.877 . . . . 0.0 111.354 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.16 163.48 23.53 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 105.561 -3.015 . . . . 0.0 105.561 169.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.06 124.4 13.04 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -169.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 52.1 mt -133.38 133.25 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.62 150.47 18.01 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.4 mt -139.79 150.44 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.35 -45.77 0.49 Allowed Glycine 0 C--N 1.33 0.237 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 169.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.2 m 115.01 140.92 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 1 C-N-CA 132.08 4.152 . . . . 0.0 108.056 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -67.81 0.84 2.97 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -63.62 -30.58 71.67 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.719 0.808 . . . . 0.0 109.994 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -70.8 156.43 39.55 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.467 0.707 . . . . 0.0 110.853 174.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.14 -37.5 83.06 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.659 0.783 . . . . 0.0 111.785 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.6 m . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 172.115 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.0 tp -57.93 -28.11 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.755 1.222 . . . . 0.0 110.834 175.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -52.3 -38.68 59.1 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.194 0.997 . . . . 0.0 112.288 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -73.52 -41.12 63.44 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 121.84 -0.537 . . . . 0.0 110.489 -174.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 50.0 mt -64.2 -51.56 63.12 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.17 -38.67 82.31 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -169.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.35 75.23 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 122.049 -0.407 . . . . 0.0 110.576 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -74.13 -31.06 62.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.708 0.685 . . . . 0.0 110.691 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.88 -43.34 96.36 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.429 1.013 . . . . 0.0 108.885 169.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -61.98 -43.79 98.1 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.842 0.457 . . . . 0.0 109.826 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -64.28 -35.92 82.41 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.441 0.696 . . . . 0.0 111.132 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.5 m -71.47 -7.39 47.15 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.164 0.986 . . . . 0.0 112.927 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.85 -17.49 10.85 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.765 1.174 . . . . 0.0 113.787 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.2 171.61 1.29 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.266 1.033 . . . . 0.0 111.158 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -142.5 153.4 43.59 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 121.114 -0.991 . . . . 0.0 111.714 172.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -71.24 156.62 39.33 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.362 174.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 66.2 m -128.0 151.74 48.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.819 2.048 . . . . 0.0 106.675 169.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 62.0 -146.19 49.11 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -172.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -135.44 156.4 48.97 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.647 1.179 . . . . 0.0 108.206 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.66 152.64 45.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.986 1.314 . . . . 0.0 110.462 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.8 tp -129.98 144.17 51.19 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.443 1.097 . . . . 0.0 108.826 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -115.52 153.83 30.46 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 169.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 38.1 mt -134.76 109.14 11.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -172.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -77.63 135.9 38.17 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.555 0.742 . . . . 0.0 109.353 170.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 46.5 pt -129.23 -15.69 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.945 1.698 . . . . 0.0 112.131 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.2 mt . . . . . 0 N--CA 1.467 0.388 0 CA-C-N 119.121 0.873 . . . . 0.0 112.761 -170.06 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.136 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -62.37 -44.61 96.05 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.022 0.529 . . . . 0.0 110.363 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -62.44 -49.77 74.11 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.666 0.386 . . . . 0.0 110.306 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 9.1 t-105 -67.95 -36.25 79.79 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 122.172 -0.33 . . . . 0.0 110.871 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.35 -41.38 93.54 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 118.906 -0.569 . . . . 0.0 110.032 173.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.81 -49.85 60.35 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 173.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.7 m -62.05 -36.6 82.1 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.161 0.584 . . . . 0.0 111.261 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 21.0 t90 -66.36 -53.05 40.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 119.137 -0.459 . . . . 0.0 110.124 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.1 m -66.21 -29.88 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 118.997 0.817 . . . . 0.0 111.514 -176.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -54.36 -25.33 23.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.89 0.876 . . . . 0.0 112.314 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 29.5 mt -100.29 -0.26 38.83 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.255 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.9 pp -124.71 -8.8 7.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.218 1.372 . . . . 0.0 113.59 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 71.8 mttt . . . . . 0 C--O 1.252 1.189 0 CA-C-N 119.542 1.065 . . . . 0.0 110.73 178.256 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -75.72 -30.84 59.41 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.812 0.845 . . . . 0.0 109.949 -171.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.0 mt -124.96 74.71 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 m -74.45 114.1 12.45 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 mp -74.27 155.03 38.68 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.0 mt -122.4 86.53 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 m -81.21 157.14 25.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.44 1.496 . . . . 0.0 111.722 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.0 135.26 1.92 Allowed Glycine 0 N--CA 1.444 -0.795 0 O-C-N 121.204 -0.935 . . . . 0.0 110.934 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 31.2 p . . . . . 0 C--N 1.329 -0.283 0 C-N-CA 123.723 0.809 . . . . 0.0 111.943 169.018 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.696 0 CA-C-O 119.791 -0.449 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.02 -21.17 66.39 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.184 0.992 . . . . 0.0 111.139 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.61 -35.8 77.03 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.206 0.602 . . . . 0.0 110.409 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -71.82 -40.22 69.28 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 122.062 -0.398 . . . . 0.0 110.155 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.97 -39.31 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.98 99.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.273 0.629 . . . . 0.0 110.084 175.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.19 -42.1 98.97 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.741 0.7 . . . . 0.0 110.571 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -61.51 -48.25 81.91 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.429 0.559 . . . . 0.0 110.814 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.0 mt -59.67 -46.3 89.47 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.343 0.657 . . . . 0.0 109.988 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.32 87.19 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.911 0.884 . . . . 0.0 111.397 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 -68.96 -45.52 70.49 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.567 0.747 . . . . 0.0 109.82 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -61.97 -41.3 97.85 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.363 0.528 . . . . 0.0 110.499 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.0 mt -62.72 -37.59 87.14 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.008 0.523 . . . . 0.0 111.396 173.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -67.15 -38.67 85.9 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.692 0.678 . . . . 0.0 110.373 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.54 -35.55 81.18 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.872 0.469 . . . . 0.0 110.839 173.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.89 -28.0 68.63 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.408 0.549 . . . . 0.0 111.335 172.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.39 -8.76 6.23 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.984 1.278 . . . . 0.0 114.155 169.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -80.0 143.76 33.83 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.962 1.381 . . . . 0.0 110.029 -174.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 p -70.95 141.05 51.09 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 169.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.8 p -134.91 159.44 41.43 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.143 0.497 . . . . 0.0 111.624 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -152.18 162.99 40.3 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -135.71 79.29 1.77 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.67 113.56 13.26 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -82.76 110.63 17.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.25 51.97 56.03 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-O 118.018 -1.434 . . . . 0.0 115.613 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -67.49 178.05 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.954 2.436 . . . . 0.0 111.322 170.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.0 mt -131.04 163.61 27.22 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 125.453 1.501 . . . . 0.0 109.56 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.3 tp -59.91 -36.18 76.44 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.656 1.182 . . . . 0.0 111.216 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.63 -3.79 10.04 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -134.56 22.63 3.67 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.783 1.633 . . . . 0.0 110.567 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.3 mt -137.41 123.1 12.93 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 125.286 1.434 . . . . 0.0 108.102 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.41 159.61 48.86 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.201 1.934 . . . . 0.0 110.486 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.02 17.23 1.26 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.586 1.155 . . . . 0.0 113.256 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.1 m -146.02 132.48 19.7 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.477 1.111 . . . . 0.0 108.429 -174.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 153.28 178.53 27.93 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.35 94.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -91.73 168.55 11.39 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.248 0.619 . . . . 0.0 109.402 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.3 tp -146.23 105.92 3.97 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.8 t -91.19 147.77 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -172.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.14 140.71 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 m -151.09 150.85 31.18 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.568 1.147 . . . . 0.0 108.623 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.6 m -69.62 159.29 33.7 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.044 0.45 . . . . 0.0 111.871 174.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.57 63.72 1.51 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 168.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -84.19 23.19 1.1 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.905 1.682 . . . . 0.0 110.855 -169.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.6 -13.48 41.41 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.484 1.04 . . . . 0.0 113.027 -170.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.86 -29.23 63.03 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.729 1.265 . . . . 0.0 112.916 -176.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.09 33.12 78.14 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.008 0.814 . . . . 0.0 112.003 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -144.43 149.12 35.52 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.081 1.352 . . . . 0.0 107.683 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.4 mt -64.91 142.12 98.55 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -170.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.39 143.49 93.61 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.187 1.924 . . . . 0.0 110.939 -176.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.29 -28.48 58.88 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -169.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -70.83 -25.18 62.72 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 122.018 -0.426 . . . . 0.0 112.03 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.8 tp -120.5 -23.46 6.1 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.534 1.134 . . . . 0.0 111.832 -169.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 89.0 p -54.58 -30.32 6.67 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -52.21 -24.92 21.9 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.529 2.153 . . . . 0.0 114.598 169.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -60.26 -45.46 93.2 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.412 1.005 . . . . 0.0 110.542 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -64.43 -36.67 84.91 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.91 0.484 . . . . 0.0 110.661 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -65.35 -45.95 82.12 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.15 0.432 . . . . 0.0 110.183 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.51 -41.21 93.44 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.724 -0.61 . . . . 0.0 111.188 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.8 mt -60.42 -52.23 66.12 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.431 0.692 . . . . 0.0 110.334 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -70.92 -27.83 64.06 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.565 0.621 . . . . 0.0 111.505 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.82 -51.59 46.81 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.845 0.748 . . . . 0.0 109.686 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -85.17 -24.01 28.11 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.629 -169.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm 41.71 60.1 8.96 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.143 1.377 . . . . 0.0 111.166 -171.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -68.43 176.62 5.5 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.771 2.981 . . . . 0.0 111.971 -174.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -106.6 107.24 18.16 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 169.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.7 mt -119.62 24.38 10.65 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 126.44 1.896 . . . . 0.0 110.058 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.7 m -52.83 -10.2 0.15 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.89 -1.68 13.8 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.488 1.115 . . . . 0.0 111.222 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.0 t -80.91 141.99 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 168.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.92 146.97 50.81 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 168.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -137.9 171.71 14.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.295 0.569 . . . . 0.0 112.17 -169.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.52 167.48 26.17 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 105.64 -2.984 . . . . 0.0 105.64 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.69 134.41 19.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.653 0.727 . . . . 0.0 109.649 -169.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.7 mm -128.14 132.77 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.05 130.48 9.65 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 173.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -127.37 126.07 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -172.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 171.22 -141.64 6.57 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -169.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.9 m -115.94 99.21 7.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.172 0.989 . . . . 0.0 108.759 -171.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -13.06 57.97 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.295 0.638 . . . . 0.0 112.561 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -56.76 -28.26 60.9 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.969 0.908 . . . . 0.0 111.002 169.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -123.25 -31.56 3.55 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.522 1.129 . . . . 0.0 110.914 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.7 t70 66.57 -16.31 0.13 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 129.608 3.163 . . . . 0.0 114.859 172.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.552 1.047 0 C-N-CA 126.635 1.974 . . . . 0.0 112.36 -177.742 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.558 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 tp -141.15 -34.1 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.028 1.331 . . . . 0.0 109.772 172.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -50.97 -36.01 36.7 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.322 1.049 . . . . 0.0 112.492 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -71.68 -55.35 7.88 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.59 -0.694 . . . . 0.0 110.676 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 pp -65.04 -40.51 94.91 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -72.1 -39.25 69.04 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -172.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.69 -30.64 70.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 119.05 -0.5 . . . . 0.0 110.431 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -70.83 -33.56 70.79 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.207 0.912 . . . . 0.0 110.912 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.1 mt -64.0 -40.82 97.21 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.129 1.332 . . . . 0.0 109.235 169.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -63.42 -43.43 97.51 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -63.04 -38.71 92.29 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.708 0.803 . . . . 0.0 110.762 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.6 m -67.9 -10.62 54.68 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.986 0.914 . . . . 0.0 112.75 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.56 -18.17 8.22 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.013 1.292 . . . . 0.0 113.606 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.24 175.79 0.89 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.371 1.086 . . . . 0.0 111.522 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -146.62 159.66 43.17 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.362 -0.836 . . . . 0.0 109.784 169.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -73.46 168.14 19.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.534 1.134 . . . . 0.0 109.473 175.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 m -133.25 145.27 50.37 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 127.105 2.162 . . . . 0.0 106.237 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.58 -133.12 52.8 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -173.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -140.99 160.12 40.75 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.355 1.862 . . . . 0.0 106.149 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.58 157.89 16.38 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.086 1.354 . . . . 0.0 111.033 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 51.4 tp -126.86 149.84 49.53 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.86 0.864 . . . . 0.0 109.333 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -116.33 147.93 41.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 172.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 25.7 mm -132.89 138.73 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -108.94 133.98 52.21 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.664 1.186 . . . . 0.0 108.802 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.7 pp -127.1 4.96 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.868 1.267 . . . . 0.0 111.273 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.4 tp . . . . . 0 CA--C 1.532 0.253 0 C-N-CA 123.435 0.694 . . . . 0.0 111.872 -177.704 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.299 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.64 -37.83 73.99 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.681 0.792 . . . . 0.0 111.242 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -69.74 -38.57 76.87 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.848 -0.533 . . . . 0.0 110.494 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -65.52 -43.04 91.3 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.619 0.368 . . . . 0.0 110.063 172.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 28.2 tp -60.6 -39.46 88.22 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.3 0.64 . . . . 0.0 110.498 -173.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.15 -48.88 65.7 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.6 m -65.31 -35.98 82.67 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.047 -0.678 . . . . 0.0 111.148 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 17.1 t90 -66.18 -51.16 60.41 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.3 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.0 m -65.78 -28.98 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 119.128 0.876 . . . . 0.0 111.528 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -57.65 -24.23 55.51 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.808 -0.615 . . . . 0.0 112.169 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.5 mt -102.04 3.08 38.41 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 pp -124.6 -10.21 7.36 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.717 1.144 . . . . 0.0 113.24 174.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.249 1.036 0 C-N-CA 125.845 1.658 . . . . 0.0 112.188 -179.958 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.332 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -131.82 -28.43 1.79 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.487 1.515 . . . . 0.0 110.404 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.1 mt -123.93 84.51 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 169.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.5 m -75.94 109.55 9.66 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.74 154.39 38.41 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 89.1 mt -126.85 88.81 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 m -69.55 145.87 52.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.113 1.365 . . . . 0.0 109.933 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.07 49.82 0.66 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.411 0.529 . . . . 0.0 114.064 -169.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.234 0.252 0 C-N-CA 124.677 1.191 . . . . 0.0 108.138 169.408 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.271 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.8 -42.17 95.24 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 122.673 0.389 . . . . 0.0 109.974 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -67.44 -31.8 72.24 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.024 0.93 . . . . 0.0 112.082 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -70.18 -46.66 64.15 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.3 t -68.43 -35.65 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 118.998 -0.525 . . . . 0.0 109.723 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.09 88.09 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 119.026 0.83 . . . . 0.0 110.873 173.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -62.54 -42.02 99.26 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.052 0.842 . . . . 0.0 110.778 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -66.06 -45.7 80.38 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 122.027 -0.42 . . . . 0.0 110.488 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -59.97 -43.54 95.03 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.418 0.687 . . . . 0.0 110.098 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.51 99.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.751 0.82 . . . . 0.0 110.669 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -63.4 -44.18 95.41 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.559 0.618 . . . . 0.0 110.406 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -62.59 -40.44 96.9 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 121.635 -0.665 . . . . 0.0 110.516 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 41.2 mt -63.48 -38.35 90.8 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 118.449 -0.786 . . . . 0.0 111.954 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.95 -38.8 92.15 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.411 1.005 . . . . 0.0 110.358 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -66.47 -35.81 81.2 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.251 0.478 . . . . 0.0 110.872 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.72 -26.37 65.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.163 0.585 . . . . 0.0 111.712 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.44 -2.83 10.37 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.266 1.412 . . . . 0.0 114.137 169.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -82.07 142.91 31.89 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.094 1.447 . . . . 0.0 109.579 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 p -80.97 142.41 33.49 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.1 p -136.94 166.23 24.12 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.575 0.702 . . . . 0.0 110.991 -169.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -150.31 159.53 44.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 169.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 p -128.04 76.62 1.7 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.1 mt -70.54 113.59 7.8 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -76.69 107.29 8.88 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 52.8 52.13 40.64 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-O 118.521 -1.155 . . . . 0.0 115.057 172.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -67.7 177.74 3.88 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.092 2.528 . . . . 0.0 111.13 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.2 mt -127.91 166.84 17.54 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.271 1.428 . . . . 0.0 108.968 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -53.21 -36.85 61.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.489 1.516 . . . . 0.0 112.127 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.46 -7.13 8.88 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.237 1.015 . . . . 0.0 113.415 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -132.14 21.88 4.47 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.778 1.631 . . . . 0.0 110.976 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.2 mt -134.12 112.95 12.35 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.558 1.143 . . . . 0.0 109.273 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -66.34 157.44 60.18 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.35 2.034 . . . . 0.0 111.963 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.33 10.61 26.71 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.757 1.223 . . . . 0.0 114.288 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.7 m -144.4 124.57 13.69 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 150.79 -171.36 30.56 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.8 mp -124.92 99.22 5.89 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -94.23 174.09 7.32 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.722 0.809 . . . . 0.0 109.515 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.6 tp -144.87 98.6 3.21 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.7 138.61 19.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 mt -130.11 148.57 33.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.8 m -146.33 137.64 24.54 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 m -70.54 144.57 51.26 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 168.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 p -85.34 1.96 46.25 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -177.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 45.08 19.61 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 129.537 3.135 . . . . 0.0 114.394 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.58 23.74 29.29 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 120.905 -1.122 . . . . 0.0 113.149 -169.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.82 -9.09 0.41 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.342 1.071 . . . . 0.0 113.515 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.81 34.72 42.2 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 118.862 0.756 . . . . 0.0 111.642 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -140.32 146.93 39.13 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.053 0.941 . . . . 0.0 109.214 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.6 mp -76.73 146.1 75.84 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -57.42 155.07 32.13 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.951 2.434 . . . . 0.0 111.663 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -59.56 -16.28 24.17 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.115 1.366 . . . . 0.0 114.107 -174.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -64.46 -39.82 94.54 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.519 0.728 . . . . 0.0 111.083 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.2 tp -122.97 -20.64 5.73 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.185 0.594 . . . . 0.0 112.313 -171.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 t -49.2 -39.05 33.4 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.75 -23.78 8.91 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.463 2.775 . . . . 0.0 116.162 172.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -59.94 -37.03 78.33 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.658 1.117 . . . . 0.0 111.16 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -59.03 -42.94 91.4 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.237 0.615 . . . . 0.0 110.34 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -68.65 -48.24 64.51 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.401 0.68 . . . . 0.0 109.79 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.34 84.03 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 118.924 -0.56 . . . . 0.0 112.094 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.6 mt -65.84 -53.82 34.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 118.65 -0.69 . . . . 0.0 109.503 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -69.15 -28.58 66.56 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.162 0.892 . . . . 0.0 111.847 -174.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -66.09 -36.44 83.19 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.709 0.686 . . . . 0.0 110.725 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -107.22 -20.74 13.19 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -169.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm 39.71 60.54 6.31 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.873 1.669 . . . . 0.0 111.057 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.95 167.25 14.38 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.752 2.968 . . . . 0.0 111.997 -174.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -95.52 73.27 3.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.386 1.075 . . . . 0.0 109.332 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.47 16.68 9.82 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.26 1.424 . . . . 0.0 111.517 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.9 m -51.57 10.95 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 129.601 3.161 . . . . 0.0 116.921 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.22 2.18 2.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.168 1.387 . . . . 0.0 112.213 174.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.5 t -80.16 140.87 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 169.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -116.84 151.07 37.31 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 168.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -147.43 170.83 16.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.189 0.904 . . . . 0.0 112.48 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.55 161.16 23.95 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 104.766 -3.334 . . . . 0.0 104.766 169.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.98 132.88 27.59 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -169.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.2 mt -137.72 126.32 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 -173.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -114.93 121.07 5.2 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.1 mt -123.47 134.32 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 118.232 1.016 . . . . 0.0 108.34 -169.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.02 -164.42 37.96 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.5 m -75.06 75.22 2.25 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 125.621 1.569 . . . . 0.0 109.186 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -65.1 -12.2 48.19 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.448 1.099 . . . . 0.0 113.39 -171.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -65.56 -22.49 66.7 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.379 0.536 . . . . 0.0 111.475 170.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -75.01 174.31 9.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.055 0.942 . . . . 0.0 110.326 175.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.34 -29.9 70.96 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.712 0.805 . . . . 0.0 113.16 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 58.3 m . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -178.866 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.04 -34.99 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.0 -37.33 63.9 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.279 1.032 . . . . 0.0 112.528 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -63.7 -43.68 95.9 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.202 0.91 . . . . 0.0 111.35 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.3 mt -63.14 -50.43 70.46 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -70.22 -30.44 67.52 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.496 -173.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.01 91.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.481 0.582 . . . . 0.0 109.975 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -75.89 -29.6 58.53 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 117.771 -1.109 . . . . 0.0 112.4 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.26 -45.46 87.99 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 121.059 1.754 . . . . 0.0 109.855 172.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -71.4 -31.95 67.85 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.142 0.428 . . . . 0.0 110.964 -177.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -62.56 -39.47 93.74 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.013 0.37 . . . . 0.0 110.367 169.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.1 m -71.56 -0.53 10.82 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.82 1.248 . . . . 0.0 112.945 172.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.71 -14.31 41.9 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.809 1.195 . . . . 0.0 114.004 169.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.55 171.63 1.91 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.79 1.295 . . . . 0.0 110.839 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -142.81 150.68 40.27 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.993 -1.067 . . . . 0.0 112.237 170.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 17.3 tm0? -70.85 148.18 48.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.738 1.615 . . . . 0.0 108.438 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.3 m -128.22 144.96 51.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.936 1.695 . . . . 0.0 107.53 174.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.02 -127.84 8.68 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -143.98 164.41 30.68 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.993 1.717 . . . . 0.0 107.209 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.7 m -68.12 139.95 56.18 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.3 tp -105.8 150.2 25.77 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.209 1.003 . . . . 0.0 108.662 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.32 136.65 35.06 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.6 mm -135.49 113.81 15.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.176 -1.786 . . . . 0.0 106.176 -170.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -72.07 142.78 49.23 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 169.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.4 pp -128.92 3.62 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.518 1.127 . . . . 0.0 112.378 171.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 tp . . . . . 0 N--CA 1.466 0.374 0 CA-C-N 119.096 0.862 . . . . 0.0 112.351 -172.303 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 119.243 -0.408 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.1 -37.87 89.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.288 0.635 . . . . 0.0 111.252 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -71.46 -41.43 69.4 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.763 -0.586 . . . . 0.0 109.562 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -61.05 -45.15 95.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.62 -43.75 95.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.481 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.31 -45.36 92.87 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -63.97 -36.86 85.37 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.154 0.582 . . . . 0.0 111.168 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -67.91 -54.06 21.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.934 0.894 . . . . 0.0 109.8 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.93 -31.35 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 118.818 0.735 . . . . 0.0 111.141 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.24 -25.09 58.57 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.416 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.5 mt -101.46 -5.84 24.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.038 -0.982 . . . . 0.0 113.293 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.5 pp -120.3 -9.41 9.52 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.308 1.413 . . . . 0.0 113.08 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.251 1.133 0 C-N-CA 125.703 1.601 . . . . 0.0 111.961 178.264 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.38 0 CA-C-O 121.041 0.448 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -135.44 -25.94 1.28 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.765 1.226 . . . . 0.0 110.977 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.8 mt -129.53 84.77 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 169.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.5 m -75.56 115.85 15.67 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 176.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mp -74.35 156.89 36.62 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 171.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.6 mt -126.39 80.22 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.5 m -68.45 153.88 42.91 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.527 1.531 . . . . 0.0 110.561 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.1 100.42 0.19 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 121.656 0.741 . . . . 0.0 109.976 171.523 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.48 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.68 -26.83 64.56 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.483 0.641 . . . . 0.0 110.74 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -69.96 -36.64 75.4 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.328 0.513 . . . . 0.0 110.685 175.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -67.02 -44.28 80.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.735 0.698 . . . . 0.0 109.504 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.65 -39.15 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 119.057 -0.497 . . . . 0.0 109.967 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.88 -41.74 96.58 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.296 0.953 . . . . 0.0 110.987 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -63.32 -42.5 99.0 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.746 0.703 . . . . 0.0 110.553 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -62.02 -45.41 93.7 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.845 -0.534 . . . . 0.0 110.706 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.7 mt -62.06 -41.78 98.5 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.474 0.71 . . . . 0.0 110.464 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.18 -38.24 85.8 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.028 0.531 . . . . 0.0 110.662 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.18 -41.33 90.44 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.417 ' N ' ' HE2' ' A' ' 25' ' ' LYS . 6.8 mmpt? -62.89 -36.34 83.01 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 121.685 -0.634 . . . . 0.0 110.009 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.3 mt -68.45 -37.53 80.31 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 118.965 -0.541 . . . . 0.0 110.984 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -62.9 -42.11 99.67 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.924 0.783 . . . . 0.0 109.974 175.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.93 -37.29 87.16 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.145 0.43 . . . . 0.0 111.012 175.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.16 -22.03 63.96 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.792 0.837 . . . . 0.0 112.186 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.56 28.75 2.89 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.567 -1.13 . . . . 0.0 113.973 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -125.98 137.44 53.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.286 1.543 . . . . 0.0 109.223 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.5 p -76.07 146.85 39.08 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.43 0.633 . . . . 0.0 109.513 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.4 p -135.36 167.63 20.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.781 0.832 . . . . 0.0 110.212 -170.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -150.97 160.75 43.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 169.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.7 78.65 1.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -175.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.09 110.85 4.71 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -93.93 92.02 7.19 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -171.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.51 56.6 12.65 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.931 -0.927 . . . . 0.0 113.071 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.19 -179.14 3.3 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.91 2.407 . . . . 0.0 110.345 170.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.3 mt -114.77 160.16 19.75 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 169.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -55.5 -40.04 71.22 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.781 0.832 . . . . 0.0 111.403 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -64.83 -14.54 59.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.808 0.843 . . . . 0.0 113.198 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -90.76 -2.91 57.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.932 0.893 . . . . 0.0 112.309 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -137.44 154.4 75.26 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.147 0.979 . . . . 0.0 111.179 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.8 163.58 26.1 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.826 2.351 . . . . 0.0 111.77 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.04 18.67 0.99 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.41 1.484 . . . . 0.0 113.22 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.7 m -146.45 136.7 23.7 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.223 1.409 . . . . 0.0 107.887 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.71 -176.2 30.19 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.95 104.28 13.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -104.95 172.85 6.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.199 0.999 . . . . 0.0 109.931 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.6 tp -141.31 100.55 3.82 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 t -79.35 131.57 34.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.9 mt -133.0 127.58 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.2 m -134.29 129.31 35.39 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -170.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.9 m -69.07 160.51 30.89 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.505 169.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.9 m -132.82 109.21 9.48 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -63.28 -24.89 68.07 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.04 0.382 . . . . 0.0 111.956 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.09 -32.24 0.33 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.052 0.834 . . . . 0.0 112.234 171.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.93 30.31 4.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.27 1.028 . . . . 0.0 111.922 -171.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.81 -0.01 59.14 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.376 -0.68 . . . . 0.0 113.641 173.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -69.14 110.82 4.73 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 118.484 1.142 . . . . 0.0 109.982 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 61.2 mt -69.3 141.86 91.76 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 171.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.51 136.76 56.23 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.204 2.602 . . . . 0.0 110.985 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.9 -21.48 43.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.407 1.483 . . . . 0.0 113.237 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -64.87 -34.94 79.58 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.446 0.699 . . . . 0.0 111.454 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 tt -121.76 -22.17 5.88 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.615 0.766 . . . . 0.0 112.306 -169.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 81.7 p -51.13 -34.01 11.51 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-O 116.439 -1.743 . . . . 0.0 115.259 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -52.11 -22.9 15.99 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.989 2.46 . . . . 0.0 115.728 172.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -59.46 -37.21 77.58 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.336 0.971 . . . . 0.0 110.913 175.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -65.21 -42.26 93.69 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.602 0.761 . . . . 0.0 110.179 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -63.35 -50.95 67.95 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.714 0.406 . . . . 0.0 109.997 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.56 -29.21 70.23 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.993 0.815 . . . . 0.0 112.745 -174.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.3 mt -68.69 -57.07 6.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.382 171.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -69.86 -27.46 64.85 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.041 0.837 . . . . 0.0 112.431 -170.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.92 -26.05 61.27 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.123 0.874 . . . . 0.0 111.256 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -109.44 -24.4 11.04 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.573 -173.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt 40.13 59.81 7.05 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.778 1.631 . . . . 0.0 110.577 -169.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.25 167.62 17.94 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.846 2.364 . . . . 0.0 111.068 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -96.53 106.72 19.02 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 169.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 82' ' ' ALA . 50.1 mt -118.98 24.93 10.54 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.128 1.771 . . . . 0.0 110.022 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -61.0 20.0 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.524 1.929 . . . . 0.0 115.569 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.437 ' H ' ' C ' ' A' ' 80' ' ' LEU . . . -140.13 1.86 1.86 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.35 1.46 . . . . 0.0 111.992 173.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.5 t -84.09 142.66 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -123.42 148.65 45.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 168.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -144.08 171.3 14.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.452 0.644 . . . . 0.0 111.45 -174.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.42 161.54 22.16 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 104.461 -3.456 . . . . 0.0 104.461 168.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.31 124.77 13.93 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -169.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 mt -134.65 133.43 54.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.8 140.03 15.93 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 170.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 mt -138.73 131.47 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -171.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.7 -169.01 41.46 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 120.231 1.378 . . . . 0.0 110.541 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.9 m -79.34 74.17 5.95 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 126.02 1.728 . . . . 0.0 108.223 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -52.6 -33.93 48.57 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.962 1.305 . . . . 0.0 112.211 -173.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -80.84 -12.02 59.5 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.671 1.188 . . . . 0.0 112.349 -174.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -67.49 -52.54 38.03 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 118.978 0.808 . . . . 0.0 111.836 -169.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -162.87 -47.06 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.346 1.058 . . . . 0.0 110.915 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.8 m . . . . . 0 C--O 1.234 0.245 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -174.358 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.6 tp -60.86 -28.21 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.361 1.464 . . . . 0.0 111.163 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -57.22 -40.35 77.34 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -169.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -63.62 -44.35 94.18 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.927 -0.483 . . . . 0.0 111.047 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.9 mt -69.34 -48.61 60.85 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.566 0.747 . . . . 0.0 109.398 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.63 -38.57 87.21 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.56 -37.65 88.27 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.316 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -70.62 -29.16 65.47 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.596 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.6 mt -66.23 -43.05 87.7 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.948 1.704 . . . . 0.0 109.259 170.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -62.71 -42.81 99.83 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 122.732 0.413 . . . . 0.0 109.985 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -60.82 -40.51 92.99 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.207 1.003 . . . . 0.0 110.826 174.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.0 m -70.3 -5.78 30.34 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.478 1.111 . . . . 0.0 113.186 175.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.19 -13.9 21.33 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.53 1.062 . . . . 0.0 113.612 169.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.73 178.97 0.7 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.379 1.089 . . . . 0.0 110.589 174.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -151.73 148.08 27.47 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.873 -1.142 . . . . 0.0 113.204 169.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 39.7 tp60 -56.77 155.94 7.13 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.715 2.006 . . . . 0.0 109.928 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.5 m -141.3 131.96 25.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.57 174.77 17.01 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -169.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -71.55 158.3 36.46 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.625 -0.926 . . . . 0.0 108.963 170.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.88 160.52 20.28 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 169.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 54.2 tp -129.54 148.44 51.44 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.517 -0.739 . . . . 0.0 109.637 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -125.71 147.33 49.4 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 169.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.7 mm -131.66 106.88 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -78.14 134.96 37.59 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 169.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.24 -17.64 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 118.294 0.497 . . . . 0.0 111.699 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.0 tp . . . . . 0 CA--C 1.533 0.322 0 CA-C-N 118.552 0.614 . . . . 0.0 111.274 -171.469 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 111.153 0.057 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -58.63 -33.73 70.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.49 1.116 . . . . 0.0 111.565 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -69.52 -42.08 75.16 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.851 0.75 . . . . 0.0 109.954 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -64.68 -43.88 92.11 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.98 -43.34 99.06 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.354 0.662 . . . . 0.0 110.513 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.71 -44.54 97.8 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.954 0.787 . . . . 0.0 111.513 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -63.47 -35.58 80.93 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.023 -0.692 . . . . 0.0 111.053 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -68.88 -48.51 63.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.918 0.887 . . . . 0.0 110.403 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.15 -32.55 57.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 CA-C-N 119.161 0.891 . . . . 0.0 111.169 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -62.14 -22.23 65.68 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.344 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.1 mt -96.53 -43.8 7.45 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.438 1.017 . . . . 0.0 111.621 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 pp -70.92 -25.41 62.75 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.355 0.98 . . . . 0.0 112.32 -175.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 C--O 1.252 1.209 0 C-N-CA 127.796 2.438 . . . . 0.0 112.02 177.767 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.282 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -137.36 -25.09 1.05 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.69 1.596 . . . . 0.0 110.992 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.8 mt -124.9 79.3 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 169.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.4 m -74.83 117.77 17.05 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.65 151.0 34.5 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.3 mt -116.2 80.34 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 m -71.44 148.34 46.96 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.254 1.422 . . . . 0.0 109.683 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.6 80.7 0.18 Allowed Glycine 0 C--N 1.339 0.735 0 O-C-N 122.237 -0.289 . . . . 0.0 113.794 -169.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.451 -0.402 0 C-N-CA 123.899 0.88 . . . . 0.0 108.734 168.92 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.478 0 CA-C-O 120.026 -0.319 . . . . 0.0 113.109 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.02 -27.97 67.0 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 117.568 0.684 . . . . 0.0 110.972 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -76.33 -22.7 54.6 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.192 -173.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -65.75 -41.6 91.92 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.94 0.791 . . . . 0.0 109.182 169.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.5 t -72.22 -32.76 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 121.822 -0.549 . . . . 0.0 109.937 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.86 87.12 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.409 -0.807 . . . . 0.0 110.277 170.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.07 -38.93 89.56 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.412 0.551 . . . . 0.0 111.157 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -59.23 -46.8 87.51 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.095 0.861 . . . . 0.0 110.032 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.6 mt -65.14 -43.18 92.7 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.799 -0.563 . . . . 0.0 110.103 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.47 -42.61 92.43 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.549 0.74 . . . . 0.0 111.004 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -52.79 -47.43 67.56 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.799 0.84 . . . . 0.0 110.031 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -67.87 -40.9 83.54 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.2 mt -66.41 -39.59 89.09 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 119.259 -0.4 . . . . 0.0 110.641 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -61.12 -46.18 91.63 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.111 0.564 . . . . 0.0 109.655 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -65.5 -34.94 79.45 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.846 0.458 . . . . 0.0 111.34 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.6 -22.36 64.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.877 0.871 . . . . 0.0 112.035 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.25 1.67 23.47 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.656 1.122 . . . . 0.0 113.212 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -74.97 174.74 8.89 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.444 1.122 . . . . 0.0 109.475 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.4 p -122.61 137.32 54.93 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.5 p -132.51 170.32 15.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.135 0.974 . . . . 0.0 110.336 -170.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -153.54 126.1 8.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 104.518 -2.401 . . . . 0.0 104.518 169.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.0 p -82.54 70.63 9.55 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -69.58 113.59 7.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -169.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.436 ' CE1' HD21 ' A' ' 65' ' ' ASN . 54.9 t60 -72.27 107.98 5.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.261 1.024 . . . . 0.0 108.744 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.82 56.65 15.13 Favored Glycine 0 CA--C 1.539 1.577 0 CA-C-O 118.341 -1.255 . . . . 0.0 115.766 169.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.2 175.71 5.46 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.771 2.314 . . . . 0.0 111.685 173.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.7 mt -128.67 164.35 23.12 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.346 1.458 . . . . 0.0 109.226 174.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.4 tp -62.27 -27.8 69.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.816 1.247 . . . . 0.0 112.169 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.75 -10.38 12.6 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.136 0.974 . . . . 0.0 113.101 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -128.56 19.88 6.19 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.348 1.459 . . . . 0.0 110.872 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.94 97.67 13.61 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.08 1.352 . . . . 0.0 107.886 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.76 165.22 28.45 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.404 2.069 . . . . 0.0 111.774 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.71 4.67 1.8 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.69 1.596 . . . . 0.0 114.788 -175.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.2 m -144.94 133.85 22.47 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.354 1.462 . . . . 0.0 107.276 -175.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.71 175.53 23.54 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.5 mt -114.54 101.83 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -110.42 166.63 10.83 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.573 0.749 . . . . 0.0 108.98 -176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.8 tp -146.37 99.28 3.2 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 t -79.52 132.31 32.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.793 1.237 . . . . 0.0 107.839 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 mt -135.98 132.29 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.6 m -134.18 133.67 41.23 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -169.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 m -80.08 166.71 21.24 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 169.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.5 m -141.15 112.27 7.29 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 174.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -71.61 -5.25 32.08 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -169.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 160.89 -38.58 0.43 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-N 119.794 1.179 . . . . 0.0 113.761 169.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.22 10.25 3.0 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.273 1.036 . . . . 0.0 113.259 -170.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.62 -14.88 4.71 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.135 0.874 . . . . 0.0 113.289 172.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.07 119.43 6.3 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.353 1.061 . . . . 0.0 111.632 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.4 mt -83.47 132.23 50.27 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -51.13 136.46 45.51 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 124.016 3.144 . . . . 0.0 113.292 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.39 -18.6 62.0 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.283 1.033 . . . . 0.0 113.315 -176.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.436 HD21 ' CE1' ' A' ' 37' ' ' HIS . 2.7 p-10 -73.89 -27.11 60.89 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.413 -0.804 . . . . 0.0 112.179 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.9 tp -121.04 -27.1 5.02 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.283 0.947 . . . . 0.0 111.92 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -46.73 -39.76 17.37 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-O 117.549 -1.215 . . . . 0.0 113.935 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.42 -25.64 14.46 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.502 2.801 . . . . 0.0 116.077 172.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -60.56 -37.5 81.47 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.157 -0.965 . . . . 0.0 110.855 176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -65.71 -43.3 89.54 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.113 0.565 . . . . 0.0 110.9 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.26 -38.04 68.95 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.583 0.629 . . . . 0.0 110.784 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.04 -35.91 80.92 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.726 0.693 . . . . 0.0 111.576 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.9 mt -64.45 -54.41 33.02 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.744 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -69.54 -25.96 64.27 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.147 0.885 . . . . 0.0 111.957 -173.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -68.88 -37.27 78.94 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.86 0.755 . . . . 0.0 110.697 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -105.07 -34.33 8.0 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -169.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm 31.0 57.92 0.98 Allowed Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 127.306 2.242 . . . . 0.0 113.675 -173.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.23 169.83 15.93 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.929 1.753 . . . . 0.0 110.167 174.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -72.04 114.83 10.57 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 169.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.1 mt -119.72 18.74 12.62 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.674 1.59 . . . . 0.0 110.901 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.8 m -57.87 4.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.43 1.22 8.96 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.848 1.204 . . . . 0.0 111.614 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 79.8 t -74.56 131.63 34.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 169.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -107.62 102.73 11.95 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 102.197 -3.26 . . . . 0.0 102.197 168.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -95.88 167.35 11.31 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.803 0.811 . . . . 0.0 108.933 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -123.13 154.46 17.17 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 104.839 -3.305 . . . . 0.0 104.839 169.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.47 122.48 11.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.8 mt -135.68 131.82 50.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -102.26 138.11 13.73 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.9 mt -133.21 153.35 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 165.66 173.4 34.13 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-O 123.278 1.488 . . . . 0.0 110.732 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.1 m -74.48 56.94 0.69 Allowed 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 126.511 1.924 . . . . 0.0 109.952 174.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.14 -52.5 7.23 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.894 2.078 . . . . 0.0 110.978 -174.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -65.14 -11.7 43.07 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.093 0.557 . . . . 0.0 112.498 -171.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -66.27 -50.43 63.73 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.908 0.776 . . . . 0.0 110.184 170.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -171.61 -49.02 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.412 1.485 . . . . 0.0 111.797 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.536 0.44 0 C-N-CA 124.739 1.216 . . . . 0.0 114.02 -169.685 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.8 tp -67.88 -27.87 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.174 0.59 . . . . 0.0 110.841 -176.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -61.02 -43.52 98.76 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 118.354 0.524 . . . . 0.0 111.787 -169.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -65.81 -44.52 85.4 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 122.016 -0.427 . . . . 0.0 110.802 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.9 mt -63.33 -46.66 85.61 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.331 0.652 . . . . 0.0 109.948 -176.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.89 -40.38 75.7 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.997 0.362 . . . . 0.0 110.075 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.31 -35.02 79.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.032 -169.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -74.21 -29.94 61.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.18 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.8 mt -66.62 -41.78 87.84 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.16 1.346 . . . . 0.0 109.02 169.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -61.55 -43.92 97.98 Favored 'General case' 0 N--CA 1.458 -0.062 0 C-N-CA 124.002 0.921 . . . . 0.0 109.343 -177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -67.5 -36.41 81.01 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.023 0.929 . . . . 0.0 111.347 176.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.1 m -68.84 -2.09 8.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.225 1.01 . . . . 0.0 112.876 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.28 -15.66 30.16 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.32 1.438 . . . . 0.0 113.693 169.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.19 171.95 2.73 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.6 1.2 . . . . 0.0 110.989 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -142.66 154.47 44.37 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.364 -0.835 . . . . 0.0 111.462 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -63.85 161.35 15.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.774 2.029 . . . . 0.0 110.244 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.6 m -133.99 152.85 52.01 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.509 1.923 . . . . 0.0 106.321 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.37 -135.27 51.84 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -169.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -140.47 150.67 44.09 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.8 m -63.22 149.64 44.98 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.269 1.428 . . . . 0.0 110.551 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.9 tp -132.88 147.89 52.3 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.388 1.075 . . . . 0.0 109.084 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -120.06 139.25 52.82 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.221 1.808 . . . . 0.0 106.227 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.8 mt -138.07 107.25 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -67.57 141.13 56.92 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 170.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.3 pt -122.06 -9.66 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.036 1.335 . . . . 0.0 112.1 171.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.4 tp . . . . . 0 C--N 1.343 0.283 0 CA-C-N 119.883 1.22 . . . . 0.0 108.378 176.562 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.408 0 CA-C-O 119.353 -0.356 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -62.15 -38.93 90.89 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.51 0.724 . . . . 0.0 110.908 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -76.13 -49.09 18.29 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -64.67 -33.16 75.28 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.216 -0.303 . . . . 0.0 111.744 -174.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 48.9 tp -56.98 -30.18 63.9 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 118.68 -0.676 . . . . 0.0 111.358 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.92 -45.7 70.34 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 118.841 0.746 . . . . 0.0 111.297 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.9 m -66.77 -30.76 71.05 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 117.492 0.646 . . . . 0.0 111.319 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -72.61 -51.31 20.18 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.532 0.733 . . . . 0.0 110.03 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 31.4 m -66.52 -30.64 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 O-C-N 121.331 -0.855 . . . . 0.0 111.246 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -60.74 -21.25 62.78 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.846 0.859 . . . . 0.0 112.482 175.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 28.8 mt -102.78 -35.93 8.46 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 118.069 -0.967 . . . . 0.0 112.109 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -35.78 79.52 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 120.005 1.275 . . . . 0.0 111.838 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt . . . . . 0 C--O 1.251 1.176 0 C-N-CA 128.658 2.783 . . . . 0.0 113.236 -179.474 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 121.006 0.431 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -134.34 -26.03 1.48 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.122 1.369 . . . . 0.0 110.973 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.6 mt -129.04 82.36 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 169.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.8 m -74.6 121.29 21.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.5 mp -78.98 146.17 33.54 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.5 mt -109.91 82.31 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.4 m -64.1 140.33 58.86 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.014 0.926 . . . . 0.0 110.431 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.57 72.12 0.41 Allowed Glycine 0 C--N 1.339 0.739 0 C-N-CA 123.584 0.611 . . . . 0.0 113.851 -169.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 C--O 1.234 0.238 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 168.51 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.815 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.9 -29.23 69.06 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.542 -0.742 . . . . 0.0 110.644 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -69.88 -35.32 74.56 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.15 0.886 . . . . 0.0 110.231 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -70.91 -41.73 70.88 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.998 0.817 . . . . 0.0 109.784 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.11 -44.81 99.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.87 -36.47 79.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.524 -0.751 . . . . 0.0 111.01 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.82 -41.69 99.42 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.52 1.055 . . . . 0.0 110.7 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -64.57 -48.87 73.4 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.161 0.437 . . . . 0.0 109.962 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.84 -46.11 88.49 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.86 0.464 . . . . 0.0 110.233 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.51 98.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.474 1.11 . . . . 0.0 111.029 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.39 -43.66 96.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.288 0.495 . . . . 0.0 110.355 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -67.45 -34.29 76.88 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.356 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.0 mt -63.99 -37.02 85.9 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 119.381 0.991 . . . . 0.0 111.755 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -63.44 -40.91 98.4 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.586 1.085 . . . . 0.0 110.15 175.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.22 -37.04 86.03 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.296 0.498 . . . . 0.0 111.087 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.84 -21.86 63.33 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.74 0.816 . . . . 0.0 112.256 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.27 26.04 3.32 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.533 -1.148 . . . . 0.0 114.022 170.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -125.88 131.58 52.33 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.244 1.522 . . . . 0.0 108.72 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 p -73.26 147.47 44.56 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.5 p -140.72 169.28 17.94 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.084 0.954 . . . . 0.0 109.588 -169.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -152.5 140.67 20.38 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 169.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.5 p -96.42 68.65 2.57 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.87 119.3 17.9 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -169.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -69.29 99.96 1.26 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.264 1.026 . . . . 0.0 109.665 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.13 54.22 10.04 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.347 1.451 . . . . 0.0 115.549 171.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -60.6 142.97 99.31 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 CA-C-N 120.494 2.147 . . . . 0.0 109.815 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.1 mt -69.23 155.03 41.08 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.75 -34.26 71.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.311 0.644 . . . . 0.0 109.761 169.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -65.58 -9.57 27.83 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.386 1.475 . . . . 0.0 112.909 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -118.06 13.23 13.84 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.007 1.323 . . . . 0.0 111.556 -170.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 pp -141.98 154.78 65.53 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.513 1.125 . . . . 0.0 109.592 171.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.48 161.29 37.57 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.594 2.196 . . . . 0.0 112.07 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.06 18.63 0.48 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.567 1.547 . . . . 0.0 112.931 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.8 t -152.37 133.68 14.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.03 179.39 31.93 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.0 mt -117.25 106.66 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.096 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -107.75 169.07 8.83 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 123.152 0.581 . . . . 0.0 109.516 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.4 tp -142.41 101.04 3.82 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.01 144.09 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.217 -171.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.57 143.42 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 172.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 m -147.24 134.49 20.59 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.402 -0.812 . . . . 0.0 108.876 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.4 m -75.91 160.36 29.99 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 169.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.8 m -128.64 106.22 8.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.778 1.631 . . . . 0.0 106.921 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -67.11 169.82 7.9 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.2 -23.82 34.3 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.754 -1.026 . . . . 0.0 114.947 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.92 11.7 16.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.996 1.318 . . . . 0.0 112.709 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.14 16.97 70.61 Favored Glycine 0 C--N 1.339 0.697 0 O-C-N 121.439 -0.788 . . . . 0.0 113.721 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -66.45 119.99 12.59 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.659 1.23 . . . . 0.0 108.419 170.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.2 mt -70.18 142.58 90.15 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -61.28 144.64 98.74 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.085 2.523 . . . . 0.0 112.065 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -59.01 -21.91 59.8 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.359 1.464 . . . . 0.0 113.598 -173.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.91 -27.97 68.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.38 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 63.6 tp -130.79 -20.72 2.81 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.734 0.814 . . . . 0.0 112.508 -170.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.0 p -53.19 -31.5 7.88 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -53.52 -20.89 17.14 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.014 2.476 . . . . 0.0 115.583 169.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -56.99 -35.65 69.45 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.177 0.898 . . . . 0.0 110.96 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -65.35 -48.83 71.64 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.58 -43.44 98.85 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.605 0.762 . . . . 0.0 110.009 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.57 -29.8 68.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.419 0.688 . . . . 0.0 112.492 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.4 mt -76.68 -29.8 56.48 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.771 176.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -73.62 -46.84 44.43 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.494 1.043 . . . . 0.0 109.115 175.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.11 -25.73 67.9 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.831 0.853 . . . . 0.0 111.837 -171.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -118.14 -25.26 6.71 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 117.974 -1.012 . . . . 0.0 113.167 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? 36.55 59.06 3.51 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 125.026 1.33 . . . . 0.0 110.605 -169.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -68.17 173.84 8.89 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.603 2.869 . . . . 0.0 112.777 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -105.39 107.81 19.0 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.8 mt -117.86 22.32 12.36 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 126.146 1.778 . . . . 0.0 110.675 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 m -57.46 16.05 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.51 2.324 . . . . 0.0 116.549 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.6 0.89 2.08 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.889 1.276 . . . . 0.0 112.309 172.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 94.9 t -75.85 134.56 28.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.9 mmm-85 -121.97 144.46 48.87 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 104.972 -2.232 . . . . 0.0 104.972 168.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -150.84 169.73 20.99 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.861 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -125.37 166.31 18.15 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 105.457 -3.057 . . . . 0.0 105.457 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.81 135.84 22.46 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.831 1.315 . . . . 0.0 111.111 -169.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.1 mm -124.24 130.51 73.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -104.9 135.97 12.85 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 107.691 -2.163 . . . . 0.0 107.691 169.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.2 mt -130.01 152.92 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 161.17 175.66 32.44 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 71.0 m -78.39 91.69 4.5 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 169.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -28.87 62.05 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.472 0.709 . . . . 0.0 112.872 -169.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -73.68 -9.9 59.14 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.49 169.01 11.65 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.161 0.891 . . . . 0.0 110.173 172.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -58.48 -34.52 70.97 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.424 0.69 . . . . 0.0 112.782 -173.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.9 m . . . . . 0 C--O 1.235 0.326 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.508 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.1 tp -52.98 -33.34 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 126.075 1.75 . . . . 0.0 110.391 170.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -51.4 -39.18 56.7 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.497 1.119 . . . . 0.0 112.855 -172.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -66.44 -36.5 82.95 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.787 -0.571 . . . . 0.0 111.446 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.2 mt -71.89 -52.07 19.1 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -67.08 -35.81 80.62 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.991 -171.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.32 -38.54 90.47 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -73.25 -30.94 63.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.914 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.05 -46.69 86.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.314 1.415 . . . . 0.0 109.203 169.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -63.37 -41.06 98.79 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 122.417 0.287 . . . . 0.0 110.387 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -63.04 -39.54 95.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.581 0.752 . . . . 0.0 110.524 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.7 m -70.68 -7.11 42.15 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.469 1.108 . . . . 0.0 112.908 174.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.03 -16.9 8.71 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.728 1.156 . . . . 0.0 113.921 169.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.22 172.75 1.35 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.517 1.159 . . . . 0.0 111.277 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -140.87 136.16 32.06 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.499 -0.751 . . . . 0.0 110.904 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -62.43 170.46 2.39 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.973 1.309 . . . . 0.0 109.295 170.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 m -133.67 149.71 51.55 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.87 -136.44 46.37 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.09 157.71 45.79 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 171.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.98 135.76 57.47 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.959 0.904 . . . . 0.0 110.183 -177.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.4 tp -94.08 148.7 21.92 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -123.55 144.41 49.59 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 57.0 mt -136.95 108.82 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -68.03 143.2 55.64 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 169.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.24 9.25 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.024 0.93 . . . . 0.0 112.54 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp . . . . . 0 N--CA 1.467 0.384 0 O-C-N 121.473 -0.767 . . . . 0.0 111.318 178.617 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 118.856 -0.593 . . . . 0.0 111.958 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -54.76 -35.34 63.67 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.011 0.924 . . . . 0.0 111.515 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -65.21 -43.45 91.51 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.679 -0.638 . . . . 0.0 110.188 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -74.28 -35.42 63.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.763 0.825 . . . . 0.0 110.344 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.4 tp -61.94 -36.24 80.81 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.973 0.909 . . . . 0.0 110.742 173.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.76 -47.74 58.01 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.471 1.034 . . . . 0.0 111.102 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 m -61.82 -42.23 98.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.665 0.732 . . . . 0.0 110.778 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -60.44 -49.92 75.65 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.511 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.7 m -65.36 -34.79 72.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 119.866 1.212 . . . . 0.0 110.867 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.79 -22.4 66.98 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.426 0.69 . . . . 0.0 111.679 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.2 mt -90.67 -57.98 2.64 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.599 1.09 . . . . 0.0 110.141 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.08 -25.79 65.51 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 117.567 -1.206 . . . . 0.0 113.815 -169.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm . . . . . 0 C--O 1.251 1.181 0 C-N-CA 128.046 2.538 . . . . 0.0 113.27 175.249 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 120.913 0.387 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -133.38 -25.58 1.72 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.818 1.247 . . . . 0.0 111.028 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.0 mt -121.37 74.92 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 170.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.1 m -75.35 120.98 21.55 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.8 mt -94.85 151.06 19.55 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 80.3 mt -125.76 84.13 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -169.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.9 m -74.94 151.23 38.89 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.656 0.782 . . . . 0.0 110.35 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.81 118.16 0.8 Allowed Glycine 0 C--N 1.333 0.394 0 N-CA-C 107.576 -2.209 . . . . 0.0 107.576 170.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 122.006 0.908 . . . . 0.0 111.641 -173.625 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.558 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.6 -22.96 64.42 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 117.315 0.557 . . . . 0.0 111.571 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -75.31 -43.8 48.9 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -68.7 -41.8 78.65 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 122.862 0.465 . . . . 0.0 109.748 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.24 -48.84 85.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.244 0.618 . . . . 0.0 109.433 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.17 89.48 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 118.902 0.773 . . . . 0.0 110.667 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.0 -43.0 93.97 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.455 1.025 . . . . 0.0 111.119 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -61.86 -45.11 95.18 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.834 -0.541 . . . . 0.0 110.481 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.5 mt -65.45 -42.21 92.61 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.256 0.622 . . . . 0.0 110.153 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.1 83.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.023 0.929 . . . . 0.0 110.966 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -58.68 -46.8 86.43 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.882 0.765 . . . . 0.0 110.496 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -68.21 -37.46 80.91 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.567 -0.708 . . . . 0.0 110.835 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.3 mt -61.41 -42.04 98.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.279 0.945 . . . . 0.0 111.369 175.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.7 -38.96 84.35 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.642 0.655 . . . . 0.0 110.327 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -64.55 -36.04 82.92 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.46 0.573 . . . . 0.0 110.904 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.01 -23.71 64.13 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.54 0.736 . . . . 0.0 111.973 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.56 -0.77 12.46 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.968 1.271 . . . . 0.0 113.764 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -77.05 174.7 10.35 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.635 1.217 . . . . 0.0 110.61 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.8 p -120.88 140.0 52.41 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 p -136.49 168.98 18.45 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.254 1.022 . . . . 0.0 110.229 -169.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -153.13 155.59 37.03 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 169.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.0 p -119.55 71.55 0.88 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -172.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.3 mt -76.07 118.9 19.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -171.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -91.89 95.48 9.85 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.97 49.47 6.38 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.016 -1.436 . . . . 0.0 115.22 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -68.43 176.27 5.92 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 CA-C-N 120.686 2.243 . . . . 0.0 110.989 169.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.5 mt -130.8 168.4 17.3 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.381 1.472 . . . . 0.0 110.027 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.5 tp -56.06 -27.36 53.1 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.906 1.683 . . . . 0.0 111.881 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -64.18 -12.37 39.62 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.547 1.139 . . . . 0.0 112.593 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -137.09 20.52 3.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.933 1.293 . . . . 0.0 111.377 -173.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.2 mt -135.03 102.81 10.88 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.648 1.179 . . . . 0.0 108.319 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -73.32 169.85 21.3 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.932 2.422 . . . . 0.0 112.21 -176.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.48 8.98 2.42 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.807 1.643 . . . . 0.0 114.767 -171.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -153.15 141.18 20.31 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.929 0.786 . . . . 0.0 109.27 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.14 -178.66 24.63 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -123.3 99.5 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -94.69 176.22 6.36 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.464 0.706 . . . . 0.0 110.155 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.9 tp -140.98 98.67 3.43 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -79.64 129.0 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 mt -127.54 146.21 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.9 m -145.48 141.92 28.77 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.718 -0.614 . . . . 0.0 110.016 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.7 m -91.08 95.11 9.92 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.2 m -70.6 83.2 0.61 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 171.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -79.12 44.23 0.56 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.123 1.769 . . . . 0.0 111.442 -174.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.2 -30.05 2.15 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.33 1.443 . . . . 0.0 114.278 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.61 -21.75 64.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.395 1.078 . . . . 0.0 113.678 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.86 20.37 77.98 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -170.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -130.77 155.46 46.62 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.734 1.614 . . . . 0.0 107.083 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.37 150.07 39.43 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.227 1.411 . . . . 0.0 107.965 -169.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -53.6 139.25 66.99 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.276 2.651 . . . . 0.0 112.321 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -58.35 -23.12 55.84 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.976 1.311 . . . . 0.0 113.71 -171.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -75.21 -21.48 58.63 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.563 -0.732 . . . . 0.0 112.502 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.6 tp -126.84 -23.89 3.6 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.007 0.923 . . . . 0.0 111.902 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 91.9 p -53.72 -29.65 5.02 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-O 117.038 -1.458 . . . . 0.0 114.138 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.34 -23.34 18.2 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.639 2.226 . . . . 0.0 114.958 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -64.52 -39.96 94.74 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 120.104 1.32 . . . . 0.0 110.815 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -60.72 -41.87 96.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.105 0.562 . . . . 0.0 110.085 175.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -66.23 -47.89 72.34 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.076 0.55 . . . . 0.0 110.299 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.85 -41.28 95.83 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 121.794 -0.566 . . . . 0.0 111.362 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.7 mt -62.72 -50.82 69.61 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.888 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -70.3 -29.19 65.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.023 0.829 . . . . 0.0 111.642 -176.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.09 -50.46 47.97 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.768 0.713 . . . . 0.0 109.866 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -84.19 -23.01 30.73 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.349 -173.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.5 tttt 38.45 61.43 4.74 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 126.085 1.754 . . . . 0.0 110.806 -169.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -66.5 169.27 14.5 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.109 2.539 . . . . 0.0 111.363 -174.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -96.69 104.21 16.18 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 169.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.0 mt -118.83 26.6 9.43 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 126.414 1.886 . . . . 0.0 109.818 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.8 m -60.1 15.62 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.815 2.046 . . . . 0.0 116.048 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.85 6.09 1.58 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.039 1.336 . . . . 0.0 111.762 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.1 t -77.58 140.31 17.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -122.67 157.2 32.76 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 168.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -154.16 176.28 12.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.739 0.699 . . . . 0.0 111.77 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.55 162.76 22.17 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 105.593 -3.003 . . . . 0.0 105.593 169.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.68 126.63 19.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -169.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.7 mt -136.04 126.2 41.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -174.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -100.69 152.25 19.08 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.6 mt -134.8 137.98 50.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 175.99 -152.05 12.47 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.6 m -128.19 127.19 42.46 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.381 1.073 . . . . 0.0 109.095 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -67.58 -6.57 20.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.631 0.772 . . . . 0.0 112.09 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.35 -33.12 63.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.094 1.358 . . . . 0.0 111.592 172.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -116.36 155.96 27.56 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.448 1.099 . . . . 0.0 110.805 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.64 -34.46 77.88 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.638 0.775 . . . . 0.0 111.661 -174.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.756 0 C-N-CA 126.472 1.909 . . . . 0.0 111.011 175.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.33 -34.2 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.781 1.232 . . . . 0.0 109.579 170.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.21 -32.42 68.28 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 123.777 0.831 . . . . 0.0 111.989 -175.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -62.01 -45.41 93.71 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.512 0.596 . . . . 0.0 110.473 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.29 -53.15 61.11 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -72.22 -31.89 66.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.64 -170.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.16 -44.2 92.12 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.99 0.814 . . . . 0.0 109.858 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -74.64 -28.11 60.72 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.199 -0.905 . . . . 0.0 112.281 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.6 -45.01 92.32 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.493 1.497 . . . . 0.0 109.374 169.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -66.27 -39.77 89.66 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 122.182 -0.324 . . . . 0.0 110.473 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -61.05 -40.17 92.62 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.056 0.542 . . . . 0.0 110.511 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.5 m -69.57 -14.27 62.76 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.946 0.898 . . . . 0.0 112.878 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.58 -13.04 6.94 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.048 1.309 . . . . 0.0 113.872 169.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.87 172.6 2.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.579 1.19 . . . . 0.0 111.858 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -145.54 144.1 30.33 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.389 -0.819 . . . . 0.0 111.558 169.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 38.2 tp60 -58.26 154.44 13.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.893 1.677 . . . . 0.0 109.491 172.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.4 m -139.42 134.01 31.8 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.02 176.34 37.71 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -172.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -76.26 164.27 26.22 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.022 -0.693 . . . . 0.0 109.488 172.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.2 164.12 23.38 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 169.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.0 tp -129.84 147.61 51.63 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.246 -0.909 . . . . 0.0 109.704 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.97 142.13 47.69 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 176.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 43.3 mt -138.79 110.87 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -82.88 131.2 35.2 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 123.247 0.619 . . . . 0.0 109.696 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -127.75 14.45 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 125.028 1.331 . . . . 0.0 111.852 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 68.0 tp . . . . . 0 N--CA 1.468 0.467 0 C-N-CA 124.387 1.075 . . . . 0.0 111.449 -177.264 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -60.31 -49.14 78.78 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.428 0.691 . . . . 0.0 110.922 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -79.85 -36.63 36.46 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.787 0.835 . . . . 0.0 110.121 -174.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 86.2 t90 -58.98 -48.45 81.52 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 28.7 tp -67.51 -39.74 85.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 119.057 -0.497 . . . . 0.0 110.6 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.9 -44.73 92.34 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -65.43 -40.54 93.43 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.133 0.573 . . . . 0.0 110.629 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -63.96 -49.78 71.21 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.797 -0.621 . . . . 0.0 110.231 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.06 -34.6 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 119.297 0.953 . . . . 0.0 110.895 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -61.63 -31.62 71.73 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-O 118.848 -0.596 . . . . 0.0 111.8 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.3 mt -86.27 -46.68 10.11 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.219 0.918 . . . . 0.0 111.296 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.05 -24.35 61.52 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.945 0.793 . . . . 0.0 112.404 -172.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.9 mttp . . . . . 0 C--O 1.247 0.926 0 C-N-CA 127.572 2.349 . . . . 0.0 111.652 -179.115 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 120.709 0.29 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -135.98 -25.11 1.25 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.418 1.087 . . . . 0.0 111.453 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.0 mt -130.27 82.74 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 169.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.6 m -75.95 116.9 17.11 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.85 151.88 40.38 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.3 mt -122.31 100.08 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 m -93.73 123.73 37.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.176 0.99 . . . . 0.0 110.121 -172.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.68 60.28 0.62 Allowed Glycine 0 C--N 1.331 0.254 0 N-CA-C 105.972 -2.851 . . . . 0.0 105.972 170.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.449 -0.513 0 C-N-CA 124.576 1.15 . . . . 0.0 111.589 -167.984 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.637 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.88 -28.17 68.76 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 117.433 0.617 . . . . 0.0 111.174 177.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.39 -39.96 58.51 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -65.31 -40.06 93.29 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.3 t -57.32 -51.29 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.134 0.974 . . . . 0.0 109.639 173.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.54 -43.56 98.64 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.961 0.801 . . . . 0.0 111.088 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.73 -45.51 86.17 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.914 0.486 . . . . 0.0 110.735 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -59.8 -48.27 82.36 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.297 1.039 . . . . 0.0 110.221 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.1 mt -59.88 -46.05 90.54 Favored 'General case' 0 N--CA 1.458 -0.054 0 C-N-CA 123.369 0.667 . . . . 0.0 110.242 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.87 -50.64 73.23 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.293 0.497 . . . . 0.0 110.339 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -58.87 -47.63 84.25 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.129 0.571 . . . . 0.0 110.483 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -66.01 -38.32 88.18 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.132 -177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.6 mt -65.78 -39.93 91.46 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 119.63 1.105 . . . . 0.0 110.791 175.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.96 -40.1 95.65 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.916 0.78 . . . . 0.0 110.128 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -65.66 -37.73 87.36 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.406 0.548 . . . . 0.0 111.156 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.92 -22.4 64.16 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.708 0.803 . . . . 0.0 112.136 176.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.14 25.72 3.46 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.636 -1.091 . . . . 0.0 113.821 170.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -127.72 127.73 44.16 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.152 1.476 . . . . 0.0 108.451 -177.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 p -72.68 149.83 43.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 109.835 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.8 p -133.72 170.21 15.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.688 0.756 . . . . 0.0 110.356 -172.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -151.66 162.17 41.45 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 169.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.5 83.04 2.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -177.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.2 mt -71.19 109.99 5.57 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -78.77 108.86 12.51 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.67 50.77 60.98 Favored Glycine 0 CA--C 1.54 1.612 0 CA-C-O 118.159 -1.356 . . . . 0.0 115.367 171.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -67.86 175.57 6.22 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.706 2.271 . . . . 0.0 111.183 173.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.9 mt -123.43 157.01 34.4 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.192 1.397 . . . . 0.0 108.219 170.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.81 -30.47 71.56 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.797 0.839 . . . . 0.0 111.768 -174.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.49 -8.51 14.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.783 0.833 . . . . 0.0 112.897 176.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -118.13 18.28 13.86 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.543 1.537 . . . . 0.0 110.832 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.4 mt -127.06 142.11 42.71 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.751 1.22 . . . . 0.0 109.205 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.05 162.47 41.71 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.539 2.159 . . . . 0.0 109.823 169.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.7 21.33 0.67 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.383 1.073 . . . . 0.0 112.557 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.6 p -156.79 149.76 23.87 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.787 1.235 . . . . 0.0 109.043 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.31 179.28 22.37 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.5 mt -117.62 103.32 14.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -104.82 170.81 7.66 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.043 0.937 . . . . 0.0 109.58 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.4 tp -148.58 106.52 3.71 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.8 t -87.88 137.07 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -173.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.04 126.67 56.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.3 m -135.08 120.37 18.99 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.781 0.432 . . . . 0.0 110.401 -172.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 m -71.94 -172.81 0.91 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 168.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -127.84 141.4 51.57 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -77.16 11.87 1.68 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.608 1.563 . . . . 0.0 111.889 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.05 23.34 76.1 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 120.934 -1.104 . . . . 0.0 111.378 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.2 8.54 2.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.206 1.402 . . . . 0.0 112.151 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.59 34.58 56.73 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 119.25 0.932 . . . . 0.0 111.114 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -145.92 152.73 39.9 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.774 1.63 . . . . 0.0 107.802 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.2 mp -65.9 148.05 98.48 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -52.97 149.67 25.85 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.686 2.924 . . . . 0.0 113.298 169.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -57.21 -16.63 8.6 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.864 1.666 . . . . 0.0 113.663 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -61.99 -39.15 91.2 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.731 0.812 . . . . 0.0 110.8 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.2 tp -126.28 -22.27 4.07 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.5 0.72 . . . . 0.0 112.301 -171.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.9 p -54.37 -31.1 7.92 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-O 117.03 -1.462 . . . . 0.0 114.819 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -52.25 -22.71 16.15 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.147 2.565 . . . . 0.0 115.188 169.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -56.26 -35.64 67.67 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.029 0.932 . . . . 0.0 111.066 175.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -64.06 -40.59 96.6 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 122.991 0.517 . . . . 0.0 110.878 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.75 -46.44 58.46 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.02 -29.41 70.32 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.141 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.67 -63.74 1.09 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 170.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -67.85 -22.61 65.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.682 0.674 . . . . 0.0 112.624 -170.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -70.98 -32.95 69.94 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.602 0.761 . . . . 0.0 111.502 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -114.43 -33.98 5.41 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp 28.05 64.72 0.65 Allowed Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 127.83 2.452 . . . . 0.0 113.086 -169.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -60.57 173.38 2.14 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.695 2.263 . . . . 0.0 111.954 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -75.84 62.59 1.57 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.174 1.39 . . . . 0.0 110.561 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 82' ' ' ALA . 70.8 mt -73.27 8.33 1.76 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.358 1.463 . . . . 0.0 112.786 -177.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.9 m -45.76 10.31 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.751 1 C-N-CA 132.055 4.142 . . . . 0.0 117.649 170.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 80' ' ' LEU . . . -141.36 3.03 1.71 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.2 1.4 . . . . 0.0 112.172 175.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.2 t -78.71 137.3 22.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 169.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -119.19 141.5 48.82 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 168.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -148.86 172.46 14.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.111 0.414 . . . . 0.0 111.094 -174.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.67 163.53 24.11 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 105.761 -2.936 . . . . 0.0 105.761 169.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.19 130.37 19.65 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.306 1.053 . . . . 0.0 109.662 -169.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 23.1 mt -134.1 130.92 55.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -118.14 139.65 14.84 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.2 mp -131.44 118.37 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 176.7 -158.37 24.37 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 105.906 -2.878 . . . . 0.0 105.906 -172.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.6 m -96.82 170.14 9.37 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.187 0.995 . . . . 0.0 110.765 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -119.7 -19.76 7.92 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.203 1.001 . . . . 0.0 109.866 169.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -111.57 5.98 19.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.934 2.494 . . . . 0.0 111.089 -169.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -141.58 165.04 28.59 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.186 1.794 . . . . 0.0 109.04 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -59.28 -35.35 73.58 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.827 1.651 . . . . 0.0 113.503 -169.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 53.2 m . . . . . 0 CA--C 1.534 0.349 0 CA-C-O 121.881 0.848 . . . . 0.0 109.2 170.513 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.676 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.9 tp -54.26 -31.41 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.599 1.56 . . . . 0.0 110.969 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -50.91 -35.28 32.26 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.732 1.213 . . . . 0.0 112.962 -170.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -54.27 -51.47 64.47 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.46 0.573 . . . . 0.0 111.353 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.3 mt -68.7 -50.89 47.26 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -172.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -67.58 -35.74 79.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.901 -173.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.84 -41.66 78.22 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.38 -24.97 62.17 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 117.509 -1.234 . . . . 0.0 112.424 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.6 mt -65.86 -52.38 50.82 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.978 1.717 . . . . 0.0 108.951 169.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -68.21 -33.89 75.25 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 122.076 -0.39 . . . . 0.0 110.883 -173.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -76.13 6.55 5.2 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.875 1.27 . . . . 0.0 112.644 172.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.4 m -120.59 15.41 11.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.299 1.44 . . . . 0.0 110.328 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.75 -22.96 27.11 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.623 1.106 . . . . 0.0 113.557 169.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.83 167.92 1.41 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.587 1.194 . . . . 0.0 110.66 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -137.17 136.48 38.25 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 121.461 -0.775 . . . . 0.0 111.351 171.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -60.29 164.58 4.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.056 -1.429 . . . . 0.0 109.525 171.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 m -136.49 157.84 45.85 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 126.371 1.868 . . . . 0.0 106.036 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.408 ' H ' HD12 ' A' ' 145' ' ' LEU . . . 55.7 -128.74 45.65 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 -173.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -144.62 165.81 26.97 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.706 1.203 . . . . 0.0 107.956 169.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.75 154.42 29.71 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.041 0.937 . . . . 0.0 110.438 -178.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 57.0 tp -129.67 143.54 50.87 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.858 0.863 . . . . 0.0 109.576 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -118.15 143.09 46.77 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.4 mt -132.31 100.38 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -69.62 142.01 53.58 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.486 0.714 . . . . 0.0 111.161 -171.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 8.4 pt -105.79 -21.04 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.178 0.991 . . . . 0.0 111.858 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 CA--C 1.53 0.208 0 C-N-CA 123.559 0.744 . . . . 0.0 109.801 -172.155 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 118.885 -0.579 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -65.23 -44.14 89.17 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.039 0.836 . . . . 0.0 110.304 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -62.84 -47.55 82.91 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.126 -0.359 . . . . 0.0 110.266 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -68.69 -33.75 74.5 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.536 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.9 tt -58.74 -40.97 85.37 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.193 0.906 . . . . 0.0 110.184 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.6 -48.25 66.42 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 173.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.4 m -63.96 -41.19 97.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.401 0.601 . . . . 0.0 111.11 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -62.57 -52.51 63.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 117.739 -1.124 . . . . 0.0 110.492 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.7 m -64.71 -34.03 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 120.258 1.39 . . . . 0.0 110.685 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -59.49 -32.77 70.57 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.061 0.846 . . . . 0.0 112.118 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.408 HD12 ' H ' ' A' ' 118' ' ' GLY . 25.9 mt -94.75 -35.85 11.95 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.512 -0.756 . . . . 0.0 112.55 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.7 pp -90.99 -17.3 26.54 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 117.36 -1.305 . . . . 0.0 113.459 -173.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt . . . . . 0 C--O 1.251 1.167 0 CA-C-N 119.572 1.078 . . . . 0.0 112.104 -172.529 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.289 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -140.98 -25.17 0.74 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.435 1.094 . . . . 0.0 111.482 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.7 mt -132.89 83.65 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 173.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.6 m -78.38 116.02 18.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.72 154.25 36.54 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.632 0.773 . . . . 0.0 109.598 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.3 mt -126.49 97.87 4.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.7 m -78.75 156.98 28.6 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.761 0.824 . . . . 0.0 110.097 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.68 89.83 0.09 OUTLIER Glycine 0 C--N 1.333 0.411 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.7 p . . . . . 0 C--O 1.232 0.147 0 CA-C-N 117.462 0.631 . . . . 0.0 110.584 172.567 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.747 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.46 90.3 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.213 1.006 . . . . 0.0 110.229 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.46 -32.44 64.35 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.095 0.407 . . . . 0.0 111.912 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -65.01 -44.9 87.71 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.9 t -60.69 -46.43 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.1 -39.84 79.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.568 0.622 . . . . 0.0 111.344 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.17 -42.8 99.21 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.62 0.645 . . . . 0.0 110.837 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -71.64 -41.96 68.18 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.903 -0.498 . . . . 0.0 110.972 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.86 -44.44 97.02 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.07 -44.31 96.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.432 0.693 . . . . 0.0 110.469 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -58.0 -44.56 87.29 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.458 0.572 . . . . 0.0 110.388 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -62.73 -40.86 98.51 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.762 -0.587 . . . . 0.0 111.285 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 66.3 mt -63.9 -41.34 97.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.943 0.792 . . . . 0.0 111.142 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.24 -40.12 90.02 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.576 0.625 . . . . 0.0 110.378 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.88 -36.0 82.93 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.048 0.539 . . . . 0.0 110.805 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.62 -21.63 63.55 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.379 0.671 . . . . 0.0 112.248 174.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.52 -0.64 14.04 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.844 1.211 . . . . 0.0 113.825 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -79.2 178.94 7.69 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.424 1.112 . . . . 0.0 110.023 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.9 p -124.84 150.31 46.55 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.7 p -137.48 170.26 16.38 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.635 0.774 . . . . 0.0 109.729 -169.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -152.19 161.86 41.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 169.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.39 102.27 6.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.2 mt -80.08 153.57 28.67 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -128.76 102.47 6.57 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.42 52.83 49.33 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.487 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -66.39 174.45 6.2 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.028 2.485 . . . . 0.0 111.588 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.9 mt -129.26 163.47 25.59 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 125.249 1.42 . . . . 0.0 109.191 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.89 -30.4 58.04 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.75 1.22 . . . . 0.0 110.888 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -64.09 -11.18 27.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.314 1.446 . . . . 0.0 112.661 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -136.59 16.88 3.12 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.383 1.073 . . . . 0.0 110.907 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -135.62 101.03 10.95 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.124 1.37 . . . . 0.0 107.866 -169.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.32 164.59 34.8 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.737 2.292 . . . . 0.0 112.139 -171.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.58 7.29 1.94 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.574 1.55 . . . . 0.0 114.575 -173.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.9 m -149.61 139.33 21.75 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.8 178.08 27.06 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.5 mt -119.67 101.75 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 -176.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -114.76 167.69 10.55 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.205 1.002 . . . . 0.0 110.247 -171.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.4 tp -147.7 100.56 3.24 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 175.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.5 t -83.96 141.4 14.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.593 1.157 . . . . 0.0 109.685 -172.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.57 126.54 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.2 m -142.08 130.8 22.77 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.427 0.691 . . . . 0.0 110.656 -169.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.8 m -67.56 168.83 10.3 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.632 0.73 . . . . 0.0 111.358 169.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.2 m -141.27 135.03 30.24 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 129.02 2.928 . . . . 0.0 104.143 172.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -129.72 146.13 51.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 172.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 36.62 -97.27 0.01 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 127.088 2.28 . . . . 0.0 114.586 176.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.87 9.63 26.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.342 1.457 . . . . 0.0 113.455 -169.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.71 25.46 7.63 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 120.115 1.325 . . . . 0.0 110.837 -175.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.08 110.52 5.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.97 149.84 85.54 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.79 144.82 49.58 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.702 2.268 . . . . 0.0 110.02 -169.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -56.8 -21.01 25.62 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.036 1.334 . . . . 0.0 113.793 -175.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -69.02 -31.62 70.56 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.843 -0.535 . . . . 0.0 111.823 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.5 tp -123.83 -25.31 4.29 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.641 0.777 . . . . 0.0 112.323 -169.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 78.8 p -54.47 -30.82 7.42 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 117.027 -1.464 . . . . 0.0 114.542 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -52.68 -26.11 28.67 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.612 2.208 . . . . 0.0 114.814 169.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -62.21 -40.76 97.19 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.508 1.049 . . . . 0.0 110.238 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -63.74 -37.6 87.95 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.91 0.777 . . . . 0.0 110.354 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -68.65 -44.66 73.65 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.747 0.419 . . . . 0.0 110.377 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.85 -41.67 95.51 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.676 -0.64 . . . . 0.0 110.935 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.2 mt -61.33 -49.35 77.34 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 118.56 -0.734 . . . . 0.0 110.352 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -71.74 -28.55 63.74 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.259 0.936 . . . . 0.0 111.434 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.4 -43.54 77.01 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.562 0.619 . . . . 0.0 110.58 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -99.32 -35.0 10.09 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -169.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.0 ttpp 30.04 57.28 0.81 Allowed Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 127.39 2.276 . . . . 0.0 113.412 -169.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.31 174.76 10.31 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.263 1.975 . . . . 0.0 110.374 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' A' ' 81' ' ' SER . 13.4 p-10 -76.9 69.64 3.24 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.519 1.528 . . . . 0.0 111.024 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.2 mt -74.13 19.08 0.13 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.843 1.657 . . . . 0.0 112.158 173.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 79' ' ' ASP . 3.1 m -53.18 12.2 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.713 1 C-N-CA 131.786 4.034 . . . . 0.0 116.639 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.14 4.37 0.94 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.176 1.391 . . . . 0.0 112.232 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 79.2 t -74.1 131.36 35.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 169.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 121.14 39.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 169.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -130.44 168.95 16.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.086 0.469 . . . . 0.0 110.56 -173.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -127.62 162.76 21.51 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 104.758 -3.337 . . . . 0.0 104.758 169.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.2 137.63 24.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.139 0.97 . . . . 0.0 110.072 -169.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.5 mt -134.72 127.67 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -175.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.43 146.23 16.42 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 171.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.1 mt -137.11 147.1 27.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.66 166.38 29.47 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 176.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.4 m -81.64 111.18 17.68 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 170.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -64.63 -2.29 2.34 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 -169.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -63.64 -41.83 98.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.771 0.829 . . . . 0.0 110.877 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -75.37 155.24 36.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.963 0.801 . . . . 0.0 110.8 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -55.65 -33.83 64.43 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.835 1.254 . . . . 0.0 114.16 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.5 tp -54.87 -27.54 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.078 1.351 . . . . 0.0 110.51 171.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -52.19 -35.37 48.88 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.451 1.1 . . . . 0.0 112.817 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -66.89 -54.27 23.83 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 121.831 -0.543 . . . . 0.0 109.938 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.0 mt -61.56 -48.67 79.93 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.8 0.84 . . . . 0.0 109.456 -175.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.13 -37.87 86.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -173.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.22 -40.43 77.98 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -172.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -71.16 -31.06 67.22 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.584 -0.722 . . . . 0.0 111.504 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.9 mt -62.43 -48.15 80.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.911 1.232 . . . . 0.0 109.57 169.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -64.31 -38.83 92.43 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -65.92 -35.3 80.25 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.055 0.542 . . . . 0.0 111.339 175.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.1 m -71.73 -3.31 21.19 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.337 1.055 . . . . 0.0 112.846 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.72 -12.15 27.59 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.759 1.171 . . . . 0.0 113.201 170.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.59 171.89 1.82 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.441 1.121 . . . . 0.0 110.759 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -139.7 144.69 37.67 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.756 0.789 . . . . 0.0 110.591 169.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -78.75 171.05 15.72 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.167 171.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.46 153.03 41.05 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.916 1.287 . . . . 0.0 107.811 169.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.46 -130.73 37.76 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 172.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -136.91 162.26 33.76 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.3 1.44 . . . . 0.0 107.181 171.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.3 m -69.35 132.42 46.38 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.193 0.597 . . . . 0.0 109.476 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.4 tp -81.1 153.29 27.4 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -125.87 144.14 50.78 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 169.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 40.4 mt -132.63 101.74 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -67.58 138.37 56.39 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 171.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 18.5 pt -128.02 15.98 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 125.313 1.445 . . . . 0.0 111.73 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 N--CA 1.47 0.56 0 C-N-CA 124.413 1.085 . . . . 0.0 111.631 -178.629 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -56.69 -40.55 75.79 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.074 0.95 . . . . 0.0 112.469 -169.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -73.74 -30.82 63.03 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.785 0.721 . . . . 0.0 111.075 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -73.57 -40.23 64.07 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.518 -0.739 . . . . 0.0 109.723 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.4 tp -61.8 -44.29 97.16 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.907 1.283 . . . . 0.0 109.988 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.06 -44.42 93.0 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.682 1.134 . . . . 0.0 111.126 173.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.1 m -62.7 -40.07 95.99 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 122.313 -0.522 . . . . 0.0 110.67 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -63.04 -48.77 77.3 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 117.968 -1.015 . . . . 0.0 111.786 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 28.1 m -65.74 -33.39 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 119.978 1.263 . . . . 0.0 110.949 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.83 -32.84 74.14 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.687 -0.673 . . . . 0.0 111.854 174.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 mt -80.27 -50.9 9.58 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.004 0.82 . . . . 0.0 111.016 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 pp -79.11 -16.45 56.68 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.901 0.773 . . . . 0.0 113.052 -173.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 60.1 mttm . . . . . 0 C--O 1.25 1.129 0 C-N-CA 127.808 2.443 . . . . 0.0 111.949 176.816 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.358 0 CA-C-O 120.74 0.305 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -134.51 -26.84 1.39 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.393 1.077 . . . . 0.0 111.263 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.0 mt -128.9 81.39 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 171.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.7 m -77.46 110.69 12.45 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mp -74.78 155.89 37.13 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.7 mt -127.89 100.63 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 m -70.65 158.1 36.82 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.288 1.435 . . . . 0.0 110.88 177.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.41 59.37 0.23 Allowed Glycine 0 C--N 1.338 0.694 0 O-C-N 121.992 -0.443 . . . . 0.0 112.789 -170.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 CA--C 1.534 0.35 0 C-N-CA 125.17 1.388 . . . . 0.0 107.587 169.312 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.37 0 N-CA-C 107.404 -2.278 . . . . 0.0 107.404 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.15 -32.11 73.64 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 122.983 0.513 . . . . 0.0 111.066 175.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -66.04 -35.24 80.0 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.611 0.764 . . . . 0.0 110.572 176.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -70.64 -47.49 59.75 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -59.58 -40.95 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.31 -48.29 82.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.871 0.76 . . . . 0.0 110.599 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.96 -43.14 99.61 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.189 0.449 . . . . 0.0 110.765 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -66.8 -42.65 85.62 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.847 -0.533 . . . . 0.0 111.078 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.9 mt -65.68 -41.32 92.57 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.639 -0.663 . . . . 0.0 110.267 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.41 -41.04 93.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 119.005 -0.522 . . . . 0.0 110.761 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -55.9 -48.73 75.13 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.64 0.655 . . . . 0.0 110.128 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.18 -37.68 84.11 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 121.786 -0.571 . . . . 0.0 110.69 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.0 mt -62.68 -39.74 94.92 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.665 0.666 . . . . 0.0 111.426 175.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -66.85 -37.03 83.67 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.872 0.76 . . . . 0.0 110.534 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.84 -37.37 86.04 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.66 0.663 . . . . 0.0 110.877 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.02 -25.89 65.61 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.157 0.583 . . . . 0.0 111.661 173.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.88 -3.11 11.81 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.228 1.394 . . . . 0.0 113.88 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -79.85 143.56 34.23 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.863 1.331 . . . . 0.0 109.601 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 p -82.23 144.54 30.6 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 169.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.3 p -135.96 170.7 15.58 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.654 0.781 . . . . 0.0 110.116 -170.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -153.18 161.84 41.98 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 169.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 p -135.44 75.64 1.57 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -173.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.8 mt -66.29 115.87 6.71 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -171.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -76.88 95.34 4.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 53.26 62.69 5.75 Favored Glycine 0 CA--C 1.541 1.693 0 C-N-CA 123.894 0.759 . . . . 0.0 113.491 173.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -68.89 176.34 6.23 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.826 3.018 . . . . 0.0 111.848 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.4 mt -122.74 162.78 21.39 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.318 1.447 . . . . 0.0 107.603 169.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.7 tt -57.03 -35.93 69.87 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.733 0.813 . . . . 0.0 111.328 -176.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.23 -3.51 5.9 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.902 1.281 . . . . 0.0 113.21 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -130.47 16.54 5.43 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.908 1.283 . . . . 0.0 110.406 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -135.73 105.01 9.85 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.104 1.362 . . . . 0.0 108.826 -169.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.71 153.66 72.78 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.603 2.202 . . . . 0.0 112.388 -174.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.57 17.16 2.8 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.274 1.43 . . . . 0.0 113.347 -170.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.7 m -154.75 131.1 10.43 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 120.825 -1.172 . . . . 0.0 108.196 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.88 -173.92 26.9 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.9 mt -122.28 101.62 10.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -174.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -99.3 170.72 8.46 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.952 0.901 . . . . 0.0 109.844 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.3 tp -148.67 101.25 3.19 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 175.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.0 t -84.81 137.54 20.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 123.853 0.861 . . . . 0.0 108.725 -171.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.8 mt -133.73 115.94 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.483 ' HG ' ' CD1' ' A' ' 105' ' ' LEU . 16.1 m -130.47 127.7 39.74 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.216 0.606 . . . . 0.0 109.724 -169.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 m -76.85 165.8 24.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.135 0.493 . . . . 0.0 109.868 171.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 m -136.4 99.03 3.98 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.7 -34.05 77.3 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 157.9 155.64 7.62 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 171.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 46.24 32.44 1.49 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.632 1.973 . . . . 0.0 113.978 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.64 5.3 66.89 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.407 -0.663 . . . . 0.0 113.013 174.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.77 92.4 2.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.336 1.068 . . . . 0.0 110.115 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.0 mt -65.12 142.67 98.66 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 169.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.43 148.22 90.71 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.615 2.21 . . . . 0.0 111.497 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -57.91 -17.95 20.01 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.256 1.822 . . . . 0.0 113.785 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -62.06 -42.62 99.38 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.719 0.807 . . . . 0.0 110.401 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.5 tp -117.61 -26.07 6.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.592 0.757 . . . . 0.0 112.51 -169.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 100.0 p -55.92 -31.68 10.57 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 116.87 -1.538 . . . . 0.0 114.994 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -53.2 -25.09 28.56 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.537 2.158 . . . . 0.0 114.938 171.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -61.1 -38.34 85.95 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.262 0.937 . . . . 0.0 111.094 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -62.08 -40.98 97.68 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.679 0.792 . . . . 0.0 110.239 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.78 -46.82 62.19 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.955 0.502 . . . . 0.0 109.927 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.65 -31.34 72.31 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.765 -0.585 . . . . 0.0 112.124 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.4 mt -64.42 -59.98 3.7 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -68.1 -26.43 65.82 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.771 0.714 . . . . 0.0 112.291 -171.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -66.59 -33.85 76.58 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.299 0.64 . . . . 0.0 110.971 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -111.86 -30.48 7.28 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -169.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt 31.8 57.98 1.18 Allowed Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 126.976 2.111 . . . . 0.0 112.365 -169.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -71.37 170.78 17.55 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.367 2.045 . . . . 0.0 109.886 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -73.75 103.29 4.26 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.836 -0.54 . . . . 0.0 110.262 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.1 mt -114.34 23.13 13.09 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.639 1.576 . . . . 0.0 110.491 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.5 m -62.63 19.82 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.535 1.934 . . . . 0.0 115.696 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.18 2.57 1.5 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.321 1.448 . . . . 0.0 111.917 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.8 t -77.84 137.01 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 169.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -121.36 144.76 48.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 168.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -148.11 169.33 20.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.067 0.394 . . . . 0.0 110.186 -176.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.2 167.16 21.32 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 106.156 -2.778 . . . . 0.0 106.156 169.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.39 132.02 28.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.598 0.699 . . . . 0.0 109.79 -169.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.9 mt -132.29 130.76 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.13 146.57 18.83 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.1 mt -138.42 140.66 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -172.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 172.2 179.03 42.83 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.9 m -77.16 123.73 26.83 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 170.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.6 ptt-85 -58.94 -22.91 60.81 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -172.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -84.05 -4.42 58.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.439 0.696 . . . . 0.0 112.525 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.8 m-30 -63.51 162.03 13.47 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.453 1.024 . . . . 0.0 110.352 169.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -60.82 -27.45 68.06 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.653 0.781 . . . . 0.0 112.009 173.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.2 p . . . . . 0 C--O 1.233 0.237 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 172.85 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -30.31 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.796 0.838 . . . . 0.0 109.57 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -55.56 -31.22 61.97 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.4 1.08 . . . . 0.0 112.421 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -62.52 -49.63 74.58 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.783 0.72 . . . . 0.0 109.962 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.483 ' CD1' ' HG ' ' A' ' 54' ' ' SER . 13.5 mt -64.67 -49.09 72.33 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -71.38 -32.62 68.68 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.907 -175.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.43 -44.58 92.88 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.431 1.014 . . . . 0.0 109.474 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -73.35 -27.56 61.57 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.603 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.0 mt -64.33 -46.36 83.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.479 1.49 . . . . 0.0 109.273 169.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -64.97 -39.95 94.26 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 117.855 0.298 . . . . 0.0 110.392 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -62.37 -37.92 87.59 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.546 0.738 . . . . 0.0 110.723 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.6 m -72.8 -12.35 60.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.244 1.018 . . . . 0.0 112.82 173.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 129.36 -17.7 5.56 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.988 1.28 . . . . 0.0 114.32 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.32 173.27 1.59 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.508 1.154 . . . . 0.0 111.958 -175.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -143.1 142.24 31.46 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.264 -0.898 . . . . 0.0 112.066 169.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -63.16 161.48 13.47 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.526 1.93 . . . . 0.0 109.962 176.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.8 m -143.03 149.28 38.03 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.909 1.684 . . . . 0.0 107.031 -176.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.57 -144.06 44.98 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -136.73 149.99 48.16 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 174.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.6 m -64.08 133.49 53.13 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.904 0.882 . . . . 0.0 110.149 -173.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.5 tp -98.92 152.24 19.98 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.69 138.94 39.9 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 29.0 mt -132.04 104.93 8.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 -170.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -67.57 134.54 51.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.17 172.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 6.3 pt -110.05 -8.61 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.78 0.832 . . . . 0.0 111.889 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.1 tp . . . . . 0 C--N 1.34 0.168 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.719 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -55.84 -25.64 42.98 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.06 0.846 . . . . 0.0 113.036 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -74.12 -48.22 30.95 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.023 0.829 . . . . 0.0 109.456 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 6.4 t-105 -68.64 -27.54 66.09 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.213 1.005 . . . . 0.0 111.158 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.1 tp -56.07 -33.74 65.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.22 1.008 . . . . 0.0 111.073 171.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.15 -44.36 88.71 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 174.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.9 m -63.03 -43.2 99.36 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.319 0.56 . . . . 0.0 110.206 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -62.46 -49.61 74.74 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 118.112 -0.947 . . . . 0.0 111.832 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.03 -30.17 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 120.378 1.445 . . . . 0.0 111.405 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -70.03 -20.32 63.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.602 0.637 . . . . 0.0 111.213 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.36 -46.81 4.9 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.132 0.973 . . . . 0.0 110.21 -174.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 pp -75.87 -20.61 57.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.302 -0.856 . . . . 0.0 112.255 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.9 mttp . . . . . 0 C--O 1.25 1.117 0 C-N-CA 127.631 2.372 . . . . 0.0 112.119 179.569 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 120.812 0.339 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -136.42 -26.43 1.11 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.933 1.293 . . . . 0.0 111.226 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.8 mt -125.67 79.49 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 170.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.1 m -74.37 117.65 16.42 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -84.26 154.83 22.76 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.6 mt -126.31 85.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -173.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -71.31 152.24 43.43 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.577 1.151 . . . . 0.0 110.173 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.45 104.26 0.24 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.837 0.827 . . . . 0.0 111.65 177.188 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.759 0 CA-C-O 119.514 -0.603 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.62 -26.26 66.16 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.707 1.254 . . . . 0.0 111.092 -176.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.38 -37.94 89.22 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.273 0.229 . . . . 0.0 110.863 176.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -76.11 -50.26 15.13 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 175.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.99 -47.21 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.402 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.06 98.23 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.029 0.831 . . . . 0.0 110.593 -177.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.63 -42.35 86.89 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.604 0.638 . . . . 0.0 110.64 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -63.36 -43.16 98.48 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.858 0.463 . . . . 0.0 110.628 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.93 -42.94 89.45 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.696 -0.628 . . . . 0.0 109.522 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.15 -37.18 76.66 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.525 0.73 . . . . 0.0 111.674 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -51.73 -47.08 64.18 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.65 0.659 . . . . 0.0 110.227 175.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.9 mmtt -68.36 -39.28 81.87 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.6 mt -65.65 -40.44 92.49 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.581 0.353 . . . . 0.0 110.258 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.27 -40.29 90.01 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.192 -0.432 . . . . 0.0 110.284 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.14 -36.44 84.27 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.703 0.683 . . . . 0.0 111.174 175.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.8 -22.96 65.15 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.475 0.71 . . . . 0.0 112.024 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.71 -0.1 19.98 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.922 1.249 . . . . 0.0 113.326 171.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -75.12 174.91 8.76 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.449 1.124 . . . . 0.0 109.907 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 p -122.47 145.72 48.04 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.2 p -132.52 166.29 22.41 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.662 0.785 . . . . 0.0 110.667 -169.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -152.49 159.4 43.34 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 169.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 p -127.99 80.19 1.94 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -171.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.3 mt -73.21 110.8 7.78 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -84.78 106.28 16.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.74 52.24 54.19 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 118.496 -1.169 . . . . 0.0 114.275 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.53 179.24 3.17 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.315 2.677 . . . . 0.0 111.029 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.4 mt -130.45 168.08 17.58 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.221 1.408 . . . . 0.0 108.528 172.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.78 -35.98 64.39 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.024 1.33 . . . . 0.0 111.697 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.75 -6.94 6.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.14 0.976 . . . . 0.0 113.444 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -129.45 19.07 5.79 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.661 1.584 . . . . 0.0 111.07 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.6 mt -135.75 112.04 10.56 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.803 1.241 . . . . 0.0 108.656 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.28 161.37 45.97 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.182 1.921 . . . . 0.0 111.223 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.69 13.28 1.71 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.185 1.394 . . . . 0.0 113.816 -172.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.4 m -146.92 130.2 16.59 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.487 1.115 . . . . 0.0 108.121 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.53 -176.63 29.86 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.18 99.29 5.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -100.57 173.99 6.29 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.27 1.028 . . . . 0.0 110.013 -173.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.2 tp -143.31 110.16 5.57 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.15 136.68 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.11 119.42 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 176.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.2 m -120.39 132.72 55.38 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.932 0.893 . . . . 0.0 108.894 -175.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.469 ' H ' ' HG3' ' A' ' 63' ' ' PRO . 15.4 m -87.59 50.94 2.09 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.73 0.812 . . . . 0.0 109.937 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -54.13 99.71 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.518 2.327 . . . . 0.0 110.636 -173.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -61.95 130.15 44.26 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.87 20.14 12.6 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.406 1.003 . . . . 0.0 113.843 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 49.97 34.26 7.82 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.105 1.362 . . . . 0.0 111.743 -169.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.58 -0.58 0.33 Allowed Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.518 -1.157 . . . . 0.0 115.132 -169.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -144.02 118.14 9.49 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 119.637 1.718 . . . . 0.0 108.744 171.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.5 mt -68.37 140.79 92.93 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.469 ' HG3' ' H ' ' A' ' 55' ' ' SER . 56.0 Cg_endo -64.17 139.02 64.38 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.975 1.783 . . . . 0.0 110.683 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.86 -19.72 52.84 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.07 1.348 . . . . 0.0 113.674 -173.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -70.88 -31.6 68.31 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.66 -0.65 . . . . 0.0 111.897 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.7 tp -118.14 -25.08 6.76 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.678 0.791 . . . . 0.0 111.753 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.6 t -44.98 -42.24 15.16 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 117.39 -1.29 . . . . 0.0 114.338 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.06 -25.71 13.26 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.81 3.007 . . . . 0.0 116.176 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -59.72 -35.81 75.28 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.19 0.904 . . . . 0.0 111.288 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -58.31 -40.67 82.67 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.225 0.61 . . . . 0.0 110.585 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -72.22 -47.65 48.89 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.912 0.485 . . . . 0.0 109.942 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.43 -35.92 82.49 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.562 0.619 . . . . 0.0 111.725 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.5 mt -66.02 -52.5 48.68 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.772 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -69.88 -25.56 63.76 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.544 1.066 . . . . 0.0 112.224 -174.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.27 -37.25 83.14 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.502 0.592 . . . . 0.0 110.349 177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -107.25 -28.78 9.71 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -169.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.9 mttm 32.27 57.82 1.29 Allowed Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 127.257 2.223 . . . . 0.0 112.556 -172.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.11 171.09 14.35 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.871 2.38 . . . . 0.0 110.66 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -77.23 110.37 11.87 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.576 -0.703 . . . . 0.0 109.357 170.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.5 mt -118.23 19.77 13.38 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.996 1.718 . . . . 0.0 110.951 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.8 m -58.74 11.21 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.857 2.063 . . . . 0.0 116.39 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.16 2.79 4.74 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.626 1.171 . . . . 0.0 111.445 173.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 80.5 t -81.76 140.21 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 169.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -119.51 146.82 45.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 168.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -140.98 171.65 13.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.918 0.866 . . . . 0.0 111.145 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.01 162.6 25.62 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 104.448 -3.461 . . . . 0.0 104.448 169.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.07 132.71 25.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.6 mt -134.17 137.82 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -110.29 152.88 17.25 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 170.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.3 mt -134.31 122.83 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 175.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.62 -155.98 15.2 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.241 -1.943 . . . . 0.0 108.241 -172.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.0 m -102.88 124.17 47.9 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 24.9 ttp180 -69.21 -14.93 63.24 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -69.34 -13.87 62.61 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.461 -0.774 . . . . 0.0 111.274 169.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 52.7 179.93 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 129.732 3.213 . . . . 0.0 115.547 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -156.33 -41.47 0.08 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.214 2.206 . . . . 0.0 107.527 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 92.4 m . . . . . 0 CA--C 1.543 0.683 0 C-N-CA 127.753 2.421 . . . . 0.0 105.659 169.21 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.321 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.686 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -33.28 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 119.251 0.932 . . . . 0.0 109.809 -178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -53.32 -29.59 34.58 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 119.005 -0.521 . . . . 0.0 112.341 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.57 -42.0 95.75 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.617 1.099 . . . . 0.0 111.541 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.41 -51.86 64.03 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -70.08 -35.5 74.23 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.921 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.2 -37.13 86.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.104 0.411 . . . . 0.0 110.846 -172.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -68.79 -34.71 76.0 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.383 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 44.2 mt -65.74 -41.63 91.97 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.258 1.39 . . . . 0.0 109.515 172.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -63.21 -44.63 94.78 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.315 1.046 . . . . 0.0 109.383 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -61.23 -42.26 98.29 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.003 0.921 . . . . 0.0 110.879 172.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.7 m -68.14 -7.0 26.1 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.226 1.01 . . . . 0.0 113.013 177.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.74 -15.15 14.34 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.058 1.313 . . . . 0.0 113.627 169.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.89 169.77 3.06 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.466 1.133 . . . . 0.0 110.776 176.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -142.76 154.01 43.83 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.422 -0.799 . . . . 0.0 111.228 171.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -70.43 155.75 40.27 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.927 171.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 72.8 m -125.95 153.21 44.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.379 1.872 . . . . 0.0 106.931 169.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.94 -144.54 49.05 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -175.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -135.71 152.51 51.24 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.497 1.119 . . . . 0.0 108.25 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.82 150.83 46.86 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.284 1.434 . . . . 0.0 110.427 -176.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.3 tp -130.0 144.97 51.62 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.391 1.076 . . . . 0.0 108.815 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.36 147.42 43.53 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 169.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.3 mt -124.35 106.5 16.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 -175.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -68.09 128.1 35.31 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.077 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -124.49 10.14 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.804 1.242 . . . . 0.0 111.68 174.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 53.2 tp . . . . . 0 CA--C 1.535 0.375 0 C-N-CA 123.051 0.54 . . . . 0.0 111.339 179.225 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -56.61 -44.22 80.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.776 0.83 . . . . 0.0 111.868 -169.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -73.33 -35.04 65.97 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 122.02 -0.425 . . . . 0.0 110.748 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -69.27 -40.36 77.83 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.81 -0.556 . . . . 0.0 109.839 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 48.9 tp -65.13 -39.93 93.75 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.389 0.676 . . . . 0.0 110.194 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.8 -46.4 83.21 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 171.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.6 m -64.54 -34.11 77.48 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.647 0.779 . . . . 0.0 111.299 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -66.14 -53.65 35.11 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.519 0.727 . . . . 0.0 110.051 176.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.5 m -66.06 -25.89 36.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 118.989 0.813 . . . . 0.0 112.182 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -54.98 -25.38 29.46 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.438 0.695 . . . . 0.0 112.276 177.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 27.7 mt -101.56 0.21 36.05 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 pp -127.68 -11.96 5.49 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 120.362 1.437 . . . . 0.0 113.467 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.0 pttp . . . . . 0 C--O 1.249 1.029 0 C-N-CA 124.286 1.034 . . . . 0.0 111.105 177.526 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 121.09 0.471 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -134.23 -26.66 1.46 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.123 1.369 . . . . 0.0 110.941 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.2 mt -124.64 79.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.6 m -74.51 114.38 12.85 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mp -76.6 148.39 37.01 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 170.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.5 mt -116.89 90.6 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -175.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.5 m -80.62 137.7 36.38 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.88 1.272 . . . . 0.0 111.262 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.95 76.62 0.36 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 125.148 1.356 . . . . 0.0 111.839 -170.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 169.421 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.26 0 N-CA-C 108.405 -1.878 . . . . 0.0 108.405 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.0 -35.09 79.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.803 176.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.18 -36.29 83.14 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.436 0.562 . . . . 0.0 110.315 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -73.67 -47.15 41.94 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.9 t -60.91 -43.3 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -46.39 90.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.019 0.528 . . . . 0.0 110.438 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.4 -44.26 96.87 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.623 0.647 . . . . 0.0 110.415 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -63.48 -35.63 81.09 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.743 0.417 . . . . 0.0 111.601 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.5 mt -74.21 -46.8 39.56 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.763 0.825 . . . . 0.0 109.904 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.13 -35.2 71.14 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.402 1.081 . . . . 0.0 111.623 -174.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -48.25 -44.07 32.97 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.161 0.985 . . . . 0.0 111.477 174.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -77.91 -32.85 51.93 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.502 -0.749 . . . . 0.0 109.984 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.0 mt -64.16 -39.25 93.62 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.554 0.616 . . . . 0.0 110.043 174.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -65.41 -41.63 93.39 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.291 0.496 . . . . 0.0 110.249 176.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -64.18 -35.91 82.33 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.552 0.615 . . . . 0.0 111.287 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.88 -22.54 65.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.555 0.742 . . . . 0.0 111.984 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.19 -0.73 16.77 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.913 1.244 . . . . 0.0 113.346 170.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -75.64 174.72 9.38 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.509 1.154 . . . . 0.0 110.074 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 p -120.32 144.08 48.03 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 169.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.5 p -134.88 168.46 19.03 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.653 0.781 . . . . 0.0 110.484 -169.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -151.86 149.93 29.53 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 104.359 -2.459 . . . . 0.0 104.359 169.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -110.96 69.64 0.69 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.43 106.86 5.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -169.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -72.87 118.38 15.74 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.71 54.14 26.28 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 118.124 -1.376 . . . . 0.0 116.187 169.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.45 176.28 4.26 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 CA-C-N 120.328 2.064 . . . . 0.0 110.978 169.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.7 mt -127.33 161.52 28.44 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.093 1.357 . . . . 0.0 107.969 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.37 -27.76 69.29 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.853 0.861 . . . . 0.0 111.315 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -65.22 -7.75 14.36 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.592 1.157 . . . . 0.0 112.435 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -131.4 21.94 4.76 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.731 1.612 . . . . 0.0 110.871 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 65.8 mt -133.81 115.8 13.45 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.919 1.288 . . . . 0.0 107.835 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -70.25 163.89 37.03 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.147 1.898 . . . . 0.0 111.346 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.32 14.8 0.68 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.133 1.373 . . . . 0.0 113.52 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 p -153.46 146.1 24.22 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.221 1.008 . . . . 0.0 109.097 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.22 179.74 23.52 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.53 97.38 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 173.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -95.39 169.48 10.03 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.849 0.86 . . . . 0.0 109.055 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.4 tp -147.89 111.24 4.93 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.5 t -96.93 138.02 23.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -171.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -134.68 133.32 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.5 p -138.46 146.93 42.68 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 m -109.33 79.32 1.2 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.278 1.031 . . . . 0.0 109.508 -172.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.0 m -45.09 114.18 0.69 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.932 1.693 . . . . 0.0 109.873 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -64.52 -22.49 66.98 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -175.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 159.93 -29.29 0.37 Allowed Glycine 0 C--N 1.339 0.717 0 CA-C-O 118.833 -0.982 . . . . 0.0 113.363 169.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.11 29.14 4.07 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.454 1.127 . . . . 0.0 112.309 -170.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.1 4.23 60.04 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.426 -0.652 . . . . 0.0 113.471 175.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -81.97 121.99 27.22 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.265 1.032 . . . . 0.0 109.492 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.8 mt -80.46 142.43 53.99 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -49.85 136.85 35.71 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.031 3.154 . . . . 0.0 112.984 169.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -60.5 -20.99 61.92 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.688 1.195 . . . . 0.0 113.296 -174.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -69.26 -30.43 68.54 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 118.856 -0.592 . . . . 0.0 111.638 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.3 tp -123.34 -22.52 5.07 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.463 0.705 . . . . 0.0 112.105 -169.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.1 t -46.02 -41.08 19.26 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 117.636 -1.173 . . . . 0.0 113.546 173.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -50.96 -26.88 19.45 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.266 2.644 . . . . 0.0 116.005 172.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -62.84 -38.11 89.48 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.791 1.178 . . . . 0.0 110.802 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -63.46 -38.89 92.89 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 118.341 0.519 . . . . 0.0 110.36 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.04 -48.62 65.16 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.34 70.15 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 121.515 -0.741 . . . . 0.0 112.462 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.95 -57.42 6.94 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -69.47 -28.49 66.13 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.887 0.767 . . . . 0.0 112.346 -171.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -76.64 -22.14 54.5 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.745 0.702 . . . . 0.0 111.781 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -118.2 -36.09 3.66 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.748 0.704 . . . . 0.0 112.391 -172.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt 30.59 60.67 1.0 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 127.222 2.209 . . . . 0.0 113.376 -174.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.74 170.8 14.51 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.156 1.904 . . . . 0.0 109.924 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -72.31 111.01 7.14 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.002 0.521 . . . . 0.0 109.925 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.1 mt -118.98 24.5 10.79 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.796 1.638 . . . . 0.0 110.52 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.7 m -63.37 20.89 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.473 1.909 . . . . 0.0 115.872 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.09 2.84 1.75 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.663 1.185 . . . . 0.0 111.967 173.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.7 t -76.97 142.29 14.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 169.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 54.8 mmm-85 -119.76 144.21 47.4 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 168.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -138.25 171.28 14.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.29 0.567 . . . . 0.0 110.66 -174.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.33 165.55 25.45 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 105.553 -3.019 . . . . 0.0 105.553 169.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.32 128.85 15.02 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.677 0.739 . . . . 0.0 109.878 -169.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 37.4 mt -131.11 124.22 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -101.84 95.59 1.35 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.1 mt -79.79 155.19 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 168.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.59 174.43 33.44 Favored Glycine 0 N--CA 1.436 -1.329 0 CA-C-O 123.21 1.45 . . . . 0.0 111.468 169.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.6 m -74.78 73.65 2.07 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 125.98 1.712 . . . . 0.0 109.077 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.92 -27.89 63.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.167 1.387 . . . . 0.0 112.362 -170.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -83.78 -11.34 57.21 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.467 0.707 . . . . 0.0 112.745 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -70.09 -53.55 16.91 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.374 0.988 . . . . 0.0 111.416 -169.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -164.78 -49.41 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.386 1.074 . . . . 0.0 110.755 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.233 0.212 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -172.632 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.563 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.1 tp -59.83 -28.88 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.006 1.323 . . . . 0.0 110.839 173.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.06 -37.66 77.55 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 122.908 0.483 . . . . 0.0 111.176 -174.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -61.81 -53.28 58.01 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.745 0.818 . . . . 0.0 109.819 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.7 mt -62.09 -50.82 70.41 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.66 0.784 . . . . 0.0 109.477 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.47 -41.57 72.57 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -171.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.24 -33.74 72.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 119.118 -0.468 . . . . 0.0 110.236 -170.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.57 -29.78 66.31 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.858 0.753 . . . . 0.0 111.197 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.1 mt -64.41 -44.54 90.95 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.795 1.18 . . . . 0.0 108.777 169.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -59.63 -44.87 93.32 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -177.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -66.46 -37.1 84.38 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 122.739 0.415 . . . . 0.0 110.335 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 31.3 m -68.3 -13.06 61.99 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.833 0.853 . . . . 0.0 112.393 174.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.19 -20.69 3.35 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.745 1.164 . . . . 0.0 113.442 169.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.72 171.02 2.25 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.116 0.958 . . . . 0.0 111.841 -175.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -142.12 141.91 32.72 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.172 -0.955 . . . . 0.0 110.115 173.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -63.85 164.86 9.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.217 1.007 . . . . 0.0 109.997 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.3 m -136.0 148.29 48.35 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.914 2.086 . . . . 0.0 106.197 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.55 -133.64 52.62 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -170.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -141.28 160.58 39.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.273 1.829 . . . . 0.0 106.453 176.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.89 158.72 24.46 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.527 1.131 . . . . 0.0 110.695 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.4 tp -129.85 146.43 51.57 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.392 1.077 . . . . 0.0 108.749 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -120.18 141.98 49.39 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.9 mt -137.84 100.6 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -67.77 130.37 42.78 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 170.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 pp -113.85 -4.1 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 123.875 0.87 . . . . 0.0 111.875 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.4 tp . . . . . 0 CA--C 1.533 0.299 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 168.562 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.339 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -60.77 -41.53 95.71 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.881 0.872 . . . . 0.0 110.828 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -73.19 -40.08 65.06 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 75.7 t90 -60.51 -50.24 74.34 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 52.3 tp -64.94 -40.59 95.26 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 119.148 -0.453 . . . . 0.0 110.164 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.18 -46.83 84.86 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 173.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.5 m -63.99 -37.13 86.31 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.056 0.543 . . . . 0.0 111.071 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -65.97 -51.64 56.71 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.91 0.884 . . . . 0.0 110.286 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.8 m -67.2 -30.88 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 O-C-N 121.24 -0.913 . . . . 0.0 111.379 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -61.82 -20.12 63.29 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.632 0.773 . . . . 0.0 112.376 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.6 mt -101.87 -36.27 8.71 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.787 171.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.71 -37.22 84.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.779 1.172 . . . . 0.0 111.718 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt . . . . . 0 C--O 1.247 0.95 0 C-N-CA 128.604 2.762 . . . . 0.0 113.074 179.839 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.39 0 CA-C-O 120.713 0.292 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -132.84 -27.23 1.69 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.58 1.152 . . . . 0.0 110.962 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.8 mt -124.94 79.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.2 m -75.12 117.82 17.38 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 mt -89.09 156.84 18.57 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.783 0.833 . . . . 0.0 108.812 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.4 mt -126.44 95.32 3.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -171.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.5 m -73.29 146.27 45.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.855 0.862 . . . . 0.0 110.11 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.32 81.94 0.15 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 124.47 1.033 . . . . 0.0 110.833 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.455 -0.176 0 C-N-CA 123.444 0.697 . . . . 0.0 110.025 176.746 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.611 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.38 -35.47 80.41 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 122.001 -0.705 . . . . 0.0 110.499 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.59 -34.51 69.96 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.095 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -66.43 -46.06 77.77 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.417 0.687 . . . . 0.0 109.238 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.0 t -63.18 -47.75 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.57 -38.41 84.49 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-O 118.823 -0.608 . . . . 0.0 111.007 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.16 -45.23 89.39 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.345 0.975 . . . . 0.0 110.715 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -67.79 -40.04 83.99 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.884 -0.51 . . . . 0.0 110.795 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.3 mt -64.2 -42.51 96.6 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 119.257 -0.402 . . . . 0.0 110.157 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.08 -44.87 96.71 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.549 0.74 . . . . 0.0 110.468 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -58.77 -42.25 88.51 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.225 0.466 . . . . 0.0 110.269 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.5 mmtm -69.94 -39.47 76.08 Favored 'General case' 0 N--CA 1.462 0.142 0 O-C-N 121.682 -0.636 . . . . 0.0 111.726 176.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.6 mt -60.65 -37.12 80.47 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.084 0.856 . . . . 0.0 111.045 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -67.63 -35.75 79.51 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.863 0.756 . . . . 0.0 110.682 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.71 -37.46 84.74 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.092 0.86 . . . . 0.0 110.792 172.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.64 -26.41 67.05 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 122.844 0.457 . . . . 0.0 111.55 173.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.95 -3.28 11.68 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.345 1.45 . . . . 0.0 113.834 169.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -81.08 144.36 31.78 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.91 1.355 . . . . 0.0 109.724 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 p -84.18 144.11 29.19 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 169.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.8 p -135.7 169.33 17.72 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.613 0.765 . . . . 0.0 110.795 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -150.79 161.38 42.76 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 p -131.95 75.73 1.66 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.6 mt -69.23 121.91 17.78 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -171.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -80.51 95.49 6.49 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.64 56.17 26.76 Favored Glycine 0 CA--C 1.541 1.68 0 CA-C-O 118.783 -1.009 . . . . 0.0 113.852 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -69.47 178.84 3.99 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.556 2.838 . . . . 0.0 111.988 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.7 mt -129.04 165.93 20.21 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.44 1.496 . . . . 0.0 109.173 172.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.4 tp -63.2 -26.57 68.86 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.777 1.231 . . . . 0.0 112.288 -173.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.11 -10.15 13.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.052 0.941 . . . . 0.0 113.071 174.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -128.07 18.79 6.55 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.443 1.497 . . . . 0.0 111.068 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.6 mt -135.51 97.93 12.67 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 125.106 1.362 . . . . 0.0 107.756 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.73 165.26 30.21 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.356 2.037 . . . . 0.0 111.731 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.64 5.21 2.57 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.837 1.655 . . . . 0.0 114.71 -171.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.3 m -145.43 131.65 19.48 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.776 1.23 . . . . 0.0 107.997 -173.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.91 -172.23 35.06 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.039 -0.825 . . . . 0.0 111.039 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -129.73 97.26 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 173.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -100.52 172.27 7.22 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.602 0.761 . . . . 0.0 110.014 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.7 tp -138.78 103.17 4.76 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 120.793 -1.192 . . . . 0.0 107.809 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.6 t -80.43 129.34 37.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 mt -129.93 129.12 65.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 172.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -139.26 129.7 25.65 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -170.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.8 m -74.08 164.54 26.49 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.174 0.511 . . . . 0.0 109.981 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.8 m -135.98 138.53 42.37 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 176.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -124.84 10.47 8.3 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -169.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.59 -48.82 0.46 Allowed Glycine 0 C--N 1.34 0.773 0 CA-C-N 119.124 0.874 . . . . 0.0 112.849 169.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.28 24.53 2.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.038 0.935 . . . . 0.0 112.053 -169.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.85 9.67 57.14 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 119.614 -0.548 . . . . 0.0 112.653 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -65.08 122.27 16.65 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.276 1.038 . . . . 0.0 109.089 172.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.8 mt -83.07 145.02 48.36 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.79 138.88 85.59 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.064 2.51 . . . . 0.0 110.897 173.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -59.46 -16.93 27.09 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.914 1.285 . . . . 0.0 113.185 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -67.48 -33.12 74.46 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.259 0.624 . . . . 0.0 111.802 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.7 tp -125.67 -21.16 4.51 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.353 0.661 . . . . 0.0 112.27 -172.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 t -47.4 -40.56 27.72 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 117.618 -1.182 . . . . 0.0 113.736 174.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -50.79 -27.18 19.53 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.162 2.574 . . . . 0.0 115.669 172.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -63.02 -38.38 90.94 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.596 1.089 . . . . 0.0 110.877 177.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -64.22 -37.31 87.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.694 0.679 . . . . 0.0 110.156 177.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -69.49 -50.3 46.62 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.1 -31.73 73.04 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.448 -0.783 . . . . 0.0 112.15 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.5 mt -65.51 -55.53 17.3 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.539 -0.743 . . . . 0.0 109.605 172.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -70.18 -27.67 64.7 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.509 1.05 . . . . 0.0 112.309 -172.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -71.27 -28.41 64.13 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.769 0.713 . . . . 0.0 111.433 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -114.45 -33.69 5.5 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -170.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp 29.97 57.73 0.82 Allowed Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 127.719 2.407 . . . . 0.0 113.415 -172.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -69.41 172.63 11.95 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.125 1.883 . . . . 0.0 110.333 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -70.26 111.74 6.08 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.967 0.507 . . . . 0.0 109.83 171.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 mt -120.45 25.32 9.87 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.978 1.711 . . . . 0.0 110.323 175.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.4 m -63.7 19.9 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -174.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.87 9.44 1.52 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.684 1.194 . . . . 0.0 111.505 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.9 t -80.38 102.19 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 170.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -79.73 147.75 31.78 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 167.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -146.23 172.62 13.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 119.325 0.966 . . . . 0.0 112.019 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -125.66 162.35 19.91 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 105.847 -2.901 . . . . 0.0 105.847 169.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.7 125.93 16.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -170.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.3 mt -136.07 135.43 50.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -114.72 147.15 18.85 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.7 mt -127.83 147.81 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 164.95 157.18 9.49 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.4 m -71.51 120.32 16.93 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 171.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 -60.67 -15.32 27.55 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -64.38 -25.99 68.27 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.495 -0.753 . . . . 0.0 112.21 172.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 -61.76 156.7 19.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.856 0.753 . . . . 0.0 111.761 -177.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -57.45 -41.1 79.86 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.958 0.903 . . . . 0.0 110.784 171.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.8 m . . . . . 0 N--CA 1.446 -0.653 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 175.974 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.775 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 tp -53.91 -31.36 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.438 1.895 . . . . 0.0 110.361 169.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -57.48 -38.45 74.56 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.062 0.545 . . . . 0.0 112.209 -170.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -68.07 -45.67 73.18 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 121.946 -0.471 . . . . 0.0 110.549 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.9 mt -60.81 -49.21 78.41 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.384 0.674 . . . . 0.0 109.182 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -69.74 -33.68 72.79 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.185 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.32 93.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -74.27 -30.5 62.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.949 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.0 mt -62.11 -51.72 66.77 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 119.482 1.037 . . . . 0.0 109.483 170.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -68.29 -32.85 73.29 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.73 -173.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -64.76 -37.33 87.26 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.504 0.322 . . . . 0.0 111.106 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.5 m -71.03 -4.67 26.18 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.316 1.046 . . . . 0.0 112.917 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.79 -16.61 9.5 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.177 1.37 . . . . 0.0 113.249 169.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.69 176.14 0.55 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.037 1.335 . . . . 0.0 111.632 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.62 137.22 15.98 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.723 -1.236 . . . . 0.0 112.649 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -60.66 137.71 58.15 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.566 1.546 . . . . 0.0 108.661 169.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.3 m -121.59 139.24 53.78 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.593 1.957 . . . . 0.0 106.211 171.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.1 175.26 24.79 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.945 0.783 . . . . 0.0 111.668 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -85.47 139.07 31.79 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.924 -0.75 . . . . 0.0 109.366 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.1 m -57.73 152.84 14.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.902 1.681 . . . . 0.0 110.24 174.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 62.9 tp -128.95 149.01 50.98 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.941 0.897 . . . . 0.0 109.939 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -113.16 139.34 48.83 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 17.1 mm -117.6 96.0 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 171.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -67.43 138.37 56.61 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 172.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.0 pt -129.45 13.14 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.673 1.189 . . . . 0.0 111.745 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.4 tp . . . . . 0 N--CA 1.466 0.363 0 C-N-CA 123.452 0.701 . . . . 0.0 110.755 177.409 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.269 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -59.03 -24.29 62.71 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.367 1.467 . . . . 0.0 112.577 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -89.81 -43.49 10.61 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.899 0.772 . . . . 0.0 109.596 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -59.93 -28.92 68.01 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.44 0.696 . . . . 0.0 111.498 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 59.8 tp -51.92 -35.2 44.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.394 1.477 . . . . 0.0 111.872 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.85 -44.61 87.26 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 m -66.76 -30.99 71.34 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.548 0.739 . . . . 0.0 111.145 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -72.32 -55.35 7.27 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.251 0.478 . . . . 0.0 109.798 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.9 m -63.62 -29.53 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 118.498 0.59 . . . . 0.0 111.553 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -54.38 -28.53 43.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.896 0.879 . . . . 0.0 112.458 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 27.4 mt -101.7 -3.49 28.13 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.067 -0.968 . . . . 0.0 113.511 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.6 pp -125.94 -14.63 6.07 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.274 1.397 . . . . 0.0 113.497 -178.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.5 pttt . . . . . 0 C--O 1.25 1.126 0 C-N-CA 123.826 0.85 . . . . 0.0 111.079 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.726 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -140.97 -27.27 0.71 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.823 1.249 . . . . 0.0 111.669 177.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mt -132.96 83.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 171.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 79.6 m -73.99 119.28 17.99 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.55 148.13 35.38 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 172.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 82.7 mt -113.39 78.05 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.9 m -76.13 97.23 4.04 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.237 1.415 . . . . 0.0 109.332 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.03 52.21 0.67 Allowed Glycine 0 N--CA 1.461 0.337 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -172.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.448 -0.569 0 C-N-CA 123.296 0.639 . . . . 0.0 112.549 -167.972 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.592 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.78 -31.78 72.95 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.154 -0.45 . . . . 0.0 110.06 175.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -72.61 -35.38 67.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.816 0.735 . . . . 0.0 111.015 177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -67.11 -39.42 86.68 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.994 0.815 . . . . 0.0 109.229 175.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.87 -47.01 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 118.681 -0.676 . . . . 0.0 109.549 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.96 86.29 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.467 1.031 . . . . 0.0 111.383 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.09 -43.57 91.68 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.14 0.576 . . . . 0.0 110.593 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -64.62 -44.59 90.05 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.541 0.61 . . . . 0.0 110.66 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.3 mt -58.55 -46.97 85.74 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.327 1.051 . . . . 0.0 109.93 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.03 -46.04 89.2 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.303 0.641 . . . . 0.0 110.176 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.02 -42.2 93.84 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.016 0.526 . . . . 0.0 110.082 -179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -63.74 -36.89 85.36 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 121.744 -0.598 . . . . 0.0 110.233 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.94 -38.71 76.26 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 118.66 0.664 . . . . 0.0 111.013 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.07 -43.35 99.02 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.727 0.694 . . . . 0.0 109.398 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.04 -38.99 92.65 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.078 0.551 . . . . 0.0 111.104 176.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.38 -21.43 64.7 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.624 0.77 . . . . 0.0 112.203 176.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.95 28.71 3.54 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.758 -1.023 . . . . 0.0 113.623 170.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -124.96 133.77 52.89 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.977 1.388 . . . . 0.0 108.924 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 p -75.79 140.6 42.43 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.282 0.563 . . . . 0.0 109.7 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.1 p -131.01 168.55 17.18 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.35 1.06 . . . . 0.0 110.6 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -154.45 128.0 8.6 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 169.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 p -82.59 65.09 7.55 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.007 1.323 . . . . 0.0 108.248 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.1 121.36 15.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -169.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.0 107.23 4.61 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -173.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 37.36 56.59 1.5 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 127.642 2.544 . . . . 0.0 115.789 173.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -62.47 148.66 92.97 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 120.222 2.011 . . . . 0.0 110.63 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mt -98.62 171.06 8.37 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 124.233 1.013 . . . . 0.0 110.551 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -52.92 -38.78 62.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.425 1.49 . . . . 0.0 111.282 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.74 -6.0 18.86 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.45 1.1 . . . . 0.0 112.68 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -135.27 20.38 3.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.986 1.714 . . . . 0.0 110.924 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.2 mt -134.11 108.73 11.54 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 125.133 1.373 . . . . 0.0 107.607 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.2 160.42 48.94 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.889 1.726 . . . . 0.0 110.631 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.6 7.13 2.58 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.742 1.217 . . . . 0.0 114.098 -172.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.2 m -147.52 142.13 26.59 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -176.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.16 -177.85 29.73 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.5 101.31 8.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -109.04 170.23 8.18 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.991 0.916 . . . . 0.0 109.914 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.8 tp -144.73 106.95 4.34 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.1 t -81.79 139.58 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 124.059 0.944 . . . . 0.0 108.864 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 mp -133.34 143.45 39.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.2 m -148.46 143.91 27.04 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.192 -0.943 . . . . 0.0 110.195 176.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -69.37 150.62 47.1 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.0 m -116.43 91.59 3.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -56.66 -32.19 65.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.53 0.732 . . . . 0.0 111.714 -176.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 150.82 -29.96 1.02 Allowed Glycine 0 C--N 1.34 0.763 0 C-N-CA 123.892 0.758 . . . . 0.0 112.628 169.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.96 25.29 7.36 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.421 1.088 . . . . 0.0 111.948 -170.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.12 5.94 86.99 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-O 119.363 -0.687 . . . . 0.0 112.921 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -72.96 146.94 45.67 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 169.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.3 mt -126.03 139.69 34.99 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -172.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -51.73 138.19 50.29 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.055 2.503 . . . . 0.0 113.304 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -57.71 -12.69 3.15 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.717 1.607 . . . . 0.0 113.198 174.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -54.96 -42.59 72.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.178 1.391 . . . . 0.0 109.732 172.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.3 tp -133.64 -21.45 1.97 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -171.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 91.5 p -52.48 -33.12 11.05 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -172.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -53.68 -23.09 24.83 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.803 2.335 . . . . 0.0 115.153 171.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -59.56 -36.59 76.5 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.571 1.078 . . . . 0.0 111.441 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -61.35 -43.0 99.61 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.186 0.448 . . . . 0.0 110.047 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -68.74 -47.09 67.18 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.167 0.587 . . . . 0.0 109.864 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.36 -36.74 83.65 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.865 -0.522 . . . . 0.0 112.03 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.3 mt -67.91 -51.31 49.34 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 118.515 -0.755 . . . . 0.0 109.537 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -68.76 -28.02 66.42 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.435 1.016 . . . . 0.0 111.886 -174.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.2 -39.23 86.32 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.749 0.704 . . . . 0.0 110.483 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -100.17 -22.8 15.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.891 -0.576 . . . . 0.0 112.43 -170.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt 40.03 56.97 7.2 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.997 1.719 . . . . 0.0 110.691 -169.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.88 143.02 78.19 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.354 2.036 . . . . 0.0 110.883 -169.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -81.85 64.22 6.45 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.655 1.182 . . . . 0.0 108.731 174.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.75 -56.01 10.88 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.6 m 50.55 19.97 0.64 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 169.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -157.38 -0.63 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 80.9 t -71.56 139.26 20.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -115.05 135.11 54.57 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 169.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -139.81 173.17 11.79 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.116 0.96 . . . . 0.0 112.298 -170.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -133.63 163.4 24.43 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 106.079 -2.808 . . . . 0.0 106.079 169.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.45 123.86 7.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.218 1.009 . . . . 0.0 108.413 -169.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 29.7 mt -139.53 139.93 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.47 138.91 11.81 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 169.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.68 128.59 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 162.96 -149.74 17.85 Favored Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 172.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.3 m -85.45 55.87 3.7 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 126.144 1.778 . . . . 0.0 110.956 -169.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -53.14 -37.01 61.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.836 0.855 . . . . 0.0 112.344 -173.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.0 -16.97 64.02 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.641 0.776 . . . . 0.0 112.87 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -63.18 -47.37 82.91 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.806 0.73 . . . . 0.0 111.483 -174.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -162.76 -43.07 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.4 m . . . . . 0 CA--C 1.531 0.234 0 C-N-CA 124.062 0.945 . . . . 0.0 108.874 -169.964 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.6 tp -127.6 -34.0 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.292 1.037 . . . . 0.0 110.002 169.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -55.17 -36.91 66.36 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.41 0.684 . . . . 0.0 111.823 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.41 -54.57 45.52 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.569 0.622 . . . . 0.0 110.902 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 50.4 mt -66.26 -49.35 67.45 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -173.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.17 -35.98 74.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -171.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.84 82.78 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.86 -0.591 . . . . 0.0 110.107 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -69.13 -31.25 69.8 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.239 0.927 . . . . 0.0 112.437 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.7 mt -64.24 -42.37 96.56 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.645 1.566 . . . . 0.0 109.447 169.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -61.93 -41.4 97.91 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.504 0.722 . . . . 0.0 110.133 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -64.4 -36.44 84.15 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.056 1.342 . . . . 0.0 111.012 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.1 m -72.79 7.8 1.8 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.076 1.35 . . . . 0.0 112.849 172.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.27 -8.11 80.55 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.898 1.237 . . . . 0.0 113.353 171.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.13 167.75 4.75 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.421 1.111 . . . . 0.0 110.043 170.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -142.7 151.93 41.84 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.267 -0.896 . . . . 0.0 111.957 176.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -56.39 163.71 1.62 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.375 1.47 . . . . 0.0 110.147 169.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.72 37.69 2.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.381 1.086 . . . . 0.0 109.604 -177.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 155.52 -167.48 33.04 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.558 2.028 . . . . 0.0 108.046 -169.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.75 154.68 20.76 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 117.925 0.863 . . . . 0.0 109.007 169.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.7 m -67.61 158.21 32.64 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.0 tp -132.41 152.34 51.51 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.563 0.745 . . . . 0.0 109.141 172.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -137.4 146.46 44.46 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 169.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.8 mt -134.14 103.31 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -169.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -75.8 141.8 42.44 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -130.9 4.86 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.2 tp . . . . . 0 C--N 1.347 0.462 0 CA-C-N 119.923 1.238 . . . . 0.0 111.374 -169.977 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 119.078 -0.486 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.5 -42.99 86.56 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.717 0.69 . . . . 0.0 110.647 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.19 -40.51 78.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.867 0.467 . . . . 0.0 110.127 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -67.05 -37.78 84.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.06 175.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.03 -42.92 93.89 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.629 1.104 . . . . 0.0 109.941 177.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.84 -43.9 87.21 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 171.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.0 m -63.82 -41.48 97.85 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.177 -0.602 . . . . 0.0 110.836 176.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -49.01 79.32 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.674 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.7 m -66.57 -31.75 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 120.431 1.468 . . . . 0.0 111.634 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -67.97 -18.91 64.88 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.628 0.649 . . . . 0.0 111.794 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.37 -47.2 4.77 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.809 1.244 . . . . 0.0 110.25 -176.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.6 pp -74.55 -23.51 58.8 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.077 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 C--O 1.246 0.88 0 C-N-CA 127.73 2.412 . . . . 0.0 112.15 177.932 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.261 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -136.95 -25.1 1.1 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.045 1.338 . . . . 0.0 111.215 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.9 mt -128.83 82.1 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 169.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 m -76.6 117.94 18.75 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.76 149.74 39.64 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 171.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 68.9 mt -117.18 95.14 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 104.743 -2.318 . . . . 0.0 104.743 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.4 m -85.59 89.49 7.73 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.283 1.833 . . . . 0.0 110.847 -169.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.64 57.09 4.76 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -167.627 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 111.424 -0.671 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.09 -29.66 68.73 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.241 0.52 . . . . 0.0 110.091 172.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -80.88 -30.32 35.57 Favored 'General case' 0 N--CA 1.462 0.162 0 O-C-N 121.962 -0.461 . . . . 0.0 111.601 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -66.79 -40.54 88.17 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.094 0.861 . . . . 0.0 108.931 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.07 -42.36 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 118.675 -0.679 . . . . 0.0 109.849 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.85 85.12 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.539 1.063 . . . . 0.0 111.149 176.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -65.04 -43.03 93.68 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.192 0.597 . . . . 0.0 110.654 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -61.2 -47.22 87.12 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.417 0.553 . . . . 0.0 110.875 176.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.5 mt -59.34 -47.67 84.55 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.541 0.737 . . . . 0.0 109.374 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.5 93.58 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.586 0.754 . . . . 0.0 110.808 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 -58.93 -41.49 87.44 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.404 0.547 . . . . 0.0 110.435 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.44 -30.76 66.43 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.011 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 70.5 mt -65.76 -40.0 91.63 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 119.91 1.232 . . . . 0.0 111.62 170.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -60.09 -43.92 95.18 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.868 0.758 . . . . 0.0 109.321 177.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.41 -38.06 88.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.206 0.602 . . . . 0.0 111.311 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.86 -21.43 64.27 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.739 0.816 . . . . 0.0 112.275 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.29 28.49 3.79 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.375 171.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -126.52 129.39 48.53 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.804 1.302 . . . . 0.0 107.96 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 p -75.37 148.11 39.49 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.8 p -134.02 170.17 16.04 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.757 0.789 . . . . 0.0 111.393 -171.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -152.6 161.96 41.87 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 169.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.49 78.5 1.81 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.7 mt -69.66 113.6 7.08 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.409 ' CD2' HD21 ' A' ' 65' ' ' ASN . 43.0 t60 -73.35 106.23 5.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 52.51 55.68 21.39 Favored Glycine 0 CA--C 1.541 1.685 0 CA-C-O 118.58 -1.122 . . . . 0.0 115.575 172.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -69.26 175.33 7.83 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.161 2.574 . . . . 0.0 111.722 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.6 mt -131.69 171.28 13.67 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 126.06 1.744 . . . . 0.0 110.152 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.87 -38.26 55.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.051 1.74 . . . . 0.0 111.857 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.62 -8.56 14.77 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -133.99 18.41 3.79 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.144 1.778 . . . . 0.0 110.87 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.9 mt -134.27 98.29 14.14 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 125.223 1.409 . . . . 0.0 107.704 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.14 163.5 35.8 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.157 1.905 . . . . 0.0 110.857 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.79 3.03 4.53 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -170.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.4 m -147.68 136.96 22.39 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.654 1.182 . . . . 0.0 107.894 -171.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.1 177.26 25.62 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.5 mt -113.71 102.43 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -101.21 168.68 9.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.341 0.656 . . . . 0.0 109.43 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.0 tp -144.59 100.42 3.52 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.4 t -79.49 140.78 16.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 123.553 0.741 . . . . 0.0 109.015 -174.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.3 mp -132.31 135.97 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 171.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.3 m -126.0 137.95 53.7 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.284 0.633 . . . . 0.0 111.369 173.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.4 m -69.87 160.25 32.16 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 168.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.59 89.14 2.19 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -78.63 42.28 0.44 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.767 1.227 . . . . 0.0 112.053 -171.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.57 -39.56 1.95 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.103 1.335 . . . . 0.0 113.422 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.62 -21.35 59.51 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.124 0.969 . . . . 0.0 112.971 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.35 9.13 80.04 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.767 -1.018 . . . . 0.0 113.539 -176.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -75.92 152.54 37.08 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.83 1.315 . . . . 0.0 110.756 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.1 mt -65.98 142.89 98.23 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.325 1.45 . . . . 0.0 108.567 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -57.95 125.99 20.31 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.937 3.091 . . . . 0.0 111.714 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -56.75 -27.09 58.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.656 1.182 . . . . 0.0 114.134 -173.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.409 HD21 ' CD2' ' A' ' 37' ' ' HIS . 10.2 p-10 -73.23 -19.18 61.14 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.817 -0.552 . . . . 0.0 112.43 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.4 tp -127.29 -23.03 3.6 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.125 1.37 . . . . 0.0 111.175 -171.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.2 p -53.94 -31.66 9.04 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-O 116.832 -1.556 . . . . 0.0 114.832 -176.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -52.54 -23.57 19.78 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.481 2.121 . . . . 0.0 114.929 169.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.46 -35.92 78.95 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.952 1.251 . . . . 0.0 111.675 175.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -59.32 -43.07 92.73 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.331 0.514 . . . . 0.0 109.777 176.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.9 -48.47 58.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.929 0.492 . . . . 0.0 109.8 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.38 -31.56 72.73 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.891 0.769 . . . . 0.0 112.54 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.1 mt -68.6 -54.65 15.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.952 0.796 . . . . 0.0 109.404 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -68.89 -29.52 67.82 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.336 0.971 . . . . 0.0 112.264 -171.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -73.24 -24.16 60.44 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.786 0.721 . . . . 0.0 111.32 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -112.86 -23.64 10.0 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.865 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt 39.31 64.67 3.84 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.936 1.694 . . . . 0.0 109.807 -169.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.88 -4.68 13.87 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.295 2.663 . . . . 0.0 115.534 -169.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.7 t70 50.57 51.99 15.76 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.172 1.389 . . . . 0.0 111.592 171.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.3 mt -58.92 -46.48 87.85 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.443 1.497 . . . . 0.0 110.494 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.8 m 54.86 15.44 1.13 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 172.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -153.92 2.03 0.24 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.704 1.138 . . . . 0.0 113.857 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 79.7 t -72.56 138.12 22.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 169.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -119.96 140.32 51.11 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 104.262 -2.496 . . . . 0.0 104.262 168.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -149.69 169.91 19.92 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.364 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.42 166.65 20.9 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 105.662 -2.975 . . . . 0.0 105.662 169.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.64 135.84 23.87 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.373 1.087 . . . . 0.0 109.723 -169.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.2 mt -135.9 137.36 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -175.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.18 135.18 11.18 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 170.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.9 mt -139.57 131.13 33.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 164.96 -159.85 33.02 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 120.425 1.466 . . . . 0.0 110.369 171.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.6 m -76.33 47.45 0.47 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 127.727 2.411 . . . . 0.0 111.106 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 57.1 mtt-85 -66.57 -15.9 63.76 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.149 -0.969 . . . . 0.0 112.879 -170.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.63 -28.38 69.86 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.21 0.604 . . . . 0.0 112.051 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -66.42 -57.32 7.65 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 123.292 0.637 . . . . 0.0 110.466 -171.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -169.01 -66.33 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.263 1.425 . . . . 0.0 108.636 172.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.9 p . . . . . 0 CA--C 1.551 0.987 0 C-N-CA 127.413 2.285 . . . . 0.0 114.308 -174.516 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.09 -33.16 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -61.06 -37.77 83.83 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.957 0.903 . . . . 0.0 111.971 -172.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -68.38 -42.77 78.61 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.725 -0.609 . . . . 0.0 111.081 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.77 -50.05 73.91 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.55 -32.93 73.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 119.438 -0.315 . . . . 0.0 111.023 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.77 99.59 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -74.57 -29.2 61.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.279 -0.867 . . . . 0.0 112.259 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.1 mt -62.82 -47.91 81.38 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.191 1.359 . . . . 0.0 109.234 170.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -66.07 -36.62 83.7 Favored 'General case' 0 N--CA 1.46 0.054 0 C-N-CA 122.415 0.286 . . . . 0.0 110.829 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -63.38 -38.36 90.85 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.134 0.574 . . . . 0.0 110.7 173.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.2 m -74.46 11.77 0.92 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.661 1.184 . . . . 0.0 112.499 171.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.35 -5.52 84.64 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 120.78 -1.2 . . . . 0.0 113.857 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.9 169.39 2.6 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.0 1.4 . . . . 0.0 110.092 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -141.74 139.74 32.93 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.602 -0.686 . . . . 0.0 110.966 169.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -64.94 170.61 4.15 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.049 1.339 . . . . 0.0 109.461 175.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.1 m -140.15 152.72 46.29 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.39 -132.99 42.03 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -144.07 154.85 43.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.77 129.78 42.02 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.119 0.968 . . . . 0.0 109.958 -177.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.2 tp -91.36 142.39 27.74 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -129.71 139.46 51.33 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.2 mt -138.99 100.4 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -73.43 133.43 43.73 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 169.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -128.91 8.12 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.844 0.747 . . . . 0.0 112.538 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.5 tp . . . . . 0 N--CA 1.468 0.456 0 CA-C-N 118.941 0.792 . . . . 0.0 111.654 -178.479 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.218 0 CA-C-O 119.541 -0.266 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.29 -34.19 77.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.217 0.607 . . . . 0.0 111.563 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -79.42 -36.6 38.78 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.419 0.554 . . . . 0.0 109.756 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -66.83 -40.0 87.83 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.771 -0.581 . . . . 0.0 110.046 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.1 tp -64.77 -42.33 95.19 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.51 1.124 . . . . 0.0 110.575 174.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.52 -43.98 85.59 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.43 1.014 . . . . 0.0 110.985 172.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.8 m -63.98 -41.11 97.64 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.292 0.637 . . . . 0.0 110.568 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -52.01 66.68 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.406 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.1 m -61.79 -35.07 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 119.793 1.179 . . . . 0.0 110.796 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -61.92 -24.35 66.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.55 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.2 mt -91.64 -47.77 7.2 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.739 1.154 . . . . 0.0 111.04 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.7 pp -80.24 -10.94 59.77 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -172.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.4 pttm . . . . . 0 C--O 1.249 1.053 0 C-N-CA 125.463 1.505 . . . . 0.0 112.778 -177.565 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.299 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -136.37 -26.64 1.11 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.276 1.43 . . . . 0.0 111.038 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.0 mt -122.91 77.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 169.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -74.74 116.33 15.33 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.2 mt -87.84 155.93 19.64 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.3 mt -125.62 95.12 3.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -170.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 m -90.07 153.03 20.87 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.086 1.754 . . . . 0.0 111.022 -175.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.18 128.95 1.15 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 107.558 -2.217 . . . . 0.0 107.558 173.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.204 0 CA-C-O 121.565 0.698 . . . . 0.0 112.305 -172.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.648 0 CA-C-O 118.611 -1.105 . . . . 0.0 112.948 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.23 -32.42 73.83 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.037 1.919 . . . . 0.0 110.746 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.67 -39.34 93.5 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.494 0.318 . . . . 0.0 110.848 176.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -70.55 -48.03 57.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -61.35 -43.1 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.52 -48.15 83.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 118.73 0.696 . . . . 0.0 110.101 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.51 -43.33 94.43 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.663 0.665 . . . . 0.0 110.986 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -63.53 -38.44 91.16 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.813 0.845 . . . . 0.0 111.252 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.6 mt -74.53 -41.25 60.94 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.266 0.626 . . . . 0.0 110.275 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.89 -40.32 80.0 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 123.438 0.695 . . . . 0.0 110.84 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -52.51 -46.35 66.64 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.608 0.763 . . . . 0.0 110.638 175.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -68.0 -39.21 83.26 Favored 'General case' 0 N--CA 1.46 0.064 0 O-C-N 121.84 -0.538 . . . . 0.0 110.259 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.8 mt -66.34 -39.84 89.46 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 119.506 -0.283 . . . . 0.0 110.705 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.81 -40.44 91.88 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.409 0.549 . . . . 0.0 110.18 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -64.78 -36.19 83.51 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.33 0.514 . . . . 0.0 111.018 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.94 -23.98 64.22 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.46 0.704 . . . . 0.0 111.994 174.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.86 -0.62 13.53 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.902 1.239 . . . . 0.0 113.741 170.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -75.67 174.75 9.36 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.737 1.268 . . . . 0.0 110.305 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.9 p -119.16 144.01 46.91 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 170.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -135.64 167.69 20.66 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.063 0.945 . . . . 0.0 109.934 -169.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -153.07 160.23 42.92 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 169.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 p -124.88 72.19 1.21 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.0 mt -69.05 114.38 7.28 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -173.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -81.89 110.0 16.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.85 46.62 93.22 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-O 117.943 -1.476 . . . . 0.0 115.926 172.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -69.09 173.36 10.48 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 121.031 2.415 . . . . 0.0 110.267 169.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 mp -131.34 175.68 8.93 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.285 1.434 . . . . 0.0 108.036 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.3 tp -55.77 -32.02 63.08 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.284 1.034 . . . . 0.0 111.052 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.83 -7.5 11.43 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.068 0.947 . . . . 0.0 112.717 178.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -134.19 18.08 3.74 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.42 1.488 . . . . 0.0 111.336 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.7 mt -137.27 113.57 9.58 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.702 1.201 . . . . 0.0 108.422 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.78 164.14 36.63 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.366 2.044 . . . . 0.0 111.428 -178.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.6 20.46 1.12 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.163 1.385 . . . . 0.0 112.951 -171.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.8 m -153.94 139.1 17.43 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 120.999 -1.063 . . . . 0.0 108.41 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.42 -178.14 27.14 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.18 101.05 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -102.82 175.28 5.54 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.29 1.036 . . . . 0.0 110.462 -173.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.6 tp -145.66 108.3 4.48 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.4 t -86.56 131.65 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.6 mt -130.67 131.63 64.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.9 m -149.47 142.02 24.4 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.643 0.777 . . . . 0.0 109.192 -169.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.8 m -73.68 160.6 31.33 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 m -115.54 5.77 14.5 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.757 0.789 . . . . 0.0 112.678 -175.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 41.53 22.9 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 129.279 3.031 . . . . 0.0 114.181 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.89 19.31 29.12 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.462 -1.188 . . . . 0.0 114.562 -170.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.35 -13.32 0.13 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.491 1.646 . . . . 0.0 115.115 -169.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.43 -1.83 53.64 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 119.454 1.025 . . . . 0.0 113.081 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.96 155.87 38.18 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 169.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.9 mt -122.91 144.38 42.86 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.028 1.331 . . . . 0.0 107.863 -169.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.99 124.74 4.93 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.606 3.538 . . . . 0.0 113.62 172.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.5 -24.22 65.13 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.94 0.896 . . . . 0.0 113.066 -174.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -73.9 -22.46 59.69 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.0 tp -122.69 -29.9 3.95 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.152 0.981 . . . . 0.0 111.372 -170.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 t -45.75 -41.76 20.39 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.537 1.535 . . . . 0.0 113.684 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -51.16 -23.01 12.05 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.301 2.667 . . . . 0.0 116.122 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -56.76 -38.21 72.12 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.68 1.127 . . . . 0.0 111.027 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -58.23 -43.81 87.92 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.101 0.96 . . . . 0.0 110.458 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -72.48 -45.71 58.22 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.05 0.54 . . . . 0.0 109.841 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.62 -33.95 77.09 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 118.874 -0.584 . . . . 0.0 112.058 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.3 mt -63.85 -57.87 8.52 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -68.85 -27.24 65.64 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.829 0.741 . . . . 0.0 112.197 -172.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.06 -37.34 87.22 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.576 0.625 . . . . 0.0 110.615 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -105.65 -30.81 9.24 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -170.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.7 tttm 29.27 60.86 0.79 Allowed Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 128.019 2.528 . . . . 0.0 113.692 -174.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.09 170.08 15.21 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.711 1.608 . . . . 0.0 110.089 172.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -74.23 110.99 8.96 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.428 ' C ' ' H ' ' A' ' 82' ' ' ALA . 72.2 mt -114.58 20.24 15.48 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.418 1.487 . . . . 0.0 110.948 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.8 m -62.15 19.35 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.994 1.718 . . . . 0.0 115.558 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' A' ' 80' ' ' LEU . . . -136.12 -0.8 2.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.338 1.455 . . . . 0.0 111.861 174.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 68.0 t -81.41 142.92 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 169.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -122.63 146.72 47.2 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 168.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -143.9 172.37 12.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.588 0.709 . . . . 0.0 110.803 -173.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.68 166.95 23.36 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 107.983 -2.047 . . . . 0.0 107.983 169.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.9 134.8 17.81 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -169.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.9 mt -138.68 128.82 33.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -177.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -104.32 104.59 2.45 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 107.983 -2.047 . . . . 0.0 107.983 173.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.3 mt -84.33 128.56 38.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.798 -1.926 . . . . 0.0 105.798 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.55 -146.48 6.06 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 -172.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.2 m -161.7 149.08 14.54 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.653 1.181 . . . . 0.0 110.36 171.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -64.7 -17.18 63.86 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.81 -36.55 84.7 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.207 0.603 . . . . 0.0 109.91 175.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -74.01 158.26 34.66 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.429 0.633 . . . . 0.0 110.708 176.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.49 -19.07 62.25 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.668 0.787 . . . . 0.0 112.523 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.4 m . . . . . 0 CA--C 1.536 0.442 0 C-N-CA 124.445 1.098 . . . . 0.0 108.997 -172.495 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.393 0 N-CA-C 110.654 -0.128 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.2 tp -60.92 -31.07 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.735 0.814 . . . . 0.0 109.693 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -51.43 -38.17 52.27 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.131 0.972 . . . . 0.0 112.165 177.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -71.84 -47.87 50.03 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.972 0.806 . . . . 0.0 109.961 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.3 mt -59.58 -48.34 82.05 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.299 0.64 . . . . 0.0 109.781 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -68.98 -37.66 78.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.1 85.92 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 118.564 -0.731 . . . . 0.0 110.508 -171.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -72.02 -28.26 63.26 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.309 0.958 . . . . 0.0 112.699 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.51 -43.88 84.04 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.571 1.532 . . . . 0.0 108.498 169.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -61.11 -44.3 97.56 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.2 1.0 . . . . 0.0 109.977 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -66.14 -35.25 80.0 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.988 1.715 . . . . 0.0 111.281 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 44.4 m -73.65 -8.13 54.77 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.786 0.834 . . . . 0.0 112.675 173.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.42 -18.13 8.85 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.797 1.189 . . . . 0.0 113.935 169.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.66 171.97 2.38 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.294 1.047 . . . . 0.0 111.286 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -144.32 155.44 43.81 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.972 -1.08 . . . . 0.0 112.287 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -56.44 168.12 0.6 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.948 1.699 . . . . 0.0 110.581 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 m -134.02 37.92 3.2 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.211 1.004 . . . . 0.0 110.266 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 139.6 -168.95 24.79 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 126.945 2.212 . . . . 0.0 110.245 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -89.84 143.32 26.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 117.928 0.864 . . . . 0.0 110.858 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.1 m -58.32 137.91 56.82 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.914 1.686 . . . . 0.0 111.447 -176.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 35.9 tp -91.44 148.92 21.96 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.795 0.438 . . . . 0.0 109.892 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -116.42 138.22 51.54 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 169.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.9 mt -124.4 99.29 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.18 92.25 6.27 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.051 1.74 . . . . 0.0 108.59 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 26.5 pt -66.67 -35.28 74.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -174.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.5 tp . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 125.525 1.53 . . . . 0.0 112.518 -175.586 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -63.52 -30.2 71.35 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.693 0.797 . . . . 0.0 111.341 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -68.21 -43.98 76.8 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.214 0.915 . . . . 0.0 109.328 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -64.26 -39.17 93.39 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.81 0.844 . . . . 0.0 110.596 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.69 -30.91 71.05 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.65 -0.656 . . . . 0.0 110.954 176.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.04 -44.29 56.45 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.442 1.02 . . . . 0.0 111.49 171.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.6 m -64.16 -39.13 93.37 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.657 0.729 . . . . 0.0 110.588 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -62.47 -50.7 70.42 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 118.671 0.669 . . . . 0.0 110.869 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.5 m -66.74 -30.76 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.551 1.069 . . . . 0.0 111.027 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -67.76 -33.03 74.05 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.885 0.766 . . . . 0.0 111.333 175.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.43 -49.66 11.14 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.623 0.769 . . . . 0.0 110.154 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 pp -79.35 -21.46 45.79 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.471 -0.776 . . . . 0.0 112.716 -172.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp . . . . . 0 C--O 1.251 1.181 0 C-N-CA 127.382 2.273 . . . . 0.0 111.822 -179.366 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -128.13 -26.11 2.9 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.17 0.988 . . . . 0.0 111.476 -173.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.3 mt -130.74 85.98 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.1 m -82.01 115.16 21.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mp -74.28 155.35 38.33 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.5 mt -130.89 104.1 8.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.44 1.496 . . . . 0.0 107.076 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.25 133.14 35.23 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.708 0.803 . . . . 0.0 110.982 -177.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -125.34 86.76 0.36 Allowed Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 107.413 -2.275 . . . . 0.0 107.413 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 122.435 1.112 . . . . 0.0 111.974 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 N-CA-C 112.203 -0.359 . . . . 0.0 112.203 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.89 -22.76 63.2 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.566 -0.731 . . . . 0.0 111.231 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.25 -39.88 62.75 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.054 0.843 . . . . 0.0 110.135 176.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -68.47 -43.13 77.64 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.683 -0.636 . . . . 0.0 109.436 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.2 t -64.12 -39.71 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.049 175.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.91 -43.55 98.39 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 119.636 1.107 . . . . 0.0 110.88 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -61.02 -44.27 97.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.431 0.56 . . . . 0.0 110.411 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -60.84 -51.62 68.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.919 0.488 . . . . 0.0 110.541 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.7 mt -61.25 -43.63 98.56 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.463 0.705 . . . . 0.0 110.349 -177.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.21 -43.31 99.09 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.167 0.587 . . . . 0.0 110.294 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.0 -45.41 93.74 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.538 0.608 . . . . 0.0 110.293 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -60.98 -43.04 99.4 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.914 -0.491 . . . . 0.0 110.578 178.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 41.6 mt -64.24 -40.94 97.04 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.781 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.8 -38.22 88.37 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.944 0.793 . . . . 0.0 110.308 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -66.77 -36.74 83.13 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.294 0.497 . . . . 0.0 110.845 175.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.75 -25.46 64.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.283 0.633 . . . . 0.0 111.788 173.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.99 -0.17 14.82 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.331 1.444 . . . . 0.0 113.941 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -81.16 143.41 32.39 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.109 1.455 . . . . 0.0 109.69 -177.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 p -79.47 138.14 37.47 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.1 p -128.38 162.51 26.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.046 0.938 . . . . 0.0 109.979 -173.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -145.75 166.64 25.29 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 170.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.3 m -145.72 101.87 3.61 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 -177.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.85 106.92 18.81 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -175.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -74.93 105.71 6.09 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.53 56.13 26.74 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 118.368 -1.24 . . . . 0.0 115.355 172.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.7 172.8 7.61 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.93 2.42 . . . . 0.0 111.623 172.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.2 mt -128.14 170.23 13.2 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.977 2.111 . . . . 0.0 107.565 169.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 tt -54.49 -34.67 62.03 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.888 0.875 . . . . 0.0 111.737 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.06 -5.24 12.3 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.915 1.286 . . . . 0.0 112.591 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -135.23 17.59 3.42 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.944 1.298 . . . . 0.0 110.577 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -134.35 98.59 13.8 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 125.072 1.349 . . . . 0.0 108.628 -169.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -70.23 154.12 66.15 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.559 2.173 . . . . 0.0 111.961 -176.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.02 7.98 6.42 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.059 1.344 . . . . 0.0 114.452 -170.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.5 m -149.48 125.63 10.71 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.125 0.97 . . . . 0.0 108.444 -170.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.24 -175.74 28.32 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.0 mt -116.41 102.03 13.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -96.88 169.86 9.56 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.51 0.724 . . . . 0.0 109.428 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.6 tp -143.16 101.72 3.86 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.1 t -84.34 138.43 19.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 124.125 0.97 . . . . 0.0 108.793 -174.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mp -135.02 130.55 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.24 136.46 50.13 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.042 0.937 . . . . 0.0 110.366 -168.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 m -106.98 47.97 0.86 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.737 0.815 . . . . 0.0 111.175 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.1 m -33.02 105.83 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.178 2.191 . . . . 0.0 110.808 169.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.96 149.86 46.39 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 169.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -42.02 -35.27 1.61 Allowed Glycine 0 CA--C 1.531 1.031 0 C-N-CA 126.096 1.807 . . . . 0.0 116.437 -169.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.92 -10.64 59.25 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.46 46.45 4.34 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 -169.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -123.37 106.78 10.96 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -178.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.4 mt -65.02 141.0 98.26 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.86 141.19 89.02 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.869 2.379 . . . . 0.0 111.851 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -62.44 -14.97 46.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.911 1.684 . . . . 0.0 113.582 -173.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.72 -25.02 63.65 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.461 -0.774 . . . . 0.0 111.824 177.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 63.5 tp -128.68 -31.77 2.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.973 0.806 . . . . 0.0 112.348 -169.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.7 p -52.27 -34.25 15.22 Favored Pre-proline 0 CA--C 1.553 1.08 0 CA-C-O 116.744 -1.598 . . . . 0.0 114.298 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.15 -37.68 59.02 Favored 'Trans proline' 0 C--N 1.359 1.113 0 C-N-CA 123.296 2.664 . . . . 0.0 114.989 174.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -61.13 -44.39 97.41 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.396 0.544 . . . . 0.0 109.764 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -75.84 -30.47 58.95 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.975 0.51 . . . . 0.0 110.686 -173.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -62.56 -43.15 99.53 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.461 -0.774 . . . . 0.0 109.118 169.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.47 -20.65 66.1 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 118.4 -0.809 . . . . 0.0 112.737 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.16 -55.95 10.51 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.774 1.17 . . . . 0.0 109.051 172.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -64.78 -28.17 69.39 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.015 0.825 . . . . 0.0 111.734 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -67.09 -28.63 68.34 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.475 0.71 . . . . 0.0 111.631 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -123.22 -17.62 6.56 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 -169.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.8 tttp 41.02 58.61 8.54 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.322 1.449 . . . . 0.0 109.633 -168.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -67.19 158.47 56.79 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.803 2.335 . . . . 0.0 111.027 -170.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -81.99 84.46 6.96 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.853 0.861 . . . . 0.0 109.761 177.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 mt -108.95 26.82 10.16 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.642 1.577 . . . . 0.0 109.728 175.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.7 m -60.76 17.1 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 128.548 2.739 . . . . 0.0 116.012 -174.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.52 5.42 1.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.197 1.399 . . . . 0.0 111.909 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.9 t -77.66 137.62 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 169.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -124.02 146.94 48.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 168.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -150.03 166.91 28.27 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.421 -175.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -112.76 157.89 14.64 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 104.674 -3.37 . . . . 0.0 104.674 169.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.77 132.05 20.65 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.944 1.372 . . . . 0.0 110.187 -169.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 56.7 mt -138.39 138.75 42.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.93 150.31 17.63 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 107.864 -2.095 . . . . 0.0 107.864 169.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.7 mt -139.61 136.04 39.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.9 -164.02 30.53 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 176.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.0 m -110.33 104.21 12.97 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.218 1.407 . . . . 0.0 108.494 -175.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -59.68 -12.41 6.88 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.075 1.35 . . . . 0.0 113.056 -174.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -56.73 -32.53 65.63 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.486 1.039 . . . . 0.0 110.94 169.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -83.68 151.7 25.13 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.015 0.926 . . . . 0.0 110.026 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.75 -27.75 65.21 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -175.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 CA--C 1.537 0.47 0 C-N-CA 124.368 1.067 . . . . 0.0 110.795 -169.592 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.36 -27.45 41.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 119.714 1.143 . . . . 0.0 109.443 170.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.17 -39.16 89.54 Favored 'General case' 0 C--N 1.338 0.106 0 O-C-N 121.591 -0.693 . . . . 0.0 110.479 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -58.94 -49.02 79.42 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.96 -54.54 45.96 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.451 0.3 . . . . 0.0 110.501 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -64.19 -38.21 90.22 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.122 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.47 -36.37 78.88 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 119.396 -0.335 . . . . 0.0 111.192 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -74.5 -33.05 62.73 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.794 0.724 . . . . 0.0 110.909 -175.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.3 mt -69.24 -38.85 78.68 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.686 1.13 . . . . 0.0 109.7 169.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -62.05 -40.66 96.53 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.839 0.745 . . . . 0.0 110.124 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -65.2 -31.27 72.36 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.759 0.824 . . . . 0.0 111.415 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.6 m -77.47 4.71 10.41 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.234 1.013 . . . . 0.0 112.355 172.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.24 -11.55 63.63 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.735 1.159 . . . . 0.0 113.41 172.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.35 -178.21 0.48 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.556 1.178 . . . . 0.0 110.793 173.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.18 138.08 17.15 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.148 -0.97 . . . . 0.0 110.966 169.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.56 168.0 1.29 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.337 1.455 . . . . 0.0 108.512 169.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.6 m -135.16 151.61 50.83 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.3 -120.11 21.31 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -140.68 164.23 30.75 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.769 1.627 . . . . 0.0 106.966 170.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.0 m -83.48 139.18 33.08 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.552 -0.717 . . . . 0.0 109.532 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.4 tp -97.9 149.32 22.52 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.824 1.249 . . . . 0.0 109.893 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -119.36 146.33 45.41 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 169.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.7 mt -133.16 100.06 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -68.21 139.13 56.04 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 169.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.3 pp -129.62 15.54 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.22 1.008 . . . . 0.0 112.26 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.0 tp . . . . . 0 C--N 1.342 0.24 0 CA-C-N 119.075 0.852 . . . . 0.0 108.984 176.963 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 119.226 -0.416 . . . . 0.0 111.473 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.35 -40.25 74.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.056 0.942 . . . . 0.0 111.232 178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -73.87 -42.33 60.93 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.726 -0.609 . . . . 0.0 109.895 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -68.55 -36.47 78.85 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.555 0.342 . . . . 0.0 110.621 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.6 tp -61.19 -39.53 90.53 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.81 0.844 . . . . 0.0 110.203 171.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.36 -48.32 48.38 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.575 1.083 . . . . 0.0 111.33 170.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.2 m -61.97 -41.47 98.05 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 117.645 0.723 . . . . 0.0 110.865 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -62.86 -50.82 69.4 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.481 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.8 m -63.96 -34.23 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 120.115 1.325 . . . . 0.0 110.733 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.0 -21.37 66.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.901 0.88 . . . . 0.0 113.05 176.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.32 -49.77 4.57 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.405 1.002 . . . . 0.0 111.12 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.76 -27.23 64.76 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.376 -173.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt . . . . . 0 C--O 1.252 1.197 0 C-N-CA 128.187 2.595 . . . . 0.0 113.102 175.277 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.197 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -135.87 -25.06 1.27 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.982 1.313 . . . . 0.0 111.036 -179.202 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.7 mt -125.35 80.87 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 169.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.0 m -76.56 114.14 14.96 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.37 155.21 28.52 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.353 1.061 . . . . 0.0 109.233 174.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.1 mt -127.4 93.2 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -174.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -67.02 162.58 21.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.818 1.247 . . . . 0.0 110.158 172.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.78 58.36 0.08 OUTLIER Glycine 0 C--N 1.337 0.615 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -169.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 C--N 1.331 -0.215 0 C-N-CA 124.148 0.979 . . . . 0.0 110.502 170.947 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.603 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.03 -28.62 69.92 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 117.874 0.837 . . . . 0.0 110.737 176.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -68.84 -40.46 79.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -76.75 -37.41 55.99 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 122.72 0.408 . . . . 0.0 110.62 -179.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.58 -43.01 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 118.454 0.57 . . . . 0.0 109.474 171.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.19 93.8 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.548 0.613 . . . . 0.0 110.395 177.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.14 -42.4 99.21 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.458 0.572 . . . . 0.0 110.872 178.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -61.81 -50.41 72.41 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.704 0.802 . . . . 0.0 110.165 178.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.3 mt -62.18 -39.75 93.72 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.383 0.673 . . . . 0.0 110.655 179.216 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.96 99.3 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.952 0.501 . . . . 0.0 110.6 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.12 -43.61 94.76 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.678 0.672 . . . . 0.0 110.3 178.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -58.27 -45.99 86.84 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.914 -0.492 . . . . 0.0 110.067 175.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.6 mt -62.48 -38.83 91.35 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.996 178.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.22 -38.51 90.65 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.23 0.923 . . . . 0.0 110.316 177.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.05 -36.74 82.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.54 0.609 . . . . 0.0 110.756 175.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.16 -25.28 65.19 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.154 0.581 . . . . 0.0 111.898 173.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.78 0.61 17.57 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.395 1.474 . . . . 0.0 113.998 170.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -83.59 149.57 26.48 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.04 1.42 . . . . 0.0 109.91 -178.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -87.86 140.18 29.77 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 p -139.22 165.97 25.76 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.305 1.042 . . . . 0.0 109.812 -169.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -154.42 155.4 34.91 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 169.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.9 p -126.28 84.31 2.26 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -171.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.6 mt -68.12 119.98 13.58 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -174.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -75.54 92.36 2.89 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.192 0.997 . . . . 0.0 108.458 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.45 61.79 5.65 Favored Glycine 0 CA--C 1.542 1.772 0 C-N-CA 124.628 1.108 . . . . 0.0 113.929 175.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -69.06 177.47 5.07 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.973 3.115 . . . . 0.0 111.875 179.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 38.3 mt -107.49 154.21 21.7 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.828 1.251 . . . . 0.0 107.965 169.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.46 -38.83 72.2 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.924 0.889 . . . . 0.0 111.539 -177.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.09 -18.09 63.01 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -75.3 -19.43 59.68 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.601 0.637 . . . . 0.0 111.862 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.1 mt -99.9 143.09 25.83 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 123.983 0.913 . . . . 0.0 110.517 -173.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.19 163.19 38.72 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.364 2.043 . . . . 0.0 109.26 169.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.81 25.66 0.77 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.521 1.128 . . . . 0.0 111.904 -176.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.5 m -155.89 142.2 18.43 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.13 1.372 . . . . 0.0 107.907 177.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 150.46 -176.16 29.18 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 178.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -128.92 101.24 6.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 178.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -103.14 171.82 7.16 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.202 1.001 . . . . 0.0 108.981 -177.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.2 tp -148.0 117.2 6.87 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 176.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.52 135.39 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -169.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.78 119.91 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.0 m -123.04 -174.42 2.94 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.799 1.64 . . . . 0.0 107.793 -174.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -144.47 170.26 16.37 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 168.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.1 m -126.24 129.28 48.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -67.17 -29.75 69.53 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 117.92 0.327 . . . . 0.0 111.393 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.94 -38.95 0.32 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.692 0.663 . . . . 0.0 112.805 175.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.87 19.15 7.85 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.054 0.942 . . . . 0.0 112.732 -170.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.62 -8.07 28.08 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.266 0.936 . . . . 0.0 113.171 174.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.12 121.3 15.32 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.495 1.147 . . . . 0.0 109.834 176.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.9 mt -78.11 142.01 63.44 Favored Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 176.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.75 145.28 86.18 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.602 2.868 . . . . 0.0 112.044 176.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.49 -17.73 34.14 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.964 1.706 . . . . 0.0 114.281 -173.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -62.42 -44.8 95.56 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.502 0.721 . . . . 0.0 109.429 178.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.2 tp -120.05 -17.58 8.35 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.334 0.654 . . . . 0.0 112.329 -170.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.4 p -53.94 -32.87 12.3 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -178.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -54.69 -23.99 35.38 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.518 2.146 . . . . 0.0 114.852 171.033 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -61.23 -38.54 87.0 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.33 0.968 . . . . 0.0 110.769 177.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -66.98 -37.15 83.71 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.237 0.471 . . . . 0.0 110.474 177.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.81 -45.94 69.91 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.72 -31.19 72.04 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.764 -0.585 . . . . 0.0 112.1 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.9 mt -61.71 -60.72 3.24 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 123.45 0.7 . . . . 0.0 109.405 171.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -71.14 -26.82 63.17 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -171.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -67.69 -37.18 81.96 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.686 0.676 . . . . 0.0 110.97 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -105.95 -34.38 7.63 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.96 0.504 . . . . 0.0 111.613 -170.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.9 tttp 32.73 59.27 1.47 Allowed Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 127.759 2.424 . . . . 0.0 113.59 -174.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -69.95 159.21 54.07 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.73 1.62 . . . . 0.0 110.004 174.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -71.76 127.65 33.23 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 169.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.436 ' C ' ' H ' ' A' ' 82' ' ' ALA . 1.5 pp -140.54 38.36 1.86 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.862 1.265 . . . . 0.0 110.129 177.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.1 m -59.43 24.41 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.856 2.462 . . . . 0.0 115.497 170.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.436 ' H ' ' C ' ' A' ' 80' ' ' LEU . . . -145.73 3.51 0.97 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.311 1.445 . . . . 0.0 112.184 178.356 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.9 t -87.35 146.11 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 169.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -122.11 146.44 47.21 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 168.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -137.63 168.98 18.57 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -125.43 156.57 19.28 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 104.802 -3.319 . . . . 0.0 104.802 169.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.06 123.9 25.29 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.408 1.104 . . . . 0.0 109.986 -169.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.2 mt -132.7 135.48 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.14 162.16 13.65 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 169.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.5 mt -141.71 144.13 26.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -177.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 175.41 166.35 32.91 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 106.743 -2.543 . . . . 0.0 106.743 177.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.4 m -73.55 134.53 43.8 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 169.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -61.61 -15.21 37.33 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -67.73 -23.95 65.32 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.158 0.983 . . . . 0.0 111.647 173.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -62.32 143.23 57.19 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.861 0.864 . . . . 0.0 111.14 -175.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.91 -33.09 75.2 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.426 0.69 . . . . 0.0 111.518 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.6 m . . . . . 0 CA--C 1.539 0.535 0 C-N-CA 125.68 1.592 . . . . 0.0 108.049 178.707 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 tp -57.99 -26.66 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.497 1.119 . . . . 0.0 110.237 172.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -57.94 -38.76 76.54 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.716 -0.615 . . . . 0.0 112.119 -174.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -72.43 -41.14 66.5 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.566 -0.709 . . . . 0.0 110.416 -178.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 45.3 mt -61.39 -47.64 84.89 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.396 0.678 . . . . 0.0 109.53 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -70.31 -36.55 74.39 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.76 -178.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.72 96.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.721 -0.656 . . . . 0.0 110.87 -169.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -74.05 -25.57 59.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.159 0.89 . . . . 0.0 111.717 -175.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.1 mt -66.23 -48.35 70.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.478 1.49 . . . . 0.0 108.603 169.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -61.11 -44.31 97.55 Favored 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 123.634 0.774 . . . . 0.0 109.611 -175.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -72.99 0.31 11.68 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.035 1.734 . . . . 0.0 112.722 178.168 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.3 m -122.72 7.21 9.4 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.55 1.14 . . . . 0.0 111.838 176.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 132.43 -34.0 2.57 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 118.547 -1.141 . . . . 0.0 114.598 168.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.22 177.88 0.77 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.715 1.258 . . . . 0.0 112.211 -178.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -149.54 162.18 40.66 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 121.399 -0.813 . . . . 0.0 111.039 169.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.27 165.35 3.58 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.059 1.344 . . . . 0.0 110.119 173.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.0 m -145.58 159.69 42.75 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 174.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.78 -124.7 32.89 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -172.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -139.33 163.53 32.25 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.3 m -66.06 149.67 49.89 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.7 tp -129.56 150.62 50.82 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.426 1.091 . . . . 0.0 109.259 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.24 142.48 47.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 176.451 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.4 mt -134.75 108.97 11.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -171.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -68.15 133.19 48.51 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.85 0.86 . . . . 0.0 110.593 178.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.1 pt -125.31 16.46 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 125.537 1.535 . . . . 0.0 111.462 174.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.0 tp . . . . . 0 N--CA 1.47 0.564 0 C-N-CA 123.779 0.832 . . . . 0.0 110.863 170.955 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 119.047 -0.501 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -63.99 -41.31 97.54 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.596 0.635 . . . . 0.0 110.993 176.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.81 -46.29 88.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.665 0.666 . . . . 0.0 110.632 -177.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -66.32 -35.92 81.6 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 122.68 0.392 . . . . 0.0 111.035 175.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 30.2 tp -62.96 -36.21 82.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.204 177.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.62 -47.06 65.08 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 170.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.4 m -64.26 -42.86 96.27 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.43 0.615 . . . . 0.0 110.839 177.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -60.27 -52.85 63.5 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.849 178.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.2 m -65.21 -34.0 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 119.94 1.246 . . . . 0.0 110.948 -177.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.46 -40.52 95.87 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.55 0.614 . . . . 0.0 111.652 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.5 mt -85.62 -35.63 20.86 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.103 -175.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 pp -76.6 -29.35 56.51 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.421 1.01 . . . . 0.0 111.659 177.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? . . . . . 0 C--O 1.249 1.026 0 C-N-CA 128.823 2.849 . . . . 0.0 113.695 179.434 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttt . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 110.078 -0.341 . . . . 10.0 110.078 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.06 156.85 20.7 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.703 1.201 . . . . 10.0 109.807 176.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -114.15 -24.45 8.97 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.859 1.263 . . . . 10.0 110.686 174.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.8 mt -125.94 89.66 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.146 0 N-CA-C 105.793 -1.929 . . . . 10.0 105.793 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.8 m -74.11 115.34 13.47 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.9 mp -77.27 154.0 33.39 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.701 -1.222 . . . . 10.0 107.701 169.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.8 mt -125.62 83.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 103.084 -2.932 . . . . 10.0 103.084 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 m -69.31 147.52 51.02 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.96 1.304 . . . . 10.0 109.272 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.46 81.59 0.15 Allowed Glycine 0 C--N 1.335 0.511 0 N-CA-C 111.119 -0.792 . . . . 10.0 111.119 -172.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.7 p -147.37 155.95 42.45 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.859 0.83 . . . . 10.0 110.142 165.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 p -91.43 -37.08 13.41 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.986 1.314 . . . . 10.0 109.361 168.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -38.47 76.87 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.708 0.803 . . . . 10.0 111.116 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 112.16 -5.68 26.99 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.541 1.067 . . . . 10.0 112.916 -173.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.67 -42.99 98.12 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 119.406 1.603 . . . . 10.0 112.129 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.76 -31.24 70.14 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 117.899 0.849 . . . . 10.0 111.146 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -66.67 -42.37 86.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.099 0.863 . . . . 10.0 109.477 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -59.2 -53.04 62.84 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.133 0.573 . . . . 10.0 110.113 175.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.98 -40.37 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 119.012 -0.518 . . . . 10.0 110.006 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.54 -46.92 86.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.818 0.736 . . . . 10.0 110.433 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.75 -42.86 99.53 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.339 0.518 . . . . 10.0 110.444 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -62.6 -48.97 77.09 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.211 0.604 . . . . 10.0 110.114 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 23.7 mt -60.81 -43.59 98.0 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 124.029 0.932 . . . . 10.0 111.044 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.84 91.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.195 0.598 . . . . 10.0 110.534 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.02 -47.14 87.79 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.699 0.681 . . . . 10.0 110.281 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -61.59 -40.09 93.56 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 121.804 -0.56 . . . . 10.0 110.759 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.1 mt -64.16 -39.96 95.11 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 119.012 -0.518 . . . . 10.0 110.95 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.59 -38.81 92.28 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.847 0.749 . . . . 10.0 110.323 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.83 -33.81 75.5 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.914 0.779 . . . . 10.0 111.197 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.71 -20.58 65.28 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.266 0.626 . . . . 10.0 111.807 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.81 6.47 22.94 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.371 1.463 . . . . 10.0 113.376 171.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -103.28 135.87 44.11 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.196 1.498 . . . . 10.0 108.539 -173.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.8 p -79.69 147.42 31.97 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.024 0.53 . . . . 10.0 110.011 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.8 p -141.97 164.33 30.48 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.776 0.798 . . . . 10.0 111.309 -168.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -151.26 159.59 44.27 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.48 2.312 . . . . 10.0 105.103 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -131.0 61.45 1.63 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.356 1.462 . . . . 10.0 108.446 -171.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 mt -55.64 118.71 4.77 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.759 0.824 . . . . 10.0 108.957 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.21 116.57 16.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.178 -1.415 . . . . 10.0 107.178 171.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.8 50.49 14.78 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.027 -1.43 . . . . 10.0 115.73 167.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -65.3 164.35 26.0 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 CA-C-N 120.352 2.076 . . . . 10.0 110.391 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.7 mt -108.7 163.81 12.92 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.851 0.86 . . . . 10.0 108.754 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -56.75 -39.99 74.98 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.849 0.86 . . . . 10.0 110.356 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.35 2.1 1.36 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.545 1.138 . . . . 10.0 113.705 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -126.33 17.23 7.7 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.691 1.596 . . . . 10.0 111.263 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.6 mt -132.01 123.43 18.96 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.837 1.255 . . . . 10.0 108.558 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.55 159.45 52.77 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 121.926 1.751 . . . . 10.0 110.565 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.74 11.1 1.82 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.664 1.186 . . . . 10.0 113.963 -174.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.0 m -143.71 138.66 29.02 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.114 1.366 . . . . 10.0 107.944 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.42 -177.7 31.64 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.457 -1.057 . . . . 10.0 110.457 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mt -125.6 96.13 3.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 104.699 -2.334 . . . . 10.0 104.699 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -97.14 175.54 6.26 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.17 0.588 . . . . 10.0 110.605 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.9 tp -150.13 99.09 2.78 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 107.812 -1.181 . . . . 10.0 107.812 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.6 t -83.5 130.82 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.751 -1.203 . . . . 10.0 107.751 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.9 mt -132.75 128.35 57.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.321 -2.103 . . . . 10.0 105.321 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.7 m -137.89 133.16 33.51 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.48 0.488 . . . . 10.0 109.936 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.3 m -62.61 160.67 13.53 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.506 0.669 . . . . 10.0 110.024 157.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.1 m -126.7 117.42 22.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 103.82 -2.659 . . . . 10.0 103.82 171.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -74.54 8.7 2.14 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.7 1.0 . . . . 10.0 113.7 -168.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.99 -22.94 26.66 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.766 1.651 . . . . 10.0 112.221 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.02 8.82 8.67 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.447 1.099 . . . . 10.0 112.505 -172.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.32 -2.86 81.61 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 123.534 0.588 . . . . 10.0 112.895 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -68.26 124.35 23.25 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.031 0.916 . . . . 10.0 108.737 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.9 mt -72.73 142.56 83.62 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 106.388 -1.708 . . . . 10.0 106.388 173.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.78 140.38 93.45 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.217 2.612 . . . . 10.0 111.066 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -60.34 -21.79 62.48 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.558 1.143 . . . . 10.0 113.118 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -50.99 -44.18 60.85 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.235 1.414 . . . . 10.0 111.132 169.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.1 tp -122.45 -19.34 6.43 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.745 0.818 . . . . 10.0 112.439 -168.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.9 p -52.78 -35.06 20.46 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 115.131 1.53 . . . . 10.0 115.131 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -54.73 -24.46 37.83 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.365 2.043 . . . . 10.0 114.577 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -62.02 -36.73 82.45 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.427 1.012 . . . . 10.0 111.027 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -61.16 -42.46 98.61 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.513 0.597 . . . . 10.0 110.205 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -72.01 -45.51 60.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.149 0.58 . . . . 10.0 109.732 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.45 -37.09 82.3 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.312 0.645 . . . . 10.0 111.315 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.8 mt -64.75 -59.44 4.23 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 118.726 -0.654 . . . . 10.0 109.529 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -66.99 -29.42 69.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.113 0.869 . . . . 10.0 112.372 -170.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.72 -34.14 76.28 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.226 0.611 . . . . 10.0 111.257 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -105.74 -27.55 11.23 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.417 0.687 . . . . 10.0 111.862 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt 26.73 62.82 0.56 Allowed Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 128.657 2.783 . . . . 10.0 112.858 -169.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.0 166.91 23.14 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.631 2.22 . . . . 10.0 110.364 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -71.53 120.17 16.73 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.533 -0.914 . . . . 10.0 108.533 165.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.2 mt -124.83 24.37 7.68 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.484 1.514 . . . . 10.0 110.255 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.7 m -63.96 10.8 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 115.803 1.779 . . . . 10.0 115.803 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.33 3.01 4.67 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.849 1.26 . . . . 10.0 112.23 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.1 t -74.66 131.8 34.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.752 -1.573 . . . . 10.0 106.752 165.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -105.31 150.81 24.86 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.29 -1.744 . . . . 10.0 106.29 157.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -145.54 159.36 43.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.273 0.559 . . . . 10.0 111.081 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -113.4 163.14 12.17 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 108.445 -1.862 . . . . 10.0 108.445 162.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.54 130.32 21.6 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.492 1.117 . . . . 10.0 108.299 -172.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 mt -134.78 133.21 54.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 105.866 -1.901 . . . . 10.0 105.866 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -108.65 145.04 16.39 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 108.336 -1.906 . . . . 10.0 108.336 166.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.4 mt -130.52 142.67 43.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.331 -2.1 . . . . 10.0 105.331 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.37 174.36 40.34 Favored Glycine 0 N--CA 1.453 -0.209 0 O-C-N 121.374 -0.829 . . . . 10.0 111.532 169.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.0 m -69.06 104.71 2.2 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.064 -1.088 . . . . 10.0 108.064 168.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -75.74 -10.57 59.55 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.321 0.86 . . . . 10.0 113.321 -163.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -76.62 -12.25 59.98 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.573 1.079 . . . . 10.0 112.236 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -64.17 162.59 14.19 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.185 0.902 . . . . 10.0 111.631 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.75 -34.36 74.32 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.92 0.888 . . . . 10.0 111.924 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.3 m -109.14 146.63 33.77 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.505 -0.924 . . . . 10.0 108.505 174.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -153.04 64.27 0.77 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 106.446 -1.687 . . . . 10.0 106.446 -129.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 83.7 m 54.19 38.59 29.51 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.177 0.991 . . . . 10.0 111.255 -169.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.41 -12.1 49.41 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.814 -0.992 . . . . 10.0 112.789 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.31 -41.77 98.97 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.446 1.623 . . . . 10.0 110.811 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.5 tp -57.1 -32.31 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.636 1.175 . . . . 10.0 111.691 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -54.96 -38.06 67.28 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.72 0.808 . . . . 10.0 111.933 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.92 -42.25 85.69 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.834 0.453 . . . . 10.0 110.98 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.3 mt -67.68 -49.28 63.6 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.163 -0.68 . . . . 10.0 109.163 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -63.77 -37.9 89.11 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 118.595 -0.717 . . . . 10.0 110.443 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.29 99.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.129 0.877 . . . . 10.0 110.643 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -74.09 -30.36 62.31 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 119.557 1.071 . . . . 10.0 112.043 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.2 mt -61.59 -48.25 81.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.826 1.193 . . . . 10.0 109.315 169.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -59.44 -45.93 90.19 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.724 1.21 . . . . 10.0 110.296 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -62.38 -38.62 90.32 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.822 1.649 . . . . 10.0 111.311 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.0 m -71.81 -11.87 61.01 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.427 1.091 . . . . 10.0 112.632 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.72 -12.64 8.76 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.706 1.146 . . . . 10.0 113.264 169.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.15 169.86 3.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.437 1.118 . . . . 10.0 110.585 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -138.32 145.16 40.85 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.441 -0.787 . . . . 10.0 111.009 168.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -63.18 166.79 5.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.403 -1.271 . . . . 10.0 109.19 172.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.3 m -132.61 153.06 51.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 105.606 -1.998 . . . . 10.0 105.606 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.99 -140.98 47.09 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 110.97 -0.852 . . . . 10.0 110.97 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -133.8 167.69 20.1 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.547 1.539 . . . . 10.0 108.147 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.2 m -82.64 123.22 29.05 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.793 0.837 . . . . 10.0 109.59 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.5 tp -85.48 145.95 27.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 122.636 0.374 . . . . 10.0 110.045 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -110.64 145.4 38.0 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.005 1.722 . . . . 10.0 106.956 169.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.5 mt -140.29 102.92 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.429 -1.693 . . . . 10.0 106.429 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -73.93 135.51 43.26 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.411 -0.589 . . . . 10.0 109.411 173.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.1 pp -128.67 7.75 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.109 0.963 . . . . 10.0 112.805 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.2 tp -67.55 -54.1 22.75 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.07 0.85 . . . . 10.0 111.3 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.2 -48.69 3.15 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.917 0.887 . . . . 10.0 109.293 -164.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -109.72 -177.05 3.17 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.746 1.618 . . . . 10.0 108.886 173.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -123.98 49.54 1.75 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.324 1.849 . . . . 10.0 107.707 -171.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.296 1.5 pt 51.72 129.46 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 128.668 2.787 . . . . 10.0 113.211 -140.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -85.15 -52.92 0.03 OUTLIER 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.118 1.879 . . . . 10.0 113.316 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -148.31 -13.57 0.35 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.012 1.116 . . . . 10.0 114.012 -141.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -121.59 83.76 41.89 Favored Pre-proline 0 N--CA 1.467 0.403 0 N-CA-C 108.039 -1.097 . . . . 10.0 108.039 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -47.25 141.84 12.92 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 123.74 2.96 . . . . 10.0 112.819 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.68 -25.58 60.46 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.184 162.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -56.27 -39.84 73.27 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.987 1.715 . . . . 10.0 112.164 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -67.52 -47.18 70.68 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.01 0.823 . . . . 10.0 109.091 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -61.97 -41.02 97.55 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.389 0.676 . . . . 10.0 110.353 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.3 tp -61.58 -38.99 89.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.802 1.241 . . . . 10.0 110.646 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.07 -50.25 62.74 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.862 -0.895 . . . . 10.0 110.862 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.5 m -60.65 -30.27 69.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.007 0.523 . . . . 10.0 111.786 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -52.87 10.74 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.488 0.715 . . . . 10.0 111.852 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.0 -32.04 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -59.96 -23.53 63.66 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.476 1.111 . . . . 10.0 113.622 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.5 mt -102.06 -44.23 5.52 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 120.139 1.336 . . . . 10.0 111.382 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.95 -27.43 62.78 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.786 -1.102 . . . . 10.0 112.244 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm . . . . . 0 C--O 1.252 1.194 0 C-N-CA 128.672 2.789 . . . . 10.0 113.417 -177.296 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.2 ttm . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.99 164.27 22.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.847 0.859 . . . . 0.0 111.193 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -76.0 -29.48 58.18 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.136 0.975 . . . . 0.0 110.113 -175.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.8 mt -125.15 74.17 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.1 m -74.81 114.83 13.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.94 155.19 37.69 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 172.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.9 mt -116.95 112.06 37.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 103.829 -2.656 . . . . 0.0 103.829 172.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -113.86 155.55 25.53 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.531 1.532 . . . . 0.0 110.84 -169.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.01 131.21 1.28 Allowed Glycine 0 N--CA 1.448 -0.512 0 O-C-N 121.187 -0.945 . . . . 0.0 111.13 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.0 p -158.15 108.65 2.14 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 169.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 p -71.15 -37.09 72.24 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.806 0.442 . . . . 0.0 110.319 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 pp -70.68 -34.46 72.01 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.418 0.287 . . . . 0.0 111.513 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 124.57 160.66 10.83 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.82 1.676 . . . . 0.0 109.516 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.98 -55.93 0.69 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 125.027 1.299 . . . . 0.0 111.348 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.79 -27.7 68.47 Favored 'General case' 0 C--O 1.228 -0.075 0 CA-C-N 118.108 0.954 . . . . 0.0 110.702 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -60.48 -27.89 67.92 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.921 0.488 . . . . 0.0 111.029 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -95.89 -51.75 4.34 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.631 0.773 . . . . 0.0 110.426 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.61 -39.22 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.741 -171.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.92 89.08 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.414 1.006 . . . . 0.0 111.04 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -68.24 -41.19 81.57 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.637 0.653 . . . . 0.0 110.144 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -60.45 -49.4 77.73 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.927 0.491 . . . . 0.0 110.276 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.5 mt -60.05 -43.43 95.38 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.523 0.729 . . . . 0.0 110.42 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.83 98.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.976 0.511 . . . . 0.0 110.753 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -66.25 -42.55 88.43 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.129 0.571 . . . . 0.0 110.419 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -59.66 -39.85 85.82 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 121.507 -0.746 . . . . 0.0 111.085 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.3 mt -68.28 -29.22 67.96 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.98 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -65.56 -38.26 89.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.713 1.142 . . . . 0.0 109.875 172.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.81 -39.29 93.34 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.948 0.794 . . . . 0.0 110.496 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.07 -21.83 64.96 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.545 0.738 . . . . 0.0 112.259 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.84 31.09 3.25 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 118.651 -1.083 . . . . 0.0 113.58 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -125.29 148.25 48.78 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.026 1.413 . . . . 0.0 110.055 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 p -71.88 146.28 47.99 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.6 p -139.19 160.06 40.68 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.486 0.66 . . . . 0.0 110.956 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -149.64 161.69 41.69 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 p -134.3 81.41 1.91 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -175.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.63 105.57 3.72 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -78.97 102.67 8.44 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.17 56.58 15.03 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-O 118.348 -1.251 . . . . 0.0 114.589 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -69.24 178.3 4.38 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.043 2.495 . . . . 0.0 110.804 171.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.8 mt -125.03 158.08 34.63 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 169.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -53.53 -31.0 44.45 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.237 1.015 . . . . 0.0 111.134 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -62.45 -10.72 12.51 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.353 1.861 . . . . 0.0 112.736 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -133.87 18.67 3.83 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.393 1.077 . . . . 0.0 110.905 -175.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -134.77 106.08 10.68 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.743 1.217 . . . . 0.0 108.881 -169.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.82 161.52 41.4 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.884 2.39 . . . . 0.0 112.969 -170.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.43 7.38 5.47 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.763 1.625 . . . . 0.0 114.934 -171.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.8 m -146.81 129.72 16.29 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.7 -179.86 27.95 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.4 mt -112.94 101.83 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -99.55 168.78 9.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.3 tp -146.83 112.69 5.72 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -98.36 134.45 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -169.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 mp -132.78 125.11 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.8 p -138.6 143.2 39.24 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.945 1.298 . . . . 0.0 107.82 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.1 p -77.04 175.41 9.62 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 169.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.9 m -130.7 123.43 29.29 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 169.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -69.07 -22.2 64.03 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 159.56 -35.53 0.47 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 118.696 0.68 . . . . 0.0 113.37 170.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.78 22.87 8.09 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.124 0.969 . . . . 0.0 112.153 -169.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.75 -1.1 56.67 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 123.936 0.779 . . . . 0.0 113.094 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.5 114.67 8.84 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.301 1.051 . . . . 0.0 109.582 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.7 mt -68.91 147.8 97.86 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 125.643 1.577 . . . . 0.0 107.795 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -56.54 137.61 81.32 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.113 3.209 . . . . 0.0 112.38 175.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -63.93 -22.31 66.86 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -169.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -71.55 -24.42 61.93 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.713 -0.617 . . . . 0.0 111.941 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.6 tp -121.92 -24.76 5.13 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.279 1.032 . . . . 0.0 111.771 -169.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.0 p -55.12 -28.21 3.91 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 116.924 -1.512 . . . . 0.0 114.939 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -53.4 -24.55 28.16 Favored 'Trans proline' 0 C--N 1.354 0.86 0 CA-C-N 122.903 2.073 . . . . 0.0 114.716 169.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -62.02 -43.92 97.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.58 1.082 . . . . 0.0 110.673 175.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -60.96 -40.01 91.7 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.866 0.866 . . . . 0.0 110.101 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -68.77 -48.37 63.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.853 0.461 . . . . 0.0 110.54 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.06 -28.59 67.51 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.464 -0.772 . . . . 0.0 112.37 -176.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.1 mt -67.6 -57.74 5.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.722 -0.656 . . . . 0.0 109.385 171.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -67.25 -29.2 68.77 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.06 0.846 . . . . 0.0 112.071 -171.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.82 -31.0 71.34 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.136 0.574 . . . . 0.0 110.775 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -115.09 -23.21 9.13 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -169.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.4 tttt 37.74 66.11 2.46 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.67 1.588 . . . . 0.0 110.796 -169.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.32 168.82 10.46 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.687 2.258 . . . . 0.0 110.696 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -92.68 107.2 19.04 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 169.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.423 ' C ' ' H ' ' A' ' 82' ' ' ALA . 52.5 mt -120.02 26.15 9.46 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.262 1.825 . . . . 0.0 110.045 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -61.58 18.62 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.318 1.847 . . . . 0.0 115.424 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.423 ' H ' ' C ' ' A' ' 80' ' ' LEU . . . -140.77 3.19 1.84 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.265 1.426 . . . . 0.0 111.855 174.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.7 t -79.53 140.46 16.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.5 mmm-85 -123.79 138.4 54.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 168.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -134.39 170.87 15.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.895 0.378 . . . . 0.0 110.653 -172.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.14 162.86 23.09 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 105.347 -3.101 . . . . 0.0 105.347 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.89 124.55 11.81 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.401 1.101 . . . . 0.0 109.446 -170.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.6 mt -133.73 124.27 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -100.7 156.73 19.34 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.4 mt -134.9 139.11 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.17 -151.42 13.74 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.6 m -126.02 135.36 51.71 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.727 1.211 . . . . 0.0 108.517 -175.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -66.72 -10.25 44.95 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.78 -15.03 58.25 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.979 0.809 . . . . 0.0 112.359 171.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -64.32 148.68 49.76 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.381 0.991 . . . . 0.0 110.847 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.65 -34.22 77.7 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.511 0.725 . . . . 0.0 111.392 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.8 m -119.32 51.15 1.16 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.73 1.612 . . . . 0.0 107.467 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -45.18 113.69 0.61 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.629 1.172 . . . . 0.0 110.825 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.4 m 48.32 34.35 4.54 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.326 1.451 . . . . 0.0 112.84 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.53 -16.19 29.94 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 118.985 -0.897 . . . . 0.0 113.115 -170.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.57 -25.94 68.19 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.588 1.694 . . . . 0.0 112.893 -174.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -29.7 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.964 0.905 . . . . 0.0 109.444 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -54.75 -34.18 62.2 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.104 0.962 . . . . 0.0 112.071 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -81.58 -37.83 27.07 Favored 'General case' 0 C--O 1.232 0.14 0 O-C-N 121.731 -0.606 . . . . 0.0 110.189 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.5 mt -57.89 -50.88 71.81 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -70.58 -32.98 70.57 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.394 -174.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.28 80.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.315 0.507 . . . . 0.0 110.103 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -79.79 -28.88 40.23 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.03 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.0 -45.75 84.25 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.379 1.445 . . . . 0.0 109.578 170.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -71.27 -33.66 69.97 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.469 0.577 . . . . 0.0 111.266 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -61.23 -39.66 91.09 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.178 0.591 . . . . 0.0 110.537 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.6 m -72.03 -7.82 50.98 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.221 1.008 . . . . 0.0 113.13 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.24 -14.93 10.15 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.644 1.116 . . . . 0.0 114.102 169.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.19 173.52 1.94 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.573 1.187 . . . . 0.0 111.341 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -143.83 148.1 35.04 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.019 -1.051 . . . . 0.0 112.153 170.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -58.78 158.55 7.94 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.376 1.87 . . . . 0.0 109.851 173.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.8 m -139.88 163.33 32.94 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.465 1.906 . . . . 0.0 106.087 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.35 -135.25 48.07 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -173.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -146.5 150.18 35.07 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 169.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.2 m -61.76 149.48 39.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.125 1.37 . . . . 0.0 111.176 -171.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.3 tp -129.81 151.21 50.64 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.343 1.057 . . . . 0.0 110.388 -173.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -119.87 150.4 40.51 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 23.5 mm -131.68 100.47 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -78.33 126.47 30.83 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 118.682 -0.675 . . . . 0.0 109.363 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.57 9.46 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.768 0.827 . . . . 0.0 112.152 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.1 tp -45.54 -38.23 6.19 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.067 1.747 . . . . 0.0 113.685 -174.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -135.86 41.38 2.69 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.377 1.071 . . . . 0.0 109.768 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 47.4 m80 49.57 44.29 24.26 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.343 1.457 . . . . 0.0 110.327 -169.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -72.28 -8.2 53.58 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.62 1.968 . . . . 0.0 114.636 -169.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.5 pt -50.4 -36.89 24.52 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 -172.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.9 -7.34 20.9 Favored 'Trans proline' 0 C--N 1.356 0.942 0 CA-C-N 124.047 2.481 . . . . 0.0 113.012 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -68.25 -27.16 66.1 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.311 0.96 . . . . 0.0 110.297 171.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -152.87 72.02 7.21 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.806 1.242 . . . . 0.0 109.461 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.31 150.23 81.2 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.796 2.331 . . . . 0.0 111.131 -173.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.87 -16.66 63.28 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -56.33 -42.76 78.21 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.261 0.937 . . . . 0.0 112.041 -169.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -69.45 -40.3 77.24 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.999 -0.438 . . . . 0.0 110.453 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -72.36 -35.48 68.51 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.642 0.777 . . . . 0.0 110.58 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.97 -35.14 77.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.459 0.704 . . . . 0.0 109.958 170.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.47 -47.18 57.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.387 0.994 . . . . 0.0 111.177 169.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.8 m -62.59 -38.22 89.28 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 122.081 -0.658 . . . . 0.0 111.132 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -53.48 50.22 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.087 175.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.9 m -62.89 -31.25 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 119.799 1.182 . . . . 0.0 111.188 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -62.82 -27.03 69.04 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.593 -0.718 . . . . 0.0 112.669 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.2 mt -106.37 -37.09 6.63 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.216 0.917 . . . . 0.0 112.93 -176.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 pp -73.03 -12.59 60.98 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.465 1.03 . . . . 0.0 112.171 172.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.018 0 C-N-CA 129.451 3.1 . . . . 0.0 112.645 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.08 157.98 43.79 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.847 1.259 . . . . 0.0 108.663 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -136.97 -25.37 1.08 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.79 1.236 . . . . 0.0 111.085 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.4 mt -130.52 82.38 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.0 m -75.23 121.15 21.72 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.9 mp -85.41 152.19 23.42 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.312 0.645 . . . . 0.0 109.711 174.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.8 mt -123.49 93.28 2.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 126.294 1.837 . . . . 0.0 106.161 -175.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -72.95 155.7 39.6 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.558 1.143 . . . . 0.0 110.862 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.2 65.17 0.26 Allowed Glycine 0 C--N 1.34 0.801 0 N-CA-C 114.239 0.456 . . . . 0.0 114.239 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.4 t -139.71 144.74 37.68 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.52 1.128 . . . . 0.0 110.595 174.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 p -88.24 -46.04 9.57 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.05 1.34 . . . . 0.0 109.146 169.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.456 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -68.04 -29.38 68.35 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.272 1.029 . . . . 0.0 111.705 179.212 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.41 -0.3 16.21 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.29 0.948 . . . . 0.0 113.491 170.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.67 -54.07 40.07 Favored Glycine 0 C--N 1.337 0.63 0 CA-C-N 118.937 1.369 . . . . 0.0 110.956 -173.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.6 -28.25 68.36 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 117.51 0.655 . . . . 0.0 111.231 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -68.62 -44.8 73.5 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -70.55 -46.02 64.33 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.386 0.675 . . . . 0.0 109.94 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.9 t -62.15 -38.52 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 118.451 -0.785 . . . . 0.0 110.101 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.17 97.82 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.693 1.133 . . . . 0.0 110.777 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -63.49 -41.42 98.56 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.594 0.634 . . . . 0.0 110.551 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -63.85 -43.3 96.55 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.941 -0.474 . . . . 0.0 111.125 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.4 mt -63.78 -43.81 95.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.546 0.738 . . . . 0.0 109.666 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.33 -37.8 78.72 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.422 0.689 . . . . 0.0 111.219 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -52.55 -44.68 66.0 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.847 0.748 . . . . 0.0 110.482 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt -68.33 -37.54 80.63 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.834 -0.541 . . . . 0.0 109.813 -175.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.1 mt -68.09 -38.61 82.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.262 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.83 -38.57 89.26 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.361 0.528 . . . . 0.0 110.329 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.04 -37.05 84.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.599 0.636 . . . . 0.0 110.98 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.27 -26.0 66.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.972 0.509 . . . . 0.0 111.67 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.86 -3.88 10.77 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.32 1.438 . . . . 0.0 113.743 169.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -78.9 146.4 33.58 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.924 1.362 . . . . 0.0 109.981 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 p -83.5 146.6 28.28 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 169.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.2 p -134.43 169.29 17.47 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.806 0.842 . . . . 0.0 109.943 -170.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.1 158.73 44.41 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 169.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.4 m -130.42 81.96 2.03 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.9 mt -75.94 116.41 16.61 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -74.88 94.48 2.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.0 57.2 19.41 Favored Glycine 0 CA--C 1.54 1.635 0 CA-C-O 118.797 -1.001 . . . . 0.0 114.437 172.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.35 179.01 4.33 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.338 2.692 . . . . 0.0 111.297 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.8 mt -114.38 151.16 33.52 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 169.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -61.21 -28.89 69.47 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.348 0.659 . . . . 0.0 111.747 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.99 -21.59 63.68 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 175.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -82.89 -7.02 59.7 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.697 0.799 . . . . 0.0 111.812 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.1 mt -113.91 145.07 32.75 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 124.359 1.063 . . . . 0.0 109.989 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -70.15 162.89 40.57 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.758 2.305 . . . . 0.0 110.725 169.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.37 23.65 0.6 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.179 1.392 . . . . 0.0 112.024 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 m -156.37 142.87 18.48 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.352 1.461 . . . . 0.0 107.832 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 150.33 179.98 26.57 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.7 mt -122.24 101.74 10.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -107.12 170.59 7.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.535 1.134 . . . . 0.0 109.051 -175.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.8 tp -149.45 121.88 8.49 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.0 t -111.6 138.3 40.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -169.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -134.43 138.57 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.9 m -139.75 145.34 38.15 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.507 1.123 . . . . 0.0 109.213 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -99.21 95.72 7.27 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.752 0.786 . . . . 0.0 109.911 174.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.3 m -58.54 135.42 57.31 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 169.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.4 p-80 -136.01 41.59 2.65 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.986 1.314 . . . . 0.0 108.961 -174.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.43 -35.37 2.43 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.765 1.65 . . . . 0.0 113.118 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.61 -21.03 66.13 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.058 1.343 . . . . 0.0 113.975 -171.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.11 33.78 64.95 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -172.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -141.42 149.92 41.66 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.319 1.048 . . . . 0.0 108.482 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.2 mp -69.3 148.2 97.32 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -55.44 153.08 29.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.411 2.741 . . . . 0.0 112.635 169.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.77 -19.14 25.89 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.833 1.253 . . . . 0.0 114.003 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -63.15 -36.63 84.27 Favored 'General case' 0 C--N 1.343 0.289 0 O-C-N 121.801 -0.562 . . . . 0.0 110.591 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.2 tp -127.16 -18.25 4.6 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.883 -169.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.6 p -52.66 -32.43 9.51 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.54 -21.4 18.72 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.131 2.554 . . . . 0.0 115.773 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -56.82 -32.31 65.6 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.187 0.995 . . . . 0.0 110.96 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -62.79 -51.2 68.0 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -62.2 -42.98 99.79 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.027 0.531 . . . . 0.0 109.906 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.11 -27.52 68.43 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.445 0.698 . . . . 0.0 112.591 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 mt -75.94 -20.84 57.62 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.21 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -93.95 -41.78 9.41 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.038 1.29 . . . . 0.0 109.062 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -60.22 -36.54 77.92 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.105 0.962 . . . . 0.0 110.208 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -107.61 -37.11 6.26 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.089 0.555 . . . . 0.0 112.426 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm 27.31 64.3 0.59 Allowed Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 126.853 2.061 . . . . 0.0 113.355 -169.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -59.3 160.52 19.33 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.297 1.998 . . . . 0.0 111.276 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.35 50.72 1.12 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.978 1.311 . . . . 0.0 109.965 173.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 82' ' ' ALA . 3.8 pp -74.66 34.98 0.1 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.279 1.831 . . . . 0.0 114.168 -169.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -61.75 23.42 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 128.699 2.8 . . . . 0.0 114.745 171.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 80' ' ' LEU . . . -140.06 0.07 1.71 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.886 1.675 . . . . 0.0 111.672 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.6 t -82.47 147.97 5.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 169.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -126.29 141.34 51.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 168.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -140.01 175.38 9.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.225 0.536 . . . . 0.0 110.4 -172.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.07 164.92 26.09 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 106.631 -2.588 . . . . 0.0 106.631 169.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.69 124.89 15.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -169.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.8 mt -133.71 128.08 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 -177.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.66 120.33 5.37 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 107.576 -2.21 . . . . 0.0 107.576 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.9 mt -94.67 152.43 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 169.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 169.81 -144.01 8.26 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 172.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.2 m -132.59 127.69 35.57 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.38 -11.13 60.56 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.699 -0.626 . . . . 0.0 112.124 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.08 -28.44 69.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.513 0.725 . . . . 0.0 111.129 169.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -66.1 145.37 55.91 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 118.87 0.759 . . . . 0.0 109.479 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.98 -35.38 80.52 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 168.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.6 m -73.33 61.81 0.67 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.086 2.554 . . . . 0.0 109.138 169.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -67.52 83.36 0.17 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.111 -0.993 . . . . 0.0 112.236 -172.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 2.0 m 48.93 63.88 1.94 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.084 2.154 . . . . 0.0 112.158 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.22 6.65 2.81 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.416 -1.213 . . . . 0.0 114.701 -169.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.85 -26.23 65.67 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.098 1.949 . . . . 0.0 112.822 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 tp -56.28 -28.63 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.02 1.728 . . . . 0.0 110.723 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -53.03 -37.46 61.56 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.77 0.828 . . . . 0.0 112.73 -173.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -65.23 -42.19 93.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 118.785 0.72 . . . . 0.0 111.458 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.7 mt -68.76 -50.74 47.95 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -37.06 81.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.729 -170.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.4 -35.48 79.37 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.58 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -72.76 -31.24 64.76 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.471 1.032 . . . . 0.0 111.978 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.2 mt -62.13 -44.8 95.84 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 120.77 1.623 . . . . 0.0 108.749 169.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -61.44 -44.6 96.84 Favored 'General case' 0 C--N 1.335 -0.055 0 C-N-CA 124.037 0.935 . . . . 0.0 110.057 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -65.26 -43.34 91.58 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.917 1.287 . . . . 0.0 110.891 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m -68.07 -27.07 66.18 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 119.204 -0.427 . . . . 0.0 111.286 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.94 -32.69 0.38 Allowed Glycine 0 CA--C 1.529 0.929 0 CA-C-N 118.987 0.812 . . . . 0.0 115.002 169.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.61 177.51 0.52 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.807 1.243 . . . . 0.0 113.498 -171.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -138.49 147.31 43.04 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.689 -0.632 . . . . 0.0 110.687 169.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -64.55 166.45 8.53 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.837 1.255 . . . . 0.0 109.404 175.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 m -137.88 153.06 49.59 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.286 1.834 . . . . 0.0 106.189 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 56.08 -139.1 44.18 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -170.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -137.44 157.02 47.48 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.4 145.98 52.57 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.589 1.156 . . . . 0.0 110.074 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.3 tp -120.42 138.85 53.55 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.563 0.745 . . . . 0.0 109.26 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -101.72 141.3 34.79 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 53.0 mt -130.7 136.21 58.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 175.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -125.78 96.03 4.63 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.567 1.547 . . . . 0.0 109.279 -169.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.4 pp -80.48 -3.98 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 O-C-N 121.433 -0.792 . . . . 0.0 112.668 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.3 tp -71.37 -33.32 69.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.846 0.858 . . . . 0.0 112.124 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -149.71 -130.54 0.05 Allowed 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -169.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -54.73 130.95 42.55 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 120.279 1.399 . . . . 0.0 108.12 169.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -65.09 -16.99 64.08 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -169.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 pp -139.25 158.69 68.63 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.629 1.171 . . . . 0.0 109.587 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.8 -39.69 4.31 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.816 1.677 . . . . 0.0 112.603 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -155.51 -16.32 0.11 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -169.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -150.85 131.0 6.91 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.175 1.352 . . . . 0.0 109.831 -170.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -50.95 144.79 26.48 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.296 3.33 . . . . 0.0 114.079 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.37 -34.95 69.37 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.644 0.378 . . . . 0.0 110.946 171.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.55 -42.07 98.3 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.373 0.669 . . . . 0.0 110.411 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -76.88 -40.94 45.79 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.348 0.659 . . . . 0.0 109.703 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 -64.11 -42.15 96.98 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.928 0.491 . . . . 0.0 110.612 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 15.6 tp -66.57 -27.62 67.87 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.72 -0.612 . . . . 0.0 110.451 174.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.97 -48.37 82.99 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 169.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.6 m -63.68 -35.2 79.77 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.736 -0.861 . . . . 0.0 111.129 175.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 38.4 t90 -63.23 -50.68 69.28 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.211 0.605 . . . . 0.0 110.461 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 32.0 m -68.24 -29.21 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 121.214 -0.929 . . . . 0.0 111.444 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -60.71 -21.6 63.08 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.504 -0.76 . . . . 0.0 112.003 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.2 mt -101.77 -32.01 10.49 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 117.963 -1.018 . . . . 0.0 112.664 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.47 -28.35 66.01 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.471 1.487 . . . . 0.0 111.485 173.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttm . . . . . 0 C--O 1.251 1.167 0 C-N-CA 128.321 2.649 . . . . 0.0 111.596 -177.902 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.8 ttm . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.0 159.55 43.78 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.179 1.392 . . . . 0.0 108.499 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -79.36 -31.18 42.87 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.967 0.907 . . . . 0.0 109.898 -172.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.7 mt -122.32 70.02 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.7 m -68.4 116.46 8.99 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.7 mt -86.09 155.09 20.95 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.0 mt -123.14 90.62 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -172.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.6 m -77.62 129.07 35.14 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.153 0.981 . . . . 0.0 110.619 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.0 60.99 0.66 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 124.637 1.113 . . . . 0.0 113.123 -169.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.8 p -144.94 144.0 30.84 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 117.515 0.658 . . . . 0.0 109.894 169.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 p -79.98 -43.61 21.71 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.781 1.232 . . . . 0.0 108.746 169.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.411 ' H ' HD21 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -63.88 -27.1 68.93 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.521 1.528 . . . . 0.0 113.289 178.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.29 7.24 57.26 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.379 0.99 . . . . 0.0 113.559 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.83 -44.58 95.96 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 119.406 1.603 . . . . 0.0 110.844 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.34 -34.01 76.43 Favored 'General case' 0 C--O 1.227 -0.128 0 O-C-N 122.065 -0.667 . . . . 0.0 110.487 175.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.13 -39.84 86.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.676 0.671 . . . . 0.0 110.332 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -66.46 -46.28 76.95 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.996 0.918 . . . . 0.0 109.012 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.99 -49.19 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.88 87.59 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.927 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.57 -44.25 94.64 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.139 0.881 . . . . 0.0 111.101 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -68.91 -41.82 77.68 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.949 -0.469 . . . . 0.0 110.852 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.42 -42.05 98.72 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.66 96.33 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.769 0.828 . . . . 0.0 110.753 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -58.38 -42.87 88.01 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.595 0.634 . . . . 0.0 110.362 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -67.2 -39.61 86.36 Favored 'General case' 0 N--CA 1.461 0.109 0 O-C-N 121.738 -0.601 . . . . 0.0 111.179 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 mt -62.25 -37.64 86.2 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.54 0.609 . . . . 0.0 111.259 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.41 -38.44 87.47 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.092 0.86 . . . . 0.0 110.283 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -66.24 -35.77 81.28 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.609 0.64 . . . . 0.0 110.888 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.6 -26.79 66.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.085 0.554 . . . . 0.0 111.644 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.44 -3.36 10.32 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.269 1.414 . . . . 0.0 113.928 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -81.07 148.31 29.73 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.059 1.43 . . . . 0.0 110.342 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 p -79.05 144.42 34.65 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 169.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.8 p -140.64 163.96 31.48 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.284 0.634 . . . . 0.0 111.036 -176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -150.47 151.62 32.99 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 105.437 -2.06 . . . . 0.0 105.437 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 p -108.81 73.15 0.85 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.32 104.01 6.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -169.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -73.25 121.54 20.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.15 51.85 29.14 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 117.89 -1.505 . . . . 0.0 116.759 169.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -67.23 175.84 5.35 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 CA-C-N 120.735 2.268 . . . . 0.0 111.368 170.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 mt -128.62 168.94 15.03 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.687 1.595 . . . . 0.0 108.659 171.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.38 -37.74 67.95 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.083 0.953 . . . . 0.0 110.902 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.36 -3.46 14.25 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.15 0.98 . . . . 0.0 113.294 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -125.17 9.33 8.0 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.919 1.288 . . . . 0.0 112.332 -170.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.45 149.78 52.29 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 124.127 0.971 . . . . 0.0 110.552 169.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.31 164.28 29.15 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.745 2.297 . . . . 0.0 111.471 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.67 21.19 0.84 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.204 1.402 . . . . 0.0 112.9 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.6 p -153.12 143.66 22.62 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.575 1.15 . . . . 0.0 108.772 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.19 -176.72 27.82 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.22 93.25 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -96.54 169.18 10.07 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.718 0.807 . . . . 0.0 109.796 -172.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.0 tp -135.39 124.14 23.86 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.73 130.48 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.53 121.04 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.4 m -138.4 133.07 32.4 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.307 0.643 . . . . 0.0 109.41 -169.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -77.13 163.85 26.22 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 169.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.0 m -114.35 119.04 35.58 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -66.69 -30.04 70.19 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.402 0.281 . . . . 0.0 110.965 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.49 -35.09 0.34 Allowed Glycine 0 CA--C 1.526 0.777 0 C-N-CA 123.791 0.71 . . . . 0.0 112.81 171.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.09 23.83 7.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.24 1.016 . . . . 0.0 112.192 -173.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.01 -3.62 60.47 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.196 -0.78 . . . . 0.0 113.098 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.29 149.18 47.66 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.448 1.124 . . . . 0.0 109.71 170.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.7 mt -113.71 144.27 31.11 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 126.043 1.737 . . . . 0.0 107.096 -169.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -48.72 139.94 23.46 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 124.223 3.282 . . . . 0.0 114.381 172.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -59.46 -21.56 60.25 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.634 1.574 . . . . 0.0 113.858 -172.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -67.35 -29.63 69.22 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.305 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.0 tp -127.64 -22.11 3.66 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.607 0.763 . . . . 0.0 112.049 -171.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 92.1 p -53.2 -31.66 8.3 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -52.1 -24.05 18.97 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.203 2.602 . . . . 0.0 115.278 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -58.5 -35.58 72.44 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.162 0.892 . . . . 0.0 110.773 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -62.45 -42.76 99.7 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.779 0.718 . . . . 0.0 110.484 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -68.89 -48.05 64.34 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.354 0.662 . . . . 0.0 109.286 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.28 -35.25 79.91 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 118.969 -0.539 . . . . 0.0 111.788 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.0 mt -65.72 -53.07 45.84 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.777 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -70.03 -28.34 65.39 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.337 0.972 . . . . 0.0 112.035 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.01 -35.03 77.63 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.515 0.598 . . . . 0.0 110.825 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -109.25 -33.64 6.8 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -169.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp 30.53 57.22 0.89 Allowed Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 127.385 2.274 . . . . 0.0 113.119 -172.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -69.3 172.0 12.97 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.169 1.913 . . . . 0.0 110.029 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -71.75 106.66 4.21 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.912 -0.493 . . . . 0.0 110.077 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.412 ' C ' ' H ' ' A' ' 82' ' ' ALA . 73.1 mt -113.0 20.43 16.37 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.601 1.56 . . . . 0.0 110.899 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 m -63.31 19.97 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.957 1.703 . . . . 0.0 115.548 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 80' ' ' LEU . . . -135.28 0.1 2.77 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.208 1.403 . . . . 0.0 111.762 173.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 64.5 t -82.13 133.78 28.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -108.99 142.78 39.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 103.444 -2.798 . . . . 0.0 103.444 168.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -136.41 168.35 19.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 119.13 0.877 . . . . 0.0 111.354 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.16 163.48 23.53 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 105.561 -3.015 . . . . 0.0 105.561 169.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.06 124.4 13.04 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -169.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 52.1 mt -133.38 133.25 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.62 150.47 18.01 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.4 mt -139.79 150.44 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.35 -45.77 0.49 Allowed Glycine 0 C--N 1.33 0.237 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 169.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.2 m 115.01 140.92 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 1 C-N-CA 132.08 4.152 . . . . 0.0 108.056 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -67.81 0.84 2.97 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -63.62 -30.58 71.67 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.719 0.808 . . . . 0.0 109.994 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -70.8 156.43 39.55 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.467 0.707 . . . . 0.0 110.853 174.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.14 -37.5 83.06 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.659 0.783 . . . . 0.0 111.785 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.6 m -96.49 121.7 38.59 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 172.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -74.23 69.76 1.58 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.857 1.663 . . . . 0.0 111.783 -171.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 40.8 m 51.36 32.28 8.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.712 1.205 . . . . 0.0 111.823 -174.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.37 -0.87 79.25 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-O 118.301 -1.277 . . . . 0.0 115.051 -169.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.98 -26.79 67.81 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.4 2.1 . . . . 0.0 113.519 -173.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.0 tp -57.93 -28.11 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.755 1.222 . . . . 0.0 110.834 175.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -52.3 -38.68 59.1 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.194 0.997 . . . . 0.0 112.288 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -73.52 -41.12 63.44 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 121.84 -0.537 . . . . 0.0 110.489 -174.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 50.0 mt -64.2 -51.56 63.12 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.17 -38.67 82.31 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -169.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.35 75.23 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 122.049 -0.407 . . . . 0.0 110.576 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -74.13 -31.06 62.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.708 0.685 . . . . 0.0 110.691 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.88 -43.34 96.36 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.429 1.013 . . . . 0.0 108.885 169.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -61.98 -43.79 98.1 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.842 0.457 . . . . 0.0 109.826 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -64.28 -35.92 82.41 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.441 0.696 . . . . 0.0 111.132 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.5 m -71.47 -7.39 47.15 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.164 0.986 . . . . 0.0 112.927 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.85 -17.49 10.85 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.765 1.174 . . . . 0.0 113.787 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.2 171.61 1.29 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.266 1.033 . . . . 0.0 111.158 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -142.5 153.4 43.59 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 121.114 -0.991 . . . . 0.0 111.714 172.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -71.24 156.62 39.33 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.362 174.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 66.2 m -128.0 151.74 48.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.819 2.048 . . . . 0.0 106.675 169.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 62.0 -146.19 49.11 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -172.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -135.44 156.4 48.97 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.647 1.179 . . . . 0.0 108.206 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.66 152.64 45.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.986 1.314 . . . . 0.0 110.462 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.8 tp -129.98 144.17 51.19 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.443 1.097 . . . . 0.0 108.826 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -115.52 153.83 30.46 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 169.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 38.1 mt -134.76 109.14 11.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -172.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -77.63 135.9 38.17 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.555 0.742 . . . . 0.0 109.353 170.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 46.5 pt -129.23 -15.69 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.945 1.698 . . . . 0.0 112.131 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.2 mt -94.72 -19.51 20.33 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.121 0.873 . . . . 0.0 112.761 -170.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -144.82 -54.14 0.31 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.407 1.003 . . . . 0.0 111.97 -173.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -74.34 -37.17 63.61 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 20.8 t0 41.86 64.29 1.11 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.618 1.567 . . . . 0.0 110.095 -171.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.3 tt -44.12 130.46 4.44 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 126.043 1.737 . . . . 0.0 112.978 -169.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.55 170.57 1.77 Allowed 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.88 3.053 . . . . 0.0 114.606 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -73.83 -29.21 62.02 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.299 1.04 . . . . 0.0 111.443 175.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -54.89 -49.42 91.95 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.39 -26.28 35.05 Favored 'Trans proline' 0 C--N 1.351 0.663 0 CA-C-N 121.52 1.579 . . . . 0.0 112.641 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.59 86.88 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 120.134 1.334 . . . . 0.0 109.319 173.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -62.37 -44.61 96.05 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.022 0.529 . . . . 0.0 110.363 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -62.44 -49.77 74.11 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.666 0.386 . . . . 0.0 110.306 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 9.1 t-105 -67.95 -36.25 79.79 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 122.172 -0.33 . . . . 0.0 110.871 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.35 -41.38 93.54 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 118.906 -0.569 . . . . 0.0 110.032 173.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.81 -49.85 60.35 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 173.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.7 m -62.05 -36.6 82.1 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.161 0.584 . . . . 0.0 111.261 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 21.0 t90 -66.36 -53.05 40.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 119.137 -0.459 . . . . 0.0 110.124 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.1 m -66.21 -29.88 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 118.997 0.817 . . . . 0.0 111.514 -176.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -54.36 -25.33 23.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.89 0.876 . . . . 0.0 112.314 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 29.5 mt -100.29 -0.26 38.83 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.255 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.9 pp -124.71 -8.8 7.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.218 1.372 . . . . 0.0 113.59 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 71.8 mttt . . . . . 0 C--O 1.252 1.189 0 CA-C-N 119.542 1.065 . . . . 0.0 110.73 178.256 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.4 mtt . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.869 0.366 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.08 161.49 24.36 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 170.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -75.72 -30.84 59.41 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.812 0.845 . . . . 0.0 109.949 -171.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.0 mt -124.96 74.71 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 m -74.45 114.1 12.45 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 mp -74.27 155.03 38.68 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.0 mt -122.4 86.53 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 m -81.21 157.14 25.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.44 1.496 . . . . 0.0 111.722 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.0 135.26 1.92 Allowed Glycine 0 N--CA 1.444 -0.795 0 O-C-N 121.204 -0.935 . . . . 0.0 110.934 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 31.2 p -152.97 154.51 35.13 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.723 0.809 . . . . 0.0 111.943 169.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 p -71.79 -44.71 63.5 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.472 0.709 . . . . 0.0 109.749 169.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.403 HD22 ' H ' ' A' ' 12' ' ' LEU . 0.6 OUTLIER -64.07 -25.32 68.05 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.899 0.88 . . . . 0.0 112.798 178.264 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.55 40.16 59.8 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -129.02 -19.58 1.57 Allowed Glycine 0 CA--C 1.525 0.696 0 C-N-CA 125.031 1.301 . . . . 0.0 112.11 -175.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.02 -21.17 66.39 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.184 0.992 . . . . 0.0 111.139 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.61 -35.8 77.03 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.206 0.602 . . . . 0.0 110.409 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -71.82 -40.22 69.28 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 122.062 -0.398 . . . . 0.0 110.155 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.97 -39.31 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.98 99.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.273 0.629 . . . . 0.0 110.084 175.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.19 -42.1 98.97 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.741 0.7 . . . . 0.0 110.571 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -61.51 -48.25 81.91 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.429 0.559 . . . . 0.0 110.814 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.0 mt -59.67 -46.3 89.47 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.343 0.657 . . . . 0.0 109.988 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.32 87.19 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.911 0.884 . . . . 0.0 111.397 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 -68.96 -45.52 70.49 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.567 0.747 . . . . 0.0 109.82 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -61.97 -41.3 97.85 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.363 0.528 . . . . 0.0 110.499 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.0 mt -62.72 -37.59 87.14 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.008 0.523 . . . . 0.0 111.396 173.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -67.15 -38.67 85.9 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.692 0.678 . . . . 0.0 110.373 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.54 -35.55 81.18 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.872 0.469 . . . . 0.0 110.839 173.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.89 -28.0 68.63 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.408 0.549 . . . . 0.0 111.335 172.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.39 -8.76 6.23 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.984 1.278 . . . . 0.0 114.155 169.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -80.0 143.76 33.83 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.962 1.381 . . . . 0.0 110.029 -174.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 p -70.95 141.05 51.09 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 169.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.8 p -134.91 159.44 41.43 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.143 0.497 . . . . 0.0 111.624 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -152.18 162.99 40.3 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -135.71 79.29 1.77 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.67 113.56 13.26 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -82.76 110.63 17.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.25 51.97 56.03 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-O 118.018 -1.434 . . . . 0.0 115.613 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -67.49 178.05 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.954 2.436 . . . . 0.0 111.322 170.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.0 mt -131.04 163.61 27.22 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 125.453 1.501 . . . . 0.0 109.56 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.3 tp -59.91 -36.18 76.44 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.656 1.182 . . . . 0.0 111.216 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.63 -3.79 10.04 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -134.56 22.63 3.67 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.783 1.633 . . . . 0.0 110.567 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.3 mt -137.41 123.1 12.93 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 125.286 1.434 . . . . 0.0 108.102 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.41 159.61 48.86 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.201 1.934 . . . . 0.0 110.486 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.02 17.23 1.26 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.586 1.155 . . . . 0.0 113.256 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.1 m -146.02 132.48 19.7 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.477 1.111 . . . . 0.0 108.429 -174.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 153.28 178.53 27.93 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.35 94.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -91.73 168.55 11.39 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.248 0.619 . . . . 0.0 109.402 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.3 tp -146.23 105.92 3.97 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.8 t -91.19 147.77 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -172.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.14 140.71 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 m -151.09 150.85 31.18 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.568 1.147 . . . . 0.0 108.623 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.6 m -69.62 159.29 33.7 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.044 0.45 . . . . 0.0 111.871 174.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.57 63.72 1.51 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 168.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -84.19 23.19 1.1 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.905 1.682 . . . . 0.0 110.855 -169.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.6 -13.48 41.41 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.484 1.04 . . . . 0.0 113.027 -170.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.86 -29.23 63.03 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.729 1.265 . . . . 0.0 112.916 -176.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.09 33.12 78.14 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.008 0.814 . . . . 0.0 112.003 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -144.43 149.12 35.52 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.081 1.352 . . . . 0.0 107.683 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.4 mt -64.91 142.12 98.55 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -170.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.39 143.49 93.61 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.187 1.924 . . . . 0.0 110.939 -176.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.29 -28.48 58.88 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -169.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -70.83 -25.18 62.72 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 122.018 -0.426 . . . . 0.0 112.03 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.8 tp -120.5 -23.46 6.1 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.534 1.134 . . . . 0.0 111.832 -169.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 89.0 p -54.58 -30.32 6.67 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -52.21 -24.92 21.9 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.529 2.153 . . . . 0.0 114.598 169.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -60.26 -45.46 93.2 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.412 1.005 . . . . 0.0 110.542 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -64.43 -36.67 84.91 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.91 0.484 . . . . 0.0 110.661 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -65.35 -45.95 82.12 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.15 0.432 . . . . 0.0 110.183 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.51 -41.21 93.44 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.724 -0.61 . . . . 0.0 111.188 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.8 mt -60.42 -52.23 66.12 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.431 0.692 . . . . 0.0 110.334 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -70.92 -27.83 64.06 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.565 0.621 . . . . 0.0 111.505 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.82 -51.59 46.81 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.845 0.748 . . . . 0.0 109.686 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -85.17 -24.01 28.11 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.629 -169.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm 41.71 60.1 8.96 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.143 1.377 . . . . 0.0 111.166 -171.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -68.43 176.62 5.5 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.771 2.981 . . . . 0.0 111.971 -174.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -106.6 107.24 18.16 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 169.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.7 mt -119.62 24.38 10.65 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 126.44 1.896 . . . . 0.0 110.058 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.7 m -52.83 -10.2 0.15 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.89 -1.68 13.8 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.488 1.115 . . . . 0.0 111.222 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.0 t -80.91 141.99 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 168.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.92 146.97 50.81 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 168.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -137.9 171.71 14.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.295 0.569 . . . . 0.0 112.17 -169.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.52 167.48 26.17 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 105.64 -2.984 . . . . 0.0 105.64 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.69 134.41 19.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.653 0.727 . . . . 0.0 109.649 -169.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.7 mm -128.14 132.77 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.05 130.48 9.65 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 173.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -127.37 126.07 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -172.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 171.22 -141.64 6.57 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -169.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.9 m -115.94 99.21 7.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.172 0.989 . . . . 0.0 108.759 -171.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -13.06 57.97 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.295 0.638 . . . . 0.0 112.561 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -56.76 -28.26 60.9 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.969 0.908 . . . . 0.0 111.002 169.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -123.25 -31.56 3.55 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.522 1.129 . . . . 0.0 110.914 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.7 t70 66.57 -16.31 0.13 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 129.608 3.163 . . . . 0.0 114.859 172.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 m 59.78 171.66 0.08 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.635 1.974 . . . . 0.0 112.36 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -74.08 -2.59 25.03 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.634 -1.291 . . . . 0.0 113.027 -177.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 60.2 m 63.14 1.7 0.94 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.982 2.113 . . . . 0.0 115.046 -177.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -48.8 -32.41 11.24 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.762 1.172 . . . . 0.0 112.17 169.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.36 -5.39 1.13 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.84 2.056 . . . . 0.0 115.537 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 tp -141.15 -34.1 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.028 1.331 . . . . 0.0 109.772 172.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -50.97 -36.01 36.7 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.322 1.049 . . . . 0.0 112.492 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -71.68 -55.35 7.88 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.59 -0.694 . . . . 0.0 110.676 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 pp -65.04 -40.51 94.91 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -72.1 -39.25 69.04 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -172.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.69 -30.64 70.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 119.05 -0.5 . . . . 0.0 110.431 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -70.83 -33.56 70.79 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.207 0.912 . . . . 0.0 110.912 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.1 mt -64.0 -40.82 97.21 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.129 1.332 . . . . 0.0 109.235 169.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -63.42 -43.43 97.51 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -63.04 -38.71 92.29 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.708 0.803 . . . . 0.0 110.762 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.6 m -67.9 -10.62 54.68 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.986 0.914 . . . . 0.0 112.75 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.56 -18.17 8.22 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.013 1.292 . . . . 0.0 113.606 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.24 175.79 0.89 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.371 1.086 . . . . 0.0 111.522 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -146.62 159.66 43.17 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.362 -0.836 . . . . 0.0 109.784 169.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -73.46 168.14 19.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.534 1.134 . . . . 0.0 109.473 175.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 m -133.25 145.27 50.37 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 127.105 2.162 . . . . 0.0 106.237 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.58 -133.12 52.8 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -173.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -140.99 160.12 40.75 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.355 1.862 . . . . 0.0 106.149 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.58 157.89 16.38 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.086 1.354 . . . . 0.0 111.033 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 51.4 tp -126.86 149.84 49.53 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.86 0.864 . . . . 0.0 109.333 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -116.33 147.93 41.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 172.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 25.7 mm -132.89 138.73 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -108.94 133.98 52.21 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.664 1.186 . . . . 0.0 108.802 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.7 pp -127.1 4.96 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.868 1.267 . . . . 0.0 111.273 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.4 tp -65.57 -37.13 85.79 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.435 0.694 . . . . 0.0 111.872 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -153.03 -42.18 0.1 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -169.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -144.53 140.83 29.09 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.365 1.066 . . . . 0.0 109.398 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -85.6 58.53 5.1 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.156 2.182 . . . . 0.0 110.775 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 35.61 52.83 1.8 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 127.414 2.286 . . . . 0.0 115.031 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.11 -22.62 67.45 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.288 1.992 . . . . 0.0 113.086 -172.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -77.72 -13.55 59.86 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.086 0.954 . . . . 0.0 112.677 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -152.82 65.5 5.78 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.688 1.195 . . . . 0.0 110.096 -172.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.82 154.13 75.22 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.896 2.397 . . . . 0.0 111.835 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.87 -21.75 63.59 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.996 0.918 . . . . 0.0 113.212 -175.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.64 -37.83 73.99 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.681 0.792 . . . . 0.0 111.242 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -69.74 -38.57 76.87 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.848 -0.533 . . . . 0.0 110.494 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -65.52 -43.04 91.3 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.619 0.368 . . . . 0.0 110.063 172.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 28.2 tp -60.6 -39.46 88.22 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.3 0.64 . . . . 0.0 110.498 -173.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.15 -48.88 65.7 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.6 m -65.31 -35.98 82.67 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.047 -0.678 . . . . 0.0 111.148 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 17.1 t90 -66.18 -51.16 60.41 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.3 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.0 m -65.78 -28.98 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 119.128 0.876 . . . . 0.0 111.528 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -57.65 -24.23 55.51 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.808 -0.615 . . . . 0.0 112.169 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.5 mt -102.04 3.08 38.41 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 pp -124.6 -10.21 7.36 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.717 1.144 . . . . 0.0 113.24 174.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.249 1.036 0 C-N-CA 125.845 1.658 . . . . 0.0 112.188 -179.958 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.83 162.67 36.22 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.821 1.248 . . . . 0.0 109.15 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -131.82 -28.43 1.79 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.487 1.515 . . . . 0.0 110.404 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.1 mt -123.93 84.51 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 169.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.5 m -75.94 109.55 9.66 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.74 154.39 38.41 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 89.1 mt -126.85 88.81 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 m -69.55 145.87 52.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.113 1.365 . . . . 0.0 109.933 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.07 49.82 0.66 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.411 0.529 . . . . 0.0 114.064 -169.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.8 p -125.03 160.2 29.57 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.677 1.191 . . . . 0.0 108.138 169.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.59 -31.22 18.72 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.155 0.982 . . . . 0.0 112.138 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 pp -140.57 -30.29 0.66 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -171.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.21 153.97 11.97 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.09 -78.59 0.38 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 126.055 1.788 . . . . 0.0 109.192 170.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.8 -42.17 95.24 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 122.673 0.389 . . . . 0.0 109.974 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -67.44 -31.8 72.24 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.024 0.93 . . . . 0.0 112.082 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -70.18 -46.66 64.15 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.3 t -68.43 -35.65 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 118.998 -0.525 . . . . 0.0 109.723 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.09 88.09 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 119.026 0.83 . . . . 0.0 110.873 173.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -62.54 -42.02 99.26 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.052 0.842 . . . . 0.0 110.778 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -66.06 -45.7 80.38 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 122.027 -0.42 . . . . 0.0 110.488 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -59.97 -43.54 95.03 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.418 0.687 . . . . 0.0 110.098 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.51 99.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.751 0.82 . . . . 0.0 110.669 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -63.4 -44.18 95.41 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.559 0.618 . . . . 0.0 110.406 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -62.59 -40.44 96.9 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 121.635 -0.665 . . . . 0.0 110.516 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 41.2 mt -63.48 -38.35 90.8 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 118.449 -0.786 . . . . 0.0 111.954 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.95 -38.8 92.15 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.411 1.005 . . . . 0.0 110.358 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -66.47 -35.81 81.2 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.251 0.478 . . . . 0.0 110.872 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.72 -26.37 65.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.163 0.585 . . . . 0.0 111.712 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.44 -2.83 10.37 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.266 1.412 . . . . 0.0 114.137 169.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -82.07 142.91 31.89 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.094 1.447 . . . . 0.0 109.579 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 p -80.97 142.41 33.49 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.1 p -136.94 166.23 24.12 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.575 0.702 . . . . 0.0 110.991 -169.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -150.31 159.53 44.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 169.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 p -128.04 76.62 1.7 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.1 mt -70.54 113.59 7.8 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -76.69 107.29 8.88 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 52.8 52.13 40.64 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-O 118.521 -1.155 . . . . 0.0 115.057 172.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -67.7 177.74 3.88 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.092 2.528 . . . . 0.0 111.13 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.2 mt -127.91 166.84 17.54 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.271 1.428 . . . . 0.0 108.968 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -53.21 -36.85 61.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.489 1.516 . . . . 0.0 112.127 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.46 -7.13 8.88 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.237 1.015 . . . . 0.0 113.415 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -132.14 21.88 4.47 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.778 1.631 . . . . 0.0 110.976 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.2 mt -134.12 112.95 12.35 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.558 1.143 . . . . 0.0 109.273 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -66.34 157.44 60.18 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.35 2.034 . . . . 0.0 111.963 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.33 10.61 26.71 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.757 1.223 . . . . 0.0 114.288 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.7 m -144.4 124.57 13.69 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 150.79 -171.36 30.56 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.8 mp -124.92 99.22 5.89 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -94.23 174.09 7.32 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.722 0.809 . . . . 0.0 109.515 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.6 tp -144.87 98.6 3.21 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.7 138.61 19.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 mt -130.11 148.57 33.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.8 m -146.33 137.64 24.54 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 m -70.54 144.57 51.26 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 168.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 p -85.34 1.96 46.25 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -177.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 45.08 19.61 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 129.537 3.135 . . . . 0.0 114.394 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.58 23.74 29.29 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 120.905 -1.122 . . . . 0.0 113.149 -169.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.82 -9.09 0.41 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.342 1.071 . . . . 0.0 113.515 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.81 34.72 42.2 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 118.862 0.756 . . . . 0.0 111.642 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -140.32 146.93 39.13 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.053 0.941 . . . . 0.0 109.214 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.6 mp -76.73 146.1 75.84 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -57.42 155.07 32.13 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.951 2.434 . . . . 0.0 111.663 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -59.56 -16.28 24.17 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.115 1.366 . . . . 0.0 114.107 -174.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -64.46 -39.82 94.54 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.519 0.728 . . . . 0.0 111.083 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.2 tp -122.97 -20.64 5.73 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.185 0.594 . . . . 0.0 112.313 -171.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 t -49.2 -39.05 33.4 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.75 -23.78 8.91 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.463 2.775 . . . . 0.0 116.162 172.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -59.94 -37.03 78.33 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.658 1.117 . . . . 0.0 111.16 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -59.03 -42.94 91.4 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.237 0.615 . . . . 0.0 110.34 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -68.65 -48.24 64.51 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.401 0.68 . . . . 0.0 109.79 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.34 84.03 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 118.924 -0.56 . . . . 0.0 112.094 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.6 mt -65.84 -53.82 34.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 118.65 -0.69 . . . . 0.0 109.503 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -69.15 -28.58 66.56 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.162 0.892 . . . . 0.0 111.847 -174.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -66.09 -36.44 83.19 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.709 0.686 . . . . 0.0 110.725 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -107.22 -20.74 13.19 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -169.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm 39.71 60.54 6.31 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.873 1.669 . . . . 0.0 111.057 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.95 167.25 14.38 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.752 2.968 . . . . 0.0 111.997 -174.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -95.52 73.27 3.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.386 1.075 . . . . 0.0 109.332 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.47 16.68 9.82 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.26 1.424 . . . . 0.0 111.517 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.9 m -51.57 10.95 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 129.601 3.161 . . . . 0.0 116.921 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.22 2.18 2.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.168 1.387 . . . . 0.0 112.213 174.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.5 t -80.16 140.87 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 169.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -116.84 151.07 37.31 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 168.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -147.43 170.83 16.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.189 0.904 . . . . 0.0 112.48 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.55 161.16 23.95 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 104.766 -3.334 . . . . 0.0 104.766 169.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.98 132.88 27.59 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -169.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.2 mt -137.72 126.32 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 -173.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -114.93 121.07 5.2 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.1 mt -123.47 134.32 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 118.232 1.016 . . . . 0.0 108.34 -169.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.02 -164.42 37.96 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.5 m -75.06 75.22 2.25 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 125.621 1.569 . . . . 0.0 109.186 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -65.1 -12.2 48.19 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.448 1.099 . . . . 0.0 113.39 -171.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -65.56 -22.49 66.7 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.379 0.536 . . . . 0.0 111.475 170.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -75.01 174.31 9.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.055 0.942 . . . . 0.0 110.326 175.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.34 -29.9 70.96 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.712 0.805 . . . . 0.0 113.16 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 58.3 m -69.34 132.47 46.46 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -114.13 -59.57 2.0 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.295 0.638 . . . . 0.0 111.338 -175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 63.9 m -145.71 6.89 1.08 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.535 1.134 . . . . 0.0 112.413 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.6 -33.93 48.95 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 119.165 0.893 . . . . 0.0 114.22 -169.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.42 -59.59 4.17 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 117.949 0.875 . . . . 0.0 110.621 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.04 -34.99 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.0 -37.33 63.9 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.279 1.032 . . . . 0.0 112.528 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -63.7 -43.68 95.9 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.202 0.91 . . . . 0.0 111.35 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.3 mt -63.14 -50.43 70.46 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -70.22 -30.44 67.52 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.496 -173.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.01 91.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.481 0.582 . . . . 0.0 109.975 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -75.89 -29.6 58.53 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 117.771 -1.109 . . . . 0.0 112.4 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.26 -45.46 87.99 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 121.059 1.754 . . . . 0.0 109.855 172.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -71.4 -31.95 67.85 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.142 0.428 . . . . 0.0 110.964 -177.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -62.56 -39.47 93.74 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.013 0.37 . . . . 0.0 110.367 169.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.1 m -71.56 -0.53 10.82 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.82 1.248 . . . . 0.0 112.945 172.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.71 -14.31 41.9 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.809 1.195 . . . . 0.0 114.004 169.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.55 171.63 1.91 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.79 1.295 . . . . 0.0 110.839 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -142.81 150.68 40.27 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.993 -1.067 . . . . 0.0 112.237 170.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 17.3 tm0? -70.85 148.18 48.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.738 1.615 . . . . 0.0 108.438 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.3 m -128.22 144.96 51.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.936 1.695 . . . . 0.0 107.53 174.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.02 -127.84 8.68 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -143.98 164.41 30.68 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.993 1.717 . . . . 0.0 107.209 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.7 m -68.12 139.95 56.18 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.3 tp -105.8 150.2 25.77 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.209 1.003 . . . . 0.0 108.662 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.32 136.65 35.06 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.6 mm -135.49 113.81 15.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.176 -1.786 . . . . 0.0 106.176 -170.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -72.07 142.78 49.23 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 169.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.4 pp -128.92 3.62 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.518 1.127 . . . . 0.0 112.378 171.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 tp -64.55 -39.6 94.06 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.096 0.862 . . . . 0.0 112.351 -172.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -142.68 -7.39 0.86 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -169.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -150.12 155.27 39.51 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.392 1.477 . . . . 0.0 107.693 177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -72.86 -34.45 66.74 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -169.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.1 pt -147.32 155.32 46.26 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 126.146 1.779 . . . . 0.0 108.317 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 133' ' ' ASP . 92.9 Cg_endo -70.85 174.69 10.08 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.762 2.308 . . . . 0.0 110.677 169.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.9 mp0 -70.95 24.32 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.044 2.138 . . . . 0.0 112.538 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 131' ' ' PRO . 14.1 t0 -142.28 80.64 14.72 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 127.004 2.122 . . . . 0.0 106.726 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.99 151.03 28.64 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.781 2.987 . . . . 0.0 114.098 -169.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.12 -31.68 65.56 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.539 174.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.1 -37.87 89.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.288 0.635 . . . . 0.0 111.252 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -71.46 -41.43 69.4 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.763 -0.586 . . . . 0.0 109.562 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -61.05 -45.15 95.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.62 -43.75 95.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.481 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.31 -45.36 92.87 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -63.97 -36.86 85.37 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.154 0.582 . . . . 0.0 111.168 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -67.91 -54.06 21.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.934 0.894 . . . . 0.0 109.8 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.93 -31.35 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 118.818 0.735 . . . . 0.0 111.141 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.24 -25.09 58.57 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.416 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.5 mt -101.46 -5.84 24.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.038 -0.982 . . . . 0.0 113.293 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.5 pp -120.3 -9.41 9.52 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.308 1.413 . . . . 0.0 113.08 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.251 1.133 0 C-N-CA 125.703 1.601 . . . . 0.0 111.961 178.264 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tmm? . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.16 158.03 14.75 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.72 -0.613 . . . . 0.0 110.776 172.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -135.44 -25.94 1.28 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.765 1.226 . . . . 0.0 110.977 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.8 mt -129.53 84.77 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 169.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.5 m -75.56 115.85 15.67 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 176.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mp -74.35 156.89 36.62 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 171.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.6 mt -126.39 80.22 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.5 m -68.45 153.88 42.91 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.527 1.531 . . . . 0.0 110.561 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.1 100.42 0.19 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -150.12 170.56 18.63 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.656 0.741 . . . . 0.0 109.976 171.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -133.42 -41.4 0.87 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 127.213 2.205 . . . . 0.0 107.344 171.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.71 -33.84 76.54 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.815 0.846 . . . . 0.0 110.64 169.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.44 -8.46 52.21 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.134 1.35 . . . . 0.0 112.754 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.67 -45.17 67.38 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 118.484 1.142 . . . . 0.0 110.684 -173.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.68 -26.83 64.56 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.483 0.641 . . . . 0.0 110.74 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -69.96 -36.64 75.4 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.328 0.513 . . . . 0.0 110.685 175.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -67.02 -44.28 80.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.735 0.698 . . . . 0.0 109.504 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.65 -39.15 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 119.057 -0.497 . . . . 0.0 109.967 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.88 -41.74 96.58 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.296 0.953 . . . . 0.0 110.987 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -63.32 -42.5 99.0 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.746 0.703 . . . . 0.0 110.553 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -62.02 -45.41 93.7 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.845 -0.534 . . . . 0.0 110.706 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.7 mt -62.06 -41.78 98.5 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.474 0.71 . . . . 0.0 110.464 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.18 -38.24 85.8 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.028 0.531 . . . . 0.0 110.662 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.18 -41.33 90.44 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.417 ' N ' ' HE2' ' A' ' 25' ' ' LYS . 6.8 mmpt? -62.89 -36.34 83.01 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 121.685 -0.634 . . . . 0.0 110.009 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.3 mt -68.45 -37.53 80.31 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 118.965 -0.541 . . . . 0.0 110.984 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -62.9 -42.11 99.67 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.924 0.783 . . . . 0.0 109.974 175.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.93 -37.29 87.16 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.145 0.43 . . . . 0.0 111.012 175.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.16 -22.03 63.96 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.792 0.837 . . . . 0.0 112.186 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.56 28.75 2.89 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.567 -1.13 . . . . 0.0 113.973 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -125.98 137.44 53.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.286 1.543 . . . . 0.0 109.223 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.5 p -76.07 146.85 39.08 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.43 0.633 . . . . 0.0 109.513 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.4 p -135.36 167.63 20.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.781 0.832 . . . . 0.0 110.212 -170.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -150.97 160.75 43.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 169.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.7 78.65 1.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -175.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.09 110.85 4.71 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -93.93 92.02 7.19 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -171.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.51 56.6 12.65 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.931 -0.927 . . . . 0.0 113.071 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.19 -179.14 3.3 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.91 2.407 . . . . 0.0 110.345 170.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.3 mt -114.77 160.16 19.75 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 169.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -55.5 -40.04 71.22 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.781 0.832 . . . . 0.0 111.403 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -64.83 -14.54 59.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.808 0.843 . . . . 0.0 113.198 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -90.76 -2.91 57.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.932 0.893 . . . . 0.0 112.309 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -137.44 154.4 75.26 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.147 0.979 . . . . 0.0 111.179 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.8 163.58 26.1 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.826 2.351 . . . . 0.0 111.77 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.04 18.67 0.99 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.41 1.484 . . . . 0.0 113.22 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.7 m -146.45 136.7 23.7 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.223 1.409 . . . . 0.0 107.887 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.71 -176.2 30.19 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.95 104.28 13.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -104.95 172.85 6.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.199 0.999 . . . . 0.0 109.931 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.6 tp -141.31 100.55 3.82 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 t -79.35 131.57 34.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.9 mt -133.0 127.58 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.2 m -134.29 129.31 35.39 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -170.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.9 m -69.07 160.51 30.89 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.505 169.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.9 m -132.82 109.21 9.48 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -63.28 -24.89 68.07 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.04 0.382 . . . . 0.0 111.956 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.09 -32.24 0.33 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.052 0.834 . . . . 0.0 112.234 171.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.93 30.31 4.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.27 1.028 . . . . 0.0 111.922 -171.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.81 -0.01 59.14 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.376 -0.68 . . . . 0.0 113.641 173.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -69.14 110.82 4.73 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 118.484 1.142 . . . . 0.0 109.982 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 61.2 mt -69.3 141.86 91.76 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 171.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.51 136.76 56.23 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.204 2.602 . . . . 0.0 110.985 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.9 -21.48 43.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.407 1.483 . . . . 0.0 113.237 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -64.87 -34.94 79.58 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.446 0.699 . . . . 0.0 111.454 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 tt -121.76 -22.17 5.88 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.615 0.766 . . . . 0.0 112.306 -169.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 81.7 p -51.13 -34.01 11.51 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-O 116.439 -1.743 . . . . 0.0 115.259 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -52.11 -22.9 15.99 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.989 2.46 . . . . 0.0 115.728 172.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -59.46 -37.21 77.58 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.336 0.971 . . . . 0.0 110.913 175.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -65.21 -42.26 93.69 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.602 0.761 . . . . 0.0 110.179 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -63.35 -50.95 67.95 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.714 0.406 . . . . 0.0 109.997 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.56 -29.21 70.23 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.993 0.815 . . . . 0.0 112.745 -174.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.3 mt -68.69 -57.07 6.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.382 171.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -69.86 -27.46 64.85 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.041 0.837 . . . . 0.0 112.431 -170.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.92 -26.05 61.27 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.123 0.874 . . . . 0.0 111.256 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -109.44 -24.4 11.04 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.573 -173.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt 40.13 59.81 7.05 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.778 1.631 . . . . 0.0 110.577 -169.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.25 167.62 17.94 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.846 2.364 . . . . 0.0 111.068 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -96.53 106.72 19.02 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 169.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 82' ' ' ALA . 50.1 mt -118.98 24.93 10.54 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.128 1.771 . . . . 0.0 110.022 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -61.0 20.0 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.524 1.929 . . . . 0.0 115.569 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.437 ' H ' ' C ' ' A' ' 80' ' ' LEU . . . -140.13 1.86 1.86 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.35 1.46 . . . . 0.0 111.992 173.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.5 t -84.09 142.66 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -123.42 148.65 45.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 168.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -144.08 171.3 14.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.452 0.644 . . . . 0.0 111.45 -174.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.42 161.54 22.16 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 104.461 -3.456 . . . . 0.0 104.461 168.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.31 124.77 13.93 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -169.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 mt -134.65 133.43 54.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.8 140.03 15.93 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 170.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 mt -138.73 131.47 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -171.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.7 -169.01 41.46 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 120.231 1.378 . . . . 0.0 110.541 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.9 m -79.34 74.17 5.95 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 126.02 1.728 . . . . 0.0 108.223 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -52.6 -33.93 48.57 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.962 1.305 . . . . 0.0 112.211 -173.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -80.84 -12.02 59.5 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.671 1.188 . . . . 0.0 112.349 -174.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -67.49 -52.54 38.03 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 118.978 0.808 . . . . 0.0 111.836 -169.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -162.87 -47.06 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.346 1.058 . . . . 0.0 110.915 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.8 m -115.93 131.44 56.94 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -79.7 59.49 3.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.83 1.252 . . . . 0.0 111.434 -169.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 72.1 m 48.28 38.3 10.0 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.646 1.578 . . . . 0.0 112.613 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.02 -0.17 78.08 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 118.673 -1.07 . . . . 0.0 113.55 -172.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.17 -20.52 66.06 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.795 1.797 . . . . 0.0 113.161 -171.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.6 tp -60.86 -28.21 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.361 1.464 . . . . 0.0 111.163 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -57.22 -40.35 77.34 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -169.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -63.62 -44.35 94.18 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.927 -0.483 . . . . 0.0 111.047 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.9 mt -69.34 -48.61 60.85 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.566 0.747 . . . . 0.0 109.398 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.63 -38.57 87.21 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.56 -37.65 88.27 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.316 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -70.62 -29.16 65.47 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.596 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.6 mt -66.23 -43.05 87.7 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.948 1.704 . . . . 0.0 109.259 170.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -62.71 -42.81 99.83 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 122.732 0.413 . . . . 0.0 109.985 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -60.82 -40.51 92.99 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.207 1.003 . . . . 0.0 110.826 174.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.0 m -70.3 -5.78 30.34 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.478 1.111 . . . . 0.0 113.186 175.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.19 -13.9 21.33 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.53 1.062 . . . . 0.0 113.612 169.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.73 178.97 0.7 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.379 1.089 . . . . 0.0 110.589 174.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -151.73 148.08 27.47 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.873 -1.142 . . . . 0.0 113.204 169.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 39.7 tp60 -56.77 155.94 7.13 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.715 2.006 . . . . 0.0 109.928 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.5 m -141.3 131.96 25.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.57 174.77 17.01 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -169.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -71.55 158.3 36.46 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.625 -0.926 . . . . 0.0 108.963 170.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.88 160.52 20.28 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 169.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 54.2 tp -129.54 148.44 51.44 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.517 -0.739 . . . . 0.0 109.637 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -125.71 147.33 49.4 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 169.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.7 mm -131.66 106.88 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -78.14 134.96 37.59 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 169.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.24 -17.64 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 118.294 0.497 . . . . 0.0 111.699 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.0 tp -67.67 -34.46 76.98 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.552 0.614 . . . . 0.0 111.274 -171.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -73.77 -50.83 18.73 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -159.76 34.84 0.19 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.387 0.675 . . . . 0.0 111.018 -171.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.1 t70 67.87 -25.16 0.12 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.454 2.302 . . . . 0.0 114.738 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.0 pt -145.18 160.06 47.17 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 127.757 2.423 . . . . 0.0 107.673 171.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.66 170.31 16.76 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.536 2.157 . . . . 0.0 110.225 169.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.32 -36.98 85.88 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.17 0.588 . . . . 0.0 110.808 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -69.61 115.82 36.85 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.293 1.037 . . . . 0.0 109.91 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.23 138.02 78.65 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.559 2.173 . . . . 0.0 111.767 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.89 -28.67 67.75 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 122.704 0.402 . . . . 0.0 111.153 172.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -58.63 -33.73 70.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.49 1.116 . . . . 0.0 111.565 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -69.52 -42.08 75.16 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.851 0.75 . . . . 0.0 109.954 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -64.68 -43.88 92.11 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.98 -43.34 99.06 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.354 0.662 . . . . 0.0 110.513 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.71 -44.54 97.8 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.954 0.787 . . . . 0.0 111.513 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -63.47 -35.58 80.93 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.023 -0.692 . . . . 0.0 111.053 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -68.88 -48.51 63.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.918 0.887 . . . . 0.0 110.403 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.15 -32.55 57.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 CA-C-N 119.161 0.891 . . . . 0.0 111.169 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -62.14 -22.23 65.68 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.344 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.1 mt -96.53 -43.8 7.45 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.438 1.017 . . . . 0.0 111.621 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 pp -70.92 -25.41 62.75 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.355 0.98 . . . . 0.0 112.32 -175.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 C--O 1.252 1.209 0 C-N-CA 127.796 2.438 . . . . 0.0 112.02 177.767 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.07 158.67 43.75 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.625 1.17 . . . . 0.0 108.589 172.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -137.36 -25.09 1.05 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.69 1.596 . . . . 0.0 110.992 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.8 mt -124.9 79.3 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 169.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.4 m -74.83 117.77 17.05 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.65 151.0 34.5 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.3 mt -116.2 80.34 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 m -71.44 148.34 46.96 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.254 1.422 . . . . 0.0 109.683 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.6 80.7 0.18 Allowed Glycine 0 C--N 1.339 0.735 0 O-C-N 122.237 -0.289 . . . . 0.0 113.794 -169.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 t -150.44 134.37 16.83 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.899 0.88 . . . . 0.0 108.734 168.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -78.24 -38.48 42.86 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 169.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.6 mt -73.83 -41.24 62.58 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.754 0.822 . . . . 0.0 110.635 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.37 -8.42 11.2 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.392 1.472 . . . . 0.0 112.634 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.79 -57.98 14.13 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 125.545 1.545 . . . . 0.0 113.109 -169.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.02 -27.97 67.0 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 117.568 0.684 . . . . 0.0 110.972 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -76.33 -22.7 54.6 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.192 -173.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -65.75 -41.6 91.92 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.94 0.791 . . . . 0.0 109.182 169.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.5 t -72.22 -32.76 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 121.822 -0.549 . . . . 0.0 109.937 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.86 87.12 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.409 -0.807 . . . . 0.0 110.277 170.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.07 -38.93 89.56 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.412 0.551 . . . . 0.0 111.157 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -59.23 -46.8 87.51 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.095 0.861 . . . . 0.0 110.032 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.6 mt -65.14 -43.18 92.7 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.799 -0.563 . . . . 0.0 110.103 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.47 -42.61 92.43 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.549 0.74 . . . . 0.0 111.004 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -52.79 -47.43 67.56 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.799 0.84 . . . . 0.0 110.031 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -67.87 -40.9 83.54 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.2 mt -66.41 -39.59 89.09 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 119.259 -0.4 . . . . 0.0 110.641 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -61.12 -46.18 91.63 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.111 0.564 . . . . 0.0 109.655 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -65.5 -34.94 79.45 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.846 0.458 . . . . 0.0 111.34 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.6 -22.36 64.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.877 0.871 . . . . 0.0 112.035 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.25 1.67 23.47 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.656 1.122 . . . . 0.0 113.212 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -74.97 174.74 8.89 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.444 1.122 . . . . 0.0 109.475 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.4 p -122.61 137.32 54.93 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.5 p -132.51 170.32 15.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.135 0.974 . . . . 0.0 110.336 -170.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -153.54 126.1 8.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 104.518 -2.401 . . . . 0.0 104.518 169.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.0 p -82.54 70.63 9.55 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -69.58 113.59 7.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -169.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.436 ' CE1' HD21 ' A' ' 65' ' ' ASN . 54.9 t60 -72.27 107.98 5.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.261 1.024 . . . . 0.0 108.744 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.82 56.65 15.13 Favored Glycine 0 CA--C 1.539 1.577 0 CA-C-O 118.341 -1.255 . . . . 0.0 115.766 169.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.2 175.71 5.46 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.771 2.314 . . . . 0.0 111.685 173.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.7 mt -128.67 164.35 23.12 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.346 1.458 . . . . 0.0 109.226 174.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.4 tp -62.27 -27.8 69.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.816 1.247 . . . . 0.0 112.169 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.75 -10.38 12.6 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.136 0.974 . . . . 0.0 113.101 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -128.56 19.88 6.19 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.348 1.459 . . . . 0.0 110.872 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.94 97.67 13.61 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.08 1.352 . . . . 0.0 107.886 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.76 165.22 28.45 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.404 2.069 . . . . 0.0 111.774 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.71 4.67 1.8 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.69 1.596 . . . . 0.0 114.788 -175.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.2 m -144.94 133.85 22.47 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.354 1.462 . . . . 0.0 107.276 -175.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.71 175.53 23.54 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.5 mt -114.54 101.83 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -110.42 166.63 10.83 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.573 0.749 . . . . 0.0 108.98 -176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.8 tp -146.37 99.28 3.2 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 t -79.52 132.31 32.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.793 1.237 . . . . 0.0 107.839 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 mt -135.98 132.29 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.6 m -134.18 133.67 41.23 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -169.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 m -80.08 166.71 21.24 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 169.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.5 m -141.15 112.27 7.29 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 174.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -71.61 -5.25 32.08 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -169.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 160.89 -38.58 0.43 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-N 119.794 1.179 . . . . 0.0 113.761 169.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.22 10.25 3.0 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.273 1.036 . . . . 0.0 113.259 -170.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.62 -14.88 4.71 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.135 0.874 . . . . 0.0 113.289 172.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.07 119.43 6.3 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.353 1.061 . . . . 0.0 111.632 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.4 mt -83.47 132.23 50.27 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -51.13 136.46 45.51 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 124.016 3.144 . . . . 0.0 113.292 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.39 -18.6 62.0 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.283 1.033 . . . . 0.0 113.315 -176.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.436 HD21 ' CE1' ' A' ' 37' ' ' HIS . 2.7 p-10 -73.89 -27.11 60.89 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.413 -0.804 . . . . 0.0 112.179 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.9 tp -121.04 -27.1 5.02 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.283 0.947 . . . . 0.0 111.92 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -46.73 -39.76 17.37 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-O 117.549 -1.215 . . . . 0.0 113.935 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.42 -25.64 14.46 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.502 2.801 . . . . 0.0 116.077 172.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -60.56 -37.5 81.47 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.157 -0.965 . . . . 0.0 110.855 176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -65.71 -43.3 89.54 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.113 0.565 . . . . 0.0 110.9 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.26 -38.04 68.95 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.583 0.629 . . . . 0.0 110.784 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.04 -35.91 80.92 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.726 0.693 . . . . 0.0 111.576 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.9 mt -64.45 -54.41 33.02 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.744 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -69.54 -25.96 64.27 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.147 0.885 . . . . 0.0 111.957 -173.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -68.88 -37.27 78.94 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.86 0.755 . . . . 0.0 110.697 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -105.07 -34.33 8.0 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -169.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm 31.0 57.92 0.98 Allowed Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 127.306 2.242 . . . . 0.0 113.675 -173.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.23 169.83 15.93 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.929 1.753 . . . . 0.0 110.167 174.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -72.04 114.83 10.57 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 169.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.1 mt -119.72 18.74 12.62 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.674 1.59 . . . . 0.0 110.901 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.8 m -57.87 4.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.43 1.22 8.96 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.848 1.204 . . . . 0.0 111.614 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 79.8 t -74.56 131.63 34.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 169.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -107.62 102.73 11.95 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 102.197 -3.26 . . . . 0.0 102.197 168.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -95.88 167.35 11.31 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.803 0.811 . . . . 0.0 108.933 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -123.13 154.46 17.17 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 104.839 -3.305 . . . . 0.0 104.839 169.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.47 122.48 11.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.8 mt -135.68 131.82 50.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -102.26 138.11 13.73 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.9 mt -133.21 153.35 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 165.66 173.4 34.13 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-O 123.278 1.488 . . . . 0.0 110.732 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.1 m -74.48 56.94 0.69 Allowed 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 126.511 1.924 . . . . 0.0 109.952 174.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.14 -52.5 7.23 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.894 2.078 . . . . 0.0 110.978 -174.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -65.14 -11.7 43.07 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.093 0.557 . . . . 0.0 112.498 -171.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -66.27 -50.43 63.73 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.908 0.776 . . . . 0.0 110.184 170.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -171.61 -49.02 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.412 1.485 . . . . 0.0 111.797 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.5 t -58.65 166.22 1.93 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.739 1.216 . . . . 0.0 114.02 -169.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -112.96 43.39 1.7 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 169.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 16.4 m 45.0 52.9 8.03 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.486 1.914 . . . . 0.0 110.379 -169.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -69.7 -14.36 69.87 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.718 -169.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.38 -36.45 71.26 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.486 1.643 . . . . 0.0 113.784 -169.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.8 tp -67.88 -27.87 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.174 0.59 . . . . 0.0 110.841 -176.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -61.02 -43.52 98.76 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 118.354 0.524 . . . . 0.0 111.787 -169.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -65.81 -44.52 85.4 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 122.016 -0.427 . . . . 0.0 110.802 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.9 mt -63.33 -46.66 85.61 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.331 0.652 . . . . 0.0 109.948 -176.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.89 -40.38 75.7 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.997 0.362 . . . . 0.0 110.075 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.31 -35.02 79.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.032 -169.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -74.21 -29.94 61.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.18 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.8 mt -66.62 -41.78 87.84 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.16 1.346 . . . . 0.0 109.02 169.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -61.55 -43.92 97.98 Favored 'General case' 0 N--CA 1.458 -0.062 0 C-N-CA 124.002 0.921 . . . . 0.0 109.343 -177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -67.5 -36.41 81.01 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.023 0.929 . . . . 0.0 111.347 176.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.1 m -68.84 -2.09 8.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.225 1.01 . . . . 0.0 112.876 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.28 -15.66 30.16 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.32 1.438 . . . . 0.0 113.693 169.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.19 171.95 2.73 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.6 1.2 . . . . 0.0 110.989 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -142.66 154.47 44.37 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.364 -0.835 . . . . 0.0 111.462 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -63.85 161.35 15.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.774 2.029 . . . . 0.0 110.244 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.6 m -133.99 152.85 52.01 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.509 1.923 . . . . 0.0 106.321 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.37 -135.27 51.84 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -169.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -140.47 150.67 44.09 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.8 m -63.22 149.64 44.98 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.269 1.428 . . . . 0.0 110.551 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.9 tp -132.88 147.89 52.3 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.388 1.075 . . . . 0.0 109.084 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -120.06 139.25 52.82 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.221 1.808 . . . . 0.0 106.227 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.8 mt -138.07 107.25 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.445 HD21 ' CD2' ' A' ' 128' ' ' HIS . 41.8 t30 -67.57 141.13 56.92 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 170.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.3 pt -122.06 -9.66 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.036 1.335 . . . . 0.0 112.1 171.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.4 tp -71.69 115.29 10.71 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 119.883 1.22 . . . . 0.0 108.378 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.1 t70 56.17 31.63 18.68 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.898 1.679 . . . . 0.0 112.367 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.445 ' CD2' HD21 ' A' ' 124' ' ' ASN . 5.4 m170 -128.35 155.16 45.11 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.028 1.731 . . . . 0.0 107.924 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -143.17 12.77 1.8 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.596 1.158 . . . . 0.0 111.853 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 42.4 pt 34.91 56.51 2.17 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 127.284 2.234 . . . . 0.0 114.398 -175.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.5 -26.28 54.88 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.331 2.02 . . . . 0.0 112.612 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -77.69 -7.64 56.77 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.412 1.085 . . . . 0.0 111.288 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 36.7 t0 37.94 57.89 4.72 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 127.883 2.473 . . . . 0.0 113.715 -169.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -55.97 -24.15 46.87 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 123.532 2.821 . . . . 0.0 114.577 -173.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.87 -34.11 62.61 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.876 0.87 . . . . 0.0 111.34 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -62.15 -38.93 90.89 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.51 0.724 . . . . 0.0 110.908 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -76.13 -49.09 18.29 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -64.67 -33.16 75.28 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.216 -0.303 . . . . 0.0 111.744 -174.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 48.9 tp -56.98 -30.18 63.9 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 118.68 -0.676 . . . . 0.0 111.358 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.92 -45.7 70.34 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 118.841 0.746 . . . . 0.0 111.297 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.9 m -66.77 -30.76 71.05 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 117.492 0.646 . . . . 0.0 111.319 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -72.61 -51.31 20.18 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.532 0.733 . . . . 0.0 110.03 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 31.4 m -66.52 -30.64 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 O-C-N 121.331 -0.855 . . . . 0.0 111.246 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -60.74 -21.25 62.78 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.846 0.859 . . . . 0.0 112.482 175.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 28.8 mt -102.78 -35.93 8.46 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 118.069 -0.967 . . . . 0.0 112.109 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -35.78 79.52 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 120.005 1.275 . . . . 0.0 111.838 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt . . . . . 0 C--O 1.251 1.176 0 C-N-CA 128.658 2.783 . . . . 0.0 113.236 -179.474 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 ttm . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.7 158.62 24.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.887 0.475 . . . . 0.0 110.957 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -134.34 -26.03 1.48 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.122 1.369 . . . . 0.0 110.973 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.6 mt -129.04 82.36 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 169.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.8 m -74.6 121.29 21.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.5 mp -78.98 146.17 33.54 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.5 mt -109.91 82.31 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.4 m -64.1 140.33 58.86 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.014 0.926 . . . . 0.0 110.431 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.57 72.12 0.41 Allowed Glycine 0 C--N 1.339 0.739 0 C-N-CA 123.584 0.611 . . . . 0.0 113.851 -169.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 99.5 p -152.16 148.55 27.76 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 168.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -80.43 -44.03 19.98 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.911 0.885 . . . . 0.0 108.886 169.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.91 -27.34 68.78 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.133 1.373 . . . . 0.0 113.698 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.15 0.19 57.19 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.489 1.042 . . . . 0.0 113.064 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.15 -43.13 98.68 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 119.178 1.489 . . . . 0.0 111.204 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.9 -29.23 69.06 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.542 -0.742 . . . . 0.0 110.644 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -69.88 -35.32 74.56 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.15 0.886 . . . . 0.0 110.231 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -70.91 -41.73 70.88 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.998 0.817 . . . . 0.0 109.784 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.11 -44.81 99.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.87 -36.47 79.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.524 -0.751 . . . . 0.0 111.01 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.82 -41.69 99.42 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.52 1.055 . . . . 0.0 110.7 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -64.57 -48.87 73.4 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.161 0.437 . . . . 0.0 109.962 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.84 -46.11 88.49 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.86 0.464 . . . . 0.0 110.233 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.51 98.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.474 1.11 . . . . 0.0 111.029 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.39 -43.66 96.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.288 0.495 . . . . 0.0 110.355 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -67.45 -34.29 76.88 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.356 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.0 mt -63.99 -37.02 85.9 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 119.381 0.991 . . . . 0.0 111.755 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -63.44 -40.91 98.4 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.586 1.085 . . . . 0.0 110.15 175.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.22 -37.04 86.03 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.296 0.498 . . . . 0.0 111.087 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.84 -21.86 63.33 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.74 0.816 . . . . 0.0 112.256 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.27 26.04 3.32 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.533 -1.148 . . . . 0.0 114.022 170.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -125.88 131.58 52.33 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.244 1.522 . . . . 0.0 108.72 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 p -73.26 147.47 44.56 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.5 p -140.72 169.28 17.94 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.084 0.954 . . . . 0.0 109.588 -169.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -152.5 140.67 20.38 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 169.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.5 p -96.42 68.65 2.57 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.87 119.3 17.9 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -169.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -69.29 99.96 1.26 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.264 1.026 . . . . 0.0 109.665 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.13 54.22 10.04 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.347 1.451 . . . . 0.0 115.549 171.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -60.6 142.97 99.31 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 CA-C-N 120.494 2.147 . . . . 0.0 109.815 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.1 mt -69.23 155.03 41.08 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.75 -34.26 71.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.311 0.644 . . . . 0.0 109.761 169.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -65.58 -9.57 27.83 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.386 1.475 . . . . 0.0 112.909 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -118.06 13.23 13.84 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.007 1.323 . . . . 0.0 111.556 -170.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 pp -141.98 154.78 65.53 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.513 1.125 . . . . 0.0 109.592 171.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.48 161.29 37.57 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.594 2.196 . . . . 0.0 112.07 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.06 18.63 0.48 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.567 1.547 . . . . 0.0 112.931 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.8 t -152.37 133.68 14.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.03 179.39 31.93 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.0 mt -117.25 106.66 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.096 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -107.75 169.07 8.83 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 123.152 0.581 . . . . 0.0 109.516 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.4 tp -142.41 101.04 3.82 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.01 144.09 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.217 -171.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.57 143.42 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 172.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 m -147.24 134.49 20.59 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.402 -0.812 . . . . 0.0 108.876 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.4 m -75.91 160.36 29.99 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 169.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.8 m -128.64 106.22 8.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.778 1.631 . . . . 0.0 106.921 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -67.11 169.82 7.9 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.2 -23.82 34.3 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.754 -1.026 . . . . 0.0 114.947 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.92 11.7 16.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.996 1.318 . . . . 0.0 112.709 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.14 16.97 70.61 Favored Glycine 0 C--N 1.339 0.697 0 O-C-N 121.439 -0.788 . . . . 0.0 113.721 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -66.45 119.99 12.59 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.659 1.23 . . . . 0.0 108.419 170.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.2 mt -70.18 142.58 90.15 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -61.28 144.64 98.74 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.085 2.523 . . . . 0.0 112.065 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -59.01 -21.91 59.8 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.359 1.464 . . . . 0.0 113.598 -173.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.91 -27.97 68.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.38 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 63.6 tp -130.79 -20.72 2.81 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.734 0.814 . . . . 0.0 112.508 -170.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.0 p -53.19 -31.5 7.88 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -53.52 -20.89 17.14 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.014 2.476 . . . . 0.0 115.583 169.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -56.99 -35.65 69.45 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.177 0.898 . . . . 0.0 110.96 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -65.35 -48.83 71.64 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.58 -43.44 98.85 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.605 0.762 . . . . 0.0 110.009 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.57 -29.8 68.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.419 0.688 . . . . 0.0 112.492 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.4 mt -76.68 -29.8 56.48 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.771 176.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -73.62 -46.84 44.43 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.494 1.043 . . . . 0.0 109.115 175.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.11 -25.73 67.9 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.831 0.853 . . . . 0.0 111.837 -171.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -118.14 -25.26 6.71 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 117.974 -1.012 . . . . 0.0 113.167 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? 36.55 59.06 3.51 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 125.026 1.33 . . . . 0.0 110.605 -169.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -68.17 173.84 8.89 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.603 2.869 . . . . 0.0 112.777 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -105.39 107.81 19.0 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.8 mt -117.86 22.32 12.36 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 126.146 1.778 . . . . 0.0 110.675 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 m -57.46 16.05 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.51 2.324 . . . . 0.0 116.549 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.6 0.89 2.08 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.889 1.276 . . . . 0.0 112.309 172.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 94.9 t -75.85 134.56 28.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.9 mmm-85 -121.97 144.46 48.87 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 104.972 -2.232 . . . . 0.0 104.972 168.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -150.84 169.73 20.99 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.861 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -125.37 166.31 18.15 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 105.457 -3.057 . . . . 0.0 105.457 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.81 135.84 22.46 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.831 1.315 . . . . 0.0 111.111 -169.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.1 mm -124.24 130.51 73.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -104.9 135.97 12.85 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 107.691 -2.163 . . . . 0.0 107.691 169.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.2 mt -130.01 152.92 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 161.17 175.66 32.44 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 71.0 m -78.39 91.69 4.5 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 169.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -28.87 62.05 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.472 0.709 . . . . 0.0 112.872 -169.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -73.68 -9.9 59.14 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.49 169.01 11.65 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.161 0.891 . . . . 0.0 110.173 172.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -58.48 -34.52 70.97 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.424 0.69 . . . . 0.0 112.782 -173.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.9 m -101.13 107.85 19.38 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -64.99 153.65 40.03 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 35.1 m -41.38 106.82 0.06 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.511 2.324 . . . . 0.0 110.434 177.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.81 3.3 0.02 OUTLIER Glycine 0 CA--C 1.523 0.569 0 CA-C-O 117.938 -1.479 . . . . 0.0 115.659 -170.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.22 -18.44 63.52 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.807 2.304 . . . . 0.0 112.591 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.1 tp -52.98 -33.34 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 126.075 1.75 . . . . 0.0 110.391 170.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -51.4 -39.18 56.7 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.497 1.119 . . . . 0.0 112.855 -172.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -66.44 -36.5 82.95 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.787 -0.571 . . . . 0.0 111.446 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.2 mt -71.89 -52.07 19.1 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -67.08 -35.81 80.62 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.991 -171.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.32 -38.54 90.47 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -73.25 -30.94 63.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.914 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.05 -46.69 86.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.314 1.415 . . . . 0.0 109.203 169.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -63.37 -41.06 98.79 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 122.417 0.287 . . . . 0.0 110.387 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -63.04 -39.54 95.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.581 0.752 . . . . 0.0 110.524 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.7 m -70.68 -7.11 42.15 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.469 1.108 . . . . 0.0 112.908 174.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.03 -16.9 8.71 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.728 1.156 . . . . 0.0 113.921 169.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.22 172.75 1.35 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.517 1.159 . . . . 0.0 111.277 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -140.87 136.16 32.06 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.499 -0.751 . . . . 0.0 110.904 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -62.43 170.46 2.39 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.973 1.309 . . . . 0.0 109.295 170.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 m -133.67 149.71 51.55 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.87 -136.44 46.37 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.09 157.71 45.79 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 171.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.98 135.76 57.47 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.959 0.904 . . . . 0.0 110.183 -177.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.4 tp -94.08 148.7 21.92 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -123.55 144.41 49.59 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 57.0 mt -136.95 108.82 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -68.03 143.2 55.64 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 169.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.24 9.25 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.024 0.93 . . . . 0.0 112.54 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp -61.19 -39.65 90.98 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 121.473 -0.767 . . . . 0.0 111.318 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -149.13 35.78 0.75 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.557 1.143 . . . . 0.0 109.688 -175.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -153.77 151.76 29.95 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.785 1.634 . . . . 0.0 107.581 -172.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -154.5 42.19 0.49 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.402 1.081 . . . . 0.0 110.298 -172.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.0 pt 39.25 49.88 2.56 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 126.895 2.078 . . . . 0.0 115.22 -175.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -61.86 136.1 59.7 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.783 1.656 . . . . 0.0 109.342 174.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 59.4 18.82 7.14 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.375 1.47 . . . . 0.0 112.76 -173.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.6 t0 38.21 67.6 2.07 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 127.891 2.476 . . . . 0.0 114.771 173.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.92 -18.1 56.83 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.93 2.42 . . . . 0.0 112.939 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.25 -20.72 60.15 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.429 0.692 . . . . 0.0 111.958 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -54.76 -35.34 63.67 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.011 0.924 . . . . 0.0 111.515 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -65.21 -43.45 91.51 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.679 -0.638 . . . . 0.0 110.188 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -74.28 -35.42 63.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.763 0.825 . . . . 0.0 110.344 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.4 tp -61.94 -36.24 80.81 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.973 0.909 . . . . 0.0 110.742 173.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.76 -47.74 58.01 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.471 1.034 . . . . 0.0 111.102 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 m -61.82 -42.23 98.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.665 0.732 . . . . 0.0 110.778 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -60.44 -49.92 75.65 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.511 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.7 m -65.36 -34.79 72.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 119.866 1.212 . . . . 0.0 110.867 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.79 -22.4 66.98 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.426 0.69 . . . . 0.0 111.679 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.2 mt -90.67 -57.98 2.64 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.599 1.09 . . . . 0.0 110.141 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.08 -25.79 65.51 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 117.567 -1.206 . . . . 0.0 113.815 -169.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm . . . . . 0 C--O 1.251 1.181 0 C-N-CA 128.046 2.538 . . . . 0.0 113.27 175.249 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.88 152.73 42.24 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.979 -0.451 . . . . 0.0 110.37 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -133.38 -25.58 1.72 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.818 1.247 . . . . 0.0 111.028 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.0 mt -121.37 74.92 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 170.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.1 m -75.35 120.98 21.55 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.8 mt -94.85 151.06 19.55 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 80.3 mt -125.76 84.13 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -169.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.9 m -74.94 151.23 38.89 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.656 0.782 . . . . 0.0 110.35 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.81 118.16 0.8 Allowed Glycine 0 C--N 1.333 0.394 0 N-CA-C 107.576 -2.209 . . . . 0.0 107.576 170.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.3 t -148.54 149.11 31.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.006 0.908 . . . . 0.0 111.641 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 p -73.54 -30.23 62.94 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.036 1.735 . . . . 0.0 110.938 169.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 pp -122.95 -25.74 4.53 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -169.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.91 1.92 10.45 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.238 1.399 . . . . 0.0 112.917 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.34 -40.77 99.09 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 118.867 1.333 . . . . 0.0 111.039 -172.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.6 -22.96 64.42 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 117.315 0.557 . . . . 0.0 111.571 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -75.31 -43.8 48.9 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -68.7 -41.8 78.65 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 122.862 0.465 . . . . 0.0 109.748 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.24 -48.84 85.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.244 0.618 . . . . 0.0 109.433 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.17 89.48 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 118.902 0.773 . . . . 0.0 110.667 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.0 -43.0 93.97 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.455 1.025 . . . . 0.0 111.119 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -61.86 -45.11 95.18 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.834 -0.541 . . . . 0.0 110.481 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.5 mt -65.45 -42.21 92.61 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.256 0.622 . . . . 0.0 110.153 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.1 83.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.023 0.929 . . . . 0.0 110.966 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -58.68 -46.8 86.43 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.882 0.765 . . . . 0.0 110.496 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -68.21 -37.46 80.91 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.567 -0.708 . . . . 0.0 110.835 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.3 mt -61.41 -42.04 98.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.279 0.945 . . . . 0.0 111.369 175.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.7 -38.96 84.35 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.642 0.655 . . . . 0.0 110.327 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -64.55 -36.04 82.92 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.46 0.573 . . . . 0.0 110.904 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.01 -23.71 64.13 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.54 0.736 . . . . 0.0 111.973 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.56 -0.77 12.46 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.968 1.271 . . . . 0.0 113.764 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -77.05 174.7 10.35 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.635 1.217 . . . . 0.0 110.61 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.8 p -120.88 140.0 52.41 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 p -136.49 168.98 18.45 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.254 1.022 . . . . 0.0 110.229 -169.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -153.13 155.59 37.03 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 169.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.0 p -119.55 71.55 0.88 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -172.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.3 mt -76.07 118.9 19.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -171.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -91.89 95.48 9.85 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.97 49.47 6.38 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.016 -1.436 . . . . 0.0 115.22 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -68.43 176.27 5.92 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 CA-C-N 120.686 2.243 . . . . 0.0 110.989 169.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.5 mt -130.8 168.4 17.3 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.381 1.472 . . . . 0.0 110.027 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.5 tp -56.06 -27.36 53.1 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.906 1.683 . . . . 0.0 111.881 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -64.18 -12.37 39.62 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.547 1.139 . . . . 0.0 112.593 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -137.09 20.52 3.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.933 1.293 . . . . 0.0 111.377 -173.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.2 mt -135.03 102.81 10.88 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.648 1.179 . . . . 0.0 108.319 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -73.32 169.85 21.3 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.932 2.422 . . . . 0.0 112.21 -176.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.48 8.98 2.42 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.807 1.643 . . . . 0.0 114.767 -171.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -153.15 141.18 20.31 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.929 0.786 . . . . 0.0 109.27 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.14 -178.66 24.63 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -123.3 99.5 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -94.69 176.22 6.36 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.464 0.706 . . . . 0.0 110.155 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.9 tp -140.98 98.67 3.43 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -79.64 129.0 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 mt -127.54 146.21 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.9 m -145.48 141.92 28.77 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.718 -0.614 . . . . 0.0 110.016 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.7 m -91.08 95.11 9.92 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.2 m -70.6 83.2 0.61 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 171.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -79.12 44.23 0.56 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.123 1.769 . . . . 0.0 111.442 -174.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.2 -30.05 2.15 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.33 1.443 . . . . 0.0 114.278 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.61 -21.75 64.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.395 1.078 . . . . 0.0 113.678 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.86 20.37 77.98 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -170.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -130.77 155.46 46.62 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.734 1.614 . . . . 0.0 107.083 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.37 150.07 39.43 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.227 1.411 . . . . 0.0 107.965 -169.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -53.6 139.25 66.99 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.276 2.651 . . . . 0.0 112.321 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -58.35 -23.12 55.84 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.976 1.311 . . . . 0.0 113.71 -171.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -75.21 -21.48 58.63 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.563 -0.732 . . . . 0.0 112.502 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.6 tp -126.84 -23.89 3.6 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.007 0.923 . . . . 0.0 111.902 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 91.9 p -53.72 -29.65 5.02 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-O 117.038 -1.458 . . . . 0.0 114.138 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.34 -23.34 18.2 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.639 2.226 . . . . 0.0 114.958 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -64.52 -39.96 94.74 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 120.104 1.32 . . . . 0.0 110.815 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -60.72 -41.87 96.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.105 0.562 . . . . 0.0 110.085 175.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -66.23 -47.89 72.34 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.076 0.55 . . . . 0.0 110.299 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.85 -41.28 95.83 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 121.794 -0.566 . . . . 0.0 111.362 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.7 mt -62.72 -50.82 69.61 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.888 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -70.3 -29.19 65.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.023 0.829 . . . . 0.0 111.642 -176.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.09 -50.46 47.97 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.768 0.713 . . . . 0.0 109.866 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -84.19 -23.01 30.73 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.349 -173.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.5 tttt 38.45 61.43 4.74 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 126.085 1.754 . . . . 0.0 110.806 -169.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -66.5 169.27 14.5 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.109 2.539 . . . . 0.0 111.363 -174.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -96.69 104.21 16.18 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 169.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.0 mt -118.83 26.6 9.43 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 126.414 1.886 . . . . 0.0 109.818 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.8 m -60.1 15.62 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.815 2.046 . . . . 0.0 116.048 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.85 6.09 1.58 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.039 1.336 . . . . 0.0 111.762 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.1 t -77.58 140.31 17.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -122.67 157.2 32.76 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 168.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -154.16 176.28 12.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.739 0.699 . . . . 0.0 111.77 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.55 162.76 22.17 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 105.593 -3.003 . . . . 0.0 105.593 169.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.68 126.63 19.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -169.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.7 mt -136.04 126.2 41.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -174.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -100.69 152.25 19.08 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.6 mt -134.8 137.98 50.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 175.99 -152.05 12.47 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.6 m -128.19 127.19 42.46 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.381 1.073 . . . . 0.0 109.095 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -67.58 -6.57 20.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.631 0.772 . . . . 0.0 112.09 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.35 -33.12 63.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.094 1.358 . . . . 0.0 111.592 172.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -116.36 155.96 27.56 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.448 1.099 . . . . 0.0 110.805 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.64 -34.46 77.88 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.638 0.775 . . . . 0.0 111.661 -174.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.06 38.07 0.1 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.472 1.909 . . . . 0.0 111.011 175.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -49.06 -49.35 41.85 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.721 1.608 . . . . 0.0 111.2 -172.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 67.0 m -152.29 135.25 15.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.55 -27.9 0.09 OUTLIER Glycine 0 CA--C 1.522 0.487 0 CA-C-O 118.946 -0.919 . . . . 0.0 114.595 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.19 -18.38 65.31 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.491 1.645 . . . . 0.0 112.099 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.33 -34.2 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.781 1.232 . . . . 0.0 109.579 170.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.21 -32.42 68.28 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 123.777 0.831 . . . . 0.0 111.989 -175.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -62.01 -45.41 93.71 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.512 0.596 . . . . 0.0 110.473 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.29 -53.15 61.11 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -72.22 -31.89 66.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.64 -170.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.16 -44.2 92.12 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.99 0.814 . . . . 0.0 109.858 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -74.64 -28.11 60.72 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.199 -0.905 . . . . 0.0 112.281 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.6 -45.01 92.32 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.493 1.497 . . . . 0.0 109.374 169.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -66.27 -39.77 89.66 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 122.182 -0.324 . . . . 0.0 110.473 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -61.05 -40.17 92.62 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.056 0.542 . . . . 0.0 110.511 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.5 m -69.57 -14.27 62.76 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.946 0.898 . . . . 0.0 112.878 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.58 -13.04 6.94 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.048 1.309 . . . . 0.0 113.872 169.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.87 172.6 2.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.579 1.19 . . . . 0.0 111.858 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -145.54 144.1 30.33 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.389 -0.819 . . . . 0.0 111.558 169.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 38.2 tp60 -58.26 154.44 13.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.893 1.677 . . . . 0.0 109.491 172.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.4 m -139.42 134.01 31.8 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.02 176.34 37.71 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -172.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -76.26 164.27 26.22 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.022 -0.693 . . . . 0.0 109.488 172.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.2 164.12 23.38 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 169.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.0 tp -129.84 147.61 51.63 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.246 -0.909 . . . . 0.0 109.704 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.97 142.13 47.69 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 176.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 43.3 mt -138.79 110.87 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -82.88 131.2 35.2 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 123.247 0.619 . . . . 0.0 109.696 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -127.75 14.45 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 125.028 1.331 . . . . 0.0 111.852 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 68.0 tp -53.41 -46.42 69.74 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.387 1.075 . . . . 0.0 111.449 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -165.7 -52.71 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 125.828 1.651 . . . . 0.0 107.673 176.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.44 101.96 4.3 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -71.97 71.3 0.8 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.345 1.858 . . . . 0.0 109.941 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.293 17.8 tt 24.11 74.12 0.29 Allowed Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 129.395 3.078 . . . . 0.0 114.156 -173.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.79 -21.79 16.05 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.381 3.387 . . . . 0.0 116.111 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.56 -22.45 65.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.186 0.994 . . . . 0.0 111.826 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.8 t0 41.72 58.17 9.64 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 127.436 2.294 . . . . 0.0 113.315 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.09 -13.26 36.03 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.948 2.432 . . . . 0.0 113.287 -174.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.22 -34.56 64.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.884 0.874 . . . . 0.0 112.135 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -60.31 -49.14 78.78 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.428 0.691 . . . . 0.0 110.922 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -79.85 -36.63 36.46 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.787 0.835 . . . . 0.0 110.121 -174.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 86.2 t90 -58.98 -48.45 81.52 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 28.7 tp -67.51 -39.74 85.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 119.057 -0.497 . . . . 0.0 110.6 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.9 -44.73 92.34 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -65.43 -40.54 93.43 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.133 0.573 . . . . 0.0 110.629 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -63.96 -49.78 71.21 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.797 -0.621 . . . . 0.0 110.231 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.06 -34.6 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 119.297 0.953 . . . . 0.0 110.895 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -61.63 -31.62 71.73 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-O 118.848 -0.596 . . . . 0.0 111.8 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.3 mt -86.27 -46.68 10.11 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.219 0.918 . . . . 0.0 111.296 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.05 -24.35 61.52 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.945 0.793 . . . . 0.0 112.404 -172.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.9 mttp . . . . . 0 C--O 1.247 0.926 0 C-N-CA 127.572 2.349 . . . . 0.0 111.652 -179.115 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.41 159.57 29.2 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.931 0.493 . . . . 0.0 110.584 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -135.98 -25.11 1.25 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.418 1.087 . . . . 0.0 111.453 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.0 mt -130.27 82.74 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 169.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.6 m -75.95 116.9 17.11 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.85 151.88 40.38 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.3 mt -122.31 100.08 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 m -93.73 123.73 37.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.176 0.99 . . . . 0.0 110.121 -172.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.68 60.28 0.62 Allowed Glycine 0 C--N 1.331 0.254 0 N-CA-C 105.972 -2.851 . . . . 0.0 105.972 170.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.1 m -115.09 134.7 54.94 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.576 1.15 . . . . 0.0 111.589 -167.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.5 p -139.06 -31.06 0.72 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.272 1.429 . . . . 0.0 111.786 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.69 -4.73 13.01 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.218 1.407 . . . . 0.0 113.708 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.52 -48.01 3.75 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.387 0.994 . . . . 0.0 110.877 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.19 -44.93 96.07 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 118.168 0.984 . . . . 0.0 110.807 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.88 -28.17 68.76 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 117.433 0.617 . . . . 0.0 111.174 177.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.39 -39.96 58.51 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -65.31 -40.06 93.29 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.3 t -57.32 -51.29 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.134 0.974 . . . . 0.0 109.639 173.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.54 -43.56 98.64 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.961 0.801 . . . . 0.0 111.088 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.73 -45.51 86.17 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.914 0.486 . . . . 0.0 110.735 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -59.8 -48.27 82.36 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.297 1.039 . . . . 0.0 110.221 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.1 mt -59.88 -46.05 90.54 Favored 'General case' 0 N--CA 1.458 -0.054 0 C-N-CA 123.369 0.667 . . . . 0.0 110.242 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.87 -50.64 73.23 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.293 0.497 . . . . 0.0 110.339 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -58.87 -47.63 84.25 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.129 0.571 . . . . 0.0 110.483 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -66.01 -38.32 88.18 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.132 -177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.6 mt -65.78 -39.93 91.46 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 119.63 1.105 . . . . 0.0 110.791 175.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.96 -40.1 95.65 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.916 0.78 . . . . 0.0 110.128 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -65.66 -37.73 87.36 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.406 0.548 . . . . 0.0 111.156 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.92 -22.4 64.16 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.708 0.803 . . . . 0.0 112.136 176.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.14 25.72 3.46 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.636 -1.091 . . . . 0.0 113.821 170.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -127.72 127.73 44.16 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.152 1.476 . . . . 0.0 108.451 -177.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 p -72.68 149.83 43.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 109.835 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.8 p -133.72 170.21 15.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.688 0.756 . . . . 0.0 110.356 -172.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -151.66 162.17 41.45 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 169.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.5 83.04 2.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -177.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.2 mt -71.19 109.99 5.57 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -78.77 108.86 12.51 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.67 50.77 60.98 Favored Glycine 0 CA--C 1.54 1.612 0 CA-C-O 118.159 -1.356 . . . . 0.0 115.367 171.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -67.86 175.57 6.22 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.706 2.271 . . . . 0.0 111.183 173.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.9 mt -123.43 157.01 34.4 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.192 1.397 . . . . 0.0 108.219 170.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.81 -30.47 71.56 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.797 0.839 . . . . 0.0 111.768 -174.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.49 -8.51 14.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.783 0.833 . . . . 0.0 112.897 176.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -118.13 18.28 13.86 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.543 1.537 . . . . 0.0 110.832 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.4 mt -127.06 142.11 42.71 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.751 1.22 . . . . 0.0 109.205 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.05 162.47 41.71 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.539 2.159 . . . . 0.0 109.823 169.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.7 21.33 0.67 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.383 1.073 . . . . 0.0 112.557 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.6 p -156.79 149.76 23.87 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.787 1.235 . . . . 0.0 109.043 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.31 179.28 22.37 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.5 mt -117.62 103.32 14.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -104.82 170.81 7.66 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.043 0.937 . . . . 0.0 109.58 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.4 tp -148.58 106.52 3.71 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.8 t -87.88 137.07 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -173.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.04 126.67 56.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.3 m -135.08 120.37 18.99 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.781 0.432 . . . . 0.0 110.401 -172.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 m -71.94 -172.81 0.91 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 168.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -127.84 141.4 51.57 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -77.16 11.87 1.68 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.608 1.563 . . . . 0.0 111.889 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.05 23.34 76.1 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 120.934 -1.104 . . . . 0.0 111.378 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.2 8.54 2.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.206 1.402 . . . . 0.0 112.151 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.59 34.58 56.73 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 119.25 0.932 . . . . 0.0 111.114 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -145.92 152.73 39.9 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.774 1.63 . . . . 0.0 107.802 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.2 mp -65.9 148.05 98.48 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -52.97 149.67 25.85 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.686 2.924 . . . . 0.0 113.298 169.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -57.21 -16.63 8.6 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.864 1.666 . . . . 0.0 113.663 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -61.99 -39.15 91.2 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.731 0.812 . . . . 0.0 110.8 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.2 tp -126.28 -22.27 4.07 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.5 0.72 . . . . 0.0 112.301 -171.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.9 p -54.37 -31.1 7.92 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-O 117.03 -1.462 . . . . 0.0 114.819 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -52.25 -22.71 16.15 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.147 2.565 . . . . 0.0 115.188 169.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -56.26 -35.64 67.67 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.029 0.932 . . . . 0.0 111.066 175.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -64.06 -40.59 96.6 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 122.991 0.517 . . . . 0.0 110.878 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.75 -46.44 58.46 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.02 -29.41 70.32 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.141 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.67 -63.74 1.09 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 170.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -67.85 -22.61 65.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.682 0.674 . . . . 0.0 112.624 -170.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -70.98 -32.95 69.94 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.602 0.761 . . . . 0.0 111.502 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -114.43 -33.98 5.41 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp 28.05 64.72 0.65 Allowed Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 127.83 2.452 . . . . 0.0 113.086 -169.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -60.57 173.38 2.14 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.695 2.263 . . . . 0.0 111.954 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -75.84 62.59 1.57 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.174 1.39 . . . . 0.0 110.561 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 82' ' ' ALA . 70.8 mt -73.27 8.33 1.76 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.358 1.463 . . . . 0.0 112.786 -177.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.9 m -45.76 10.31 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.751 1 C-N-CA 132.055 4.142 . . . . 0.0 117.649 170.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 80' ' ' LEU . . . -141.36 3.03 1.71 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.2 1.4 . . . . 0.0 112.172 175.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.2 t -78.71 137.3 22.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 169.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -119.19 141.5 48.82 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 168.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -148.86 172.46 14.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.111 0.414 . . . . 0.0 111.094 -174.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.67 163.53 24.11 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 105.761 -2.936 . . . . 0.0 105.761 169.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.19 130.37 19.65 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.306 1.053 . . . . 0.0 109.662 -169.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 23.1 mt -134.1 130.92 55.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -118.14 139.65 14.84 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.2 mp -131.44 118.37 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 176.7 -158.37 24.37 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 105.906 -2.878 . . . . 0.0 105.906 -172.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.6 m -96.82 170.14 9.37 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.187 0.995 . . . . 0.0 110.765 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -119.7 -19.76 7.92 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.203 1.001 . . . . 0.0 109.866 169.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -111.57 5.98 19.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.934 2.494 . . . . 0.0 111.089 -169.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -141.58 165.04 28.59 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.186 1.794 . . . . 0.0 109.04 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -59.28 -35.35 73.58 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.827 1.651 . . . . 0.0 113.503 -169.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 53.2 m -74.73 76.55 2.07 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.881 0.848 . . . . 0.0 109.2 170.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -61.61 134.81 57.25 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 173.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 3.5 p -55.81 -21.55 20.05 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.575 1.55 . . . . 0.0 112.976 174.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.51 3.81 3.31 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.07 -1.406 . . . . 0.0 115.087 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.09 -22.85 6.67 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 120.323 2.062 . . . . 0.0 113.867 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.9 tp -54.26 -31.41 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.599 1.56 . . . . 0.0 110.969 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -50.91 -35.28 32.26 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.732 1.213 . . . . 0.0 112.962 -170.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -54.27 -51.47 64.47 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.46 0.573 . . . . 0.0 111.353 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.3 mt -68.7 -50.89 47.26 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -172.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -67.58 -35.74 79.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.901 -173.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.84 -41.66 78.22 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.38 -24.97 62.17 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 117.509 -1.234 . . . . 0.0 112.424 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.6 mt -65.86 -52.38 50.82 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.978 1.717 . . . . 0.0 108.951 169.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -68.21 -33.89 75.25 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 122.076 -0.39 . . . . 0.0 110.883 -173.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -76.13 6.55 5.2 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.875 1.27 . . . . 0.0 112.644 172.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.4 m -120.59 15.41 11.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.299 1.44 . . . . 0.0 110.328 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.75 -22.96 27.11 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.623 1.106 . . . . 0.0 113.557 169.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.83 167.92 1.41 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.587 1.194 . . . . 0.0 110.66 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -137.17 136.48 38.25 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 121.461 -0.775 . . . . 0.0 111.351 171.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -60.29 164.58 4.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.056 -1.429 . . . . 0.0 109.525 171.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 m -136.49 157.84 45.85 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 126.371 1.868 . . . . 0.0 106.036 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.408 ' H ' HD12 ' A' ' 145' ' ' LEU . . . 55.7 -128.74 45.65 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 -173.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -144.62 165.81 26.97 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.706 1.203 . . . . 0.0 107.956 169.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.75 154.42 29.71 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.041 0.937 . . . . 0.0 110.438 -178.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 57.0 tp -129.67 143.54 50.87 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.858 0.863 . . . . 0.0 109.576 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -118.15 143.09 46.77 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.4 mt -132.31 100.38 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -69.62 142.01 53.58 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.486 0.714 . . . . 0.0 111.161 -171.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 8.4 pt -105.79 -21.04 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.178 0.991 . . . . 0.0 111.858 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.03 -35.95 81.02 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.559 0.744 . . . . 0.0 109.801 -172.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -146.66 151.89 37.98 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.429 1.491 . . . . 0.0 109.082 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 64.78 -36.89 0.21 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 129.678 3.191 . . . . 0.0 115.568 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.9 t70 64.98 -44.08 0.33 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 129.068 2.947 . . . . 0.0 115.088 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.264 11.7 tt 25.13 64.46 0.45 Allowed Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 130.098 3.359 . . . . 0.0 115.558 169.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -79.42 15.5 1.57 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 123.488 2.792 . . . . 0.0 114.407 -169.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -136.49 -58.36 0.74 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.126 1.33 . . . . 0.0 112.301 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.63 -48.6 92.87 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -169.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.04 -39.12 83.22 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 121.864 1.709 . . . . 0.0 112.013 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.93 -39.77 90.8 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.885 -0.579 . . . . 0.0 110.348 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -65.23 -44.14 89.17 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.039 0.836 . . . . 0.0 110.304 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -62.84 -47.55 82.91 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.126 -0.359 . . . . 0.0 110.266 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -68.69 -33.75 74.5 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.536 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.9 tt -58.74 -40.97 85.37 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.193 0.906 . . . . 0.0 110.184 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.6 -48.25 66.42 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 173.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.4 m -63.96 -41.19 97.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.401 0.601 . . . . 0.0 111.11 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -62.57 -52.51 63.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 117.739 -1.124 . . . . 0.0 110.492 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.7 m -64.71 -34.03 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 120.258 1.39 . . . . 0.0 110.685 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -59.49 -32.77 70.57 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.061 0.846 . . . . 0.0 112.118 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.408 HD12 ' H ' ' A' ' 118' ' ' GLY . 25.9 mt -94.75 -35.85 11.95 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.512 -0.756 . . . . 0.0 112.55 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.7 pp -90.99 -17.3 26.54 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 117.36 -1.305 . . . . 0.0 113.459 -173.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt . . . . . 0 C--O 1.251 1.167 0 CA-C-N 119.572 1.078 . . . . 0.0 112.104 -172.529 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.49 157.17 43.71 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.999 1.32 . . . . 0.0 108.069 171.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -140.98 -25.17 0.74 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.435 1.094 . . . . 0.0 111.482 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.7 mt -132.89 83.65 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 173.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.6 m -78.38 116.02 18.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.72 154.25 36.54 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.632 0.773 . . . . 0.0 109.598 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.3 mt -126.49 97.87 4.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.7 m -78.75 156.98 28.6 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.761 0.824 . . . . 0.0 110.097 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.68 89.83 0.09 OUTLIER Glycine 0 C--N 1.333 0.411 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.7 p -153.89 128.15 9.1 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 117.462 0.631 . . . . 0.0 110.584 172.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.25 -32.06 72.84 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 168.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.5 mt -69.55 -14.15 62.7 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.309 1.444 . . . . 0.0 112.915 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.65 14.9 75.38 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-N 118.989 0.813 . . . . 0.0 113.537 -175.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.7 -38.48 8.1 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 118.657 1.229 . . . . 0.0 111.497 -175.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.46 90.3 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.213 1.006 . . . . 0.0 110.229 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.46 -32.44 64.35 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.095 0.407 . . . . 0.0 111.912 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -65.01 -44.9 87.71 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.9 t -60.69 -46.43 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.1 -39.84 79.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.568 0.622 . . . . 0.0 111.344 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.17 -42.8 99.21 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.62 0.645 . . . . 0.0 110.837 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -71.64 -41.96 68.18 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.903 -0.498 . . . . 0.0 110.972 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.86 -44.44 97.02 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.07 -44.31 96.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.432 0.693 . . . . 0.0 110.469 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -58.0 -44.56 87.29 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.458 0.572 . . . . 0.0 110.388 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -62.73 -40.86 98.51 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.762 -0.587 . . . . 0.0 111.285 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 66.3 mt -63.9 -41.34 97.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.943 0.792 . . . . 0.0 111.142 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.24 -40.12 90.02 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.576 0.625 . . . . 0.0 110.378 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.88 -36.0 82.93 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.048 0.539 . . . . 0.0 110.805 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.62 -21.63 63.55 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.379 0.671 . . . . 0.0 112.248 174.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.52 -0.64 14.04 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.844 1.211 . . . . 0.0 113.825 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -79.2 178.94 7.69 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.424 1.112 . . . . 0.0 110.023 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.9 p -124.84 150.31 46.55 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.7 p -137.48 170.26 16.38 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.635 0.774 . . . . 0.0 109.729 -169.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -152.19 161.86 41.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 169.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.39 102.27 6.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.2 mt -80.08 153.57 28.67 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -128.76 102.47 6.57 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.42 52.83 49.33 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.487 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -66.39 174.45 6.2 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.028 2.485 . . . . 0.0 111.588 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.9 mt -129.26 163.47 25.59 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 125.249 1.42 . . . . 0.0 109.191 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.89 -30.4 58.04 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.75 1.22 . . . . 0.0 110.888 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -64.09 -11.18 27.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.314 1.446 . . . . 0.0 112.661 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -136.59 16.88 3.12 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.383 1.073 . . . . 0.0 110.907 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -135.62 101.03 10.95 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.124 1.37 . . . . 0.0 107.866 -169.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.32 164.59 34.8 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.737 2.292 . . . . 0.0 112.139 -171.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.58 7.29 1.94 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.574 1.55 . . . . 0.0 114.575 -173.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.9 m -149.61 139.33 21.75 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.8 178.08 27.06 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.5 mt -119.67 101.75 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 -176.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -114.76 167.69 10.55 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.205 1.002 . . . . 0.0 110.247 -171.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.4 tp -147.7 100.56 3.24 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 175.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.5 t -83.96 141.4 14.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.593 1.157 . . . . 0.0 109.685 -172.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.57 126.54 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.2 m -142.08 130.8 22.77 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.427 0.691 . . . . 0.0 110.656 -169.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.8 m -67.56 168.83 10.3 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.632 0.73 . . . . 0.0 111.358 169.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.2 m -141.27 135.03 30.24 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 129.02 2.928 . . . . 0.0 104.143 172.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -129.72 146.13 51.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 172.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 36.62 -97.27 0.01 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 127.088 2.28 . . . . 0.0 114.586 176.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.87 9.63 26.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.342 1.457 . . . . 0.0 113.455 -169.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.71 25.46 7.63 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 120.115 1.325 . . . . 0.0 110.837 -175.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.08 110.52 5.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.97 149.84 85.54 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.79 144.82 49.58 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.702 2.268 . . . . 0.0 110.02 -169.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -56.8 -21.01 25.62 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.036 1.334 . . . . 0.0 113.793 -175.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -69.02 -31.62 70.56 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.843 -0.535 . . . . 0.0 111.823 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.5 tp -123.83 -25.31 4.29 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.641 0.777 . . . . 0.0 112.323 -169.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 78.8 p -54.47 -30.82 7.42 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 117.027 -1.464 . . . . 0.0 114.542 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -52.68 -26.11 28.67 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.612 2.208 . . . . 0.0 114.814 169.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -62.21 -40.76 97.19 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.508 1.049 . . . . 0.0 110.238 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -63.74 -37.6 87.95 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.91 0.777 . . . . 0.0 110.354 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -68.65 -44.66 73.65 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.747 0.419 . . . . 0.0 110.377 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.85 -41.67 95.51 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.676 -0.64 . . . . 0.0 110.935 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.2 mt -61.33 -49.35 77.34 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 118.56 -0.734 . . . . 0.0 110.352 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -71.74 -28.55 63.74 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.259 0.936 . . . . 0.0 111.434 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.4 -43.54 77.01 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.562 0.619 . . . . 0.0 110.58 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -99.32 -35.0 10.09 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -169.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.0 ttpp 30.04 57.28 0.81 Allowed Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 127.39 2.276 . . . . 0.0 113.412 -169.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.31 174.76 10.31 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.263 1.975 . . . . 0.0 110.374 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' A' ' 81' ' ' SER . 13.4 p-10 -76.9 69.64 3.24 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.519 1.528 . . . . 0.0 111.024 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.2 mt -74.13 19.08 0.13 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.843 1.657 . . . . 0.0 112.158 173.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 79' ' ' ASP . 3.1 m -53.18 12.2 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.713 1 C-N-CA 131.786 4.034 . . . . 0.0 116.639 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.14 4.37 0.94 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.176 1.391 . . . . 0.0 112.232 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 79.2 t -74.1 131.36 35.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 169.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 121.14 39.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 169.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -130.44 168.95 16.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.086 0.469 . . . . 0.0 110.56 -173.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -127.62 162.76 21.51 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 104.758 -3.337 . . . . 0.0 104.758 169.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.2 137.63 24.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.139 0.97 . . . . 0.0 110.072 -169.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.5 mt -134.72 127.67 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -175.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.43 146.23 16.42 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 171.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.1 mt -137.11 147.1 27.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.66 166.38 29.47 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 176.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.4 m -81.64 111.18 17.68 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 170.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -64.63 -2.29 2.34 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 -169.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -63.64 -41.83 98.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.771 0.829 . . . . 0.0 110.877 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -75.37 155.24 36.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.963 0.801 . . . . 0.0 110.8 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -55.65 -33.83 64.43 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.835 1.254 . . . . 0.0 114.16 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.89 11.66 33.02 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.7 p90 22.44 -83.29 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 130.373 3.469 . . . . 0.0 114.885 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 60.6 m -140.37 38.06 1.89 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.517 1.927 . . . . 0.0 108.88 -173.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.68 -6.19 30.9 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 118.246 -1.308 . . . . 0.0 115.652 -169.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.06 -19.05 65.8 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.754 2.277 . . . . 0.0 113.236 -176.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.5 tp -54.87 -27.54 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.078 1.351 . . . . 0.0 110.51 171.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -52.19 -35.37 48.88 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.451 1.1 . . . . 0.0 112.817 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -66.89 -54.27 23.83 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 121.831 -0.543 . . . . 0.0 109.938 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.0 mt -61.56 -48.67 79.93 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.8 0.84 . . . . 0.0 109.456 -175.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.13 -37.87 86.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -173.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.22 -40.43 77.98 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -172.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -71.16 -31.06 67.22 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.584 -0.722 . . . . 0.0 111.504 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.9 mt -62.43 -48.15 80.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.911 1.232 . . . . 0.0 109.57 169.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -64.31 -38.83 92.43 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -65.92 -35.3 80.25 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.055 0.542 . . . . 0.0 111.339 175.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.1 m -71.73 -3.31 21.19 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.337 1.055 . . . . 0.0 112.846 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.72 -12.15 27.59 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.759 1.171 . . . . 0.0 113.201 170.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.59 171.89 1.82 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.441 1.121 . . . . 0.0 110.759 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -139.7 144.69 37.67 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.756 0.789 . . . . 0.0 110.591 169.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -78.75 171.05 15.72 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.167 171.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.46 153.03 41.05 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.916 1.287 . . . . 0.0 107.811 169.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.46 -130.73 37.76 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 172.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -136.91 162.26 33.76 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.3 1.44 . . . . 0.0 107.181 171.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.3 m -69.35 132.42 46.38 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.193 0.597 . . . . 0.0 109.476 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.4 tp -81.1 153.29 27.4 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -125.87 144.14 50.78 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 169.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 40.4 mt -132.63 101.74 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -67.58 138.37 56.39 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 171.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 18.5 pt -128.02 15.98 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 125.313 1.445 . . . . 0.0 111.73 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.05 -42.77 69.61 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.413 1.085 . . . . 0.0 111.631 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -147.13 -54.75 0.23 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.85 0.46 . . . . 0.0 111.255 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -70.64 148.86 47.62 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 171.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -71.27 -29.69 65.38 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.404 0.682 . . . . 0.0 112.269 -176.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 31.4 pt -143.48 155.41 60.66 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 127.055 2.142 . . . . 0.0 107.298 174.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -67.4 174.51 7.14 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.514 2.143 . . . . 0.0 111.273 174.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.85 11.98 0.12 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.203 1.801 . . . . 0.0 114.172 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -138.96 110.37 7.85 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 126.159 1.783 . . . . 0.0 107.039 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -71.73 157.95 54.33 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.597 2.198 . . . . 0.0 111.707 -171.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.95 -21.03 66.4 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -56.69 -40.55 75.79 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.074 0.95 . . . . 0.0 112.469 -169.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -73.74 -30.82 63.03 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.785 0.721 . . . . 0.0 111.075 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -73.57 -40.23 64.07 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.518 -0.739 . . . . 0.0 109.723 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.4 tp -61.8 -44.29 97.16 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.907 1.283 . . . . 0.0 109.988 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.06 -44.42 93.0 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.682 1.134 . . . . 0.0 111.126 173.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.1 m -62.7 -40.07 95.99 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 122.313 -0.522 . . . . 0.0 110.67 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -63.04 -48.77 77.3 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 117.968 -1.015 . . . . 0.0 111.786 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 28.1 m -65.74 -33.39 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 119.978 1.263 . . . . 0.0 110.949 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.83 -32.84 74.14 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.687 -0.673 . . . . 0.0 111.854 174.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 mt -80.27 -50.9 9.58 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.004 0.82 . . . . 0.0 111.016 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 pp -79.11 -16.45 56.68 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.901 0.773 . . . . 0.0 113.052 -173.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 60.1 mttm . . . . . 0 C--O 1.25 1.129 0 C-N-CA 127.808 2.443 . . . . 0.0 111.949 176.816 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.39 155.5 25.08 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 122.027 -0.42 . . . . 0.0 110.282 171.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -134.51 -26.84 1.39 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.393 1.077 . . . . 0.0 111.263 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.0 mt -128.9 81.39 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 171.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.7 m -77.46 110.69 12.45 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mp -74.78 155.89 37.13 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.7 mt -127.89 100.63 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 m -70.65 158.1 36.82 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.288 1.435 . . . . 0.0 110.88 177.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.41 59.37 0.23 Allowed Glycine 0 C--N 1.338 0.694 0 O-C-N 121.992 -0.443 . . . . 0.0 112.789 -170.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.4 p -128.4 169.56 14.13 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.17 1.388 . . . . 0.0 107.587 169.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.5 p -72.92 -45.66 56.87 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.779 0.832 . . . . 0.0 111.012 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 pp -144.25 -27.6 0.51 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.314 1.045 . . . . 0.0 113.023 -169.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.78 154.74 15.83 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 107.744 -2.142 . . . . 0.0 107.744 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.69 -85.31 0.26 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 107.404 -2.278 . . . . 0.0 107.404 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.15 -32.11 73.64 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 122.983 0.513 . . . . 0.0 111.066 175.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -66.04 -35.24 80.0 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.611 0.764 . . . . 0.0 110.572 176.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -70.64 -47.49 59.75 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -59.58 -40.95 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.31 -48.29 82.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.871 0.76 . . . . 0.0 110.599 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.96 -43.14 99.61 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.189 0.449 . . . . 0.0 110.765 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -66.8 -42.65 85.62 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.847 -0.533 . . . . 0.0 111.078 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.9 mt -65.68 -41.32 92.57 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.639 -0.663 . . . . 0.0 110.267 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.41 -41.04 93.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 119.005 -0.522 . . . . 0.0 110.761 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -55.9 -48.73 75.13 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.64 0.655 . . . . 0.0 110.128 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.18 -37.68 84.11 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 121.786 -0.571 . . . . 0.0 110.69 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.0 mt -62.68 -39.74 94.92 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.665 0.666 . . . . 0.0 111.426 175.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -66.85 -37.03 83.67 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.872 0.76 . . . . 0.0 110.534 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.84 -37.37 86.04 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.66 0.663 . . . . 0.0 110.877 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.02 -25.89 65.61 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.157 0.583 . . . . 0.0 111.661 173.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.88 -3.11 11.81 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.228 1.394 . . . . 0.0 113.88 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -79.85 143.56 34.23 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.863 1.331 . . . . 0.0 109.601 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 p -82.23 144.54 30.6 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 169.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.3 p -135.96 170.7 15.58 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.654 0.781 . . . . 0.0 110.116 -170.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -153.18 161.84 41.98 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 169.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 p -135.44 75.64 1.57 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -173.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.8 mt -66.29 115.87 6.71 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -171.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -76.88 95.34 4.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 53.26 62.69 5.75 Favored Glycine 0 CA--C 1.541 1.693 0 C-N-CA 123.894 0.759 . . . . 0.0 113.491 173.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -68.89 176.34 6.23 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.826 3.018 . . . . 0.0 111.848 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.4 mt -122.74 162.78 21.39 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.318 1.447 . . . . 0.0 107.603 169.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.7 tt -57.03 -35.93 69.87 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.733 0.813 . . . . 0.0 111.328 -176.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.23 -3.51 5.9 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.902 1.281 . . . . 0.0 113.21 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -130.47 16.54 5.43 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.908 1.283 . . . . 0.0 110.406 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -135.73 105.01 9.85 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.104 1.362 . . . . 0.0 108.826 -169.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.71 153.66 72.78 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.603 2.202 . . . . 0.0 112.388 -174.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.57 17.16 2.8 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.274 1.43 . . . . 0.0 113.347 -170.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.7 m -154.75 131.1 10.43 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 120.825 -1.172 . . . . 0.0 108.196 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.88 -173.92 26.9 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.9 mt -122.28 101.62 10.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -174.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -99.3 170.72 8.46 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.952 0.901 . . . . 0.0 109.844 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.3 tp -148.67 101.25 3.19 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 175.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.0 t -84.81 137.54 20.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 123.853 0.861 . . . . 0.0 108.725 -171.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.8 mt -133.73 115.94 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.483 ' HG ' ' CD1' ' A' ' 105' ' ' LEU . 16.1 m -130.47 127.7 39.74 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.216 0.606 . . . . 0.0 109.724 -169.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 m -76.85 165.8 24.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.135 0.493 . . . . 0.0 109.868 171.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 m -136.4 99.03 3.98 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.7 -34.05 77.3 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 157.9 155.64 7.62 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 171.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 46.24 32.44 1.49 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.632 1.973 . . . . 0.0 113.978 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.64 5.3 66.89 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.407 -0.663 . . . . 0.0 113.013 174.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.77 92.4 2.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.336 1.068 . . . . 0.0 110.115 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.0 mt -65.12 142.67 98.66 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 169.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.43 148.22 90.71 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.615 2.21 . . . . 0.0 111.497 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -57.91 -17.95 20.01 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.256 1.822 . . . . 0.0 113.785 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -62.06 -42.62 99.38 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.719 0.807 . . . . 0.0 110.401 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.5 tp -117.61 -26.07 6.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.592 0.757 . . . . 0.0 112.51 -169.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 100.0 p -55.92 -31.68 10.57 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 116.87 -1.538 . . . . 0.0 114.994 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -53.2 -25.09 28.56 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.537 2.158 . . . . 0.0 114.938 171.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -61.1 -38.34 85.95 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.262 0.937 . . . . 0.0 111.094 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -62.08 -40.98 97.68 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.679 0.792 . . . . 0.0 110.239 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.78 -46.82 62.19 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.955 0.502 . . . . 0.0 109.927 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.65 -31.34 72.31 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.765 -0.585 . . . . 0.0 112.124 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.4 mt -64.42 -59.98 3.7 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -68.1 -26.43 65.82 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.771 0.714 . . . . 0.0 112.291 -171.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -66.59 -33.85 76.58 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.299 0.64 . . . . 0.0 110.971 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -111.86 -30.48 7.28 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -169.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt 31.8 57.98 1.18 Allowed Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 126.976 2.111 . . . . 0.0 112.365 -169.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -71.37 170.78 17.55 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.367 2.045 . . . . 0.0 109.886 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -73.75 103.29 4.26 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.836 -0.54 . . . . 0.0 110.262 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.1 mt -114.34 23.13 13.09 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.639 1.576 . . . . 0.0 110.491 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.5 m -62.63 19.82 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.535 1.934 . . . . 0.0 115.696 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.18 2.57 1.5 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.321 1.448 . . . . 0.0 111.917 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.8 t -77.84 137.01 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 169.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -121.36 144.76 48.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 168.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -148.11 169.33 20.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.067 0.394 . . . . 0.0 110.186 -176.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.2 167.16 21.32 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 106.156 -2.778 . . . . 0.0 106.156 169.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.39 132.02 28.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.598 0.699 . . . . 0.0 109.79 -169.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.9 mt -132.29 130.76 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.13 146.57 18.83 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.1 mt -138.42 140.66 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -172.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 172.2 179.03 42.83 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.9 m -77.16 123.73 26.83 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 170.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.41 ' HA ' ' CG ' ' A' ' 98' ' ' PHE . 31.6 ptt-85 -58.94 -22.91 60.81 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -172.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -84.05 -4.42 58.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.439 0.696 . . . . 0.0 112.525 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.8 m-30 -63.51 162.03 13.47 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.453 1.024 . . . . 0.0 110.352 169.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -60.82 -27.45 68.06 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.653 0.781 . . . . 0.0 112.009 173.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.2 p -143.59 137.41 28.34 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 172.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.41 ' CG ' ' HA ' ' A' ' 93' ' ' ARG . 4.0 p90 -133.92 1.06 3.26 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.085 0.857 . . . . 0.0 112.556 173.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 7.0 p -159.8 -37.26 0.06 Allowed 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -54.26 -22.99 24.1 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.455 1.026 . . . . 0.0 113.882 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.16 -28.53 40.82 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.502 1.121 . . . . 0.0 113.161 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -30.31 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.796 0.838 . . . . 0.0 109.57 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -55.56 -31.22 61.97 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.4 1.08 . . . . 0.0 112.421 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -62.52 -49.63 74.58 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.783 0.72 . . . . 0.0 109.962 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.483 ' CD1' ' HG ' ' A' ' 54' ' ' SER . 13.5 mt -64.67 -49.09 72.33 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -71.38 -32.62 68.68 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.907 -175.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.43 -44.58 92.88 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.431 1.014 . . . . 0.0 109.474 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -73.35 -27.56 61.57 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.603 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.0 mt -64.33 -46.36 83.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.479 1.49 . . . . 0.0 109.273 169.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -64.97 -39.95 94.26 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 117.855 0.298 . . . . 0.0 110.392 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -62.37 -37.92 87.59 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.546 0.738 . . . . 0.0 110.723 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.6 m -72.8 -12.35 60.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.244 1.018 . . . . 0.0 112.82 173.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 129.36 -17.7 5.56 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.988 1.28 . . . . 0.0 114.32 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.32 173.27 1.59 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.508 1.154 . . . . 0.0 111.958 -175.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -143.1 142.24 31.46 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.264 -0.898 . . . . 0.0 112.066 169.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -63.16 161.48 13.47 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.526 1.93 . . . . 0.0 109.962 176.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.8 m -143.03 149.28 38.03 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.909 1.684 . . . . 0.0 107.031 -176.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.57 -144.06 44.98 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -136.73 149.99 48.16 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 174.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.6 m -64.08 133.49 53.13 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.904 0.882 . . . . 0.0 110.149 -173.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.5 tp -98.92 152.24 19.98 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.69 138.94 39.9 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 29.0 mt -132.04 104.93 8.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 -170.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -67.57 134.54 51.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.17 172.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 6.3 pt -110.05 -8.61 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.78 0.832 . . . . 0.0 111.889 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.1 tp -79.35 83.71 5.35 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -151.91 -45.83 0.11 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.435 1.494 . . . . 0.0 108.186 170.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -160.28 -56.42 0.06 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 169.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -163.97 -141.54 0.06 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 102.607 -3.109 . . . . 0.0 102.607 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.1 pt -129.44 70.77 81.99 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.641 1.576 . . . . 0.0 108.063 169.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.58 -5.68 17.27 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.083 2.522 . . . . 0.0 112.376 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -143.73 159.19 42.94 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.665 2.386 . . . . 0.0 105.455 174.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -140.04 115.38 7.86 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.133 0.973 . . . . 0.0 110.089 -174.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.36 -4.59 14.36 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.353 2.702 . . . . 0.0 113.758 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.0 -21.25 58.65 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.045 1.293 . . . . 0.0 113.248 -172.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -55.84 -25.64 42.98 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.06 0.846 . . . . 0.0 113.036 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -74.12 -48.22 30.95 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.023 0.829 . . . . 0.0 109.456 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 6.4 t-105 -68.64 -27.54 66.09 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.213 1.005 . . . . 0.0 111.158 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.1 tp -56.07 -33.74 65.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.22 1.008 . . . . 0.0 111.073 171.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.15 -44.36 88.71 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 174.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.9 m -63.03 -43.2 99.36 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.319 0.56 . . . . 0.0 110.206 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -62.46 -49.61 74.74 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 118.112 -0.947 . . . . 0.0 111.832 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.03 -30.17 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 120.378 1.445 . . . . 0.0 111.405 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -70.03 -20.32 63.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.602 0.637 . . . . 0.0 111.213 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.36 -46.81 4.9 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.132 0.973 . . . . 0.0 110.21 -174.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 pp -75.87 -20.61 57.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.302 -0.856 . . . . 0.0 112.255 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.9 mttp . . . . . 0 C--O 1.25 1.117 0 C-N-CA 127.631 2.372 . . . . 0.0 112.119 179.569 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.44 158.75 23.01 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.08 0.855 . . . . 0.0 110.767 175.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -136.42 -26.43 1.11 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.933 1.293 . . . . 0.0 111.226 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.8 mt -125.67 79.49 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 170.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.1 m -74.37 117.65 16.42 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -84.26 154.83 22.76 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.6 mt -126.31 85.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -173.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -71.31 152.24 43.43 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.577 1.151 . . . . 0.0 110.173 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.45 104.26 0.24 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 t -147.45 168.11 22.72 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.837 0.827 . . . . 0.0 111.65 177.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p -139.85 -42.44 0.43 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 127.68 2.392 . . . . 0.0 107.141 170.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.47 -30.61 71.64 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 123.845 0.858 . . . . 0.0 112.101 172.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.96 34.45 3.74 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.486 1.041 . . . . 0.0 112.741 174.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.89 -43.87 2.02 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 118.026 0.913 . . . . 0.0 112.326 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.62 -26.26 66.16 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.707 1.254 . . . . 0.0 111.092 -176.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.38 -37.94 89.22 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.273 0.229 . . . . 0.0 110.863 176.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -76.11 -50.26 15.13 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 175.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.99 -47.21 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.402 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.06 98.23 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.029 0.831 . . . . 0.0 110.593 -177.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.63 -42.35 86.89 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.604 0.638 . . . . 0.0 110.64 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -63.36 -43.16 98.48 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.858 0.463 . . . . 0.0 110.628 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.93 -42.94 89.45 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.696 -0.628 . . . . 0.0 109.522 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.15 -37.18 76.66 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.525 0.73 . . . . 0.0 111.674 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -51.73 -47.08 64.18 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.65 0.659 . . . . 0.0 110.227 175.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.9 mmtt -68.36 -39.28 81.87 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.6 mt -65.65 -40.44 92.49 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.581 0.353 . . . . 0.0 110.258 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.27 -40.29 90.01 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.192 -0.432 . . . . 0.0 110.284 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.14 -36.44 84.27 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.703 0.683 . . . . 0.0 111.174 175.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.8 -22.96 65.15 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.475 0.71 . . . . 0.0 112.024 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.71 -0.1 19.98 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.922 1.249 . . . . 0.0 113.326 171.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -75.12 174.91 8.76 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.449 1.124 . . . . 0.0 109.907 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 p -122.47 145.72 48.04 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.2 p -132.52 166.29 22.41 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.662 0.785 . . . . 0.0 110.667 -169.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -152.49 159.4 43.34 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 169.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 p -127.99 80.19 1.94 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -171.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.3 mt -73.21 110.8 7.78 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -84.78 106.28 16.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.74 52.24 54.19 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 118.496 -1.169 . . . . 0.0 114.275 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.53 179.24 3.17 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.315 2.677 . . . . 0.0 111.029 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.4 mt -130.45 168.08 17.58 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.221 1.408 . . . . 0.0 108.528 172.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.78 -35.98 64.39 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.024 1.33 . . . . 0.0 111.697 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.75 -6.94 6.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.14 0.976 . . . . 0.0 113.444 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -129.45 19.07 5.79 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.661 1.584 . . . . 0.0 111.07 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.6 mt -135.75 112.04 10.56 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.803 1.241 . . . . 0.0 108.656 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.28 161.37 45.97 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.182 1.921 . . . . 0.0 111.223 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.69 13.28 1.71 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.185 1.394 . . . . 0.0 113.816 -172.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.4 m -146.92 130.2 16.59 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.487 1.115 . . . . 0.0 108.121 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.53 -176.63 29.86 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.18 99.29 5.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -100.57 173.99 6.29 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.27 1.028 . . . . 0.0 110.013 -173.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.2 tp -143.31 110.16 5.57 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.15 136.68 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.11 119.42 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 176.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.2 m -120.39 132.72 55.38 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.932 0.893 . . . . 0.0 108.894 -175.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.469 ' H ' ' HG3' ' A' ' 63' ' ' PRO . 15.4 m -87.59 50.94 2.09 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.73 0.812 . . . . 0.0 109.937 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -54.13 99.71 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.518 2.327 . . . . 0.0 110.636 -173.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -61.95 130.15 44.26 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.87 20.14 12.6 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.406 1.003 . . . . 0.0 113.843 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 49.97 34.26 7.82 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.105 1.362 . . . . 0.0 111.743 -169.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.58 -0.58 0.33 Allowed Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.518 -1.157 . . . . 0.0 115.132 -169.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -144.02 118.14 9.49 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 119.637 1.718 . . . . 0.0 108.744 171.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.5 mt -68.37 140.79 92.93 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.469 ' HG3' ' H ' ' A' ' 55' ' ' SER . 56.0 Cg_endo -64.17 139.02 64.38 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.975 1.783 . . . . 0.0 110.683 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.86 -19.72 52.84 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.07 1.348 . . . . 0.0 113.674 -173.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -70.88 -31.6 68.31 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.66 -0.65 . . . . 0.0 111.897 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.7 tp -118.14 -25.08 6.76 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.678 0.791 . . . . 0.0 111.753 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.6 t -44.98 -42.24 15.16 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 117.39 -1.29 . . . . 0.0 114.338 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.06 -25.71 13.26 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.81 3.007 . . . . 0.0 116.176 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -59.72 -35.81 75.28 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.19 0.904 . . . . 0.0 111.288 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -58.31 -40.67 82.67 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.225 0.61 . . . . 0.0 110.585 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -72.22 -47.65 48.89 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.912 0.485 . . . . 0.0 109.942 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.43 -35.92 82.49 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.562 0.619 . . . . 0.0 111.725 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.5 mt -66.02 -52.5 48.68 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.772 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -69.88 -25.56 63.76 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.544 1.066 . . . . 0.0 112.224 -174.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.27 -37.25 83.14 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.502 0.592 . . . . 0.0 110.349 177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -107.25 -28.78 9.71 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -169.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.9 mttm 32.27 57.82 1.29 Allowed Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 127.257 2.223 . . . . 0.0 112.556 -172.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.11 171.09 14.35 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.871 2.38 . . . . 0.0 110.66 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -77.23 110.37 11.87 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.576 -0.703 . . . . 0.0 109.357 170.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.5 mt -118.23 19.77 13.38 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.996 1.718 . . . . 0.0 110.951 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.8 m -58.74 11.21 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.857 2.063 . . . . 0.0 116.39 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.16 2.79 4.74 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.626 1.171 . . . . 0.0 111.445 173.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 80.5 t -81.76 140.21 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 169.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -119.51 146.82 45.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 168.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -140.98 171.65 13.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.918 0.866 . . . . 0.0 111.145 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.01 162.6 25.62 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 104.448 -3.461 . . . . 0.0 104.448 169.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.07 132.71 25.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.6 mt -134.17 137.82 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -110.29 152.88 17.25 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 170.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.3 mt -134.31 122.83 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 175.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.62 -155.98 15.2 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.241 -1.943 . . . . 0.0 108.241 -172.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.0 m -102.88 124.17 47.9 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 24.9 ttp180 -69.21 -14.93 63.24 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -69.34 -13.87 62.61 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.461 -0.774 . . . . 0.0 111.274 169.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 52.7 179.93 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 129.732 3.213 . . . . 0.0 115.547 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -156.33 -41.47 0.08 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.214 2.206 . . . . 0.0 107.527 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 92.4 m -122.15 170.53 9.78 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.753 2.421 . . . . 0.0 105.659 169.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -124.41 53.77 1.41 Allowed 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.327 -0.858 . . . . 0.0 111.338 -169.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 24.2 m 72.35 5.26 5.24 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.72 2.008 . . . . 0.0 114.75 169.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.66 -27.76 55.57 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 118.865 0.757 . . . . 0.0 112.446 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.71 -55.45 15.03 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.058 0.929 . . . . 0.0 111.686 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -33.28 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 119.251 0.932 . . . . 0.0 109.809 -178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -53.32 -29.59 34.58 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 119.005 -0.521 . . . . 0.0 112.341 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.57 -42.0 95.75 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.617 1.099 . . . . 0.0 111.541 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.41 -51.86 64.03 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -70.08 -35.5 74.23 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.921 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.2 -37.13 86.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.104 0.411 . . . . 0.0 110.846 -172.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -68.79 -34.71 76.0 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.383 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 44.2 mt -65.74 -41.63 91.97 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.258 1.39 . . . . 0.0 109.515 172.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -63.21 -44.63 94.78 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.315 1.046 . . . . 0.0 109.383 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -61.23 -42.26 98.29 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.003 0.921 . . . . 0.0 110.879 172.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.7 m -68.14 -7.0 26.1 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.226 1.01 . . . . 0.0 113.013 177.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.74 -15.15 14.34 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.058 1.313 . . . . 0.0 113.627 169.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.89 169.77 3.06 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.466 1.133 . . . . 0.0 110.776 176.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -142.76 154.01 43.83 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.422 -0.799 . . . . 0.0 111.228 171.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -70.43 155.75 40.27 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.927 171.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 72.8 m -125.95 153.21 44.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.379 1.872 . . . . 0.0 106.931 169.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.94 -144.54 49.05 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -175.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -135.71 152.51 51.24 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.497 1.119 . . . . 0.0 108.25 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.82 150.83 46.86 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.284 1.434 . . . . 0.0 110.427 -176.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.3 tp -130.0 144.97 51.62 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.391 1.076 . . . . 0.0 108.815 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.36 147.42 43.53 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 169.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.3 mt -124.35 106.5 16.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 -175.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -68.09 128.1 35.31 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.077 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -124.49 10.14 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.804 1.242 . . . . 0.0 111.68 174.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 53.2 tp -58.96 -37.46 76.84 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.051 0.54 . . . . 0.0 111.339 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -158.03 -42.34 0.06 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.528 0.731 . . . . 0.0 112.097 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -77.43 -8.55 57.91 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -170.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.6 t70 65.97 -19.02 0.1 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 128.232 2.613 . . . . 0.0 115.532 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.5 pt -141.83 166.83 19.23 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 127.997 2.519 . . . . 0.0 107.169 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -59.33 179.68 0.22 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.353 2.036 . . . . 0.0 111.672 169.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.48 -2.02 4.2 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.95 0.9 . . . . 0.0 113.254 173.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -147.04 129.93 7.94 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 126.786 2.034 . . . . 0.0 107.1 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.6 158.16 58.14 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.548 2.165 . . . . 0.0 112.306 -172.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.86 -17.73 64.85 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -174.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -56.61 -44.22 80.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.776 0.83 . . . . 0.0 111.868 -169.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -73.33 -35.04 65.97 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 122.02 -0.425 . . . . 0.0 110.748 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -69.27 -40.36 77.83 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.81 -0.556 . . . . 0.0 109.839 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 48.9 tp -65.13 -39.93 93.75 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.389 0.676 . . . . 0.0 110.194 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.8 -46.4 83.21 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 171.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.6 m -64.54 -34.11 77.48 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.647 0.779 . . . . 0.0 111.299 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -66.14 -53.65 35.11 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.519 0.727 . . . . 0.0 110.051 176.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.5 m -66.06 -25.89 36.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 118.989 0.813 . . . . 0.0 112.182 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -54.98 -25.38 29.46 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.438 0.695 . . . . 0.0 112.276 177.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 27.7 mt -101.56 0.21 36.05 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 pp -127.68 -11.96 5.49 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 120.362 1.437 . . . . 0.0 113.467 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.0 pttp . . . . . 0 C--O 1.249 1.029 0 C-N-CA 124.286 1.034 . . . . 0.0 111.105 177.526 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.73 156.37 30.68 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.033 0.533 . . . . 0.0 110.904 176.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -134.23 -26.66 1.46 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.123 1.369 . . . . 0.0 110.941 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.2 mt -124.64 79.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.6 m -74.51 114.38 12.85 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mp -76.6 148.39 37.01 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 170.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.5 mt -116.89 90.6 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -175.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.5 m -80.62 137.7 36.38 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.88 1.272 . . . . 0.0 111.262 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.95 76.62 0.36 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 125.148 1.356 . . . . 0.0 111.839 -170.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 p -146.18 145.25 30.39 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 169.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.28 -32.13 62.79 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.0 0.92 . . . . 0.0 111.967 -177.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 pp -132.5 -31.89 1.35 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.866 0.866 . . . . 0.0 112.577 -174.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.98 157.55 10.59 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 107.99 -2.044 . . . . 0.0 107.99 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 139.13 -73.43 0.41 Allowed Glycine 0 CA--C 1.518 0.26 0 N-CA-C 108.405 -1.878 . . . . 0.0 108.405 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.0 -35.09 79.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.803 176.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.18 -36.29 83.14 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.436 0.562 . . . . 0.0 110.315 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -73.67 -47.15 41.94 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.9 t -60.91 -43.3 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -46.39 90.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.019 0.528 . . . . 0.0 110.438 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.4 -44.26 96.87 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.623 0.647 . . . . 0.0 110.415 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -63.48 -35.63 81.09 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.743 0.417 . . . . 0.0 111.601 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.5 mt -74.21 -46.8 39.56 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.763 0.825 . . . . 0.0 109.904 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.13 -35.2 71.14 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.402 1.081 . . . . 0.0 111.623 -174.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -48.25 -44.07 32.97 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.161 0.985 . . . . 0.0 111.477 174.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -77.91 -32.85 51.93 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.502 -0.749 . . . . 0.0 109.984 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.0 mt -64.16 -39.25 93.62 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.554 0.616 . . . . 0.0 110.043 174.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -65.41 -41.63 93.39 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.291 0.496 . . . . 0.0 110.249 176.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -64.18 -35.91 82.33 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.552 0.615 . . . . 0.0 111.287 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.88 -22.54 65.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.555 0.742 . . . . 0.0 111.984 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.19 -0.73 16.77 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.913 1.244 . . . . 0.0 113.346 170.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -75.64 174.72 9.38 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.509 1.154 . . . . 0.0 110.074 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 p -120.32 144.08 48.03 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 169.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.5 p -134.88 168.46 19.03 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.653 0.781 . . . . 0.0 110.484 -169.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -151.86 149.93 29.53 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 104.359 -2.459 . . . . 0.0 104.359 169.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -110.96 69.64 0.69 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.43 106.86 5.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -169.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -72.87 118.38 15.74 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.71 54.14 26.28 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 118.124 -1.376 . . . . 0.0 116.187 169.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.45 176.28 4.26 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 CA-C-N 120.328 2.064 . . . . 0.0 110.978 169.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.7 mt -127.33 161.52 28.44 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.093 1.357 . . . . 0.0 107.969 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.37 -27.76 69.29 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.853 0.861 . . . . 0.0 111.315 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -65.22 -7.75 14.36 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.592 1.157 . . . . 0.0 112.435 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -131.4 21.94 4.76 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.731 1.612 . . . . 0.0 110.871 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 65.8 mt -133.81 115.8 13.45 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.919 1.288 . . . . 0.0 107.835 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -70.25 163.89 37.03 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.147 1.898 . . . . 0.0 111.346 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.32 14.8 0.68 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.133 1.373 . . . . 0.0 113.52 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 p -153.46 146.1 24.22 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.221 1.008 . . . . 0.0 109.097 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.22 179.74 23.52 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.53 97.38 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 173.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -95.39 169.48 10.03 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.849 0.86 . . . . 0.0 109.055 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.4 tp -147.89 111.24 4.93 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.5 t -96.93 138.02 23.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -171.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -134.68 133.32 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.5 p -138.46 146.93 42.68 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 m -109.33 79.32 1.2 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.278 1.031 . . . . 0.0 109.508 -172.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.0 m -45.09 114.18 0.69 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.932 1.693 . . . . 0.0 109.873 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -64.52 -22.49 66.98 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -175.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 159.93 -29.29 0.37 Allowed Glycine 0 C--N 1.339 0.717 0 CA-C-O 118.833 -0.982 . . . . 0.0 113.363 169.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.11 29.14 4.07 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.454 1.127 . . . . 0.0 112.309 -170.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.1 4.23 60.04 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.426 -0.652 . . . . 0.0 113.471 175.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -81.97 121.99 27.22 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.265 1.032 . . . . 0.0 109.492 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.8 mt -80.46 142.43 53.99 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -49.85 136.85 35.71 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.031 3.154 . . . . 0.0 112.984 169.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -60.5 -20.99 61.92 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.688 1.195 . . . . 0.0 113.296 -174.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -69.26 -30.43 68.54 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 118.856 -0.592 . . . . 0.0 111.638 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.3 tp -123.34 -22.52 5.07 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.463 0.705 . . . . 0.0 112.105 -169.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.1 t -46.02 -41.08 19.26 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 117.636 -1.173 . . . . 0.0 113.546 173.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -50.96 -26.88 19.45 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.266 2.644 . . . . 0.0 116.005 172.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -62.84 -38.11 89.48 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.791 1.178 . . . . 0.0 110.802 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -63.46 -38.89 92.89 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 118.341 0.519 . . . . 0.0 110.36 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.04 -48.62 65.16 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.34 70.15 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 121.515 -0.741 . . . . 0.0 112.462 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.95 -57.42 6.94 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -69.47 -28.49 66.13 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.887 0.767 . . . . 0.0 112.346 -171.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -76.64 -22.14 54.5 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.745 0.702 . . . . 0.0 111.781 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -118.2 -36.09 3.66 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.748 0.704 . . . . 0.0 112.391 -172.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt 30.59 60.67 1.0 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 127.222 2.209 . . . . 0.0 113.376 -174.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.74 170.8 14.51 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.156 1.904 . . . . 0.0 109.924 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -72.31 111.01 7.14 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.002 0.521 . . . . 0.0 109.925 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.1 mt -118.98 24.5 10.79 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.796 1.638 . . . . 0.0 110.52 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.7 m -63.37 20.89 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.473 1.909 . . . . 0.0 115.872 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.09 2.84 1.75 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.663 1.185 . . . . 0.0 111.967 173.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.7 t -76.97 142.29 14.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 169.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 54.8 mmm-85 -119.76 144.21 47.4 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 168.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -138.25 171.28 14.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.29 0.567 . . . . 0.0 110.66 -174.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.33 165.55 25.45 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 105.553 -3.019 . . . . 0.0 105.553 169.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.32 128.85 15.02 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.677 0.739 . . . . 0.0 109.878 -169.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 37.4 mt -131.11 124.22 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -101.84 95.59 1.35 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.1 mt -79.79 155.19 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 168.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.59 174.43 33.44 Favored Glycine 0 N--CA 1.436 -1.329 0 CA-C-O 123.21 1.45 . . . . 0.0 111.468 169.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.6 m -74.78 73.65 2.07 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 125.98 1.712 . . . . 0.0 109.077 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.92 -27.89 63.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.167 1.387 . . . . 0.0 112.362 -170.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -83.78 -11.34 57.21 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.467 0.707 . . . . 0.0 112.745 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -70.09 -53.55 16.91 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.374 0.988 . . . . 0.0 111.416 -169.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -164.78 -49.41 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.386 1.074 . . . . 0.0 110.755 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.5 m -109.72 133.9 52.61 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -172.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -82.04 61.18 5.2 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.374 1.07 . . . . 0.0 109.816 -172.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 13.5 m 46.62 50.05 13.28 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.349 1.86 . . . . 0.0 111.838 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.74 -2.11 61.5 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 118.572 -1.127 . . . . 0.0 113.208 -173.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.35 -21.75 66.73 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.942 1.871 . . . . 0.0 112.25 -175.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.1 tp -59.83 -28.88 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.006 1.323 . . . . 0.0 110.839 173.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.06 -37.66 77.55 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 122.908 0.483 . . . . 0.0 111.176 -174.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -61.81 -53.28 58.01 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.745 0.818 . . . . 0.0 109.819 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.7 mt -62.09 -50.82 70.41 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.66 0.784 . . . . 0.0 109.477 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.47 -41.57 72.57 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -171.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.24 -33.74 72.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 119.118 -0.468 . . . . 0.0 110.236 -170.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.57 -29.78 66.31 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.858 0.753 . . . . 0.0 111.197 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.1 mt -64.41 -44.54 90.95 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.795 1.18 . . . . 0.0 108.777 169.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -59.63 -44.87 93.32 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -177.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -66.46 -37.1 84.38 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 122.739 0.415 . . . . 0.0 110.335 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 31.3 m -68.3 -13.06 61.99 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.833 0.853 . . . . 0.0 112.393 174.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.19 -20.69 3.35 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.745 1.164 . . . . 0.0 113.442 169.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.72 171.02 2.25 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.116 0.958 . . . . 0.0 111.841 -175.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -142.12 141.91 32.72 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.172 -0.955 . . . . 0.0 110.115 173.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -63.85 164.86 9.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.217 1.007 . . . . 0.0 109.997 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.3 m -136.0 148.29 48.35 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.914 2.086 . . . . 0.0 106.197 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.55 -133.64 52.62 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -170.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -141.28 160.58 39.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.273 1.829 . . . . 0.0 106.453 176.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.89 158.72 24.46 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.527 1.131 . . . . 0.0 110.695 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.4 tp -129.85 146.43 51.57 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.392 1.077 . . . . 0.0 108.749 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -120.18 141.98 49.39 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.9 mt -137.84 100.6 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -67.77 130.37 42.78 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 170.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 pp -113.85 -4.1 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 123.875 0.87 . . . . 0.0 111.875 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.4 tp -88.47 61.31 6.07 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 168.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -142.9 -172.76 3.73 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.438 1.895 . . . . 0.0 108.996 -168.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -56.87 -43.41 81.19 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 169.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -161.76 -50.98 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.855 1.262 . . . . 0.0 109.555 169.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.4 pt -149.83 163.38 24.95 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 128.013 2.525 . . . . 0.0 107.667 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.46 164.39 23.57 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.394 2.062 . . . . 0.0 111.072 169.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -74.31 -12.47 60.55 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.74 0.816 . . . . 0.0 112.385 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -58.69 124.48 72.89 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 124.118 0.967 . . . . 0.0 110.852 -177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.14 114.85 4.13 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.728 2.285 . . . . 0.0 111.232 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.28 -27.97 62.58 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.193 0.597 . . . . 0.0 111.428 171.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -60.77 -41.53 95.71 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.881 0.872 . . . . 0.0 110.828 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -73.19 -40.08 65.06 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 75.7 t90 -60.51 -50.24 74.34 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 52.3 tp -64.94 -40.59 95.26 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 119.148 -0.453 . . . . 0.0 110.164 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.18 -46.83 84.86 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 173.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.5 m -63.99 -37.13 86.31 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.056 0.543 . . . . 0.0 111.071 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -65.97 -51.64 56.71 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.91 0.884 . . . . 0.0 110.286 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.8 m -67.2 -30.88 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 O-C-N 121.24 -0.913 . . . . 0.0 111.379 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -61.82 -20.12 63.29 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.632 0.773 . . . . 0.0 112.376 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.6 mt -101.87 -36.27 8.71 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.787 171.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.71 -37.22 84.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.779 1.172 . . . . 0.0 111.718 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt . . . . . 0 C--O 1.247 0.95 0 C-N-CA 128.604 2.762 . . . . 0.0 113.074 179.839 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.78 154.74 28.78 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 122.104 -0.373 . . . . 0.0 110.278 171.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -132.84 -27.23 1.69 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.58 1.152 . . . . 0.0 110.962 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.8 mt -124.94 79.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.2 m -75.12 117.82 17.38 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 mt -89.09 156.84 18.57 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.783 0.833 . . . . 0.0 108.812 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.4 mt -126.44 95.32 3.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -171.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.5 m -73.29 146.27 45.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.855 0.862 . . . . 0.0 110.11 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.32 81.94 0.15 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 124.47 1.033 . . . . 0.0 110.833 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.0 t -154.87 141.69 19.08 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.444 0.697 . . . . 0.0 110.025 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 p -86.37 -35.9 19.52 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.956 1.302 . . . . 0.0 108.503 168.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.5 mt -68.46 -29.76 68.47 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.205 1.402 . . . . 0.0 111.167 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.31 17.61 33.67 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.355 0.978 . . . . 0.0 112.219 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.82 -41.96 9.31 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 118.52 1.16 . . . . 0.0 110.666 -176.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.38 -35.47 80.41 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 122.001 -0.705 . . . . 0.0 110.499 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.59 -34.51 69.96 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.095 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -66.43 -46.06 77.77 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.417 0.687 . . . . 0.0 109.238 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.0 t -63.18 -47.75 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.57 -38.41 84.49 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-O 118.823 -0.608 . . . . 0.0 111.007 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.16 -45.23 89.39 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.345 0.975 . . . . 0.0 110.715 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -67.79 -40.04 83.99 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.884 -0.51 . . . . 0.0 110.795 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.3 mt -64.2 -42.51 96.6 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 119.257 -0.402 . . . . 0.0 110.157 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.08 -44.87 96.71 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.549 0.74 . . . . 0.0 110.468 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -58.77 -42.25 88.51 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.225 0.466 . . . . 0.0 110.269 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.5 mmtm -69.94 -39.47 76.08 Favored 'General case' 0 N--CA 1.462 0.142 0 O-C-N 121.682 -0.636 . . . . 0.0 111.726 176.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.6 mt -60.65 -37.12 80.47 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.084 0.856 . . . . 0.0 111.045 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -67.63 -35.75 79.51 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.863 0.756 . . . . 0.0 110.682 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.71 -37.46 84.74 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.092 0.86 . . . . 0.0 110.792 172.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.64 -26.41 67.05 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 122.844 0.457 . . . . 0.0 111.55 173.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.95 -3.28 11.68 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.345 1.45 . . . . 0.0 113.834 169.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -81.08 144.36 31.78 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.91 1.355 . . . . 0.0 109.724 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 p -84.18 144.11 29.19 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 169.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.8 p -135.7 169.33 17.72 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.613 0.765 . . . . 0.0 110.795 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -150.79 161.38 42.76 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 p -131.95 75.73 1.66 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.6 mt -69.23 121.91 17.78 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -171.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -80.51 95.49 6.49 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.64 56.17 26.76 Favored Glycine 0 CA--C 1.541 1.68 0 CA-C-O 118.783 -1.009 . . . . 0.0 113.852 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -69.47 178.84 3.99 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.556 2.838 . . . . 0.0 111.988 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.7 mt -129.04 165.93 20.21 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.44 1.496 . . . . 0.0 109.173 172.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.4 tp -63.2 -26.57 68.86 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.777 1.231 . . . . 0.0 112.288 -173.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.11 -10.15 13.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.052 0.941 . . . . 0.0 113.071 174.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -128.07 18.79 6.55 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.443 1.497 . . . . 0.0 111.068 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.6 mt -135.51 97.93 12.67 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 125.106 1.362 . . . . 0.0 107.756 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.73 165.26 30.21 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.356 2.037 . . . . 0.0 111.731 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.64 5.21 2.57 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.837 1.655 . . . . 0.0 114.71 -171.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.3 m -145.43 131.65 19.48 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.776 1.23 . . . . 0.0 107.997 -173.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.91 -172.23 35.06 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.039 -0.825 . . . . 0.0 111.039 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -129.73 97.26 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 173.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -100.52 172.27 7.22 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.602 0.761 . . . . 0.0 110.014 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.7 tp -138.78 103.17 4.76 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 120.793 -1.192 . . . . 0.0 107.809 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.6 t -80.43 129.34 37.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 mt -129.93 129.12 65.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 172.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -139.26 129.7 25.65 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -170.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.8 m -74.08 164.54 26.49 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.174 0.511 . . . . 0.0 109.981 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.8 m -135.98 138.53 42.37 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 176.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -124.84 10.47 8.3 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -169.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.59 -48.82 0.46 Allowed Glycine 0 C--N 1.34 0.773 0 CA-C-N 119.124 0.874 . . . . 0.0 112.849 169.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.28 24.53 2.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.038 0.935 . . . . 0.0 112.053 -169.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.85 9.67 57.14 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 119.614 -0.548 . . . . 0.0 112.653 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -65.08 122.27 16.65 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.276 1.038 . . . . 0.0 109.089 172.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.8 mt -83.07 145.02 48.36 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.79 138.88 85.59 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.064 2.51 . . . . 0.0 110.897 173.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -59.46 -16.93 27.09 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.914 1.285 . . . . 0.0 113.185 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -67.48 -33.12 74.46 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.259 0.624 . . . . 0.0 111.802 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.7 tp -125.67 -21.16 4.51 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.353 0.661 . . . . 0.0 112.27 -172.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 t -47.4 -40.56 27.72 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 117.618 -1.182 . . . . 0.0 113.736 174.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -50.79 -27.18 19.53 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.162 2.574 . . . . 0.0 115.669 172.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -63.02 -38.38 90.94 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.596 1.089 . . . . 0.0 110.877 177.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -64.22 -37.31 87.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.694 0.679 . . . . 0.0 110.156 177.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -69.49 -50.3 46.62 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.1 -31.73 73.04 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.448 -0.783 . . . . 0.0 112.15 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.5 mt -65.51 -55.53 17.3 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.539 -0.743 . . . . 0.0 109.605 172.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -70.18 -27.67 64.7 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.509 1.05 . . . . 0.0 112.309 -172.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -71.27 -28.41 64.13 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.769 0.713 . . . . 0.0 111.433 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -114.45 -33.69 5.5 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -170.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp 29.97 57.73 0.82 Allowed Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 127.719 2.407 . . . . 0.0 113.415 -172.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -69.41 172.63 11.95 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.125 1.883 . . . . 0.0 110.333 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -70.26 111.74 6.08 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.967 0.507 . . . . 0.0 109.83 171.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 mt -120.45 25.32 9.87 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.978 1.711 . . . . 0.0 110.323 175.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.4 m -63.7 19.9 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -174.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.87 9.44 1.52 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.684 1.194 . . . . 0.0 111.505 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.9 t -80.38 102.19 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 170.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -79.73 147.75 31.78 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 167.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -146.23 172.62 13.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 119.325 0.966 . . . . 0.0 112.019 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -125.66 162.35 19.91 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 105.847 -2.901 . . . . 0.0 105.847 169.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.7 125.93 16.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -170.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.3 mt -136.07 135.43 50.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -114.72 147.15 18.85 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.7 mt -127.83 147.81 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 164.95 157.18 9.49 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.4 m -71.51 120.32 16.93 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 171.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 -60.67 -15.32 27.55 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -64.38 -25.99 68.27 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.495 -0.753 . . . . 0.0 112.21 172.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 -61.76 156.7 19.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.856 0.753 . . . . 0.0 111.761 -177.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -57.45 -41.1 79.86 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.958 0.903 . . . . 0.0 110.784 171.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.8 m -131.01 126.57 36.29 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -139.42 150.11 44.87 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -177.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 57.9 m 42.91 39.5 1.78 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.868 1.267 . . . . 0.0 113.131 177.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.03 -11.76 0.4 Allowed Glycine 0 C--N 1.338 0.64 0 CA-C-O 118.752 -1.027 . . . . 0.0 114.057 -169.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.72 -18.81 65.35 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.622 1.711 . . . . 0.0 112.013 174.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 tp -53.91 -31.36 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.438 1.895 . . . . 0.0 110.361 169.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -57.48 -38.45 74.56 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.062 0.545 . . . . 0.0 112.209 -170.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -68.07 -45.67 73.18 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 121.946 -0.471 . . . . 0.0 110.549 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.9 mt -60.81 -49.21 78.41 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.384 0.674 . . . . 0.0 109.182 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -69.74 -33.68 72.79 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.185 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.32 93.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -74.27 -30.5 62.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.949 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.0 mt -62.11 -51.72 66.77 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 119.482 1.037 . . . . 0.0 109.483 170.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -68.29 -32.85 73.29 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.73 -173.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -64.76 -37.33 87.26 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.504 0.322 . . . . 0.0 111.106 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.5 m -71.03 -4.67 26.18 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.316 1.046 . . . . 0.0 112.917 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.79 -16.61 9.5 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.177 1.37 . . . . 0.0 113.249 169.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.69 176.14 0.55 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.037 1.335 . . . . 0.0 111.632 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.62 137.22 15.98 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.723 -1.236 . . . . 0.0 112.649 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -60.66 137.71 58.15 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.566 1.546 . . . . 0.0 108.661 169.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.3 m -121.59 139.24 53.78 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.593 1.957 . . . . 0.0 106.211 171.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.1 175.26 24.79 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.945 0.783 . . . . 0.0 111.668 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -85.47 139.07 31.79 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.924 -0.75 . . . . 0.0 109.366 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.1 m -57.73 152.84 14.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.902 1.681 . . . . 0.0 110.24 174.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 62.9 tp -128.95 149.01 50.98 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.941 0.897 . . . . 0.0 109.939 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -113.16 139.34 48.83 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 17.1 mm -117.6 96.0 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 171.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -67.43 138.37 56.61 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 172.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.0 pt -129.45 13.14 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.673 1.189 . . . . 0.0 111.745 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.4 tp -58.29 -45.72 87.42 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.452 0.701 . . . . 0.0 110.755 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -164.63 -48.81 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.978 1.311 . . . . 0.0 109.327 177.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.61 69.84 3.06 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.755 1.222 . . . . 0.0 109.169 175.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -66.57 73.74 0.09 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.273 2.229 . . . . 0.0 110.367 171.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.253 34.4 pt 36.91 56.0 3.39 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 128.127 2.571 . . . . 0.0 114.918 -177.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -70.05 -11.57 30.7 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.998 2.465 . . . . 0.0 112.346 175.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -144.17 157.86 44.06 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.026 2.13 . . . . 0.0 106.135 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.2 t70 41.46 61.81 7.53 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.871 1.669 . . . . 0.0 113.532 -169.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -54.82 158.3 11.2 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.206 2.604 . . . . 0.0 113.389 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.52 -36.58 69.36 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.629 0.372 . . . . 0.0 110.369 171.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -59.03 -24.29 62.71 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.367 1.467 . . . . 0.0 112.577 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -89.81 -43.49 10.61 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.899 0.772 . . . . 0.0 109.596 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -59.93 -28.92 68.01 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.44 0.696 . . . . 0.0 111.498 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 59.8 tp -51.92 -35.2 44.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.394 1.477 . . . . 0.0 111.872 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.85 -44.61 87.26 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 m -66.76 -30.99 71.34 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.548 0.739 . . . . 0.0 111.145 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -72.32 -55.35 7.27 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.251 0.478 . . . . 0.0 109.798 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.9 m -63.62 -29.53 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 118.498 0.59 . . . . 0.0 111.553 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -54.38 -28.53 43.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.896 0.879 . . . . 0.0 112.458 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 27.4 mt -101.7 -3.49 28.13 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.067 -0.968 . . . . 0.0 113.511 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.6 pp -125.94 -14.63 6.07 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.274 1.397 . . . . 0.0 113.497 -178.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.5 pttt . . . . . 0 C--O 1.25 1.126 0 C-N-CA 123.826 0.85 . . . . 0.0 111.079 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.59 -161.03 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.86 1.664 . . . . 0.0 112.542 -174.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -140.97 -27.27 0.71 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.823 1.249 . . . . 0.0 111.669 177.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mt -132.96 83.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 171.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 79.6 m -73.99 119.28 17.99 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.55 148.13 35.38 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 172.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 82.7 mt -113.39 78.05 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.9 m -76.13 97.23 4.04 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.237 1.415 . . . . 0.0 109.332 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.03 52.21 0.67 Allowed Glycine 0 N--CA 1.461 0.337 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -172.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.3 m -127.76 164.53 21.95 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.296 0.639 . . . . 0.0 112.549 -167.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.2 p -146.9 -30.59 0.35 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.03 1.332 . . . . 0.0 112.916 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 70.7 mt -64.17 -20.02 65.71 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -171.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.62 -43.67 1.63 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 125.374 1.464 . . . . 0.0 110.429 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.29 -42.61 90.25 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 -176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.78 -31.78 72.95 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.154 -0.45 . . . . 0.0 110.06 175.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -72.61 -35.38 67.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.816 0.735 . . . . 0.0 111.015 177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -67.11 -39.42 86.68 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.994 0.815 . . . . 0.0 109.229 175.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.87 -47.01 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 118.681 -0.676 . . . . 0.0 109.549 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.96 86.29 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.467 1.031 . . . . 0.0 111.383 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.09 -43.57 91.68 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.14 0.576 . . . . 0.0 110.593 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -64.62 -44.59 90.05 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.541 0.61 . . . . 0.0 110.66 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.3 mt -58.55 -46.97 85.74 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.327 1.051 . . . . 0.0 109.93 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.03 -46.04 89.2 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.303 0.641 . . . . 0.0 110.176 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.02 -42.2 93.84 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.016 0.526 . . . . 0.0 110.082 -179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -63.74 -36.89 85.36 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 121.744 -0.598 . . . . 0.0 110.233 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.94 -38.71 76.26 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 118.66 0.664 . . . . 0.0 111.013 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.07 -43.35 99.02 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.727 0.694 . . . . 0.0 109.398 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.04 -38.99 92.65 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.078 0.551 . . . . 0.0 111.104 176.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.38 -21.43 64.7 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.624 0.77 . . . . 0.0 112.203 176.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.95 28.71 3.54 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.758 -1.023 . . . . 0.0 113.623 170.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -124.96 133.77 52.89 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.977 1.388 . . . . 0.0 108.924 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 p -75.79 140.6 42.43 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.282 0.563 . . . . 0.0 109.7 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.1 p -131.01 168.55 17.18 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.35 1.06 . . . . 0.0 110.6 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -154.45 128.0 8.6 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 169.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 p -82.59 65.09 7.55 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.007 1.323 . . . . 0.0 108.248 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.1 121.36 15.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -169.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.0 107.23 4.61 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -173.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 37.36 56.59 1.5 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 127.642 2.544 . . . . 0.0 115.789 173.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -62.47 148.66 92.97 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 120.222 2.011 . . . . 0.0 110.63 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mt -98.62 171.06 8.37 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 124.233 1.013 . . . . 0.0 110.551 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -52.92 -38.78 62.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.425 1.49 . . . . 0.0 111.282 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.74 -6.0 18.86 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.45 1.1 . . . . 0.0 112.68 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -135.27 20.38 3.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.986 1.714 . . . . 0.0 110.924 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.2 mt -134.11 108.73 11.54 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 125.133 1.373 . . . . 0.0 107.607 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.2 160.42 48.94 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.889 1.726 . . . . 0.0 110.631 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.6 7.13 2.58 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.742 1.217 . . . . 0.0 114.098 -172.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.2 m -147.52 142.13 26.59 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -176.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.16 -177.85 29.73 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.5 101.31 8.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -109.04 170.23 8.18 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.991 0.916 . . . . 0.0 109.914 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.8 tp -144.73 106.95 4.34 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.1 t -81.79 139.58 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 124.059 0.944 . . . . 0.0 108.864 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 mp -133.34 143.45 39.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.2 m -148.46 143.91 27.04 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.192 -0.943 . . . . 0.0 110.195 176.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -69.37 150.62 47.1 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.0 m -116.43 91.59 3.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -56.66 -32.19 65.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.53 0.732 . . . . 0.0 111.714 -176.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 150.82 -29.96 1.02 Allowed Glycine 0 C--N 1.34 0.763 0 C-N-CA 123.892 0.758 . . . . 0.0 112.628 169.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.96 25.29 7.36 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.421 1.088 . . . . 0.0 111.948 -170.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.12 5.94 86.99 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-O 119.363 -0.687 . . . . 0.0 112.921 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -72.96 146.94 45.67 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 169.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.3 mt -126.03 139.69 34.99 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -172.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -51.73 138.19 50.29 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.055 2.503 . . . . 0.0 113.304 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -57.71 -12.69 3.15 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.717 1.607 . . . . 0.0 113.198 174.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -54.96 -42.59 72.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.178 1.391 . . . . 0.0 109.732 172.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.3 tp -133.64 -21.45 1.97 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -171.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 91.5 p -52.48 -33.12 11.05 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -172.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -53.68 -23.09 24.83 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.803 2.335 . . . . 0.0 115.153 171.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -59.56 -36.59 76.5 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.571 1.078 . . . . 0.0 111.441 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -61.35 -43.0 99.61 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.186 0.448 . . . . 0.0 110.047 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -68.74 -47.09 67.18 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.167 0.587 . . . . 0.0 109.864 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.36 -36.74 83.65 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.865 -0.522 . . . . 0.0 112.03 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.3 mt -67.91 -51.31 49.34 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 118.515 -0.755 . . . . 0.0 109.537 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -68.76 -28.02 66.42 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.435 1.016 . . . . 0.0 111.886 -174.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.2 -39.23 86.32 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.749 0.704 . . . . 0.0 110.483 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -100.17 -22.8 15.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.891 -0.576 . . . . 0.0 112.43 -170.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt 40.03 56.97 7.2 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.997 1.719 . . . . 0.0 110.691 -169.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.88 143.02 78.19 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.354 2.036 . . . . 0.0 110.883 -169.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -81.85 64.22 6.45 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.655 1.182 . . . . 0.0 108.731 174.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.75 -56.01 10.88 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.6 m 50.55 19.97 0.64 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 169.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -157.38 -0.63 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 80.9 t -71.56 139.26 20.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -115.05 135.11 54.57 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 169.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -139.81 173.17 11.79 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.116 0.96 . . . . 0.0 112.298 -170.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -133.63 163.4 24.43 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 106.079 -2.808 . . . . 0.0 106.079 169.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.45 123.86 7.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.218 1.009 . . . . 0.0 108.413 -169.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 29.7 mt -139.53 139.93 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.47 138.91 11.81 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 169.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.68 128.59 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 162.96 -149.74 17.85 Favored Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 172.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.3 m -85.45 55.87 3.7 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 126.144 1.778 . . . . 0.0 110.956 -169.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -53.14 -37.01 61.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.836 0.855 . . . . 0.0 112.344 -173.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.0 -16.97 64.02 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.641 0.776 . . . . 0.0 112.87 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -63.18 -47.37 82.91 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.806 0.73 . . . . 0.0 111.483 -174.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -162.76 -43.07 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.4 m -128.0 132.55 49.14 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.062 0.945 . . . . 0.0 108.874 -169.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -106.98 -2.38 21.23 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -169.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 20.3 p -155.17 -25.65 0.11 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -47.65 -38.01 14.52 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.726 1.155 . . . . 0.0 114.303 -172.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.33 -8.7 19.44 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.6 tp -127.6 -34.0 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.292 1.037 . . . . 0.0 110.002 169.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -55.17 -36.91 66.36 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.41 0.684 . . . . 0.0 111.823 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.41 -54.57 45.52 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.569 0.622 . . . . 0.0 110.902 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 50.4 mt -66.26 -49.35 67.45 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -173.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.17 -35.98 74.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -171.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.84 82.78 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.86 -0.591 . . . . 0.0 110.107 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -69.13 -31.25 69.8 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.239 0.927 . . . . 0.0 112.437 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.7 mt -64.24 -42.37 96.56 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.645 1.566 . . . . 0.0 109.447 169.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -61.93 -41.4 97.91 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.504 0.722 . . . . 0.0 110.133 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -64.4 -36.44 84.15 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.056 1.342 . . . . 0.0 111.012 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.1 m -72.79 7.8 1.8 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.076 1.35 . . . . 0.0 112.849 172.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.27 -8.11 80.55 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.898 1.237 . . . . 0.0 113.353 171.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.13 167.75 4.75 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.421 1.111 . . . . 0.0 110.043 170.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -142.7 151.93 41.84 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.267 -0.896 . . . . 0.0 111.957 176.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -56.39 163.71 1.62 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.375 1.47 . . . . 0.0 110.147 169.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.72 37.69 2.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.381 1.086 . . . . 0.0 109.604 -177.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 155.52 -167.48 33.04 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.558 2.028 . . . . 0.0 108.046 -169.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.75 154.68 20.76 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 117.925 0.863 . . . . 0.0 109.007 169.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.7 m -67.61 158.21 32.64 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.0 tp -132.41 152.34 51.51 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.563 0.745 . . . . 0.0 109.141 172.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -137.4 146.46 44.46 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 169.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.8 mt -134.14 103.31 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -169.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -75.8 141.8 42.44 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -130.9 4.86 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.2 tp -74.66 -67.85 0.59 Allowed 'General case' 0 C--N 1.347 0.462 0 CA-C-N 119.923 1.238 . . . . 0.0 111.374 -169.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -72.56 -27.6 62.3 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.653 0.661 . . . . 0.0 112.673 -177.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -149.37 153.83 38.01 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 124.328 1.051 . . . . 0.0 110.224 -169.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -82.06 6.72 15.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.275 1.43 . . . . 0.0 112.932 -175.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.315 14.2 tt 39.27 62.06 5.2 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 127.509 2.324 . . . . 0.0 113.197 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.32 -10.27 25.33 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.237 2.625 . . . . 0.0 113.587 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.32 -21.16 65.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.871 0.869 . . . . 0.0 111.457 169.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.8 t0 41.11 62.93 6.31 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.315 2.246 . . . . 0.0 113.88 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -63.96 -17.26 59.13 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.014 2.476 . . . . 0.0 113.115 -174.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.79 -38.51 61.23 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.715 0.806 . . . . 0.0 111.463 176.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.5 -42.99 86.56 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.717 0.69 . . . . 0.0 110.647 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.19 -40.51 78.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.867 0.467 . . . . 0.0 110.127 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -67.05 -37.78 84.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.06 175.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.03 -42.92 93.89 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.629 1.104 . . . . 0.0 109.941 177.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.84 -43.9 87.21 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 171.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.0 m -63.82 -41.48 97.85 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.177 -0.602 . . . . 0.0 110.836 176.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -49.01 79.32 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.674 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.7 m -66.57 -31.75 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 120.431 1.468 . . . . 0.0 111.634 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -67.97 -18.91 64.88 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.628 0.649 . . . . 0.0 111.794 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.37 -47.2 4.77 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.809 1.244 . . . . 0.0 110.25 -176.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.6 pp -74.55 -23.51 58.8 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.077 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 C--O 1.246 0.88 0 C-N-CA 127.73 2.412 . . . . 0.0 112.15 177.932 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.52 159.66 42.77 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.892 1.277 . . . . 0.0 108.81 176.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -136.95 -25.1 1.1 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.045 1.338 . . . . 0.0 111.215 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.9 mt -128.83 82.1 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 169.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 m -76.6 117.94 18.75 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.76 149.74 39.64 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 171.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 68.9 mt -117.18 95.14 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 104.743 -2.318 . . . . 0.0 104.743 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.4 m -85.59 89.49 7.73 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.283 1.833 . . . . 0.0 110.847 -169.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.64 57.09 4.76 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.9 m -105.23 58.57 0.68 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -167.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 p -60.6 -36.5 78.71 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.065 0.546 . . . . 0.0 111.248 171.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.9 mt -65.84 -19.51 65.91 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.53 -41.31 1.39 Allowed Glycine 0 CA--C 1.532 1.106 0 CA-C-N 119.418 1.008 . . . . 0.0 112.328 -174.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.93 -36.3 93.24 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 118.502 1.151 . . . . 0.0 111.424 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.09 -29.66 68.73 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.241 0.52 . . . . 0.0 110.091 172.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -80.88 -30.32 35.57 Favored 'General case' 0 N--CA 1.462 0.162 0 O-C-N 121.962 -0.461 . . . . 0.0 111.601 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -66.79 -40.54 88.17 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.094 0.861 . . . . 0.0 108.931 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.07 -42.36 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 118.675 -0.679 . . . . 0.0 109.849 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.85 85.12 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.539 1.063 . . . . 0.0 111.149 176.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -65.04 -43.03 93.68 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.192 0.597 . . . . 0.0 110.654 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -61.2 -47.22 87.12 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.417 0.553 . . . . 0.0 110.875 176.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.5 mt -59.34 -47.67 84.55 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.541 0.737 . . . . 0.0 109.374 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.5 93.58 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.586 0.754 . . . . 0.0 110.808 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 -58.93 -41.49 87.44 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.404 0.547 . . . . 0.0 110.435 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.44 -30.76 66.43 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.011 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 70.5 mt -65.76 -40.0 91.63 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 119.91 1.232 . . . . 0.0 111.62 170.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -60.09 -43.92 95.18 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.868 0.758 . . . . 0.0 109.321 177.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.41 -38.06 88.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.206 0.602 . . . . 0.0 111.311 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.86 -21.43 64.27 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.739 0.816 . . . . 0.0 112.275 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.29 28.49 3.79 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.375 171.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -126.52 129.39 48.53 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.804 1.302 . . . . 0.0 107.96 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 p -75.37 148.11 39.49 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.8 p -134.02 170.17 16.04 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.757 0.789 . . . . 0.0 111.393 -171.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -152.6 161.96 41.87 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 169.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.49 78.5 1.81 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.7 mt -69.66 113.6 7.08 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.409 ' CD2' HD21 ' A' ' 65' ' ' ASN . 43.0 t60 -73.35 106.23 5.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 52.51 55.68 21.39 Favored Glycine 0 CA--C 1.541 1.685 0 CA-C-O 118.58 -1.122 . . . . 0.0 115.575 172.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -69.26 175.33 7.83 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.161 2.574 . . . . 0.0 111.722 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.6 mt -131.69 171.28 13.67 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 126.06 1.744 . . . . 0.0 110.152 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.87 -38.26 55.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.051 1.74 . . . . 0.0 111.857 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.62 -8.56 14.77 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -133.99 18.41 3.79 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.144 1.778 . . . . 0.0 110.87 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.9 mt -134.27 98.29 14.14 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 125.223 1.409 . . . . 0.0 107.704 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.14 163.5 35.8 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.157 1.905 . . . . 0.0 110.857 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.79 3.03 4.53 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -170.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.4 m -147.68 136.96 22.39 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.654 1.182 . . . . 0.0 107.894 -171.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.1 177.26 25.62 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.5 mt -113.71 102.43 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -101.21 168.68 9.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.341 0.656 . . . . 0.0 109.43 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.0 tp -144.59 100.42 3.52 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.4 t -79.49 140.78 16.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 123.553 0.741 . . . . 0.0 109.015 -174.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.3 mp -132.31 135.97 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 171.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.3 m -126.0 137.95 53.7 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.284 0.633 . . . . 0.0 111.369 173.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.4 m -69.87 160.25 32.16 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 168.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.59 89.14 2.19 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -78.63 42.28 0.44 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.767 1.227 . . . . 0.0 112.053 -171.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.57 -39.56 1.95 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.103 1.335 . . . . 0.0 113.422 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.62 -21.35 59.51 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.124 0.969 . . . . 0.0 112.971 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.35 9.13 80.04 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.767 -1.018 . . . . 0.0 113.539 -176.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -75.92 152.54 37.08 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.83 1.315 . . . . 0.0 110.756 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.1 mt -65.98 142.89 98.23 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.325 1.45 . . . . 0.0 108.567 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -57.95 125.99 20.31 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.937 3.091 . . . . 0.0 111.714 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -56.75 -27.09 58.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.656 1.182 . . . . 0.0 114.134 -173.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.409 HD21 ' CD2' ' A' ' 37' ' ' HIS . 10.2 p-10 -73.23 -19.18 61.14 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.817 -0.552 . . . . 0.0 112.43 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.4 tp -127.29 -23.03 3.6 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.125 1.37 . . . . 0.0 111.175 -171.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.2 p -53.94 -31.66 9.04 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-O 116.832 -1.556 . . . . 0.0 114.832 -176.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -52.54 -23.57 19.78 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.481 2.121 . . . . 0.0 114.929 169.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.46 -35.92 78.95 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.952 1.251 . . . . 0.0 111.675 175.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -59.32 -43.07 92.73 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.331 0.514 . . . . 0.0 109.777 176.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.9 -48.47 58.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.929 0.492 . . . . 0.0 109.8 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.38 -31.56 72.73 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.891 0.769 . . . . 0.0 112.54 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.1 mt -68.6 -54.65 15.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.952 0.796 . . . . 0.0 109.404 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -68.89 -29.52 67.82 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.336 0.971 . . . . 0.0 112.264 -171.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -73.24 -24.16 60.44 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.786 0.721 . . . . 0.0 111.32 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -112.86 -23.64 10.0 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.865 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt 39.31 64.67 3.84 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.936 1.694 . . . . 0.0 109.807 -169.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.88 -4.68 13.87 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.295 2.663 . . . . 0.0 115.534 -169.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.7 t70 50.57 51.99 15.76 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.172 1.389 . . . . 0.0 111.592 171.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.3 mt -58.92 -46.48 87.85 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.443 1.497 . . . . 0.0 110.494 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.8 m 54.86 15.44 1.13 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 172.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -153.92 2.03 0.24 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.704 1.138 . . . . 0.0 113.857 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 79.7 t -72.56 138.12 22.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 169.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -119.96 140.32 51.11 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 104.262 -2.496 . . . . 0.0 104.262 168.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -149.69 169.91 19.92 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.364 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.42 166.65 20.9 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 105.662 -2.975 . . . . 0.0 105.662 169.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.64 135.84 23.87 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.373 1.087 . . . . 0.0 109.723 -169.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.2 mt -135.9 137.36 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -175.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.18 135.18 11.18 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 170.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.9 mt -139.57 131.13 33.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 164.96 -159.85 33.02 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 120.425 1.466 . . . . 0.0 110.369 171.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.6 m -76.33 47.45 0.47 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 127.727 2.411 . . . . 0.0 111.106 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 57.1 mtt-85 -66.57 -15.9 63.76 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.149 -0.969 . . . . 0.0 112.879 -170.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.63 -28.38 69.86 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.21 0.604 . . . . 0.0 112.051 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -66.42 -57.32 7.65 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 123.292 0.637 . . . . 0.0 110.466 -171.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -169.01 -66.33 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.263 1.425 . . . . 0.0 108.636 172.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.9 p 49.21 -177.99 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 127.413 2.285 . . . . 0.0 114.308 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -151.82 5.45 0.43 Allowed 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.116 -0.99 . . . . 0.0 112.742 -171.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 63.7 m 56.55 -11.51 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 127.402 2.281 . . . . 0.0 116.353 -170.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -45.35 -35.02 4.97 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 126.154 1.835 . . . . 0.0 112.88 173.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.34 -25.8 6.56 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.123 1.769 . . . . 0.0 114.641 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.09 -33.16 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -61.06 -37.77 83.83 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.957 0.903 . . . . 0.0 111.971 -172.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -68.38 -42.77 78.61 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.725 -0.609 . . . . 0.0 111.081 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.77 -50.05 73.91 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.55 -32.93 73.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 119.438 -0.315 . . . . 0.0 111.023 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.77 99.59 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -74.57 -29.2 61.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.279 -0.867 . . . . 0.0 112.259 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.1 mt -62.82 -47.91 81.38 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.191 1.359 . . . . 0.0 109.234 170.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -66.07 -36.62 83.7 Favored 'General case' 0 N--CA 1.46 0.054 0 C-N-CA 122.415 0.286 . . . . 0.0 110.829 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -63.38 -38.36 90.85 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.134 0.574 . . . . 0.0 110.7 173.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.2 m -74.46 11.77 0.92 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.661 1.184 . . . . 0.0 112.499 171.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.35 -5.52 84.64 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 120.78 -1.2 . . . . 0.0 113.857 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.9 169.39 2.6 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.0 1.4 . . . . 0.0 110.092 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -141.74 139.74 32.93 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.602 -0.686 . . . . 0.0 110.966 169.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -64.94 170.61 4.15 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.049 1.339 . . . . 0.0 109.461 175.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.1 m -140.15 152.72 46.29 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.39 -132.99 42.03 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -144.07 154.85 43.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.77 129.78 42.02 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.119 0.968 . . . . 0.0 109.958 -177.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.2 tp -91.36 142.39 27.74 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -129.71 139.46 51.33 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.2 mt -138.99 100.4 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -73.43 133.43 43.73 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 169.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -128.91 8.12 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.844 0.747 . . . . 0.0 112.538 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.5 tp -55.71 -32.37 63.27 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.941 0.792 . . . . 0.0 111.654 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -137.07 47.68 2.11 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.032 1.333 . . . . 0.0 109.252 172.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 44.39 40.27 3.68 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.72 2.008 . . . . 0.0 113.059 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -80.36 49.82 1.19 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.212 2.205 . . . . 0.0 112.128 -171.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.4 pt -54.28 149.33 19.96 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.437 1.095 . . . . 0.0 110.938 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.06 162.87 30.9 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.783 2.322 . . . . 0.0 112.498 -175.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -73.74 -1.14 17.95 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.423 1.489 . . . . 0.0 112.879 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -125.88 111.18 24.76 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 173.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -53.56 152.68 20.53 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.553 2.836 . . . . 0.0 114.517 -169.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.3 -37.49 62.27 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.417 0.687 . . . . 0.0 110.775 170.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.29 -34.19 77.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.217 0.607 . . . . 0.0 111.563 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -79.42 -36.6 38.78 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.419 0.554 . . . . 0.0 109.756 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -66.83 -40.0 87.83 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.771 -0.581 . . . . 0.0 110.046 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.1 tp -64.77 -42.33 95.19 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.51 1.124 . . . . 0.0 110.575 174.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.52 -43.98 85.59 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.43 1.014 . . . . 0.0 110.985 172.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.8 m -63.98 -41.11 97.64 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.292 0.637 . . . . 0.0 110.568 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -52.01 66.68 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.406 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.1 m -61.79 -35.07 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 119.793 1.179 . . . . 0.0 110.796 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -61.92 -24.35 66.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.55 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.2 mt -91.64 -47.77 7.2 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.739 1.154 . . . . 0.0 111.04 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.7 pp -80.24 -10.94 59.77 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -172.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.4 pttm . . . . . 0 C--O 1.249 1.053 0 C-N-CA 125.463 1.505 . . . . 0.0 112.778 -177.565 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.58 157.31 43.51 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.741 1.217 . . . . 0.0 108.614 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -136.37 -26.64 1.11 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.276 1.43 . . . . 0.0 111.038 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.0 mt -122.91 77.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 169.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -74.74 116.33 15.33 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.2 mt -87.84 155.93 19.64 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.3 mt -125.62 95.12 3.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -170.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 m -90.07 153.03 20.87 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.086 1.754 . . . . 0.0 111.022 -175.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.18 128.95 1.15 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 107.558 -2.217 . . . . 0.0 107.558 173.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.75 155.36 41.62 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.565 0.698 . . . . 0.0 112.305 -172.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 p -129.7 -34.57 1.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.853 2.061 . . . . 0.0 108.656 169.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt -67.1 -20.76 65.85 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.083 0.553 . . . . 0.0 110.57 169.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.18 35.4 18.05 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.05 -24.15 0.99 Allowed Glycine 0 CA--C 1.524 0.648 0 CA-C-O 118.611 -1.105 . . . . 0.0 112.948 -173.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.23 -32.42 73.83 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.037 1.919 . . . . 0.0 110.746 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.67 -39.34 93.5 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.494 0.318 . . . . 0.0 110.848 176.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -70.55 -48.03 57.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -61.35 -43.1 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.52 -48.15 83.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 118.73 0.696 . . . . 0.0 110.101 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.51 -43.33 94.43 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.663 0.665 . . . . 0.0 110.986 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -63.53 -38.44 91.16 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.813 0.845 . . . . 0.0 111.252 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.6 mt -74.53 -41.25 60.94 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.266 0.626 . . . . 0.0 110.275 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.89 -40.32 80.0 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 123.438 0.695 . . . . 0.0 110.84 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -52.51 -46.35 66.64 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.608 0.763 . . . . 0.0 110.638 175.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -68.0 -39.21 83.26 Favored 'General case' 0 N--CA 1.46 0.064 0 O-C-N 121.84 -0.538 . . . . 0.0 110.259 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.8 mt -66.34 -39.84 89.46 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 119.506 -0.283 . . . . 0.0 110.705 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.81 -40.44 91.88 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.409 0.549 . . . . 0.0 110.18 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -64.78 -36.19 83.51 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.33 0.514 . . . . 0.0 111.018 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.94 -23.98 64.22 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.46 0.704 . . . . 0.0 111.994 174.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.86 -0.62 13.53 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.902 1.239 . . . . 0.0 113.741 170.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -75.67 174.75 9.36 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.737 1.268 . . . . 0.0 110.305 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.9 p -119.16 144.01 46.91 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 170.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -135.64 167.69 20.66 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.063 0.945 . . . . 0.0 109.934 -169.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -153.07 160.23 42.92 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 169.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 p -124.88 72.19 1.21 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.0 mt -69.05 114.38 7.28 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -173.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -81.89 110.0 16.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.85 46.62 93.22 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-O 117.943 -1.476 . . . . 0.0 115.926 172.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -69.09 173.36 10.48 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 121.031 2.415 . . . . 0.0 110.267 169.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 mp -131.34 175.68 8.93 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.285 1.434 . . . . 0.0 108.036 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.3 tp -55.77 -32.02 63.08 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.284 1.034 . . . . 0.0 111.052 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.83 -7.5 11.43 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.068 0.947 . . . . 0.0 112.717 178.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -134.19 18.08 3.74 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.42 1.488 . . . . 0.0 111.336 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.7 mt -137.27 113.57 9.58 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.702 1.201 . . . . 0.0 108.422 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.78 164.14 36.63 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.366 2.044 . . . . 0.0 111.428 -178.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.6 20.46 1.12 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.163 1.385 . . . . 0.0 112.951 -171.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.8 m -153.94 139.1 17.43 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 120.999 -1.063 . . . . 0.0 108.41 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.42 -178.14 27.14 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.18 101.05 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -102.82 175.28 5.54 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.29 1.036 . . . . 0.0 110.462 -173.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.6 tp -145.66 108.3 4.48 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.4 t -86.56 131.65 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.6 mt -130.67 131.63 64.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.9 m -149.47 142.02 24.4 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.643 0.777 . . . . 0.0 109.192 -169.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.8 m -73.68 160.6 31.33 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 m -115.54 5.77 14.5 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.757 0.789 . . . . 0.0 112.678 -175.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 41.53 22.9 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 129.279 3.031 . . . . 0.0 114.181 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.89 19.31 29.12 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.462 -1.188 . . . . 0.0 114.562 -170.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.35 -13.32 0.13 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.491 1.646 . . . . 0.0 115.115 -169.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.43 -1.83 53.64 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 119.454 1.025 . . . . 0.0 113.081 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.96 155.87 38.18 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 169.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.9 mt -122.91 144.38 42.86 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.028 1.331 . . . . 0.0 107.863 -169.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.99 124.74 4.93 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.606 3.538 . . . . 0.0 113.62 172.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.5 -24.22 65.13 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.94 0.896 . . . . 0.0 113.066 -174.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -73.9 -22.46 59.69 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.0 tp -122.69 -29.9 3.95 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.152 0.981 . . . . 0.0 111.372 -170.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 t -45.75 -41.76 20.39 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.537 1.535 . . . . 0.0 113.684 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -51.16 -23.01 12.05 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.301 2.667 . . . . 0.0 116.122 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -56.76 -38.21 72.12 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.68 1.127 . . . . 0.0 111.027 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -58.23 -43.81 87.92 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.101 0.96 . . . . 0.0 110.458 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -72.48 -45.71 58.22 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.05 0.54 . . . . 0.0 109.841 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.62 -33.95 77.09 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 118.874 -0.584 . . . . 0.0 112.058 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.3 mt -63.85 -57.87 8.52 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -68.85 -27.24 65.64 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.829 0.741 . . . . 0.0 112.197 -172.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.06 -37.34 87.22 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.576 0.625 . . . . 0.0 110.615 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -105.65 -30.81 9.24 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -170.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.7 tttm 29.27 60.86 0.79 Allowed Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 128.019 2.528 . . . . 0.0 113.692 -174.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.09 170.08 15.21 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.711 1.608 . . . . 0.0 110.089 172.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -74.23 110.99 8.96 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.428 ' C ' ' H ' ' A' ' 82' ' ' ALA . 72.2 mt -114.58 20.24 15.48 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.418 1.487 . . . . 0.0 110.948 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.8 m -62.15 19.35 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.994 1.718 . . . . 0.0 115.558 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' A' ' 80' ' ' LEU . . . -136.12 -0.8 2.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.338 1.455 . . . . 0.0 111.861 174.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 68.0 t -81.41 142.92 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 169.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -122.63 146.72 47.2 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 168.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -143.9 172.37 12.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.588 0.709 . . . . 0.0 110.803 -173.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.68 166.95 23.36 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 107.983 -2.047 . . . . 0.0 107.983 169.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.9 134.8 17.81 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -169.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.9 mt -138.68 128.82 33.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -177.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -104.32 104.59 2.45 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 107.983 -2.047 . . . . 0.0 107.983 173.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.3 mt -84.33 128.56 38.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.798 -1.926 . . . . 0.0 105.798 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.55 -146.48 6.06 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 -172.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.2 m -161.7 149.08 14.54 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.653 1.181 . . . . 0.0 110.36 171.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -64.7 -17.18 63.86 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.81 -36.55 84.7 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.207 0.603 . . . . 0.0 109.91 175.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -74.01 158.26 34.66 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.429 0.633 . . . . 0.0 110.708 176.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.49 -19.07 62.25 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.668 0.787 . . . . 0.0 112.523 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.4 m -110.79 139.63 45.93 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.445 1.098 . . . . 0.0 108.997 -172.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -117.41 -45.21 2.73 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.884 0.874 . . . . 0.0 111.126 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.2 m -136.35 -0.48 2.44 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.942 0.897 . . . . 0.0 113.172 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.77 -16.31 30.43 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 120.176 1.353 . . . . 0.0 115.087 -171.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.22 -59.49 2.62 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.477 1.139 . . . . 0.0 110.654 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.2 tp -60.92 -31.07 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.735 0.814 . . . . 0.0 109.693 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -51.43 -38.17 52.27 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.131 0.972 . . . . 0.0 112.165 177.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -71.84 -47.87 50.03 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.972 0.806 . . . . 0.0 109.961 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.3 mt -59.58 -48.34 82.05 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.299 0.64 . . . . 0.0 109.781 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -68.98 -37.66 78.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.1 85.92 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 118.564 -0.731 . . . . 0.0 110.508 -171.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -72.02 -28.26 63.26 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.309 0.958 . . . . 0.0 112.699 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.51 -43.88 84.04 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.571 1.532 . . . . 0.0 108.498 169.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -61.11 -44.3 97.56 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.2 1.0 . . . . 0.0 109.977 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -66.14 -35.25 80.0 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.988 1.715 . . . . 0.0 111.281 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 44.4 m -73.65 -8.13 54.77 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.786 0.834 . . . . 0.0 112.675 173.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.42 -18.13 8.85 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.797 1.189 . . . . 0.0 113.935 169.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.66 171.97 2.38 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.294 1.047 . . . . 0.0 111.286 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -144.32 155.44 43.81 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.972 -1.08 . . . . 0.0 112.287 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -56.44 168.12 0.6 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.948 1.699 . . . . 0.0 110.581 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 m -134.02 37.92 3.2 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.211 1.004 . . . . 0.0 110.266 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 139.6 -168.95 24.79 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 126.945 2.212 . . . . 0.0 110.245 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -89.84 143.32 26.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 117.928 0.864 . . . . 0.0 110.858 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.1 m -58.32 137.91 56.82 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.914 1.686 . . . . 0.0 111.447 -176.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 35.9 tp -91.44 148.92 21.96 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.795 0.438 . . . . 0.0 109.892 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -116.42 138.22 51.54 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 169.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.9 mt -124.4 99.29 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.18 92.25 6.27 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.051 1.74 . . . . 0.0 108.59 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 26.5 pt -66.67 -35.28 74.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -174.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.5 tp -63.1 -16.08 58.77 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.525 1.53 . . . . 0.0 112.518 -175.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -58.53 -37.68 76.15 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.653 0.66 . . . . 0.0 111.692 176.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -168.82 -52.07 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.228 1.411 . . . . 0.0 108.684 171.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -160.61 -34.72 0.05 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.271 1.828 . . . . 0.0 109.639 174.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.3 pt -142.38 161.01 52.34 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 129.026 2.931 . . . . 0.0 105.466 169.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.03 164.63 29.24 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 121.979 1.786 . . . . 0.0 111.042 176.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -64.18 -35.64 81.45 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.536 0.735 . . . . 0.0 111.126 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.26 117.13 40.29 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 123.989 0.916 . . . . 0.0 109.888 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.05 137.07 25.86 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.293 1.995 . . . . 0.0 110.463 -174.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.13 -22.6 65.98 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.895 0.478 . . . . 0.0 112.035 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -63.52 -30.2 71.35 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.693 0.797 . . . . 0.0 111.341 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -68.21 -43.98 76.8 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.214 0.915 . . . . 0.0 109.328 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -64.26 -39.17 93.39 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.81 0.844 . . . . 0.0 110.596 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.69 -30.91 71.05 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.65 -0.656 . . . . 0.0 110.954 176.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.04 -44.29 56.45 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.442 1.02 . . . . 0.0 111.49 171.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.6 m -64.16 -39.13 93.37 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.657 0.729 . . . . 0.0 110.588 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -62.47 -50.7 70.42 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 118.671 0.669 . . . . 0.0 110.869 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.5 m -66.74 -30.76 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.551 1.069 . . . . 0.0 111.027 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -67.76 -33.03 74.05 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.885 0.766 . . . . 0.0 111.333 175.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.43 -49.66 11.14 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.623 0.769 . . . . 0.0 110.154 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 pp -79.35 -21.46 45.79 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.471 -0.776 . . . . 0.0 112.716 -172.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp . . . . . 0 C--O 1.251 1.181 0 C-N-CA 127.382 2.273 . . . . 0.0 111.822 -179.366 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.83 -177.69 6.28 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.364 1.466 . . . . 0.0 108.962 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -128.13 -26.11 2.9 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.17 0.988 . . . . 0.0 111.476 -173.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.3 mt -130.74 85.98 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.1 m -82.01 115.16 21.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mp -74.28 155.35 38.33 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.5 mt -130.89 104.1 8.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.44 1.496 . . . . 0.0 107.076 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.25 133.14 35.23 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.708 0.803 . . . . 0.0 110.982 -177.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -125.34 86.76 0.36 Allowed Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 107.413 -2.275 . . . . 0.0 107.413 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.16 164.84 31.85 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.435 1.112 . . . . 0.0 111.974 173.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.3 p -135.92 -43.7 0.65 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 127.746 2.418 . . . . 0.0 106.742 169.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.79 -34.96 79.59 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.714 1.206 . . . . 0.0 111.468 173.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.72 -9.47 14.48 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.508 1.528 . . . . 0.0 113.194 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.52 -51.27 59.79 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 119.213 1.506 . . . . 0.0 112.203 -169.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.89 -22.76 63.2 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.566 -0.731 . . . . 0.0 111.231 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.25 -39.88 62.75 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.054 0.843 . . . . 0.0 110.135 176.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -68.47 -43.13 77.64 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.683 -0.636 . . . . 0.0 109.436 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.2 t -64.12 -39.71 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.049 175.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.91 -43.55 98.39 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 119.636 1.107 . . . . 0.0 110.88 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -61.02 -44.27 97.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.431 0.56 . . . . 0.0 110.411 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -60.84 -51.62 68.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.919 0.488 . . . . 0.0 110.541 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.7 mt -61.25 -43.63 98.56 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.463 0.705 . . . . 0.0 110.349 -177.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.21 -43.31 99.09 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.167 0.587 . . . . 0.0 110.294 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.0 -45.41 93.74 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.538 0.608 . . . . 0.0 110.293 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -60.98 -43.04 99.4 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.914 -0.491 . . . . 0.0 110.578 178.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 41.6 mt -64.24 -40.94 97.04 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.781 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.8 -38.22 88.37 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.944 0.793 . . . . 0.0 110.308 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -66.77 -36.74 83.13 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.294 0.497 . . . . 0.0 110.845 175.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.75 -25.46 64.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.283 0.633 . . . . 0.0 111.788 173.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.99 -0.17 14.82 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.331 1.444 . . . . 0.0 113.941 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -81.16 143.41 32.39 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.109 1.455 . . . . 0.0 109.69 -177.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 p -79.47 138.14 37.47 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.1 p -128.38 162.51 26.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.046 0.938 . . . . 0.0 109.979 -173.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -145.75 166.64 25.29 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 170.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.3 m -145.72 101.87 3.61 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 -177.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.85 106.92 18.81 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -175.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -74.93 105.71 6.09 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.53 56.13 26.74 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 118.368 -1.24 . . . . 0.0 115.355 172.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.7 172.8 7.61 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.93 2.42 . . . . 0.0 111.623 172.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.2 mt -128.14 170.23 13.2 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.977 2.111 . . . . 0.0 107.565 169.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 tt -54.49 -34.67 62.03 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.888 0.875 . . . . 0.0 111.737 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.06 -5.24 12.3 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.915 1.286 . . . . 0.0 112.591 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -135.23 17.59 3.42 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.944 1.298 . . . . 0.0 110.577 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -134.35 98.59 13.8 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 125.072 1.349 . . . . 0.0 108.628 -169.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -70.23 154.12 66.15 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.559 2.173 . . . . 0.0 111.961 -176.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.02 7.98 6.42 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.059 1.344 . . . . 0.0 114.452 -170.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.5 m -149.48 125.63 10.71 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.125 0.97 . . . . 0.0 108.444 -170.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.24 -175.74 28.32 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.0 mt -116.41 102.03 13.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -96.88 169.86 9.56 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.51 0.724 . . . . 0.0 109.428 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.6 tp -143.16 101.72 3.86 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.1 t -84.34 138.43 19.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 124.125 0.97 . . . . 0.0 108.793 -174.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mp -135.02 130.55 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.24 136.46 50.13 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.042 0.937 . . . . 0.0 110.366 -168.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 m -106.98 47.97 0.86 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.737 0.815 . . . . 0.0 111.175 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.1 m -33.02 105.83 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.178 2.191 . . . . 0.0 110.808 169.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.96 149.86 46.39 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 169.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -42.02 -35.27 1.61 Allowed Glycine 0 CA--C 1.531 1.031 0 C-N-CA 126.096 1.807 . . . . 0.0 116.437 -169.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.92 -10.64 59.25 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.46 46.45 4.34 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 -169.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -123.37 106.78 10.96 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -178.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.4 mt -65.02 141.0 98.26 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.86 141.19 89.02 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.869 2.379 . . . . 0.0 111.851 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -62.44 -14.97 46.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.911 1.684 . . . . 0.0 113.582 -173.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.72 -25.02 63.65 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.461 -0.774 . . . . 0.0 111.824 177.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 63.5 tp -128.68 -31.77 2.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.973 0.806 . . . . 0.0 112.348 -169.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.7 p -52.27 -34.25 15.22 Favored Pre-proline 0 CA--C 1.553 1.08 0 CA-C-O 116.744 -1.598 . . . . 0.0 114.298 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.15 -37.68 59.02 Favored 'Trans proline' 0 C--N 1.359 1.113 0 C-N-CA 123.296 2.664 . . . . 0.0 114.989 174.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -61.13 -44.39 97.41 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.396 0.544 . . . . 0.0 109.764 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -75.84 -30.47 58.95 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.975 0.51 . . . . 0.0 110.686 -173.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -62.56 -43.15 99.53 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.461 -0.774 . . . . 0.0 109.118 169.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.47 -20.65 66.1 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 118.4 -0.809 . . . . 0.0 112.737 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.16 -55.95 10.51 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.774 1.17 . . . . 0.0 109.051 172.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -64.78 -28.17 69.39 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.015 0.825 . . . . 0.0 111.734 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -67.09 -28.63 68.34 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.475 0.71 . . . . 0.0 111.631 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -123.22 -17.62 6.56 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 -169.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.8 tttp 41.02 58.61 8.54 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.322 1.449 . . . . 0.0 109.633 -168.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -67.19 158.47 56.79 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.803 2.335 . . . . 0.0 111.027 -170.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -81.99 84.46 6.96 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.853 0.861 . . . . 0.0 109.761 177.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 mt -108.95 26.82 10.16 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.642 1.577 . . . . 0.0 109.728 175.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.7 m -60.76 17.1 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 128.548 2.739 . . . . 0.0 116.012 -174.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.52 5.42 1.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.197 1.399 . . . . 0.0 111.909 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.9 t -77.66 137.62 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 169.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -124.02 146.94 48.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 168.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -150.03 166.91 28.27 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.421 -175.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -112.76 157.89 14.64 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 104.674 -3.37 . . . . 0.0 104.674 169.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.77 132.05 20.65 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.944 1.372 . . . . 0.0 110.187 -169.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 56.7 mt -138.39 138.75 42.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.93 150.31 17.63 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 107.864 -2.095 . . . . 0.0 107.864 169.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.7 mt -139.61 136.04 39.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.9 -164.02 30.53 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 176.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.0 m -110.33 104.21 12.97 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.218 1.407 . . . . 0.0 108.494 -175.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -59.68 -12.41 6.88 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.075 1.35 . . . . 0.0 113.056 -174.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -56.73 -32.53 65.63 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.486 1.039 . . . . 0.0 110.94 169.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -83.68 151.7 25.13 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.015 0.926 . . . . 0.0 110.026 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.75 -27.75 65.21 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -175.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.9 m -120.17 28.61 7.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.368 1.067 . . . . 0.0 110.795 -169.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -50.45 -33.82 22.51 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 -169.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 75.7 m -132.29 8.99 4.36 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.474 1.109 . . . . 0.0 110.888 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.09 -38.38 89.29 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 119.302 0.956 . . . . 0.0 112.452 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.16 -8.77 41.48 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.36 -27.45 41.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 119.714 1.143 . . . . 0.0 109.443 170.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.17 -39.16 89.54 Favored 'General case' 0 C--N 1.338 0.106 0 O-C-N 121.591 -0.693 . . . . 0.0 110.479 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -58.94 -49.02 79.42 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.96 -54.54 45.96 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.451 0.3 . . . . 0.0 110.501 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -64.19 -38.21 90.22 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.122 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.47 -36.37 78.88 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 119.396 -0.335 . . . . 0.0 111.192 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -74.5 -33.05 62.73 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.794 0.724 . . . . 0.0 110.909 -175.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.3 mt -69.24 -38.85 78.68 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.686 1.13 . . . . 0.0 109.7 169.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -62.05 -40.66 96.53 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.839 0.745 . . . . 0.0 110.124 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -65.2 -31.27 72.36 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.759 0.824 . . . . 0.0 111.415 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.6 m -77.47 4.71 10.41 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.234 1.013 . . . . 0.0 112.355 172.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.24 -11.55 63.63 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.735 1.159 . . . . 0.0 113.41 172.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.35 -178.21 0.48 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.556 1.178 . . . . 0.0 110.793 173.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.18 138.08 17.15 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.148 -0.97 . . . . 0.0 110.966 169.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.56 168.0 1.29 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.337 1.455 . . . . 0.0 108.512 169.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.6 m -135.16 151.61 50.83 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.3 -120.11 21.31 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -140.68 164.23 30.75 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.769 1.627 . . . . 0.0 106.966 170.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.0 m -83.48 139.18 33.08 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.552 -0.717 . . . . 0.0 109.532 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.4 tp -97.9 149.32 22.52 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.824 1.249 . . . . 0.0 109.893 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -119.36 146.33 45.41 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 169.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.7 mt -133.16 100.06 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -68.21 139.13 56.04 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 169.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.3 pp -129.62 15.54 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.22 1.008 . . . . 0.0 112.26 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.0 tp -128.09 131.87 49.03 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.075 0.852 . . . . 0.0 108.984 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.0 t70 68.01 -30.92 0.18 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.573 2.749 . . . . 0.0 114.146 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -142.76 173.7 11.31 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.446 2.298 . . . . 0.0 107.782 175.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -129.45 -140.51 0.23 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.557 1.943 . . . . 0.0 105.94 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.1 pt -132.9 40.05 0.55 Allowed Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.369 1.467 . . . . 0.0 112.214 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.44 -25.41 55.94 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 121.857 1.705 . . . . 0.0 112.979 -171.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.17 -10.82 59.57 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.054 0.942 . . . . 0.0 112.455 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -153.23 63.75 4.79 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 125.226 1.41 . . . . 0.0 108.466 -174.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -67.17 157.88 59.6 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.065 2.51 . . . . 0.0 112.459 -169.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.88 -33.52 64.67 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.559 0.744 . . . . 0.0 111.473 177.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.35 -40.25 74.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.056 0.942 . . . . 0.0 111.232 178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -73.87 -42.33 60.93 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.726 -0.609 . . . . 0.0 109.895 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -68.55 -36.47 78.85 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.555 0.342 . . . . 0.0 110.621 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.6 tp -61.19 -39.53 90.53 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.81 0.844 . . . . 0.0 110.203 171.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.36 -48.32 48.38 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.575 1.083 . . . . 0.0 111.33 170.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.2 m -61.97 -41.47 98.05 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 117.645 0.723 . . . . 0.0 110.865 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -62.86 -50.82 69.4 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.481 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.8 m -63.96 -34.23 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 120.115 1.325 . . . . 0.0 110.733 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.0 -21.37 66.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.901 0.88 . . . . 0.0 113.05 176.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.32 -49.77 4.57 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.405 1.002 . . . . 0.0 111.12 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.76 -27.23 64.76 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.376 -173.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt . . . . . 0 C--O 1.252 1.197 0 C-N-CA 128.187 2.595 . . . . 0.0 113.102 175.277 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.05 154.38 42.44 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.939 1.295 . . . . 0.0 108.318 173.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -135.87 -25.06 1.27 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.982 1.313 . . . . 0.0 111.036 -179.202 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.7 mt -125.35 80.87 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 169.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.0 m -76.56 114.14 14.96 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.37 155.21 28.52 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.353 1.061 . . . . 0.0 109.233 174.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.1 mt -127.4 93.2 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -174.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -67.02 162.58 21.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.818 1.247 . . . . 0.0 110.158 172.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.78 58.36 0.08 OUTLIER Glycine 0 C--N 1.337 0.615 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -169.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.8 p -135.1 153.03 52.16 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.148 0.979 . . . . 0.0 110.502 170.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 p -99.46 -34.96 10.06 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.963 1.305 . . . . 0.0 109.323 169.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.1 pp -60.72 -25.98 66.83 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.695 1.198 . . . . 0.0 112.502 177.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.94 68.6 1.36 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.53 -47.03 0.05 OUTLIER Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 178.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.03 -28.62 69.92 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 117.874 0.837 . . . . 0.0 110.737 176.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -68.84 -40.46 79.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -76.75 -37.41 55.99 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 122.72 0.408 . . . . 0.0 110.62 -179.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.58 -43.01 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 118.454 0.57 . . . . 0.0 109.474 171.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.19 93.8 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.548 0.613 . . . . 0.0 110.395 177.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.14 -42.4 99.21 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.458 0.572 . . . . 0.0 110.872 178.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -61.81 -50.41 72.41 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.704 0.802 . . . . 0.0 110.165 178.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.3 mt -62.18 -39.75 93.72 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.383 0.673 . . . . 0.0 110.655 179.216 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.96 99.3 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.952 0.501 . . . . 0.0 110.6 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.12 -43.61 94.76 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.678 0.672 . . . . 0.0 110.3 178.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -58.27 -45.99 86.84 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.914 -0.492 . . . . 0.0 110.067 175.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.6 mt -62.48 -38.83 91.35 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.996 178.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.22 -38.51 90.65 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.23 0.923 . . . . 0.0 110.316 177.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.05 -36.74 82.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.54 0.609 . . . . 0.0 110.756 175.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.16 -25.28 65.19 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.154 0.581 . . . . 0.0 111.898 173.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.78 0.61 17.57 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.395 1.474 . . . . 0.0 113.998 170.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -83.59 149.57 26.48 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.04 1.42 . . . . 0.0 109.91 -178.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -87.86 140.18 29.77 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 p -139.22 165.97 25.76 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.305 1.042 . . . . 0.0 109.812 -169.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -154.42 155.4 34.91 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 169.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.9 p -126.28 84.31 2.26 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -171.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.6 mt -68.12 119.98 13.58 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -174.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -75.54 92.36 2.89 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.192 0.997 . . . . 0.0 108.458 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.45 61.79 5.65 Favored Glycine 0 CA--C 1.542 1.772 0 C-N-CA 124.628 1.108 . . . . 0.0 113.929 175.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -69.06 177.47 5.07 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.973 3.115 . . . . 0.0 111.875 179.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 38.3 mt -107.49 154.21 21.7 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.828 1.251 . . . . 0.0 107.965 169.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.46 -38.83 72.2 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.924 0.889 . . . . 0.0 111.539 -177.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.09 -18.09 63.01 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -75.3 -19.43 59.68 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.601 0.637 . . . . 0.0 111.862 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.1 mt -99.9 143.09 25.83 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 123.983 0.913 . . . . 0.0 110.517 -173.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.19 163.19 38.72 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.364 2.043 . . . . 0.0 109.26 169.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.81 25.66 0.77 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.521 1.128 . . . . 0.0 111.904 -176.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.5 m -155.89 142.2 18.43 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.13 1.372 . . . . 0.0 107.907 177.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 150.46 -176.16 29.18 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 178.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -128.92 101.24 6.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 178.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -103.14 171.82 7.16 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.202 1.001 . . . . 0.0 108.981 -177.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.2 tp -148.0 117.2 6.87 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 176.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.52 135.39 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -169.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.78 119.91 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.0 m -123.04 -174.42 2.94 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.799 1.64 . . . . 0.0 107.793 -174.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -144.47 170.26 16.37 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 168.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.1 m -126.24 129.28 48.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -67.17 -29.75 69.53 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 117.92 0.327 . . . . 0.0 111.393 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.94 -38.95 0.32 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.692 0.663 . . . . 0.0 112.805 175.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.87 19.15 7.85 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.054 0.942 . . . . 0.0 112.732 -170.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.62 -8.07 28.08 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.266 0.936 . . . . 0.0 113.171 174.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.12 121.3 15.32 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.495 1.147 . . . . 0.0 109.834 176.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.9 mt -78.11 142.01 63.44 Favored Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 176.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.75 145.28 86.18 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.602 2.868 . . . . 0.0 112.044 176.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.49 -17.73 34.14 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.964 1.706 . . . . 0.0 114.281 -173.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -62.42 -44.8 95.56 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.502 0.721 . . . . 0.0 109.429 178.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.2 tp -120.05 -17.58 8.35 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.334 0.654 . . . . 0.0 112.329 -170.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.4 p -53.94 -32.87 12.3 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -178.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -54.69 -23.99 35.38 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.518 2.146 . . . . 0.0 114.852 171.033 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -61.23 -38.54 87.0 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.33 0.968 . . . . 0.0 110.769 177.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -66.98 -37.15 83.71 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.237 0.471 . . . . 0.0 110.474 177.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.81 -45.94 69.91 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.72 -31.19 72.04 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.764 -0.585 . . . . 0.0 112.1 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.9 mt -61.71 -60.72 3.24 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 123.45 0.7 . . . . 0.0 109.405 171.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -71.14 -26.82 63.17 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -171.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -67.69 -37.18 81.96 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.686 0.676 . . . . 0.0 110.97 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -105.95 -34.38 7.63 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.96 0.504 . . . . 0.0 111.613 -170.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.9 tttp 32.73 59.27 1.47 Allowed Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 127.759 2.424 . . . . 0.0 113.59 -174.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -69.95 159.21 54.07 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.73 1.62 . . . . 0.0 110.004 174.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -71.76 127.65 33.23 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 169.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.436 ' C ' ' H ' ' A' ' 82' ' ' ALA . 1.5 pp -140.54 38.36 1.86 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.862 1.265 . . . . 0.0 110.129 177.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.1 m -59.43 24.41 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.856 2.462 . . . . 0.0 115.497 170.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.436 ' H ' ' C ' ' A' ' 80' ' ' LEU . . . -145.73 3.51 0.97 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.311 1.445 . . . . 0.0 112.184 178.356 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.9 t -87.35 146.11 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 169.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -122.11 146.44 47.21 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 168.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -137.63 168.98 18.57 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -125.43 156.57 19.28 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 104.802 -3.319 . . . . 0.0 104.802 169.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.06 123.9 25.29 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.408 1.104 . . . . 0.0 109.986 -169.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.2 mt -132.7 135.48 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.14 162.16 13.65 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 169.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.5 mt -141.71 144.13 26.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -177.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 175.41 166.35 32.91 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 106.743 -2.543 . . . . 0.0 106.743 177.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.4 m -73.55 134.53 43.8 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 169.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -61.61 -15.21 37.33 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -67.73 -23.95 65.32 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.158 0.983 . . . . 0.0 111.647 173.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -62.32 143.23 57.19 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.861 0.864 . . . . 0.0 111.14 -175.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.91 -33.09 75.2 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.426 0.69 . . . . 0.0 111.518 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.6 m -117.21 43.61 2.28 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.68 1.592 . . . . 0.0 108.049 178.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -43.96 117.33 1.17 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.73 1.212 . . . . 0.0 110.762 175.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 64.2 m 48.46 33.07 3.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.113 1.765 . . . . 0.0 113.751 -178.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.71 -24.9 19.46 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.366 -0.686 . . . . 0.0 112.912 -175.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.44 -21.76 65.54 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.169 1.484 . . . . 0.0 113.807 -169.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 tp -57.99 -26.66 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.497 1.119 . . . . 0.0 110.237 172.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -57.94 -38.76 76.54 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.716 -0.615 . . . . 0.0 112.119 -174.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -72.43 -41.14 66.5 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.566 -0.709 . . . . 0.0 110.416 -178.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 45.3 mt -61.39 -47.64 84.89 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.396 0.678 . . . . 0.0 109.53 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -70.31 -36.55 74.39 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.76 -178.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.72 96.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.721 -0.656 . . . . 0.0 110.87 -169.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -74.05 -25.57 59.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.159 0.89 . . . . 0.0 111.717 -175.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.1 mt -66.23 -48.35 70.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.478 1.49 . . . . 0.0 108.603 169.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -61.11 -44.31 97.55 Favored 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 123.634 0.774 . . . . 0.0 109.611 -175.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -72.99 0.31 11.68 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.035 1.734 . . . . 0.0 112.722 178.168 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.3 m -122.72 7.21 9.4 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.55 1.14 . . . . 0.0 111.838 176.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 132.43 -34.0 2.57 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 118.547 -1.141 . . . . 0.0 114.598 168.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.22 177.88 0.77 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.715 1.258 . . . . 0.0 112.211 -178.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -149.54 162.18 40.66 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 121.399 -0.813 . . . . 0.0 111.039 169.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.27 165.35 3.58 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.059 1.344 . . . . 0.0 110.119 173.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.0 m -145.58 159.69 42.75 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 174.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.78 -124.7 32.89 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -172.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -139.33 163.53 32.25 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.3 m -66.06 149.67 49.89 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.7 tp -129.56 150.62 50.82 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.426 1.091 . . . . 0.0 109.259 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.24 142.48 47.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 176.451 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.4 mt -134.75 108.97 11.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -171.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -68.15 133.19 48.51 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.85 0.86 . . . . 0.0 110.593 178.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.1 pt -125.31 16.46 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 125.537 1.535 . . . . 0.0 111.462 174.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.18 -24.15 66.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.779 0.832 . . . . 0.0 110.863 170.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -126.07 161.99 26.35 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.578 1.551 . . . . 0.0 107.972 171.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -49.68 -48.97 49.25 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 127.234 2.214 . . . . 0.0 113.26 -169.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -158.74 103.37 1.72 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.686 1.195 . . . . 0.0 107.82 -173.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.3 tp -53.36 137.7 49.78 Favored Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 125.579 1.552 . . . . 0.0 110.077 175.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -56.43 169.21 1.73 Allowed 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.701 2.934 . . . . 0.0 114.582 177.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 58.36 -166.21 0.16 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.329 1.852 . . . . 0.0 111.68 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -138.53 69.58 45.77 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.562 1.145 . . . . 0.0 109.142 -178.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.29 -23.52 51.73 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.171 1.914 . . . . 0.0 111.533 179.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.74 -46.75 88.16 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.458 0.572 . . . . 0.0 109.807 175.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -63.99 -41.31 97.54 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.596 0.635 . . . . 0.0 110.993 176.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.81 -46.29 88.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.665 0.666 . . . . 0.0 110.632 -177.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -66.32 -35.92 81.6 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 122.68 0.392 . . . . 0.0 111.035 175.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 30.2 tp -62.96 -36.21 82.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.204 177.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.62 -47.06 65.08 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 170.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.4 m -64.26 -42.86 96.27 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.43 0.615 . . . . 0.0 110.839 177.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -60.27 -52.85 63.5 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.849 178.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.2 m -65.21 -34.0 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 119.94 1.246 . . . . 0.0 110.948 -177.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.46 -40.52 95.87 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.55 0.614 . . . . 0.0 111.652 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.5 mt -85.62 -35.63 20.86 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.103 -175.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 pp -76.6 -29.35 56.51 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.421 1.01 . . . . 0.0 111.659 177.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? . . . . . 0 C--O 1.249 1.026 0 C-N-CA 128.823 2.849 . . . . 0.0 113.695 179.434 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.206 0 N-CA-C 109.807 -0.442 . . . . 10.0 109.807 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -114.15 -24.45 8.97 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.859 1.263 . . . . 10.0 110.686 174.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.8 mt -125.94 89.66 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.146 0 N-CA-C 105.793 -1.929 . . . . 10.0 105.793 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.8 m -74.11 115.34 13.47 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.9 mp -77.27 154.0 33.39 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.701 -1.222 . . . . 10.0 107.701 169.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.8 mt -125.62 83.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 103.084 -2.932 . . . . 10.0 103.084 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 m -69.31 147.52 51.02 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.96 1.304 . . . . 10.0 109.272 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.46 81.59 0.15 Allowed Glycine 0 C--N 1.335 0.511 0 N-CA-C 111.119 -0.792 . . . . 10.0 111.119 -172.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.7 p . . . . . 0 C--O 1.232 0.176 0 CA-C-N 117.859 0.83 . . . . 10.0 110.142 165.954 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.99 0 N-CA-C 112.129 -0.389 . . . . 10.0 112.129 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.76 -31.24 70.14 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 117.899 0.849 . . . . 10.0 111.146 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -66.67 -42.37 86.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.099 0.863 . . . . 10.0 109.477 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -59.2 -53.04 62.84 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.133 0.573 . . . . 10.0 110.113 175.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.98 -40.37 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 119.012 -0.518 . . . . 10.0 110.006 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.54 -46.92 86.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.818 0.736 . . . . 10.0 110.433 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.75 -42.86 99.53 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.339 0.518 . . . . 10.0 110.444 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -62.6 -48.97 77.09 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.211 0.604 . . . . 10.0 110.114 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.439 HD21 ' HB1' ' A' ' 135' ' ' ALA . 23.7 mt -60.81 -43.59 98.0 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 124.029 0.932 . . . . 10.0 111.044 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.84 91.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.195 0.598 . . . . 10.0 110.534 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.02 -47.14 87.79 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.699 0.681 . . . . 10.0 110.281 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -61.59 -40.09 93.56 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 121.804 -0.56 . . . . 10.0 110.759 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.509 HD21 HD11 ' A' ' 139' ' ' LEU . 40.1 mt -64.16 -39.96 95.11 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 119.012 -0.518 . . . . 10.0 110.95 177.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.59 -38.81 92.28 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.847 0.749 . . . . 10.0 110.323 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.83 -33.81 75.5 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.914 0.779 . . . . 10.0 111.197 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.71 -20.58 65.28 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.266 0.626 . . . . 10.0 111.807 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.81 6.47 22.94 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.371 1.463 . . . . 10.0 113.376 171.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -103.28 135.87 44.11 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.196 1.498 . . . . 10.0 108.539 -173.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.8 p -79.69 147.42 31.97 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.024 0.53 . . . . 10.0 110.011 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.8 p -141.97 164.33 30.48 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.776 0.798 . . . . 10.0 111.309 -168.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -151.26 159.59 44.27 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.48 2.312 . . . . 10.0 105.103 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -131.0 61.45 1.63 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.356 1.462 . . . . 10.0 108.446 -171.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 mt -55.64 118.71 4.77 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.759 0.824 . . . . 10.0 108.957 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.21 116.57 16.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.178 -1.415 . . . . 10.0 107.178 171.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.8 50.49 14.78 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.027 -1.43 . . . . 10.0 115.73 167.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -65.3 164.35 26.0 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 CA-C-N 120.352 2.076 . . . . 10.0 110.391 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.7 mt -108.7 163.81 12.92 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.851 0.86 . . . . 10.0 108.754 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.408 HD13 ' C ' ' A' ' 41' ' ' LEU . 3.0 tm? -56.75 -39.99 74.98 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.849 0.86 . . . . 10.0 110.356 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.35 2.1 1.36 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.545 1.138 . . . . 10.0 113.705 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -126.33 17.23 7.7 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.691 1.596 . . . . 10.0 111.263 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.6 mt -132.01 123.43 18.96 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.837 1.255 . . . . 10.0 108.558 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.55 159.45 52.77 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 121.926 1.751 . . . . 10.0 110.565 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.74 11.1 1.82 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.664 1.186 . . . . 10.0 113.963 -174.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.0 m -143.71 138.66 29.02 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.114 1.366 . . . . 10.0 107.944 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.42 -177.7 31.64 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.457 -1.057 . . . . 10.0 110.457 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mt -125.6 96.13 3.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 104.699 -2.334 . . . . 10.0 104.699 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -97.14 175.54 6.26 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.17 0.588 . . . . 10.0 110.605 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.9 tp -150.13 99.09 2.78 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 107.812 -1.181 . . . . 10.0 107.812 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.6 t -83.5 130.82 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.751 -1.203 . . . . 10.0 107.751 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.9 mt -132.75 128.35 57.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.321 -2.103 . . . . 10.0 105.321 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.7 m -137.89 133.16 33.51 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.48 0.488 . . . . 10.0 109.936 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.3 m -62.61 160.67 13.53 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.506 0.669 . . . . 10.0 110.024 157.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.1 m -126.7 117.42 22.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 103.82 -2.659 . . . . 10.0 103.82 171.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -74.54 8.7 2.14 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.7 1.0 . . . . 10.0 113.7 -168.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.99 -22.94 26.66 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.766 1.651 . . . . 10.0 112.221 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.02 8.82 8.67 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.447 1.099 . . . . 10.0 112.505 -172.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.32 -2.86 81.61 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 123.534 0.588 . . . . 10.0 112.895 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -68.26 124.35 23.25 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.031 0.916 . . . . 10.0 108.737 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.9 mt -72.73 142.56 83.62 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 106.388 -1.708 . . . . 10.0 106.388 173.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.78 140.38 93.45 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.217 2.612 . . . . 10.0 111.066 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -60.34 -21.79 62.48 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.558 1.143 . . . . 10.0 113.118 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -50.99 -44.18 60.85 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.235 1.414 . . . . 10.0 111.132 169.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.1 tp -122.45 -19.34 6.43 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.745 0.818 . . . . 10.0 112.439 -168.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.9 p -52.78 -35.06 20.46 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 115.131 1.53 . . . . 10.0 115.131 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -54.73 -24.46 37.83 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.365 2.043 . . . . 10.0 114.577 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -62.02 -36.73 82.45 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.427 1.012 . . . . 10.0 111.027 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -61.16 -42.46 98.61 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.513 0.597 . . . . 10.0 110.205 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -72.01 -45.51 60.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.149 0.58 . . . . 10.0 109.732 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.45 -37.09 82.3 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.312 0.645 . . . . 10.0 111.315 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.8 mt -64.75 -59.44 4.23 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 118.726 -0.654 . . . . 10.0 109.529 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -66.99 -29.42 69.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.113 0.869 . . . . 10.0 112.372 -170.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.72 -34.14 76.28 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.226 0.611 . . . . 10.0 111.257 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -105.74 -27.55 11.23 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.417 0.687 . . . . 10.0 111.862 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt 26.73 62.82 0.56 Allowed Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 128.657 2.783 . . . . 10.0 112.858 -169.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.0 166.91 23.14 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.631 2.22 . . . . 10.0 110.364 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -71.53 120.17 16.73 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.533 -0.914 . . . . 10.0 108.533 165.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.2 mt -124.83 24.37 7.68 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.484 1.514 . . . . 10.0 110.255 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.7 m -63.96 10.8 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 115.803 1.779 . . . . 10.0 115.803 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.33 3.01 4.67 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.849 1.26 . . . . 10.0 112.23 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.1 t -74.66 131.8 34.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.752 -1.573 . . . . 10.0 106.752 165.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -105.31 150.81 24.86 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.29 -1.744 . . . . 10.0 106.29 157.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -145.54 159.36 43.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.273 0.559 . . . . 10.0 111.081 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -113.4 163.14 12.17 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 108.445 -1.862 . . . . 10.0 108.445 162.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.54 130.32 21.6 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.492 1.117 . . . . 10.0 108.299 -172.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 mt -134.78 133.21 54.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 105.866 -1.901 . . . . 10.0 105.866 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -108.65 145.04 16.39 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 108.336 -1.906 . . . . 10.0 108.336 166.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.4 mt -130.52 142.67 43.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.331 -2.1 . . . . 10.0 105.331 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.37 174.36 40.34 Favored Glycine 0 N--CA 1.453 -0.209 0 O-C-N 121.374 -0.829 . . . . 10.0 111.532 169.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.0 m -69.06 104.71 2.2 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.064 -1.088 . . . . 10.0 108.064 168.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -75.74 -10.57 59.55 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.321 0.86 . . . . 10.0 113.321 -163.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -76.62 -12.25 59.98 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.573 1.079 . . . . 10.0 112.236 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -64.17 162.59 14.19 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.185 0.902 . . . . 10.0 111.631 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.75 -34.36 74.32 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.92 0.888 . . . . 10.0 111.924 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 108.505 -0.924 . . . . 10.0 108.505 174.734 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.364 0 CA-C-O 120.685 0.279 . . . . 10.0 110.811 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.5 tp -57.1 -32.31 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.636 1.175 . . . . 10.0 111.691 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -54.96 -38.06 67.28 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.72 0.808 . . . . 10.0 111.933 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.92 -42.25 85.69 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.834 0.453 . . . . 10.0 110.98 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.3 mt -67.68 -49.28 63.6 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.163 -0.68 . . . . 10.0 109.163 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -63.77 -37.9 89.11 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 118.595 -0.717 . . . . 10.0 110.443 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.29 99.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.129 0.877 . . . . 10.0 110.643 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -74.09 -30.36 62.31 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 119.557 1.071 . . . . 10.0 112.043 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.2 mt -61.59 -48.25 81.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.826 1.193 . . . . 10.0 109.315 169.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -59.44 -45.93 90.19 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.724 1.21 . . . . 10.0 110.296 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -62.38 -38.62 90.32 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.822 1.649 . . . . 10.0 111.311 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.0 m -71.81 -11.87 61.01 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.427 1.091 . . . . 10.0 112.632 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.72 -12.64 8.76 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.706 1.146 . . . . 10.0 113.264 169.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.15 169.86 3.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.437 1.118 . . . . 10.0 110.585 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -138.32 145.16 40.85 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.441 -0.787 . . . . 10.0 111.009 168.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -63.18 166.79 5.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.403 -1.271 . . . . 10.0 109.19 172.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.3 m -132.61 153.06 51.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 105.606 -1.998 . . . . 10.0 105.606 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.99 -140.98 47.09 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 110.97 -0.852 . . . . 10.0 110.97 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -133.8 167.69 20.1 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.547 1.539 . . . . 10.0 108.147 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.2 m -82.64 123.22 29.05 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.793 0.837 . . . . 10.0 109.59 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.5 tp -85.48 145.95 27.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 122.636 0.374 . . . . 10.0 110.045 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -110.64 145.4 38.0 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.005 1.722 . . . . 10.0 106.956 169.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.5 mt -140.29 102.92 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.429 -1.693 . . . . 10.0 106.429 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -73.93 135.51 43.26 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.411 -0.589 . . . . 10.0 109.411 173.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.1 pp -128.67 7.75 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.109 0.963 . . . . 10.0 112.805 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.2 tp . . . . . 0 N--CA 1.469 0.489 0 CA-C-N 119.07 0.85 . . . . 10.0 111.3 -177.616 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.439 ' HB1' HD21 ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 110.184 -0.302 . . . . 10.0 110.184 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -56.27 -39.84 73.27 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.987 1.715 . . . . 10.0 112.164 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -67.52 -47.18 70.68 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.01 0.823 . . . . 10.0 109.091 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -61.97 -41.02 97.55 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.389 0.676 . . . . 10.0 110.353 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.509 HD11 HD21 ' A' ' 26' ' ' LEU . 35.3 tp -61.58 -38.99 89.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.802 1.241 . . . . 10.0 110.646 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.07 -50.25 62.74 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.862 -0.895 . . . . 10.0 110.862 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.5 m -60.65 -30.27 69.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.007 0.523 . . . . 10.0 111.786 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -52.87 10.74 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.488 0.715 . . . . 10.0 111.852 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.0 -32.04 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -59.96 -23.53 63.66 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.476 1.111 . . . . 10.0 113.622 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.5 mt -102.06 -44.23 5.52 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 120.139 1.336 . . . . 10.0 111.382 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.95 -27.43 62.78 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.786 -1.102 . . . . 10.0 112.244 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm . . . . . 0 C--O 1.252 1.194 0 C-N-CA 128.672 2.789 . . . . 10.0 113.417 -177.296 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 121.063 0.459 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -76.0 -29.48 58.18 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.136 0.975 . . . . 0.0 110.113 -175.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.8 mt -125.15 74.17 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.1 m -74.81 114.83 13.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.94 155.19 37.69 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 172.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.9 mt -116.95 112.06 37.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 103.829 -2.656 . . . . 0.0 103.829 172.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -113.86 155.55 25.53 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.531 1.532 . . . . 0.0 110.84 -169.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.01 131.21 1.28 Allowed Glycine 0 N--CA 1.448 -0.512 0 O-C-N 121.187 -0.945 . . . . 0.0 111.13 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.0 p . . . . . 0 C--N 1.328 -0.33 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 169.433 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.279 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.79 -27.7 68.47 Favored 'General case' 0 C--O 1.228 -0.075 0 CA-C-N 118.108 0.954 . . . . 0.0 110.702 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -60.48 -27.89 67.92 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.921 0.488 . . . . 0.0 111.029 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -95.89 -51.75 4.34 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.631 0.773 . . . . 0.0 110.426 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.61 -39.22 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.741 -171.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.92 89.08 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.414 1.006 . . . . 0.0 111.04 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -68.24 -41.19 81.57 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.637 0.653 . . . . 0.0 110.144 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -60.45 -49.4 77.73 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.927 0.491 . . . . 0.0 110.276 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.5 mt -60.05 -43.43 95.38 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.523 0.729 . . . . 0.0 110.42 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.83 98.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.976 0.511 . . . . 0.0 110.753 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -66.25 -42.55 88.43 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.129 0.571 . . . . 0.0 110.419 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -59.66 -39.85 85.82 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 121.507 -0.746 . . . . 0.0 111.085 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.513 ' HB2' HG21 ' A' ' 33' ' ' THR . 55.3 mt -68.28 -29.22 67.96 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.98 177.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -65.56 -38.26 89.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.713 1.142 . . . . 0.0 109.875 172.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.81 -39.29 93.34 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.948 0.794 . . . . 0.0 110.496 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.07 -21.83 64.96 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.545 0.738 . . . . 0.0 112.259 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.84 31.09 3.25 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 118.651 -1.083 . . . . 0.0 113.58 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -125.29 148.25 48.78 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.026 1.413 . . . . 0.0 110.055 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 p -71.88 146.28 47.99 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.513 HG21 ' HB2' ' A' ' 26' ' ' LEU . 12.6 p -139.19 160.06 40.68 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.486 0.66 . . . . 0.0 110.956 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -149.64 161.69 41.69 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 p -134.3 81.41 1.91 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -175.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.63 105.57 3.72 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -78.97 102.67 8.44 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.17 56.58 15.03 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-O 118.348 -1.251 . . . . 0.0 114.589 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -69.24 178.3 4.38 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.043 2.495 . . . . 0.0 110.804 171.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.8 mt -125.03 158.08 34.63 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 169.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -53.53 -31.0 44.45 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.237 1.015 . . . . 0.0 111.134 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -62.45 -10.72 12.51 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.353 1.861 . . . . 0.0 112.736 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -133.87 18.67 3.83 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.393 1.077 . . . . 0.0 110.905 -175.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -134.77 106.08 10.68 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.743 1.217 . . . . 0.0 108.881 -169.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.82 161.52 41.4 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.884 2.39 . . . . 0.0 112.969 -170.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.43 7.38 5.47 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.763 1.625 . . . . 0.0 114.934 -171.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.8 m -146.81 129.72 16.29 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.7 -179.86 27.95 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.4 mt -112.94 101.83 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -99.55 168.78 9.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.3 tp -146.83 112.69 5.72 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -98.36 134.45 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -169.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 mp -132.78 125.11 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.8 p -138.6 143.2 39.24 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.945 1.298 . . . . 0.0 107.82 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.1 p -77.04 175.41 9.62 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 169.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 97' ' ' THR . 40.9 m -130.7 123.43 29.29 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 169.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -69.07 -22.2 64.03 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 159.56 -35.53 0.47 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 118.696 0.68 . . . . 0.0 113.37 170.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.78 22.87 8.09 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.124 0.969 . . . . 0.0 112.153 -169.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.75 -1.1 56.67 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 123.936 0.779 . . . . 0.0 113.094 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.5 114.67 8.84 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.301 1.051 . . . . 0.0 109.582 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.7 mt -68.91 147.8 97.86 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 125.643 1.577 . . . . 0.0 107.795 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -56.54 137.61 81.32 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.113 3.209 . . . . 0.0 112.38 175.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -63.93 -22.31 66.86 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -169.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -71.55 -24.42 61.93 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.713 -0.617 . . . . 0.0 111.941 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.6 tp -121.92 -24.76 5.13 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.279 1.032 . . . . 0.0 111.771 -169.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.0 p -55.12 -28.21 3.91 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 116.924 -1.512 . . . . 0.0 114.939 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -53.4 -24.55 28.16 Favored 'Trans proline' 0 C--N 1.354 0.86 0 CA-C-N 122.903 2.073 . . . . 0.0 114.716 169.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -62.02 -43.92 97.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.58 1.082 . . . . 0.0 110.673 175.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -60.96 -40.01 91.7 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.866 0.866 . . . . 0.0 110.101 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -68.77 -48.37 63.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.853 0.461 . . . . 0.0 110.54 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.06 -28.59 67.51 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.464 -0.772 . . . . 0.0 112.37 -176.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.1 mt -67.6 -57.74 5.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.722 -0.656 . . . . 0.0 109.385 171.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -67.25 -29.2 68.77 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.06 0.846 . . . . 0.0 112.071 -171.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.82 -31.0 71.34 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.136 0.574 . . . . 0.0 110.775 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -115.09 -23.21 9.13 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -169.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.4 tttt 37.74 66.11 2.46 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.67 1.588 . . . . 0.0 110.796 -169.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.32 168.82 10.46 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.687 2.258 . . . . 0.0 110.696 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -92.68 107.2 19.04 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 169.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.5 mt -120.02 26.15 9.46 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.262 1.825 . . . . 0.0 110.045 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -61.58 18.62 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.318 1.847 . . . . 0.0 115.424 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.77 3.19 1.84 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.265 1.426 . . . . 0.0 111.855 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.7 t -79.53 140.46 16.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.5 mmm-85 -123.79 138.4 54.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 168.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -134.39 170.87 15.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.895 0.378 . . . . 0.0 110.653 -172.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.14 162.86 23.09 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 105.347 -3.101 . . . . 0.0 105.347 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.428 ' HB1' HD12 ' A' ' 102' ' ' ILE . . . -146.89 124.55 11.81 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.401 1.101 . . . . 0.0 109.446 -170.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.6 mt -133.73 124.27 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -100.7 156.73 19.34 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.4 mt -134.9 139.11 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.17 -151.42 13.74 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.6 m -126.02 135.36 51.71 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.727 1.211 . . . . 0.0 108.517 -175.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -66.72 -10.25 44.95 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.78 -15.03 58.25 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.979 0.809 . . . . 0.0 112.359 171.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -64.32 148.68 49.76 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.381 0.991 . . . . 0.0 110.847 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.65 -34.22 77.7 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.511 0.725 . . . . 0.0 111.392 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.461 ' O ' HG21 ' A' ' 56' ' ' THR . 34.8 m . . . . . 0 CA--C 1.536 0.42 0 C-N-CA 125.73 1.612 . . . . 0.0 107.467 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.438 ' N ' ' HG1' ' A' ' 56' ' ' THR . . . . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.428 HD12 ' HB1' ' A' ' 87' ' ' ALA . 0.1 OUTLIER -59.19 -29.7 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.964 0.905 . . . . 0.0 109.444 178.302 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -54.75 -34.18 62.2 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.104 0.962 . . . . 0.0 112.071 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -81.58 -37.83 27.07 Favored 'General case' 0 C--O 1.232 0.14 0 O-C-N 121.731 -0.606 . . . . 0.0 110.189 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.5 mt -57.89 -50.88 71.81 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -70.58 -32.98 70.57 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.394 -174.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.28 80.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.315 0.507 . . . . 0.0 110.103 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -79.79 -28.88 40.23 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.03 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.0 -45.75 84.25 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.379 1.445 . . . . 0.0 109.578 170.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -71.27 -33.66 69.97 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.469 0.577 . . . . 0.0 111.266 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -61.23 -39.66 91.09 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.178 0.591 . . . . 0.0 110.537 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.6 m -72.03 -7.82 50.98 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.221 1.008 . . . . 0.0 113.13 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.24 -14.93 10.15 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.644 1.116 . . . . 0.0 114.102 169.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.19 173.52 1.94 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.573 1.187 . . . . 0.0 111.341 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -143.83 148.1 35.04 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.019 -1.051 . . . . 0.0 112.153 170.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -58.78 158.55 7.94 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.376 1.87 . . . . 0.0 109.851 173.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.8 m -139.88 163.33 32.94 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.465 1.906 . . . . 0.0 106.087 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.35 -135.25 48.07 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -173.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -146.5 150.18 35.07 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 169.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.2 m -61.76 149.48 39.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.125 1.37 . . . . 0.0 111.176 -171.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.3 tp -129.81 151.21 50.64 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.343 1.057 . . . . 0.0 110.388 -173.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -119.87 150.4 40.51 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 23.5 mm -131.68 100.47 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -78.33 126.47 30.83 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 118.682 -0.675 . . . . 0.0 109.363 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.57 9.46 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.768 0.827 . . . . 0.0 112.152 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.1 tp . . . . . 0 N--CA 1.469 0.479 0 C-N-CA 126.067 1.747 . . . . 0.0 113.685 -174.228 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -56.33 -42.76 78.21 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.261 0.937 . . . . 0.0 112.041 -169.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -69.45 -40.3 77.24 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.999 -0.438 . . . . 0.0 110.453 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -72.36 -35.48 68.51 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.642 0.777 . . . . 0.0 110.58 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.97 -35.14 77.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.459 0.704 . . . . 0.0 109.958 170.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.47 -47.18 57.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.387 0.994 . . . . 0.0 111.177 169.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.8 m -62.59 -38.22 89.28 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 122.081 -0.658 . . . . 0.0 111.132 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -53.48 50.22 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.087 175.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.9 m -62.89 -31.25 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 119.799 1.182 . . . . 0.0 111.188 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -62.82 -27.03 69.04 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.593 -0.718 . . . . 0.0 112.669 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.2 mt -106.37 -37.09 6.63 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.216 0.917 . . . . 0.0 112.93 -176.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 pp -73.03 -12.59 60.98 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.465 1.03 . . . . 0.0 112.171 172.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.018 0 C-N-CA 129.451 3.1 . . . . 0.0 112.645 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.246 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -136.97 -25.37 1.08 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.79 1.236 . . . . 0.0 111.085 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.4 mt -130.52 82.38 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.0 m -75.23 121.15 21.72 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.9 mp -85.41 152.19 23.42 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.312 0.645 . . . . 0.0 109.711 174.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.8 mt -123.49 93.28 2.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 126.294 1.837 . . . . 0.0 106.161 -175.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -72.95 155.7 39.6 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.558 1.143 . . . . 0.0 110.862 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.2 65.17 0.26 Allowed Glycine 0 C--N 1.34 0.801 0 N-CA-C 114.239 0.456 . . . . 0.0 114.239 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.499 ' HG ' ' N ' ' A' ' 14' ' ' GLY . 9.4 t . . . . . 0 N--CA 1.455 -0.211 0 C-N-CA 124.52 1.128 . . . . 0.0 110.595 174.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.499 ' N ' ' HG ' ' A' ' 10' ' ' SER . . . . . . . . 0 CA--C 1.523 0.566 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.448 ' H ' ' HB2' ' A' ' 10' ' ' SER . . . -66.6 -28.25 68.36 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 117.51 0.655 . . . . 0.0 111.231 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -68.62 -44.8 73.5 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -70.55 -46.02 64.33 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.386 0.675 . . . . 0.0 109.94 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.9 t -62.15 -38.52 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 118.451 -0.785 . . . . 0.0 110.101 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.17 97.82 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.693 1.133 . . . . 0.0 110.777 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -63.49 -41.42 98.56 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.594 0.634 . . . . 0.0 110.551 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -63.85 -43.3 96.55 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.941 -0.474 . . . . 0.0 111.125 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.4 mt -63.78 -43.81 95.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.546 0.738 . . . . 0.0 109.666 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.33 -37.8 78.72 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.422 0.689 . . . . 0.0 111.219 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -52.55 -44.68 66.0 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.847 0.748 . . . . 0.0 110.482 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt -68.33 -37.54 80.63 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.834 -0.541 . . . . 0.0 109.813 -175.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.1 mt -68.09 -38.61 82.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.262 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.83 -38.57 89.26 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.361 0.528 . . . . 0.0 110.329 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.04 -37.05 84.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.599 0.636 . . . . 0.0 110.98 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.27 -26.0 66.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.972 0.509 . . . . 0.0 111.67 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.86 -3.88 10.77 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.32 1.438 . . . . 0.0 113.743 169.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -78.9 146.4 33.58 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.924 1.362 . . . . 0.0 109.981 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 p -83.5 146.6 28.28 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 169.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.2 p -134.43 169.29 17.47 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.806 0.842 . . . . 0.0 109.943 -170.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.1 158.73 44.41 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 169.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.4 m -130.42 81.96 2.03 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.9 mt -75.94 116.41 16.61 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -74.88 94.48 2.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.0 57.2 19.41 Favored Glycine 0 CA--C 1.54 1.635 0 CA-C-O 118.797 -1.001 . . . . 0.0 114.437 172.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.35 179.01 4.33 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.338 2.692 . . . . 0.0 111.297 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.8 mt -114.38 151.16 33.52 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 169.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -61.21 -28.89 69.47 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.348 0.659 . . . . 0.0 111.747 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.99 -21.59 63.68 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 175.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -82.89 -7.02 59.7 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.697 0.799 . . . . 0.0 111.812 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.1 mt -113.91 145.07 32.75 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 124.359 1.063 . . . . 0.0 109.989 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -70.15 162.89 40.57 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.758 2.305 . . . . 0.0 110.725 169.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.37 23.65 0.6 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.179 1.392 . . . . 0.0 112.024 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 m -156.37 142.87 18.48 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.352 1.461 . . . . 0.0 107.832 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 150.33 179.98 26.57 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.7 mt -122.24 101.74 10.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -107.12 170.59 7.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.535 1.134 . . . . 0.0 109.051 -175.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.8 tp -149.45 121.88 8.49 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.0 t -111.6 138.3 40.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -169.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -134.43 138.57 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.9 m -139.75 145.34 38.15 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.507 1.123 . . . . 0.0 109.213 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -99.21 95.72 7.27 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.752 0.786 . . . . 0.0 109.911 174.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.467 ' HG1' ' N ' ' A' ' 101' ' ' ALA . 24.3 m -58.54 135.42 57.31 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 169.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.4 p-80 -136.01 41.59 2.65 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.986 1.314 . . . . 0.0 108.961 -174.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.43 -35.37 2.43 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.765 1.65 . . . . 0.0 113.118 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.61 -21.03 66.13 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.058 1.343 . . . . 0.0 113.975 -171.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.11 33.78 64.95 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -172.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -141.42 149.92 41.66 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.319 1.048 . . . . 0.0 108.482 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 62' ' ' ILE . 4.2 mp -69.3 148.2 97.32 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -55.44 153.08 29.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.411 2.741 . . . . 0.0 112.635 169.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.77 -19.14 25.89 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.833 1.253 . . . . 0.0 114.003 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -63.15 -36.63 84.27 Favored 'General case' 0 C--N 1.343 0.289 0 O-C-N 121.801 -0.562 . . . . 0.0 110.591 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.2 tp -127.16 -18.25 4.6 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.883 -169.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.6 p -52.66 -32.43 9.51 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.54 -21.4 18.72 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.131 2.554 . . . . 0.0 115.773 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -56.82 -32.31 65.6 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.187 0.995 . . . . 0.0 110.96 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -62.79 -51.2 68.0 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -62.2 -42.98 99.79 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.027 0.531 . . . . 0.0 109.906 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.11 -27.52 68.43 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.445 0.698 . . . . 0.0 112.591 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 mt -75.94 -20.84 57.62 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.21 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -93.95 -41.78 9.41 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.038 1.29 . . . . 0.0 109.062 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -60.22 -36.54 77.92 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.105 0.962 . . . . 0.0 110.208 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -107.61 -37.11 6.26 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.089 0.555 . . . . 0.0 112.426 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm 27.31 64.3 0.59 Allowed Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 126.853 2.061 . . . . 0.0 113.355 -169.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -59.3 160.52 19.33 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.297 1.998 . . . . 0.0 111.276 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.35 50.72 1.12 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.978 1.311 . . . . 0.0 109.965 173.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.66 34.98 0.1 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.279 1.831 . . . . 0.0 114.168 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -61.75 23.42 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 128.699 2.8 . . . . 0.0 114.745 171.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.06 0.07 1.71 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.886 1.675 . . . . 0.0 111.672 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.6 t -82.47 147.97 5.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 169.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -126.29 141.34 51.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 168.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -140.01 175.38 9.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.225 0.536 . . . . 0.0 110.4 -172.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.07 164.92 26.09 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 106.631 -2.588 . . . . 0.0 106.631 169.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.69 124.89 15.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -169.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.8 mt -133.71 128.08 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 -177.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.66 120.33 5.37 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 107.576 -2.21 . . . . 0.0 107.576 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.9 mt -94.67 152.43 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 169.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 169.81 -144.01 8.26 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 172.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.2 m -132.59 127.69 35.57 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.38 -11.13 60.56 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.699 -0.626 . . . . 0.0 112.124 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.08 -28.44 69.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.513 0.725 . . . . 0.0 111.129 169.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -66.1 145.37 55.91 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 118.87 0.759 . . . . 0.0 109.479 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.98 -35.38 80.52 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 168.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 CA--C 1.544 0.736 0 C-N-CA 128.086 2.554 . . . . 0.0 109.138 169.592 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.467 ' N ' ' HG1' ' A' ' 56' ' ' THR . . . . . . . . 0 N--CA 1.468 0.446 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 tp -56.28 -28.63 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.02 1.728 . . . . 0.0 110.723 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -53.03 -37.46 61.56 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.77 0.828 . . . . 0.0 112.73 -173.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -65.23 -42.19 93.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 118.785 0.72 . . . . 0.0 111.458 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.7 mt -68.76 -50.74 47.95 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -37.06 81.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.729 -170.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.4 -35.48 79.37 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.58 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -72.76 -31.24 64.76 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.471 1.032 . . . . 0.0 111.978 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.2 mt -62.13 -44.8 95.84 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 120.77 1.623 . . . . 0.0 108.749 169.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -61.44 -44.6 96.84 Favored 'General case' 0 C--N 1.335 -0.055 0 C-N-CA 124.037 0.935 . . . . 0.0 110.057 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -65.26 -43.34 91.58 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.917 1.287 . . . . 0.0 110.891 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m -68.07 -27.07 66.18 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 119.204 -0.427 . . . . 0.0 111.286 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.94 -32.69 0.38 Allowed Glycine 0 CA--C 1.529 0.929 0 CA-C-N 118.987 0.812 . . . . 0.0 115.002 169.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.61 177.51 0.52 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.807 1.243 . . . . 0.0 113.498 -171.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -138.49 147.31 43.04 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.689 -0.632 . . . . 0.0 110.687 169.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -64.55 166.45 8.53 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.837 1.255 . . . . 0.0 109.404 175.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 m -137.88 153.06 49.59 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.286 1.834 . . . . 0.0 106.189 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 56.08 -139.1 44.18 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -170.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -137.44 157.02 47.48 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.4 145.98 52.57 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.589 1.156 . . . . 0.0 110.074 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.3 tp -120.42 138.85 53.55 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.563 0.745 . . . . 0.0 109.26 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -101.72 141.3 34.79 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 53.0 mt -130.7 136.21 58.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 175.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -125.78 96.03 4.63 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.567 1.547 . . . . 0.0 109.279 -169.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.4 pp -80.48 -3.98 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 O-C-N 121.433 -0.792 . . . . 0.0 112.668 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.3 tp . . . . . 0 CA--C 1.534 0.361 0 C-N-CA 123.846 0.858 . . . . 0.0 112.124 178.907 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 119.582 -0.247 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.55 -42.07 98.3 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.373 0.669 . . . . 0.0 110.411 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -76.88 -40.94 45.79 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.348 0.659 . . . . 0.0 109.703 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 -64.11 -42.15 96.98 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.928 0.491 . . . . 0.0 110.612 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 15.6 tp -66.57 -27.62 67.87 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.72 -0.612 . . . . 0.0 110.451 174.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.97 -48.37 82.99 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 169.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.6 m -63.68 -35.2 79.77 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.736 -0.861 . . . . 0.0 111.129 175.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 38.4 t90 -63.23 -50.68 69.28 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.211 0.605 . . . . 0.0 110.461 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 32.0 m -68.24 -29.21 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 121.214 -0.929 . . . . 0.0 111.444 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -60.71 -21.6 63.08 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.504 -0.76 . . . . 0.0 112.003 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.2 mt -101.77 -32.01 10.49 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 117.963 -1.018 . . . . 0.0 112.664 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.47 -28.35 66.01 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.471 1.487 . . . . 0.0 111.485 173.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttm . . . . . 0 C--O 1.251 1.167 0 C-N-CA 128.321 2.649 . . . . 0.0 111.596 -177.902 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.222 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -79.36 -31.18 42.87 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.967 0.907 . . . . 0.0 109.898 -172.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.7 mt -122.32 70.02 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.7 m -68.4 116.46 8.99 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.7 mt -86.09 155.09 20.95 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.0 mt -123.14 90.62 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -172.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.6 m -77.62 129.07 35.14 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.153 0.981 . . . . 0.0 110.619 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.0 60.99 0.66 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 124.637 1.113 . . . . 0.0 113.123 -169.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.41 ' HG ' ' N ' ' A' ' 14' ' ' GLY . 91.8 p . . . . . 0 N--CA 1.453 -0.275 0 CA-C-N 117.515 0.658 . . . . 0.0 109.894 169.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.41 ' N ' ' HG ' ' A' ' 10' ' ' SER . . . . . . . . 0 CA--C 1.529 0.915 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.34 -34.01 76.43 Favored 'General case' 0 C--O 1.227 -0.128 0 O-C-N 122.065 -0.667 . . . . 0.0 110.487 175.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.13 -39.84 86.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.676 0.671 . . . . 0.0 110.332 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -66.46 -46.28 76.95 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.996 0.918 . . . . 0.0 109.012 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.99 -49.19 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.88 87.59 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.927 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.57 -44.25 94.64 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.139 0.881 . . . . 0.0 111.101 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -68.91 -41.82 77.68 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.949 -0.469 . . . . 0.0 110.852 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.42 -42.05 98.72 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.66 96.33 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.769 0.828 . . . . 0.0 110.753 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -58.38 -42.87 88.01 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.595 0.634 . . . . 0.0 110.362 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -67.2 -39.61 86.36 Favored 'General case' 0 N--CA 1.461 0.109 0 O-C-N 121.738 -0.601 . . . . 0.0 111.179 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 mt -62.25 -37.64 86.2 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.54 0.609 . . . . 0.0 111.259 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.41 -38.44 87.47 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.092 0.86 . . . . 0.0 110.283 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -66.24 -35.77 81.28 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.609 0.64 . . . . 0.0 110.888 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.6 -26.79 66.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.085 0.554 . . . . 0.0 111.644 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.44 -3.36 10.32 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.269 1.414 . . . . 0.0 113.928 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -81.07 148.31 29.73 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.059 1.43 . . . . 0.0 110.342 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 p -79.05 144.42 34.65 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 169.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.8 p -140.64 163.96 31.48 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.284 0.634 . . . . 0.0 111.036 -176.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -150.47 151.62 32.99 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 105.437 -2.06 . . . . 0.0 105.437 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 p -108.81 73.15 0.85 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.32 104.01 6.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -169.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -73.25 121.54 20.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.15 51.85 29.14 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 117.89 -1.505 . . . . 0.0 116.759 169.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -67.23 175.84 5.35 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 CA-C-N 120.735 2.268 . . . . 0.0 111.368 170.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 mt -128.62 168.94 15.03 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.687 1.595 . . . . 0.0 108.659 171.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.38 -37.74 67.95 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.083 0.953 . . . . 0.0 110.902 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.36 -3.46 14.25 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.15 0.98 . . . . 0.0 113.294 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -125.17 9.33 8.0 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.919 1.288 . . . . 0.0 112.332 -170.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.45 149.78 52.29 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 124.127 0.971 . . . . 0.0 110.552 169.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.31 164.28 29.15 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.745 2.297 . . . . 0.0 111.471 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.67 21.19 0.84 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.204 1.402 . . . . 0.0 112.9 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.6 p -153.12 143.66 22.62 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.575 1.15 . . . . 0.0 108.772 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.19 -176.72 27.82 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.22 93.25 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -96.54 169.18 10.07 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.718 0.807 . . . . 0.0 109.796 -172.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.0 tp -135.39 124.14 23.86 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.73 130.48 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.53 121.04 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.4 m -138.4 133.07 32.4 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.307 0.643 . . . . 0.0 109.41 -169.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -77.13 163.85 26.22 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 169.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.0 m -114.35 119.04 35.58 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -66.69 -30.04 70.19 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.402 0.281 . . . . 0.0 110.965 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.49 -35.09 0.34 Allowed Glycine 0 CA--C 1.526 0.777 0 C-N-CA 123.791 0.71 . . . . 0.0 112.81 171.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.09 23.83 7.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.24 1.016 . . . . 0.0 112.192 -173.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.01 -3.62 60.47 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.196 -0.78 . . . . 0.0 113.098 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.29 149.18 47.66 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.448 1.124 . . . . 0.0 109.71 170.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.7 mt -113.71 144.27 31.11 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 126.043 1.737 . . . . 0.0 107.096 -169.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -48.72 139.94 23.46 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 124.223 3.282 . . . . 0.0 114.381 172.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -59.46 -21.56 60.25 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.634 1.574 . . . . 0.0 113.858 -172.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -67.35 -29.63 69.22 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.305 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.0 tp -127.64 -22.11 3.66 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.607 0.763 . . . . 0.0 112.049 -171.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 92.1 p -53.2 -31.66 8.3 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -52.1 -24.05 18.97 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.203 2.602 . . . . 0.0 115.278 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -58.5 -35.58 72.44 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.162 0.892 . . . . 0.0 110.773 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -62.45 -42.76 99.7 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.779 0.718 . . . . 0.0 110.484 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -68.89 -48.05 64.34 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.354 0.662 . . . . 0.0 109.286 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.28 -35.25 79.91 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 118.969 -0.539 . . . . 0.0 111.788 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.0 mt -65.72 -53.07 45.84 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.777 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -70.03 -28.34 65.39 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.337 0.972 . . . . 0.0 112.035 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.01 -35.03 77.63 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.515 0.598 . . . . 0.0 110.825 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -109.25 -33.64 6.8 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -169.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp 30.53 57.22 0.89 Allowed Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 127.385 2.274 . . . . 0.0 113.119 -172.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -69.3 172.0 12.97 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.169 1.913 . . . . 0.0 110.029 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -71.75 106.66 4.21 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.912 -0.493 . . . . 0.0 110.077 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.1 mt -113.0 20.43 16.37 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.601 1.56 . . . . 0.0 110.899 176.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 m -63.31 19.97 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.957 1.703 . . . . 0.0 115.548 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -135.28 0.1 2.77 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.208 1.403 . . . . 0.0 111.762 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 64.5 t -82.13 133.78 28.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -108.99 142.78 39.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 103.444 -2.798 . . . . 0.0 103.444 168.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -136.41 168.35 19.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 119.13 0.877 . . . . 0.0 111.354 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.16 163.48 23.53 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 105.561 -3.015 . . . . 0.0 105.561 169.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.06 124.4 13.04 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -169.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 52.1 mt -133.38 133.25 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.62 150.47 18.01 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.4 mt -139.79 150.44 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.35 -45.77 0.49 Allowed Glycine 0 C--N 1.33 0.237 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 169.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.2 m 115.01 140.92 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 1 C-N-CA 132.08 4.152 . . . . 0.0 108.056 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -67.81 0.84 2.97 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -63.62 -30.58 71.67 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.719 0.808 . . . . 0.0 109.994 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -70.8 156.43 39.55 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.467 0.707 . . . . 0.0 110.853 174.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.14 -37.5 83.06 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.659 0.783 . . . . 0.0 111.785 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.6 m . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 172.115 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.0 tp -57.93 -28.11 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.755 1.222 . . . . 0.0 110.834 175.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -52.3 -38.68 59.1 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.194 0.997 . . . . 0.0 112.288 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -73.52 -41.12 63.44 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 121.84 -0.537 . . . . 0.0 110.489 -174.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 50.0 mt -64.2 -51.56 63.12 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.17 -38.67 82.31 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -169.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.35 75.23 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 122.049 -0.407 . . . . 0.0 110.576 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -74.13 -31.06 62.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.708 0.685 . . . . 0.0 110.691 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.88 -43.34 96.36 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.429 1.013 . . . . 0.0 108.885 169.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -61.98 -43.79 98.1 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.842 0.457 . . . . 0.0 109.826 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -64.28 -35.92 82.41 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.441 0.696 . . . . 0.0 111.132 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.5 m -71.47 -7.39 47.15 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.164 0.986 . . . . 0.0 112.927 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.85 -17.49 10.85 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.765 1.174 . . . . 0.0 113.787 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.2 171.61 1.29 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.266 1.033 . . . . 0.0 111.158 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -142.5 153.4 43.59 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 121.114 -0.991 . . . . 0.0 111.714 172.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -71.24 156.62 39.33 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.362 174.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 66.2 m -128.0 151.74 48.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.819 2.048 . . . . 0.0 106.675 169.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 62.0 -146.19 49.11 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -172.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -135.44 156.4 48.97 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.647 1.179 . . . . 0.0 108.206 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.66 152.64 45.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.986 1.314 . . . . 0.0 110.462 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.8 tp -129.98 144.17 51.19 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.443 1.097 . . . . 0.0 108.826 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -115.52 153.83 30.46 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 169.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 38.1 mt -134.76 109.14 11.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -172.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -77.63 135.9 38.17 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.555 0.742 . . . . 0.0 109.353 170.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 46.5 pt -129.23 -15.69 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.945 1.698 . . . . 0.0 112.131 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.2 mt . . . . . 0 N--CA 1.467 0.388 0 CA-C-N 119.121 0.873 . . . . 0.0 112.761 -170.06 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.136 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -62.37 -44.61 96.05 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.022 0.529 . . . . 0.0 110.363 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -62.44 -49.77 74.11 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.666 0.386 . . . . 0.0 110.306 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 9.1 t-105 -67.95 -36.25 79.79 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 122.172 -0.33 . . . . 0.0 110.871 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.35 -41.38 93.54 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 118.906 -0.569 . . . . 0.0 110.032 173.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.81 -49.85 60.35 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 173.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.7 m -62.05 -36.6 82.1 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.161 0.584 . . . . 0.0 111.261 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 21.0 t90 -66.36 -53.05 40.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 119.137 -0.459 . . . . 0.0 110.124 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.1 m -66.21 -29.88 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 118.997 0.817 . . . . 0.0 111.514 -176.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -54.36 -25.33 23.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.89 0.876 . . . . 0.0 112.314 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 29.5 mt -100.29 -0.26 38.83 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.255 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.9 pp -124.71 -8.8 7.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.218 1.372 . . . . 0.0 113.59 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 71.8 mttt . . . . . 0 C--O 1.252 1.189 0 CA-C-N 119.542 1.065 . . . . 0.0 110.73 178.256 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -75.72 -30.84 59.41 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.812 0.845 . . . . 0.0 109.949 -171.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.0 mt -124.96 74.71 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 m -74.45 114.1 12.45 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 mp -74.27 155.03 38.68 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.0 mt -122.4 86.53 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 m -81.21 157.14 25.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.44 1.496 . . . . 0.0 111.722 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.0 135.26 1.92 Allowed Glycine 0 N--CA 1.444 -0.795 0 O-C-N 121.204 -0.935 . . . . 0.0 110.934 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 31.2 p . . . . . 0 C--N 1.329 -0.283 0 C-N-CA 123.723 0.809 . . . . 0.0 111.943 169.018 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.696 0 CA-C-O 119.791 -0.449 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.02 -21.17 66.39 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.184 0.992 . . . . 0.0 111.139 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.61 -35.8 77.03 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.206 0.602 . . . . 0.0 110.409 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -71.82 -40.22 69.28 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 122.062 -0.398 . . . . 0.0 110.155 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.97 -39.31 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.98 99.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.273 0.629 . . . . 0.0 110.084 175.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.19 -42.1 98.97 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.741 0.7 . . . . 0.0 110.571 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -61.51 -48.25 81.91 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.429 0.559 . . . . 0.0 110.814 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.0 mt -59.67 -46.3 89.47 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.343 0.657 . . . . 0.0 109.988 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.32 87.19 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.911 0.884 . . . . 0.0 111.397 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 -68.96 -45.52 70.49 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.567 0.747 . . . . 0.0 109.82 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -61.97 -41.3 97.85 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.363 0.528 . . . . 0.0 110.499 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.0 mt -62.72 -37.59 87.14 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.008 0.523 . . . . 0.0 111.396 173.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -67.15 -38.67 85.9 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.692 0.678 . . . . 0.0 110.373 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.54 -35.55 81.18 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.872 0.469 . . . . 0.0 110.839 173.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.89 -28.0 68.63 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.408 0.549 . . . . 0.0 111.335 172.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.39 -8.76 6.23 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.984 1.278 . . . . 0.0 114.155 169.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -80.0 143.76 33.83 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.962 1.381 . . . . 0.0 110.029 -174.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 p -70.95 141.05 51.09 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 169.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.8 p -134.91 159.44 41.43 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.143 0.497 . . . . 0.0 111.624 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -152.18 162.99 40.3 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -135.71 79.29 1.77 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.67 113.56 13.26 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -82.76 110.63 17.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.25 51.97 56.03 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-O 118.018 -1.434 . . . . 0.0 115.613 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -67.49 178.05 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.954 2.436 . . . . 0.0 111.322 170.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.0 mt -131.04 163.61 27.22 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 125.453 1.501 . . . . 0.0 109.56 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.3 tp -59.91 -36.18 76.44 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.656 1.182 . . . . 0.0 111.216 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.63 -3.79 10.04 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -134.56 22.63 3.67 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.783 1.633 . . . . 0.0 110.567 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.3 mt -137.41 123.1 12.93 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 125.286 1.434 . . . . 0.0 108.102 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.41 159.61 48.86 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.201 1.934 . . . . 0.0 110.486 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.02 17.23 1.26 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.586 1.155 . . . . 0.0 113.256 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.1 m -146.02 132.48 19.7 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.477 1.111 . . . . 0.0 108.429 -174.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 153.28 178.53 27.93 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.35 94.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -91.73 168.55 11.39 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.248 0.619 . . . . 0.0 109.402 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.3 tp -146.23 105.92 3.97 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.8 t -91.19 147.77 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -172.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.14 140.71 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 m -151.09 150.85 31.18 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.568 1.147 . . . . 0.0 108.623 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.6 m -69.62 159.29 33.7 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.044 0.45 . . . . 0.0 111.871 174.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.57 63.72 1.51 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 168.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -84.19 23.19 1.1 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.905 1.682 . . . . 0.0 110.855 -169.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.6 -13.48 41.41 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.484 1.04 . . . . 0.0 113.027 -170.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.86 -29.23 63.03 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.729 1.265 . . . . 0.0 112.916 -176.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.417 ' H ' HG21 ' A' ' 97' ' ' THR . . . 60.09 33.12 78.14 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.008 0.814 . . . . 0.0 112.003 -175.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -144.43 149.12 35.52 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.081 1.352 . . . . 0.0 107.683 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.4 mt -64.91 142.12 98.55 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -170.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.39 143.49 93.61 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.187 1.924 . . . . 0.0 110.939 -176.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.29 -28.48 58.88 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -169.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -70.83 -25.18 62.72 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 122.018 -0.426 . . . . 0.0 112.03 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.8 tp -120.5 -23.46 6.1 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.534 1.134 . . . . 0.0 111.832 -169.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 89.0 p -54.58 -30.32 6.67 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -52.21 -24.92 21.9 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.529 2.153 . . . . 0.0 114.598 169.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -60.26 -45.46 93.2 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.412 1.005 . . . . 0.0 110.542 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -64.43 -36.67 84.91 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.91 0.484 . . . . 0.0 110.661 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -65.35 -45.95 82.12 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.15 0.432 . . . . 0.0 110.183 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.51 -41.21 93.44 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.724 -0.61 . . . . 0.0 111.188 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.8 mt -60.42 -52.23 66.12 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.431 0.692 . . . . 0.0 110.334 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -70.92 -27.83 64.06 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.565 0.621 . . . . 0.0 111.505 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.82 -51.59 46.81 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.845 0.748 . . . . 0.0 109.686 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -85.17 -24.01 28.11 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.629 -169.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm 41.71 60.1 8.96 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.143 1.377 . . . . 0.0 111.166 -171.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -68.43 176.62 5.5 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.771 2.981 . . . . 0.0 111.971 -174.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -106.6 107.24 18.16 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 169.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.7 mt -119.62 24.38 10.65 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 126.44 1.896 . . . . 0.0 110.058 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.7 m -52.83 -10.2 0.15 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.89 -1.68 13.8 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.488 1.115 . . . . 0.0 111.222 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.0 t -80.91 141.99 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 168.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.92 146.97 50.81 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 168.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -137.9 171.71 14.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.295 0.569 . . . . 0.0 112.17 -169.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.52 167.48 26.17 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 105.64 -2.984 . . . . 0.0 105.64 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.419 ' HB3' HG23 ' A' ' 120' ' ' THR . . . -147.69 134.41 19.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.653 0.727 . . . . 0.0 109.649 -169.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.7 mm -128.14 132.77 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.05 130.48 9.65 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 173.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -127.37 126.07 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -172.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 171.22 -141.64 6.57 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -169.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.9 m -115.94 99.21 7.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.172 0.989 . . . . 0.0 108.759 -171.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -13.06 57.97 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.295 0.638 . . . . 0.0 112.561 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -56.76 -28.26 60.9 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.969 0.908 . . . . 0.0 111.002 169.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -123.25 -31.56 3.55 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.522 1.129 . . . . 0.0 110.914 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.7 t70 66.57 -16.31 0.13 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 129.608 3.163 . . . . 0.0 114.859 172.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.417 HG21 ' H ' ' A' ' 60' ' ' GLY . 1.8 m . . . . . 0 CA--C 1.552 1.047 0 C-N-CA 126.635 1.974 . . . . 0.0 112.36 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.558 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 tp -141.15 -34.1 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.028 1.331 . . . . 0.0 109.772 172.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -50.97 -36.01 36.7 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.322 1.049 . . . . 0.0 112.492 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -71.68 -55.35 7.88 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.59 -0.694 . . . . 0.0 110.676 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 pp -65.04 -40.51 94.91 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -72.1 -39.25 69.04 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -172.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.69 -30.64 70.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 119.05 -0.5 . . . . 0.0 110.431 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -70.83 -33.56 70.79 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.207 0.912 . . . . 0.0 110.912 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.1 mt -64.0 -40.82 97.21 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.129 1.332 . . . . 0.0 109.235 169.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -63.42 -43.43 97.51 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -63.04 -38.71 92.29 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.708 0.803 . . . . 0.0 110.762 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.6 m -67.9 -10.62 54.68 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.986 0.914 . . . . 0.0 112.75 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.56 -18.17 8.22 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.013 1.292 . . . . 0.0 113.606 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.24 175.79 0.89 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.371 1.086 . . . . 0.0 111.522 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -146.62 159.66 43.17 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.362 -0.836 . . . . 0.0 109.784 169.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -73.46 168.14 19.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.534 1.134 . . . . 0.0 109.473 175.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 m -133.25 145.27 50.37 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 127.105 2.162 . . . . 0.0 106.237 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.58 -133.12 52.8 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -173.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -140.99 160.12 40.75 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.355 1.862 . . . . 0.0 106.149 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.419 HG23 ' HB3' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -61.58 157.89 16.38 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.086 1.354 . . . . 0.0 111.033 -178.315 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 51.4 tp -126.86 149.84 49.53 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.86 0.864 . . . . 0.0 109.333 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -116.33 147.93 41.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 172.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 25.7 mm -132.89 138.73 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -108.94 133.98 52.21 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.664 1.186 . . . . 0.0 108.802 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.7 pp -127.1 4.96 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.868 1.267 . . . . 0.0 111.273 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.4 tp . . . . . 0 CA--C 1.532 0.253 0 C-N-CA 123.435 0.694 . . . . 0.0 111.872 -177.704 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.299 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.64 -37.83 73.99 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.681 0.792 . . . . 0.0 111.242 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -69.74 -38.57 76.87 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.848 -0.533 . . . . 0.0 110.494 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -65.52 -43.04 91.3 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.619 0.368 . . . . 0.0 110.063 172.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 28.2 tp -60.6 -39.46 88.22 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.3 0.64 . . . . 0.0 110.498 -173.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.15 -48.88 65.7 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.6 m -65.31 -35.98 82.67 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.047 -0.678 . . . . 0.0 111.148 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 17.1 t90 -66.18 -51.16 60.41 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.3 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.0 m -65.78 -28.98 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 119.128 0.876 . . . . 0.0 111.528 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -57.65 -24.23 55.51 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.808 -0.615 . . . . 0.0 112.169 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.5 mt -102.04 3.08 38.41 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 pp -124.6 -10.21 7.36 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.717 1.144 . . . . 0.0 113.24 174.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.249 1.036 0 C-N-CA 125.845 1.658 . . . . 0.0 112.188 -179.958 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.332 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -131.82 -28.43 1.79 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.487 1.515 . . . . 0.0 110.404 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.1 mt -123.93 84.51 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 169.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.5 m -75.94 109.55 9.66 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.74 154.39 38.41 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 89.1 mt -126.85 88.81 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 m -69.55 145.87 52.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.113 1.365 . . . . 0.0 109.933 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.07 49.82 0.66 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.411 0.529 . . . . 0.0 114.064 -169.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.234 0.252 0 C-N-CA 124.677 1.191 . . . . 0.0 108.138 169.408 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.271 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.8 -42.17 95.24 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 122.673 0.389 . . . . 0.0 109.974 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -67.44 -31.8 72.24 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.024 0.93 . . . . 0.0 112.082 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -70.18 -46.66 64.15 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.3 t -68.43 -35.65 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 118.998 -0.525 . . . . 0.0 109.723 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.09 88.09 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 119.026 0.83 . . . . 0.0 110.873 173.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -62.54 -42.02 99.26 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.052 0.842 . . . . 0.0 110.778 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -66.06 -45.7 80.38 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 122.027 -0.42 . . . . 0.0 110.488 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -59.97 -43.54 95.03 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.418 0.687 . . . . 0.0 110.098 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.51 99.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.751 0.82 . . . . 0.0 110.669 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -63.4 -44.18 95.41 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.559 0.618 . . . . 0.0 110.406 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -62.59 -40.44 96.9 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 121.635 -0.665 . . . . 0.0 110.516 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 41.2 mt -63.48 -38.35 90.8 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 118.449 -0.786 . . . . 0.0 111.954 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.95 -38.8 92.15 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.411 1.005 . . . . 0.0 110.358 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -66.47 -35.81 81.2 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.251 0.478 . . . . 0.0 110.872 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.72 -26.37 65.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.163 0.585 . . . . 0.0 111.712 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.44 -2.83 10.37 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.266 1.412 . . . . 0.0 114.137 169.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -82.07 142.91 31.89 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.094 1.447 . . . . 0.0 109.579 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 p -80.97 142.41 33.49 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.1 p -136.94 166.23 24.12 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.575 0.702 . . . . 0.0 110.991 -169.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -150.31 159.53 44.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 169.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 p -128.04 76.62 1.7 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.1 mt -70.54 113.59 7.8 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -76.69 107.29 8.88 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 52.8 52.13 40.64 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-O 118.521 -1.155 . . . . 0.0 115.057 172.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -67.7 177.74 3.88 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.092 2.528 . . . . 0.0 111.13 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.2 mt -127.91 166.84 17.54 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.271 1.428 . . . . 0.0 108.968 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -53.21 -36.85 61.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.489 1.516 . . . . 0.0 112.127 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.46 -7.13 8.88 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.237 1.015 . . . . 0.0 113.415 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -132.14 21.88 4.47 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.778 1.631 . . . . 0.0 110.976 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.2 mt -134.12 112.95 12.35 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.558 1.143 . . . . 0.0 109.273 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -66.34 157.44 60.18 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.35 2.034 . . . . 0.0 111.963 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.33 10.61 26.71 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.757 1.223 . . . . 0.0 114.288 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.7 m -144.4 124.57 13.69 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 150.79 -171.36 30.56 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.8 mp -124.92 99.22 5.89 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -94.23 174.09 7.32 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.722 0.809 . . . . 0.0 109.515 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.6 tp -144.87 98.6 3.21 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.7 138.61 19.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 mt -130.11 148.57 33.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.8 m -146.33 137.64 24.54 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 m -70.54 144.57 51.26 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 168.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 p -85.34 1.96 46.25 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -177.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 45.08 19.61 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 129.537 3.135 . . . . 0.0 114.394 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.58 23.74 29.29 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 120.905 -1.122 . . . . 0.0 113.149 -169.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.82 -9.09 0.41 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.342 1.071 . . . . 0.0 113.515 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.81 34.72 42.2 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 118.862 0.756 . . . . 0.0 111.642 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -140.32 146.93 39.13 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.053 0.941 . . . . 0.0 109.214 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.482 ' H ' HD12 ' A' ' 62' ' ' ILE . 3.6 mp -76.73 146.1 75.84 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -57.42 155.07 32.13 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.951 2.434 . . . . 0.0 111.663 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -59.56 -16.28 24.17 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.115 1.366 . . . . 0.0 114.107 -174.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -64.46 -39.82 94.54 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.519 0.728 . . . . 0.0 111.083 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.2 tp -122.97 -20.64 5.73 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.185 0.594 . . . . 0.0 112.313 -171.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 t -49.2 -39.05 33.4 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.75 -23.78 8.91 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.463 2.775 . . . . 0.0 116.162 172.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -59.94 -37.03 78.33 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.658 1.117 . . . . 0.0 111.16 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -59.03 -42.94 91.4 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.237 0.615 . . . . 0.0 110.34 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -68.65 -48.24 64.51 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.401 0.68 . . . . 0.0 109.79 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.34 84.03 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 118.924 -0.56 . . . . 0.0 112.094 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.6 mt -65.84 -53.82 34.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 118.65 -0.69 . . . . 0.0 109.503 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -69.15 -28.58 66.56 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.162 0.892 . . . . 0.0 111.847 -174.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -66.09 -36.44 83.19 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.709 0.686 . . . . 0.0 110.725 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -107.22 -20.74 13.19 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -169.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm 39.71 60.54 6.31 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.873 1.669 . . . . 0.0 111.057 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.95 167.25 14.38 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.752 2.968 . . . . 0.0 111.997 -174.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -95.52 73.27 3.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.386 1.075 . . . . 0.0 109.332 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.47 16.68 9.82 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.26 1.424 . . . . 0.0 111.517 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.9 m -51.57 10.95 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 129.601 3.161 . . . . 0.0 116.921 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.22 2.18 2.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.168 1.387 . . . . 0.0 112.213 174.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.5 t -80.16 140.87 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 169.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -116.84 151.07 37.31 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 168.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -147.43 170.83 16.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.189 0.904 . . . . 0.0 112.48 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.55 161.16 23.95 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 104.766 -3.334 . . . . 0.0 104.766 169.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.423 ' HB1' HD12 ' A' ' 102' ' ' ILE . . . -140.98 132.88 27.59 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -169.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.2 mt -137.72 126.32 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 -173.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -114.93 121.07 5.2 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.1 mt -123.47 134.32 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 118.232 1.016 . . . . 0.0 108.34 -169.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.02 -164.42 37.96 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.5 m -75.06 75.22 2.25 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 125.621 1.569 . . . . 0.0 109.186 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -65.1 -12.2 48.19 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.448 1.099 . . . . 0.0 113.39 -171.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -65.56 -22.49 66.7 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.379 0.536 . . . . 0.0 111.475 170.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -75.01 174.31 9.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.055 0.942 . . . . 0.0 110.326 175.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.34 -29.9 70.96 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.712 0.805 . . . . 0.0 113.16 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 58.3 m . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -178.866 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.423 HD12 ' HB1' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -66.04 -34.99 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -175.14 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.0 -37.33 63.9 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.279 1.032 . . . . 0.0 112.528 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -63.7 -43.68 95.9 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.202 0.91 . . . . 0.0 111.35 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.3 mt -63.14 -50.43 70.46 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -70.22 -30.44 67.52 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.496 -173.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.01 91.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.481 0.582 . . . . 0.0 109.975 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -75.89 -29.6 58.53 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 117.771 -1.109 . . . . 0.0 112.4 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.26 -45.46 87.99 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 121.059 1.754 . . . . 0.0 109.855 172.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -71.4 -31.95 67.85 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.142 0.428 . . . . 0.0 110.964 -177.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -62.56 -39.47 93.74 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.013 0.37 . . . . 0.0 110.367 169.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.1 m -71.56 -0.53 10.82 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.82 1.248 . . . . 0.0 112.945 172.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.71 -14.31 41.9 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.809 1.195 . . . . 0.0 114.004 169.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.55 171.63 1.91 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.79 1.295 . . . . 0.0 110.839 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -142.81 150.68 40.27 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.993 -1.067 . . . . 0.0 112.237 170.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 17.3 tm0? -70.85 148.18 48.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.738 1.615 . . . . 0.0 108.438 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.3 m -128.22 144.96 51.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.936 1.695 . . . . 0.0 107.53 174.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.02 -127.84 8.68 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -143.98 164.41 30.68 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.993 1.717 . . . . 0.0 107.209 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.7 m -68.12 139.95 56.18 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.3 tp -105.8 150.2 25.77 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.209 1.003 . . . . 0.0 108.662 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.32 136.65 35.06 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.6 mm -135.49 113.81 15.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.176 -1.786 . . . . 0.0 106.176 -170.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -72.07 142.78 49.23 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 169.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.4 pp -128.92 3.62 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.518 1.127 . . . . 0.0 112.378 171.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 tp . . . . . 0 N--CA 1.466 0.374 0 CA-C-N 119.096 0.862 . . . . 0.0 112.351 -172.303 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 119.243 -0.408 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.1 -37.87 89.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.288 0.635 . . . . 0.0 111.252 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -71.46 -41.43 69.4 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.763 -0.586 . . . . 0.0 109.562 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -61.05 -45.15 95.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.62 -43.75 95.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.481 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.31 -45.36 92.87 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -63.97 -36.86 85.37 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.154 0.582 . . . . 0.0 111.168 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -67.91 -54.06 21.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.934 0.894 . . . . 0.0 109.8 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.93 -31.35 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 118.818 0.735 . . . . 0.0 111.141 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.24 -25.09 58.57 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.416 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.5 mt -101.46 -5.84 24.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.038 -0.982 . . . . 0.0 113.293 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.5 pp -120.3 -9.41 9.52 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.308 1.413 . . . . 0.0 113.08 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.251 1.133 0 C-N-CA 125.703 1.601 . . . . 0.0 111.961 178.264 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.38 0 CA-C-O 121.041 0.448 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -135.44 -25.94 1.28 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.765 1.226 . . . . 0.0 110.977 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.8 mt -129.53 84.77 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 169.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.5 m -75.56 115.85 15.67 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 176.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mp -74.35 156.89 36.62 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 171.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.6 mt -126.39 80.22 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.5 m -68.45 153.88 42.91 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.527 1.531 . . . . 0.0 110.561 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.1 100.42 0.19 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 121.656 0.741 . . . . 0.0 109.976 171.523 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.48 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.68 -26.83 64.56 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.483 0.641 . . . . 0.0 110.74 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -69.96 -36.64 75.4 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.328 0.513 . . . . 0.0 110.685 175.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -67.02 -44.28 80.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.735 0.698 . . . . 0.0 109.504 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.65 -39.15 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 119.057 -0.497 . . . . 0.0 109.967 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.88 -41.74 96.58 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.296 0.953 . . . . 0.0 110.987 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -63.32 -42.5 99.0 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.746 0.703 . . . . 0.0 110.553 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -62.02 -45.41 93.7 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.845 -0.534 . . . . 0.0 110.706 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.7 mt -62.06 -41.78 98.5 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.474 0.71 . . . . 0.0 110.464 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.18 -38.24 85.8 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.028 0.531 . . . . 0.0 110.662 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.18 -41.33 90.44 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.425 ' N ' ' HE2' ' A' ' 25' ' ' LYS . 6.8 mmpt? -62.89 -36.34 83.01 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 121.685 -0.634 . . . . 0.0 110.009 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.3 mt -68.45 -37.53 80.31 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 118.965 -0.541 . . . . 0.0 110.984 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -62.9 -42.11 99.67 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.924 0.783 . . . . 0.0 109.974 175.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.93 -37.29 87.16 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.145 0.43 . . . . 0.0 111.012 175.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.16 -22.03 63.96 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.792 0.837 . . . . 0.0 112.186 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.56 28.75 2.89 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.567 -1.13 . . . . 0.0 113.973 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -125.98 137.44 53.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.286 1.543 . . . . 0.0 109.223 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.5 p -76.07 146.85 39.08 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.43 0.633 . . . . 0.0 109.513 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.4 p -135.36 167.63 20.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.781 0.832 . . . . 0.0 110.212 -170.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -150.97 160.75 43.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 169.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.7 78.65 1.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -175.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.09 110.85 4.71 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -93.93 92.02 7.19 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -171.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.51 56.6 12.65 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.931 -0.927 . . . . 0.0 113.071 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.19 -179.14 3.3 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.91 2.407 . . . . 0.0 110.345 170.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.3 mt -114.77 160.16 19.75 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 169.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -55.5 -40.04 71.22 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.781 0.832 . . . . 0.0 111.403 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -64.83 -14.54 59.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.808 0.843 . . . . 0.0 113.198 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -90.76 -2.91 57.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.932 0.893 . . . . 0.0 112.309 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -137.44 154.4 75.26 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.147 0.979 . . . . 0.0 111.179 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.8 163.58 26.1 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.826 2.351 . . . . 0.0 111.77 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.04 18.67 0.99 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.41 1.484 . . . . 0.0 113.22 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.7 m -146.45 136.7 23.7 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.223 1.409 . . . . 0.0 107.887 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.71 -176.2 30.19 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.95 104.28 13.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -104.95 172.85 6.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.199 0.999 . . . . 0.0 109.931 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.6 tp -141.31 100.55 3.82 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 t -79.35 131.57 34.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.9 mt -133.0 127.58 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.2 m -134.29 129.31 35.39 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -170.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.9 m -69.07 160.51 30.89 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.505 169.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.9 m -132.82 109.21 9.48 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -63.28 -24.89 68.07 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.04 0.382 . . . . 0.0 111.956 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.09 -32.24 0.33 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.052 0.834 . . . . 0.0 112.234 171.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.93 30.31 4.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.27 1.028 . . . . 0.0 111.922 -171.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.81 -0.01 59.14 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.376 -0.68 . . . . 0.0 113.641 173.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -69.14 110.82 4.73 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 118.484 1.142 . . . . 0.0 109.982 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 61.2 mt -69.3 141.86 91.76 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 171.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.51 136.76 56.23 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.204 2.602 . . . . 0.0 110.985 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.9 -21.48 43.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.407 1.483 . . . . 0.0 113.237 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -64.87 -34.94 79.58 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.446 0.699 . . . . 0.0 111.454 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 tt -121.76 -22.17 5.88 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.615 0.766 . . . . 0.0 112.306 -169.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 81.7 p -51.13 -34.01 11.51 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-O 116.439 -1.743 . . . . 0.0 115.259 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -52.11 -22.9 15.99 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.989 2.46 . . . . 0.0 115.728 172.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -59.46 -37.21 77.58 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.336 0.971 . . . . 0.0 110.913 175.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -65.21 -42.26 93.69 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.602 0.761 . . . . 0.0 110.179 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -63.35 -50.95 67.95 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.714 0.406 . . . . 0.0 109.997 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.56 -29.21 70.23 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.993 0.815 . . . . 0.0 112.745 -174.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.3 mt -68.69 -57.07 6.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.382 171.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -69.86 -27.46 64.85 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.041 0.837 . . . . 0.0 112.431 -170.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.92 -26.05 61.27 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.123 0.874 . . . . 0.0 111.256 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -109.44 -24.4 11.04 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.573 -173.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt 40.13 59.81 7.05 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.778 1.631 . . . . 0.0 110.577 -169.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.25 167.62 17.94 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.846 2.364 . . . . 0.0 111.068 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -96.53 106.72 19.02 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 169.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.1 mt -118.98 24.93 10.54 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.128 1.771 . . . . 0.0 110.022 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -61.0 20.0 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.524 1.929 . . . . 0.0 115.569 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.13 1.86 1.86 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.35 1.46 . . . . 0.0 111.992 173.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.5 t -84.09 142.66 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -123.42 148.65 45.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 168.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -144.08 171.3 14.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.452 0.644 . . . . 0.0 111.45 -174.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.42 161.54 22.16 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 104.461 -3.456 . . . . 0.0 104.461 168.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.31 124.77 13.93 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -169.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 mt -134.65 133.43 54.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.8 140.03 15.93 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 170.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 mt -138.73 131.47 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -171.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.7 -169.01 41.46 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 120.231 1.378 . . . . 0.0 110.541 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.9 m -79.34 74.17 5.95 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 126.02 1.728 . . . . 0.0 108.223 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -52.6 -33.93 48.57 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.962 1.305 . . . . 0.0 112.211 -173.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -80.84 -12.02 59.5 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.671 1.188 . . . . 0.0 112.349 -174.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -67.49 -52.54 38.03 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 118.978 0.808 . . . . 0.0 111.836 -169.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -162.87 -47.06 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.346 1.058 . . . . 0.0 110.915 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.8 m . . . . . 0 C--O 1.234 0.245 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -174.358 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.6 tp -60.86 -28.21 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.361 1.464 . . . . 0.0 111.163 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -57.22 -40.35 77.34 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -169.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -63.62 -44.35 94.18 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.927 -0.483 . . . . 0.0 111.047 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.9 mt -69.34 -48.61 60.85 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.566 0.747 . . . . 0.0 109.398 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.63 -38.57 87.21 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.56 -37.65 88.27 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.316 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -70.62 -29.16 65.47 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.596 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.6 mt -66.23 -43.05 87.7 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.948 1.704 . . . . 0.0 109.259 170.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -62.71 -42.81 99.83 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 122.732 0.413 . . . . 0.0 109.985 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -60.82 -40.51 92.99 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.207 1.003 . . . . 0.0 110.826 174.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.0 m -70.3 -5.78 30.34 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.478 1.111 . . . . 0.0 113.186 175.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.19 -13.9 21.33 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.53 1.062 . . . . 0.0 113.612 169.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.73 178.97 0.7 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.379 1.089 . . . . 0.0 110.589 174.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -151.73 148.08 27.47 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.873 -1.142 . . . . 0.0 113.204 169.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 39.7 tp60 -56.77 155.94 7.13 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.715 2.006 . . . . 0.0 109.928 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.5 m -141.3 131.96 25.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.57 174.77 17.01 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -169.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -71.55 158.3 36.46 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.625 -0.926 . . . . 0.0 108.963 170.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.88 160.52 20.28 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 169.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 54.2 tp -129.54 148.44 51.44 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.517 -0.739 . . . . 0.0 109.637 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -125.71 147.33 49.4 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 169.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.7 mm -131.66 106.88 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -78.14 134.96 37.59 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 169.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.24 -17.64 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 118.294 0.497 . . . . 0.0 111.699 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.0 tp . . . . . 0 CA--C 1.533 0.322 0 CA-C-N 118.552 0.614 . . . . 0.0 111.274 -171.469 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 111.153 0.057 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -58.63 -33.73 70.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.49 1.116 . . . . 0.0 111.565 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -69.52 -42.08 75.16 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.851 0.75 . . . . 0.0 109.954 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -64.68 -43.88 92.11 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.98 -43.34 99.06 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.354 0.662 . . . . 0.0 110.513 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.71 -44.54 97.8 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.954 0.787 . . . . 0.0 111.513 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -63.47 -35.58 80.93 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.023 -0.692 . . . . 0.0 111.053 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -68.88 -48.51 63.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.918 0.887 . . . . 0.0 110.403 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.15 -32.55 57.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 CA-C-N 119.161 0.891 . . . . 0.0 111.169 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -62.14 -22.23 65.68 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.344 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.1 mt -96.53 -43.8 7.45 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.438 1.017 . . . . 0.0 111.621 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 pp -70.92 -25.41 62.75 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.355 0.98 . . . . 0.0 112.32 -175.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 C--O 1.252 1.209 0 C-N-CA 127.796 2.438 . . . . 0.0 112.02 177.767 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.282 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -137.36 -25.09 1.05 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.69 1.596 . . . . 0.0 110.992 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.8 mt -124.9 79.3 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 169.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.4 m -74.83 117.77 17.05 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.65 151.0 34.5 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.3 mt -116.2 80.34 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 m -71.44 148.34 46.96 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.254 1.422 . . . . 0.0 109.683 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.6 80.7 0.18 Allowed Glycine 0 C--N 1.339 0.735 0 O-C-N 122.237 -0.289 . . . . 0.0 113.794 -169.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.537 ' HG ' ' N ' ' A' ' 14' ' ' GLY . 5.0 t . . . . . 0 N--CA 1.451 -0.402 0 C-N-CA 123.899 0.88 . . . . 0.0 108.734 168.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.537 ' N ' ' HG ' ' A' ' 10' ' ' SER . . . . . . . . 0 CA--C 1.522 0.478 0 CA-C-O 120.026 -0.319 . . . . 0.0 113.109 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.02 -27.97 67.0 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 117.568 0.684 . . . . 0.0 110.972 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -76.33 -22.7 54.6 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.192 -173.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -65.75 -41.6 91.92 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.94 0.791 . . . . 0.0 109.182 169.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.5 t -72.22 -32.76 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 121.822 -0.549 . . . . 0.0 109.937 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.86 87.12 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.409 -0.807 . . . . 0.0 110.277 170.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.07 -38.93 89.56 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.412 0.551 . . . . 0.0 111.157 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -59.23 -46.8 87.51 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.095 0.861 . . . . 0.0 110.032 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.6 mt -65.14 -43.18 92.7 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.799 -0.563 . . . . 0.0 110.103 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.47 -42.61 92.43 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.549 0.74 . . . . 0.0 111.004 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -52.79 -47.43 67.56 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.799 0.84 . . . . 0.0 110.031 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -67.87 -40.9 83.54 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.2 mt -66.41 -39.59 89.09 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 119.259 -0.4 . . . . 0.0 110.641 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -61.12 -46.18 91.63 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.111 0.564 . . . . 0.0 109.655 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -65.5 -34.94 79.45 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.846 0.458 . . . . 0.0 111.34 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.6 -22.36 64.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.877 0.871 . . . . 0.0 112.035 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.25 1.67 23.47 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.656 1.122 . . . . 0.0 113.212 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -74.97 174.74 8.89 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.444 1.122 . . . . 0.0 109.475 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.4 p -122.61 137.32 54.93 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.5 p -132.51 170.32 15.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.135 0.974 . . . . 0.0 110.336 -170.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -153.54 126.1 8.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 104.518 -2.401 . . . . 0.0 104.518 169.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.0 p -82.54 70.63 9.55 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -69.58 113.59 7.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -169.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -72.27 107.98 5.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.261 1.024 . . . . 0.0 108.744 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.82 56.65 15.13 Favored Glycine 0 CA--C 1.539 1.577 0 CA-C-O 118.341 -1.255 . . . . 0.0 115.766 169.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.2 175.71 5.46 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.771 2.314 . . . . 0.0 111.685 173.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.7 mt -128.67 164.35 23.12 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.346 1.458 . . . . 0.0 109.226 174.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.4 tp -62.27 -27.8 69.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.816 1.247 . . . . 0.0 112.169 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.75 -10.38 12.6 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.136 0.974 . . . . 0.0 113.101 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -128.56 19.88 6.19 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.348 1.459 . . . . 0.0 110.872 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.94 97.67 13.61 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.08 1.352 . . . . 0.0 107.886 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.76 165.22 28.45 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.404 2.069 . . . . 0.0 111.774 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.71 4.67 1.8 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.69 1.596 . . . . 0.0 114.788 -175.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.2 m -144.94 133.85 22.47 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.354 1.462 . . . . 0.0 107.276 -175.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.71 175.53 23.54 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.5 mt -114.54 101.83 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -110.42 166.63 10.83 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.573 0.749 . . . . 0.0 108.98 -176.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.8 tp -146.37 99.28 3.2 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 t -79.52 132.31 32.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.793 1.237 . . . . 0.0 107.839 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 mt -135.98 132.29 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.6 m -134.18 133.67 41.23 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -169.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 m -80.08 166.71 21.24 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 169.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.5 m -141.15 112.27 7.29 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 174.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -71.61 -5.25 32.08 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -169.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 160.89 -38.58 0.43 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-N 119.794 1.179 . . . . 0.0 113.761 169.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.22 10.25 3.0 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.273 1.036 . . . . 0.0 113.259 -170.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.62 -14.88 4.71 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.135 0.874 . . . . 0.0 113.289 172.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.07 119.43 6.3 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.353 1.061 . . . . 0.0 111.632 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.4 mt -83.47 132.23 50.27 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -51.13 136.46 45.51 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 124.016 3.144 . . . . 0.0 113.292 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.39 -18.6 62.0 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.283 1.033 . . . . 0.0 113.315 -176.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -73.89 -27.11 60.89 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.413 -0.804 . . . . 0.0 112.179 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.9 tp -121.04 -27.1 5.02 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.283 0.947 . . . . 0.0 111.92 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -46.73 -39.76 17.37 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-O 117.549 -1.215 . . . . 0.0 113.935 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.42 -25.64 14.46 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.502 2.801 . . . . 0.0 116.077 172.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -60.56 -37.5 81.47 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.157 -0.965 . . . . 0.0 110.855 176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -65.71 -43.3 89.54 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.113 0.565 . . . . 0.0 110.9 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.26 -38.04 68.95 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.583 0.629 . . . . 0.0 110.784 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.04 -35.91 80.92 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.726 0.693 . . . . 0.0 111.576 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.9 mt -64.45 -54.41 33.02 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.744 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -69.54 -25.96 64.27 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.147 0.885 . . . . 0.0 111.957 -173.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -68.88 -37.27 78.94 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.86 0.755 . . . . 0.0 110.697 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -105.07 -34.33 8.0 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -169.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm 31.0 57.92 0.98 Allowed Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 127.306 2.242 . . . . 0.0 113.675 -173.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.23 169.83 15.93 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.929 1.753 . . . . 0.0 110.167 174.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -72.04 114.83 10.57 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 169.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.1 mt -119.72 18.74 12.62 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.674 1.59 . . . . 0.0 110.901 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.8 m -57.87 4.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.43 1.22 8.96 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.848 1.204 . . . . 0.0 111.614 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 79.8 t -74.56 131.63 34.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 169.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -107.62 102.73 11.95 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 102.197 -3.26 . . . . 0.0 102.197 168.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -95.88 167.35 11.31 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.803 0.811 . . . . 0.0 108.933 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -123.13 154.46 17.17 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 104.839 -3.305 . . . . 0.0 104.839 169.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.47 122.48 11.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.8 mt -135.68 131.82 50.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -102.26 138.11 13.73 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.9 mt -133.21 153.35 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 165.66 173.4 34.13 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-O 123.278 1.488 . . . . 0.0 110.732 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.1 m -74.48 56.94 0.69 Allowed 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 126.511 1.924 . . . . 0.0 109.952 174.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.14 -52.5 7.23 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.894 2.078 . . . . 0.0 110.978 -174.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -65.14 -11.7 43.07 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.093 0.557 . . . . 0.0 112.498 -171.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -66.27 -50.43 63.73 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.908 0.776 . . . . 0.0 110.184 170.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -171.61 -49.02 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.412 1.485 . . . . 0.0 111.797 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.536 0.44 0 C-N-CA 124.739 1.216 . . . . 0.0 114.02 -169.685 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.8 tp -67.88 -27.87 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.174 0.59 . . . . 0.0 110.841 -176.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -61.02 -43.52 98.76 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 118.354 0.524 . . . . 0.0 111.787 -169.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -65.81 -44.52 85.4 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 122.016 -0.427 . . . . 0.0 110.802 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.9 mt -63.33 -46.66 85.61 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.331 0.652 . . . . 0.0 109.948 -176.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.89 -40.38 75.7 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.997 0.362 . . . . 0.0 110.075 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.31 -35.02 79.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.032 -169.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -74.21 -29.94 61.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.18 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.8 mt -66.62 -41.78 87.84 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.16 1.346 . . . . 0.0 109.02 169.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -61.55 -43.92 97.98 Favored 'General case' 0 N--CA 1.458 -0.062 0 C-N-CA 124.002 0.921 . . . . 0.0 109.343 -177.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -67.5 -36.41 81.01 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.023 0.929 . . . . 0.0 111.347 176.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.1 m -68.84 -2.09 8.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.225 1.01 . . . . 0.0 112.876 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.28 -15.66 30.16 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.32 1.438 . . . . 0.0 113.693 169.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.19 171.95 2.73 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.6 1.2 . . . . 0.0 110.989 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -142.66 154.47 44.37 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.364 -0.835 . . . . 0.0 111.462 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -63.85 161.35 15.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.774 2.029 . . . . 0.0 110.244 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.6 m -133.99 152.85 52.01 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.509 1.923 . . . . 0.0 106.321 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.37 -135.27 51.84 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -169.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -140.47 150.67 44.09 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.8 m -63.22 149.64 44.98 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.269 1.428 . . . . 0.0 110.551 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.9 tp -132.88 147.89 52.3 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.388 1.075 . . . . 0.0 109.084 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -120.06 139.25 52.82 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.221 1.808 . . . . 0.0 106.227 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.8 mt -138.07 107.25 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -67.57 141.13 56.92 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 170.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.3 pt -122.06 -9.66 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.036 1.335 . . . . 0.0 112.1 171.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.4 tp . . . . . 0 C--N 1.343 0.283 0 CA-C-N 119.883 1.22 . . . . 0.0 108.378 176.562 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.408 0 CA-C-O 119.353 -0.356 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -62.15 -38.93 90.89 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.51 0.724 . . . . 0.0 110.908 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -76.13 -49.09 18.29 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -64.67 -33.16 75.28 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.216 -0.303 . . . . 0.0 111.744 -174.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 48.9 tp -56.98 -30.18 63.9 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 118.68 -0.676 . . . . 0.0 111.358 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.92 -45.7 70.34 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 118.841 0.746 . . . . 0.0 111.297 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.9 m -66.77 -30.76 71.05 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 117.492 0.646 . . . . 0.0 111.319 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -72.61 -51.31 20.18 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.532 0.733 . . . . 0.0 110.03 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 31.4 m -66.52 -30.64 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 O-C-N 121.331 -0.855 . . . . 0.0 111.246 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -60.74 -21.25 62.78 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.846 0.859 . . . . 0.0 112.482 175.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 28.8 mt -102.78 -35.93 8.46 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 118.069 -0.967 . . . . 0.0 112.109 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -35.78 79.52 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 120.005 1.275 . . . . 0.0 111.838 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt . . . . . 0 C--O 1.251 1.176 0 C-N-CA 128.658 2.783 . . . . 0.0 113.236 -179.474 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 121.006 0.431 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -134.34 -26.03 1.48 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.122 1.369 . . . . 0.0 110.973 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.6 mt -129.04 82.36 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 169.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.8 m -74.6 121.29 21.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.5 mp -78.98 146.17 33.54 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.5 mt -109.91 82.31 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.4 m -64.1 140.33 58.86 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.014 0.926 . . . . 0.0 110.431 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.57 72.12 0.41 Allowed Glycine 0 C--N 1.339 0.739 0 C-N-CA 123.584 0.611 . . . . 0.0 113.851 -169.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 C--O 1.234 0.238 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 168.51 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.815 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.9 -29.23 69.06 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.542 -0.742 . . . . 0.0 110.644 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -69.88 -35.32 74.56 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.15 0.886 . . . . 0.0 110.231 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -70.91 -41.73 70.88 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.998 0.817 . . . . 0.0 109.784 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.11 -44.81 99.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.87 -36.47 79.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.524 -0.751 . . . . 0.0 111.01 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.82 -41.69 99.42 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.52 1.055 . . . . 0.0 110.7 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -64.57 -48.87 73.4 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.161 0.437 . . . . 0.0 109.962 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.84 -46.11 88.49 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.86 0.464 . . . . 0.0 110.233 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.51 98.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.474 1.11 . . . . 0.0 111.029 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.39 -43.66 96.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.288 0.495 . . . . 0.0 110.355 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -67.45 -34.29 76.88 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.356 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.0 mt -63.99 -37.02 85.9 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 119.381 0.991 . . . . 0.0 111.755 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -63.44 -40.91 98.4 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.586 1.085 . . . . 0.0 110.15 175.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.22 -37.04 86.03 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.296 0.498 . . . . 0.0 111.087 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.84 -21.86 63.33 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.74 0.816 . . . . 0.0 112.256 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.27 26.04 3.32 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.533 -1.148 . . . . 0.0 114.022 170.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -125.88 131.58 52.33 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.244 1.522 . . . . 0.0 108.72 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 p -73.26 147.47 44.56 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.5 p -140.72 169.28 17.94 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.084 0.954 . . . . 0.0 109.588 -169.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -152.5 140.67 20.38 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 169.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.5 p -96.42 68.65 2.57 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.87 119.3 17.9 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -169.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -69.29 99.96 1.26 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.264 1.026 . . . . 0.0 109.665 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.13 54.22 10.04 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.347 1.451 . . . . 0.0 115.549 171.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -60.6 142.97 99.31 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 CA-C-N 120.494 2.147 . . . . 0.0 109.815 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.1 mt -69.23 155.03 41.08 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.75 -34.26 71.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.311 0.644 . . . . 0.0 109.761 169.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -65.58 -9.57 27.83 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.386 1.475 . . . . 0.0 112.909 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -118.06 13.23 13.84 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.007 1.323 . . . . 0.0 111.556 -170.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 pp -141.98 154.78 65.53 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.513 1.125 . . . . 0.0 109.592 171.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.48 161.29 37.57 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.594 2.196 . . . . 0.0 112.07 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.06 18.63 0.48 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.567 1.547 . . . . 0.0 112.931 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.8 t -152.37 133.68 14.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.03 179.39 31.93 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.0 mt -117.25 106.66 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.096 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -107.75 169.07 8.83 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 123.152 0.581 . . . . 0.0 109.516 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.4 tp -142.41 101.04 3.82 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.01 144.09 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.217 -171.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.57 143.42 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 172.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 m -147.24 134.49 20.59 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.402 -0.812 . . . . 0.0 108.876 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.4 m -75.91 160.36 29.99 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 169.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.471 ' HG1' ' N ' ' A' ' 101' ' ' ALA . 90.8 m -128.64 106.22 8.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.778 1.631 . . . . 0.0 106.921 -174.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -67.11 169.82 7.9 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.2 -23.82 34.3 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.754 -1.026 . . . . 0.0 114.947 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.92 11.7 16.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.996 1.318 . . . . 0.0 112.709 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.14 16.97 70.61 Favored Glycine 0 C--N 1.339 0.697 0 O-C-N 121.439 -0.788 . . . . 0.0 113.721 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -66.45 119.99 12.59 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.659 1.23 . . . . 0.0 108.419 170.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.2 mt -70.18 142.58 90.15 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -61.28 144.64 98.74 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.085 2.523 . . . . 0.0 112.065 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -59.01 -21.91 59.8 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.359 1.464 . . . . 0.0 113.598 -173.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.91 -27.97 68.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.38 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 63.6 tp -130.79 -20.72 2.81 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.734 0.814 . . . . 0.0 112.508 -170.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.0 p -53.19 -31.5 7.88 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -53.52 -20.89 17.14 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.014 2.476 . . . . 0.0 115.583 169.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -56.99 -35.65 69.45 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.177 0.898 . . . . 0.0 110.96 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -65.35 -48.83 71.64 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.58 -43.44 98.85 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.605 0.762 . . . . 0.0 110.009 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.57 -29.8 68.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.419 0.688 . . . . 0.0 112.492 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.4 mt -76.68 -29.8 56.48 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.771 176.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -73.62 -46.84 44.43 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.494 1.043 . . . . 0.0 109.115 175.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.11 -25.73 67.9 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.831 0.853 . . . . 0.0 111.837 -171.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -118.14 -25.26 6.71 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 117.974 -1.012 . . . . 0.0 113.167 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? 36.55 59.06 3.51 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 125.026 1.33 . . . . 0.0 110.605 -169.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -68.17 173.84 8.89 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.603 2.869 . . . . 0.0 112.777 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -105.39 107.81 19.0 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.8 mt -117.86 22.32 12.36 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 126.146 1.778 . . . . 0.0 110.675 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 m -57.46 16.05 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.51 2.324 . . . . 0.0 116.549 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.6 0.89 2.08 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.889 1.276 . . . . 0.0 112.309 172.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 94.9 t -75.85 134.56 28.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.9 mmm-85 -121.97 144.46 48.87 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 104.972 -2.232 . . . . 0.0 104.972 168.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -150.84 169.73 20.99 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.861 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -125.37 166.31 18.15 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 105.457 -3.057 . . . . 0.0 105.457 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.81 135.84 22.46 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.831 1.315 . . . . 0.0 111.111 -169.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.1 mm -124.24 130.51 73.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -104.9 135.97 12.85 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 107.691 -2.163 . . . . 0.0 107.691 169.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.2 mt -130.01 152.92 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 161.17 175.66 32.44 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 71.0 m -78.39 91.69 4.5 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 169.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -28.87 62.05 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.472 0.709 . . . . 0.0 112.872 -169.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -73.68 -9.9 59.14 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.49 169.01 11.65 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.161 0.891 . . . . 0.0 110.173 172.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -58.48 -34.52 70.97 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.424 0.69 . . . . 0.0 112.782 -173.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.9 m . . . . . 0 C--O 1.235 0.326 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.508 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.471 ' N ' ' HG1' ' A' ' 56' ' ' THR . . . . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 102' ' ' ILE . 2.1 tp -52.98 -33.34 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 126.075 1.75 . . . . 0.0 110.391 170.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -51.4 -39.18 56.7 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.497 1.119 . . . . 0.0 112.855 -172.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -66.44 -36.5 82.95 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.787 -0.571 . . . . 0.0 111.446 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.2 mt -71.89 -52.07 19.1 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -67.08 -35.81 80.62 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.991 -171.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.32 -38.54 90.47 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -73.25 -30.94 63.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.914 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.05 -46.69 86.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.314 1.415 . . . . 0.0 109.203 169.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -63.37 -41.06 98.79 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 122.417 0.287 . . . . 0.0 110.387 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -63.04 -39.54 95.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.581 0.752 . . . . 0.0 110.524 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.7 m -70.68 -7.11 42.15 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.469 1.108 . . . . 0.0 112.908 174.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.03 -16.9 8.71 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.728 1.156 . . . . 0.0 113.921 169.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.22 172.75 1.35 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.517 1.159 . . . . 0.0 111.277 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -140.87 136.16 32.06 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.499 -0.751 . . . . 0.0 110.904 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -62.43 170.46 2.39 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.973 1.309 . . . . 0.0 109.295 170.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 m -133.67 149.71 51.55 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.419 ' H ' HD12 ' A' ' 145' ' ' LEU . . . 61.87 -136.44 46.37 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.09 157.71 45.79 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 171.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.98 135.76 57.47 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.959 0.904 . . . . 0.0 110.183 -177.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.4 tp -94.08 148.7 21.92 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -123.55 144.41 49.59 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 57.0 mt -136.95 108.82 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -68.03 143.2 55.64 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 169.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.24 9.25 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.024 0.93 . . . . 0.0 112.54 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp . . . . . 0 N--CA 1.467 0.384 0 O-C-N 121.473 -0.767 . . . . 0.0 111.318 178.617 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 118.856 -0.593 . . . . 0.0 111.958 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -54.76 -35.34 63.67 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.011 0.924 . . . . 0.0 111.515 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -65.21 -43.45 91.51 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.679 -0.638 . . . . 0.0 110.188 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -74.28 -35.42 63.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.763 0.825 . . . . 0.0 110.344 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.4 tp -61.94 -36.24 80.81 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.973 0.909 . . . . 0.0 110.742 173.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.76 -47.74 58.01 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.471 1.034 . . . . 0.0 111.102 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 m -61.82 -42.23 98.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.665 0.732 . . . . 0.0 110.778 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -60.44 -49.92 75.65 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.511 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.7 m -65.36 -34.79 72.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 119.866 1.212 . . . . 0.0 110.867 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.79 -22.4 66.98 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.426 0.69 . . . . 0.0 111.679 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.419 HD12 ' H ' ' A' ' 118' ' ' GLY . 7.2 mt -90.67 -57.98 2.64 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.599 1.09 . . . . 0.0 110.141 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.08 -25.79 65.51 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 117.567 -1.206 . . . . 0.0 113.815 -169.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm . . . . . 0 C--O 1.251 1.181 0 C-N-CA 128.046 2.538 . . . . 0.0 113.27 175.249 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 120.913 0.387 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -133.38 -25.58 1.72 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.818 1.247 . . . . 0.0 111.028 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.0 mt -121.37 74.92 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 170.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.1 m -75.35 120.98 21.55 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.8 mt -94.85 151.06 19.55 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 80.3 mt -125.76 84.13 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -169.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.9 m -74.94 151.23 38.89 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.656 0.782 . . . . 0.0 110.35 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.81 118.16 0.8 Allowed Glycine 0 C--N 1.333 0.394 0 N-CA-C 107.576 -2.209 . . . . 0.0 107.576 170.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 122.006 0.908 . . . . 0.0 111.641 -173.625 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.558 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.6 -22.96 64.42 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 117.315 0.557 . . . . 0.0 111.571 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -75.31 -43.8 48.9 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -68.7 -41.8 78.65 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 122.862 0.465 . . . . 0.0 109.748 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.24 -48.84 85.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.244 0.618 . . . . 0.0 109.433 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.17 89.48 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 118.902 0.773 . . . . 0.0 110.667 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.0 -43.0 93.97 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.455 1.025 . . . . 0.0 111.119 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -61.86 -45.11 95.18 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.834 -0.541 . . . . 0.0 110.481 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.5 mt -65.45 -42.21 92.61 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.256 0.622 . . . . 0.0 110.153 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.1 83.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.023 0.929 . . . . 0.0 110.966 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -58.68 -46.8 86.43 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.882 0.765 . . . . 0.0 110.496 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -68.21 -37.46 80.91 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.567 -0.708 . . . . 0.0 110.835 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.3 mt -61.41 -42.04 98.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.279 0.945 . . . . 0.0 111.369 175.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.7 -38.96 84.35 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.642 0.655 . . . . 0.0 110.327 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -64.55 -36.04 82.92 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.46 0.573 . . . . 0.0 110.904 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.01 -23.71 64.13 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.54 0.736 . . . . 0.0 111.973 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.56 -0.77 12.46 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.968 1.271 . . . . 0.0 113.764 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -77.05 174.7 10.35 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.635 1.217 . . . . 0.0 110.61 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.8 p -120.88 140.0 52.41 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 p -136.49 168.98 18.45 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.254 1.022 . . . . 0.0 110.229 -169.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -153.13 155.59 37.03 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 169.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.0 p -119.55 71.55 0.88 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -172.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.3 mt -76.07 118.9 19.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -171.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -91.89 95.48 9.85 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.97 49.47 6.38 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.016 -1.436 . . . . 0.0 115.22 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -68.43 176.27 5.92 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 CA-C-N 120.686 2.243 . . . . 0.0 110.989 169.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.5 mt -130.8 168.4 17.3 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.381 1.472 . . . . 0.0 110.027 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.5 tp -56.06 -27.36 53.1 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.906 1.683 . . . . 0.0 111.881 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -64.18 -12.37 39.62 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.547 1.139 . . . . 0.0 112.593 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -137.09 20.52 3.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.933 1.293 . . . . 0.0 111.377 -173.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.2 mt -135.03 102.81 10.88 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.648 1.179 . . . . 0.0 108.319 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -73.32 169.85 21.3 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.932 2.422 . . . . 0.0 112.21 -176.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.48 8.98 2.42 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.807 1.643 . . . . 0.0 114.767 -171.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -153.15 141.18 20.31 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.929 0.786 . . . . 0.0 109.27 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.14 -178.66 24.63 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -123.3 99.5 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -94.69 176.22 6.36 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.464 0.706 . . . . 0.0 110.155 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.9 tp -140.98 98.67 3.43 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -79.64 129.0 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 mt -127.54 146.21 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.9 m -145.48 141.92 28.77 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.718 -0.614 . . . . 0.0 110.016 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.7 m -91.08 95.11 9.92 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.48 ' HG1' ' N ' ' A' ' 101' ' ' ALA . 44.2 m -70.6 83.2 0.61 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 171.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -79.12 44.23 0.56 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.123 1.769 . . . . 0.0 111.442 -174.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.2 -30.05 2.15 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.33 1.443 . . . . 0.0 114.278 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.61 -21.75 64.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.395 1.078 . . . . 0.0 113.678 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.86 20.37 77.98 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -170.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -130.77 155.46 46.62 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.734 1.614 . . . . 0.0 107.083 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.37 150.07 39.43 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.227 1.411 . . . . 0.0 107.965 -169.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -53.6 139.25 66.99 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.276 2.651 . . . . 0.0 112.321 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -58.35 -23.12 55.84 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.976 1.311 . . . . 0.0 113.71 -171.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -75.21 -21.48 58.63 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.563 -0.732 . . . . 0.0 112.502 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.6 tp -126.84 -23.89 3.6 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.007 0.923 . . . . 0.0 111.902 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 91.9 p -53.72 -29.65 5.02 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-O 117.038 -1.458 . . . . 0.0 114.138 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.34 -23.34 18.2 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.639 2.226 . . . . 0.0 114.958 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -64.52 -39.96 94.74 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 120.104 1.32 . . . . 0.0 110.815 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -60.72 -41.87 96.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.105 0.562 . . . . 0.0 110.085 175.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -66.23 -47.89 72.34 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.076 0.55 . . . . 0.0 110.299 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.85 -41.28 95.83 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 121.794 -0.566 . . . . 0.0 111.362 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.7 mt -62.72 -50.82 69.61 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.888 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -70.3 -29.19 65.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.023 0.829 . . . . 0.0 111.642 -176.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.09 -50.46 47.97 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.768 0.713 . . . . 0.0 109.866 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -84.19 -23.01 30.73 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.349 -173.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.5 tttt 38.45 61.43 4.74 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 126.085 1.754 . . . . 0.0 110.806 -169.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -66.5 169.27 14.5 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.109 2.539 . . . . 0.0 111.363 -174.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -96.69 104.21 16.18 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 169.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.0 mt -118.83 26.6 9.43 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 126.414 1.886 . . . . 0.0 109.818 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.8 m -60.1 15.62 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.815 2.046 . . . . 0.0 116.048 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.85 6.09 1.58 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.039 1.336 . . . . 0.0 111.762 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.1 t -77.58 140.31 17.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -122.67 157.2 32.76 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 168.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -154.16 176.28 12.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.739 0.699 . . . . 0.0 111.77 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.55 162.76 22.17 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 105.593 -3.003 . . . . 0.0 105.593 169.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.68 126.63 19.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -169.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.7 mt -136.04 126.2 41.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -174.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -100.69 152.25 19.08 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.6 mt -134.8 137.98 50.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 175.99 -152.05 12.47 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.6 m -128.19 127.19 42.46 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.381 1.073 . . . . 0.0 109.095 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -67.58 -6.57 20.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.631 0.772 . . . . 0.0 112.09 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.35 -33.12 63.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.094 1.358 . . . . 0.0 111.592 172.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -116.36 155.96 27.56 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.448 1.099 . . . . 0.0 110.805 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.64 -34.46 77.88 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.638 0.775 . . . . 0.0 111.661 -174.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.756 0 C-N-CA 126.472 1.909 . . . . 0.0 111.011 175.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.48 ' N ' ' HG1' ' A' ' 56' ' ' THR . . . . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.33 -34.2 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.781 1.232 . . . . 0.0 109.579 170.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.21 -32.42 68.28 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 123.777 0.831 . . . . 0.0 111.989 -175.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -62.01 -45.41 93.71 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.512 0.596 . . . . 0.0 110.473 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.29 -53.15 61.11 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -72.22 -31.89 66.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.64 -170.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.16 -44.2 92.12 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.99 0.814 . . . . 0.0 109.858 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -74.64 -28.11 60.72 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.199 -0.905 . . . . 0.0 112.281 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.6 -45.01 92.32 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.493 1.497 . . . . 0.0 109.374 169.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -66.27 -39.77 89.66 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 122.182 -0.324 . . . . 0.0 110.473 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -61.05 -40.17 92.62 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.056 0.542 . . . . 0.0 110.511 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.5 m -69.57 -14.27 62.76 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.946 0.898 . . . . 0.0 112.878 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.58 -13.04 6.94 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.048 1.309 . . . . 0.0 113.872 169.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.87 172.6 2.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.579 1.19 . . . . 0.0 111.858 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -145.54 144.1 30.33 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.389 -0.819 . . . . 0.0 111.558 169.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 38.2 tp60 -58.26 154.44 13.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.893 1.677 . . . . 0.0 109.491 172.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.4 m -139.42 134.01 31.8 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.02 176.34 37.71 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -172.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -76.26 164.27 26.22 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.022 -0.693 . . . . 0.0 109.488 172.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.2 164.12 23.38 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 169.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.0 tp -129.84 147.61 51.63 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.246 -0.909 . . . . 0.0 109.704 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.97 142.13 47.69 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 176.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 43.3 mt -138.79 110.87 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -82.88 131.2 35.2 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 123.247 0.619 . . . . 0.0 109.696 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -127.75 14.45 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 125.028 1.331 . . . . 0.0 111.852 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 68.0 tp . . . . . 0 N--CA 1.468 0.467 0 C-N-CA 124.387 1.075 . . . . 0.0 111.449 -177.264 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -60.31 -49.14 78.78 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.428 0.691 . . . . 0.0 110.922 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -79.85 -36.63 36.46 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.787 0.835 . . . . 0.0 110.121 -174.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 86.2 t90 -58.98 -48.45 81.52 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 28.7 tp -67.51 -39.74 85.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 119.057 -0.497 . . . . 0.0 110.6 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.9 -44.73 92.34 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -65.43 -40.54 93.43 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.133 0.573 . . . . 0.0 110.629 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -63.96 -49.78 71.21 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.797 -0.621 . . . . 0.0 110.231 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.06 -34.6 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 119.297 0.953 . . . . 0.0 110.895 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -61.63 -31.62 71.73 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-O 118.848 -0.596 . . . . 0.0 111.8 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.3 mt -86.27 -46.68 10.11 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.219 0.918 . . . . 0.0 111.296 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.05 -24.35 61.52 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.945 0.793 . . . . 0.0 112.404 -172.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.9 mttp . . . . . 0 C--O 1.247 0.926 0 C-N-CA 127.572 2.349 . . . . 0.0 111.652 -179.115 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 120.709 0.29 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -135.98 -25.11 1.25 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.418 1.087 . . . . 0.0 111.453 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.0 mt -130.27 82.74 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 169.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.6 m -75.95 116.9 17.11 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.85 151.88 40.38 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.3 mt -122.31 100.08 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 m -93.73 123.73 37.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.176 0.99 . . . . 0.0 110.121 -172.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.68 60.28 0.62 Allowed Glycine 0 C--N 1.331 0.254 0 N-CA-C 105.972 -2.851 . . . . 0.0 105.972 170.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.449 -0.513 0 C-N-CA 124.576 1.15 . . . . 0.0 111.589 -167.984 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.637 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.88 -28.17 68.76 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 117.433 0.617 . . . . 0.0 111.174 177.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.39 -39.96 58.51 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -65.31 -40.06 93.29 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.3 t -57.32 -51.29 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.134 0.974 . . . . 0.0 109.639 173.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.54 -43.56 98.64 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.961 0.801 . . . . 0.0 111.088 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.73 -45.51 86.17 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.914 0.486 . . . . 0.0 110.735 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -59.8 -48.27 82.36 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.297 1.039 . . . . 0.0 110.221 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.1 mt -59.88 -46.05 90.54 Favored 'General case' 0 N--CA 1.458 -0.054 0 C-N-CA 123.369 0.667 . . . . 0.0 110.242 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.87 -50.64 73.23 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.293 0.497 . . . . 0.0 110.339 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -58.87 -47.63 84.25 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.129 0.571 . . . . 0.0 110.483 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -66.01 -38.32 88.18 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.132 -177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.6 mt -65.78 -39.93 91.46 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 119.63 1.105 . . . . 0.0 110.791 175.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.96 -40.1 95.65 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.916 0.78 . . . . 0.0 110.128 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -65.66 -37.73 87.36 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.406 0.548 . . . . 0.0 111.156 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.92 -22.4 64.16 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.708 0.803 . . . . 0.0 112.136 176.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.14 25.72 3.46 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.636 -1.091 . . . . 0.0 113.821 170.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -127.72 127.73 44.16 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.152 1.476 . . . . 0.0 108.451 -177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 p -72.68 149.83 43.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 109.835 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.8 p -133.72 170.21 15.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.688 0.756 . . . . 0.0 110.356 -172.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -151.66 162.17 41.45 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 169.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.5 83.04 2.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -177.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.2 mt -71.19 109.99 5.57 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -78.77 108.86 12.51 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.67 50.77 60.98 Favored Glycine 0 CA--C 1.54 1.612 0 CA-C-O 118.159 -1.356 . . . . 0.0 115.367 171.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -67.86 175.57 6.22 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.706 2.271 . . . . 0.0 111.183 173.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.9 mt -123.43 157.01 34.4 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.192 1.397 . . . . 0.0 108.219 170.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.81 -30.47 71.56 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.797 0.839 . . . . 0.0 111.768 -174.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.49 -8.51 14.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.783 0.833 . . . . 0.0 112.897 176.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -118.13 18.28 13.86 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.543 1.537 . . . . 0.0 110.832 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.4 mt -127.06 142.11 42.71 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.751 1.22 . . . . 0.0 109.205 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.05 162.47 41.71 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.539 2.159 . . . . 0.0 109.823 169.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.7 21.33 0.67 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.383 1.073 . . . . 0.0 112.557 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.6 p -156.79 149.76 23.87 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.787 1.235 . . . . 0.0 109.043 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.31 179.28 22.37 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.5 mt -117.62 103.32 14.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -104.82 170.81 7.66 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.043 0.937 . . . . 0.0 109.58 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.4 tp -148.58 106.52 3.71 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.8 t -87.88 137.07 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -173.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.04 126.67 56.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.3 m -135.08 120.37 18.99 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.781 0.432 . . . . 0.0 110.401 -172.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 m -71.94 -172.81 0.91 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 168.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -127.84 141.4 51.57 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -77.16 11.87 1.68 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.608 1.563 . . . . 0.0 111.889 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.05 23.34 76.1 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 120.934 -1.104 . . . . 0.0 111.378 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.2 8.54 2.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.206 1.402 . . . . 0.0 112.151 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.421 ' H ' HG23 ' A' ' 97' ' ' THR . . . 73.59 34.58 56.73 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 119.25 0.932 . . . . 0.0 111.114 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -145.92 152.73 39.9 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.774 1.63 . . . . 0.0 107.802 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 62' ' ' ILE . 4.2 mp -65.9 148.05 98.48 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -52.97 149.67 25.85 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.686 2.924 . . . . 0.0 113.298 169.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -57.21 -16.63 8.6 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.864 1.666 . . . . 0.0 113.663 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -61.99 -39.15 91.2 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.731 0.812 . . . . 0.0 110.8 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.2 tp -126.28 -22.27 4.07 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.5 0.72 . . . . 0.0 112.301 -171.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.9 p -54.37 -31.1 7.92 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-O 117.03 -1.462 . . . . 0.0 114.819 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -52.25 -22.71 16.15 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.147 2.565 . . . . 0.0 115.188 169.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -56.26 -35.64 67.67 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.029 0.932 . . . . 0.0 111.066 175.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -64.06 -40.59 96.6 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 122.991 0.517 . . . . 0.0 110.878 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.75 -46.44 58.46 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.02 -29.41 70.32 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.141 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.67 -63.74 1.09 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 170.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -67.85 -22.61 65.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.682 0.674 . . . . 0.0 112.624 -170.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -70.98 -32.95 69.94 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.602 0.761 . . . . 0.0 111.502 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -114.43 -33.98 5.41 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp 28.05 64.72 0.65 Allowed Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 127.83 2.452 . . . . 0.0 113.086 -169.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -60.57 173.38 2.14 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.695 2.263 . . . . 0.0 111.954 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -75.84 62.59 1.57 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.174 1.39 . . . . 0.0 110.561 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 70.8 mt -73.27 8.33 1.76 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.358 1.463 . . . . 0.0 112.786 -177.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.9 m -45.76 10.31 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.751 1 C-N-CA 132.055 4.142 . . . . 0.0 117.649 170.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.36 3.03 1.71 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.2 1.4 . . . . 0.0 112.172 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.2 t -78.71 137.3 22.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 169.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -119.19 141.5 48.82 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 168.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -148.86 172.46 14.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.111 0.414 . . . . 0.0 111.094 -174.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.67 163.53 24.11 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 105.761 -2.936 . . . . 0.0 105.761 169.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.19 130.37 19.65 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.306 1.053 . . . . 0.0 109.662 -169.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 23.1 mt -134.1 130.92 55.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -118.14 139.65 14.84 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.2 mp -131.44 118.37 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 176.7 -158.37 24.37 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 105.906 -2.878 . . . . 0.0 105.906 -172.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.6 m -96.82 170.14 9.37 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.187 0.995 . . . . 0.0 110.765 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -119.7 -19.76 7.92 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.203 1.001 . . . . 0.0 109.866 169.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -111.57 5.98 19.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.934 2.494 . . . . 0.0 111.089 -169.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -141.58 165.04 28.59 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.186 1.794 . . . . 0.0 109.04 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -59.28 -35.35 73.58 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.827 1.651 . . . . 0.0 113.503 -169.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 60' ' ' GLY . 53.2 m . . . . . 0 CA--C 1.534 0.349 0 CA-C-O 121.881 0.848 . . . . 0.0 109.2 170.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.676 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.9 tp -54.26 -31.41 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.599 1.56 . . . . 0.0 110.969 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -50.91 -35.28 32.26 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.732 1.213 . . . . 0.0 112.962 -170.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -54.27 -51.47 64.47 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.46 0.573 . . . . 0.0 111.353 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.3 mt -68.7 -50.89 47.26 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -172.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -67.58 -35.74 79.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.901 -173.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.84 -41.66 78.22 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.38 -24.97 62.17 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 117.509 -1.234 . . . . 0.0 112.424 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.6 mt -65.86 -52.38 50.82 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.978 1.717 . . . . 0.0 108.951 169.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -68.21 -33.89 75.25 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 122.076 -0.39 . . . . 0.0 110.883 -173.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -76.13 6.55 5.2 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.875 1.27 . . . . 0.0 112.644 172.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.4 m -120.59 15.41 11.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.299 1.44 . . . . 0.0 110.328 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.75 -22.96 27.11 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.623 1.106 . . . . 0.0 113.557 169.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.83 167.92 1.41 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.587 1.194 . . . . 0.0 110.66 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -137.17 136.48 38.25 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 121.461 -0.775 . . . . 0.0 111.351 171.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -60.29 164.58 4.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.056 -1.429 . . . . 0.0 109.525 171.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 m -136.49 157.84 45.85 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 126.371 1.868 . . . . 0.0 106.036 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.434 ' H ' HD12 ' A' ' 145' ' ' LEU . . . 55.7 -128.74 45.65 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 -173.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -144.62 165.81 26.97 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.706 1.203 . . . . 0.0 107.956 169.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.75 154.42 29.71 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.041 0.937 . . . . 0.0 110.438 -178.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 57.0 tp -129.67 143.54 50.87 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.858 0.863 . . . . 0.0 109.576 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -118.15 143.09 46.77 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.4 mt -132.31 100.38 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -69.62 142.01 53.58 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.486 0.714 . . . . 0.0 111.161 -171.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 8.4 pt -105.79 -21.04 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.178 0.991 . . . . 0.0 111.858 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 CA--C 1.53 0.208 0 C-N-CA 123.559 0.744 . . . . 0.0 109.801 -172.155 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 118.885 -0.579 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -65.23 -44.14 89.17 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.039 0.836 . . . . 0.0 110.304 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -62.84 -47.55 82.91 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.126 -0.359 . . . . 0.0 110.266 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -68.69 -33.75 74.5 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.536 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.9 tt -58.74 -40.97 85.37 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.193 0.906 . . . . 0.0 110.184 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.6 -48.25 66.42 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 173.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.4 m -63.96 -41.19 97.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.401 0.601 . . . . 0.0 111.11 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -62.57 -52.51 63.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 117.739 -1.124 . . . . 0.0 110.492 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.7 m -64.71 -34.03 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 120.258 1.39 . . . . 0.0 110.685 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -59.49 -32.77 70.57 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.061 0.846 . . . . 0.0 112.118 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.434 HD12 ' H ' ' A' ' 118' ' ' GLY . 25.9 mt -94.75 -35.85 11.95 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.512 -0.756 . . . . 0.0 112.55 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.7 pp -90.99 -17.3 26.54 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 117.36 -1.305 . . . . 0.0 113.459 -173.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt . . . . . 0 C--O 1.251 1.167 0 CA-C-N 119.572 1.078 . . . . 0.0 112.104 -172.529 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.289 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -140.98 -25.17 0.74 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.435 1.094 . . . . 0.0 111.482 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.7 mt -132.89 83.65 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 173.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.6 m -78.38 116.02 18.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.72 154.25 36.54 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.632 0.773 . . . . 0.0 109.598 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.3 mt -126.49 97.87 4.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.7 m -78.75 156.98 28.6 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.761 0.824 . . . . 0.0 110.097 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.68 89.83 0.09 OUTLIER Glycine 0 C--N 1.333 0.411 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.509 ' HG ' ' N ' ' A' ' 14' ' ' GLY . 23.7 p . . . . . 0 C--O 1.232 0.147 0 CA-C-N 117.462 0.631 . . . . 0.0 110.584 172.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.509 ' N ' ' HG ' ' A' ' 10' ' ' SER . . . . . . . . 0 CA--C 1.526 0.747 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.46 90.3 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.213 1.006 . . . . 0.0 110.229 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.46 -32.44 64.35 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.095 0.407 . . . . 0.0 111.912 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -65.01 -44.9 87.71 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.9 t -60.69 -46.43 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.1 -39.84 79.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.568 0.622 . . . . 0.0 111.344 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.17 -42.8 99.21 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.62 0.645 . . . . 0.0 110.837 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -71.64 -41.96 68.18 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.903 -0.498 . . . . 0.0 110.972 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.86 -44.44 97.02 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.07 -44.31 96.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.432 0.693 . . . . 0.0 110.469 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -58.0 -44.56 87.29 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.458 0.572 . . . . 0.0 110.388 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -62.73 -40.86 98.51 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.762 -0.587 . . . . 0.0 111.285 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 66.3 mt -63.9 -41.34 97.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.943 0.792 . . . . 0.0 111.142 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.24 -40.12 90.02 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.576 0.625 . . . . 0.0 110.378 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.88 -36.0 82.93 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.048 0.539 . . . . 0.0 110.805 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.62 -21.63 63.55 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.379 0.671 . . . . 0.0 112.248 174.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.52 -0.64 14.04 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.844 1.211 . . . . 0.0 113.825 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -79.2 178.94 7.69 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.424 1.112 . . . . 0.0 110.023 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.9 p -124.84 150.31 46.55 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.7 p -137.48 170.26 16.38 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.635 0.774 . . . . 0.0 109.729 -169.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -152.19 161.86 41.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 169.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.39 102.27 6.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.2 mt -80.08 153.57 28.67 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -128.76 102.47 6.57 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.42 52.83 49.33 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.487 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -66.39 174.45 6.2 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.028 2.485 . . . . 0.0 111.588 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.9 mt -129.26 163.47 25.59 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 125.249 1.42 . . . . 0.0 109.191 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.89 -30.4 58.04 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.75 1.22 . . . . 0.0 110.888 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -64.09 -11.18 27.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.314 1.446 . . . . 0.0 112.661 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -136.59 16.88 3.12 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.383 1.073 . . . . 0.0 110.907 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -135.62 101.03 10.95 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.124 1.37 . . . . 0.0 107.866 -169.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.32 164.59 34.8 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.737 2.292 . . . . 0.0 112.139 -171.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.58 7.29 1.94 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.574 1.55 . . . . 0.0 114.575 -173.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.9 m -149.61 139.33 21.75 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.8 178.08 27.06 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.5 mt -119.67 101.75 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 -176.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -114.76 167.69 10.55 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.205 1.002 . . . . 0.0 110.247 -171.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.4 tp -147.7 100.56 3.24 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 175.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.5 t -83.96 141.4 14.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.593 1.157 . . . . 0.0 109.685 -172.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.57 126.54 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.2 m -142.08 130.8 22.77 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.427 0.691 . . . . 0.0 110.656 -169.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.8 m -67.56 168.83 10.3 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.632 0.73 . . . . 0.0 111.358 169.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.573 ' HG1' ' N ' ' A' ' 101' ' ' ALA . 87.2 m -141.27 135.03 30.24 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 129.02 2.928 . . . . 0.0 104.143 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -129.72 146.13 51.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 172.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 36.62 -97.27 0.01 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 127.088 2.28 . . . . 0.0 114.586 176.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.87 9.63 26.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.342 1.457 . . . . 0.0 113.455 -169.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.71 25.46 7.63 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 120.115 1.325 . . . . 0.0 110.837 -175.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.08 110.52 5.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.97 149.84 85.54 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.79 144.82 49.58 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.702 2.268 . . . . 0.0 110.02 -169.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -56.8 -21.01 25.62 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.036 1.334 . . . . 0.0 113.793 -175.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -69.02 -31.62 70.56 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.843 -0.535 . . . . 0.0 111.823 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.5 tp -123.83 -25.31 4.29 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.641 0.777 . . . . 0.0 112.323 -169.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 78.8 p -54.47 -30.82 7.42 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 117.027 -1.464 . . . . 0.0 114.542 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -52.68 -26.11 28.67 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.612 2.208 . . . . 0.0 114.814 169.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -62.21 -40.76 97.19 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.508 1.049 . . . . 0.0 110.238 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -63.74 -37.6 87.95 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.91 0.777 . . . . 0.0 110.354 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -68.65 -44.66 73.65 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.747 0.419 . . . . 0.0 110.377 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.85 -41.67 95.51 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.676 -0.64 . . . . 0.0 110.935 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.2 mt -61.33 -49.35 77.34 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 118.56 -0.734 . . . . 0.0 110.352 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -71.74 -28.55 63.74 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.259 0.936 . . . . 0.0 111.434 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.4 -43.54 77.01 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.562 0.619 . . . . 0.0 110.58 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -99.32 -35.0 10.09 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -169.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.0 ttpp 30.04 57.28 0.81 Allowed Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 127.39 2.276 . . . . 0.0 113.412 -169.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.31 174.76 10.31 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.263 1.975 . . . . 0.0 110.374 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 81' ' ' SER . 13.4 p-10 -76.9 69.64 3.24 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.519 1.528 . . . . 0.0 111.024 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.2 mt -74.13 19.08 0.13 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.843 1.657 . . . . 0.0 112.158 173.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 79' ' ' ASP . 3.1 m -53.18 12.2 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.713 1 C-N-CA 131.786 4.034 . . . . 0.0 116.639 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.14 4.37 0.94 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.176 1.391 . . . . 0.0 112.232 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 79.2 t -74.1 131.36 35.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 169.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 121.14 39.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 169.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -130.44 168.95 16.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.086 0.469 . . . . 0.0 110.56 -173.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -127.62 162.76 21.51 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 104.758 -3.337 . . . . 0.0 104.758 169.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.2 137.63 24.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.139 0.97 . . . . 0.0 110.072 -169.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.5 mt -134.72 127.67 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -175.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.43 146.23 16.42 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 171.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.1 mt -137.11 147.1 27.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.66 166.38 29.47 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 176.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.4 m -81.64 111.18 17.68 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 170.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -64.63 -2.29 2.34 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 -169.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -63.64 -41.83 98.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.771 0.829 . . . . 0.0 110.877 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -75.37 155.24 36.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.963 0.801 . . . . 0.0 110.8 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -55.65 -33.83 64.43 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.835 1.254 . . . . 0.0 114.16 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.402 ' O ' HG21 ' A' ' 56' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.573 ' N ' ' HG1' ' A' ' 56' ' ' THR . . . . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.5 tp -54.87 -27.54 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.078 1.351 . . . . 0.0 110.51 171.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -52.19 -35.37 48.88 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.451 1.1 . . . . 0.0 112.817 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -66.89 -54.27 23.83 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 121.831 -0.543 . . . . 0.0 109.938 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.0 mt -61.56 -48.67 79.93 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.8 0.84 . . . . 0.0 109.456 -175.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.13 -37.87 86.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -173.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.22 -40.43 77.98 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -172.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -71.16 -31.06 67.22 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.584 -0.722 . . . . 0.0 111.504 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.9 mt -62.43 -48.15 80.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.911 1.232 . . . . 0.0 109.57 169.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -64.31 -38.83 92.43 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -65.92 -35.3 80.25 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.055 0.542 . . . . 0.0 111.339 175.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.1 m -71.73 -3.31 21.19 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.337 1.055 . . . . 0.0 112.846 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.72 -12.15 27.59 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.759 1.171 . . . . 0.0 113.201 170.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.59 171.89 1.82 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.441 1.121 . . . . 0.0 110.759 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -139.7 144.69 37.67 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.756 0.789 . . . . 0.0 110.591 169.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -78.75 171.05 15.72 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.167 171.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.46 153.03 41.05 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.916 1.287 . . . . 0.0 107.811 169.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.46 -130.73 37.76 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 172.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -136.91 162.26 33.76 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.3 1.44 . . . . 0.0 107.181 171.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.3 m -69.35 132.42 46.38 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.193 0.597 . . . . 0.0 109.476 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.4 tp -81.1 153.29 27.4 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -125.87 144.14 50.78 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 169.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 40.4 mt -132.63 101.74 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -67.58 138.37 56.39 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 171.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 18.5 pt -128.02 15.98 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 125.313 1.445 . . . . 0.0 111.73 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 N--CA 1.47 0.56 0 C-N-CA 124.413 1.085 . . . . 0.0 111.631 -178.629 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -56.69 -40.55 75.79 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.074 0.95 . . . . 0.0 112.469 -169.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -73.74 -30.82 63.03 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.785 0.721 . . . . 0.0 111.075 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -73.57 -40.23 64.07 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.518 -0.739 . . . . 0.0 109.723 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.4 tp -61.8 -44.29 97.16 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.907 1.283 . . . . 0.0 109.988 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.06 -44.42 93.0 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.682 1.134 . . . . 0.0 111.126 173.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.1 m -62.7 -40.07 95.99 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 122.313 -0.522 . . . . 0.0 110.67 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -63.04 -48.77 77.3 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 117.968 -1.015 . . . . 0.0 111.786 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 28.1 m -65.74 -33.39 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 119.978 1.263 . . . . 0.0 110.949 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.83 -32.84 74.14 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.687 -0.673 . . . . 0.0 111.854 174.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 mt -80.27 -50.9 9.58 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.004 0.82 . . . . 0.0 111.016 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 pp -79.11 -16.45 56.68 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.901 0.773 . . . . 0.0 113.052 -173.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 60.1 mttm . . . . . 0 C--O 1.25 1.129 0 C-N-CA 127.808 2.443 . . . . 0.0 111.949 176.816 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.358 0 CA-C-O 120.74 0.305 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -134.51 -26.84 1.39 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.393 1.077 . . . . 0.0 111.263 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.0 mt -128.9 81.39 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 171.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.7 m -77.46 110.69 12.45 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mp -74.78 155.89 37.13 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.7 mt -127.89 100.63 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 m -70.65 158.1 36.82 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.288 1.435 . . . . 0.0 110.88 177.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.41 59.37 0.23 Allowed Glycine 0 C--N 1.338 0.694 0 O-C-N 121.992 -0.443 . . . . 0.0 112.789 -170.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 CA--C 1.534 0.35 0 C-N-CA 125.17 1.388 . . . . 0.0 107.587 169.312 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.37 0 N-CA-C 107.404 -2.278 . . . . 0.0 107.404 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.15 -32.11 73.64 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 122.983 0.513 . . . . 0.0 111.066 175.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -66.04 -35.24 80.0 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.611 0.764 . . . . 0.0 110.572 176.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -70.64 -47.49 59.75 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -59.58 -40.95 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.31 -48.29 82.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.871 0.76 . . . . 0.0 110.599 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.96 -43.14 99.61 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.189 0.449 . . . . 0.0 110.765 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -66.8 -42.65 85.62 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.847 -0.533 . . . . 0.0 111.078 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.9 mt -65.68 -41.32 92.57 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.639 -0.663 . . . . 0.0 110.267 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.41 -41.04 93.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 119.005 -0.522 . . . . 0.0 110.761 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -55.9 -48.73 75.13 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.64 0.655 . . . . 0.0 110.128 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.18 -37.68 84.11 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 121.786 -0.571 . . . . 0.0 110.69 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.0 mt -62.68 -39.74 94.92 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.665 0.666 . . . . 0.0 111.426 175.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -66.85 -37.03 83.67 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.872 0.76 . . . . 0.0 110.534 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.84 -37.37 86.04 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.66 0.663 . . . . 0.0 110.877 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.02 -25.89 65.61 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.157 0.583 . . . . 0.0 111.661 173.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.88 -3.11 11.81 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.228 1.394 . . . . 0.0 113.88 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -79.85 143.56 34.23 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.863 1.331 . . . . 0.0 109.601 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 p -82.23 144.54 30.6 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 169.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.3 p -135.96 170.7 15.58 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.654 0.781 . . . . 0.0 110.116 -170.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -153.18 161.84 41.98 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 169.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 p -135.44 75.64 1.57 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -173.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.8 mt -66.29 115.87 6.71 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -171.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -76.88 95.34 4.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 53.26 62.69 5.75 Favored Glycine 0 CA--C 1.541 1.693 0 C-N-CA 123.894 0.759 . . . . 0.0 113.491 173.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -68.89 176.34 6.23 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.826 3.018 . . . . 0.0 111.848 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.4 mt -122.74 162.78 21.39 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.318 1.447 . . . . 0.0 107.603 169.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.7 tt -57.03 -35.93 69.87 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.733 0.813 . . . . 0.0 111.328 -176.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.23 -3.51 5.9 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.902 1.281 . . . . 0.0 113.21 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -130.47 16.54 5.43 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.908 1.283 . . . . 0.0 110.406 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -135.73 105.01 9.85 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.104 1.362 . . . . 0.0 108.826 -169.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.71 153.66 72.78 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.603 2.202 . . . . 0.0 112.388 -174.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.57 17.16 2.8 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.274 1.43 . . . . 0.0 113.347 -170.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.7 m -154.75 131.1 10.43 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 120.825 -1.172 . . . . 0.0 108.196 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.88 -173.92 26.9 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.9 mt -122.28 101.62 10.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -174.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -99.3 170.72 8.46 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.952 0.901 . . . . 0.0 109.844 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.3 tp -148.67 101.25 3.19 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 175.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.0 t -84.81 137.54 20.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 123.853 0.861 . . . . 0.0 108.725 -171.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.8 mt -133.73 115.94 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.1 m -130.47 127.7 39.74 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.216 0.606 . . . . 0.0 109.724 -169.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 m -76.85 165.8 24.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.135 0.493 . . . . 0.0 109.868 171.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 m -136.4 99.03 3.98 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.7 -34.05 77.3 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 157.9 155.64 7.62 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 171.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 46.24 32.44 1.49 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.632 1.973 . . . . 0.0 113.978 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.64 5.3 66.89 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.407 -0.663 . . . . 0.0 113.013 174.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.77 92.4 2.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.336 1.068 . . . . 0.0 110.115 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.0 mt -65.12 142.67 98.66 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 169.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.43 148.22 90.71 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.615 2.21 . . . . 0.0 111.497 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -57.91 -17.95 20.01 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.256 1.822 . . . . 0.0 113.785 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -62.06 -42.62 99.38 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.719 0.807 . . . . 0.0 110.401 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.5 tp -117.61 -26.07 6.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.592 0.757 . . . . 0.0 112.51 -169.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 100.0 p -55.92 -31.68 10.57 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 116.87 -1.538 . . . . 0.0 114.994 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -53.2 -25.09 28.56 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.537 2.158 . . . . 0.0 114.938 171.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -61.1 -38.34 85.95 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.262 0.937 . . . . 0.0 111.094 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -62.08 -40.98 97.68 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.679 0.792 . . . . 0.0 110.239 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.78 -46.82 62.19 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.955 0.502 . . . . 0.0 109.927 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.65 -31.34 72.31 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.765 -0.585 . . . . 0.0 112.124 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.4 mt -64.42 -59.98 3.7 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -68.1 -26.43 65.82 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.771 0.714 . . . . 0.0 112.291 -171.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -66.59 -33.85 76.58 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.299 0.64 . . . . 0.0 110.971 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -111.86 -30.48 7.28 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -169.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt 31.8 57.98 1.18 Allowed Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 126.976 2.111 . . . . 0.0 112.365 -169.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -71.37 170.78 17.55 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.367 2.045 . . . . 0.0 109.886 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -73.75 103.29 4.26 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.836 -0.54 . . . . 0.0 110.262 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.1 mt -114.34 23.13 13.09 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.639 1.576 . . . . 0.0 110.491 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.5 m -62.63 19.82 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.535 1.934 . . . . 0.0 115.696 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.18 2.57 1.5 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.321 1.448 . . . . 0.0 111.917 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.8 t -77.84 137.01 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 169.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -121.36 144.76 48.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 168.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -148.11 169.33 20.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.067 0.394 . . . . 0.0 110.186 -176.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.2 167.16 21.32 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 106.156 -2.778 . . . . 0.0 106.156 169.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.39 132.02 28.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.598 0.699 . . . . 0.0 109.79 -169.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.9 mt -132.29 130.76 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.13 146.57 18.83 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.1 mt -138.42 140.66 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -172.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 172.2 179.03 42.83 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.9 m -77.16 123.73 26.83 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 170.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.6 ptt-85 -58.94 -22.91 60.81 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -172.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -84.05 -4.42 58.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.439 0.696 . . . . 0.0 112.525 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.8 m-30 -63.51 162.03 13.47 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.453 1.024 . . . . 0.0 110.352 169.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -60.82 -27.45 68.06 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.653 0.781 . . . . 0.0 112.009 173.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.2 p . . . . . 0 C--O 1.233 0.237 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 172.85 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -30.31 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.796 0.838 . . . . 0.0 109.57 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -55.56 -31.22 61.97 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.4 1.08 . . . . 0.0 112.421 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -62.52 -49.63 74.58 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.783 0.72 . . . . 0.0 109.962 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.5 mt -64.67 -49.09 72.33 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -71.38 -32.62 68.68 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.907 -175.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.43 -44.58 92.88 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.431 1.014 . . . . 0.0 109.474 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -73.35 -27.56 61.57 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.603 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.0 mt -64.33 -46.36 83.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.479 1.49 . . . . 0.0 109.273 169.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -64.97 -39.95 94.26 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 117.855 0.298 . . . . 0.0 110.392 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -62.37 -37.92 87.59 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.546 0.738 . . . . 0.0 110.723 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.6 m -72.8 -12.35 60.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.244 1.018 . . . . 0.0 112.82 173.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 129.36 -17.7 5.56 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.988 1.28 . . . . 0.0 114.32 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.32 173.27 1.59 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.508 1.154 . . . . 0.0 111.958 -175.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -143.1 142.24 31.46 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.264 -0.898 . . . . 0.0 112.066 169.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -63.16 161.48 13.47 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.526 1.93 . . . . 0.0 109.962 176.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.8 m -143.03 149.28 38.03 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.909 1.684 . . . . 0.0 107.031 -176.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.57 -144.06 44.98 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -136.73 149.99 48.16 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 174.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.6 m -64.08 133.49 53.13 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.904 0.882 . . . . 0.0 110.149 -173.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.5 tp -98.92 152.24 19.98 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.69 138.94 39.9 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 29.0 mt -132.04 104.93 8.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 -170.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -67.57 134.54 51.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.17 172.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 6.3 pt -110.05 -8.61 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.78 0.832 . . . . 0.0 111.889 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.1 tp . . . . . 0 C--N 1.34 0.168 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.719 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -55.84 -25.64 42.98 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.06 0.846 . . . . 0.0 113.036 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -74.12 -48.22 30.95 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.023 0.829 . . . . 0.0 109.456 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 6.4 t-105 -68.64 -27.54 66.09 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.213 1.005 . . . . 0.0 111.158 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.1 tp -56.07 -33.74 65.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.22 1.008 . . . . 0.0 111.073 171.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.15 -44.36 88.71 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 174.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.9 m -63.03 -43.2 99.36 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.319 0.56 . . . . 0.0 110.206 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -62.46 -49.61 74.74 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 118.112 -0.947 . . . . 0.0 111.832 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.03 -30.17 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 120.378 1.445 . . . . 0.0 111.405 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -70.03 -20.32 63.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.602 0.637 . . . . 0.0 111.213 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.36 -46.81 4.9 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.132 0.973 . . . . 0.0 110.21 -174.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 pp -75.87 -20.61 57.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.302 -0.856 . . . . 0.0 112.255 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.9 mttp . . . . . 0 C--O 1.25 1.117 0 C-N-CA 127.631 2.372 . . . . 0.0 112.119 179.569 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 120.812 0.339 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -136.42 -26.43 1.11 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.933 1.293 . . . . 0.0 111.226 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.8 mt -125.67 79.49 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 170.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.1 m -74.37 117.65 16.42 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -84.26 154.83 22.76 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.6 mt -126.31 85.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -173.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -71.31 152.24 43.43 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.577 1.151 . . . . 0.0 110.173 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.45 104.26 0.24 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.837 0.827 . . . . 0.0 111.65 177.188 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.759 0 CA-C-O 119.514 -0.603 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.62 -26.26 66.16 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.707 1.254 . . . . 0.0 111.092 -176.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.38 -37.94 89.22 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.273 0.229 . . . . 0.0 110.863 176.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -76.11 -50.26 15.13 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 175.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.99 -47.21 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.402 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.06 98.23 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.029 0.831 . . . . 0.0 110.593 -177.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.63 -42.35 86.89 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.604 0.638 . . . . 0.0 110.64 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -63.36 -43.16 98.48 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.858 0.463 . . . . 0.0 110.628 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.93 -42.94 89.45 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.696 -0.628 . . . . 0.0 109.522 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.15 -37.18 76.66 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.525 0.73 . . . . 0.0 111.674 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -51.73 -47.08 64.18 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.65 0.659 . . . . 0.0 110.227 175.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.9 mmtt -68.36 -39.28 81.87 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.6 mt -65.65 -40.44 92.49 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.581 0.353 . . . . 0.0 110.258 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.27 -40.29 90.01 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.192 -0.432 . . . . 0.0 110.284 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.14 -36.44 84.27 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.703 0.683 . . . . 0.0 111.174 175.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.8 -22.96 65.15 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.475 0.71 . . . . 0.0 112.024 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.71 -0.1 19.98 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.922 1.249 . . . . 0.0 113.326 171.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -75.12 174.91 8.76 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.449 1.124 . . . . 0.0 109.907 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 p -122.47 145.72 48.04 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.2 p -132.52 166.29 22.41 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.662 0.785 . . . . 0.0 110.667 -169.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -152.49 159.4 43.34 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 169.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 p -127.99 80.19 1.94 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -171.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.3 mt -73.21 110.8 7.78 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -84.78 106.28 16.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.74 52.24 54.19 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 118.496 -1.169 . . . . 0.0 114.275 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.53 179.24 3.17 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.315 2.677 . . . . 0.0 111.029 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.4 mt -130.45 168.08 17.58 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.221 1.408 . . . . 0.0 108.528 172.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.78 -35.98 64.39 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.024 1.33 . . . . 0.0 111.697 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.75 -6.94 6.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.14 0.976 . . . . 0.0 113.444 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -129.45 19.07 5.79 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.661 1.584 . . . . 0.0 111.07 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.6 mt -135.75 112.04 10.56 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.803 1.241 . . . . 0.0 108.656 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.28 161.37 45.97 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.182 1.921 . . . . 0.0 111.223 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.69 13.28 1.71 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.185 1.394 . . . . 0.0 113.816 -172.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.4 m -146.92 130.2 16.59 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.487 1.115 . . . . 0.0 108.121 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.53 -176.63 29.86 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.18 99.29 5.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -100.57 173.99 6.29 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.27 1.028 . . . . 0.0 110.013 -173.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.2 tp -143.31 110.16 5.57 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.15 136.68 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.11 119.42 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 176.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.2 m -120.39 132.72 55.38 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.932 0.893 . . . . 0.0 108.894 -175.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.506 ' H ' ' HG3' ' A' ' 63' ' ' PRO . 15.4 m -87.59 50.94 2.09 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.73 0.812 . . . . 0.0 109.937 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -54.13 99.71 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.518 2.327 . . . . 0.0 110.636 -173.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -61.95 130.15 44.26 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.87 20.14 12.6 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.406 1.003 . . . . 0.0 113.843 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 49.97 34.26 7.82 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.105 1.362 . . . . 0.0 111.743 -169.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.58 -0.58 0.33 Allowed Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.518 -1.157 . . . . 0.0 115.132 -169.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -144.02 118.14 9.49 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 119.637 1.718 . . . . 0.0 108.744 171.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.5 mt -68.37 140.79 92.93 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.506 ' HG3' ' H ' ' A' ' 55' ' ' SER . 56.0 Cg_endo -64.17 139.02 64.38 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.975 1.783 . . . . 0.0 110.683 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.86 -19.72 52.84 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.07 1.348 . . . . 0.0 113.674 -173.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -70.88 -31.6 68.31 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.66 -0.65 . . . . 0.0 111.897 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.7 tp -118.14 -25.08 6.76 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.678 0.791 . . . . 0.0 111.753 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.6 t -44.98 -42.24 15.16 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 117.39 -1.29 . . . . 0.0 114.338 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.06 -25.71 13.26 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.81 3.007 . . . . 0.0 116.176 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -59.72 -35.81 75.28 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.19 0.904 . . . . 0.0 111.288 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -58.31 -40.67 82.67 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.225 0.61 . . . . 0.0 110.585 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -72.22 -47.65 48.89 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.912 0.485 . . . . 0.0 109.942 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.43 -35.92 82.49 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.562 0.619 . . . . 0.0 111.725 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.5 mt -66.02 -52.5 48.68 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.772 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -69.88 -25.56 63.76 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.544 1.066 . . . . 0.0 112.224 -174.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.27 -37.25 83.14 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.502 0.592 . . . . 0.0 110.349 177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -107.25 -28.78 9.71 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -169.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.9 mttm 32.27 57.82 1.29 Allowed Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 127.257 2.223 . . . . 0.0 112.556 -172.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.11 171.09 14.35 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.871 2.38 . . . . 0.0 110.66 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -77.23 110.37 11.87 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.576 -0.703 . . . . 0.0 109.357 170.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.5 mt -118.23 19.77 13.38 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.996 1.718 . . . . 0.0 110.951 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.8 m -58.74 11.21 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.857 2.063 . . . . 0.0 116.39 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.16 2.79 4.74 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.626 1.171 . . . . 0.0 111.445 173.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 80.5 t -81.76 140.21 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 169.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -119.51 146.82 45.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 168.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -140.98 171.65 13.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.918 0.866 . . . . 0.0 111.145 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.01 162.6 25.62 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 104.448 -3.461 . . . . 0.0 104.448 169.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.07 132.71 25.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.6 mt -134.17 137.82 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -110.29 152.88 17.25 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 170.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.3 mt -134.31 122.83 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 175.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.62 -155.98 15.2 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.241 -1.943 . . . . 0.0 108.241 -172.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.0 m -102.88 124.17 47.9 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 24.9 ttp180 -69.21 -14.93 63.24 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -69.34 -13.87 62.61 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.461 -0.774 . . . . 0.0 111.274 169.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 52.7 179.93 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 129.732 3.213 . . . . 0.0 115.547 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -156.33 -41.47 0.08 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.214 2.206 . . . . 0.0 107.527 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 92.4 m . . . . . 0 CA--C 1.543 0.683 0 C-N-CA 127.753 2.421 . . . . 0.0 105.659 169.21 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.321 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.686 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -33.28 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 119.251 0.932 . . . . 0.0 109.809 -178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -53.32 -29.59 34.58 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 119.005 -0.521 . . . . 0.0 112.341 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.57 -42.0 95.75 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.617 1.099 . . . . 0.0 111.541 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.41 -51.86 64.03 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -70.08 -35.5 74.23 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.921 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.2 -37.13 86.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.104 0.411 . . . . 0.0 110.846 -172.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -68.79 -34.71 76.0 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.383 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 44.2 mt -65.74 -41.63 91.97 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.258 1.39 . . . . 0.0 109.515 172.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -63.21 -44.63 94.78 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.315 1.046 . . . . 0.0 109.383 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -61.23 -42.26 98.29 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.003 0.921 . . . . 0.0 110.879 172.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.7 m -68.14 -7.0 26.1 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.226 1.01 . . . . 0.0 113.013 177.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.74 -15.15 14.34 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.058 1.313 . . . . 0.0 113.627 169.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.89 169.77 3.06 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.466 1.133 . . . . 0.0 110.776 176.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -142.76 154.01 43.83 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.422 -0.799 . . . . 0.0 111.228 171.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -70.43 155.75 40.27 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.927 171.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 72.8 m -125.95 153.21 44.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.379 1.872 . . . . 0.0 106.931 169.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.94 -144.54 49.05 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -175.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -135.71 152.51 51.24 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.497 1.119 . . . . 0.0 108.25 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.82 150.83 46.86 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.284 1.434 . . . . 0.0 110.427 -176.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.3 tp -130.0 144.97 51.62 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.391 1.076 . . . . 0.0 108.815 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.36 147.42 43.53 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 169.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.3 mt -124.35 106.5 16.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 -175.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -68.09 128.1 35.31 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.077 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -124.49 10.14 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.804 1.242 . . . . 0.0 111.68 174.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 53.2 tp . . . . . 0 CA--C 1.535 0.375 0 C-N-CA 123.051 0.54 . . . . 0.0 111.339 179.225 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -56.61 -44.22 80.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.776 0.83 . . . . 0.0 111.868 -169.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -73.33 -35.04 65.97 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 122.02 -0.425 . . . . 0.0 110.748 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -69.27 -40.36 77.83 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.81 -0.556 . . . . 0.0 109.839 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 48.9 tp -65.13 -39.93 93.75 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.389 0.676 . . . . 0.0 110.194 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.8 -46.4 83.21 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 171.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.6 m -64.54 -34.11 77.48 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.647 0.779 . . . . 0.0 111.299 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -66.14 -53.65 35.11 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.519 0.727 . . . . 0.0 110.051 176.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.5 m -66.06 -25.89 36.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 118.989 0.813 . . . . 0.0 112.182 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -54.98 -25.38 29.46 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.438 0.695 . . . . 0.0 112.276 177.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 27.7 mt -101.56 0.21 36.05 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 pp -127.68 -11.96 5.49 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 120.362 1.437 . . . . 0.0 113.467 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.0 pttp . . . . . 0 C--O 1.249 1.029 0 C-N-CA 124.286 1.034 . . . . 0.0 111.105 177.526 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 121.09 0.471 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -134.23 -26.66 1.46 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.123 1.369 . . . . 0.0 110.941 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.2 mt -124.64 79.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.6 m -74.51 114.38 12.85 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mp -76.6 148.39 37.01 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 170.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.5 mt -116.89 90.6 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -175.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.5 m -80.62 137.7 36.38 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.88 1.272 . . . . 0.0 111.262 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.95 76.62 0.36 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 125.148 1.356 . . . . 0.0 111.839 -170.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 169.421 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.26 0 N-CA-C 108.405 -1.878 . . . . 0.0 108.405 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.0 -35.09 79.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.803 176.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.18 -36.29 83.14 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.436 0.562 . . . . 0.0 110.315 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -73.67 -47.15 41.94 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.9 t -60.91 -43.3 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -46.39 90.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.019 0.528 . . . . 0.0 110.438 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.4 -44.26 96.87 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.623 0.647 . . . . 0.0 110.415 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -63.48 -35.63 81.09 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.743 0.417 . . . . 0.0 111.601 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.5 mt -74.21 -46.8 39.56 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.763 0.825 . . . . 0.0 109.904 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.13 -35.2 71.14 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.402 1.081 . . . . 0.0 111.623 -174.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -48.25 -44.07 32.97 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.161 0.985 . . . . 0.0 111.477 174.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -77.91 -32.85 51.93 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.502 -0.749 . . . . 0.0 109.984 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.0 mt -64.16 -39.25 93.62 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.554 0.616 . . . . 0.0 110.043 174.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -65.41 -41.63 93.39 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.291 0.496 . . . . 0.0 110.249 176.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -64.18 -35.91 82.33 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.552 0.615 . . . . 0.0 111.287 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.88 -22.54 65.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.555 0.742 . . . . 0.0 111.984 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.19 -0.73 16.77 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.913 1.244 . . . . 0.0 113.346 170.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -75.64 174.72 9.38 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.509 1.154 . . . . 0.0 110.074 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 p -120.32 144.08 48.03 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 169.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.5 p -134.88 168.46 19.03 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.653 0.781 . . . . 0.0 110.484 -169.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -151.86 149.93 29.53 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 104.359 -2.459 . . . . 0.0 104.359 169.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -110.96 69.64 0.69 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.43 106.86 5.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -169.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -72.87 118.38 15.74 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.71 54.14 26.28 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 118.124 -1.376 . . . . 0.0 116.187 169.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.45 176.28 4.26 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 CA-C-N 120.328 2.064 . . . . 0.0 110.978 169.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.7 mt -127.33 161.52 28.44 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.093 1.357 . . . . 0.0 107.969 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.37 -27.76 69.29 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.853 0.861 . . . . 0.0 111.315 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -65.22 -7.75 14.36 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.592 1.157 . . . . 0.0 112.435 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -131.4 21.94 4.76 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.731 1.612 . . . . 0.0 110.871 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 65.8 mt -133.81 115.8 13.45 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.919 1.288 . . . . 0.0 107.835 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -70.25 163.89 37.03 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.147 1.898 . . . . 0.0 111.346 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.32 14.8 0.68 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.133 1.373 . . . . 0.0 113.52 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 p -153.46 146.1 24.22 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.221 1.008 . . . . 0.0 109.097 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.22 179.74 23.52 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.53 97.38 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 173.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -95.39 169.48 10.03 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.849 0.86 . . . . 0.0 109.055 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.4 tp -147.89 111.24 4.93 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.5 t -96.93 138.02 23.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -171.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -134.68 133.32 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.5 p -138.46 146.93 42.68 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 m -109.33 79.32 1.2 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.278 1.031 . . . . 0.0 109.508 -172.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.0 m -45.09 114.18 0.69 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.932 1.693 . . . . 0.0 109.873 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -64.52 -22.49 66.98 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -175.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 159.93 -29.29 0.37 Allowed Glycine 0 C--N 1.339 0.717 0 CA-C-O 118.833 -0.982 . . . . 0.0 113.363 169.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.11 29.14 4.07 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.454 1.127 . . . . 0.0 112.309 -170.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.1 4.23 60.04 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.426 -0.652 . . . . 0.0 113.471 175.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -81.97 121.99 27.22 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.265 1.032 . . . . 0.0 109.492 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.8 mt -80.46 142.43 53.99 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -49.85 136.85 35.71 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.031 3.154 . . . . 0.0 112.984 169.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -60.5 -20.99 61.92 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.688 1.195 . . . . 0.0 113.296 -174.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -69.26 -30.43 68.54 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 118.856 -0.592 . . . . 0.0 111.638 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.3 tp -123.34 -22.52 5.07 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.463 0.705 . . . . 0.0 112.105 -169.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.1 t -46.02 -41.08 19.26 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 117.636 -1.173 . . . . 0.0 113.546 173.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -50.96 -26.88 19.45 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.266 2.644 . . . . 0.0 116.005 172.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -62.84 -38.11 89.48 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.791 1.178 . . . . 0.0 110.802 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -63.46 -38.89 92.89 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 118.341 0.519 . . . . 0.0 110.36 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.04 -48.62 65.16 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.34 70.15 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 121.515 -0.741 . . . . 0.0 112.462 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.95 -57.42 6.94 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -69.47 -28.49 66.13 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.887 0.767 . . . . 0.0 112.346 -171.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -76.64 -22.14 54.5 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.745 0.702 . . . . 0.0 111.781 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -118.2 -36.09 3.66 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.748 0.704 . . . . 0.0 112.391 -172.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt 30.59 60.67 1.0 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 127.222 2.209 . . . . 0.0 113.376 -174.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.74 170.8 14.51 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.156 1.904 . . . . 0.0 109.924 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -72.31 111.01 7.14 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.002 0.521 . . . . 0.0 109.925 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.1 mt -118.98 24.5 10.79 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.796 1.638 . . . . 0.0 110.52 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.7 m -63.37 20.89 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.473 1.909 . . . . 0.0 115.872 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.09 2.84 1.75 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.663 1.185 . . . . 0.0 111.967 173.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.7 t -76.97 142.29 14.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 169.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 54.8 mmm-85 -119.76 144.21 47.4 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 168.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -138.25 171.28 14.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.29 0.567 . . . . 0.0 110.66 -174.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.33 165.55 25.45 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 105.553 -3.019 . . . . 0.0 105.553 169.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.32 128.85 15.02 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.677 0.739 . . . . 0.0 109.878 -169.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 37.4 mt -131.11 124.22 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -101.84 95.59 1.35 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.1 mt -79.79 155.19 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 168.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.59 174.43 33.44 Favored Glycine 0 N--CA 1.436 -1.329 0 CA-C-O 123.21 1.45 . . . . 0.0 111.468 169.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.6 m -74.78 73.65 2.07 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 125.98 1.712 . . . . 0.0 109.077 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.92 -27.89 63.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.167 1.387 . . . . 0.0 112.362 -170.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -83.78 -11.34 57.21 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.467 0.707 . . . . 0.0 112.745 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -70.09 -53.55 16.91 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.374 0.988 . . . . 0.0 111.416 -169.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -164.78 -49.41 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.386 1.074 . . . . 0.0 110.755 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.233 0.212 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -172.632 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.563 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.1 tp -59.83 -28.88 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.006 1.323 . . . . 0.0 110.839 173.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.06 -37.66 77.55 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 122.908 0.483 . . . . 0.0 111.176 -174.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -61.81 -53.28 58.01 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.745 0.818 . . . . 0.0 109.819 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.7 mt -62.09 -50.82 70.41 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.66 0.784 . . . . 0.0 109.477 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.47 -41.57 72.57 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -171.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.24 -33.74 72.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 119.118 -0.468 . . . . 0.0 110.236 -170.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.57 -29.78 66.31 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.858 0.753 . . . . 0.0 111.197 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.1 mt -64.41 -44.54 90.95 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.795 1.18 . . . . 0.0 108.777 169.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -59.63 -44.87 93.32 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -177.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -66.46 -37.1 84.38 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 122.739 0.415 . . . . 0.0 110.335 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 31.3 m -68.3 -13.06 61.99 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.833 0.853 . . . . 0.0 112.393 174.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.19 -20.69 3.35 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.745 1.164 . . . . 0.0 113.442 169.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.72 171.02 2.25 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.116 0.958 . . . . 0.0 111.841 -175.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -142.12 141.91 32.72 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.172 -0.955 . . . . 0.0 110.115 173.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -63.85 164.86 9.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.217 1.007 . . . . 0.0 109.997 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.3 m -136.0 148.29 48.35 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.914 2.086 . . . . 0.0 106.197 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.55 -133.64 52.62 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -170.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -141.28 160.58 39.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.273 1.829 . . . . 0.0 106.453 176.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.89 158.72 24.46 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.527 1.131 . . . . 0.0 110.695 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.4 tp -129.85 146.43 51.57 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.392 1.077 . . . . 0.0 108.749 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -120.18 141.98 49.39 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.9 mt -137.84 100.6 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -67.77 130.37 42.78 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 170.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 pp -113.85 -4.1 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 123.875 0.87 . . . . 0.0 111.875 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.4 tp . . . . . 0 CA--C 1.533 0.299 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 168.562 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.339 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -60.77 -41.53 95.71 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.881 0.872 . . . . 0.0 110.828 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -73.19 -40.08 65.06 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 75.7 t90 -60.51 -50.24 74.34 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 52.3 tp -64.94 -40.59 95.26 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 119.148 -0.453 . . . . 0.0 110.164 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.18 -46.83 84.86 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 173.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.5 m -63.99 -37.13 86.31 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.056 0.543 . . . . 0.0 111.071 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -65.97 -51.64 56.71 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.91 0.884 . . . . 0.0 110.286 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.8 m -67.2 -30.88 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 O-C-N 121.24 -0.913 . . . . 0.0 111.379 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -61.82 -20.12 63.29 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.632 0.773 . . . . 0.0 112.376 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.6 mt -101.87 -36.27 8.71 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.787 171.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.71 -37.22 84.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.779 1.172 . . . . 0.0 111.718 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt . . . . . 0 C--O 1.247 0.95 0 C-N-CA 128.604 2.762 . . . . 0.0 113.074 179.839 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.39 0 CA-C-O 120.713 0.292 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -132.84 -27.23 1.69 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.58 1.152 . . . . 0.0 110.962 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.8 mt -124.94 79.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.2 m -75.12 117.82 17.38 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 mt -89.09 156.84 18.57 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.783 0.833 . . . . 0.0 108.812 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.4 mt -126.44 95.32 3.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -171.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.5 m -73.29 146.27 45.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.855 0.862 . . . . 0.0 110.11 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.32 81.94 0.15 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 124.47 1.033 . . . . 0.0 110.833 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.463 ' HG ' ' N ' ' A' ' 14' ' ' GLY . 23.0 t . . . . . 0 N--CA 1.455 -0.176 0 C-N-CA 123.444 0.697 . . . . 0.0 110.025 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.463 ' N ' ' HG ' ' A' ' 10' ' ' SER . . . . . . . . 0 CA--C 1.524 0.611 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.38 -35.47 80.41 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 122.001 -0.705 . . . . 0.0 110.499 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.59 -34.51 69.96 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.095 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -66.43 -46.06 77.77 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.417 0.687 . . . . 0.0 109.238 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.0 t -63.18 -47.75 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.57 -38.41 84.49 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-O 118.823 -0.608 . . . . 0.0 111.007 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.16 -45.23 89.39 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.345 0.975 . . . . 0.0 110.715 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -67.79 -40.04 83.99 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.884 -0.51 . . . . 0.0 110.795 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.3 mt -64.2 -42.51 96.6 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 119.257 -0.402 . . . . 0.0 110.157 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.08 -44.87 96.71 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.549 0.74 . . . . 0.0 110.468 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -58.77 -42.25 88.51 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.225 0.466 . . . . 0.0 110.269 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.5 mmtm -69.94 -39.47 76.08 Favored 'General case' 0 N--CA 1.462 0.142 0 O-C-N 121.682 -0.636 . . . . 0.0 111.726 176.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.6 mt -60.65 -37.12 80.47 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.084 0.856 . . . . 0.0 111.045 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -67.63 -35.75 79.51 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.863 0.756 . . . . 0.0 110.682 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.71 -37.46 84.74 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.092 0.86 . . . . 0.0 110.792 172.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.64 -26.41 67.05 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 122.844 0.457 . . . . 0.0 111.55 173.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.95 -3.28 11.68 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.345 1.45 . . . . 0.0 113.834 169.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -81.08 144.36 31.78 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.91 1.355 . . . . 0.0 109.724 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 p -84.18 144.11 29.19 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 169.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.8 p -135.7 169.33 17.72 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.613 0.765 . . . . 0.0 110.795 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -150.79 161.38 42.76 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 p -131.95 75.73 1.66 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.6 mt -69.23 121.91 17.78 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -171.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -80.51 95.49 6.49 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.64 56.17 26.76 Favored Glycine 0 CA--C 1.541 1.68 0 CA-C-O 118.783 -1.009 . . . . 0.0 113.852 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -69.47 178.84 3.99 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.556 2.838 . . . . 0.0 111.988 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.7 mt -129.04 165.93 20.21 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.44 1.496 . . . . 0.0 109.173 172.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.4 tp -63.2 -26.57 68.86 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.777 1.231 . . . . 0.0 112.288 -173.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.11 -10.15 13.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.052 0.941 . . . . 0.0 113.071 174.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -128.07 18.79 6.55 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.443 1.497 . . . . 0.0 111.068 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.6 mt -135.51 97.93 12.67 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 125.106 1.362 . . . . 0.0 107.756 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.73 165.26 30.21 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.356 2.037 . . . . 0.0 111.731 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.64 5.21 2.57 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.837 1.655 . . . . 0.0 114.71 -171.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.3 m -145.43 131.65 19.48 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.776 1.23 . . . . 0.0 107.997 -173.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.91 -172.23 35.06 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.039 -0.825 . . . . 0.0 111.039 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -129.73 97.26 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 173.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -100.52 172.27 7.22 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.602 0.761 . . . . 0.0 110.014 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.7 tp -138.78 103.17 4.76 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 120.793 -1.192 . . . . 0.0 107.809 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.6 t -80.43 129.34 37.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 mt -129.93 129.12 65.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 172.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -139.26 129.7 25.65 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -170.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.8 m -74.08 164.54 26.49 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.174 0.511 . . . . 0.0 109.981 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.8 m -135.98 138.53 42.37 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 176.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -124.84 10.47 8.3 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -169.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.59 -48.82 0.46 Allowed Glycine 0 C--N 1.34 0.773 0 CA-C-N 119.124 0.874 . . . . 0.0 112.849 169.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.28 24.53 2.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.038 0.935 . . . . 0.0 112.053 -169.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.85 9.67 57.14 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 119.614 -0.548 . . . . 0.0 112.653 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -65.08 122.27 16.65 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.276 1.038 . . . . 0.0 109.089 172.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.8 mt -83.07 145.02 48.36 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.79 138.88 85.59 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.064 2.51 . . . . 0.0 110.897 173.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -59.46 -16.93 27.09 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.914 1.285 . . . . 0.0 113.185 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -67.48 -33.12 74.46 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.259 0.624 . . . . 0.0 111.802 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.7 tp -125.67 -21.16 4.51 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.353 0.661 . . . . 0.0 112.27 -172.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 t -47.4 -40.56 27.72 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 117.618 -1.182 . . . . 0.0 113.736 174.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -50.79 -27.18 19.53 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.162 2.574 . . . . 0.0 115.669 172.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -63.02 -38.38 90.94 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.596 1.089 . . . . 0.0 110.877 177.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -64.22 -37.31 87.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.694 0.679 . . . . 0.0 110.156 177.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -69.49 -50.3 46.62 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.1 -31.73 73.04 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.448 -0.783 . . . . 0.0 112.15 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.5 mt -65.51 -55.53 17.3 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.539 -0.743 . . . . 0.0 109.605 172.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -70.18 -27.67 64.7 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.509 1.05 . . . . 0.0 112.309 -172.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -71.27 -28.41 64.13 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.769 0.713 . . . . 0.0 111.433 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -114.45 -33.69 5.5 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -170.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp 29.97 57.73 0.82 Allowed Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 127.719 2.407 . . . . 0.0 113.415 -172.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -69.41 172.63 11.95 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.125 1.883 . . . . 0.0 110.333 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -70.26 111.74 6.08 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.967 0.507 . . . . 0.0 109.83 171.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 mt -120.45 25.32 9.87 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.978 1.711 . . . . 0.0 110.323 175.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.4 m -63.7 19.9 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -174.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.87 9.44 1.52 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.684 1.194 . . . . 0.0 111.505 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.9 t -80.38 102.19 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 170.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -79.73 147.75 31.78 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 167.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -146.23 172.62 13.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 119.325 0.966 . . . . 0.0 112.019 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -125.66 162.35 19.91 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 105.847 -2.901 . . . . 0.0 105.847 169.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.7 125.93 16.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -170.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.3 mt -136.07 135.43 50.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -114.72 147.15 18.85 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.7 mt -127.83 147.81 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 164.95 157.18 9.49 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.4 m -71.51 120.32 16.93 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 171.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 -60.67 -15.32 27.55 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -64.38 -25.99 68.27 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.495 -0.753 . . . . 0.0 112.21 172.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 -61.76 156.7 19.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.856 0.753 . . . . 0.0 111.761 -177.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -57.45 -41.1 79.86 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.958 0.903 . . . . 0.0 110.784 171.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.8 m . . . . . 0 N--CA 1.446 -0.653 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 175.974 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.775 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 tp -53.91 -31.36 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.438 1.895 . . . . 0.0 110.361 169.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -57.48 -38.45 74.56 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.062 0.545 . . . . 0.0 112.209 -170.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -68.07 -45.67 73.18 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 121.946 -0.471 . . . . 0.0 110.549 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.9 mt -60.81 -49.21 78.41 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.384 0.674 . . . . 0.0 109.182 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -69.74 -33.68 72.79 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.185 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.32 93.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -74.27 -30.5 62.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.949 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.0 mt -62.11 -51.72 66.77 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 119.482 1.037 . . . . 0.0 109.483 170.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -68.29 -32.85 73.29 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.73 -173.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -64.76 -37.33 87.26 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.504 0.322 . . . . 0.0 111.106 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.5 m -71.03 -4.67 26.18 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.316 1.046 . . . . 0.0 112.917 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.79 -16.61 9.5 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.177 1.37 . . . . 0.0 113.249 169.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.69 176.14 0.55 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.037 1.335 . . . . 0.0 111.632 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.62 137.22 15.98 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.723 -1.236 . . . . 0.0 112.649 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -60.66 137.71 58.15 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.566 1.546 . . . . 0.0 108.661 169.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.3 m -121.59 139.24 53.78 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.593 1.957 . . . . 0.0 106.211 171.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.1 175.26 24.79 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.945 0.783 . . . . 0.0 111.668 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -85.47 139.07 31.79 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.924 -0.75 . . . . 0.0 109.366 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.1 m -57.73 152.84 14.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.902 1.681 . . . . 0.0 110.24 174.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 62.9 tp -128.95 149.01 50.98 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.941 0.897 . . . . 0.0 109.939 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -113.16 139.34 48.83 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 17.1 mm -117.6 96.0 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 171.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -67.43 138.37 56.61 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 172.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.0 pt -129.45 13.14 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.673 1.189 . . . . 0.0 111.745 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.4 tp . . . . . 0 N--CA 1.466 0.363 0 C-N-CA 123.452 0.701 . . . . 0.0 110.755 177.409 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.269 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -59.03 -24.29 62.71 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.367 1.467 . . . . 0.0 112.577 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -89.81 -43.49 10.61 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.899 0.772 . . . . 0.0 109.596 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -59.93 -28.92 68.01 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.44 0.696 . . . . 0.0 111.498 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 59.8 tp -51.92 -35.2 44.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.394 1.477 . . . . 0.0 111.872 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.85 -44.61 87.26 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 m -66.76 -30.99 71.34 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.548 0.739 . . . . 0.0 111.145 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -72.32 -55.35 7.27 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.251 0.478 . . . . 0.0 109.798 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.9 m -63.62 -29.53 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 118.498 0.59 . . . . 0.0 111.553 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -54.38 -28.53 43.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.896 0.879 . . . . 0.0 112.458 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 27.4 mt -101.7 -3.49 28.13 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.067 -0.968 . . . . 0.0 113.511 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.6 pp -125.94 -14.63 6.07 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.274 1.397 . . . . 0.0 113.497 -178.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.5 pttt . . . . . 0 C--O 1.25 1.126 0 C-N-CA 123.826 0.85 . . . . 0.0 111.079 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.726 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -140.97 -27.27 0.71 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.823 1.249 . . . . 0.0 111.669 177.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mt -132.96 83.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 171.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 79.6 m -73.99 119.28 17.99 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.55 148.13 35.38 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 172.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 82.7 mt -113.39 78.05 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.9 m -76.13 97.23 4.04 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.237 1.415 . . . . 0.0 109.332 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.03 52.21 0.67 Allowed Glycine 0 N--CA 1.461 0.337 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -172.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.448 -0.569 0 C-N-CA 123.296 0.639 . . . . 0.0 112.549 -167.972 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.592 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.78 -31.78 72.95 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.154 -0.45 . . . . 0.0 110.06 175.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -72.61 -35.38 67.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.816 0.735 . . . . 0.0 111.015 177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -67.11 -39.42 86.68 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.994 0.815 . . . . 0.0 109.229 175.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.87 -47.01 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 118.681 -0.676 . . . . 0.0 109.549 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.96 86.29 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.467 1.031 . . . . 0.0 111.383 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.09 -43.57 91.68 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.14 0.576 . . . . 0.0 110.593 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -64.62 -44.59 90.05 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.541 0.61 . . . . 0.0 110.66 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.3 mt -58.55 -46.97 85.74 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.327 1.051 . . . . 0.0 109.93 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.03 -46.04 89.2 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.303 0.641 . . . . 0.0 110.176 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.02 -42.2 93.84 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.016 0.526 . . . . 0.0 110.082 -179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.403 ' N ' ' HE2' ' A' ' 25' ' ' LYS . 6.1 mmpt? -63.74 -36.89 85.36 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 121.744 -0.598 . . . . 0.0 110.233 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.94 -38.71 76.26 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 118.66 0.664 . . . . 0.0 111.013 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.07 -43.35 99.02 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.727 0.694 . . . . 0.0 109.398 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.04 -38.99 92.65 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.078 0.551 . . . . 0.0 111.104 176.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.38 -21.43 64.7 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.624 0.77 . . . . 0.0 112.203 176.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.95 28.71 3.54 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.758 -1.023 . . . . 0.0 113.623 170.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -124.96 133.77 52.89 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.977 1.388 . . . . 0.0 108.924 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 p -75.79 140.6 42.43 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.282 0.563 . . . . 0.0 109.7 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.1 p -131.01 168.55 17.18 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.35 1.06 . . . . 0.0 110.6 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -154.45 128.0 8.6 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 169.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 p -82.59 65.09 7.55 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.007 1.323 . . . . 0.0 108.248 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.1 121.36 15.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -169.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.0 107.23 4.61 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -173.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 37.36 56.59 1.5 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 127.642 2.544 . . . . 0.0 115.789 173.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -62.47 148.66 92.97 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 120.222 2.011 . . . . 0.0 110.63 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mt -98.62 171.06 8.37 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 124.233 1.013 . . . . 0.0 110.551 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -52.92 -38.78 62.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.425 1.49 . . . . 0.0 111.282 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.74 -6.0 18.86 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.45 1.1 . . . . 0.0 112.68 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -135.27 20.38 3.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.986 1.714 . . . . 0.0 110.924 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.2 mt -134.11 108.73 11.54 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 125.133 1.373 . . . . 0.0 107.607 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.2 160.42 48.94 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.889 1.726 . . . . 0.0 110.631 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.6 7.13 2.58 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.742 1.217 . . . . 0.0 114.098 -172.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.2 m -147.52 142.13 26.59 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -176.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.16 -177.85 29.73 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.5 101.31 8.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -109.04 170.23 8.18 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.991 0.916 . . . . 0.0 109.914 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.8 tp -144.73 106.95 4.34 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.1 t -81.79 139.58 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 124.059 0.944 . . . . 0.0 108.864 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 mp -133.34 143.45 39.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.2 m -148.46 143.91 27.04 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.192 -0.943 . . . . 0.0 110.195 176.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -69.37 150.62 47.1 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.0 m -116.43 91.59 3.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -56.66 -32.19 65.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.53 0.732 . . . . 0.0 111.714 -176.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 150.82 -29.96 1.02 Allowed Glycine 0 C--N 1.34 0.763 0 C-N-CA 123.892 0.758 . . . . 0.0 112.628 169.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.96 25.29 7.36 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.421 1.088 . . . . 0.0 111.948 -170.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.12 5.94 86.99 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-O 119.363 -0.687 . . . . 0.0 112.921 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -72.96 146.94 45.67 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 169.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.3 mt -126.03 139.69 34.99 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -172.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -51.73 138.19 50.29 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.055 2.503 . . . . 0.0 113.304 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -57.71 -12.69 3.15 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.717 1.607 . . . . 0.0 113.198 174.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -54.96 -42.59 72.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.178 1.391 . . . . 0.0 109.732 172.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.3 tp -133.64 -21.45 1.97 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -171.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 91.5 p -52.48 -33.12 11.05 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -172.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -53.68 -23.09 24.83 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.803 2.335 . . . . 0.0 115.153 171.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -59.56 -36.59 76.5 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.571 1.078 . . . . 0.0 111.441 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -61.35 -43.0 99.61 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.186 0.448 . . . . 0.0 110.047 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -68.74 -47.09 67.18 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.167 0.587 . . . . 0.0 109.864 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.36 -36.74 83.65 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.865 -0.522 . . . . 0.0 112.03 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.3 mt -67.91 -51.31 49.34 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 118.515 -0.755 . . . . 0.0 109.537 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -68.76 -28.02 66.42 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.435 1.016 . . . . 0.0 111.886 -174.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.2 -39.23 86.32 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.749 0.704 . . . . 0.0 110.483 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -100.17 -22.8 15.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.891 -0.576 . . . . 0.0 112.43 -170.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt 40.03 56.97 7.2 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.997 1.719 . . . . 0.0 110.691 -169.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.88 143.02 78.19 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.354 2.036 . . . . 0.0 110.883 -169.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -81.85 64.22 6.45 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.655 1.182 . . . . 0.0 108.731 174.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.75 -56.01 10.88 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.6 m 50.55 19.97 0.64 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 169.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -157.38 -0.63 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 80.9 t -71.56 139.26 20.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -115.05 135.11 54.57 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 169.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -139.81 173.17 11.79 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.116 0.96 . . . . 0.0 112.298 -170.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -133.63 163.4 24.43 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 106.079 -2.808 . . . . 0.0 106.079 169.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.45 123.86 7.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.218 1.009 . . . . 0.0 108.413 -169.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 29.7 mt -139.53 139.93 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.47 138.91 11.81 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 169.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.68 128.59 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 162.96 -149.74 17.85 Favored Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 172.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.3 m -85.45 55.87 3.7 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 126.144 1.778 . . . . 0.0 110.956 -169.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -53.14 -37.01 61.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.836 0.855 . . . . 0.0 112.344 -173.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.0 -16.97 64.02 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.641 0.776 . . . . 0.0 112.87 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -63.18 -47.37 82.91 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.806 0.73 . . . . 0.0 111.483 -174.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -162.76 -43.07 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.4 m . . . . . 0 CA--C 1.531 0.234 0 C-N-CA 124.062 0.945 . . . . 0.0 108.874 -169.964 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.6 tp -127.6 -34.0 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.292 1.037 . . . . 0.0 110.002 169.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -55.17 -36.91 66.36 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.41 0.684 . . . . 0.0 111.823 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.41 -54.57 45.52 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.569 0.622 . . . . 0.0 110.902 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 50.4 mt -66.26 -49.35 67.45 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -173.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.17 -35.98 74.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -171.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.84 82.78 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.86 -0.591 . . . . 0.0 110.107 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -69.13 -31.25 69.8 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.239 0.927 . . . . 0.0 112.437 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.7 mt -64.24 -42.37 96.56 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.645 1.566 . . . . 0.0 109.447 169.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -61.93 -41.4 97.91 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.504 0.722 . . . . 0.0 110.133 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -64.4 -36.44 84.15 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.056 1.342 . . . . 0.0 111.012 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.1 m -72.79 7.8 1.8 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.076 1.35 . . . . 0.0 112.849 172.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.27 -8.11 80.55 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.898 1.237 . . . . 0.0 113.353 171.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.13 167.75 4.75 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.421 1.111 . . . . 0.0 110.043 170.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -142.7 151.93 41.84 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.267 -0.896 . . . . 0.0 111.957 176.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -56.39 163.71 1.62 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.375 1.47 . . . . 0.0 110.147 169.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.72 37.69 2.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.381 1.086 . . . . 0.0 109.604 -177.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 155.52 -167.48 33.04 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.558 2.028 . . . . 0.0 108.046 -169.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.75 154.68 20.76 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 117.925 0.863 . . . . 0.0 109.007 169.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.7 m -67.61 158.21 32.64 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.0 tp -132.41 152.34 51.51 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.563 0.745 . . . . 0.0 109.141 172.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -137.4 146.46 44.46 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 169.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.8 mt -134.14 103.31 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -169.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -75.8 141.8 42.44 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -130.9 4.86 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.2 tp . . . . . 0 C--N 1.347 0.462 0 CA-C-N 119.923 1.238 . . . . 0.0 111.374 -169.977 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 119.078 -0.486 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.5 -42.99 86.56 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.717 0.69 . . . . 0.0 110.647 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.19 -40.51 78.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.867 0.467 . . . . 0.0 110.127 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -67.05 -37.78 84.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.06 175.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.03 -42.92 93.89 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.629 1.104 . . . . 0.0 109.941 177.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.84 -43.9 87.21 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 171.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.0 m -63.82 -41.48 97.85 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.177 -0.602 . . . . 0.0 110.836 176.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -49.01 79.32 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.674 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.7 m -66.57 -31.75 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 120.431 1.468 . . . . 0.0 111.634 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -67.97 -18.91 64.88 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.628 0.649 . . . . 0.0 111.794 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.37 -47.2 4.77 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.809 1.244 . . . . 0.0 110.25 -176.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.6 pp -74.55 -23.51 58.8 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.077 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 C--O 1.246 0.88 0 C-N-CA 127.73 2.412 . . . . 0.0 112.15 177.932 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.261 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -136.95 -25.1 1.1 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.045 1.338 . . . . 0.0 111.215 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.9 mt -128.83 82.1 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 169.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 m -76.6 117.94 18.75 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.76 149.74 39.64 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 171.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 68.9 mt -117.18 95.14 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 104.743 -2.318 . . . . 0.0 104.743 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.4 m -85.59 89.49 7.73 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.283 1.833 . . . . 0.0 110.847 -169.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.64 57.09 4.76 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -167.627 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 111.424 -0.671 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.09 -29.66 68.73 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.241 0.52 . . . . 0.0 110.091 172.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -80.88 -30.32 35.57 Favored 'General case' 0 N--CA 1.462 0.162 0 O-C-N 121.962 -0.461 . . . . 0.0 111.601 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -66.79 -40.54 88.17 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.094 0.861 . . . . 0.0 108.931 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.07 -42.36 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 118.675 -0.679 . . . . 0.0 109.849 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.85 85.12 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.539 1.063 . . . . 0.0 111.149 176.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -65.04 -43.03 93.68 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.192 0.597 . . . . 0.0 110.654 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -61.2 -47.22 87.12 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.417 0.553 . . . . 0.0 110.875 176.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.5 mt -59.34 -47.67 84.55 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.541 0.737 . . . . 0.0 109.374 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.5 93.58 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.586 0.754 . . . . 0.0 110.808 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 -58.93 -41.49 87.44 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.404 0.547 . . . . 0.0 110.435 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.44 -30.76 66.43 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.011 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 70.5 mt -65.76 -40.0 91.63 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 119.91 1.232 . . . . 0.0 111.62 170.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -60.09 -43.92 95.18 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.868 0.758 . . . . 0.0 109.321 177.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.41 -38.06 88.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.206 0.602 . . . . 0.0 111.311 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.86 -21.43 64.27 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.739 0.816 . . . . 0.0 112.275 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.29 28.49 3.79 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.375 171.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -126.52 129.39 48.53 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.804 1.302 . . . . 0.0 107.96 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 p -75.37 148.11 39.49 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.8 p -134.02 170.17 16.04 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.757 0.789 . . . . 0.0 111.393 -171.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -152.6 161.96 41.87 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 169.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.49 78.5 1.81 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.7 mt -69.66 113.6 7.08 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.429 ' CD2' HD22 ' A' ' 65' ' ' ASN . 43.0 t60 -73.35 106.23 5.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 52.51 55.68 21.39 Favored Glycine 0 CA--C 1.541 1.685 0 CA-C-O 118.58 -1.122 . . . . 0.0 115.575 172.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -69.26 175.33 7.83 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.161 2.574 . . . . 0.0 111.722 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.6 mt -131.69 171.28 13.67 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 126.06 1.744 . . . . 0.0 110.152 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.87 -38.26 55.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.051 1.74 . . . . 0.0 111.857 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.62 -8.56 14.77 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -133.99 18.41 3.79 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.144 1.778 . . . . 0.0 110.87 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.9 mt -134.27 98.29 14.14 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 125.223 1.409 . . . . 0.0 107.704 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.14 163.5 35.8 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.157 1.905 . . . . 0.0 110.857 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.79 3.03 4.53 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -170.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.4 m -147.68 136.96 22.39 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.654 1.182 . . . . 0.0 107.894 -171.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.1 177.26 25.62 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.5 mt -113.71 102.43 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -101.21 168.68 9.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.341 0.656 . . . . 0.0 109.43 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.0 tp -144.59 100.42 3.52 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.4 t -79.49 140.78 16.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 123.553 0.741 . . . . 0.0 109.015 -174.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.3 mp -132.31 135.97 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 171.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.3 m -126.0 137.95 53.7 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.284 0.633 . . . . 0.0 111.369 173.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.4 m -69.87 160.25 32.16 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 168.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.59 89.14 2.19 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -78.63 42.28 0.44 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.767 1.227 . . . . 0.0 112.053 -171.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.57 -39.56 1.95 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.103 1.335 . . . . 0.0 113.422 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.62 -21.35 59.51 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.124 0.969 . . . . 0.0 112.971 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.35 9.13 80.04 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.767 -1.018 . . . . 0.0 113.539 -176.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -75.92 152.54 37.08 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.83 1.315 . . . . 0.0 110.756 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.1 mt -65.98 142.89 98.23 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.325 1.45 . . . . 0.0 108.567 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -57.95 125.99 20.31 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.937 3.091 . . . . 0.0 111.714 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -56.75 -27.09 58.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.656 1.182 . . . . 0.0 114.134 -173.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.429 HD22 ' CD2' ' A' ' 37' ' ' HIS . 10.2 p-10 -73.23 -19.18 61.14 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.817 -0.552 . . . . 0.0 112.43 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.4 tp -127.29 -23.03 3.6 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.125 1.37 . . . . 0.0 111.175 -171.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.2 p -53.94 -31.66 9.04 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-O 116.832 -1.556 . . . . 0.0 114.832 -176.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -52.54 -23.57 19.78 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.481 2.121 . . . . 0.0 114.929 169.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.46 -35.92 78.95 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.952 1.251 . . . . 0.0 111.675 175.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -59.32 -43.07 92.73 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.331 0.514 . . . . 0.0 109.777 176.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.9 -48.47 58.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.929 0.492 . . . . 0.0 109.8 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.38 -31.56 72.73 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.891 0.769 . . . . 0.0 112.54 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.1 mt -68.6 -54.65 15.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.952 0.796 . . . . 0.0 109.404 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -68.89 -29.52 67.82 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.336 0.971 . . . . 0.0 112.264 -171.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -73.24 -24.16 60.44 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.786 0.721 . . . . 0.0 111.32 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -112.86 -23.64 10.0 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.865 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt 39.31 64.67 3.84 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.936 1.694 . . . . 0.0 109.807 -169.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.88 -4.68 13.87 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.295 2.663 . . . . 0.0 115.534 -169.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.7 t70 50.57 51.99 15.76 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.172 1.389 . . . . 0.0 111.592 171.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.3 mt -58.92 -46.48 87.85 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.443 1.497 . . . . 0.0 110.494 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.8 m 54.86 15.44 1.13 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 172.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -153.92 2.03 0.24 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.704 1.138 . . . . 0.0 113.857 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 79.7 t -72.56 138.12 22.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 169.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -119.96 140.32 51.11 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 104.262 -2.496 . . . . 0.0 104.262 168.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -149.69 169.91 19.92 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.364 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.42 166.65 20.9 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 105.662 -2.975 . . . . 0.0 105.662 169.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.64 135.84 23.87 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.373 1.087 . . . . 0.0 109.723 -169.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.2 mt -135.9 137.36 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -175.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.18 135.18 11.18 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 170.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.9 mt -139.57 131.13 33.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 164.96 -159.85 33.02 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 120.425 1.466 . . . . 0.0 110.369 171.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.6 m -76.33 47.45 0.47 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 127.727 2.411 . . . . 0.0 111.106 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 57.1 mtt-85 -66.57 -15.9 63.76 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.149 -0.969 . . . . 0.0 112.879 -170.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.63 -28.38 69.86 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.21 0.604 . . . . 0.0 112.051 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -66.42 -57.32 7.65 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 123.292 0.637 . . . . 0.0 110.466 -171.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -169.01 -66.33 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.263 1.425 . . . . 0.0 108.636 172.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.9 p . . . . . 0 CA--C 1.551 0.987 0 C-N-CA 127.413 2.285 . . . . 0.0 114.308 -174.516 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.09 -33.16 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -61.06 -37.77 83.83 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.957 0.903 . . . . 0.0 111.971 -172.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -68.38 -42.77 78.61 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.725 -0.609 . . . . 0.0 111.081 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.77 -50.05 73.91 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.55 -32.93 73.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 119.438 -0.315 . . . . 0.0 111.023 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.77 99.59 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -74.57 -29.2 61.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.279 -0.867 . . . . 0.0 112.259 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.1 mt -62.82 -47.91 81.38 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.191 1.359 . . . . 0.0 109.234 170.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -66.07 -36.62 83.7 Favored 'General case' 0 N--CA 1.46 0.054 0 C-N-CA 122.415 0.286 . . . . 0.0 110.829 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -63.38 -38.36 90.85 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.134 0.574 . . . . 0.0 110.7 173.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.2 m -74.46 11.77 0.92 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.661 1.184 . . . . 0.0 112.499 171.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.35 -5.52 84.64 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 120.78 -1.2 . . . . 0.0 113.857 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.9 169.39 2.6 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.0 1.4 . . . . 0.0 110.092 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -141.74 139.74 32.93 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.602 -0.686 . . . . 0.0 110.966 169.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -64.94 170.61 4.15 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.049 1.339 . . . . 0.0 109.461 175.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.1 m -140.15 152.72 46.29 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.39 -132.99 42.03 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -144.07 154.85 43.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.77 129.78 42.02 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.119 0.968 . . . . 0.0 109.958 -177.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.2 tp -91.36 142.39 27.74 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -129.71 139.46 51.33 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.2 mt -138.99 100.4 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -73.43 133.43 43.73 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 169.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -128.91 8.12 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.844 0.747 . . . . 0.0 112.538 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.5 tp . . . . . 0 N--CA 1.468 0.456 0 CA-C-N 118.941 0.792 . . . . 0.0 111.654 -178.479 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.218 0 CA-C-O 119.541 -0.266 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.29 -34.19 77.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.217 0.607 . . . . 0.0 111.563 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -79.42 -36.6 38.78 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.419 0.554 . . . . 0.0 109.756 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -66.83 -40.0 87.83 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.771 -0.581 . . . . 0.0 110.046 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.1 tp -64.77 -42.33 95.19 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.51 1.124 . . . . 0.0 110.575 174.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.52 -43.98 85.59 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.43 1.014 . . . . 0.0 110.985 172.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.8 m -63.98 -41.11 97.64 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.292 0.637 . . . . 0.0 110.568 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -52.01 66.68 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.406 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.1 m -61.79 -35.07 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 119.793 1.179 . . . . 0.0 110.796 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -61.92 -24.35 66.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.55 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.2 mt -91.64 -47.77 7.2 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.739 1.154 . . . . 0.0 111.04 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.7 pp -80.24 -10.94 59.77 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -172.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.4 pttm . . . . . 0 C--O 1.249 1.053 0 C-N-CA 125.463 1.505 . . . . 0.0 112.778 -177.565 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.299 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -136.37 -26.64 1.11 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.276 1.43 . . . . 0.0 111.038 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.0 mt -122.91 77.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 169.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -74.74 116.33 15.33 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.2 mt -87.84 155.93 19.64 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.3 mt -125.62 95.12 3.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -170.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 m -90.07 153.03 20.87 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.086 1.754 . . . . 0.0 111.022 -175.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.18 128.95 1.15 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 107.558 -2.217 . . . . 0.0 107.558 173.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.204 0 CA-C-O 121.565 0.698 . . . . 0.0 112.305 -172.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.648 0 CA-C-O 118.611 -1.105 . . . . 0.0 112.948 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.23 -32.42 73.83 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.037 1.919 . . . . 0.0 110.746 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.67 -39.34 93.5 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.494 0.318 . . . . 0.0 110.848 176.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -70.55 -48.03 57.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -61.35 -43.1 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.52 -48.15 83.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 118.73 0.696 . . . . 0.0 110.101 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.51 -43.33 94.43 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.663 0.665 . . . . 0.0 110.986 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -63.53 -38.44 91.16 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.813 0.845 . . . . 0.0 111.252 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.6 mt -74.53 -41.25 60.94 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.266 0.626 . . . . 0.0 110.275 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.89 -40.32 80.0 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 123.438 0.695 . . . . 0.0 110.84 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -52.51 -46.35 66.64 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.608 0.763 . . . . 0.0 110.638 175.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -68.0 -39.21 83.26 Favored 'General case' 0 N--CA 1.46 0.064 0 O-C-N 121.84 -0.538 . . . . 0.0 110.259 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.8 mt -66.34 -39.84 89.46 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 119.506 -0.283 . . . . 0.0 110.705 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.81 -40.44 91.88 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.409 0.549 . . . . 0.0 110.18 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -64.78 -36.19 83.51 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.33 0.514 . . . . 0.0 111.018 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.94 -23.98 64.22 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.46 0.704 . . . . 0.0 111.994 174.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.86 -0.62 13.53 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.902 1.239 . . . . 0.0 113.741 170.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -75.67 174.75 9.36 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.737 1.268 . . . . 0.0 110.305 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.9 p -119.16 144.01 46.91 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 170.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -135.64 167.69 20.66 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.063 0.945 . . . . 0.0 109.934 -169.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -153.07 160.23 42.92 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 169.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 p -124.88 72.19 1.21 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.0 mt -69.05 114.38 7.28 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -173.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -81.89 110.0 16.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.85 46.62 93.22 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-O 117.943 -1.476 . . . . 0.0 115.926 172.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -69.09 173.36 10.48 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 121.031 2.415 . . . . 0.0 110.267 169.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 mp -131.34 175.68 8.93 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.285 1.434 . . . . 0.0 108.036 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.408 HD21 ' HG3' ' A' ' 78' ' ' PRO . 45.3 tp -55.77 -32.02 63.08 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.284 1.034 . . . . 0.0 111.052 175.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.83 -7.5 11.43 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.068 0.947 . . . . 0.0 112.717 178.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -134.19 18.08 3.74 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.42 1.488 . . . . 0.0 111.336 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.7 mt -137.27 113.57 9.58 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.702 1.201 . . . . 0.0 108.422 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.78 164.14 36.63 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.366 2.044 . . . . 0.0 111.428 -178.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.6 20.46 1.12 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.163 1.385 . . . . 0.0 112.951 -171.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.8 m -153.94 139.1 17.43 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 120.999 -1.063 . . . . 0.0 108.41 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.42 -178.14 27.14 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.18 101.05 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -102.82 175.28 5.54 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.29 1.036 . . . . 0.0 110.462 -173.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.6 tp -145.66 108.3 4.48 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.4 t -86.56 131.65 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.6 mt -130.67 131.63 64.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.9 m -149.47 142.02 24.4 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.643 0.777 . . . . 0.0 109.192 -169.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.8 m -73.68 160.6 31.33 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 m -115.54 5.77 14.5 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.757 0.789 . . . . 0.0 112.678 -175.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 41.53 22.9 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 129.279 3.031 . . . . 0.0 114.181 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.89 19.31 29.12 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.462 -1.188 . . . . 0.0 114.562 -170.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.35 -13.32 0.13 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.491 1.646 . . . . 0.0 115.115 -169.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.43 -1.83 53.64 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 119.454 1.025 . . . . 0.0 113.081 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.96 155.87 38.18 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 169.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.9 mt -122.91 144.38 42.86 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.028 1.331 . . . . 0.0 107.863 -169.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.99 124.74 4.93 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.606 3.538 . . . . 0.0 113.62 172.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.5 -24.22 65.13 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.94 0.896 . . . . 0.0 113.066 -174.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -73.9 -22.46 59.69 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.0 tp -122.69 -29.9 3.95 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.152 0.981 . . . . 0.0 111.372 -170.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 t -45.75 -41.76 20.39 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.537 1.535 . . . . 0.0 113.684 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -51.16 -23.01 12.05 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.301 2.667 . . . . 0.0 116.122 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -56.76 -38.21 72.12 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.68 1.127 . . . . 0.0 111.027 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -58.23 -43.81 87.92 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.101 0.96 . . . . 0.0 110.458 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -72.48 -45.71 58.22 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.05 0.54 . . . . 0.0 109.841 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.62 -33.95 77.09 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 118.874 -0.584 . . . . 0.0 112.058 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.3 mt -63.85 -57.87 8.52 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -68.85 -27.24 65.64 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.829 0.741 . . . . 0.0 112.197 -172.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.06 -37.34 87.22 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.576 0.625 . . . . 0.0 110.615 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -105.65 -30.81 9.24 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -170.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.7 tttm 29.27 60.86 0.79 Allowed Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 128.019 2.528 . . . . 0.0 113.692 -174.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.408 ' HG3' HD21 ' A' ' 41' ' ' LEU . 83.3 Cg_endo -68.09 170.08 15.21 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.711 1.608 . . . . 0.0 110.089 172.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -74.23 110.99 8.96 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.2 mt -114.58 20.24 15.48 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.418 1.487 . . . . 0.0 110.948 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.8 m -62.15 19.35 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.994 1.718 . . . . 0.0 115.558 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.12 -0.8 2.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.338 1.455 . . . . 0.0 111.861 174.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 68.0 t -81.41 142.92 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 169.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -122.63 146.72 47.2 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 168.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -143.9 172.37 12.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.588 0.709 . . . . 0.0 110.803 -173.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.68 166.95 23.36 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 107.983 -2.047 . . . . 0.0 107.983 169.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.9 134.8 17.81 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -169.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.9 mt -138.68 128.82 33.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -177.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -104.32 104.59 2.45 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 107.983 -2.047 . . . . 0.0 107.983 173.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.3 mt -84.33 128.56 38.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.798 -1.926 . . . . 0.0 105.798 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.55 -146.48 6.06 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 -172.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.2 m -161.7 149.08 14.54 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.653 1.181 . . . . 0.0 110.36 171.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -64.7 -17.18 63.86 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.81 -36.55 84.7 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.207 0.603 . . . . 0.0 109.91 175.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -74.01 158.26 34.66 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.429 0.633 . . . . 0.0 110.708 176.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.49 -19.07 62.25 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.668 0.787 . . . . 0.0 112.523 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.4 m . . . . . 0 CA--C 1.536 0.442 0 C-N-CA 124.445 1.098 . . . . 0.0 108.997 -172.495 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.393 0 N-CA-C 110.654 -0.128 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.2 tp -60.92 -31.07 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.735 0.814 . . . . 0.0 109.693 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -51.43 -38.17 52.27 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.131 0.972 . . . . 0.0 112.165 177.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -71.84 -47.87 50.03 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.972 0.806 . . . . 0.0 109.961 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.3 mt -59.58 -48.34 82.05 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.299 0.64 . . . . 0.0 109.781 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -68.98 -37.66 78.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.1 85.92 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 118.564 -0.731 . . . . 0.0 110.508 -171.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -72.02 -28.26 63.26 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.309 0.958 . . . . 0.0 112.699 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.51 -43.88 84.04 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.571 1.532 . . . . 0.0 108.498 169.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -61.11 -44.3 97.56 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.2 1.0 . . . . 0.0 109.977 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -66.14 -35.25 80.0 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.988 1.715 . . . . 0.0 111.281 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 44.4 m -73.65 -8.13 54.77 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.786 0.834 . . . . 0.0 112.675 173.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.42 -18.13 8.85 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.797 1.189 . . . . 0.0 113.935 169.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.66 171.97 2.38 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.294 1.047 . . . . 0.0 111.286 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -144.32 155.44 43.81 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.972 -1.08 . . . . 0.0 112.287 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -56.44 168.12 0.6 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.948 1.699 . . . . 0.0 110.581 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 m -134.02 37.92 3.2 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.211 1.004 . . . . 0.0 110.266 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 139.6 -168.95 24.79 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 126.945 2.212 . . . . 0.0 110.245 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -89.84 143.32 26.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 117.928 0.864 . . . . 0.0 110.858 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.1 m -58.32 137.91 56.82 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.914 1.686 . . . . 0.0 111.447 -176.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 35.9 tp -91.44 148.92 21.96 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.795 0.438 . . . . 0.0 109.892 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -116.42 138.22 51.54 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 169.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.9 mt -124.4 99.29 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.18 92.25 6.27 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.051 1.74 . . . . 0.0 108.59 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 26.5 pt -66.67 -35.28 74.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -174.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.5 tp . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 125.525 1.53 . . . . 0.0 112.518 -175.586 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -63.52 -30.2 71.35 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.693 0.797 . . . . 0.0 111.341 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -68.21 -43.98 76.8 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.214 0.915 . . . . 0.0 109.328 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -64.26 -39.17 93.39 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.81 0.844 . . . . 0.0 110.596 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.69 -30.91 71.05 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.65 -0.656 . . . . 0.0 110.954 176.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.04 -44.29 56.45 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.442 1.02 . . . . 0.0 111.49 171.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.6 m -64.16 -39.13 93.37 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.657 0.729 . . . . 0.0 110.588 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -62.47 -50.7 70.42 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 118.671 0.669 . . . . 0.0 110.869 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.5 m -66.74 -30.76 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.551 1.069 . . . . 0.0 111.027 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -67.76 -33.03 74.05 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.885 0.766 . . . . 0.0 111.333 175.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.43 -49.66 11.14 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.623 0.769 . . . . 0.0 110.154 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 pp -79.35 -21.46 45.79 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.471 -0.776 . . . . 0.0 112.716 -172.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp . . . . . 0 C--O 1.251 1.181 0 C-N-CA 127.382 2.273 . . . . 0.0 111.822 -179.366 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -128.13 -26.11 2.9 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.17 0.988 . . . . 0.0 111.476 -173.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.3 mt -130.74 85.98 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.1 m -82.01 115.16 21.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mp -74.28 155.35 38.33 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.5 mt -130.89 104.1 8.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.44 1.496 . . . . 0.0 107.076 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.25 133.14 35.23 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.708 0.803 . . . . 0.0 110.982 -177.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -125.34 86.76 0.36 Allowed Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 107.413 -2.275 . . . . 0.0 107.413 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 122.435 1.112 . . . . 0.0 111.974 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 N-CA-C 112.203 -0.359 . . . . 0.0 112.203 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.89 -22.76 63.2 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.566 -0.731 . . . . 0.0 111.231 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.25 -39.88 62.75 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.054 0.843 . . . . 0.0 110.135 176.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -68.47 -43.13 77.64 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.683 -0.636 . . . . 0.0 109.436 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.2 t -64.12 -39.71 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.049 175.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.91 -43.55 98.39 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 119.636 1.107 . . . . 0.0 110.88 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -61.02 -44.27 97.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.431 0.56 . . . . 0.0 110.411 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -60.84 -51.62 68.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.919 0.488 . . . . 0.0 110.541 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.7 mt -61.25 -43.63 98.56 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.463 0.705 . . . . 0.0 110.349 -177.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.21 -43.31 99.09 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.167 0.587 . . . . 0.0 110.294 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.0 -45.41 93.74 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.538 0.608 . . . . 0.0 110.293 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -60.98 -43.04 99.4 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.914 -0.491 . . . . 0.0 110.578 178.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 41.6 mt -64.24 -40.94 97.04 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.781 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.8 -38.22 88.37 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.944 0.793 . . . . 0.0 110.308 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -66.77 -36.74 83.13 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.294 0.497 . . . . 0.0 110.845 175.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.75 -25.46 64.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.283 0.633 . . . . 0.0 111.788 173.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.99 -0.17 14.82 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.331 1.444 . . . . 0.0 113.941 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -81.16 143.41 32.39 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.109 1.455 . . . . 0.0 109.69 -177.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 p -79.47 138.14 37.47 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.1 p -128.38 162.51 26.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.046 0.938 . . . . 0.0 109.979 -173.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -145.75 166.64 25.29 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 170.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.3 m -145.72 101.87 3.61 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 -177.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.85 106.92 18.81 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -175.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -74.93 105.71 6.09 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.53 56.13 26.74 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 118.368 -1.24 . . . . 0.0 115.355 172.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.7 172.8 7.61 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.93 2.42 . . . . 0.0 111.623 172.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.2 mt -128.14 170.23 13.2 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.977 2.111 . . . . 0.0 107.565 169.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 tt -54.49 -34.67 62.03 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.888 0.875 . . . . 0.0 111.737 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.06 -5.24 12.3 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.915 1.286 . . . . 0.0 112.591 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -135.23 17.59 3.42 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.944 1.298 . . . . 0.0 110.577 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -134.35 98.59 13.8 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 125.072 1.349 . . . . 0.0 108.628 -169.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -70.23 154.12 66.15 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.559 2.173 . . . . 0.0 111.961 -176.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.02 7.98 6.42 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.059 1.344 . . . . 0.0 114.452 -170.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.5 m -149.48 125.63 10.71 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.125 0.97 . . . . 0.0 108.444 -170.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.24 -175.74 28.32 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.0 mt -116.41 102.03 13.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -96.88 169.86 9.56 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.51 0.724 . . . . 0.0 109.428 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.6 tp -143.16 101.72 3.86 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.1 t -84.34 138.43 19.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 124.125 0.97 . . . . 0.0 108.793 -174.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mp -135.02 130.55 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.24 136.46 50.13 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.042 0.937 . . . . 0.0 110.366 -168.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 m -106.98 47.97 0.86 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.737 0.815 . . . . 0.0 111.175 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.1 m -33.02 105.83 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.178 2.191 . . . . 0.0 110.808 169.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.96 149.86 46.39 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 169.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -42.02 -35.27 1.61 Allowed Glycine 0 CA--C 1.531 1.031 0 C-N-CA 126.096 1.807 . . . . 0.0 116.437 -169.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.92 -10.64 59.25 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.46 46.45 4.34 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 -169.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -123.37 106.78 10.96 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -178.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.4 mt -65.02 141.0 98.26 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.86 141.19 89.02 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.869 2.379 . . . . 0.0 111.851 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -62.44 -14.97 46.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.911 1.684 . . . . 0.0 113.582 -173.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.72 -25.02 63.65 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.461 -0.774 . . . . 0.0 111.824 177.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 63.5 tp -128.68 -31.77 2.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.973 0.806 . . . . 0.0 112.348 -169.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.7 p -52.27 -34.25 15.22 Favored Pre-proline 0 CA--C 1.553 1.08 0 CA-C-O 116.744 -1.598 . . . . 0.0 114.298 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.15 -37.68 59.02 Favored 'Trans proline' 0 C--N 1.359 1.113 0 C-N-CA 123.296 2.664 . . . . 0.0 114.989 174.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -61.13 -44.39 97.41 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.396 0.544 . . . . 0.0 109.764 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -75.84 -30.47 58.95 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.975 0.51 . . . . 0.0 110.686 -173.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -62.56 -43.15 99.53 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.461 -0.774 . . . . 0.0 109.118 169.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.47 -20.65 66.1 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 118.4 -0.809 . . . . 0.0 112.737 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.16 -55.95 10.51 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.774 1.17 . . . . 0.0 109.051 172.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -64.78 -28.17 69.39 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.015 0.825 . . . . 0.0 111.734 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -67.09 -28.63 68.34 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.475 0.71 . . . . 0.0 111.631 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -123.22 -17.62 6.56 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 -169.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.8 tttp 41.02 58.61 8.54 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.322 1.449 . . . . 0.0 109.633 -168.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -67.19 158.47 56.79 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.803 2.335 . . . . 0.0 111.027 -170.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -81.99 84.46 6.96 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.853 0.861 . . . . 0.0 109.761 177.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 mt -108.95 26.82 10.16 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.642 1.577 . . . . 0.0 109.728 175.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.7 m -60.76 17.1 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 128.548 2.739 . . . . 0.0 116.012 -174.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.52 5.42 1.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.197 1.399 . . . . 0.0 111.909 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.9 t -77.66 137.62 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 169.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -124.02 146.94 48.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 168.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -150.03 166.91 28.27 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.421 -175.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -112.76 157.89 14.64 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 104.674 -3.37 . . . . 0.0 104.674 169.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.77 132.05 20.65 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.944 1.372 . . . . 0.0 110.187 -169.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 56.7 mt -138.39 138.75 42.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.93 150.31 17.63 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 107.864 -2.095 . . . . 0.0 107.864 169.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.7 mt -139.61 136.04 39.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.9 -164.02 30.53 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 176.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.0 m -110.33 104.21 12.97 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.218 1.407 . . . . 0.0 108.494 -175.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -59.68 -12.41 6.88 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.075 1.35 . . . . 0.0 113.056 -174.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -56.73 -32.53 65.63 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.486 1.039 . . . . 0.0 110.94 169.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -83.68 151.7 25.13 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.015 0.926 . . . . 0.0 110.026 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.75 -27.75 65.21 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -175.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 CA--C 1.537 0.47 0 C-N-CA 124.368 1.067 . . . . 0.0 110.795 -169.592 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.36 -27.45 41.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 119.714 1.143 . . . . 0.0 109.443 170.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.17 -39.16 89.54 Favored 'General case' 0 C--N 1.338 0.106 0 O-C-N 121.591 -0.693 . . . . 0.0 110.479 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -58.94 -49.02 79.42 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.96 -54.54 45.96 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.451 0.3 . . . . 0.0 110.501 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -64.19 -38.21 90.22 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.122 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.47 -36.37 78.88 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 119.396 -0.335 . . . . 0.0 111.192 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -74.5 -33.05 62.73 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.794 0.724 . . . . 0.0 110.909 -175.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.3 mt -69.24 -38.85 78.68 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.686 1.13 . . . . 0.0 109.7 169.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -62.05 -40.66 96.53 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.839 0.745 . . . . 0.0 110.124 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -65.2 -31.27 72.36 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.759 0.824 . . . . 0.0 111.415 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.6 m -77.47 4.71 10.41 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.234 1.013 . . . . 0.0 112.355 172.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.24 -11.55 63.63 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.735 1.159 . . . . 0.0 113.41 172.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.35 -178.21 0.48 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.556 1.178 . . . . 0.0 110.793 173.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.18 138.08 17.15 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.148 -0.97 . . . . 0.0 110.966 169.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.56 168.0 1.29 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.337 1.455 . . . . 0.0 108.512 169.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.6 m -135.16 151.61 50.83 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.3 -120.11 21.31 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -140.68 164.23 30.75 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.769 1.627 . . . . 0.0 106.966 170.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.0 m -83.48 139.18 33.08 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.552 -0.717 . . . . 0.0 109.532 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.4 tp -97.9 149.32 22.52 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.824 1.249 . . . . 0.0 109.893 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -119.36 146.33 45.41 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 169.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.7 mt -133.16 100.06 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -68.21 139.13 56.04 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 169.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.3 pp -129.62 15.54 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.22 1.008 . . . . 0.0 112.26 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.0 tp . . . . . 0 C--N 1.342 0.24 0 CA-C-N 119.075 0.852 . . . . 0.0 108.984 176.963 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 119.226 -0.416 . . . . 0.0 111.473 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.35 -40.25 74.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.056 0.942 . . . . 0.0 111.232 178.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -73.87 -42.33 60.93 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.726 -0.609 . . . . 0.0 109.895 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -68.55 -36.47 78.85 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.555 0.342 . . . . 0.0 110.621 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.6 tp -61.19 -39.53 90.53 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.81 0.844 . . . . 0.0 110.203 171.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.36 -48.32 48.38 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.575 1.083 . . . . 0.0 111.33 170.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.2 m -61.97 -41.47 98.05 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 117.645 0.723 . . . . 0.0 110.865 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -62.86 -50.82 69.4 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.481 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.8 m -63.96 -34.23 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 120.115 1.325 . . . . 0.0 110.733 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.0 -21.37 66.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.901 0.88 . . . . 0.0 113.05 176.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.32 -49.77 4.57 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.405 1.002 . . . . 0.0 111.12 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.76 -27.23 64.76 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.376 -173.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt . . . . . 0 C--O 1.252 1.197 0 C-N-CA 128.187 2.595 . . . . 0.0 113.102 175.277 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.197 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -135.87 -25.06 1.27 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.982 1.313 . . . . 0.0 111.036 -179.202 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.7 mt -125.35 80.87 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 169.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.0 m -76.56 114.14 14.96 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.37 155.21 28.52 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.353 1.061 . . . . 0.0 109.233 174.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.1 mt -127.4 93.2 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -174.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -67.02 162.58 21.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.818 1.247 . . . . 0.0 110.158 172.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.78 58.36 0.08 OUTLIER Glycine 0 C--N 1.337 0.615 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -169.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 C--N 1.331 -0.215 0 C-N-CA 124.148 0.979 . . . . 0.0 110.502 170.947 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.603 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.03 -28.62 69.92 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 117.874 0.837 . . . . 0.0 110.737 176.218 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -68.84 -40.46 79.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.094 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -76.75 -37.41 55.99 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 122.72 0.408 . . . . 0.0 110.62 -179.395 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.58 -43.01 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 118.454 0.57 . . . . 0.0 109.474 171.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.19 93.8 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.548 0.613 . . . . 0.0 110.395 177.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.14 -42.4 99.21 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.458 0.572 . . . . 0.0 110.872 178.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -61.81 -50.41 72.41 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.704 0.802 . . . . 0.0 110.165 178.27 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.3 mt -62.18 -39.75 93.72 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.383 0.673 . . . . 0.0 110.655 179.216 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.96 99.3 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.952 0.501 . . . . 0.0 110.6 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.12 -43.61 94.76 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.678 0.672 . . . . 0.0 110.3 178.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -58.27 -45.99 86.84 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.914 -0.492 . . . . 0.0 110.067 175.387 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.6 mt -62.48 -38.83 91.35 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.996 178.027 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.22 -38.51 90.65 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.23 0.923 . . . . 0.0 110.316 177.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.05 -36.74 82.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.54 0.609 . . . . 0.0 110.756 175.087 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.16 -25.28 65.19 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.154 0.581 . . . . 0.0 111.898 173.712 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.78 0.61 17.57 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.395 1.474 . . . . 0.0 113.998 170.225 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -83.59 149.57 26.48 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.04 1.42 . . . . 0.0 109.91 -178.669 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -87.86 140.18 29.77 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.191 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 p -139.22 165.97 25.76 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.305 1.042 . . . . 0.0 109.812 -169.818 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -154.42 155.4 34.91 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 169.629 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.9 p -126.28 84.31 2.26 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -171.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.6 mt -68.12 119.98 13.58 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -174.074 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -75.54 92.36 2.89 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.192 0.997 . . . . 0.0 108.458 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.45 61.79 5.65 Favored Glycine 0 CA--C 1.542 1.772 0 C-N-CA 124.628 1.108 . . . . 0.0 113.929 175.243 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -69.06 177.47 5.07 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.973 3.115 . . . . 0.0 111.875 179.036 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 38.3 mt -107.49 154.21 21.7 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.828 1.251 . . . . 0.0 107.965 169.835 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.46 -38.83 72.2 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.924 0.889 . . . . 0.0 111.539 -177.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.09 -18.09 63.01 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.743 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -75.3 -19.43 59.68 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.601 0.637 . . . . 0.0 111.862 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.1 mt -99.9 143.09 25.83 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 123.983 0.913 . . . . 0.0 110.517 -173.231 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.19 163.19 38.72 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.364 2.043 . . . . 0.0 109.26 169.052 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.81 25.66 0.77 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.521 1.128 . . . . 0.0 111.904 -176.575 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.5 m -155.89 142.2 18.43 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.13 1.372 . . . . 0.0 107.907 177.313 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 150.46 -176.16 29.18 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 178.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -128.92 101.24 6.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 178.002 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -103.14 171.82 7.16 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.202 1.001 . . . . 0.0 108.981 -177.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.2 tp -148.0 117.2 6.87 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 176.403 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.52 135.39 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -169.663 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.78 119.91 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.0 m -123.04 -174.42 2.94 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.799 1.64 . . . . 0.0 107.793 -174.083 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -144.47 170.26 16.37 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 168.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.452 HG21 ' O ' ' A' ' 97' ' ' THR . 24.1 m -126.24 129.28 48.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -67.17 -29.75 69.53 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 117.92 0.327 . . . . 0.0 111.393 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.94 -38.95 0.32 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.692 0.663 . . . . 0.0 112.805 175.006 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.87 19.15 7.85 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.054 0.942 . . . . 0.0 112.732 -170.054 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.62 -8.07 28.08 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.266 0.936 . . . . 0.0 113.171 174.702 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.12 121.3 15.32 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.495 1.147 . . . . 0.0 109.834 176.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.9 mt -78.11 142.01 63.44 Favored Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 176.702 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.75 145.28 86.18 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.602 2.868 . . . . 0.0 112.044 176.511 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.49 -17.73 34.14 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.964 1.706 . . . . 0.0 114.281 -173.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -62.42 -44.8 95.56 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.502 0.721 . . . . 0.0 109.429 178.214 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.2 tp -120.05 -17.58 8.35 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.334 0.654 . . . . 0.0 112.329 -170.008 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.4 p -53.94 -32.87 12.3 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -178.538 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -54.69 -23.99 35.38 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.518 2.146 . . . . 0.0 114.852 171.033 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -61.23 -38.54 87.0 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.33 0.968 . . . . 0.0 110.769 177.611 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -66.98 -37.15 83.71 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.237 0.471 . . . . 0.0 110.474 177.512 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.81 -45.94 69.91 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.392 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.72 -31.19 72.04 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.764 -0.585 . . . . 0.0 112.1 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.9 mt -61.71 -60.72 3.24 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 123.45 0.7 . . . . 0.0 109.405 171.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -71.14 -26.82 63.17 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -171.255 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -67.69 -37.18 81.96 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.686 0.676 . . . . 0.0 110.97 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -105.95 -34.38 7.63 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.96 0.504 . . . . 0.0 111.613 -170.306 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.9 tttp 32.73 59.27 1.47 Allowed Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 127.759 2.424 . . . . 0.0 113.59 -174.265 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -69.95 159.21 54.07 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.73 1.62 . . . . 0.0 110.004 174.877 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -71.76 127.65 33.23 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 169.306 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 pp -140.54 38.36 1.86 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.862 1.265 . . . . 0.0 110.129 177.698 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.1 m -59.43 24.41 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.856 2.462 . . . . 0.0 115.497 170.256 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.73 3.51 0.97 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.311 1.445 . . . . 0.0 112.184 178.356 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.9 t -87.35 146.11 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 169.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -122.11 146.44 47.21 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 168.093 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -137.63 168.98 18.57 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.009 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -125.43 156.57 19.28 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 104.802 -3.319 . . . . 0.0 104.802 169.007 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.06 123.9 25.29 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.408 1.104 . . . . 0.0 109.986 -169.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.2 mt -132.7 135.48 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.14 162.16 13.65 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 169.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.5 mt -141.71 144.13 26.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -177.498 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 175.41 166.35 32.91 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 106.743 -2.543 . . . . 0.0 106.743 177.622 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.4 m -73.55 134.53 43.8 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 169.742 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -61.61 -15.21 37.33 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -67.73 -23.95 65.32 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.158 0.983 . . . . 0.0 111.647 173.4 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -62.32 143.23 57.19 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.861 0.864 . . . . 0.0 111.14 -175.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.91 -33.09 75.2 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.426 0.69 . . . . 0.0 111.518 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.452 ' O ' HG21 ' A' ' 56' ' ' THR . 24.6 m . . . . . 0 CA--C 1.539 0.535 0 C-N-CA 125.68 1.592 . . . . 0.0 108.049 178.707 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.44 ' N ' ' HG1' ' A' ' 56' ' ' THR . . . . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 tp -57.99 -26.66 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.497 1.119 . . . . 0.0 110.237 172.65 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -57.94 -38.76 76.54 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.716 -0.615 . . . . 0.0 112.119 -174.504 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -72.43 -41.14 66.5 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.566 -0.709 . . . . 0.0 110.416 -178.67 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 45.3 mt -61.39 -47.64 84.89 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.396 0.678 . . . . 0.0 109.53 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -70.31 -36.55 74.39 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.76 -178.524 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.72 96.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.721 -0.656 . . . . 0.0 110.87 -169.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -74.05 -25.57 59.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.159 0.89 . . . . 0.0 111.717 -175.186 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.1 mt -66.23 -48.35 70.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.478 1.49 . . . . 0.0 108.603 169.687 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -61.11 -44.31 97.55 Favored 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 123.634 0.774 . . . . 0.0 109.611 -175.625 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -72.99 0.31 11.68 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.035 1.734 . . . . 0.0 112.722 178.168 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.3 m -122.72 7.21 9.4 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.55 1.14 . . . . 0.0 111.838 176.393 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 132.43 -34.0 2.57 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 118.547 -1.141 . . . . 0.0 114.598 168.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.22 177.88 0.77 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.715 1.258 . . . . 0.0 112.211 -178.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -149.54 162.18 40.66 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 121.399 -0.813 . . . . 0.0 111.039 169.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.27 165.35 3.58 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.059 1.344 . . . . 0.0 110.119 173.179 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.0 m -145.58 159.69 42.75 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 174.146 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.78 -124.7 32.89 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -172.798 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -139.33 163.53 32.25 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.3 m -66.06 149.67 49.89 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.605 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.7 tp -129.56 150.62 50.82 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.426 1.091 . . . . 0.0 109.259 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.24 142.48 47.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 176.451 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.4 mt -134.75 108.97 11.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -171.467 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -68.15 133.19 48.51 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.85 0.86 . . . . 0.0 110.593 178.229 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.1 pt -125.31 16.46 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 125.537 1.535 . . . . 0.0 111.462 174.029 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.0 tp . . . . . 0 N--CA 1.47 0.564 0 C-N-CA 123.779 0.832 . . . . 0.0 110.863 170.955 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 119.047 -0.501 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -63.99 -41.31 97.54 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.596 0.635 . . . . 0.0 110.993 176.421 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.81 -46.29 88.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.665 0.666 . . . . 0.0 110.632 -177.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -66.32 -35.92 81.6 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 122.68 0.392 . . . . 0.0 111.035 175.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 30.2 tp -62.96 -36.21 82.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.204 177.242 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.62 -47.06 65.08 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 170.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.4 m -64.26 -42.86 96.27 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.43 0.615 . . . . 0.0 110.839 177.021 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -60.27 -52.85 63.5 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.849 178.629 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.2 m -65.21 -34.0 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 119.94 1.246 . . . . 0.0 110.948 -177.576 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.46 -40.52 95.87 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.55 0.614 . . . . 0.0 111.652 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.5 mt -85.62 -35.63 20.86 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.103 -175.698 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 pp -76.6 -29.35 56.51 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.421 1.01 . . . . 0.0 111.659 177.212 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? . . . . . 0 C--O 1.249 1.026 0 C-N-CA 128.823 2.849 . . . . 0.0 113.695 179.434 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttt . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 110.078 -0.341 . . . . 10.0 110.078 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.06 156.85 20.7 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.703 1.201 . . . . 10.0 109.807 176.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -114.15 -24.45 8.97 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.859 1.263 . . . . 10.0 110.686 174.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.8 mt -125.94 89.66 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.146 0 N-CA-C 105.793 -1.929 . . . . 10.0 105.793 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.8 m -74.11 115.34 13.47 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.9 mp -77.27 154.0 33.39 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.701 -1.222 . . . . 10.0 107.701 169.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.8 mt -125.62 83.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 103.084 -2.932 . . . . 10.0 103.084 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 m -69.31 147.52 51.02 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.96 1.304 . . . . 10.0 109.272 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.46 81.59 0.15 Allowed Glycine 0 C--N 1.335 0.511 0 N-CA-C 111.119 -0.792 . . . . 10.0 111.119 -172.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.7 p -147.37 155.95 42.45 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.859 0.83 . . . . 10.0 110.142 165.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 p -91.43 -37.08 13.41 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.986 1.314 . . . . 10.0 109.361 168.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -38.47 76.87 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.708 0.803 . . . . 10.0 111.116 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 112.16 -5.68 26.99 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.541 1.067 . . . . 10.0 112.916 -173.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.67 -42.99 98.12 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 119.406 1.603 . . . . 10.0 112.129 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.76 -31.24 70.14 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 117.899 0.849 . . . . 10.0 111.146 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -66.67 -42.37 86.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.099 0.863 . . . . 10.0 109.477 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -59.2 -53.04 62.84 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.133 0.573 . . . . 10.0 110.113 175.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.98 -40.37 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 119.012 -0.518 . . . . 10.0 110.006 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.54 -46.92 86.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.818 0.736 . . . . 10.0 110.433 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.75 -42.86 99.53 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.339 0.518 . . . . 10.0 110.444 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -62.6 -48.97 77.09 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.211 0.604 . . . . 10.0 110.114 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.439 HD21 ' HB1' ' A' ' 135' ' ' ALA . 23.7 mt -60.81 -43.59 98.0 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 124.029 0.932 . . . . 10.0 111.044 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.84 91.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.195 0.598 . . . . 10.0 110.534 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.02 -47.14 87.79 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.699 0.681 . . . . 10.0 110.281 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -61.59 -40.09 93.56 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 121.804 -0.56 . . . . 10.0 110.759 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.509 HD21 HD11 ' A' ' 139' ' ' LEU . 40.1 mt -64.16 -39.96 95.11 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 119.012 -0.518 . . . . 10.0 110.95 177.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.59 -38.81 92.28 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.847 0.749 . . . . 10.0 110.323 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.83 -33.81 75.5 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.914 0.779 . . . . 10.0 111.197 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.71 -20.58 65.28 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.266 0.626 . . . . 10.0 111.807 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.81 6.47 22.94 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.371 1.463 . . . . 10.0 113.376 171.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -103.28 135.87 44.11 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.196 1.498 . . . . 10.0 108.539 -173.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.8 p -79.69 147.42 31.97 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.024 0.53 . . . . 10.0 110.011 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.8 p -141.97 164.33 30.48 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.776 0.798 . . . . 10.0 111.309 -168.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -151.26 159.59 44.27 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.48 2.312 . . . . 10.0 105.103 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -131.0 61.45 1.63 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.356 1.462 . . . . 10.0 108.446 -171.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 mt -55.64 118.71 4.77 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.759 0.824 . . . . 10.0 108.957 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.21 116.57 16.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.178 -1.415 . . . . 10.0 107.178 171.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.8 50.49 14.78 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.027 -1.43 . . . . 10.0 115.73 167.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -65.3 164.35 26.0 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 CA-C-N 120.352 2.076 . . . . 10.0 110.391 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.7 mt -108.7 163.81 12.92 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.851 0.86 . . . . 10.0 108.754 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.408 HD13 ' C ' ' A' ' 41' ' ' LEU . 3.0 tm? -56.75 -39.99 74.98 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.849 0.86 . . . . 10.0 110.356 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.35 2.1 1.36 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.545 1.138 . . . . 10.0 113.705 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -126.33 17.23 7.7 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.691 1.596 . . . . 10.0 111.263 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.6 mt -132.01 123.43 18.96 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.837 1.255 . . . . 10.0 108.558 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.55 159.45 52.77 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 121.926 1.751 . . . . 10.0 110.565 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.74 11.1 1.82 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.664 1.186 . . . . 10.0 113.963 -174.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.0 m -143.71 138.66 29.02 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.114 1.366 . . . . 10.0 107.944 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.42 -177.7 31.64 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.457 -1.057 . . . . 10.0 110.457 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mt -125.6 96.13 3.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 104.699 -2.334 . . . . 10.0 104.699 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -97.14 175.54 6.26 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.17 0.588 . . . . 10.0 110.605 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.9 tp -150.13 99.09 2.78 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 107.812 -1.181 . . . . 10.0 107.812 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.6 t -83.5 130.82 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.751 -1.203 . . . . 10.0 107.751 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.9 mt -132.75 128.35 57.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.321 -2.103 . . . . 10.0 105.321 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.7 m -137.89 133.16 33.51 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.48 0.488 . . . . 10.0 109.936 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.3 m -62.61 160.67 13.53 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.506 0.669 . . . . 10.0 110.024 157.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.1 m -126.7 117.42 22.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 103.82 -2.659 . . . . 10.0 103.82 171.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -74.54 8.7 2.14 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.7 1.0 . . . . 10.0 113.7 -168.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.99 -22.94 26.66 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.766 1.651 . . . . 10.0 112.221 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.02 8.82 8.67 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.447 1.099 . . . . 10.0 112.505 -172.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.32 -2.86 81.61 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 123.534 0.588 . . . . 10.0 112.895 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -68.26 124.35 23.25 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.031 0.916 . . . . 10.0 108.737 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.9 mt -72.73 142.56 83.62 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 106.388 -1.708 . . . . 10.0 106.388 173.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.78 140.38 93.45 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.217 2.612 . . . . 10.0 111.066 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -60.34 -21.79 62.48 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.558 1.143 . . . . 10.0 113.118 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -50.99 -44.18 60.85 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.235 1.414 . . . . 10.0 111.132 169.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.1 tp -122.45 -19.34 6.43 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.745 0.818 . . . . 10.0 112.439 -168.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.9 p -52.78 -35.06 20.46 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 115.131 1.53 . . . . 10.0 115.131 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -54.73 -24.46 37.83 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.365 2.043 . . . . 10.0 114.577 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -62.02 -36.73 82.45 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.427 1.012 . . . . 10.0 111.027 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -61.16 -42.46 98.61 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.513 0.597 . . . . 10.0 110.205 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -72.01 -45.51 60.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.149 0.58 . . . . 10.0 109.732 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.45 -37.09 82.3 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.312 0.645 . . . . 10.0 111.315 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.8 mt -64.75 -59.44 4.23 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 118.726 -0.654 . . . . 10.0 109.529 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -66.99 -29.42 69.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.113 0.869 . . . . 10.0 112.372 -170.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.72 -34.14 76.28 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.226 0.611 . . . . 10.0 111.257 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -105.74 -27.55 11.23 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.417 0.687 . . . . 10.0 111.862 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt 26.73 62.82 0.56 Allowed Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 128.657 2.783 . . . . 10.0 112.858 -169.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.0 166.91 23.14 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.631 2.22 . . . . 10.0 110.364 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -71.53 120.17 16.73 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.533 -0.914 . . . . 10.0 108.533 165.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.2 mt -124.83 24.37 7.68 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.484 1.514 . . . . 10.0 110.255 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.7 m -63.96 10.8 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 115.803 1.779 . . . . 10.0 115.803 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.33 3.01 4.67 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.849 1.26 . . . . 10.0 112.23 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.1 t -74.66 131.8 34.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.752 -1.573 . . . . 10.0 106.752 165.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -105.31 150.81 24.86 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.29 -1.744 . . . . 10.0 106.29 157.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -145.54 159.36 43.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.273 0.559 . . . . 10.0 111.081 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -113.4 163.14 12.17 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 108.445 -1.862 . . . . 10.0 108.445 162.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.54 130.32 21.6 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.492 1.117 . . . . 10.0 108.299 -172.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 mt -134.78 133.21 54.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 105.866 -1.901 . . . . 10.0 105.866 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -108.65 145.04 16.39 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 108.336 -1.906 . . . . 10.0 108.336 166.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.4 mt -130.52 142.67 43.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.331 -2.1 . . . . 10.0 105.331 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.37 174.36 40.34 Favored Glycine 0 N--CA 1.453 -0.209 0 O-C-N 121.374 -0.829 . . . . 10.0 111.532 169.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.0 m -69.06 104.71 2.2 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.064 -1.088 . . . . 10.0 108.064 168.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -75.74 -10.57 59.55 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.321 0.86 . . . . 10.0 113.321 -163.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -76.62 -12.25 59.98 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.573 1.079 . . . . 10.0 112.236 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -64.17 162.59 14.19 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.185 0.902 . . . . 10.0 111.631 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.75 -34.36 74.32 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.92 0.888 . . . . 10.0 111.924 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.3 m -109.14 146.63 33.77 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.505 -0.924 . . . . 10.0 108.505 174.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -153.04 64.27 0.77 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 106.446 -1.687 . . . . 10.0 106.446 -129.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 83.7 m 54.19 38.59 29.51 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.177 0.991 . . . . 10.0 111.255 -169.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.41 -12.1 49.41 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.814 -0.992 . . . . 10.0 112.789 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.31 -41.77 98.97 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.446 1.623 . . . . 10.0 110.811 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.5 tp -57.1 -32.31 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.636 1.175 . . . . 10.0 111.691 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -54.96 -38.06 67.28 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.72 0.808 . . . . 10.0 111.933 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.92 -42.25 85.69 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.834 0.453 . . . . 10.0 110.98 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.3 mt -67.68 -49.28 63.6 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.163 -0.68 . . . . 10.0 109.163 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -63.77 -37.9 89.11 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 118.595 -0.717 . . . . 10.0 110.443 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.29 99.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.129 0.877 . . . . 10.0 110.643 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -74.09 -30.36 62.31 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 119.557 1.071 . . . . 10.0 112.043 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.2 mt -61.59 -48.25 81.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.826 1.193 . . . . 10.0 109.315 169.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -59.44 -45.93 90.19 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.724 1.21 . . . . 10.0 110.296 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -62.38 -38.62 90.32 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.822 1.649 . . . . 10.0 111.311 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.0 m -71.81 -11.87 61.01 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.427 1.091 . . . . 10.0 112.632 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.72 -12.64 8.76 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.706 1.146 . . . . 10.0 113.264 169.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.15 169.86 3.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.437 1.118 . . . . 10.0 110.585 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -138.32 145.16 40.85 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.441 -0.787 . . . . 10.0 111.009 168.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -63.18 166.79 5.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.403 -1.271 . . . . 10.0 109.19 172.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.3 m -132.61 153.06 51.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 105.606 -1.998 . . . . 10.0 105.606 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.99 -140.98 47.09 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 110.97 -0.852 . . . . 10.0 110.97 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -133.8 167.69 20.1 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.547 1.539 . . . . 10.0 108.147 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.2 m -82.64 123.22 29.05 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.793 0.837 . . . . 10.0 109.59 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.5 tp -85.48 145.95 27.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 122.636 0.374 . . . . 10.0 110.045 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -110.64 145.4 38.0 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.005 1.722 . . . . 10.0 106.956 169.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.473 HG23 ' CG2' ' A' ' 130' ' ' ILE . 13.5 mt -140.29 102.92 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.429 -1.693 . . . . 10.0 106.429 -176.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -73.93 135.51 43.26 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.411 -0.589 . . . . 10.0 109.411 173.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.1 pp -128.67 7.75 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.109 0.963 . . . . 10.0 112.805 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.2 tp -67.55 -54.1 22.75 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.07 0.85 . . . . 10.0 111.3 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.2 -48.69 3.15 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.917 0.887 . . . . 10.0 109.293 -164.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -109.72 -177.05 3.17 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.746 1.618 . . . . 10.0 108.886 173.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -123.98 49.54 1.75 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.324 1.849 . . . . 10.0 107.707 -171.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.473 ' CG2' HG23 ' A' ' 123' ' ' ILE 0.296 1.5 pt 51.72 129.46 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 128.668 2.787 . . . . 10.0 113.211 -140.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -85.15 -52.92 0.03 OUTLIER 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.118 1.879 . . . . 10.0 113.316 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -148.31 -13.57 0.35 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.012 1.116 . . . . 10.0 114.012 -141.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -121.59 83.76 41.89 Favored Pre-proline 0 N--CA 1.467 0.403 0 N-CA-C 108.039 -1.097 . . . . 10.0 108.039 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -47.25 141.84 12.92 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 123.74 2.96 . . . . 10.0 112.819 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.439 ' HB1' HD21 ' A' ' 22' ' ' LEU . . . -57.68 -25.58 60.46 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.184 162.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -56.27 -39.84 73.27 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.987 1.715 . . . . 10.0 112.164 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -67.52 -47.18 70.68 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.01 0.823 . . . . 10.0 109.091 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -61.97 -41.02 97.55 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.389 0.676 . . . . 10.0 110.353 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.509 HD11 HD21 ' A' ' 26' ' ' LEU . 35.3 tp -61.58 -38.99 89.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.802 1.241 . . . . 10.0 110.646 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.07 -50.25 62.74 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.862 -0.895 . . . . 10.0 110.862 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.5 m -60.65 -30.27 69.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.007 0.523 . . . . 10.0 111.786 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -52.87 10.74 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.488 0.715 . . . . 10.0 111.852 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.0 -32.04 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -59.96 -23.53 63.66 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.476 1.111 . . . . 10.0 113.622 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.5 mt -102.06 -44.23 5.52 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 120.139 1.336 . . . . 10.0 111.382 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.95 -27.43 62.78 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.786 -1.102 . . . . 10.0 112.244 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm . . . . . 0 C--O 1.252 1.194 0 C-N-CA 128.672 2.789 . . . . 10.0 113.417 -177.296 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.2 ttm . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.99 164.27 22.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.847 0.859 . . . . 0.0 111.193 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -76.0 -29.48 58.18 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.136 0.975 . . . . 0.0 110.113 -175.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.8 mt -125.15 74.17 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.1 m -74.81 114.83 13.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.94 155.19 37.69 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 172.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.9 mt -116.95 112.06 37.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 103.829 -2.656 . . . . 0.0 103.829 172.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -113.86 155.55 25.53 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.531 1.532 . . . . 0.0 110.84 -169.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.01 131.21 1.28 Allowed Glycine 0 N--CA 1.448 -0.512 0 O-C-N 121.187 -0.945 . . . . 0.0 111.13 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.0 p -158.15 108.65 2.14 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 169.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.441 ' H ' ' HB3' ' A' ' 63' ' ' PRO . 1.1 p -71.15 -37.09 72.24 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.806 0.442 . . . . 0.0 110.319 175.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 pp -70.68 -34.46 72.01 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.418 0.287 . . . . 0.0 111.513 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 124.57 160.66 10.83 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.82 1.676 . . . . 0.0 109.516 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.98 -55.93 0.69 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 125.027 1.299 . . . . 0.0 111.348 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.79 -27.7 68.47 Favored 'General case' 0 C--O 1.228 -0.075 0 CA-C-N 118.108 0.954 . . . . 0.0 110.702 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -60.48 -27.89 67.92 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.921 0.488 . . . . 0.0 111.029 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -95.89 -51.75 4.34 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.631 0.773 . . . . 0.0 110.426 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.61 -39.22 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.741 -171.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.92 89.08 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.414 1.006 . . . . 0.0 111.04 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -68.24 -41.19 81.57 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.637 0.653 . . . . 0.0 110.144 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -60.45 -49.4 77.73 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.927 0.491 . . . . 0.0 110.276 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.5 mt -60.05 -43.43 95.38 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.523 0.729 . . . . 0.0 110.42 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.83 98.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.976 0.511 . . . . 0.0 110.753 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -66.25 -42.55 88.43 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.129 0.571 . . . . 0.0 110.419 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -59.66 -39.85 85.82 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 121.507 -0.746 . . . . 0.0 111.085 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.513 ' HB2' HG21 ' A' ' 33' ' ' THR . 55.3 mt -68.28 -29.22 67.96 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.98 177.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -65.56 -38.26 89.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.713 1.142 . . . . 0.0 109.875 172.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.81 -39.29 93.34 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.948 0.794 . . . . 0.0 110.496 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.07 -21.83 64.96 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.545 0.738 . . . . 0.0 112.259 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.84 31.09 3.25 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 118.651 -1.083 . . . . 0.0 113.58 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -125.29 148.25 48.78 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.026 1.413 . . . . 0.0 110.055 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 p -71.88 146.28 47.99 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.513 HG21 ' HB2' ' A' ' 26' ' ' LEU . 12.6 p -139.19 160.06 40.68 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.486 0.66 . . . . 0.0 110.956 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -149.64 161.69 41.69 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 p -134.3 81.41 1.91 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -175.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.63 105.57 3.72 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -78.97 102.67 8.44 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.17 56.58 15.03 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-O 118.348 -1.251 . . . . 0.0 114.589 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -69.24 178.3 4.38 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.043 2.495 . . . . 0.0 110.804 171.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.8 mt -125.03 158.08 34.63 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 169.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -53.53 -31.0 44.45 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.237 1.015 . . . . 0.0 111.134 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -62.45 -10.72 12.51 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.353 1.861 . . . . 0.0 112.736 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -133.87 18.67 3.83 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.393 1.077 . . . . 0.0 110.905 -175.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -134.77 106.08 10.68 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.743 1.217 . . . . 0.0 108.881 -169.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.82 161.52 41.4 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.884 2.39 . . . . 0.0 112.969 -170.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.43 7.38 5.47 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.763 1.625 . . . . 0.0 114.934 -171.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.8 m -146.81 129.72 16.29 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.7 -179.86 27.95 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.4 mt -112.94 101.83 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -99.55 168.78 9.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.3 tp -146.83 112.69 5.72 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -98.36 134.45 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -169.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 mp -132.78 125.11 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.8 p -138.6 143.2 39.24 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.945 1.298 . . . . 0.0 107.82 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.1 p -77.04 175.41 9.62 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 169.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 97' ' ' THR . 40.9 m -130.7 123.43 29.29 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 169.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -69.07 -22.2 64.03 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 159.56 -35.53 0.47 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 118.696 0.68 . . . . 0.0 113.37 170.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.78 22.87 8.09 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.124 0.969 . . . . 0.0 112.153 -169.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.75 -1.1 56.67 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 123.936 0.779 . . . . 0.0 113.094 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.5 114.67 8.84 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.301 1.051 . . . . 0.0 109.582 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.7 mt -68.91 147.8 97.86 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 125.643 1.577 . . . . 0.0 107.795 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.441 ' HB3' ' H ' ' A' ' 11' ' ' THR . 27.0 Cg_endo -56.54 137.61 81.32 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.113 3.209 . . . . 0.0 112.38 175.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -63.93 -22.31 66.86 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -169.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -71.55 -24.42 61.93 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.713 -0.617 . . . . 0.0 111.941 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.6 tp -121.92 -24.76 5.13 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.279 1.032 . . . . 0.0 111.771 -169.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.0 p -55.12 -28.21 3.91 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 116.924 -1.512 . . . . 0.0 114.939 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -53.4 -24.55 28.16 Favored 'Trans proline' 0 C--N 1.354 0.86 0 CA-C-N 122.903 2.073 . . . . 0.0 114.716 169.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -62.02 -43.92 97.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.58 1.082 . . . . 0.0 110.673 175.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -60.96 -40.01 91.7 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.866 0.866 . . . . 0.0 110.101 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -68.77 -48.37 63.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.853 0.461 . . . . 0.0 110.54 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.06 -28.59 67.51 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.464 -0.772 . . . . 0.0 112.37 -176.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.1 mt -67.6 -57.74 5.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.722 -0.656 . . . . 0.0 109.385 171.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -67.25 -29.2 68.77 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.06 0.846 . . . . 0.0 112.071 -171.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.82 -31.0 71.34 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.136 0.574 . . . . 0.0 110.775 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -115.09 -23.21 9.13 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -169.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.4 tttt 37.74 66.11 2.46 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.67 1.588 . . . . 0.0 110.796 -169.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.32 168.82 10.46 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.687 2.258 . . . . 0.0 110.696 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -92.68 107.2 19.04 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 169.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.5 mt -120.02 26.15 9.46 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.262 1.825 . . . . 0.0 110.045 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -61.58 18.62 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.318 1.847 . . . . 0.0 115.424 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.77 3.19 1.84 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.265 1.426 . . . . 0.0 111.855 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.7 t -79.53 140.46 16.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.5 mmm-85 -123.79 138.4 54.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 168.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -134.39 170.87 15.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.895 0.378 . . . . 0.0 110.653 -172.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.14 162.86 23.09 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 105.347 -3.101 . . . . 0.0 105.347 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.428 ' HB1' HD12 ' A' ' 102' ' ' ILE . . . -146.89 124.55 11.81 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.401 1.101 . . . . 0.0 109.446 -170.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.6 mt -133.73 124.27 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -100.7 156.73 19.34 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.4 mt -134.9 139.11 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.17 -151.42 13.74 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.6 m -126.02 135.36 51.71 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.727 1.211 . . . . 0.0 108.517 -175.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -66.72 -10.25 44.95 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.78 -15.03 58.25 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.979 0.809 . . . . 0.0 112.359 171.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -64.32 148.68 49.76 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.381 0.991 . . . . 0.0 110.847 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.65 -34.22 77.7 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.511 0.725 . . . . 0.0 111.392 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.461 ' O ' HG21 ' A' ' 56' ' ' THR . 34.8 m -119.32 51.15 1.16 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.73 1.612 . . . . 0.0 107.467 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -45.18 113.69 0.61 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.629 1.172 . . . . 0.0 110.825 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.4 m 48.32 34.35 4.54 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.326 1.451 . . . . 0.0 112.84 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.53 -16.19 29.94 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 118.985 -0.897 . . . . 0.0 113.115 -170.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.412 ' HB2' HG23 ' A' ' 56' ' ' THR . . . -64.57 -25.94 68.19 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.588 1.694 . . . . 0.0 112.893 -174.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.428 HD12 ' HB1' ' A' ' 87' ' ' ALA . 0.1 OUTLIER -59.19 -29.7 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.964 0.905 . . . . 0.0 109.444 178.302 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -54.75 -34.18 62.2 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.104 0.962 . . . . 0.0 112.071 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -81.58 -37.83 27.07 Favored 'General case' 0 C--O 1.232 0.14 0 O-C-N 121.731 -0.606 . . . . 0.0 110.189 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.5 mt -57.89 -50.88 71.81 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -70.58 -32.98 70.57 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.394 -174.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.28 80.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.315 0.507 . . . . 0.0 110.103 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -79.79 -28.88 40.23 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.03 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.0 -45.75 84.25 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.379 1.445 . . . . 0.0 109.578 170.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -71.27 -33.66 69.97 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.469 0.577 . . . . 0.0 111.266 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -61.23 -39.66 91.09 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.178 0.591 . . . . 0.0 110.537 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.6 m -72.03 -7.82 50.98 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.221 1.008 . . . . 0.0 113.13 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.24 -14.93 10.15 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.644 1.116 . . . . 0.0 114.102 169.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.19 173.52 1.94 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.573 1.187 . . . . 0.0 111.341 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -143.83 148.1 35.04 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.019 -1.051 . . . . 0.0 112.153 170.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -58.78 158.55 7.94 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.376 1.87 . . . . 0.0 109.851 173.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.8 m -139.88 163.33 32.94 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.465 1.906 . . . . 0.0 106.087 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.35 -135.25 48.07 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -173.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -146.5 150.18 35.07 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 169.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.2 m -61.76 149.48 39.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.125 1.37 . . . . 0.0 111.176 -171.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.3 tp -129.81 151.21 50.64 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.343 1.057 . . . . 0.0 110.388 -173.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -119.87 150.4 40.51 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 23.5 mm -131.68 100.47 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -78.33 126.47 30.83 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 118.682 -0.675 . . . . 0.0 109.363 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.57 9.46 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.768 0.827 . . . . 0.0 112.152 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.1 tp -45.54 -38.23 6.19 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.067 1.747 . . . . 0.0 113.685 -174.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -135.86 41.38 2.69 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.377 1.071 . . . . 0.0 109.768 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 47.4 m80 49.57 44.29 24.26 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.343 1.457 . . . . 0.0 110.327 -169.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -72.28 -8.2 53.58 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.62 1.968 . . . . 0.0 114.636 -169.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.5 pt -50.4 -36.89 24.52 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 -172.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.9 -7.34 20.9 Favored 'Trans proline' 0 C--N 1.356 0.942 0 CA-C-N 124.047 2.481 . . . . 0.0 113.012 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -68.25 -27.16 66.1 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.311 0.96 . . . . 0.0 110.297 171.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -152.87 72.02 7.21 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.806 1.242 . . . . 0.0 109.461 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.31 150.23 81.2 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.796 2.331 . . . . 0.0 111.131 -173.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.87 -16.66 63.28 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -56.33 -42.76 78.21 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.261 0.937 . . . . 0.0 112.041 -169.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -69.45 -40.3 77.24 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.999 -0.438 . . . . 0.0 110.453 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -72.36 -35.48 68.51 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.642 0.777 . . . . 0.0 110.58 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.97 -35.14 77.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.459 0.704 . . . . 0.0 109.958 170.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.47 -47.18 57.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.387 0.994 . . . . 0.0 111.177 169.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.8 m -62.59 -38.22 89.28 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 122.081 -0.658 . . . . 0.0 111.132 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -53.48 50.22 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.087 175.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.9 m -62.89 -31.25 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 119.799 1.182 . . . . 0.0 111.188 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -62.82 -27.03 69.04 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.593 -0.718 . . . . 0.0 112.669 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.2 mt -106.37 -37.09 6.63 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.216 0.917 . . . . 0.0 112.93 -176.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 pp -73.03 -12.59 60.98 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.465 1.03 . . . . 0.0 112.171 172.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.018 0 C-N-CA 129.451 3.1 . . . . 0.0 112.645 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.08 157.98 43.79 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.847 1.259 . . . . 0.0 108.663 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -136.97 -25.37 1.08 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.79 1.236 . . . . 0.0 111.085 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.4 mt -130.52 82.38 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.0 m -75.23 121.15 21.72 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.9 mp -85.41 152.19 23.42 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.312 0.645 . . . . 0.0 109.711 174.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.8 mt -123.49 93.28 2.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 126.294 1.837 . . . . 0.0 106.161 -175.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -72.95 155.7 39.6 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.558 1.143 . . . . 0.0 110.862 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.2 65.17 0.26 Allowed Glycine 0 C--N 1.34 0.801 0 N-CA-C 114.239 0.456 . . . . 0.0 114.239 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.448 ' HB2' ' H ' ' A' ' 15' ' ' ALA . 9.4 t -139.71 144.74 37.68 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.52 1.128 . . . . 0.0 110.595 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 p -88.24 -46.04 9.57 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.05 1.34 . . . . 0.0 109.146 169.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.569 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -68.04 -29.38 68.35 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.272 1.029 . . . . 0.0 111.705 179.212 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.41 -0.3 16.21 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.29 0.948 . . . . 0.0 113.491 170.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.67 -54.07 40.07 Favored Glycine 0 C--N 1.337 0.63 0 CA-C-N 118.937 1.369 . . . . 0.0 110.956 -173.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.448 ' H ' ' HB2' ' A' ' 10' ' ' SER . . . -66.6 -28.25 68.36 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 117.51 0.655 . . . . 0.0 111.231 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -68.62 -44.8 73.5 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -70.55 -46.02 64.33 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.386 0.675 . . . . 0.0 109.94 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.9 t -62.15 -38.52 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 118.451 -0.785 . . . . 0.0 110.101 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.17 97.82 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.693 1.133 . . . . 0.0 110.777 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -63.49 -41.42 98.56 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.594 0.634 . . . . 0.0 110.551 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -63.85 -43.3 96.55 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.941 -0.474 . . . . 0.0 111.125 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.4 mt -63.78 -43.81 95.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.546 0.738 . . . . 0.0 109.666 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.33 -37.8 78.72 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.422 0.689 . . . . 0.0 111.219 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -52.55 -44.68 66.0 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.847 0.748 . . . . 0.0 110.482 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt -68.33 -37.54 80.63 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.834 -0.541 . . . . 0.0 109.813 -175.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.1 mt -68.09 -38.61 82.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.262 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.83 -38.57 89.26 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.361 0.528 . . . . 0.0 110.329 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.04 -37.05 84.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.599 0.636 . . . . 0.0 110.98 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.27 -26.0 66.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.972 0.509 . . . . 0.0 111.67 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.86 -3.88 10.77 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.32 1.438 . . . . 0.0 113.743 169.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -78.9 146.4 33.58 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.924 1.362 . . . . 0.0 109.981 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 p -83.5 146.6 28.28 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 169.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.2 p -134.43 169.29 17.47 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.806 0.842 . . . . 0.0 109.943 -170.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.1 158.73 44.41 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 169.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.4 m -130.42 81.96 2.03 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.9 mt -75.94 116.41 16.61 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -74.88 94.48 2.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.0 57.2 19.41 Favored Glycine 0 CA--C 1.54 1.635 0 CA-C-O 118.797 -1.001 . . . . 0.0 114.437 172.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.35 179.01 4.33 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.338 2.692 . . . . 0.0 111.297 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.8 mt -114.38 151.16 33.52 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 169.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -61.21 -28.89 69.47 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.348 0.659 . . . . 0.0 111.747 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.99 -21.59 63.68 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 175.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -82.89 -7.02 59.7 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.697 0.799 . . . . 0.0 111.812 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.1 mt -113.91 145.07 32.75 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 124.359 1.063 . . . . 0.0 109.989 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -70.15 162.89 40.57 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.758 2.305 . . . . 0.0 110.725 169.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.37 23.65 0.6 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.179 1.392 . . . . 0.0 112.024 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 m -156.37 142.87 18.48 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.352 1.461 . . . . 0.0 107.832 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 150.33 179.98 26.57 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.7 mt -122.24 101.74 10.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -107.12 170.59 7.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.535 1.134 . . . . 0.0 109.051 -175.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.8 tp -149.45 121.88 8.49 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.0 t -111.6 138.3 40.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -169.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -134.43 138.57 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.9 m -139.75 145.34 38.15 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.507 1.123 . . . . 0.0 109.213 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -99.21 95.72 7.27 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.752 0.786 . . . . 0.0 109.911 174.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.3 m -58.54 135.42 57.31 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 169.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.4 p-80 -136.01 41.59 2.65 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.986 1.314 . . . . 0.0 108.961 -174.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.43 -35.37 2.43 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.765 1.65 . . . . 0.0 113.118 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.61 -21.03 66.13 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.058 1.343 . . . . 0.0 113.975 -171.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.11 33.78 64.95 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -172.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -141.42 149.92 41.66 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.319 1.048 . . . . 0.0 108.482 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 62' ' ' ILE . 4.2 mp -69.3 148.2 97.32 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -55.44 153.08 29.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.411 2.741 . . . . 0.0 112.635 169.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.77 -19.14 25.89 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.833 1.253 . . . . 0.0 114.003 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -63.15 -36.63 84.27 Favored 'General case' 0 C--N 1.343 0.289 0 O-C-N 121.801 -0.562 . . . . 0.0 110.591 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.2 tp -127.16 -18.25 4.6 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.883 -169.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.6 p -52.66 -32.43 9.51 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.54 -21.4 18.72 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.131 2.554 . . . . 0.0 115.773 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -56.82 -32.31 65.6 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.187 0.995 . . . . 0.0 110.96 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -62.79 -51.2 68.0 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -62.2 -42.98 99.79 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.027 0.531 . . . . 0.0 109.906 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.11 -27.52 68.43 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.445 0.698 . . . . 0.0 112.591 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 mt -75.94 -20.84 57.62 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.21 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -93.95 -41.78 9.41 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.038 1.29 . . . . 0.0 109.062 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -60.22 -36.54 77.92 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.105 0.962 . . . . 0.0 110.208 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -107.61 -37.11 6.26 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.089 0.555 . . . . 0.0 112.426 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm 27.31 64.3 0.59 Allowed Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 126.853 2.061 . . . . 0.0 113.355 -169.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -59.3 160.52 19.33 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.297 1.998 . . . . 0.0 111.276 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.35 50.72 1.12 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.978 1.311 . . . . 0.0 109.965 173.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.66 34.98 0.1 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.279 1.831 . . . . 0.0 114.168 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -61.75 23.42 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 128.699 2.8 . . . . 0.0 114.745 171.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.06 0.07 1.71 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.886 1.675 . . . . 0.0 111.672 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.6 t -82.47 147.97 5.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 169.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -126.29 141.34 51.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 168.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -140.01 175.38 9.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.225 0.536 . . . . 0.0 110.4 -172.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.07 164.92 26.09 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 106.631 -2.588 . . . . 0.0 106.631 169.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.69 124.89 15.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -169.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.8 mt -133.71 128.08 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 -177.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.66 120.33 5.37 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 107.576 -2.21 . . . . 0.0 107.576 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.9 mt -94.67 152.43 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 169.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 169.81 -144.01 8.26 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 172.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.2 m -132.59 127.69 35.57 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.38 -11.13 60.56 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.699 -0.626 . . . . 0.0 112.124 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.08 -28.44 69.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.513 0.725 . . . . 0.0 111.129 169.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -66.1 145.37 55.91 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 118.87 0.759 . . . . 0.0 109.479 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.98 -35.38 80.52 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 168.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.6 m -73.33 61.81 0.67 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.086 2.554 . . . . 0.0 109.138 169.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -67.52 83.36 0.17 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.111 -0.993 . . . . 0.0 112.236 -172.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 2.0 m 48.93 63.88 1.94 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.084 2.154 . . . . 0.0 112.158 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.22 6.65 2.81 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.416 -1.213 . . . . 0.0 114.701 -169.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.85 -26.23 65.67 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.098 1.949 . . . . 0.0 112.822 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 tp -56.28 -28.63 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.02 1.728 . . . . 0.0 110.723 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -53.03 -37.46 61.56 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.77 0.828 . . . . 0.0 112.73 -173.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -65.23 -42.19 93.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 118.785 0.72 . . . . 0.0 111.458 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.7 mt -68.76 -50.74 47.95 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -37.06 81.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.729 -170.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.4 -35.48 79.37 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.58 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -72.76 -31.24 64.76 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.471 1.032 . . . . 0.0 111.978 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.2 mt -62.13 -44.8 95.84 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 120.77 1.623 . . . . 0.0 108.749 169.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -61.44 -44.6 96.84 Favored 'General case' 0 C--N 1.335 -0.055 0 C-N-CA 124.037 0.935 . . . . 0.0 110.057 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -65.26 -43.34 91.58 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.917 1.287 . . . . 0.0 110.891 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m -68.07 -27.07 66.18 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 119.204 -0.427 . . . . 0.0 111.286 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.94 -32.69 0.38 Allowed Glycine 0 CA--C 1.529 0.929 0 CA-C-N 118.987 0.812 . . . . 0.0 115.002 169.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.61 177.51 0.52 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.807 1.243 . . . . 0.0 113.498 -171.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -138.49 147.31 43.04 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.689 -0.632 . . . . 0.0 110.687 169.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -64.55 166.45 8.53 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.837 1.255 . . . . 0.0 109.404 175.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 m -137.88 153.06 49.59 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.286 1.834 . . . . 0.0 106.189 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 56.08 -139.1 44.18 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -170.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -137.44 157.02 47.48 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.4 145.98 52.57 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.589 1.156 . . . . 0.0 110.074 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.3 tp -120.42 138.85 53.55 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.563 0.745 . . . . 0.0 109.26 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -101.72 141.3 34.79 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 53.0 mt -130.7 136.21 58.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 175.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -125.78 96.03 4.63 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.567 1.547 . . . . 0.0 109.279 -169.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.4 pp -80.48 -3.98 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 O-C-N 121.433 -0.792 . . . . 0.0 112.668 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.3 tp -71.37 -33.32 69.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.846 0.858 . . . . 0.0 112.124 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -149.71 -130.54 0.05 Allowed 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -169.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -54.73 130.95 42.55 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 120.279 1.399 . . . . 0.0 108.12 169.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -65.09 -16.99 64.08 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -169.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 pp -139.25 158.69 68.63 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.629 1.171 . . . . 0.0 109.587 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.8 -39.69 4.31 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.816 1.677 . . . . 0.0 112.603 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -155.51 -16.32 0.11 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -169.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -150.85 131.0 6.91 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.175 1.352 . . . . 0.0 109.831 -170.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -50.95 144.79 26.48 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.296 3.33 . . . . 0.0 114.079 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.37 -34.95 69.37 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.644 0.378 . . . . 0.0 110.946 171.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.55 -42.07 98.3 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.373 0.669 . . . . 0.0 110.411 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -76.88 -40.94 45.79 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.348 0.659 . . . . 0.0 109.703 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 -64.11 -42.15 96.98 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.928 0.491 . . . . 0.0 110.612 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 15.6 tp -66.57 -27.62 67.87 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.72 -0.612 . . . . 0.0 110.451 174.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.97 -48.37 82.99 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 169.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.6 m -63.68 -35.2 79.77 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.736 -0.861 . . . . 0.0 111.129 175.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 38.4 t90 -63.23 -50.68 69.28 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.211 0.605 . . . . 0.0 110.461 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 32.0 m -68.24 -29.21 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 121.214 -0.929 . . . . 0.0 111.444 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -60.71 -21.6 63.08 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.504 -0.76 . . . . 0.0 112.003 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.2 mt -101.77 -32.01 10.49 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 117.963 -1.018 . . . . 0.0 112.664 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.47 -28.35 66.01 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.471 1.487 . . . . 0.0 111.485 173.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttm . . . . . 0 C--O 1.251 1.167 0 C-N-CA 128.321 2.649 . . . . 0.0 111.596 -177.902 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.8 ttm . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.0 159.55 43.78 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.179 1.392 . . . . 0.0 108.499 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -79.36 -31.18 42.87 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.967 0.907 . . . . 0.0 109.898 -172.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.7 mt -122.32 70.02 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.7 m -68.4 116.46 8.99 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.7 mt -86.09 155.09 20.95 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.0 mt -123.14 90.62 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -172.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.6 m -77.62 129.07 35.14 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.153 0.981 . . . . 0.0 110.619 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.0 60.99 0.66 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 124.637 1.113 . . . . 0.0 113.123 -169.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.8 p -144.94 144.0 30.84 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 117.515 0.658 . . . . 0.0 109.894 169.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 p -79.98 -43.61 21.71 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.781 1.232 . . . . 0.0 108.746 169.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.518 ' H ' HD23 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -63.88 -27.1 68.93 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.521 1.528 . . . . 0.0 113.289 178.221 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.29 7.24 57.26 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.379 0.99 . . . . 0.0 113.559 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.83 -44.58 95.96 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 119.406 1.603 . . . . 0.0 110.844 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.34 -34.01 76.43 Favored 'General case' 0 C--O 1.227 -0.128 0 O-C-N 122.065 -0.667 . . . . 0.0 110.487 175.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.13 -39.84 86.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.676 0.671 . . . . 0.0 110.332 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -66.46 -46.28 76.95 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.996 0.918 . . . . 0.0 109.012 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.99 -49.19 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.88 87.59 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.927 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.57 -44.25 94.64 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.139 0.881 . . . . 0.0 111.101 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -68.91 -41.82 77.68 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.949 -0.469 . . . . 0.0 110.852 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.42 -42.05 98.72 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.66 96.33 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.769 0.828 . . . . 0.0 110.753 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -58.38 -42.87 88.01 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.595 0.634 . . . . 0.0 110.362 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -67.2 -39.61 86.36 Favored 'General case' 0 N--CA 1.461 0.109 0 O-C-N 121.738 -0.601 . . . . 0.0 111.179 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 mt -62.25 -37.64 86.2 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.54 0.609 . . . . 0.0 111.259 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.41 -38.44 87.47 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.092 0.86 . . . . 0.0 110.283 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -66.24 -35.77 81.28 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.609 0.64 . . . . 0.0 110.888 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.6 -26.79 66.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.085 0.554 . . . . 0.0 111.644 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.44 -3.36 10.32 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.269 1.414 . . . . 0.0 113.928 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -81.07 148.31 29.73 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.059 1.43 . . . . 0.0 110.342 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 p -79.05 144.42 34.65 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 169.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.8 p -140.64 163.96 31.48 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.284 0.634 . . . . 0.0 111.036 -176.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -150.47 151.62 32.99 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 105.437 -2.06 . . . . 0.0 105.437 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 p -108.81 73.15 0.85 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.32 104.01 6.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -169.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -73.25 121.54 20.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.15 51.85 29.14 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 117.89 -1.505 . . . . 0.0 116.759 169.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -67.23 175.84 5.35 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 CA-C-N 120.735 2.268 . . . . 0.0 111.368 170.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 mt -128.62 168.94 15.03 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.687 1.595 . . . . 0.0 108.659 171.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.38 -37.74 67.95 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.083 0.953 . . . . 0.0 110.902 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.36 -3.46 14.25 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.15 0.98 . . . . 0.0 113.294 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -125.17 9.33 8.0 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.919 1.288 . . . . 0.0 112.332 -170.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.45 149.78 52.29 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 124.127 0.971 . . . . 0.0 110.552 169.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.31 164.28 29.15 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.745 2.297 . . . . 0.0 111.471 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.67 21.19 0.84 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.204 1.402 . . . . 0.0 112.9 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.6 p -153.12 143.66 22.62 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.575 1.15 . . . . 0.0 108.772 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.19 -176.72 27.82 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.22 93.25 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -96.54 169.18 10.07 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.718 0.807 . . . . 0.0 109.796 -172.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.0 tp -135.39 124.14 23.86 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.73 130.48 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.53 121.04 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.4 m -138.4 133.07 32.4 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.307 0.643 . . . . 0.0 109.41 -169.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -77.13 163.85 26.22 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 169.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.0 m -114.35 119.04 35.58 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -66.69 -30.04 70.19 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.402 0.281 . . . . 0.0 110.965 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.49 -35.09 0.34 Allowed Glycine 0 CA--C 1.526 0.777 0 C-N-CA 123.791 0.71 . . . . 0.0 112.81 171.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.09 23.83 7.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.24 1.016 . . . . 0.0 112.192 -173.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.01 -3.62 60.47 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.196 -0.78 . . . . 0.0 113.098 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.29 149.18 47.66 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.448 1.124 . . . . 0.0 109.71 170.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.7 mt -113.71 144.27 31.11 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 126.043 1.737 . . . . 0.0 107.096 -169.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -48.72 139.94 23.46 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 124.223 3.282 . . . . 0.0 114.381 172.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -59.46 -21.56 60.25 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.634 1.574 . . . . 0.0 113.858 -172.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -67.35 -29.63 69.22 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.305 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.0 tp -127.64 -22.11 3.66 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.607 0.763 . . . . 0.0 112.049 -171.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 92.1 p -53.2 -31.66 8.3 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -52.1 -24.05 18.97 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.203 2.602 . . . . 0.0 115.278 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -58.5 -35.58 72.44 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.162 0.892 . . . . 0.0 110.773 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -62.45 -42.76 99.7 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.779 0.718 . . . . 0.0 110.484 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -68.89 -48.05 64.34 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.354 0.662 . . . . 0.0 109.286 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.28 -35.25 79.91 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 118.969 -0.539 . . . . 0.0 111.788 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.0 mt -65.72 -53.07 45.84 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.777 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -70.03 -28.34 65.39 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.337 0.972 . . . . 0.0 112.035 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.01 -35.03 77.63 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.515 0.598 . . . . 0.0 110.825 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -109.25 -33.64 6.8 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -169.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp 30.53 57.22 0.89 Allowed Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 127.385 2.274 . . . . 0.0 113.119 -172.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -69.3 172.0 12.97 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.169 1.913 . . . . 0.0 110.029 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -71.75 106.66 4.21 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.912 -0.493 . . . . 0.0 110.077 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.1 mt -113.0 20.43 16.37 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.601 1.56 . . . . 0.0 110.899 176.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 m -63.31 19.97 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.957 1.703 . . . . 0.0 115.548 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -135.28 0.1 2.77 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.208 1.403 . . . . 0.0 111.762 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 64.5 t -82.13 133.78 28.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -108.99 142.78 39.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 103.444 -2.798 . . . . 0.0 103.444 168.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -136.41 168.35 19.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 119.13 0.877 . . . . 0.0 111.354 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.16 163.48 23.53 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 105.561 -3.015 . . . . 0.0 105.561 169.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.06 124.4 13.04 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -169.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 52.1 mt -133.38 133.25 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.62 150.47 18.01 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.4 mt -139.79 150.44 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.35 -45.77 0.49 Allowed Glycine 0 C--N 1.33 0.237 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 169.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.2 m 115.01 140.92 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 1 C-N-CA 132.08 4.152 . . . . 0.0 108.056 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -67.81 0.84 2.97 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -63.62 -30.58 71.67 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.719 0.808 . . . . 0.0 109.994 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -70.8 156.43 39.55 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.467 0.707 . . . . 0.0 110.853 174.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.14 -37.5 83.06 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.659 0.783 . . . . 0.0 111.785 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.6 m -96.49 121.7 38.59 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 172.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -74.23 69.76 1.58 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.857 1.663 . . . . 0.0 111.783 -171.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 40.8 m 51.36 32.28 8.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.712 1.205 . . . . 0.0 111.823 -174.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.37 -0.87 79.25 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-O 118.301 -1.277 . . . . 0.0 115.051 -169.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.98 -26.79 67.81 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.4 2.1 . . . . 0.0 113.519 -173.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.0 tp -57.93 -28.11 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.755 1.222 . . . . 0.0 110.834 175.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -52.3 -38.68 59.1 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.194 0.997 . . . . 0.0 112.288 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -73.52 -41.12 63.44 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 121.84 -0.537 . . . . 0.0 110.489 -174.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 50.0 mt -64.2 -51.56 63.12 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.17 -38.67 82.31 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -169.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.35 75.23 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 122.049 -0.407 . . . . 0.0 110.576 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -74.13 -31.06 62.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.708 0.685 . . . . 0.0 110.691 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.88 -43.34 96.36 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.429 1.013 . . . . 0.0 108.885 169.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -61.98 -43.79 98.1 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.842 0.457 . . . . 0.0 109.826 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -64.28 -35.92 82.41 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.441 0.696 . . . . 0.0 111.132 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.5 m -71.47 -7.39 47.15 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.164 0.986 . . . . 0.0 112.927 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.85 -17.49 10.85 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.765 1.174 . . . . 0.0 113.787 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.2 171.61 1.29 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.266 1.033 . . . . 0.0 111.158 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -142.5 153.4 43.59 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 121.114 -0.991 . . . . 0.0 111.714 172.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -71.24 156.62 39.33 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.362 174.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 66.2 m -128.0 151.74 48.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.819 2.048 . . . . 0.0 106.675 169.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 62.0 -146.19 49.11 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -172.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -135.44 156.4 48.97 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.647 1.179 . . . . 0.0 108.206 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.66 152.64 45.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.986 1.314 . . . . 0.0 110.462 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.8 tp -129.98 144.17 51.19 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.443 1.097 . . . . 0.0 108.826 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -115.52 153.83 30.46 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 169.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 38.1 mt -134.76 109.14 11.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -172.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -77.63 135.9 38.17 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.555 0.742 . . . . 0.0 109.353 170.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 46.5 pt -129.23 -15.69 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.945 1.698 . . . . 0.0 112.131 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.2 mt -94.72 -19.51 20.33 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.121 0.873 . . . . 0.0 112.761 -170.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -144.82 -54.14 0.31 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.407 1.003 . . . . 0.0 111.97 -173.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -74.34 -37.17 63.61 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 20.8 t0 41.86 64.29 1.11 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.618 1.567 . . . . 0.0 110.095 -171.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.3 tt -44.12 130.46 4.44 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 126.043 1.737 . . . . 0.0 112.978 -169.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.55 170.57 1.77 Allowed 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.88 3.053 . . . . 0.0 114.606 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -73.83 -29.21 62.02 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.299 1.04 . . . . 0.0 111.443 175.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -54.89 -49.42 91.95 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.39 -26.28 35.05 Favored 'Trans proline' 0 C--N 1.351 0.663 0 CA-C-N 121.52 1.579 . . . . 0.0 112.641 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.59 86.88 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 120.134 1.334 . . . . 0.0 109.319 173.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -62.37 -44.61 96.05 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.022 0.529 . . . . 0.0 110.363 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -62.44 -49.77 74.11 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.666 0.386 . . . . 0.0 110.306 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 9.1 t-105 -67.95 -36.25 79.79 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 122.172 -0.33 . . . . 0.0 110.871 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.35 -41.38 93.54 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 118.906 -0.569 . . . . 0.0 110.032 173.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.81 -49.85 60.35 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 173.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.7 m -62.05 -36.6 82.1 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.161 0.584 . . . . 0.0 111.261 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 21.0 t90 -66.36 -53.05 40.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 119.137 -0.459 . . . . 0.0 110.124 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.1 m -66.21 -29.88 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 118.997 0.817 . . . . 0.0 111.514 -176.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -54.36 -25.33 23.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.89 0.876 . . . . 0.0 112.314 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 29.5 mt -100.29 -0.26 38.83 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.255 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.9 pp -124.71 -8.8 7.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.218 1.372 . . . . 0.0 113.59 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 71.8 mttt . . . . . 0 C--O 1.252 1.189 0 CA-C-N 119.542 1.065 . . . . 0.0 110.73 178.256 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.4 mtt . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.869 0.366 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.08 161.49 24.36 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 170.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -75.72 -30.84 59.41 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.812 0.845 . . . . 0.0 109.949 -171.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.0 mt -124.96 74.71 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 m -74.45 114.1 12.45 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 mp -74.27 155.03 38.68 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.0 mt -122.4 86.53 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 m -81.21 157.14 25.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.44 1.496 . . . . 0.0 111.722 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.0 135.26 1.92 Allowed Glycine 0 N--CA 1.444 -0.795 0 O-C-N 121.204 -0.935 . . . . 0.0 110.934 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 31.2 p -152.97 154.51 35.13 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.723 0.809 . . . . 0.0 111.943 169.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 p -71.79 -44.71 63.5 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.472 0.709 . . . . 0.0 109.749 169.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.468 ' H ' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -64.07 -25.32 68.05 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.899 0.88 . . . . 0.0 112.798 178.264 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.55 40.16 59.8 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -129.02 -19.58 1.57 Allowed Glycine 0 CA--C 1.525 0.696 0 C-N-CA 125.031 1.301 . . . . 0.0 112.11 -175.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.02 -21.17 66.39 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.184 0.992 . . . . 0.0 111.139 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.61 -35.8 77.03 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.206 0.602 . . . . 0.0 110.409 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -71.82 -40.22 69.28 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 122.062 -0.398 . . . . 0.0 110.155 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.97 -39.31 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.98 99.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.273 0.629 . . . . 0.0 110.084 175.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.19 -42.1 98.97 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.741 0.7 . . . . 0.0 110.571 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -61.51 -48.25 81.91 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.429 0.559 . . . . 0.0 110.814 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.0 mt -59.67 -46.3 89.47 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.343 0.657 . . . . 0.0 109.988 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.32 87.19 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.911 0.884 . . . . 0.0 111.397 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 -68.96 -45.52 70.49 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.567 0.747 . . . . 0.0 109.82 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -61.97 -41.3 97.85 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.363 0.528 . . . . 0.0 110.499 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.0 mt -62.72 -37.59 87.14 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.008 0.523 . . . . 0.0 111.396 173.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -67.15 -38.67 85.9 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.692 0.678 . . . . 0.0 110.373 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.54 -35.55 81.18 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.872 0.469 . . . . 0.0 110.839 173.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.89 -28.0 68.63 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.408 0.549 . . . . 0.0 111.335 172.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.39 -8.76 6.23 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.984 1.278 . . . . 0.0 114.155 169.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -80.0 143.76 33.83 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.962 1.381 . . . . 0.0 110.029 -174.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 p -70.95 141.05 51.09 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 169.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.8 p -134.91 159.44 41.43 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.143 0.497 . . . . 0.0 111.624 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -152.18 162.99 40.3 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -135.71 79.29 1.77 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.67 113.56 13.26 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -82.76 110.63 17.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.25 51.97 56.03 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-O 118.018 -1.434 . . . . 0.0 115.613 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -67.49 178.05 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.954 2.436 . . . . 0.0 111.322 170.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.0 mt -131.04 163.61 27.22 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 125.453 1.501 . . . . 0.0 109.56 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.3 tp -59.91 -36.18 76.44 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.656 1.182 . . . . 0.0 111.216 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.63 -3.79 10.04 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -134.56 22.63 3.67 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.783 1.633 . . . . 0.0 110.567 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.3 mt -137.41 123.1 12.93 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 125.286 1.434 . . . . 0.0 108.102 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.41 159.61 48.86 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.201 1.934 . . . . 0.0 110.486 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.02 17.23 1.26 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.586 1.155 . . . . 0.0 113.256 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.1 m -146.02 132.48 19.7 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.477 1.111 . . . . 0.0 108.429 -174.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 153.28 178.53 27.93 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.35 94.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -91.73 168.55 11.39 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.248 0.619 . . . . 0.0 109.402 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.3 tp -146.23 105.92 3.97 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.8 t -91.19 147.77 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -172.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.14 140.71 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 m -151.09 150.85 31.18 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.568 1.147 . . . . 0.0 108.623 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.6 m -69.62 159.29 33.7 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.044 0.45 . . . . 0.0 111.871 174.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.57 63.72 1.51 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 168.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -84.19 23.19 1.1 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.905 1.682 . . . . 0.0 110.855 -169.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.6 -13.48 41.41 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.484 1.04 . . . . 0.0 113.027 -170.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.86 -29.23 63.03 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.729 1.265 . . . . 0.0 112.916 -176.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.417 ' H ' HG21 ' A' ' 97' ' ' THR . . . 60.09 33.12 78.14 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.008 0.814 . . . . 0.0 112.003 -175.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -144.43 149.12 35.52 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.081 1.352 . . . . 0.0 107.683 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.4 mt -64.91 142.12 98.55 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -170.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.39 143.49 93.61 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.187 1.924 . . . . 0.0 110.939 -176.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.29 -28.48 58.88 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -169.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -70.83 -25.18 62.72 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 122.018 -0.426 . . . . 0.0 112.03 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.8 tp -120.5 -23.46 6.1 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.534 1.134 . . . . 0.0 111.832 -169.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 89.0 p -54.58 -30.32 6.67 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -52.21 -24.92 21.9 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.529 2.153 . . . . 0.0 114.598 169.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -60.26 -45.46 93.2 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.412 1.005 . . . . 0.0 110.542 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -64.43 -36.67 84.91 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.91 0.484 . . . . 0.0 110.661 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -65.35 -45.95 82.12 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.15 0.432 . . . . 0.0 110.183 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.51 -41.21 93.44 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.724 -0.61 . . . . 0.0 111.188 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.8 mt -60.42 -52.23 66.12 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.431 0.692 . . . . 0.0 110.334 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -70.92 -27.83 64.06 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.565 0.621 . . . . 0.0 111.505 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.82 -51.59 46.81 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.845 0.748 . . . . 0.0 109.686 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -85.17 -24.01 28.11 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.629 -169.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm 41.71 60.1 8.96 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.143 1.377 . . . . 0.0 111.166 -171.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -68.43 176.62 5.5 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.771 2.981 . . . . 0.0 111.971 -174.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -106.6 107.24 18.16 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 169.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.7 mt -119.62 24.38 10.65 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 126.44 1.896 . . . . 0.0 110.058 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.7 m -52.83 -10.2 0.15 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.89 -1.68 13.8 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.488 1.115 . . . . 0.0 111.222 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.0 t -80.91 141.99 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 168.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.92 146.97 50.81 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 168.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -137.9 171.71 14.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.295 0.569 . . . . 0.0 112.17 -169.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.52 167.48 26.17 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 105.64 -2.984 . . . . 0.0 105.64 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.419 ' HB3' HG23 ' A' ' 120' ' ' THR . . . -147.69 134.41 19.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.653 0.727 . . . . 0.0 109.649 -169.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.7 mm -128.14 132.77 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.05 130.48 9.65 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 173.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -127.37 126.07 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -172.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 171.22 -141.64 6.57 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -169.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.9 m -115.94 99.21 7.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.172 0.989 . . . . 0.0 108.759 -171.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -13.06 57.97 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.295 0.638 . . . . 0.0 112.561 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -56.76 -28.26 60.9 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.969 0.908 . . . . 0.0 111.002 169.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -123.25 -31.56 3.55 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.522 1.129 . . . . 0.0 110.914 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.7 t70 66.57 -16.31 0.13 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 129.608 3.163 . . . . 0.0 114.859 172.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.417 HG21 ' H ' ' A' ' 60' ' ' GLY . 1.8 m 59.78 171.66 0.08 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.635 1.974 . . . . 0.0 112.36 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.411 ' H ' HG22 ' A' ' 97' ' ' THR . 33.7 t80 -74.08 -2.59 25.03 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.634 -1.291 . . . . 0.0 113.027 -177.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 60.2 m 63.14 1.7 0.94 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.982 2.113 . . . . 0.0 115.046 -177.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -48.8 -32.41 11.24 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.762 1.172 . . . . 0.0 112.17 169.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.36 -5.39 1.13 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.84 2.056 . . . . 0.0 115.537 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 tp -141.15 -34.1 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.028 1.331 . . . . 0.0 109.772 172.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -50.97 -36.01 36.7 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.322 1.049 . . . . 0.0 112.492 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -71.68 -55.35 7.88 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.59 -0.694 . . . . 0.0 110.676 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 pp -65.04 -40.51 94.91 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -72.1 -39.25 69.04 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -172.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.69 -30.64 70.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 119.05 -0.5 . . . . 0.0 110.431 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -70.83 -33.56 70.79 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.207 0.912 . . . . 0.0 110.912 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.1 mt -64.0 -40.82 97.21 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.129 1.332 . . . . 0.0 109.235 169.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -63.42 -43.43 97.51 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -63.04 -38.71 92.29 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.708 0.803 . . . . 0.0 110.762 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.6 m -67.9 -10.62 54.68 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.986 0.914 . . . . 0.0 112.75 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.56 -18.17 8.22 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.013 1.292 . . . . 0.0 113.606 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.24 175.79 0.89 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.371 1.086 . . . . 0.0 111.522 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -146.62 159.66 43.17 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.362 -0.836 . . . . 0.0 109.784 169.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -73.46 168.14 19.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.534 1.134 . . . . 0.0 109.473 175.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 m -133.25 145.27 50.37 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 127.105 2.162 . . . . 0.0 106.237 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.58 -133.12 52.8 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -173.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -140.99 160.12 40.75 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.355 1.862 . . . . 0.0 106.149 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.419 HG23 ' HB3' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -61.58 157.89 16.38 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.086 1.354 . . . . 0.0 111.033 -178.315 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 51.4 tp -126.86 149.84 49.53 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.86 0.864 . . . . 0.0 109.333 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -116.33 147.93 41.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 172.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 25.7 mm -132.89 138.73 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -108.94 133.98 52.21 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.664 1.186 . . . . 0.0 108.802 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.7 pp -127.1 4.96 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.868 1.267 . . . . 0.0 111.273 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.4 tp -65.57 -37.13 85.79 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.435 0.694 . . . . 0.0 111.872 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -153.03 -42.18 0.1 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -169.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -144.53 140.83 29.09 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.365 1.066 . . . . 0.0 109.398 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -85.6 58.53 5.1 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.156 2.182 . . . . 0.0 110.775 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 35.61 52.83 1.8 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 127.414 2.286 . . . . 0.0 115.031 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.11 -22.62 67.45 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.288 1.992 . . . . 0.0 113.086 -172.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -77.72 -13.55 59.86 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.086 0.954 . . . . 0.0 112.677 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -152.82 65.5 5.78 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.688 1.195 . . . . 0.0 110.096 -172.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.82 154.13 75.22 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.896 2.397 . . . . 0.0 111.835 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.87 -21.75 63.59 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.996 0.918 . . . . 0.0 113.212 -175.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.64 -37.83 73.99 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.681 0.792 . . . . 0.0 111.242 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -69.74 -38.57 76.87 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.848 -0.533 . . . . 0.0 110.494 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -65.52 -43.04 91.3 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.619 0.368 . . . . 0.0 110.063 172.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 28.2 tp -60.6 -39.46 88.22 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.3 0.64 . . . . 0.0 110.498 -173.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.15 -48.88 65.7 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.6 m -65.31 -35.98 82.67 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.047 -0.678 . . . . 0.0 111.148 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 17.1 t90 -66.18 -51.16 60.41 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.3 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.0 m -65.78 -28.98 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 119.128 0.876 . . . . 0.0 111.528 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -57.65 -24.23 55.51 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.808 -0.615 . . . . 0.0 112.169 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.5 mt -102.04 3.08 38.41 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 pp -124.6 -10.21 7.36 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.717 1.144 . . . . 0.0 113.24 174.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.249 1.036 0 C-N-CA 125.845 1.658 . . . . 0.0 112.188 -179.958 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.83 162.67 36.22 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.821 1.248 . . . . 0.0 109.15 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -131.82 -28.43 1.79 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.487 1.515 . . . . 0.0 110.404 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.1 mt -123.93 84.51 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 169.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.5 m -75.94 109.55 9.66 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.74 154.39 38.41 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 89.1 mt -126.85 88.81 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 m -69.55 145.87 52.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.113 1.365 . . . . 0.0 109.933 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.07 49.82 0.66 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.411 0.529 . . . . 0.0 114.064 -169.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.8 p -125.03 160.2 29.57 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.677 1.191 . . . . 0.0 108.138 169.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.59 -31.22 18.72 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.155 0.982 . . . . 0.0 112.138 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 pp -140.57 -30.29 0.66 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -171.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.21 153.97 11.97 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.09 -78.59 0.38 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 126.055 1.788 . . . . 0.0 109.192 170.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.8 -42.17 95.24 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 122.673 0.389 . . . . 0.0 109.974 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -67.44 -31.8 72.24 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.024 0.93 . . . . 0.0 112.082 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -70.18 -46.66 64.15 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.3 t -68.43 -35.65 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 118.998 -0.525 . . . . 0.0 109.723 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.09 88.09 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 119.026 0.83 . . . . 0.0 110.873 173.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -62.54 -42.02 99.26 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.052 0.842 . . . . 0.0 110.778 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -66.06 -45.7 80.38 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 122.027 -0.42 . . . . 0.0 110.488 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -59.97 -43.54 95.03 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.418 0.687 . . . . 0.0 110.098 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.51 99.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.751 0.82 . . . . 0.0 110.669 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -63.4 -44.18 95.41 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.559 0.618 . . . . 0.0 110.406 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -62.59 -40.44 96.9 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 121.635 -0.665 . . . . 0.0 110.516 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 41.2 mt -63.48 -38.35 90.8 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 118.449 -0.786 . . . . 0.0 111.954 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.95 -38.8 92.15 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.411 1.005 . . . . 0.0 110.358 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -66.47 -35.81 81.2 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.251 0.478 . . . . 0.0 110.872 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.72 -26.37 65.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.163 0.585 . . . . 0.0 111.712 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.44 -2.83 10.37 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.266 1.412 . . . . 0.0 114.137 169.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -82.07 142.91 31.89 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.094 1.447 . . . . 0.0 109.579 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 p -80.97 142.41 33.49 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.1 p -136.94 166.23 24.12 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.575 0.702 . . . . 0.0 110.991 -169.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -150.31 159.53 44.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 169.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 p -128.04 76.62 1.7 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.1 mt -70.54 113.59 7.8 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -76.69 107.29 8.88 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 52.8 52.13 40.64 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-O 118.521 -1.155 . . . . 0.0 115.057 172.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -67.7 177.74 3.88 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.092 2.528 . . . . 0.0 111.13 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.2 mt -127.91 166.84 17.54 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.271 1.428 . . . . 0.0 108.968 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -53.21 -36.85 61.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.489 1.516 . . . . 0.0 112.127 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.46 -7.13 8.88 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.237 1.015 . . . . 0.0 113.415 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -132.14 21.88 4.47 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.778 1.631 . . . . 0.0 110.976 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.2 mt -134.12 112.95 12.35 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.558 1.143 . . . . 0.0 109.273 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -66.34 157.44 60.18 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.35 2.034 . . . . 0.0 111.963 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.33 10.61 26.71 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.757 1.223 . . . . 0.0 114.288 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.7 m -144.4 124.57 13.69 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 150.79 -171.36 30.56 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.8 mp -124.92 99.22 5.89 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -94.23 174.09 7.32 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.722 0.809 . . . . 0.0 109.515 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.6 tp -144.87 98.6 3.21 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.7 138.61 19.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 mt -130.11 148.57 33.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.8 m -146.33 137.64 24.54 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 m -70.54 144.57 51.26 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 168.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 p -85.34 1.96 46.25 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -177.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 45.08 19.61 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 129.537 3.135 . . . . 0.0 114.394 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.58 23.74 29.29 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 120.905 -1.122 . . . . 0.0 113.149 -169.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.82 -9.09 0.41 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.342 1.071 . . . . 0.0 113.515 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.81 34.72 42.2 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 118.862 0.756 . . . . 0.0 111.642 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -140.32 146.93 39.13 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.053 0.941 . . . . 0.0 109.214 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.482 ' H ' HD12 ' A' ' 62' ' ' ILE . 3.6 mp -76.73 146.1 75.84 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -57.42 155.07 32.13 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.951 2.434 . . . . 0.0 111.663 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -59.56 -16.28 24.17 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.115 1.366 . . . . 0.0 114.107 -174.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -64.46 -39.82 94.54 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.519 0.728 . . . . 0.0 111.083 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.2 tp -122.97 -20.64 5.73 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.185 0.594 . . . . 0.0 112.313 -171.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 t -49.2 -39.05 33.4 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.75 -23.78 8.91 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.463 2.775 . . . . 0.0 116.162 172.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -59.94 -37.03 78.33 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.658 1.117 . . . . 0.0 111.16 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -59.03 -42.94 91.4 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.237 0.615 . . . . 0.0 110.34 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -68.65 -48.24 64.51 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.401 0.68 . . . . 0.0 109.79 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.34 84.03 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 118.924 -0.56 . . . . 0.0 112.094 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.6 mt -65.84 -53.82 34.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 118.65 -0.69 . . . . 0.0 109.503 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -69.15 -28.58 66.56 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.162 0.892 . . . . 0.0 111.847 -174.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -66.09 -36.44 83.19 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.709 0.686 . . . . 0.0 110.725 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -107.22 -20.74 13.19 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -169.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm 39.71 60.54 6.31 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.873 1.669 . . . . 0.0 111.057 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.95 167.25 14.38 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.752 2.968 . . . . 0.0 111.997 -174.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -95.52 73.27 3.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.386 1.075 . . . . 0.0 109.332 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.47 16.68 9.82 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.26 1.424 . . . . 0.0 111.517 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.9 m -51.57 10.95 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 129.601 3.161 . . . . 0.0 116.921 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.22 2.18 2.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.168 1.387 . . . . 0.0 112.213 174.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.5 t -80.16 140.87 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 169.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -116.84 151.07 37.31 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 168.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -147.43 170.83 16.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.189 0.904 . . . . 0.0 112.48 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.55 161.16 23.95 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 104.766 -3.334 . . . . 0.0 104.766 169.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.423 ' HB1' HD12 ' A' ' 102' ' ' ILE . . . -140.98 132.88 27.59 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -169.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.2 mt -137.72 126.32 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 -173.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -114.93 121.07 5.2 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.1 mt -123.47 134.32 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 118.232 1.016 . . . . 0.0 108.34 -169.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.02 -164.42 37.96 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.5 m -75.06 75.22 2.25 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 125.621 1.569 . . . . 0.0 109.186 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -65.1 -12.2 48.19 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.448 1.099 . . . . 0.0 113.39 -171.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -65.56 -22.49 66.7 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.379 0.536 . . . . 0.0 111.475 170.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -75.01 174.31 9.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.055 0.942 . . . . 0.0 110.326 175.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.34 -29.9 70.96 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.712 0.805 . . . . 0.0 113.16 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 58.3 m -69.34 132.47 46.46 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -114.13 -59.57 2.0 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.295 0.638 . . . . 0.0 111.338 -175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 63.9 m -145.71 6.89 1.08 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.535 1.134 . . . . 0.0 112.413 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.6 -33.93 48.95 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 119.165 0.893 . . . . 0.0 114.22 -169.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.42 -59.59 4.17 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 117.949 0.875 . . . . 0.0 110.621 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.423 HD12 ' HB1' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -66.04 -34.99 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -175.14 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.0 -37.33 63.9 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.279 1.032 . . . . 0.0 112.528 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -63.7 -43.68 95.9 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.202 0.91 . . . . 0.0 111.35 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.3 mt -63.14 -50.43 70.46 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -70.22 -30.44 67.52 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.496 -173.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.01 91.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.481 0.582 . . . . 0.0 109.975 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -75.89 -29.6 58.53 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 117.771 -1.109 . . . . 0.0 112.4 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.26 -45.46 87.99 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 121.059 1.754 . . . . 0.0 109.855 172.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -71.4 -31.95 67.85 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.142 0.428 . . . . 0.0 110.964 -177.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -62.56 -39.47 93.74 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.013 0.37 . . . . 0.0 110.367 169.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.1 m -71.56 -0.53 10.82 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.82 1.248 . . . . 0.0 112.945 172.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.71 -14.31 41.9 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.809 1.195 . . . . 0.0 114.004 169.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.55 171.63 1.91 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.79 1.295 . . . . 0.0 110.839 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -142.81 150.68 40.27 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.993 -1.067 . . . . 0.0 112.237 170.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 17.3 tm0? -70.85 148.18 48.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.738 1.615 . . . . 0.0 108.438 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.3 m -128.22 144.96 51.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.936 1.695 . . . . 0.0 107.53 174.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.02 -127.84 8.68 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -143.98 164.41 30.68 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.993 1.717 . . . . 0.0 107.209 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.7 m -68.12 139.95 56.18 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.3 tp -105.8 150.2 25.77 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.209 1.003 . . . . 0.0 108.662 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.32 136.65 35.06 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.6 mm -135.49 113.81 15.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.176 -1.786 . . . . 0.0 106.176 -170.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -72.07 142.78 49.23 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 169.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.4 pp -128.92 3.62 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.518 1.127 . . . . 0.0 112.378 171.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 tp -64.55 -39.6 94.06 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.096 0.862 . . . . 0.0 112.351 -172.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -142.68 -7.39 0.86 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -169.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -150.12 155.27 39.51 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.392 1.477 . . . . 0.0 107.693 177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -72.86 -34.45 66.74 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -169.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.1 pt -147.32 155.32 46.26 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 126.146 1.779 . . . . 0.0 108.317 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.85 174.69 10.08 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.762 2.308 . . . . 0.0 110.677 169.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.9 mp0 -70.95 24.32 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.044 2.138 . . . . 0.0 112.538 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -142.28 80.64 14.72 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 127.004 2.122 . . . . 0.0 106.726 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.99 151.03 28.64 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.781 2.987 . . . . 0.0 114.098 -169.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.12 -31.68 65.56 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.539 174.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.1 -37.87 89.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.288 0.635 . . . . 0.0 111.252 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -71.46 -41.43 69.4 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.763 -0.586 . . . . 0.0 109.562 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -61.05 -45.15 95.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.62 -43.75 95.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.481 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.31 -45.36 92.87 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -63.97 -36.86 85.37 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.154 0.582 . . . . 0.0 111.168 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -67.91 -54.06 21.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.934 0.894 . . . . 0.0 109.8 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.93 -31.35 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 118.818 0.735 . . . . 0.0 111.141 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.24 -25.09 58.57 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.416 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.5 mt -101.46 -5.84 24.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.038 -0.982 . . . . 0.0 113.293 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.5 pp -120.3 -9.41 9.52 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.308 1.413 . . . . 0.0 113.08 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.251 1.133 0 C-N-CA 125.703 1.601 . . . . 0.0 111.961 178.264 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tmm? . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.16 158.03 14.75 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.72 -0.613 . . . . 0.0 110.776 172.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -135.44 -25.94 1.28 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.765 1.226 . . . . 0.0 110.977 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.8 mt -129.53 84.77 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 169.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.5 m -75.56 115.85 15.67 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 176.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mp -74.35 156.89 36.62 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 171.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.6 mt -126.39 80.22 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.5 m -68.45 153.88 42.91 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.527 1.531 . . . . 0.0 110.561 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.1 100.42 0.19 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -150.12 170.56 18.63 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.656 0.741 . . . . 0.0 109.976 171.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -133.42 -41.4 0.87 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 127.213 2.205 . . . . 0.0 107.344 171.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.71 -33.84 76.54 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.815 0.846 . . . . 0.0 110.64 169.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.44 -8.46 52.21 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.134 1.35 . . . . 0.0 112.754 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.67 -45.17 67.38 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 118.484 1.142 . . . . 0.0 110.684 -173.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.68 -26.83 64.56 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.483 0.641 . . . . 0.0 110.74 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -69.96 -36.64 75.4 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.328 0.513 . . . . 0.0 110.685 175.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -67.02 -44.28 80.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.735 0.698 . . . . 0.0 109.504 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.65 -39.15 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 119.057 -0.497 . . . . 0.0 109.967 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.88 -41.74 96.58 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.296 0.953 . . . . 0.0 110.987 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -63.32 -42.5 99.0 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.746 0.703 . . . . 0.0 110.553 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -62.02 -45.41 93.7 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.845 -0.534 . . . . 0.0 110.706 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.7 mt -62.06 -41.78 98.5 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.474 0.71 . . . . 0.0 110.464 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.18 -38.24 85.8 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.028 0.531 . . . . 0.0 110.662 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.18 -41.33 90.44 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.425 ' N ' ' HE2' ' A' ' 25' ' ' LYS . 6.8 mmpt? -62.89 -36.34 83.01 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 121.685 -0.634 . . . . 0.0 110.009 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.3 mt -68.45 -37.53 80.31 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 118.965 -0.541 . . . . 0.0 110.984 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -62.9 -42.11 99.67 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.924 0.783 . . . . 0.0 109.974 175.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.93 -37.29 87.16 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.145 0.43 . . . . 0.0 111.012 175.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.16 -22.03 63.96 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.792 0.837 . . . . 0.0 112.186 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.56 28.75 2.89 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.567 -1.13 . . . . 0.0 113.973 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -125.98 137.44 53.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.286 1.543 . . . . 0.0 109.223 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.5 p -76.07 146.85 39.08 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.43 0.633 . . . . 0.0 109.513 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.4 p -135.36 167.63 20.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.781 0.832 . . . . 0.0 110.212 -170.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -150.97 160.75 43.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 169.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.7 78.65 1.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -175.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.09 110.85 4.71 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -93.93 92.02 7.19 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -171.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.51 56.6 12.65 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.931 -0.927 . . . . 0.0 113.071 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.19 -179.14 3.3 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.91 2.407 . . . . 0.0 110.345 170.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.3 mt -114.77 160.16 19.75 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 169.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -55.5 -40.04 71.22 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.781 0.832 . . . . 0.0 111.403 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -64.83 -14.54 59.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.808 0.843 . . . . 0.0 113.198 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -90.76 -2.91 57.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.932 0.893 . . . . 0.0 112.309 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -137.44 154.4 75.26 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.147 0.979 . . . . 0.0 111.179 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.8 163.58 26.1 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.826 2.351 . . . . 0.0 111.77 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.04 18.67 0.99 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.41 1.484 . . . . 0.0 113.22 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.7 m -146.45 136.7 23.7 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.223 1.409 . . . . 0.0 107.887 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.71 -176.2 30.19 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.95 104.28 13.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -104.95 172.85 6.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.199 0.999 . . . . 0.0 109.931 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.6 tp -141.31 100.55 3.82 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 t -79.35 131.57 34.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.9 mt -133.0 127.58 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.2 m -134.29 129.31 35.39 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -170.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.9 m -69.07 160.51 30.89 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.505 169.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.9 m -132.82 109.21 9.48 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -63.28 -24.89 68.07 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.04 0.382 . . . . 0.0 111.956 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.09 -32.24 0.33 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.052 0.834 . . . . 0.0 112.234 171.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.93 30.31 4.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.27 1.028 . . . . 0.0 111.922 -171.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.81 -0.01 59.14 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.376 -0.68 . . . . 0.0 113.641 173.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -69.14 110.82 4.73 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 118.484 1.142 . . . . 0.0 109.982 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 61.2 mt -69.3 141.86 91.76 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 171.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.51 136.76 56.23 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.204 2.602 . . . . 0.0 110.985 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.9 -21.48 43.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.407 1.483 . . . . 0.0 113.237 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -64.87 -34.94 79.58 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.446 0.699 . . . . 0.0 111.454 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 tt -121.76 -22.17 5.88 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.615 0.766 . . . . 0.0 112.306 -169.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 81.7 p -51.13 -34.01 11.51 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-O 116.439 -1.743 . . . . 0.0 115.259 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -52.11 -22.9 15.99 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.989 2.46 . . . . 0.0 115.728 172.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -59.46 -37.21 77.58 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.336 0.971 . . . . 0.0 110.913 175.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -65.21 -42.26 93.69 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.602 0.761 . . . . 0.0 110.179 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -63.35 -50.95 67.95 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.714 0.406 . . . . 0.0 109.997 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.56 -29.21 70.23 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.993 0.815 . . . . 0.0 112.745 -174.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.3 mt -68.69 -57.07 6.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.382 171.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -69.86 -27.46 64.85 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.041 0.837 . . . . 0.0 112.431 -170.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.92 -26.05 61.27 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.123 0.874 . . . . 0.0 111.256 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -109.44 -24.4 11.04 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.573 -173.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt 40.13 59.81 7.05 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.778 1.631 . . . . 0.0 110.577 -169.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.25 167.62 17.94 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.846 2.364 . . . . 0.0 111.068 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -96.53 106.72 19.02 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 169.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.1 mt -118.98 24.93 10.54 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.128 1.771 . . . . 0.0 110.022 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -61.0 20.0 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.524 1.929 . . . . 0.0 115.569 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.13 1.86 1.86 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.35 1.46 . . . . 0.0 111.992 173.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.5 t -84.09 142.66 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -123.42 148.65 45.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 168.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -144.08 171.3 14.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.452 0.644 . . . . 0.0 111.45 -174.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.42 161.54 22.16 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 104.461 -3.456 . . . . 0.0 104.461 168.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.31 124.77 13.93 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -169.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 mt -134.65 133.43 54.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.8 140.03 15.93 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 170.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 mt -138.73 131.47 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -171.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.7 -169.01 41.46 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 120.231 1.378 . . . . 0.0 110.541 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.9 m -79.34 74.17 5.95 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 126.02 1.728 . . . . 0.0 108.223 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -52.6 -33.93 48.57 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.962 1.305 . . . . 0.0 112.211 -173.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -80.84 -12.02 59.5 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.671 1.188 . . . . 0.0 112.349 -174.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -67.49 -52.54 38.03 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 118.978 0.808 . . . . 0.0 111.836 -169.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -162.87 -47.06 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.346 1.058 . . . . 0.0 110.915 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.8 m -115.93 131.44 56.94 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -79.7 59.49 3.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.83 1.252 . . . . 0.0 111.434 -169.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 72.1 m 48.28 38.3 10.0 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.646 1.578 . . . . 0.0 112.613 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.02 -0.17 78.08 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 118.673 -1.07 . . . . 0.0 113.55 -172.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.17 -20.52 66.06 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.795 1.797 . . . . 0.0 113.161 -171.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.6 tp -60.86 -28.21 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.361 1.464 . . . . 0.0 111.163 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -57.22 -40.35 77.34 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -169.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -63.62 -44.35 94.18 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.927 -0.483 . . . . 0.0 111.047 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.9 mt -69.34 -48.61 60.85 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.566 0.747 . . . . 0.0 109.398 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.63 -38.57 87.21 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.56 -37.65 88.27 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.316 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -70.62 -29.16 65.47 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.596 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.6 mt -66.23 -43.05 87.7 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.948 1.704 . . . . 0.0 109.259 170.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -62.71 -42.81 99.83 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 122.732 0.413 . . . . 0.0 109.985 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -60.82 -40.51 92.99 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.207 1.003 . . . . 0.0 110.826 174.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.0 m -70.3 -5.78 30.34 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.478 1.111 . . . . 0.0 113.186 175.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.19 -13.9 21.33 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.53 1.062 . . . . 0.0 113.612 169.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.73 178.97 0.7 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.379 1.089 . . . . 0.0 110.589 174.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -151.73 148.08 27.47 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.873 -1.142 . . . . 0.0 113.204 169.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 39.7 tp60 -56.77 155.94 7.13 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.715 2.006 . . . . 0.0 109.928 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.5 m -141.3 131.96 25.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.57 174.77 17.01 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -169.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -71.55 158.3 36.46 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.625 -0.926 . . . . 0.0 108.963 170.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.88 160.52 20.28 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 169.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 54.2 tp -129.54 148.44 51.44 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.517 -0.739 . . . . 0.0 109.637 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -125.71 147.33 49.4 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 169.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.7 mm -131.66 106.88 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -78.14 134.96 37.59 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 169.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.24 -17.64 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 118.294 0.497 . . . . 0.0 111.699 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.0 tp -67.67 -34.46 76.98 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.552 0.614 . . . . 0.0 111.274 -171.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -73.77 -50.83 18.73 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -159.76 34.84 0.19 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.387 0.675 . . . . 0.0 111.018 -171.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.1 t70 67.87 -25.16 0.12 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.454 2.302 . . . . 0.0 114.738 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.0 pt -145.18 160.06 47.17 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 127.757 2.423 . . . . 0.0 107.673 171.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.66 170.31 16.76 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.536 2.157 . . . . 0.0 110.225 169.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.32 -36.98 85.88 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.17 0.588 . . . . 0.0 110.808 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -69.61 115.82 36.85 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.293 1.037 . . . . 0.0 109.91 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.23 138.02 78.65 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.559 2.173 . . . . 0.0 111.767 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.89 -28.67 67.75 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 122.704 0.402 . . . . 0.0 111.153 172.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -58.63 -33.73 70.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.49 1.116 . . . . 0.0 111.565 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -69.52 -42.08 75.16 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.851 0.75 . . . . 0.0 109.954 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -64.68 -43.88 92.11 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.98 -43.34 99.06 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.354 0.662 . . . . 0.0 110.513 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.71 -44.54 97.8 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.954 0.787 . . . . 0.0 111.513 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -63.47 -35.58 80.93 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.023 -0.692 . . . . 0.0 111.053 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -68.88 -48.51 63.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.918 0.887 . . . . 0.0 110.403 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.15 -32.55 57.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 CA-C-N 119.161 0.891 . . . . 0.0 111.169 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -62.14 -22.23 65.68 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.344 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.1 mt -96.53 -43.8 7.45 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.438 1.017 . . . . 0.0 111.621 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 pp -70.92 -25.41 62.75 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.355 0.98 . . . . 0.0 112.32 -175.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 C--O 1.252 1.209 0 C-N-CA 127.796 2.438 . . . . 0.0 112.02 177.767 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.07 158.67 43.75 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.625 1.17 . . . . 0.0 108.589 172.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -137.36 -25.09 1.05 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.69 1.596 . . . . 0.0 110.992 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.8 mt -124.9 79.3 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 169.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.4 m -74.83 117.77 17.05 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.65 151.0 34.5 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.3 mt -116.2 80.34 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 m -71.44 148.34 46.96 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.254 1.422 . . . . 0.0 109.683 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.6 80.7 0.18 Allowed Glycine 0 C--N 1.339 0.735 0 O-C-N 122.237 -0.289 . . . . 0.0 113.794 -169.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 t -150.44 134.37 16.83 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.899 0.88 . . . . 0.0 108.734 168.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -78.24 -38.48 42.86 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 169.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.6 mt -73.83 -41.24 62.58 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.754 0.822 . . . . 0.0 110.635 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.37 -8.42 11.2 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.392 1.472 . . . . 0.0 112.634 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.79 -57.98 14.13 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 125.545 1.545 . . . . 0.0 113.109 -169.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.02 -27.97 67.0 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 117.568 0.684 . . . . 0.0 110.972 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -76.33 -22.7 54.6 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.192 -173.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -65.75 -41.6 91.92 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.94 0.791 . . . . 0.0 109.182 169.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.5 t -72.22 -32.76 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 121.822 -0.549 . . . . 0.0 109.937 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.86 87.12 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.409 -0.807 . . . . 0.0 110.277 170.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.07 -38.93 89.56 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.412 0.551 . . . . 0.0 111.157 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -59.23 -46.8 87.51 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.095 0.861 . . . . 0.0 110.032 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.6 mt -65.14 -43.18 92.7 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.799 -0.563 . . . . 0.0 110.103 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.47 -42.61 92.43 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.549 0.74 . . . . 0.0 111.004 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -52.79 -47.43 67.56 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.799 0.84 . . . . 0.0 110.031 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -67.87 -40.9 83.54 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.2 mt -66.41 -39.59 89.09 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 119.259 -0.4 . . . . 0.0 110.641 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -61.12 -46.18 91.63 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.111 0.564 . . . . 0.0 109.655 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -65.5 -34.94 79.45 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.846 0.458 . . . . 0.0 111.34 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.6 -22.36 64.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.877 0.871 . . . . 0.0 112.035 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.25 1.67 23.47 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.656 1.122 . . . . 0.0 113.212 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -74.97 174.74 8.89 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.444 1.122 . . . . 0.0 109.475 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.4 p -122.61 137.32 54.93 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.5 p -132.51 170.32 15.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.135 0.974 . . . . 0.0 110.336 -170.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -153.54 126.1 8.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 104.518 -2.401 . . . . 0.0 104.518 169.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.0 p -82.54 70.63 9.55 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -69.58 113.59 7.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -169.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -72.27 107.98 5.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.261 1.024 . . . . 0.0 108.744 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.82 56.65 15.13 Favored Glycine 0 CA--C 1.539 1.577 0 CA-C-O 118.341 -1.255 . . . . 0.0 115.766 169.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.2 175.71 5.46 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.771 2.314 . . . . 0.0 111.685 173.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.7 mt -128.67 164.35 23.12 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.346 1.458 . . . . 0.0 109.226 174.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.4 tp -62.27 -27.8 69.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.816 1.247 . . . . 0.0 112.169 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.75 -10.38 12.6 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.136 0.974 . . . . 0.0 113.101 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -128.56 19.88 6.19 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.348 1.459 . . . . 0.0 110.872 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.94 97.67 13.61 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.08 1.352 . . . . 0.0 107.886 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.76 165.22 28.45 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.404 2.069 . . . . 0.0 111.774 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.71 4.67 1.8 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.69 1.596 . . . . 0.0 114.788 -175.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.2 m -144.94 133.85 22.47 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.354 1.462 . . . . 0.0 107.276 -175.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.71 175.53 23.54 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.5 mt -114.54 101.83 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -110.42 166.63 10.83 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.573 0.749 . . . . 0.0 108.98 -176.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.8 tp -146.37 99.28 3.2 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 t -79.52 132.31 32.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.793 1.237 . . . . 0.0 107.839 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 mt -135.98 132.29 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.6 m -134.18 133.67 41.23 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -169.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 m -80.08 166.71 21.24 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 169.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.5 m -141.15 112.27 7.29 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 174.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -71.61 -5.25 32.08 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -169.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 160.89 -38.58 0.43 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-N 119.794 1.179 . . . . 0.0 113.761 169.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.22 10.25 3.0 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.273 1.036 . . . . 0.0 113.259 -170.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.62 -14.88 4.71 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.135 0.874 . . . . 0.0 113.289 172.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.07 119.43 6.3 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.353 1.061 . . . . 0.0 111.632 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.4 mt -83.47 132.23 50.27 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -51.13 136.46 45.51 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 124.016 3.144 . . . . 0.0 113.292 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.39 -18.6 62.0 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.283 1.033 . . . . 0.0 113.315 -176.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -73.89 -27.11 60.89 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.413 -0.804 . . . . 0.0 112.179 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.9 tp -121.04 -27.1 5.02 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.283 0.947 . . . . 0.0 111.92 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -46.73 -39.76 17.37 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-O 117.549 -1.215 . . . . 0.0 113.935 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.42 -25.64 14.46 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.502 2.801 . . . . 0.0 116.077 172.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -60.56 -37.5 81.47 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.157 -0.965 . . . . 0.0 110.855 176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -65.71 -43.3 89.54 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.113 0.565 . . . . 0.0 110.9 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.26 -38.04 68.95 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.583 0.629 . . . . 0.0 110.784 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.04 -35.91 80.92 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.726 0.693 . . . . 0.0 111.576 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.9 mt -64.45 -54.41 33.02 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.744 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -69.54 -25.96 64.27 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.147 0.885 . . . . 0.0 111.957 -173.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -68.88 -37.27 78.94 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.86 0.755 . . . . 0.0 110.697 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -105.07 -34.33 8.0 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -169.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm 31.0 57.92 0.98 Allowed Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 127.306 2.242 . . . . 0.0 113.675 -173.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.23 169.83 15.93 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.929 1.753 . . . . 0.0 110.167 174.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -72.04 114.83 10.57 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 169.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.1 mt -119.72 18.74 12.62 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.674 1.59 . . . . 0.0 110.901 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.8 m -57.87 4.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.43 1.22 8.96 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.848 1.204 . . . . 0.0 111.614 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 79.8 t -74.56 131.63 34.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 169.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -107.62 102.73 11.95 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 102.197 -3.26 . . . . 0.0 102.197 168.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -95.88 167.35 11.31 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.803 0.811 . . . . 0.0 108.933 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -123.13 154.46 17.17 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 104.839 -3.305 . . . . 0.0 104.839 169.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.47 122.48 11.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.8 mt -135.68 131.82 50.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -102.26 138.11 13.73 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.9 mt -133.21 153.35 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 165.66 173.4 34.13 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-O 123.278 1.488 . . . . 0.0 110.732 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.1 m -74.48 56.94 0.69 Allowed 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 126.511 1.924 . . . . 0.0 109.952 174.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.14 -52.5 7.23 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.894 2.078 . . . . 0.0 110.978 -174.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -65.14 -11.7 43.07 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.093 0.557 . . . . 0.0 112.498 -171.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -66.27 -50.43 63.73 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.908 0.776 . . . . 0.0 110.184 170.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -171.61 -49.02 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.412 1.485 . . . . 0.0 111.797 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.5 t -58.65 166.22 1.93 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.739 1.216 . . . . 0.0 114.02 -169.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -112.96 43.39 1.7 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 169.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 16.4 m 45.0 52.9 8.03 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.486 1.914 . . . . 0.0 110.379 -169.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -69.7 -14.36 69.87 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.718 -169.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.38 -36.45 71.26 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.486 1.643 . . . . 0.0 113.784 -169.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.8 tp -67.88 -27.87 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.174 0.59 . . . . 0.0 110.841 -176.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -61.02 -43.52 98.76 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 118.354 0.524 . . . . 0.0 111.787 -169.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -65.81 -44.52 85.4 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 122.016 -0.427 . . . . 0.0 110.802 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.9 mt -63.33 -46.66 85.61 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.331 0.652 . . . . 0.0 109.948 -176.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.89 -40.38 75.7 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.997 0.362 . . . . 0.0 110.075 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.31 -35.02 79.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.032 -169.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -74.21 -29.94 61.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.18 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.8 mt -66.62 -41.78 87.84 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.16 1.346 . . . . 0.0 109.02 169.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -61.55 -43.92 97.98 Favored 'General case' 0 N--CA 1.458 -0.062 0 C-N-CA 124.002 0.921 . . . . 0.0 109.343 -177.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -67.5 -36.41 81.01 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.023 0.929 . . . . 0.0 111.347 176.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.1 m -68.84 -2.09 8.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.225 1.01 . . . . 0.0 112.876 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.28 -15.66 30.16 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.32 1.438 . . . . 0.0 113.693 169.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.19 171.95 2.73 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.6 1.2 . . . . 0.0 110.989 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -142.66 154.47 44.37 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.364 -0.835 . . . . 0.0 111.462 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -63.85 161.35 15.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.774 2.029 . . . . 0.0 110.244 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.6 m -133.99 152.85 52.01 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.509 1.923 . . . . 0.0 106.321 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.37 -135.27 51.84 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -169.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -140.47 150.67 44.09 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.8 m -63.22 149.64 44.98 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.269 1.428 . . . . 0.0 110.551 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.9 tp -132.88 147.89 52.3 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.388 1.075 . . . . 0.0 109.084 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -120.06 139.25 52.82 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.221 1.808 . . . . 0.0 106.227 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.8 mt -138.07 107.25 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.419 HD22 ' CD2' ' A' ' 128' ' ' HIS . 41.8 t30 -67.57 141.13 56.92 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 170.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.3 pt -122.06 -9.66 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.036 1.335 . . . . 0.0 112.1 171.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.4 tp -71.69 115.29 10.71 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 119.883 1.22 . . . . 0.0 108.378 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.1 t70 56.17 31.63 18.68 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.898 1.679 . . . . 0.0 112.367 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.419 ' CD2' HD22 ' A' ' 124' ' ' ASN . 5.4 m170 -128.35 155.16 45.11 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.028 1.731 . . . . 0.0 107.924 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -143.17 12.77 1.8 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.596 1.158 . . . . 0.0 111.853 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 42.4 pt 34.91 56.51 2.17 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 127.284 2.234 . . . . 0.0 114.398 -175.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.5 -26.28 54.88 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.331 2.02 . . . . 0.0 112.612 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -77.69 -7.64 56.77 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.412 1.085 . . . . 0.0 111.288 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 36.7 t0 37.94 57.89 4.72 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 127.883 2.473 . . . . 0.0 113.715 -169.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -55.97 -24.15 46.87 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 123.532 2.821 . . . . 0.0 114.577 -173.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.87 -34.11 62.61 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.876 0.87 . . . . 0.0 111.34 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -62.15 -38.93 90.89 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.51 0.724 . . . . 0.0 110.908 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -76.13 -49.09 18.29 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -64.67 -33.16 75.28 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.216 -0.303 . . . . 0.0 111.744 -174.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 48.9 tp -56.98 -30.18 63.9 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 118.68 -0.676 . . . . 0.0 111.358 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.92 -45.7 70.34 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 118.841 0.746 . . . . 0.0 111.297 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.9 m -66.77 -30.76 71.05 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 117.492 0.646 . . . . 0.0 111.319 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -72.61 -51.31 20.18 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.532 0.733 . . . . 0.0 110.03 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 31.4 m -66.52 -30.64 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 O-C-N 121.331 -0.855 . . . . 0.0 111.246 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -60.74 -21.25 62.78 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.846 0.859 . . . . 0.0 112.482 175.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 28.8 mt -102.78 -35.93 8.46 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 118.069 -0.967 . . . . 0.0 112.109 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -35.78 79.52 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 120.005 1.275 . . . . 0.0 111.838 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt . . . . . 0 C--O 1.251 1.176 0 C-N-CA 128.658 2.783 . . . . 0.0 113.236 -179.474 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 ttm . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.7 158.62 24.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.887 0.475 . . . . 0.0 110.957 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -134.34 -26.03 1.48 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.122 1.369 . . . . 0.0 110.973 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.6 mt -129.04 82.36 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 169.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.8 m -74.6 121.29 21.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.5 mp -78.98 146.17 33.54 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.5 mt -109.91 82.31 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.4 m -64.1 140.33 58.86 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.014 0.926 . . . . 0.0 110.431 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.57 72.12 0.41 Allowed Glycine 0 C--N 1.339 0.739 0 C-N-CA 123.584 0.611 . . . . 0.0 113.851 -169.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 99.5 p -152.16 148.55 27.76 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 168.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -80.43 -44.03 19.98 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.911 0.885 . . . . 0.0 108.886 169.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.492 ' H ' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -64.91 -27.34 68.78 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.133 1.373 . . . . 0.0 113.698 -179.106 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.15 0.19 57.19 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.489 1.042 . . . . 0.0 113.064 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.15 -43.13 98.68 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 119.178 1.489 . . . . 0.0 111.204 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.9 -29.23 69.06 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.542 -0.742 . . . . 0.0 110.644 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -69.88 -35.32 74.56 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.15 0.886 . . . . 0.0 110.231 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -70.91 -41.73 70.88 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.998 0.817 . . . . 0.0 109.784 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.11 -44.81 99.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.87 -36.47 79.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.524 -0.751 . . . . 0.0 111.01 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.82 -41.69 99.42 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.52 1.055 . . . . 0.0 110.7 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -64.57 -48.87 73.4 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.161 0.437 . . . . 0.0 109.962 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.84 -46.11 88.49 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.86 0.464 . . . . 0.0 110.233 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.51 98.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.474 1.11 . . . . 0.0 111.029 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.39 -43.66 96.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.288 0.495 . . . . 0.0 110.355 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -67.45 -34.29 76.88 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.356 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.0 mt -63.99 -37.02 85.9 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 119.381 0.991 . . . . 0.0 111.755 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -63.44 -40.91 98.4 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.586 1.085 . . . . 0.0 110.15 175.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.22 -37.04 86.03 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.296 0.498 . . . . 0.0 111.087 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.84 -21.86 63.33 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.74 0.816 . . . . 0.0 112.256 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.27 26.04 3.32 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.533 -1.148 . . . . 0.0 114.022 170.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -125.88 131.58 52.33 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.244 1.522 . . . . 0.0 108.72 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 p -73.26 147.47 44.56 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.5 p -140.72 169.28 17.94 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.084 0.954 . . . . 0.0 109.588 -169.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -152.5 140.67 20.38 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 169.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.5 p -96.42 68.65 2.57 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.87 119.3 17.9 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -169.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -69.29 99.96 1.26 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.264 1.026 . . . . 0.0 109.665 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.13 54.22 10.04 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.347 1.451 . . . . 0.0 115.549 171.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -60.6 142.97 99.31 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 CA-C-N 120.494 2.147 . . . . 0.0 109.815 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.1 mt -69.23 155.03 41.08 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.75 -34.26 71.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.311 0.644 . . . . 0.0 109.761 169.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -65.58 -9.57 27.83 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.386 1.475 . . . . 0.0 112.909 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -118.06 13.23 13.84 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.007 1.323 . . . . 0.0 111.556 -170.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 pp -141.98 154.78 65.53 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.513 1.125 . . . . 0.0 109.592 171.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.48 161.29 37.57 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.594 2.196 . . . . 0.0 112.07 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.06 18.63 0.48 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.567 1.547 . . . . 0.0 112.931 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.8 t -152.37 133.68 14.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.03 179.39 31.93 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.0 mt -117.25 106.66 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.096 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -107.75 169.07 8.83 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 123.152 0.581 . . . . 0.0 109.516 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.4 tp -142.41 101.04 3.82 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.01 144.09 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.217 -171.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.57 143.42 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 172.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 m -147.24 134.49 20.59 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.402 -0.812 . . . . 0.0 108.876 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.4 m -75.91 160.36 29.99 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 169.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.8 m -128.64 106.22 8.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.778 1.631 . . . . 0.0 106.921 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -67.11 169.82 7.9 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.2 -23.82 34.3 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.754 -1.026 . . . . 0.0 114.947 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.92 11.7 16.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.996 1.318 . . . . 0.0 112.709 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.14 16.97 70.61 Favored Glycine 0 C--N 1.339 0.697 0 O-C-N 121.439 -0.788 . . . . 0.0 113.721 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -66.45 119.99 12.59 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.659 1.23 . . . . 0.0 108.419 170.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.2 mt -70.18 142.58 90.15 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -61.28 144.64 98.74 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.085 2.523 . . . . 0.0 112.065 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -59.01 -21.91 59.8 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.359 1.464 . . . . 0.0 113.598 -173.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.91 -27.97 68.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.38 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 63.6 tp -130.79 -20.72 2.81 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.734 0.814 . . . . 0.0 112.508 -170.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.0 p -53.19 -31.5 7.88 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -53.52 -20.89 17.14 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.014 2.476 . . . . 0.0 115.583 169.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -56.99 -35.65 69.45 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.177 0.898 . . . . 0.0 110.96 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -65.35 -48.83 71.64 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.58 -43.44 98.85 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.605 0.762 . . . . 0.0 110.009 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.57 -29.8 68.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.419 0.688 . . . . 0.0 112.492 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.4 mt -76.68 -29.8 56.48 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.771 176.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -73.62 -46.84 44.43 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.494 1.043 . . . . 0.0 109.115 175.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.11 -25.73 67.9 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.831 0.853 . . . . 0.0 111.837 -171.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -118.14 -25.26 6.71 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 117.974 -1.012 . . . . 0.0 113.167 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? 36.55 59.06 3.51 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 125.026 1.33 . . . . 0.0 110.605 -169.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -68.17 173.84 8.89 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.603 2.869 . . . . 0.0 112.777 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -105.39 107.81 19.0 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.8 mt -117.86 22.32 12.36 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 126.146 1.778 . . . . 0.0 110.675 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 m -57.46 16.05 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.51 2.324 . . . . 0.0 116.549 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.6 0.89 2.08 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.889 1.276 . . . . 0.0 112.309 172.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 94.9 t -75.85 134.56 28.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.9 mmm-85 -121.97 144.46 48.87 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 104.972 -2.232 . . . . 0.0 104.972 168.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -150.84 169.73 20.99 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.861 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -125.37 166.31 18.15 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 105.457 -3.057 . . . . 0.0 105.457 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.81 135.84 22.46 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.831 1.315 . . . . 0.0 111.111 -169.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.1 mm -124.24 130.51 73.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -104.9 135.97 12.85 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 107.691 -2.163 . . . . 0.0 107.691 169.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.2 mt -130.01 152.92 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 161.17 175.66 32.44 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 71.0 m -78.39 91.69 4.5 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 169.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -28.87 62.05 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.472 0.709 . . . . 0.0 112.872 -169.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -73.68 -9.9 59.14 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.49 169.01 11.65 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.161 0.891 . . . . 0.0 110.173 172.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -58.48 -34.52 70.97 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.424 0.69 . . . . 0.0 112.782 -173.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.9 m -101.13 107.85 19.38 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -64.99 153.65 40.03 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 35.1 m -41.38 106.82 0.06 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.511 2.324 . . . . 0.0 110.434 177.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.81 3.3 0.02 OUTLIER Glycine 0 CA--C 1.523 0.569 0 CA-C-O 117.938 -1.479 . . . . 0.0 115.659 -170.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.22 -18.44 63.52 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.807 2.304 . . . . 0.0 112.591 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 102' ' ' ILE . 2.1 tp -52.98 -33.34 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 126.075 1.75 . . . . 0.0 110.391 170.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -51.4 -39.18 56.7 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.497 1.119 . . . . 0.0 112.855 -172.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -66.44 -36.5 82.95 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.787 -0.571 . . . . 0.0 111.446 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.2 mt -71.89 -52.07 19.1 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -67.08 -35.81 80.62 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.991 -171.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.32 -38.54 90.47 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -73.25 -30.94 63.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.914 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.05 -46.69 86.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.314 1.415 . . . . 0.0 109.203 169.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -63.37 -41.06 98.79 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 122.417 0.287 . . . . 0.0 110.387 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -63.04 -39.54 95.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.581 0.752 . . . . 0.0 110.524 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.7 m -70.68 -7.11 42.15 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.469 1.108 . . . . 0.0 112.908 174.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.03 -16.9 8.71 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.728 1.156 . . . . 0.0 113.921 169.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.22 172.75 1.35 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.517 1.159 . . . . 0.0 111.277 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -140.87 136.16 32.06 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.499 -0.751 . . . . 0.0 110.904 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -62.43 170.46 2.39 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.973 1.309 . . . . 0.0 109.295 170.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 m -133.67 149.71 51.55 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.419 ' H ' HD12 ' A' ' 145' ' ' LEU . . . 61.87 -136.44 46.37 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.09 157.71 45.79 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 171.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.98 135.76 57.47 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.959 0.904 . . . . 0.0 110.183 -177.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.4 tp -94.08 148.7 21.92 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -123.55 144.41 49.59 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 57.0 mt -136.95 108.82 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -68.03 143.2 55.64 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 169.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.24 9.25 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.024 0.93 . . . . 0.0 112.54 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp -61.19 -39.65 90.98 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 121.473 -0.767 . . . . 0.0 111.318 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -149.13 35.78 0.75 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.557 1.143 . . . . 0.0 109.688 -175.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -153.77 151.76 29.95 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.785 1.634 . . . . 0.0 107.581 -172.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -154.5 42.19 0.49 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.402 1.081 . . . . 0.0 110.298 -172.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.0 pt 39.25 49.88 2.56 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 126.895 2.078 . . . . 0.0 115.22 -175.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -61.86 136.1 59.7 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.783 1.656 . . . . 0.0 109.342 174.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 59.4 18.82 7.14 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.375 1.47 . . . . 0.0 112.76 -173.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.6 t0 38.21 67.6 2.07 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 127.891 2.476 . . . . 0.0 114.771 173.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.92 -18.1 56.83 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.93 2.42 . . . . 0.0 112.939 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.25 -20.72 60.15 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.429 0.692 . . . . 0.0 111.958 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -54.76 -35.34 63.67 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.011 0.924 . . . . 0.0 111.515 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -65.21 -43.45 91.51 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.679 -0.638 . . . . 0.0 110.188 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -74.28 -35.42 63.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.763 0.825 . . . . 0.0 110.344 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.4 tp -61.94 -36.24 80.81 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.973 0.909 . . . . 0.0 110.742 173.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.76 -47.74 58.01 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.471 1.034 . . . . 0.0 111.102 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 m -61.82 -42.23 98.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.665 0.732 . . . . 0.0 110.778 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -60.44 -49.92 75.65 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.511 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.7 m -65.36 -34.79 72.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 119.866 1.212 . . . . 0.0 110.867 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.79 -22.4 66.98 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.426 0.69 . . . . 0.0 111.679 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.419 HD12 ' H ' ' A' ' 118' ' ' GLY . 7.2 mt -90.67 -57.98 2.64 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.599 1.09 . . . . 0.0 110.141 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.08 -25.79 65.51 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 117.567 -1.206 . . . . 0.0 113.815 -169.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm . . . . . 0 C--O 1.251 1.181 0 C-N-CA 128.046 2.538 . . . . 0.0 113.27 175.249 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.88 152.73 42.24 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.979 -0.451 . . . . 0.0 110.37 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -133.38 -25.58 1.72 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.818 1.247 . . . . 0.0 111.028 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.0 mt -121.37 74.92 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 170.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.1 m -75.35 120.98 21.55 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.8 mt -94.85 151.06 19.55 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 80.3 mt -125.76 84.13 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -169.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.9 m -74.94 151.23 38.89 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.656 0.782 . . . . 0.0 110.35 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.81 118.16 0.8 Allowed Glycine 0 C--N 1.333 0.394 0 N-CA-C 107.576 -2.209 . . . . 0.0 107.576 170.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.3 t -148.54 149.11 31.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.006 0.908 . . . . 0.0 111.641 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 p -73.54 -30.23 62.94 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.036 1.735 . . . . 0.0 110.938 169.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 pp -122.95 -25.74 4.53 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -169.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.91 1.92 10.45 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.238 1.399 . . . . 0.0 112.917 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.34 -40.77 99.09 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 118.867 1.333 . . . . 0.0 111.039 -172.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.6 -22.96 64.42 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 117.315 0.557 . . . . 0.0 111.571 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -75.31 -43.8 48.9 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -68.7 -41.8 78.65 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 122.862 0.465 . . . . 0.0 109.748 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.24 -48.84 85.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.244 0.618 . . . . 0.0 109.433 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.17 89.48 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 118.902 0.773 . . . . 0.0 110.667 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.0 -43.0 93.97 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.455 1.025 . . . . 0.0 111.119 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -61.86 -45.11 95.18 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.834 -0.541 . . . . 0.0 110.481 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.5 mt -65.45 -42.21 92.61 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.256 0.622 . . . . 0.0 110.153 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.1 83.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.023 0.929 . . . . 0.0 110.966 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -58.68 -46.8 86.43 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.882 0.765 . . . . 0.0 110.496 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -68.21 -37.46 80.91 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.567 -0.708 . . . . 0.0 110.835 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.3 mt -61.41 -42.04 98.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.279 0.945 . . . . 0.0 111.369 175.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.7 -38.96 84.35 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.642 0.655 . . . . 0.0 110.327 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -64.55 -36.04 82.92 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.46 0.573 . . . . 0.0 110.904 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.01 -23.71 64.13 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.54 0.736 . . . . 0.0 111.973 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.56 -0.77 12.46 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.968 1.271 . . . . 0.0 113.764 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -77.05 174.7 10.35 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.635 1.217 . . . . 0.0 110.61 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.8 p -120.88 140.0 52.41 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 p -136.49 168.98 18.45 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.254 1.022 . . . . 0.0 110.229 -169.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -153.13 155.59 37.03 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 169.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.0 p -119.55 71.55 0.88 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -172.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.3 mt -76.07 118.9 19.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -171.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -91.89 95.48 9.85 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.97 49.47 6.38 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.016 -1.436 . . . . 0.0 115.22 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -68.43 176.27 5.92 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 CA-C-N 120.686 2.243 . . . . 0.0 110.989 169.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.5 mt -130.8 168.4 17.3 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.381 1.472 . . . . 0.0 110.027 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.5 tp -56.06 -27.36 53.1 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.906 1.683 . . . . 0.0 111.881 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -64.18 -12.37 39.62 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.547 1.139 . . . . 0.0 112.593 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -137.09 20.52 3.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.933 1.293 . . . . 0.0 111.377 -173.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.2 mt -135.03 102.81 10.88 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.648 1.179 . . . . 0.0 108.319 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -73.32 169.85 21.3 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.932 2.422 . . . . 0.0 112.21 -176.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.48 8.98 2.42 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.807 1.643 . . . . 0.0 114.767 -171.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -153.15 141.18 20.31 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.929 0.786 . . . . 0.0 109.27 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.14 -178.66 24.63 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -123.3 99.5 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -94.69 176.22 6.36 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.464 0.706 . . . . 0.0 110.155 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.9 tp -140.98 98.67 3.43 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -79.64 129.0 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 mt -127.54 146.21 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.9 m -145.48 141.92 28.77 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.718 -0.614 . . . . 0.0 110.016 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.7 m -91.08 95.11 9.92 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.2 m -70.6 83.2 0.61 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 171.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -79.12 44.23 0.56 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.123 1.769 . . . . 0.0 111.442 -174.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.2 -30.05 2.15 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.33 1.443 . . . . 0.0 114.278 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.61 -21.75 64.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.395 1.078 . . . . 0.0 113.678 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.86 20.37 77.98 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -170.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -130.77 155.46 46.62 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.734 1.614 . . . . 0.0 107.083 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.37 150.07 39.43 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.227 1.411 . . . . 0.0 107.965 -169.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -53.6 139.25 66.99 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.276 2.651 . . . . 0.0 112.321 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -58.35 -23.12 55.84 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.976 1.311 . . . . 0.0 113.71 -171.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -75.21 -21.48 58.63 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.563 -0.732 . . . . 0.0 112.502 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.6 tp -126.84 -23.89 3.6 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.007 0.923 . . . . 0.0 111.902 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 91.9 p -53.72 -29.65 5.02 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-O 117.038 -1.458 . . . . 0.0 114.138 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.34 -23.34 18.2 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.639 2.226 . . . . 0.0 114.958 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -64.52 -39.96 94.74 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 120.104 1.32 . . . . 0.0 110.815 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -60.72 -41.87 96.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.105 0.562 . . . . 0.0 110.085 175.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -66.23 -47.89 72.34 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.076 0.55 . . . . 0.0 110.299 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.85 -41.28 95.83 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 121.794 -0.566 . . . . 0.0 111.362 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.7 mt -62.72 -50.82 69.61 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.888 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -70.3 -29.19 65.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.023 0.829 . . . . 0.0 111.642 -176.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.09 -50.46 47.97 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.768 0.713 . . . . 0.0 109.866 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -84.19 -23.01 30.73 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.349 -173.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.5 tttt 38.45 61.43 4.74 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 126.085 1.754 . . . . 0.0 110.806 -169.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -66.5 169.27 14.5 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.109 2.539 . . . . 0.0 111.363 -174.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -96.69 104.21 16.18 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 169.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.0 mt -118.83 26.6 9.43 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 126.414 1.886 . . . . 0.0 109.818 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.8 m -60.1 15.62 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.815 2.046 . . . . 0.0 116.048 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.85 6.09 1.58 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.039 1.336 . . . . 0.0 111.762 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.1 t -77.58 140.31 17.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -122.67 157.2 32.76 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 168.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -154.16 176.28 12.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.739 0.699 . . . . 0.0 111.77 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.55 162.76 22.17 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 105.593 -3.003 . . . . 0.0 105.593 169.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.68 126.63 19.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -169.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.7 mt -136.04 126.2 41.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -174.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -100.69 152.25 19.08 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.6 mt -134.8 137.98 50.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 175.99 -152.05 12.47 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.6 m -128.19 127.19 42.46 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.381 1.073 . . . . 0.0 109.095 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -67.58 -6.57 20.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.631 0.772 . . . . 0.0 112.09 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.35 -33.12 63.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.094 1.358 . . . . 0.0 111.592 172.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -116.36 155.96 27.56 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.448 1.099 . . . . 0.0 110.805 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.64 -34.46 77.88 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.638 0.775 . . . . 0.0 111.661 -174.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.06 38.07 0.1 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.472 1.909 . . . . 0.0 111.011 175.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -49.06 -49.35 41.85 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.721 1.608 . . . . 0.0 111.2 -172.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 67.0 m -152.29 135.25 15.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.55 -27.9 0.09 OUTLIER Glycine 0 CA--C 1.522 0.487 0 CA-C-O 118.946 -0.919 . . . . 0.0 114.595 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.19 -18.38 65.31 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.491 1.645 . . . . 0.0 112.099 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.33 -34.2 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.781 1.232 . . . . 0.0 109.579 170.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.21 -32.42 68.28 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 123.777 0.831 . . . . 0.0 111.989 -175.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -62.01 -45.41 93.71 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.512 0.596 . . . . 0.0 110.473 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.29 -53.15 61.11 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -72.22 -31.89 66.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.64 -170.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.16 -44.2 92.12 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.99 0.814 . . . . 0.0 109.858 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -74.64 -28.11 60.72 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.199 -0.905 . . . . 0.0 112.281 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.6 -45.01 92.32 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.493 1.497 . . . . 0.0 109.374 169.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -66.27 -39.77 89.66 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 122.182 -0.324 . . . . 0.0 110.473 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -61.05 -40.17 92.62 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.056 0.542 . . . . 0.0 110.511 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.5 m -69.57 -14.27 62.76 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.946 0.898 . . . . 0.0 112.878 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.58 -13.04 6.94 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.048 1.309 . . . . 0.0 113.872 169.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.87 172.6 2.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.579 1.19 . . . . 0.0 111.858 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -145.54 144.1 30.33 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.389 -0.819 . . . . 0.0 111.558 169.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 38.2 tp60 -58.26 154.44 13.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.893 1.677 . . . . 0.0 109.491 172.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.4 m -139.42 134.01 31.8 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.02 176.34 37.71 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -172.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -76.26 164.27 26.22 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.022 -0.693 . . . . 0.0 109.488 172.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.2 164.12 23.38 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 169.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.0 tp -129.84 147.61 51.63 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.246 -0.909 . . . . 0.0 109.704 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.97 142.13 47.69 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 176.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 43.3 mt -138.79 110.87 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -82.88 131.2 35.2 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 123.247 0.619 . . . . 0.0 109.696 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -127.75 14.45 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 125.028 1.331 . . . . 0.0 111.852 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 68.0 tp -53.41 -46.42 69.74 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.387 1.075 . . . . 0.0 111.449 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -165.7 -52.71 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 125.828 1.651 . . . . 0.0 107.673 176.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.44 101.96 4.3 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -71.97 71.3 0.8 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.345 1.858 . . . . 0.0 109.941 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.293 17.8 tt 24.11 74.12 0.29 Allowed Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 129.395 3.078 . . . . 0.0 114.156 -173.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.79 -21.79 16.05 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.381 3.387 . . . . 0.0 116.111 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.56 -22.45 65.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.186 0.994 . . . . 0.0 111.826 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.8 t0 41.72 58.17 9.64 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 127.436 2.294 . . . . 0.0 113.315 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.09 -13.26 36.03 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.948 2.432 . . . . 0.0 113.287 -174.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.22 -34.56 64.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.884 0.874 . . . . 0.0 112.135 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -60.31 -49.14 78.78 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.428 0.691 . . . . 0.0 110.922 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -79.85 -36.63 36.46 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.787 0.835 . . . . 0.0 110.121 -174.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 86.2 t90 -58.98 -48.45 81.52 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 28.7 tp -67.51 -39.74 85.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 119.057 -0.497 . . . . 0.0 110.6 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.9 -44.73 92.34 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -65.43 -40.54 93.43 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.133 0.573 . . . . 0.0 110.629 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -63.96 -49.78 71.21 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.797 -0.621 . . . . 0.0 110.231 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.06 -34.6 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 119.297 0.953 . . . . 0.0 110.895 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -61.63 -31.62 71.73 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-O 118.848 -0.596 . . . . 0.0 111.8 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.3 mt -86.27 -46.68 10.11 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.219 0.918 . . . . 0.0 111.296 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.05 -24.35 61.52 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.945 0.793 . . . . 0.0 112.404 -172.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.9 mttp . . . . . 0 C--O 1.247 0.926 0 C-N-CA 127.572 2.349 . . . . 0.0 111.652 -179.115 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.41 159.57 29.2 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.931 0.493 . . . . 0.0 110.584 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -135.98 -25.11 1.25 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.418 1.087 . . . . 0.0 111.453 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.0 mt -130.27 82.74 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 169.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.6 m -75.95 116.9 17.11 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.85 151.88 40.38 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.3 mt -122.31 100.08 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 m -93.73 123.73 37.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.176 0.99 . . . . 0.0 110.121 -172.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.68 60.28 0.62 Allowed Glycine 0 C--N 1.331 0.254 0 N-CA-C 105.972 -2.851 . . . . 0.0 105.972 170.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.1 m -115.09 134.7 54.94 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.576 1.15 . . . . 0.0 111.589 -167.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.5 p -139.06 -31.06 0.72 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.272 1.429 . . . . 0.0 111.786 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.69 -4.73 13.01 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.218 1.407 . . . . 0.0 113.708 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.52 -48.01 3.75 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.387 0.994 . . . . 0.0 110.877 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.19 -44.93 96.07 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 118.168 0.984 . . . . 0.0 110.807 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.88 -28.17 68.76 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 117.433 0.617 . . . . 0.0 111.174 177.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.39 -39.96 58.51 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -65.31 -40.06 93.29 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.3 t -57.32 -51.29 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.134 0.974 . . . . 0.0 109.639 173.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.54 -43.56 98.64 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.961 0.801 . . . . 0.0 111.088 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.73 -45.51 86.17 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.914 0.486 . . . . 0.0 110.735 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -59.8 -48.27 82.36 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.297 1.039 . . . . 0.0 110.221 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.1 mt -59.88 -46.05 90.54 Favored 'General case' 0 N--CA 1.458 -0.054 0 C-N-CA 123.369 0.667 . . . . 0.0 110.242 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.87 -50.64 73.23 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.293 0.497 . . . . 0.0 110.339 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -58.87 -47.63 84.25 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.129 0.571 . . . . 0.0 110.483 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -66.01 -38.32 88.18 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.132 -177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.6 mt -65.78 -39.93 91.46 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 119.63 1.105 . . . . 0.0 110.791 175.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.96 -40.1 95.65 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.916 0.78 . . . . 0.0 110.128 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -65.66 -37.73 87.36 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.406 0.548 . . . . 0.0 111.156 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.92 -22.4 64.16 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.708 0.803 . . . . 0.0 112.136 176.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.14 25.72 3.46 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.636 -1.091 . . . . 0.0 113.821 170.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -127.72 127.73 44.16 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.152 1.476 . . . . 0.0 108.451 -177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 p -72.68 149.83 43.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 109.835 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.8 p -133.72 170.21 15.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.688 0.756 . . . . 0.0 110.356 -172.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -151.66 162.17 41.45 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 169.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.5 83.04 2.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -177.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.2 mt -71.19 109.99 5.57 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -78.77 108.86 12.51 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.67 50.77 60.98 Favored Glycine 0 CA--C 1.54 1.612 0 CA-C-O 118.159 -1.356 . . . . 0.0 115.367 171.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -67.86 175.57 6.22 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.706 2.271 . . . . 0.0 111.183 173.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.9 mt -123.43 157.01 34.4 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.192 1.397 . . . . 0.0 108.219 170.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.81 -30.47 71.56 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.797 0.839 . . . . 0.0 111.768 -174.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.49 -8.51 14.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.783 0.833 . . . . 0.0 112.897 176.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -118.13 18.28 13.86 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.543 1.537 . . . . 0.0 110.832 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.4 mt -127.06 142.11 42.71 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.751 1.22 . . . . 0.0 109.205 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.05 162.47 41.71 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.539 2.159 . . . . 0.0 109.823 169.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.7 21.33 0.67 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.383 1.073 . . . . 0.0 112.557 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.6 p -156.79 149.76 23.87 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.787 1.235 . . . . 0.0 109.043 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.31 179.28 22.37 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.5 mt -117.62 103.32 14.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -104.82 170.81 7.66 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.043 0.937 . . . . 0.0 109.58 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.4 tp -148.58 106.52 3.71 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.8 t -87.88 137.07 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -173.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.04 126.67 56.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.3 m -135.08 120.37 18.99 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.781 0.432 . . . . 0.0 110.401 -172.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 m -71.94 -172.81 0.91 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 168.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -127.84 141.4 51.57 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -77.16 11.87 1.68 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.608 1.563 . . . . 0.0 111.889 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.05 23.34 76.1 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 120.934 -1.104 . . . . 0.0 111.378 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.2 8.54 2.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.206 1.402 . . . . 0.0 112.151 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.421 ' H ' HG23 ' A' ' 97' ' ' THR . . . 73.59 34.58 56.73 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 119.25 0.932 . . . . 0.0 111.114 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -145.92 152.73 39.9 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.774 1.63 . . . . 0.0 107.802 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 62' ' ' ILE . 4.2 mp -65.9 148.05 98.48 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -52.97 149.67 25.85 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.686 2.924 . . . . 0.0 113.298 169.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -57.21 -16.63 8.6 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.864 1.666 . . . . 0.0 113.663 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -61.99 -39.15 91.2 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.731 0.812 . . . . 0.0 110.8 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.2 tp -126.28 -22.27 4.07 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.5 0.72 . . . . 0.0 112.301 -171.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.9 p -54.37 -31.1 7.92 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-O 117.03 -1.462 . . . . 0.0 114.819 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -52.25 -22.71 16.15 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.147 2.565 . . . . 0.0 115.188 169.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -56.26 -35.64 67.67 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.029 0.932 . . . . 0.0 111.066 175.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -64.06 -40.59 96.6 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 122.991 0.517 . . . . 0.0 110.878 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.75 -46.44 58.46 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.02 -29.41 70.32 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.141 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.67 -63.74 1.09 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 170.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -67.85 -22.61 65.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.682 0.674 . . . . 0.0 112.624 -170.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -70.98 -32.95 69.94 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.602 0.761 . . . . 0.0 111.502 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -114.43 -33.98 5.41 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp 28.05 64.72 0.65 Allowed Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 127.83 2.452 . . . . 0.0 113.086 -169.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -60.57 173.38 2.14 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.695 2.263 . . . . 0.0 111.954 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -75.84 62.59 1.57 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.174 1.39 . . . . 0.0 110.561 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 70.8 mt -73.27 8.33 1.76 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.358 1.463 . . . . 0.0 112.786 -177.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.9 m -45.76 10.31 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.751 1 C-N-CA 132.055 4.142 . . . . 0.0 117.649 170.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.36 3.03 1.71 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.2 1.4 . . . . 0.0 112.172 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.2 t -78.71 137.3 22.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 169.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -119.19 141.5 48.82 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 168.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -148.86 172.46 14.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.111 0.414 . . . . 0.0 111.094 -174.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.67 163.53 24.11 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 105.761 -2.936 . . . . 0.0 105.761 169.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.19 130.37 19.65 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.306 1.053 . . . . 0.0 109.662 -169.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 23.1 mt -134.1 130.92 55.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -118.14 139.65 14.84 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.2 mp -131.44 118.37 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 176.7 -158.37 24.37 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 105.906 -2.878 . . . . 0.0 105.906 -172.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.6 m -96.82 170.14 9.37 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.187 0.995 . . . . 0.0 110.765 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -119.7 -19.76 7.92 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.203 1.001 . . . . 0.0 109.866 169.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -111.57 5.98 19.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.934 2.494 . . . . 0.0 111.089 -169.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -141.58 165.04 28.59 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.186 1.794 . . . . 0.0 109.04 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -59.28 -35.35 73.58 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.827 1.651 . . . . 0.0 113.503 -169.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 60' ' ' GLY . 53.2 m -74.73 76.55 2.07 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.881 0.848 . . . . 0.0 109.2 170.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -61.61 134.81 57.25 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 173.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 3.5 p -55.81 -21.55 20.05 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.575 1.55 . . . . 0.0 112.976 174.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.51 3.81 3.31 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.07 -1.406 . . . . 0.0 115.087 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.09 -22.85 6.67 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 120.323 2.062 . . . . 0.0 113.867 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.9 tp -54.26 -31.41 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.599 1.56 . . . . 0.0 110.969 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -50.91 -35.28 32.26 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.732 1.213 . . . . 0.0 112.962 -170.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -54.27 -51.47 64.47 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.46 0.573 . . . . 0.0 111.353 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.3 mt -68.7 -50.89 47.26 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -172.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -67.58 -35.74 79.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.901 -173.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.84 -41.66 78.22 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.38 -24.97 62.17 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 117.509 -1.234 . . . . 0.0 112.424 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.6 mt -65.86 -52.38 50.82 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.978 1.717 . . . . 0.0 108.951 169.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -68.21 -33.89 75.25 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 122.076 -0.39 . . . . 0.0 110.883 -173.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -76.13 6.55 5.2 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.875 1.27 . . . . 0.0 112.644 172.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.4 m -120.59 15.41 11.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.299 1.44 . . . . 0.0 110.328 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.75 -22.96 27.11 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.623 1.106 . . . . 0.0 113.557 169.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.83 167.92 1.41 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.587 1.194 . . . . 0.0 110.66 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -137.17 136.48 38.25 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 121.461 -0.775 . . . . 0.0 111.351 171.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -60.29 164.58 4.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.056 -1.429 . . . . 0.0 109.525 171.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 m -136.49 157.84 45.85 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 126.371 1.868 . . . . 0.0 106.036 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.434 ' H ' HD12 ' A' ' 145' ' ' LEU . . . 55.7 -128.74 45.65 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 -173.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -144.62 165.81 26.97 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.706 1.203 . . . . 0.0 107.956 169.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.75 154.42 29.71 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.041 0.937 . . . . 0.0 110.438 -178.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 57.0 tp -129.67 143.54 50.87 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.858 0.863 . . . . 0.0 109.576 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -118.15 143.09 46.77 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.4 mt -132.31 100.38 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -69.62 142.01 53.58 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.486 0.714 . . . . 0.0 111.161 -171.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 8.4 pt -105.79 -21.04 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.178 0.991 . . . . 0.0 111.858 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.03 -35.95 81.02 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.559 0.744 . . . . 0.0 109.801 -172.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -146.66 151.89 37.98 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.429 1.491 . . . . 0.0 109.082 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 64.78 -36.89 0.21 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 129.678 3.191 . . . . 0.0 115.568 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.9 t70 64.98 -44.08 0.33 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 129.068 2.947 . . . . 0.0 115.088 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.264 11.7 tt 25.13 64.46 0.45 Allowed Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 130.098 3.359 . . . . 0.0 115.558 169.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -79.42 15.5 1.57 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 123.488 2.792 . . . . 0.0 114.407 -169.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -136.49 -58.36 0.74 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.126 1.33 . . . . 0.0 112.301 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.63 -48.6 92.87 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -169.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.04 -39.12 83.22 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 121.864 1.709 . . . . 0.0 112.013 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.93 -39.77 90.8 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.885 -0.579 . . . . 0.0 110.348 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -65.23 -44.14 89.17 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.039 0.836 . . . . 0.0 110.304 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -62.84 -47.55 82.91 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.126 -0.359 . . . . 0.0 110.266 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -68.69 -33.75 74.5 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.536 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.9 tt -58.74 -40.97 85.37 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.193 0.906 . . . . 0.0 110.184 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.6 -48.25 66.42 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 173.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.4 m -63.96 -41.19 97.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.401 0.601 . . . . 0.0 111.11 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -62.57 -52.51 63.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 117.739 -1.124 . . . . 0.0 110.492 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.7 m -64.71 -34.03 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 120.258 1.39 . . . . 0.0 110.685 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -59.49 -32.77 70.57 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.061 0.846 . . . . 0.0 112.118 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.434 HD12 ' H ' ' A' ' 118' ' ' GLY . 25.9 mt -94.75 -35.85 11.95 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.512 -0.756 . . . . 0.0 112.55 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.7 pp -90.99 -17.3 26.54 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 117.36 -1.305 . . . . 0.0 113.459 -173.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt . . . . . 0 C--O 1.251 1.167 0 CA-C-N 119.572 1.078 . . . . 0.0 112.104 -172.529 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.49 157.17 43.71 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.999 1.32 . . . . 0.0 108.069 171.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -140.98 -25.17 0.74 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.435 1.094 . . . . 0.0 111.482 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.7 mt -132.89 83.65 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 173.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.6 m -78.38 116.02 18.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.72 154.25 36.54 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.632 0.773 . . . . 0.0 109.598 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.3 mt -126.49 97.87 4.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.7 m -78.75 156.98 28.6 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.761 0.824 . . . . 0.0 110.097 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.68 89.83 0.09 OUTLIER Glycine 0 C--N 1.333 0.411 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.7 p -153.89 128.15 9.1 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 117.462 0.631 . . . . 0.0 110.584 172.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.25 -32.06 72.84 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 168.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.5 mt -69.55 -14.15 62.7 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.309 1.444 . . . . 0.0 112.915 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.65 14.9 75.38 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-N 118.989 0.813 . . . . 0.0 113.537 -175.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.7 -38.48 8.1 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 118.657 1.229 . . . . 0.0 111.497 -175.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.46 90.3 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.213 1.006 . . . . 0.0 110.229 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.46 -32.44 64.35 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.095 0.407 . . . . 0.0 111.912 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -65.01 -44.9 87.71 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.9 t -60.69 -46.43 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.1 -39.84 79.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.568 0.622 . . . . 0.0 111.344 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.17 -42.8 99.21 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.62 0.645 . . . . 0.0 110.837 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -71.64 -41.96 68.18 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.903 -0.498 . . . . 0.0 110.972 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.86 -44.44 97.02 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.07 -44.31 96.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.432 0.693 . . . . 0.0 110.469 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -58.0 -44.56 87.29 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.458 0.572 . . . . 0.0 110.388 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -62.73 -40.86 98.51 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.762 -0.587 . . . . 0.0 111.285 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 66.3 mt -63.9 -41.34 97.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.943 0.792 . . . . 0.0 111.142 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.24 -40.12 90.02 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.576 0.625 . . . . 0.0 110.378 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.88 -36.0 82.93 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.048 0.539 . . . . 0.0 110.805 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.62 -21.63 63.55 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.379 0.671 . . . . 0.0 112.248 174.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.52 -0.64 14.04 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.844 1.211 . . . . 0.0 113.825 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -79.2 178.94 7.69 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.424 1.112 . . . . 0.0 110.023 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.9 p -124.84 150.31 46.55 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.7 p -137.48 170.26 16.38 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.635 0.774 . . . . 0.0 109.729 -169.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -152.19 161.86 41.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 169.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.39 102.27 6.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.2 mt -80.08 153.57 28.67 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -128.76 102.47 6.57 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.42 52.83 49.33 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.487 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -66.39 174.45 6.2 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.028 2.485 . . . . 0.0 111.588 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.9 mt -129.26 163.47 25.59 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 125.249 1.42 . . . . 0.0 109.191 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.89 -30.4 58.04 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.75 1.22 . . . . 0.0 110.888 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -64.09 -11.18 27.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.314 1.446 . . . . 0.0 112.661 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -136.59 16.88 3.12 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.383 1.073 . . . . 0.0 110.907 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -135.62 101.03 10.95 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.124 1.37 . . . . 0.0 107.866 -169.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.32 164.59 34.8 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.737 2.292 . . . . 0.0 112.139 -171.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.58 7.29 1.94 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.574 1.55 . . . . 0.0 114.575 -173.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.9 m -149.61 139.33 21.75 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.8 178.08 27.06 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.5 mt -119.67 101.75 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 -176.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -114.76 167.69 10.55 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.205 1.002 . . . . 0.0 110.247 -171.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.4 tp -147.7 100.56 3.24 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 175.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.5 t -83.96 141.4 14.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.593 1.157 . . . . 0.0 109.685 -172.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.57 126.54 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.2 m -142.08 130.8 22.77 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.427 0.691 . . . . 0.0 110.656 -169.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.8 m -67.56 168.83 10.3 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.632 0.73 . . . . 0.0 111.358 169.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 97' ' ' THR . 87.2 m -141.27 135.03 30.24 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 129.02 2.928 . . . . 0.0 104.143 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -129.72 146.13 51.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 172.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 36.62 -97.27 0.01 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 127.088 2.28 . . . . 0.0 114.586 176.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.87 9.63 26.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.342 1.457 . . . . 0.0 113.455 -169.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.71 25.46 7.63 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 120.115 1.325 . . . . 0.0 110.837 -175.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.08 110.52 5.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.97 149.84 85.54 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.79 144.82 49.58 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.702 2.268 . . . . 0.0 110.02 -169.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -56.8 -21.01 25.62 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.036 1.334 . . . . 0.0 113.793 -175.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -69.02 -31.62 70.56 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.843 -0.535 . . . . 0.0 111.823 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.5 tp -123.83 -25.31 4.29 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.641 0.777 . . . . 0.0 112.323 -169.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 78.8 p -54.47 -30.82 7.42 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 117.027 -1.464 . . . . 0.0 114.542 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -52.68 -26.11 28.67 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.612 2.208 . . . . 0.0 114.814 169.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -62.21 -40.76 97.19 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.508 1.049 . . . . 0.0 110.238 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -63.74 -37.6 87.95 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.91 0.777 . . . . 0.0 110.354 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -68.65 -44.66 73.65 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.747 0.419 . . . . 0.0 110.377 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.85 -41.67 95.51 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.676 -0.64 . . . . 0.0 110.935 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.2 mt -61.33 -49.35 77.34 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 118.56 -0.734 . . . . 0.0 110.352 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -71.74 -28.55 63.74 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.259 0.936 . . . . 0.0 111.434 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.4 -43.54 77.01 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.562 0.619 . . . . 0.0 110.58 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -99.32 -35.0 10.09 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -169.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.0 ttpp 30.04 57.28 0.81 Allowed Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 127.39 2.276 . . . . 0.0 113.412 -169.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.31 174.76 10.31 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.263 1.975 . . . . 0.0 110.374 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 81' ' ' SER . 13.4 p-10 -76.9 69.64 3.24 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.519 1.528 . . . . 0.0 111.024 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.2 mt -74.13 19.08 0.13 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.843 1.657 . . . . 0.0 112.158 173.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 79' ' ' ASP . 3.1 m -53.18 12.2 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.713 1 C-N-CA 131.786 4.034 . . . . 0.0 116.639 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.14 4.37 0.94 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.176 1.391 . . . . 0.0 112.232 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 79.2 t -74.1 131.36 35.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 169.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 121.14 39.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 169.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -130.44 168.95 16.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.086 0.469 . . . . 0.0 110.56 -173.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -127.62 162.76 21.51 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 104.758 -3.337 . . . . 0.0 104.758 169.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.2 137.63 24.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.139 0.97 . . . . 0.0 110.072 -169.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.5 mt -134.72 127.67 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -175.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.43 146.23 16.42 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 171.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.1 mt -137.11 147.1 27.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.66 166.38 29.47 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 176.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.4 m -81.64 111.18 17.68 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 170.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -64.63 -2.29 2.34 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 -169.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -63.64 -41.83 98.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.771 0.829 . . . . 0.0 110.877 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -75.37 155.24 36.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.963 0.801 . . . . 0.0 110.8 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -55.65 -33.83 64.43 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.835 1.254 . . . . 0.0 114.16 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.402 ' O ' HG21 ' A' ' 56' ' ' THR . 0.3 OUTLIER -95.89 11.66 33.02 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.701 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.7 p90 22.44 -83.29 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 130.373 3.469 . . . . 0.0 114.885 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 60.6 m -140.37 38.06 1.89 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.517 1.927 . . . . 0.0 108.88 -173.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.68 -6.19 30.9 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 118.246 -1.308 . . . . 0.0 115.652 -169.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.06 -19.05 65.8 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.754 2.277 . . . . 0.0 113.236 -176.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.5 tp -54.87 -27.54 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.078 1.351 . . . . 0.0 110.51 171.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -52.19 -35.37 48.88 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.451 1.1 . . . . 0.0 112.817 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -66.89 -54.27 23.83 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 121.831 -0.543 . . . . 0.0 109.938 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.0 mt -61.56 -48.67 79.93 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.8 0.84 . . . . 0.0 109.456 -175.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.13 -37.87 86.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -173.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.22 -40.43 77.98 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -172.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -71.16 -31.06 67.22 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.584 -0.722 . . . . 0.0 111.504 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.9 mt -62.43 -48.15 80.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.911 1.232 . . . . 0.0 109.57 169.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -64.31 -38.83 92.43 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -65.92 -35.3 80.25 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.055 0.542 . . . . 0.0 111.339 175.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.1 m -71.73 -3.31 21.19 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.337 1.055 . . . . 0.0 112.846 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.72 -12.15 27.59 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.759 1.171 . . . . 0.0 113.201 170.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.59 171.89 1.82 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.441 1.121 . . . . 0.0 110.759 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -139.7 144.69 37.67 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.756 0.789 . . . . 0.0 110.591 169.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -78.75 171.05 15.72 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.167 171.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.46 153.03 41.05 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.916 1.287 . . . . 0.0 107.811 169.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.46 -130.73 37.76 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 172.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -136.91 162.26 33.76 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.3 1.44 . . . . 0.0 107.181 171.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.3 m -69.35 132.42 46.38 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.193 0.597 . . . . 0.0 109.476 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.4 tp -81.1 153.29 27.4 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -125.87 144.14 50.78 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 169.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 40.4 mt -132.63 101.74 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -67.58 138.37 56.39 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 171.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 18.5 pt -128.02 15.98 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 125.313 1.445 . . . . 0.0 111.73 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.05 -42.77 69.61 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.413 1.085 . . . . 0.0 111.631 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -147.13 -54.75 0.23 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.85 0.46 . . . . 0.0 111.255 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -70.64 148.86 47.62 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 171.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -71.27 -29.69 65.38 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.404 0.682 . . . . 0.0 112.269 -176.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 31.4 pt -143.48 155.41 60.66 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 127.055 2.142 . . . . 0.0 107.298 174.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -67.4 174.51 7.14 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.514 2.143 . . . . 0.0 111.273 174.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.85 11.98 0.12 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.203 1.801 . . . . 0.0 114.172 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -138.96 110.37 7.85 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 126.159 1.783 . . . . 0.0 107.039 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -71.73 157.95 54.33 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.597 2.198 . . . . 0.0 111.707 -171.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.95 -21.03 66.4 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -56.69 -40.55 75.79 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.074 0.95 . . . . 0.0 112.469 -169.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -73.74 -30.82 63.03 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.785 0.721 . . . . 0.0 111.075 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -73.57 -40.23 64.07 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.518 -0.739 . . . . 0.0 109.723 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.4 tp -61.8 -44.29 97.16 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.907 1.283 . . . . 0.0 109.988 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.06 -44.42 93.0 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.682 1.134 . . . . 0.0 111.126 173.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.1 m -62.7 -40.07 95.99 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 122.313 -0.522 . . . . 0.0 110.67 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -63.04 -48.77 77.3 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 117.968 -1.015 . . . . 0.0 111.786 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 28.1 m -65.74 -33.39 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 119.978 1.263 . . . . 0.0 110.949 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.83 -32.84 74.14 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.687 -0.673 . . . . 0.0 111.854 174.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 mt -80.27 -50.9 9.58 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.004 0.82 . . . . 0.0 111.016 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 pp -79.11 -16.45 56.68 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.901 0.773 . . . . 0.0 113.052 -173.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 60.1 mttm . . . . . 0 C--O 1.25 1.129 0 C-N-CA 127.808 2.443 . . . . 0.0 111.949 176.816 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.39 155.5 25.08 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 122.027 -0.42 . . . . 0.0 110.282 171.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -134.51 -26.84 1.39 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.393 1.077 . . . . 0.0 111.263 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.0 mt -128.9 81.39 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 171.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.7 m -77.46 110.69 12.45 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mp -74.78 155.89 37.13 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.7 mt -127.89 100.63 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 m -70.65 158.1 36.82 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.288 1.435 . . . . 0.0 110.88 177.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.41 59.37 0.23 Allowed Glycine 0 C--N 1.338 0.694 0 O-C-N 121.992 -0.443 . . . . 0.0 112.789 -170.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.4 p -128.4 169.56 14.13 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.17 1.388 . . . . 0.0 107.587 169.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.5 p -72.92 -45.66 56.87 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.779 0.832 . . . . 0.0 111.012 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 pp -144.25 -27.6 0.51 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.314 1.045 . . . . 0.0 113.023 -169.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.78 154.74 15.83 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 107.744 -2.142 . . . . 0.0 107.744 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.69 -85.31 0.26 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 107.404 -2.278 . . . . 0.0 107.404 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.15 -32.11 73.64 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 122.983 0.513 . . . . 0.0 111.066 175.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -66.04 -35.24 80.0 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.611 0.764 . . . . 0.0 110.572 176.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -70.64 -47.49 59.75 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -59.58 -40.95 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.31 -48.29 82.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.871 0.76 . . . . 0.0 110.599 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.96 -43.14 99.61 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.189 0.449 . . . . 0.0 110.765 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -66.8 -42.65 85.62 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.847 -0.533 . . . . 0.0 111.078 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.9 mt -65.68 -41.32 92.57 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.639 -0.663 . . . . 0.0 110.267 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.41 -41.04 93.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 119.005 -0.522 . . . . 0.0 110.761 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -55.9 -48.73 75.13 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.64 0.655 . . . . 0.0 110.128 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.18 -37.68 84.11 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 121.786 -0.571 . . . . 0.0 110.69 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.0 mt -62.68 -39.74 94.92 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.665 0.666 . . . . 0.0 111.426 175.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -66.85 -37.03 83.67 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.872 0.76 . . . . 0.0 110.534 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.84 -37.37 86.04 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.66 0.663 . . . . 0.0 110.877 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.02 -25.89 65.61 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.157 0.583 . . . . 0.0 111.661 173.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.88 -3.11 11.81 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.228 1.394 . . . . 0.0 113.88 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -79.85 143.56 34.23 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.863 1.331 . . . . 0.0 109.601 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 p -82.23 144.54 30.6 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 169.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.3 p -135.96 170.7 15.58 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.654 0.781 . . . . 0.0 110.116 -170.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -153.18 161.84 41.98 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 169.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 p -135.44 75.64 1.57 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -173.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.8 mt -66.29 115.87 6.71 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -171.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -76.88 95.34 4.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 53.26 62.69 5.75 Favored Glycine 0 CA--C 1.541 1.693 0 C-N-CA 123.894 0.759 . . . . 0.0 113.491 173.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -68.89 176.34 6.23 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.826 3.018 . . . . 0.0 111.848 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.4 mt -122.74 162.78 21.39 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.318 1.447 . . . . 0.0 107.603 169.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.7 tt -57.03 -35.93 69.87 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.733 0.813 . . . . 0.0 111.328 -176.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.23 -3.51 5.9 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.902 1.281 . . . . 0.0 113.21 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -130.47 16.54 5.43 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.908 1.283 . . . . 0.0 110.406 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -135.73 105.01 9.85 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.104 1.362 . . . . 0.0 108.826 -169.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.71 153.66 72.78 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.603 2.202 . . . . 0.0 112.388 -174.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.57 17.16 2.8 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.274 1.43 . . . . 0.0 113.347 -170.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.7 m -154.75 131.1 10.43 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 120.825 -1.172 . . . . 0.0 108.196 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.88 -173.92 26.9 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.9 mt -122.28 101.62 10.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -174.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -99.3 170.72 8.46 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.952 0.901 . . . . 0.0 109.844 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.3 tp -148.67 101.25 3.19 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 175.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.0 t -84.81 137.54 20.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 123.853 0.861 . . . . 0.0 108.725 -171.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.8 mt -133.73 115.94 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.1 m -130.47 127.7 39.74 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.216 0.606 . . . . 0.0 109.724 -169.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 m -76.85 165.8 24.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.135 0.493 . . . . 0.0 109.868 171.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 m -136.4 99.03 3.98 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.7 -34.05 77.3 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 157.9 155.64 7.62 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 171.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 46.24 32.44 1.49 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.632 1.973 . . . . 0.0 113.978 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.64 5.3 66.89 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.407 -0.663 . . . . 0.0 113.013 174.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.77 92.4 2.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.336 1.068 . . . . 0.0 110.115 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.0 mt -65.12 142.67 98.66 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 169.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.43 148.22 90.71 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.615 2.21 . . . . 0.0 111.497 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -57.91 -17.95 20.01 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.256 1.822 . . . . 0.0 113.785 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -62.06 -42.62 99.38 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.719 0.807 . . . . 0.0 110.401 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.5 tp -117.61 -26.07 6.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.592 0.757 . . . . 0.0 112.51 -169.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 100.0 p -55.92 -31.68 10.57 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 116.87 -1.538 . . . . 0.0 114.994 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -53.2 -25.09 28.56 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.537 2.158 . . . . 0.0 114.938 171.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -61.1 -38.34 85.95 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.262 0.937 . . . . 0.0 111.094 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -62.08 -40.98 97.68 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.679 0.792 . . . . 0.0 110.239 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.78 -46.82 62.19 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.955 0.502 . . . . 0.0 109.927 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.65 -31.34 72.31 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.765 -0.585 . . . . 0.0 112.124 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.4 mt -64.42 -59.98 3.7 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -68.1 -26.43 65.82 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.771 0.714 . . . . 0.0 112.291 -171.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -66.59 -33.85 76.58 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.299 0.64 . . . . 0.0 110.971 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -111.86 -30.48 7.28 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -169.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt 31.8 57.98 1.18 Allowed Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 126.976 2.111 . . . . 0.0 112.365 -169.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -71.37 170.78 17.55 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.367 2.045 . . . . 0.0 109.886 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -73.75 103.29 4.26 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.836 -0.54 . . . . 0.0 110.262 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.1 mt -114.34 23.13 13.09 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.639 1.576 . . . . 0.0 110.491 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.5 m -62.63 19.82 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.535 1.934 . . . . 0.0 115.696 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.18 2.57 1.5 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.321 1.448 . . . . 0.0 111.917 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.8 t -77.84 137.01 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 169.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -121.36 144.76 48.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 168.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -148.11 169.33 20.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.067 0.394 . . . . 0.0 110.186 -176.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.2 167.16 21.32 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 106.156 -2.778 . . . . 0.0 106.156 169.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.39 132.02 28.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.598 0.699 . . . . 0.0 109.79 -169.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.9 mt -132.29 130.76 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.13 146.57 18.83 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.1 mt -138.42 140.66 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -172.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 172.2 179.03 42.83 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.9 m -77.16 123.73 26.83 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 170.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.41 ' HA ' ' CG ' ' A' ' 98' ' ' PHE . 31.6 ptt-85 -58.94 -22.91 60.81 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -172.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -84.05 -4.42 58.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.439 0.696 . . . . 0.0 112.525 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.8 m-30 -63.51 162.03 13.47 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.453 1.024 . . . . 0.0 110.352 169.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -60.82 -27.45 68.06 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.653 0.781 . . . . 0.0 112.009 173.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.2 p -143.59 137.41 28.34 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 172.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.41 ' CG ' ' HA ' ' A' ' 93' ' ' ARG . 4.0 p90 -133.92 1.06 3.26 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.085 0.857 . . . . 0.0 112.556 173.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 7.0 p -159.8 -37.26 0.06 Allowed 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -54.26 -22.99 24.1 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.455 1.026 . . . . 0.0 113.882 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.16 -28.53 40.82 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.502 1.121 . . . . 0.0 113.161 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -30.31 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.796 0.838 . . . . 0.0 109.57 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -55.56 -31.22 61.97 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.4 1.08 . . . . 0.0 112.421 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -62.52 -49.63 74.58 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.783 0.72 . . . . 0.0 109.962 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.5 mt -64.67 -49.09 72.33 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -71.38 -32.62 68.68 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.907 -175.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.43 -44.58 92.88 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.431 1.014 . . . . 0.0 109.474 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -73.35 -27.56 61.57 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.603 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.0 mt -64.33 -46.36 83.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.479 1.49 . . . . 0.0 109.273 169.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -64.97 -39.95 94.26 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 117.855 0.298 . . . . 0.0 110.392 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -62.37 -37.92 87.59 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.546 0.738 . . . . 0.0 110.723 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.6 m -72.8 -12.35 60.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.244 1.018 . . . . 0.0 112.82 173.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 129.36 -17.7 5.56 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.988 1.28 . . . . 0.0 114.32 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.32 173.27 1.59 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.508 1.154 . . . . 0.0 111.958 -175.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -143.1 142.24 31.46 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.264 -0.898 . . . . 0.0 112.066 169.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -63.16 161.48 13.47 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.526 1.93 . . . . 0.0 109.962 176.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.8 m -143.03 149.28 38.03 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.909 1.684 . . . . 0.0 107.031 -176.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.57 -144.06 44.98 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -136.73 149.99 48.16 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 174.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.6 m -64.08 133.49 53.13 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.904 0.882 . . . . 0.0 110.149 -173.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.5 tp -98.92 152.24 19.98 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.69 138.94 39.9 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 29.0 mt -132.04 104.93 8.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 -170.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -67.57 134.54 51.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.17 172.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 6.3 pt -110.05 -8.61 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.78 0.832 . . . . 0.0 111.889 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.1 tp -79.35 83.71 5.35 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -151.91 -45.83 0.11 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.435 1.494 . . . . 0.0 108.186 170.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -160.28 -56.42 0.06 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 169.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -163.97 -141.54 0.06 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 102.607 -3.109 . . . . 0.0 102.607 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.1 pt -129.44 70.77 81.99 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.641 1.576 . . . . 0.0 108.063 169.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.58 -5.68 17.27 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.083 2.522 . . . . 0.0 112.376 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -143.73 159.19 42.94 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.665 2.386 . . . . 0.0 105.455 174.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -140.04 115.38 7.86 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.133 0.973 . . . . 0.0 110.089 -174.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.36 -4.59 14.36 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.353 2.702 . . . . 0.0 113.758 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.0 -21.25 58.65 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.045 1.293 . . . . 0.0 113.248 -172.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -55.84 -25.64 42.98 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.06 0.846 . . . . 0.0 113.036 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -74.12 -48.22 30.95 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.023 0.829 . . . . 0.0 109.456 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 6.4 t-105 -68.64 -27.54 66.09 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.213 1.005 . . . . 0.0 111.158 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.1 tp -56.07 -33.74 65.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.22 1.008 . . . . 0.0 111.073 171.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.15 -44.36 88.71 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 174.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.9 m -63.03 -43.2 99.36 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.319 0.56 . . . . 0.0 110.206 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -62.46 -49.61 74.74 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 118.112 -0.947 . . . . 0.0 111.832 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.03 -30.17 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 120.378 1.445 . . . . 0.0 111.405 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -70.03 -20.32 63.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.602 0.637 . . . . 0.0 111.213 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.36 -46.81 4.9 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.132 0.973 . . . . 0.0 110.21 -174.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 pp -75.87 -20.61 57.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.302 -0.856 . . . . 0.0 112.255 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.9 mttp . . . . . 0 C--O 1.25 1.117 0 C-N-CA 127.631 2.372 . . . . 0.0 112.119 179.569 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.44 158.75 23.01 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.08 0.855 . . . . 0.0 110.767 175.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -136.42 -26.43 1.11 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.933 1.293 . . . . 0.0 111.226 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.8 mt -125.67 79.49 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 170.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.1 m -74.37 117.65 16.42 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -84.26 154.83 22.76 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.6 mt -126.31 85.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -173.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -71.31 152.24 43.43 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.577 1.151 . . . . 0.0 110.173 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.45 104.26 0.24 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 t -147.45 168.11 22.72 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.837 0.827 . . . . 0.0 111.65 177.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p -139.85 -42.44 0.43 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 127.68 2.392 . . . . 0.0 107.141 170.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.47 -30.61 71.64 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 123.845 0.858 . . . . 0.0 112.101 172.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.96 34.45 3.74 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.486 1.041 . . . . 0.0 112.741 174.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.89 -43.87 2.02 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 118.026 0.913 . . . . 0.0 112.326 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.62 -26.26 66.16 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.707 1.254 . . . . 0.0 111.092 -176.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.38 -37.94 89.22 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.273 0.229 . . . . 0.0 110.863 176.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -76.11 -50.26 15.13 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 175.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.99 -47.21 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.402 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.06 98.23 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.029 0.831 . . . . 0.0 110.593 -177.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.63 -42.35 86.89 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.604 0.638 . . . . 0.0 110.64 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -63.36 -43.16 98.48 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.858 0.463 . . . . 0.0 110.628 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.93 -42.94 89.45 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.696 -0.628 . . . . 0.0 109.522 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.15 -37.18 76.66 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.525 0.73 . . . . 0.0 111.674 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -51.73 -47.08 64.18 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.65 0.659 . . . . 0.0 110.227 175.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.9 mmtt -68.36 -39.28 81.87 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.6 mt -65.65 -40.44 92.49 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.581 0.353 . . . . 0.0 110.258 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.27 -40.29 90.01 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.192 -0.432 . . . . 0.0 110.284 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.14 -36.44 84.27 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.703 0.683 . . . . 0.0 111.174 175.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.8 -22.96 65.15 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.475 0.71 . . . . 0.0 112.024 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.71 -0.1 19.98 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.922 1.249 . . . . 0.0 113.326 171.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -75.12 174.91 8.76 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.449 1.124 . . . . 0.0 109.907 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 p -122.47 145.72 48.04 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.2 p -132.52 166.29 22.41 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.662 0.785 . . . . 0.0 110.667 -169.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -152.49 159.4 43.34 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 169.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 p -127.99 80.19 1.94 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -171.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.3 mt -73.21 110.8 7.78 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -84.78 106.28 16.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.74 52.24 54.19 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 118.496 -1.169 . . . . 0.0 114.275 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.53 179.24 3.17 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.315 2.677 . . . . 0.0 111.029 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.4 mt -130.45 168.08 17.58 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.221 1.408 . . . . 0.0 108.528 172.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.78 -35.98 64.39 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.024 1.33 . . . . 0.0 111.697 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.75 -6.94 6.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.14 0.976 . . . . 0.0 113.444 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -129.45 19.07 5.79 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.661 1.584 . . . . 0.0 111.07 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.6 mt -135.75 112.04 10.56 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.803 1.241 . . . . 0.0 108.656 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.28 161.37 45.97 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.182 1.921 . . . . 0.0 111.223 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.69 13.28 1.71 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.185 1.394 . . . . 0.0 113.816 -172.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.4 m -146.92 130.2 16.59 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.487 1.115 . . . . 0.0 108.121 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.53 -176.63 29.86 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.18 99.29 5.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -100.57 173.99 6.29 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.27 1.028 . . . . 0.0 110.013 -173.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.2 tp -143.31 110.16 5.57 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.15 136.68 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.11 119.42 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 176.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.2 m -120.39 132.72 55.38 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.932 0.893 . . . . 0.0 108.894 -175.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.506 ' H ' ' HG3' ' A' ' 63' ' ' PRO . 15.4 m -87.59 50.94 2.09 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.73 0.812 . . . . 0.0 109.937 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -54.13 99.71 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.518 2.327 . . . . 0.0 110.636 -173.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -61.95 130.15 44.26 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.87 20.14 12.6 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.406 1.003 . . . . 0.0 113.843 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 49.97 34.26 7.82 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.105 1.362 . . . . 0.0 111.743 -169.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.58 -0.58 0.33 Allowed Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.518 -1.157 . . . . 0.0 115.132 -169.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -144.02 118.14 9.49 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 119.637 1.718 . . . . 0.0 108.744 171.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.5 mt -68.37 140.79 92.93 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.506 ' HG3' ' H ' ' A' ' 55' ' ' SER . 56.0 Cg_endo -64.17 139.02 64.38 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.975 1.783 . . . . 0.0 110.683 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.86 -19.72 52.84 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.07 1.348 . . . . 0.0 113.674 -173.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -70.88 -31.6 68.31 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.66 -0.65 . . . . 0.0 111.897 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.7 tp -118.14 -25.08 6.76 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.678 0.791 . . . . 0.0 111.753 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.6 t -44.98 -42.24 15.16 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 117.39 -1.29 . . . . 0.0 114.338 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.06 -25.71 13.26 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.81 3.007 . . . . 0.0 116.176 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -59.72 -35.81 75.28 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.19 0.904 . . . . 0.0 111.288 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -58.31 -40.67 82.67 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.225 0.61 . . . . 0.0 110.585 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -72.22 -47.65 48.89 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.912 0.485 . . . . 0.0 109.942 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.43 -35.92 82.49 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.562 0.619 . . . . 0.0 111.725 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.5 mt -66.02 -52.5 48.68 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.772 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -69.88 -25.56 63.76 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.544 1.066 . . . . 0.0 112.224 -174.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.27 -37.25 83.14 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.502 0.592 . . . . 0.0 110.349 177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -107.25 -28.78 9.71 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -169.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.9 mttm 32.27 57.82 1.29 Allowed Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 127.257 2.223 . . . . 0.0 112.556 -172.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.11 171.09 14.35 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.871 2.38 . . . . 0.0 110.66 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -77.23 110.37 11.87 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.576 -0.703 . . . . 0.0 109.357 170.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.5 mt -118.23 19.77 13.38 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.996 1.718 . . . . 0.0 110.951 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.8 m -58.74 11.21 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.857 2.063 . . . . 0.0 116.39 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.16 2.79 4.74 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.626 1.171 . . . . 0.0 111.445 173.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 80.5 t -81.76 140.21 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 169.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -119.51 146.82 45.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 168.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -140.98 171.65 13.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.918 0.866 . . . . 0.0 111.145 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.01 162.6 25.62 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 104.448 -3.461 . . . . 0.0 104.448 169.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.07 132.71 25.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.6 mt -134.17 137.82 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -110.29 152.88 17.25 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 170.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.3 mt -134.31 122.83 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 175.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.62 -155.98 15.2 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.241 -1.943 . . . . 0.0 108.241 -172.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.0 m -102.88 124.17 47.9 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 24.9 ttp180 -69.21 -14.93 63.24 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -69.34 -13.87 62.61 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.461 -0.774 . . . . 0.0 111.274 169.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 52.7 179.93 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 129.732 3.213 . . . . 0.0 115.547 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -156.33 -41.47 0.08 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.214 2.206 . . . . 0.0 107.527 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 92.4 m -122.15 170.53 9.78 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.753 2.421 . . . . 0.0 105.659 169.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -124.41 53.77 1.41 Allowed 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.327 -0.858 . . . . 0.0 111.338 -169.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 24.2 m 72.35 5.26 5.24 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.72 2.008 . . . . 0.0 114.75 169.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.66 -27.76 55.57 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 118.865 0.757 . . . . 0.0 112.446 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.71 -55.45 15.03 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.058 0.929 . . . . 0.0 111.686 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -33.28 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 119.251 0.932 . . . . 0.0 109.809 -178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -53.32 -29.59 34.58 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 119.005 -0.521 . . . . 0.0 112.341 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.57 -42.0 95.75 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.617 1.099 . . . . 0.0 111.541 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.41 -51.86 64.03 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -70.08 -35.5 74.23 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.921 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.2 -37.13 86.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.104 0.411 . . . . 0.0 110.846 -172.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -68.79 -34.71 76.0 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.383 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 44.2 mt -65.74 -41.63 91.97 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.258 1.39 . . . . 0.0 109.515 172.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -63.21 -44.63 94.78 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.315 1.046 . . . . 0.0 109.383 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -61.23 -42.26 98.29 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.003 0.921 . . . . 0.0 110.879 172.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.7 m -68.14 -7.0 26.1 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.226 1.01 . . . . 0.0 113.013 177.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.74 -15.15 14.34 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.058 1.313 . . . . 0.0 113.627 169.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.89 169.77 3.06 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.466 1.133 . . . . 0.0 110.776 176.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -142.76 154.01 43.83 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.422 -0.799 . . . . 0.0 111.228 171.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -70.43 155.75 40.27 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.927 171.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 72.8 m -125.95 153.21 44.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.379 1.872 . . . . 0.0 106.931 169.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.94 -144.54 49.05 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -175.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -135.71 152.51 51.24 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.497 1.119 . . . . 0.0 108.25 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.82 150.83 46.86 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.284 1.434 . . . . 0.0 110.427 -176.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.3 tp -130.0 144.97 51.62 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.391 1.076 . . . . 0.0 108.815 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.36 147.42 43.53 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 169.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.3 mt -124.35 106.5 16.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 -175.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -68.09 128.1 35.31 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.077 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -124.49 10.14 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.804 1.242 . . . . 0.0 111.68 174.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 53.2 tp -58.96 -37.46 76.84 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.051 0.54 . . . . 0.0 111.339 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -158.03 -42.34 0.06 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.528 0.731 . . . . 0.0 112.097 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -77.43 -8.55 57.91 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -170.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.6 t70 65.97 -19.02 0.1 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 128.232 2.613 . . . . 0.0 115.532 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.5 pt -141.83 166.83 19.23 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 127.997 2.519 . . . . 0.0 107.169 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -59.33 179.68 0.22 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.353 2.036 . . . . 0.0 111.672 169.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.48 -2.02 4.2 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.95 0.9 . . . . 0.0 113.254 173.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -147.04 129.93 7.94 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 126.786 2.034 . . . . 0.0 107.1 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.6 158.16 58.14 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.548 2.165 . . . . 0.0 112.306 -172.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.86 -17.73 64.85 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -174.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -56.61 -44.22 80.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.776 0.83 . . . . 0.0 111.868 -169.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -73.33 -35.04 65.97 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 122.02 -0.425 . . . . 0.0 110.748 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -69.27 -40.36 77.83 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.81 -0.556 . . . . 0.0 109.839 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 48.9 tp -65.13 -39.93 93.75 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.389 0.676 . . . . 0.0 110.194 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.8 -46.4 83.21 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 171.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.6 m -64.54 -34.11 77.48 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.647 0.779 . . . . 0.0 111.299 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -66.14 -53.65 35.11 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.519 0.727 . . . . 0.0 110.051 176.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.5 m -66.06 -25.89 36.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 118.989 0.813 . . . . 0.0 112.182 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -54.98 -25.38 29.46 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.438 0.695 . . . . 0.0 112.276 177.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 27.7 mt -101.56 0.21 36.05 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 pp -127.68 -11.96 5.49 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 120.362 1.437 . . . . 0.0 113.467 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.0 pttp . . . . . 0 C--O 1.249 1.029 0 C-N-CA 124.286 1.034 . . . . 0.0 111.105 177.526 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.73 156.37 30.68 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.033 0.533 . . . . 0.0 110.904 176.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -134.23 -26.66 1.46 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.123 1.369 . . . . 0.0 110.941 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.2 mt -124.64 79.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.6 m -74.51 114.38 12.85 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mp -76.6 148.39 37.01 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 170.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.5 mt -116.89 90.6 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -175.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.5 m -80.62 137.7 36.38 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.88 1.272 . . . . 0.0 111.262 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.95 76.62 0.36 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 125.148 1.356 . . . . 0.0 111.839 -170.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 p -146.18 145.25 30.39 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 169.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.28 -32.13 62.79 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.0 0.92 . . . . 0.0 111.967 -177.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 pp -132.5 -31.89 1.35 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.866 0.866 . . . . 0.0 112.577 -174.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.98 157.55 10.59 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 107.99 -2.044 . . . . 0.0 107.99 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 139.13 -73.43 0.41 Allowed Glycine 0 CA--C 1.518 0.26 0 N-CA-C 108.405 -1.878 . . . . 0.0 108.405 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.0 -35.09 79.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.803 176.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.18 -36.29 83.14 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.436 0.562 . . . . 0.0 110.315 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -73.67 -47.15 41.94 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.9 t -60.91 -43.3 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -46.39 90.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.019 0.528 . . . . 0.0 110.438 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.4 -44.26 96.87 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.623 0.647 . . . . 0.0 110.415 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -63.48 -35.63 81.09 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.743 0.417 . . . . 0.0 111.601 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.5 mt -74.21 -46.8 39.56 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.763 0.825 . . . . 0.0 109.904 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.13 -35.2 71.14 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.402 1.081 . . . . 0.0 111.623 -174.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -48.25 -44.07 32.97 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.161 0.985 . . . . 0.0 111.477 174.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -77.91 -32.85 51.93 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.502 -0.749 . . . . 0.0 109.984 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.0 mt -64.16 -39.25 93.62 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.554 0.616 . . . . 0.0 110.043 174.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -65.41 -41.63 93.39 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.291 0.496 . . . . 0.0 110.249 176.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -64.18 -35.91 82.33 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.552 0.615 . . . . 0.0 111.287 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.88 -22.54 65.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.555 0.742 . . . . 0.0 111.984 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.19 -0.73 16.77 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.913 1.244 . . . . 0.0 113.346 170.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -75.64 174.72 9.38 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.509 1.154 . . . . 0.0 110.074 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 p -120.32 144.08 48.03 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 169.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.5 p -134.88 168.46 19.03 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.653 0.781 . . . . 0.0 110.484 -169.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -151.86 149.93 29.53 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 104.359 -2.459 . . . . 0.0 104.359 169.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -110.96 69.64 0.69 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.43 106.86 5.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -169.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -72.87 118.38 15.74 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.71 54.14 26.28 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 118.124 -1.376 . . . . 0.0 116.187 169.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.45 176.28 4.26 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 CA-C-N 120.328 2.064 . . . . 0.0 110.978 169.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.7 mt -127.33 161.52 28.44 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.093 1.357 . . . . 0.0 107.969 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.37 -27.76 69.29 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.853 0.861 . . . . 0.0 111.315 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -65.22 -7.75 14.36 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.592 1.157 . . . . 0.0 112.435 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -131.4 21.94 4.76 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.731 1.612 . . . . 0.0 110.871 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 65.8 mt -133.81 115.8 13.45 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.919 1.288 . . . . 0.0 107.835 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -70.25 163.89 37.03 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.147 1.898 . . . . 0.0 111.346 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.32 14.8 0.68 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.133 1.373 . . . . 0.0 113.52 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 p -153.46 146.1 24.22 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.221 1.008 . . . . 0.0 109.097 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.22 179.74 23.52 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.53 97.38 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 173.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -95.39 169.48 10.03 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.849 0.86 . . . . 0.0 109.055 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.4 tp -147.89 111.24 4.93 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.5 t -96.93 138.02 23.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -171.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -134.68 133.32 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.5 p -138.46 146.93 42.68 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 m -109.33 79.32 1.2 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.278 1.031 . . . . 0.0 109.508 -172.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.0 m -45.09 114.18 0.69 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.932 1.693 . . . . 0.0 109.873 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -64.52 -22.49 66.98 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -175.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 159.93 -29.29 0.37 Allowed Glycine 0 C--N 1.339 0.717 0 CA-C-O 118.833 -0.982 . . . . 0.0 113.363 169.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.11 29.14 4.07 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.454 1.127 . . . . 0.0 112.309 -170.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.1 4.23 60.04 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.426 -0.652 . . . . 0.0 113.471 175.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -81.97 121.99 27.22 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.265 1.032 . . . . 0.0 109.492 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.8 mt -80.46 142.43 53.99 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -49.85 136.85 35.71 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.031 3.154 . . . . 0.0 112.984 169.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -60.5 -20.99 61.92 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.688 1.195 . . . . 0.0 113.296 -174.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -69.26 -30.43 68.54 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 118.856 -0.592 . . . . 0.0 111.638 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.3 tp -123.34 -22.52 5.07 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.463 0.705 . . . . 0.0 112.105 -169.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.1 t -46.02 -41.08 19.26 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 117.636 -1.173 . . . . 0.0 113.546 173.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -50.96 -26.88 19.45 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.266 2.644 . . . . 0.0 116.005 172.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -62.84 -38.11 89.48 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.791 1.178 . . . . 0.0 110.802 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -63.46 -38.89 92.89 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 118.341 0.519 . . . . 0.0 110.36 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.04 -48.62 65.16 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.34 70.15 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 121.515 -0.741 . . . . 0.0 112.462 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.95 -57.42 6.94 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -69.47 -28.49 66.13 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.887 0.767 . . . . 0.0 112.346 -171.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -76.64 -22.14 54.5 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.745 0.702 . . . . 0.0 111.781 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -118.2 -36.09 3.66 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.748 0.704 . . . . 0.0 112.391 -172.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt 30.59 60.67 1.0 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 127.222 2.209 . . . . 0.0 113.376 -174.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.74 170.8 14.51 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.156 1.904 . . . . 0.0 109.924 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -72.31 111.01 7.14 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.002 0.521 . . . . 0.0 109.925 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.1 mt -118.98 24.5 10.79 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.796 1.638 . . . . 0.0 110.52 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.7 m -63.37 20.89 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.473 1.909 . . . . 0.0 115.872 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.09 2.84 1.75 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.663 1.185 . . . . 0.0 111.967 173.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.7 t -76.97 142.29 14.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 169.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 54.8 mmm-85 -119.76 144.21 47.4 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 168.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -138.25 171.28 14.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.29 0.567 . . . . 0.0 110.66 -174.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.33 165.55 25.45 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 105.553 -3.019 . . . . 0.0 105.553 169.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.32 128.85 15.02 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.677 0.739 . . . . 0.0 109.878 -169.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 37.4 mt -131.11 124.22 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -101.84 95.59 1.35 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.1 mt -79.79 155.19 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 168.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.59 174.43 33.44 Favored Glycine 0 N--CA 1.436 -1.329 0 CA-C-O 123.21 1.45 . . . . 0.0 111.468 169.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.6 m -74.78 73.65 2.07 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 125.98 1.712 . . . . 0.0 109.077 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.92 -27.89 63.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.167 1.387 . . . . 0.0 112.362 -170.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -83.78 -11.34 57.21 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.467 0.707 . . . . 0.0 112.745 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -70.09 -53.55 16.91 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.374 0.988 . . . . 0.0 111.416 -169.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -164.78 -49.41 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.386 1.074 . . . . 0.0 110.755 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.5 m -109.72 133.9 52.61 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -172.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -82.04 61.18 5.2 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.374 1.07 . . . . 0.0 109.816 -172.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 13.5 m 46.62 50.05 13.28 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.349 1.86 . . . . 0.0 111.838 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.74 -2.11 61.5 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 118.572 -1.127 . . . . 0.0 113.208 -173.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.35 -21.75 66.73 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.942 1.871 . . . . 0.0 112.25 -175.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.1 tp -59.83 -28.88 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.006 1.323 . . . . 0.0 110.839 173.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.06 -37.66 77.55 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 122.908 0.483 . . . . 0.0 111.176 -174.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -61.81 -53.28 58.01 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.745 0.818 . . . . 0.0 109.819 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.7 mt -62.09 -50.82 70.41 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.66 0.784 . . . . 0.0 109.477 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.47 -41.57 72.57 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -171.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.24 -33.74 72.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 119.118 -0.468 . . . . 0.0 110.236 -170.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.57 -29.78 66.31 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.858 0.753 . . . . 0.0 111.197 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.1 mt -64.41 -44.54 90.95 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.795 1.18 . . . . 0.0 108.777 169.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -59.63 -44.87 93.32 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -177.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -66.46 -37.1 84.38 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 122.739 0.415 . . . . 0.0 110.335 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 31.3 m -68.3 -13.06 61.99 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.833 0.853 . . . . 0.0 112.393 174.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.19 -20.69 3.35 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.745 1.164 . . . . 0.0 113.442 169.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.72 171.02 2.25 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.116 0.958 . . . . 0.0 111.841 -175.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -142.12 141.91 32.72 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.172 -0.955 . . . . 0.0 110.115 173.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -63.85 164.86 9.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.217 1.007 . . . . 0.0 109.997 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.3 m -136.0 148.29 48.35 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.914 2.086 . . . . 0.0 106.197 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.55 -133.64 52.62 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -170.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -141.28 160.58 39.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.273 1.829 . . . . 0.0 106.453 176.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.89 158.72 24.46 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.527 1.131 . . . . 0.0 110.695 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.4 tp -129.85 146.43 51.57 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.392 1.077 . . . . 0.0 108.749 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -120.18 141.98 49.39 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.9 mt -137.84 100.6 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -67.77 130.37 42.78 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 170.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 pp -113.85 -4.1 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 123.875 0.87 . . . . 0.0 111.875 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.4 tp -88.47 61.31 6.07 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 168.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -142.9 -172.76 3.73 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.438 1.895 . . . . 0.0 108.996 -168.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -56.87 -43.41 81.19 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 169.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -161.76 -50.98 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.855 1.262 . . . . 0.0 109.555 169.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.4 pt -149.83 163.38 24.95 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 128.013 2.525 . . . . 0.0 107.667 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.46 164.39 23.57 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.394 2.062 . . . . 0.0 111.072 169.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -74.31 -12.47 60.55 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.74 0.816 . . . . 0.0 112.385 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -58.69 124.48 72.89 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 124.118 0.967 . . . . 0.0 110.852 -177.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.14 114.85 4.13 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.728 2.285 . . . . 0.0 111.232 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.28 -27.97 62.58 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.193 0.597 . . . . 0.0 111.428 171.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -60.77 -41.53 95.71 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.881 0.872 . . . . 0.0 110.828 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -73.19 -40.08 65.06 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 75.7 t90 -60.51 -50.24 74.34 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 52.3 tp -64.94 -40.59 95.26 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 119.148 -0.453 . . . . 0.0 110.164 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.18 -46.83 84.86 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 173.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.5 m -63.99 -37.13 86.31 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.056 0.543 . . . . 0.0 111.071 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -65.97 -51.64 56.71 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.91 0.884 . . . . 0.0 110.286 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.8 m -67.2 -30.88 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 O-C-N 121.24 -0.913 . . . . 0.0 111.379 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -61.82 -20.12 63.29 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.632 0.773 . . . . 0.0 112.376 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.6 mt -101.87 -36.27 8.71 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.787 171.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.71 -37.22 84.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.779 1.172 . . . . 0.0 111.718 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt . . . . . 0 C--O 1.247 0.95 0 C-N-CA 128.604 2.762 . . . . 0.0 113.074 179.839 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.78 154.74 28.78 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 122.104 -0.373 . . . . 0.0 110.278 171.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -132.84 -27.23 1.69 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.58 1.152 . . . . 0.0 110.962 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.8 mt -124.94 79.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.2 m -75.12 117.82 17.38 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 mt -89.09 156.84 18.57 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.783 0.833 . . . . 0.0 108.812 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.4 mt -126.44 95.32 3.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -171.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.5 m -73.29 146.27 45.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.855 0.862 . . . . 0.0 110.11 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.32 81.94 0.15 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 124.47 1.033 . . . . 0.0 110.833 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.0 t -154.87 141.69 19.08 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.444 0.697 . . . . 0.0 110.025 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 p -86.37 -35.9 19.52 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.956 1.302 . . . . 0.0 108.503 168.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.5 mt -68.46 -29.76 68.47 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.205 1.402 . . . . 0.0 111.167 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.31 17.61 33.67 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.355 0.978 . . . . 0.0 112.219 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.82 -41.96 9.31 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 118.52 1.16 . . . . 0.0 110.666 -176.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.38 -35.47 80.41 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 122.001 -0.705 . . . . 0.0 110.499 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.59 -34.51 69.96 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.095 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -66.43 -46.06 77.77 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.417 0.687 . . . . 0.0 109.238 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.0 t -63.18 -47.75 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.57 -38.41 84.49 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-O 118.823 -0.608 . . . . 0.0 111.007 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.16 -45.23 89.39 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.345 0.975 . . . . 0.0 110.715 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -67.79 -40.04 83.99 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.884 -0.51 . . . . 0.0 110.795 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.3 mt -64.2 -42.51 96.6 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 119.257 -0.402 . . . . 0.0 110.157 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.08 -44.87 96.71 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.549 0.74 . . . . 0.0 110.468 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -58.77 -42.25 88.51 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.225 0.466 . . . . 0.0 110.269 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.5 mmtm -69.94 -39.47 76.08 Favored 'General case' 0 N--CA 1.462 0.142 0 O-C-N 121.682 -0.636 . . . . 0.0 111.726 176.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.6 mt -60.65 -37.12 80.47 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.084 0.856 . . . . 0.0 111.045 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -67.63 -35.75 79.51 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.863 0.756 . . . . 0.0 110.682 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.71 -37.46 84.74 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.092 0.86 . . . . 0.0 110.792 172.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.64 -26.41 67.05 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 122.844 0.457 . . . . 0.0 111.55 173.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.95 -3.28 11.68 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.345 1.45 . . . . 0.0 113.834 169.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -81.08 144.36 31.78 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.91 1.355 . . . . 0.0 109.724 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 p -84.18 144.11 29.19 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 169.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.8 p -135.7 169.33 17.72 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.613 0.765 . . . . 0.0 110.795 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -150.79 161.38 42.76 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 p -131.95 75.73 1.66 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.6 mt -69.23 121.91 17.78 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -171.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -80.51 95.49 6.49 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.64 56.17 26.76 Favored Glycine 0 CA--C 1.541 1.68 0 CA-C-O 118.783 -1.009 . . . . 0.0 113.852 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -69.47 178.84 3.99 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.556 2.838 . . . . 0.0 111.988 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.7 mt -129.04 165.93 20.21 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.44 1.496 . . . . 0.0 109.173 172.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.4 tp -63.2 -26.57 68.86 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.777 1.231 . . . . 0.0 112.288 -173.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.11 -10.15 13.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.052 0.941 . . . . 0.0 113.071 174.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -128.07 18.79 6.55 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.443 1.497 . . . . 0.0 111.068 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.6 mt -135.51 97.93 12.67 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 125.106 1.362 . . . . 0.0 107.756 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.73 165.26 30.21 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.356 2.037 . . . . 0.0 111.731 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.64 5.21 2.57 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.837 1.655 . . . . 0.0 114.71 -171.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.3 m -145.43 131.65 19.48 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.776 1.23 . . . . 0.0 107.997 -173.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.91 -172.23 35.06 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.039 -0.825 . . . . 0.0 111.039 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -129.73 97.26 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 173.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -100.52 172.27 7.22 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.602 0.761 . . . . 0.0 110.014 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.7 tp -138.78 103.17 4.76 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 120.793 -1.192 . . . . 0.0 107.809 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.6 t -80.43 129.34 37.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 mt -129.93 129.12 65.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 172.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -139.26 129.7 25.65 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -170.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.8 m -74.08 164.54 26.49 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.174 0.511 . . . . 0.0 109.981 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.8 m -135.98 138.53 42.37 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 176.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -124.84 10.47 8.3 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -169.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.59 -48.82 0.46 Allowed Glycine 0 C--N 1.34 0.773 0 CA-C-N 119.124 0.874 . . . . 0.0 112.849 169.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.28 24.53 2.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.038 0.935 . . . . 0.0 112.053 -169.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.85 9.67 57.14 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 119.614 -0.548 . . . . 0.0 112.653 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -65.08 122.27 16.65 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.276 1.038 . . . . 0.0 109.089 172.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.8 mt -83.07 145.02 48.36 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.79 138.88 85.59 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.064 2.51 . . . . 0.0 110.897 173.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -59.46 -16.93 27.09 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.914 1.285 . . . . 0.0 113.185 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -67.48 -33.12 74.46 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.259 0.624 . . . . 0.0 111.802 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.7 tp -125.67 -21.16 4.51 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.353 0.661 . . . . 0.0 112.27 -172.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 t -47.4 -40.56 27.72 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 117.618 -1.182 . . . . 0.0 113.736 174.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -50.79 -27.18 19.53 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.162 2.574 . . . . 0.0 115.669 172.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -63.02 -38.38 90.94 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.596 1.089 . . . . 0.0 110.877 177.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -64.22 -37.31 87.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.694 0.679 . . . . 0.0 110.156 177.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -69.49 -50.3 46.62 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.1 -31.73 73.04 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.448 -0.783 . . . . 0.0 112.15 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.5 mt -65.51 -55.53 17.3 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.539 -0.743 . . . . 0.0 109.605 172.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -70.18 -27.67 64.7 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.509 1.05 . . . . 0.0 112.309 -172.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -71.27 -28.41 64.13 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.769 0.713 . . . . 0.0 111.433 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -114.45 -33.69 5.5 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -170.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp 29.97 57.73 0.82 Allowed Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 127.719 2.407 . . . . 0.0 113.415 -172.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -69.41 172.63 11.95 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.125 1.883 . . . . 0.0 110.333 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -70.26 111.74 6.08 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.967 0.507 . . . . 0.0 109.83 171.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 mt -120.45 25.32 9.87 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.978 1.711 . . . . 0.0 110.323 175.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.4 m -63.7 19.9 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -174.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.87 9.44 1.52 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.684 1.194 . . . . 0.0 111.505 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.9 t -80.38 102.19 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 170.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -79.73 147.75 31.78 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 167.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -146.23 172.62 13.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 119.325 0.966 . . . . 0.0 112.019 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -125.66 162.35 19.91 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 105.847 -2.901 . . . . 0.0 105.847 169.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.7 125.93 16.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -170.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.3 mt -136.07 135.43 50.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -114.72 147.15 18.85 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.7 mt -127.83 147.81 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 164.95 157.18 9.49 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.4 m -71.51 120.32 16.93 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 171.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 -60.67 -15.32 27.55 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -64.38 -25.99 68.27 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.495 -0.753 . . . . 0.0 112.21 172.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 -61.76 156.7 19.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.856 0.753 . . . . 0.0 111.761 -177.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -57.45 -41.1 79.86 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.958 0.903 . . . . 0.0 110.784 171.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.8 m -131.01 126.57 36.29 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -139.42 150.11 44.87 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -177.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 57.9 m 42.91 39.5 1.78 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.868 1.267 . . . . 0.0 113.131 177.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.03 -11.76 0.4 Allowed Glycine 0 C--N 1.338 0.64 0 CA-C-O 118.752 -1.027 . . . . 0.0 114.057 -169.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.72 -18.81 65.35 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.622 1.711 . . . . 0.0 112.013 174.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 tp -53.91 -31.36 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.438 1.895 . . . . 0.0 110.361 169.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -57.48 -38.45 74.56 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.062 0.545 . . . . 0.0 112.209 -170.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -68.07 -45.67 73.18 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 121.946 -0.471 . . . . 0.0 110.549 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.9 mt -60.81 -49.21 78.41 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.384 0.674 . . . . 0.0 109.182 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -69.74 -33.68 72.79 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.185 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.32 93.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -74.27 -30.5 62.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.949 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.0 mt -62.11 -51.72 66.77 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 119.482 1.037 . . . . 0.0 109.483 170.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -68.29 -32.85 73.29 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.73 -173.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -64.76 -37.33 87.26 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.504 0.322 . . . . 0.0 111.106 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.5 m -71.03 -4.67 26.18 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.316 1.046 . . . . 0.0 112.917 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.79 -16.61 9.5 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.177 1.37 . . . . 0.0 113.249 169.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.69 176.14 0.55 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.037 1.335 . . . . 0.0 111.632 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.62 137.22 15.98 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.723 -1.236 . . . . 0.0 112.649 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -60.66 137.71 58.15 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.566 1.546 . . . . 0.0 108.661 169.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.3 m -121.59 139.24 53.78 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.593 1.957 . . . . 0.0 106.211 171.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.1 175.26 24.79 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.945 0.783 . . . . 0.0 111.668 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -85.47 139.07 31.79 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.924 -0.75 . . . . 0.0 109.366 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.1 m -57.73 152.84 14.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.902 1.681 . . . . 0.0 110.24 174.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 62.9 tp -128.95 149.01 50.98 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.941 0.897 . . . . 0.0 109.939 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -113.16 139.34 48.83 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 17.1 mm -117.6 96.0 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 171.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -67.43 138.37 56.61 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 172.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.0 pt -129.45 13.14 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.673 1.189 . . . . 0.0 111.745 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.4 tp -58.29 -45.72 87.42 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.452 0.701 . . . . 0.0 110.755 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -164.63 -48.81 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.978 1.311 . . . . 0.0 109.327 177.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.61 69.84 3.06 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.755 1.222 . . . . 0.0 109.169 175.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -66.57 73.74 0.09 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.273 2.229 . . . . 0.0 110.367 171.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.253 34.4 pt 36.91 56.0 3.39 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 128.127 2.571 . . . . 0.0 114.918 -177.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -70.05 -11.57 30.7 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.998 2.465 . . . . 0.0 112.346 175.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -144.17 157.86 44.06 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.026 2.13 . . . . 0.0 106.135 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.2 t70 41.46 61.81 7.53 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.871 1.669 . . . . 0.0 113.532 -169.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -54.82 158.3 11.2 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.206 2.604 . . . . 0.0 113.389 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.52 -36.58 69.36 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.629 0.372 . . . . 0.0 110.369 171.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -59.03 -24.29 62.71 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.367 1.467 . . . . 0.0 112.577 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -89.81 -43.49 10.61 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.899 0.772 . . . . 0.0 109.596 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -59.93 -28.92 68.01 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.44 0.696 . . . . 0.0 111.498 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 59.8 tp -51.92 -35.2 44.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.394 1.477 . . . . 0.0 111.872 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.85 -44.61 87.26 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 m -66.76 -30.99 71.34 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.548 0.739 . . . . 0.0 111.145 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -72.32 -55.35 7.27 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.251 0.478 . . . . 0.0 109.798 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.9 m -63.62 -29.53 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 118.498 0.59 . . . . 0.0 111.553 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -54.38 -28.53 43.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.896 0.879 . . . . 0.0 112.458 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 27.4 mt -101.7 -3.49 28.13 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.067 -0.968 . . . . 0.0 113.511 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.6 pp -125.94 -14.63 6.07 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.274 1.397 . . . . 0.0 113.497 -178.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.5 pttt . . . . . 0 C--O 1.25 1.126 0 C-N-CA 123.826 0.85 . . . . 0.0 111.079 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.59 -161.03 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.86 1.664 . . . . 0.0 112.542 -174.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -140.97 -27.27 0.71 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.823 1.249 . . . . 0.0 111.669 177.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mt -132.96 83.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 171.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 79.6 m -73.99 119.28 17.99 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.55 148.13 35.38 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 172.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 82.7 mt -113.39 78.05 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.9 m -76.13 97.23 4.04 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.237 1.415 . . . . 0.0 109.332 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.03 52.21 0.67 Allowed Glycine 0 N--CA 1.461 0.337 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -172.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.3 m -127.76 164.53 21.95 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.296 0.639 . . . . 0.0 112.549 -167.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.2 p -146.9 -30.59 0.35 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.03 1.332 . . . . 0.0 112.916 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 70.7 mt -64.17 -20.02 65.71 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -171.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.62 -43.67 1.63 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 125.374 1.464 . . . . 0.0 110.429 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.29 -42.61 90.25 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 -176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.78 -31.78 72.95 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.154 -0.45 . . . . 0.0 110.06 175.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -72.61 -35.38 67.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.816 0.735 . . . . 0.0 111.015 177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -67.11 -39.42 86.68 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.994 0.815 . . . . 0.0 109.229 175.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.87 -47.01 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 118.681 -0.676 . . . . 0.0 109.549 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.96 86.29 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.467 1.031 . . . . 0.0 111.383 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.09 -43.57 91.68 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.14 0.576 . . . . 0.0 110.593 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -64.62 -44.59 90.05 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.541 0.61 . . . . 0.0 110.66 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.3 mt -58.55 -46.97 85.74 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.327 1.051 . . . . 0.0 109.93 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.03 -46.04 89.2 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.303 0.641 . . . . 0.0 110.176 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.02 -42.2 93.84 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.016 0.526 . . . . 0.0 110.082 -179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.403 ' N ' ' HE2' ' A' ' 25' ' ' LYS . 6.1 mmpt? -63.74 -36.89 85.36 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 121.744 -0.598 . . . . 0.0 110.233 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.94 -38.71 76.26 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 118.66 0.664 . . . . 0.0 111.013 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.07 -43.35 99.02 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.727 0.694 . . . . 0.0 109.398 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.04 -38.99 92.65 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.078 0.551 . . . . 0.0 111.104 176.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.38 -21.43 64.7 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.624 0.77 . . . . 0.0 112.203 176.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.95 28.71 3.54 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.758 -1.023 . . . . 0.0 113.623 170.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -124.96 133.77 52.89 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.977 1.388 . . . . 0.0 108.924 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 p -75.79 140.6 42.43 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.282 0.563 . . . . 0.0 109.7 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.1 p -131.01 168.55 17.18 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.35 1.06 . . . . 0.0 110.6 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -154.45 128.0 8.6 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 169.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 p -82.59 65.09 7.55 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.007 1.323 . . . . 0.0 108.248 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.1 121.36 15.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -169.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.0 107.23 4.61 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -173.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 37.36 56.59 1.5 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 127.642 2.544 . . . . 0.0 115.789 173.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -62.47 148.66 92.97 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 120.222 2.011 . . . . 0.0 110.63 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mt -98.62 171.06 8.37 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 124.233 1.013 . . . . 0.0 110.551 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -52.92 -38.78 62.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.425 1.49 . . . . 0.0 111.282 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.74 -6.0 18.86 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.45 1.1 . . . . 0.0 112.68 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -135.27 20.38 3.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.986 1.714 . . . . 0.0 110.924 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.2 mt -134.11 108.73 11.54 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 125.133 1.373 . . . . 0.0 107.607 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.2 160.42 48.94 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.889 1.726 . . . . 0.0 110.631 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.6 7.13 2.58 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.742 1.217 . . . . 0.0 114.098 -172.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.2 m -147.52 142.13 26.59 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -176.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.16 -177.85 29.73 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.5 101.31 8.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -109.04 170.23 8.18 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.991 0.916 . . . . 0.0 109.914 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.8 tp -144.73 106.95 4.34 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.1 t -81.79 139.58 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 124.059 0.944 . . . . 0.0 108.864 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 mp -133.34 143.45 39.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.2 m -148.46 143.91 27.04 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.192 -0.943 . . . . 0.0 110.195 176.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -69.37 150.62 47.1 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.0 m -116.43 91.59 3.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -56.66 -32.19 65.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.53 0.732 . . . . 0.0 111.714 -176.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 150.82 -29.96 1.02 Allowed Glycine 0 C--N 1.34 0.763 0 C-N-CA 123.892 0.758 . . . . 0.0 112.628 169.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.96 25.29 7.36 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.421 1.088 . . . . 0.0 111.948 -170.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.12 5.94 86.99 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-O 119.363 -0.687 . . . . 0.0 112.921 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -72.96 146.94 45.67 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 169.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.3 mt -126.03 139.69 34.99 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -172.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -51.73 138.19 50.29 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.055 2.503 . . . . 0.0 113.304 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -57.71 -12.69 3.15 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.717 1.607 . . . . 0.0 113.198 174.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -54.96 -42.59 72.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.178 1.391 . . . . 0.0 109.732 172.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.3 tp -133.64 -21.45 1.97 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -171.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 91.5 p -52.48 -33.12 11.05 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -172.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -53.68 -23.09 24.83 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.803 2.335 . . . . 0.0 115.153 171.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -59.56 -36.59 76.5 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.571 1.078 . . . . 0.0 111.441 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -61.35 -43.0 99.61 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.186 0.448 . . . . 0.0 110.047 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -68.74 -47.09 67.18 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.167 0.587 . . . . 0.0 109.864 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.36 -36.74 83.65 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.865 -0.522 . . . . 0.0 112.03 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.3 mt -67.91 -51.31 49.34 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 118.515 -0.755 . . . . 0.0 109.537 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -68.76 -28.02 66.42 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.435 1.016 . . . . 0.0 111.886 -174.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.2 -39.23 86.32 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.749 0.704 . . . . 0.0 110.483 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -100.17 -22.8 15.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.891 -0.576 . . . . 0.0 112.43 -170.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt 40.03 56.97 7.2 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.997 1.719 . . . . 0.0 110.691 -169.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.88 143.02 78.19 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.354 2.036 . . . . 0.0 110.883 -169.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -81.85 64.22 6.45 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.655 1.182 . . . . 0.0 108.731 174.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.75 -56.01 10.88 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.6 m 50.55 19.97 0.64 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 169.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -157.38 -0.63 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 80.9 t -71.56 139.26 20.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -115.05 135.11 54.57 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 169.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -139.81 173.17 11.79 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.116 0.96 . . . . 0.0 112.298 -170.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -133.63 163.4 24.43 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 106.079 -2.808 . . . . 0.0 106.079 169.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.45 123.86 7.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.218 1.009 . . . . 0.0 108.413 -169.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 29.7 mt -139.53 139.93 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.47 138.91 11.81 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 169.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.68 128.59 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 162.96 -149.74 17.85 Favored Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 172.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.3 m -85.45 55.87 3.7 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 126.144 1.778 . . . . 0.0 110.956 -169.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -53.14 -37.01 61.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.836 0.855 . . . . 0.0 112.344 -173.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.0 -16.97 64.02 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.641 0.776 . . . . 0.0 112.87 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -63.18 -47.37 82.91 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.806 0.73 . . . . 0.0 111.483 -174.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -162.76 -43.07 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.4 m -128.0 132.55 49.14 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.062 0.945 . . . . 0.0 108.874 -169.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -106.98 -2.38 21.23 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -169.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 20.3 p -155.17 -25.65 0.11 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -47.65 -38.01 14.52 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.726 1.155 . . . . 0.0 114.303 -172.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.33 -8.7 19.44 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.6 tp -127.6 -34.0 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.292 1.037 . . . . 0.0 110.002 169.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -55.17 -36.91 66.36 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.41 0.684 . . . . 0.0 111.823 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.41 -54.57 45.52 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.569 0.622 . . . . 0.0 110.902 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 50.4 mt -66.26 -49.35 67.45 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -173.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.17 -35.98 74.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -171.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.84 82.78 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.86 -0.591 . . . . 0.0 110.107 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -69.13 -31.25 69.8 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.239 0.927 . . . . 0.0 112.437 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.7 mt -64.24 -42.37 96.56 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.645 1.566 . . . . 0.0 109.447 169.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -61.93 -41.4 97.91 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.504 0.722 . . . . 0.0 110.133 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -64.4 -36.44 84.15 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.056 1.342 . . . . 0.0 111.012 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.1 m -72.79 7.8 1.8 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.076 1.35 . . . . 0.0 112.849 172.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.27 -8.11 80.55 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.898 1.237 . . . . 0.0 113.353 171.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.13 167.75 4.75 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.421 1.111 . . . . 0.0 110.043 170.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -142.7 151.93 41.84 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.267 -0.896 . . . . 0.0 111.957 176.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -56.39 163.71 1.62 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.375 1.47 . . . . 0.0 110.147 169.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.72 37.69 2.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.381 1.086 . . . . 0.0 109.604 -177.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 155.52 -167.48 33.04 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.558 2.028 . . . . 0.0 108.046 -169.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.75 154.68 20.76 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 117.925 0.863 . . . . 0.0 109.007 169.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.7 m -67.61 158.21 32.64 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.0 tp -132.41 152.34 51.51 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.563 0.745 . . . . 0.0 109.141 172.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -137.4 146.46 44.46 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 169.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.8 mt -134.14 103.31 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -169.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -75.8 141.8 42.44 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -130.9 4.86 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.2 tp -74.66 -67.85 0.59 Allowed 'General case' 0 C--N 1.347 0.462 0 CA-C-N 119.923 1.238 . . . . 0.0 111.374 -169.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -72.56 -27.6 62.3 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.653 0.661 . . . . 0.0 112.673 -177.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -149.37 153.83 38.01 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 124.328 1.051 . . . . 0.0 110.224 -169.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -82.06 6.72 15.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.275 1.43 . . . . 0.0 112.932 -175.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.315 14.2 tt 39.27 62.06 5.2 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 127.509 2.324 . . . . 0.0 113.197 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.32 -10.27 25.33 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.237 2.625 . . . . 0.0 113.587 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.32 -21.16 65.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.871 0.869 . . . . 0.0 111.457 169.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.8 t0 41.11 62.93 6.31 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.315 2.246 . . . . 0.0 113.88 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -63.96 -17.26 59.13 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.014 2.476 . . . . 0.0 113.115 -174.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.79 -38.51 61.23 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.715 0.806 . . . . 0.0 111.463 176.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.5 -42.99 86.56 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.717 0.69 . . . . 0.0 110.647 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.19 -40.51 78.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.867 0.467 . . . . 0.0 110.127 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -67.05 -37.78 84.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.06 175.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.03 -42.92 93.89 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.629 1.104 . . . . 0.0 109.941 177.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.84 -43.9 87.21 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 171.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.0 m -63.82 -41.48 97.85 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.177 -0.602 . . . . 0.0 110.836 176.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -49.01 79.32 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.674 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.7 m -66.57 -31.75 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 120.431 1.468 . . . . 0.0 111.634 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -67.97 -18.91 64.88 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.628 0.649 . . . . 0.0 111.794 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.37 -47.2 4.77 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.809 1.244 . . . . 0.0 110.25 -176.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.6 pp -74.55 -23.51 58.8 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.077 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 C--O 1.246 0.88 0 C-N-CA 127.73 2.412 . . . . 0.0 112.15 177.932 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.52 159.66 42.77 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.892 1.277 . . . . 0.0 108.81 176.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -136.95 -25.1 1.1 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.045 1.338 . . . . 0.0 111.215 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.9 mt -128.83 82.1 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 169.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 m -76.6 117.94 18.75 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.76 149.74 39.64 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 171.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 68.9 mt -117.18 95.14 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 104.743 -2.318 . . . . 0.0 104.743 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.4 m -85.59 89.49 7.73 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.283 1.833 . . . . 0.0 110.847 -169.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.64 57.09 4.76 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.9 m -105.23 58.57 0.68 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -167.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 p -60.6 -36.5 78.71 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.065 0.546 . . . . 0.0 111.248 171.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.9 mt -65.84 -19.51 65.91 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.53 -41.31 1.39 Allowed Glycine 0 CA--C 1.532 1.106 0 CA-C-N 119.418 1.008 . . . . 0.0 112.328 -174.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.93 -36.3 93.24 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 118.502 1.151 . . . . 0.0 111.424 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.09 -29.66 68.73 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.241 0.52 . . . . 0.0 110.091 172.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -80.88 -30.32 35.57 Favored 'General case' 0 N--CA 1.462 0.162 0 O-C-N 121.962 -0.461 . . . . 0.0 111.601 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -66.79 -40.54 88.17 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.094 0.861 . . . . 0.0 108.931 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.07 -42.36 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 118.675 -0.679 . . . . 0.0 109.849 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.85 85.12 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.539 1.063 . . . . 0.0 111.149 176.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -65.04 -43.03 93.68 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.192 0.597 . . . . 0.0 110.654 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -61.2 -47.22 87.12 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.417 0.553 . . . . 0.0 110.875 176.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.5 mt -59.34 -47.67 84.55 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.541 0.737 . . . . 0.0 109.374 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.5 93.58 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.586 0.754 . . . . 0.0 110.808 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 -58.93 -41.49 87.44 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.404 0.547 . . . . 0.0 110.435 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.44 -30.76 66.43 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.011 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 70.5 mt -65.76 -40.0 91.63 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 119.91 1.232 . . . . 0.0 111.62 170.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -60.09 -43.92 95.18 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.868 0.758 . . . . 0.0 109.321 177.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.41 -38.06 88.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.206 0.602 . . . . 0.0 111.311 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.86 -21.43 64.27 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.739 0.816 . . . . 0.0 112.275 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.29 28.49 3.79 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.375 171.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -126.52 129.39 48.53 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.804 1.302 . . . . 0.0 107.96 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 p -75.37 148.11 39.49 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.8 p -134.02 170.17 16.04 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.757 0.789 . . . . 0.0 111.393 -171.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -152.6 161.96 41.87 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 169.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.49 78.5 1.81 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.7 mt -69.66 113.6 7.08 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.429 ' CD2' HD22 ' A' ' 65' ' ' ASN . 43.0 t60 -73.35 106.23 5.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 52.51 55.68 21.39 Favored Glycine 0 CA--C 1.541 1.685 0 CA-C-O 118.58 -1.122 . . . . 0.0 115.575 172.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -69.26 175.33 7.83 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.161 2.574 . . . . 0.0 111.722 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.6 mt -131.69 171.28 13.67 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 126.06 1.744 . . . . 0.0 110.152 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.87 -38.26 55.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.051 1.74 . . . . 0.0 111.857 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.62 -8.56 14.77 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -133.99 18.41 3.79 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.144 1.778 . . . . 0.0 110.87 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.9 mt -134.27 98.29 14.14 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 125.223 1.409 . . . . 0.0 107.704 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.14 163.5 35.8 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.157 1.905 . . . . 0.0 110.857 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.79 3.03 4.53 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -170.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.4 m -147.68 136.96 22.39 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.654 1.182 . . . . 0.0 107.894 -171.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.1 177.26 25.62 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.5 mt -113.71 102.43 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -101.21 168.68 9.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.341 0.656 . . . . 0.0 109.43 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.0 tp -144.59 100.42 3.52 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.4 t -79.49 140.78 16.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 123.553 0.741 . . . . 0.0 109.015 -174.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.3 mp -132.31 135.97 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 171.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.3 m -126.0 137.95 53.7 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.284 0.633 . . . . 0.0 111.369 173.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.4 m -69.87 160.25 32.16 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 168.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.59 89.14 2.19 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -78.63 42.28 0.44 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.767 1.227 . . . . 0.0 112.053 -171.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.57 -39.56 1.95 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.103 1.335 . . . . 0.0 113.422 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.62 -21.35 59.51 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.124 0.969 . . . . 0.0 112.971 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.35 9.13 80.04 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.767 -1.018 . . . . 0.0 113.539 -176.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -75.92 152.54 37.08 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.83 1.315 . . . . 0.0 110.756 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.1 mt -65.98 142.89 98.23 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.325 1.45 . . . . 0.0 108.567 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -57.95 125.99 20.31 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.937 3.091 . . . . 0.0 111.714 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -56.75 -27.09 58.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.656 1.182 . . . . 0.0 114.134 -173.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.429 HD22 ' CD2' ' A' ' 37' ' ' HIS . 10.2 p-10 -73.23 -19.18 61.14 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.817 -0.552 . . . . 0.0 112.43 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.4 tp -127.29 -23.03 3.6 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.125 1.37 . . . . 0.0 111.175 -171.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.2 p -53.94 -31.66 9.04 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-O 116.832 -1.556 . . . . 0.0 114.832 -176.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -52.54 -23.57 19.78 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.481 2.121 . . . . 0.0 114.929 169.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.46 -35.92 78.95 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.952 1.251 . . . . 0.0 111.675 175.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -59.32 -43.07 92.73 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.331 0.514 . . . . 0.0 109.777 176.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.9 -48.47 58.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.929 0.492 . . . . 0.0 109.8 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.38 -31.56 72.73 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.891 0.769 . . . . 0.0 112.54 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.1 mt -68.6 -54.65 15.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.952 0.796 . . . . 0.0 109.404 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -68.89 -29.52 67.82 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.336 0.971 . . . . 0.0 112.264 -171.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -73.24 -24.16 60.44 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.786 0.721 . . . . 0.0 111.32 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -112.86 -23.64 10.0 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.865 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt 39.31 64.67 3.84 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.936 1.694 . . . . 0.0 109.807 -169.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.88 -4.68 13.87 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.295 2.663 . . . . 0.0 115.534 -169.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.7 t70 50.57 51.99 15.76 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.172 1.389 . . . . 0.0 111.592 171.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.3 mt -58.92 -46.48 87.85 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.443 1.497 . . . . 0.0 110.494 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.8 m 54.86 15.44 1.13 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 172.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -153.92 2.03 0.24 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.704 1.138 . . . . 0.0 113.857 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 79.7 t -72.56 138.12 22.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 169.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -119.96 140.32 51.11 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 104.262 -2.496 . . . . 0.0 104.262 168.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -149.69 169.91 19.92 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.364 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.42 166.65 20.9 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 105.662 -2.975 . . . . 0.0 105.662 169.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.64 135.84 23.87 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.373 1.087 . . . . 0.0 109.723 -169.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.2 mt -135.9 137.36 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -175.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.18 135.18 11.18 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 170.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.9 mt -139.57 131.13 33.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 164.96 -159.85 33.02 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 120.425 1.466 . . . . 0.0 110.369 171.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.6 m -76.33 47.45 0.47 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 127.727 2.411 . . . . 0.0 111.106 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 57.1 mtt-85 -66.57 -15.9 63.76 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.149 -0.969 . . . . 0.0 112.879 -170.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.63 -28.38 69.86 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.21 0.604 . . . . 0.0 112.051 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -66.42 -57.32 7.65 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 123.292 0.637 . . . . 0.0 110.466 -171.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -169.01 -66.33 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.263 1.425 . . . . 0.0 108.636 172.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.9 p 49.21 -177.99 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 127.413 2.285 . . . . 0.0 114.308 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -151.82 5.45 0.43 Allowed 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.116 -0.99 . . . . 0.0 112.742 -171.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 63.7 m 56.55 -11.51 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 127.402 2.281 . . . . 0.0 116.353 -170.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -45.35 -35.02 4.97 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 126.154 1.835 . . . . 0.0 112.88 173.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.34 -25.8 6.56 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.123 1.769 . . . . 0.0 114.641 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.09 -33.16 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -61.06 -37.77 83.83 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.957 0.903 . . . . 0.0 111.971 -172.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -68.38 -42.77 78.61 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.725 -0.609 . . . . 0.0 111.081 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.77 -50.05 73.91 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.55 -32.93 73.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 119.438 -0.315 . . . . 0.0 111.023 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.77 99.59 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -74.57 -29.2 61.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.279 -0.867 . . . . 0.0 112.259 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.1 mt -62.82 -47.91 81.38 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.191 1.359 . . . . 0.0 109.234 170.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -66.07 -36.62 83.7 Favored 'General case' 0 N--CA 1.46 0.054 0 C-N-CA 122.415 0.286 . . . . 0.0 110.829 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -63.38 -38.36 90.85 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.134 0.574 . . . . 0.0 110.7 173.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.2 m -74.46 11.77 0.92 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.661 1.184 . . . . 0.0 112.499 171.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.35 -5.52 84.64 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 120.78 -1.2 . . . . 0.0 113.857 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.9 169.39 2.6 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.0 1.4 . . . . 0.0 110.092 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -141.74 139.74 32.93 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.602 -0.686 . . . . 0.0 110.966 169.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -64.94 170.61 4.15 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.049 1.339 . . . . 0.0 109.461 175.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.1 m -140.15 152.72 46.29 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.39 -132.99 42.03 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -144.07 154.85 43.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.77 129.78 42.02 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.119 0.968 . . . . 0.0 109.958 -177.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.2 tp -91.36 142.39 27.74 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -129.71 139.46 51.33 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.2 mt -138.99 100.4 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -73.43 133.43 43.73 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 169.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -128.91 8.12 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.844 0.747 . . . . 0.0 112.538 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.5 tp -55.71 -32.37 63.27 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.941 0.792 . . . . 0.0 111.654 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -137.07 47.68 2.11 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.032 1.333 . . . . 0.0 109.252 172.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 44.39 40.27 3.68 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.72 2.008 . . . . 0.0 113.059 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -80.36 49.82 1.19 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.212 2.205 . . . . 0.0 112.128 -171.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.4 pt -54.28 149.33 19.96 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.437 1.095 . . . . 0.0 110.938 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.06 162.87 30.9 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.783 2.322 . . . . 0.0 112.498 -175.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -73.74 -1.14 17.95 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.423 1.489 . . . . 0.0 112.879 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -125.88 111.18 24.76 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 173.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -53.56 152.68 20.53 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.553 2.836 . . . . 0.0 114.517 -169.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.3 -37.49 62.27 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.417 0.687 . . . . 0.0 110.775 170.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.29 -34.19 77.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.217 0.607 . . . . 0.0 111.563 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -79.42 -36.6 38.78 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.419 0.554 . . . . 0.0 109.756 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -66.83 -40.0 87.83 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.771 -0.581 . . . . 0.0 110.046 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.1 tp -64.77 -42.33 95.19 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.51 1.124 . . . . 0.0 110.575 174.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.52 -43.98 85.59 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.43 1.014 . . . . 0.0 110.985 172.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.8 m -63.98 -41.11 97.64 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.292 0.637 . . . . 0.0 110.568 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -52.01 66.68 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.406 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.1 m -61.79 -35.07 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 119.793 1.179 . . . . 0.0 110.796 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -61.92 -24.35 66.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.55 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.2 mt -91.64 -47.77 7.2 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.739 1.154 . . . . 0.0 111.04 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.7 pp -80.24 -10.94 59.77 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -172.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.4 pttm . . . . . 0 C--O 1.249 1.053 0 C-N-CA 125.463 1.505 . . . . 0.0 112.778 -177.565 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.58 157.31 43.51 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.741 1.217 . . . . 0.0 108.614 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -136.37 -26.64 1.11 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.276 1.43 . . . . 0.0 111.038 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.0 mt -122.91 77.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 169.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -74.74 116.33 15.33 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.2 mt -87.84 155.93 19.64 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.3 mt -125.62 95.12 3.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -170.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 m -90.07 153.03 20.87 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.086 1.754 . . . . 0.0 111.022 -175.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.18 128.95 1.15 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 107.558 -2.217 . . . . 0.0 107.558 173.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.75 155.36 41.62 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.565 0.698 . . . . 0.0 112.305 -172.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 p -129.7 -34.57 1.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.853 2.061 . . . . 0.0 108.656 169.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt -67.1 -20.76 65.85 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.083 0.553 . . . . 0.0 110.57 169.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.18 35.4 18.05 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.05 -24.15 0.99 Allowed Glycine 0 CA--C 1.524 0.648 0 CA-C-O 118.611 -1.105 . . . . 0.0 112.948 -173.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.23 -32.42 73.83 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.037 1.919 . . . . 0.0 110.746 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.67 -39.34 93.5 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.494 0.318 . . . . 0.0 110.848 176.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -70.55 -48.03 57.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -61.35 -43.1 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.52 -48.15 83.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 118.73 0.696 . . . . 0.0 110.101 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.51 -43.33 94.43 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.663 0.665 . . . . 0.0 110.986 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -63.53 -38.44 91.16 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.813 0.845 . . . . 0.0 111.252 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.6 mt -74.53 -41.25 60.94 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.266 0.626 . . . . 0.0 110.275 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.89 -40.32 80.0 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 123.438 0.695 . . . . 0.0 110.84 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -52.51 -46.35 66.64 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.608 0.763 . . . . 0.0 110.638 175.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -68.0 -39.21 83.26 Favored 'General case' 0 N--CA 1.46 0.064 0 O-C-N 121.84 -0.538 . . . . 0.0 110.259 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.8 mt -66.34 -39.84 89.46 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 119.506 -0.283 . . . . 0.0 110.705 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.81 -40.44 91.88 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.409 0.549 . . . . 0.0 110.18 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -64.78 -36.19 83.51 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.33 0.514 . . . . 0.0 111.018 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.94 -23.98 64.22 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.46 0.704 . . . . 0.0 111.994 174.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.86 -0.62 13.53 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.902 1.239 . . . . 0.0 113.741 170.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -75.67 174.75 9.36 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.737 1.268 . . . . 0.0 110.305 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.9 p -119.16 144.01 46.91 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 170.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -135.64 167.69 20.66 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.063 0.945 . . . . 0.0 109.934 -169.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -153.07 160.23 42.92 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 169.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 p -124.88 72.19 1.21 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.0 mt -69.05 114.38 7.28 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -173.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -81.89 110.0 16.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.85 46.62 93.22 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-O 117.943 -1.476 . . . . 0.0 115.926 172.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -69.09 173.36 10.48 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 121.031 2.415 . . . . 0.0 110.267 169.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 mp -131.34 175.68 8.93 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.285 1.434 . . . . 0.0 108.036 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.408 HD21 ' HG3' ' A' ' 78' ' ' PRO . 45.3 tp -55.77 -32.02 63.08 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.284 1.034 . . . . 0.0 111.052 175.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.83 -7.5 11.43 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.068 0.947 . . . . 0.0 112.717 178.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -134.19 18.08 3.74 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.42 1.488 . . . . 0.0 111.336 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.7 mt -137.27 113.57 9.58 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.702 1.201 . . . . 0.0 108.422 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.78 164.14 36.63 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.366 2.044 . . . . 0.0 111.428 -178.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.6 20.46 1.12 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.163 1.385 . . . . 0.0 112.951 -171.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.8 m -153.94 139.1 17.43 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 120.999 -1.063 . . . . 0.0 108.41 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.42 -178.14 27.14 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.18 101.05 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -102.82 175.28 5.54 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.29 1.036 . . . . 0.0 110.462 -173.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.6 tp -145.66 108.3 4.48 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.4 t -86.56 131.65 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.6 mt -130.67 131.63 64.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.9 m -149.47 142.02 24.4 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.643 0.777 . . . . 0.0 109.192 -169.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.8 m -73.68 160.6 31.33 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 m -115.54 5.77 14.5 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.757 0.789 . . . . 0.0 112.678 -175.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 41.53 22.9 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 129.279 3.031 . . . . 0.0 114.181 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.89 19.31 29.12 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.462 -1.188 . . . . 0.0 114.562 -170.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.35 -13.32 0.13 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.491 1.646 . . . . 0.0 115.115 -169.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.43 -1.83 53.64 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 119.454 1.025 . . . . 0.0 113.081 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.96 155.87 38.18 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 169.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.9 mt -122.91 144.38 42.86 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.028 1.331 . . . . 0.0 107.863 -169.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.99 124.74 4.93 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.606 3.538 . . . . 0.0 113.62 172.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.5 -24.22 65.13 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.94 0.896 . . . . 0.0 113.066 -174.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -73.9 -22.46 59.69 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.0 tp -122.69 -29.9 3.95 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.152 0.981 . . . . 0.0 111.372 -170.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 t -45.75 -41.76 20.39 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.537 1.535 . . . . 0.0 113.684 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -51.16 -23.01 12.05 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.301 2.667 . . . . 0.0 116.122 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -56.76 -38.21 72.12 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.68 1.127 . . . . 0.0 111.027 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -58.23 -43.81 87.92 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.101 0.96 . . . . 0.0 110.458 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -72.48 -45.71 58.22 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.05 0.54 . . . . 0.0 109.841 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.62 -33.95 77.09 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 118.874 -0.584 . . . . 0.0 112.058 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.3 mt -63.85 -57.87 8.52 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -68.85 -27.24 65.64 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.829 0.741 . . . . 0.0 112.197 -172.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.06 -37.34 87.22 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.576 0.625 . . . . 0.0 110.615 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -105.65 -30.81 9.24 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -170.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.7 tttm 29.27 60.86 0.79 Allowed Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 128.019 2.528 . . . . 0.0 113.692 -174.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.408 ' HG3' HD21 ' A' ' 41' ' ' LEU . 83.3 Cg_endo -68.09 170.08 15.21 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.711 1.608 . . . . 0.0 110.089 172.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -74.23 110.99 8.96 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.2 mt -114.58 20.24 15.48 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.418 1.487 . . . . 0.0 110.948 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.8 m -62.15 19.35 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.994 1.718 . . . . 0.0 115.558 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.12 -0.8 2.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.338 1.455 . . . . 0.0 111.861 174.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 68.0 t -81.41 142.92 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 169.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -122.63 146.72 47.2 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 168.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -143.9 172.37 12.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.588 0.709 . . . . 0.0 110.803 -173.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.68 166.95 23.36 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 107.983 -2.047 . . . . 0.0 107.983 169.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.9 134.8 17.81 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -169.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.9 mt -138.68 128.82 33.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -177.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -104.32 104.59 2.45 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 107.983 -2.047 . . . . 0.0 107.983 173.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.3 mt -84.33 128.56 38.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.798 -1.926 . . . . 0.0 105.798 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.55 -146.48 6.06 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 -172.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.2 m -161.7 149.08 14.54 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.653 1.181 . . . . 0.0 110.36 171.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -64.7 -17.18 63.86 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.81 -36.55 84.7 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.207 0.603 . . . . 0.0 109.91 175.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -74.01 158.26 34.66 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.429 0.633 . . . . 0.0 110.708 176.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.49 -19.07 62.25 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.668 0.787 . . . . 0.0 112.523 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.4 m -110.79 139.63 45.93 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.445 1.098 . . . . 0.0 108.997 -172.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -117.41 -45.21 2.73 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.884 0.874 . . . . 0.0 111.126 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.2 m -136.35 -0.48 2.44 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.942 0.897 . . . . 0.0 113.172 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.77 -16.31 30.43 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 120.176 1.353 . . . . 0.0 115.087 -171.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.22 -59.49 2.62 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.477 1.139 . . . . 0.0 110.654 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.2 tp -60.92 -31.07 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.735 0.814 . . . . 0.0 109.693 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -51.43 -38.17 52.27 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.131 0.972 . . . . 0.0 112.165 177.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -71.84 -47.87 50.03 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.972 0.806 . . . . 0.0 109.961 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.3 mt -59.58 -48.34 82.05 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.299 0.64 . . . . 0.0 109.781 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -68.98 -37.66 78.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.1 85.92 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 118.564 -0.731 . . . . 0.0 110.508 -171.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -72.02 -28.26 63.26 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.309 0.958 . . . . 0.0 112.699 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.51 -43.88 84.04 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.571 1.532 . . . . 0.0 108.498 169.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -61.11 -44.3 97.56 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.2 1.0 . . . . 0.0 109.977 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -66.14 -35.25 80.0 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.988 1.715 . . . . 0.0 111.281 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 44.4 m -73.65 -8.13 54.77 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.786 0.834 . . . . 0.0 112.675 173.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.42 -18.13 8.85 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.797 1.189 . . . . 0.0 113.935 169.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.66 171.97 2.38 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.294 1.047 . . . . 0.0 111.286 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -144.32 155.44 43.81 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.972 -1.08 . . . . 0.0 112.287 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -56.44 168.12 0.6 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.948 1.699 . . . . 0.0 110.581 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 m -134.02 37.92 3.2 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.211 1.004 . . . . 0.0 110.266 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 139.6 -168.95 24.79 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 126.945 2.212 . . . . 0.0 110.245 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -89.84 143.32 26.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 117.928 0.864 . . . . 0.0 110.858 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.1 m -58.32 137.91 56.82 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.914 1.686 . . . . 0.0 111.447 -176.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 35.9 tp -91.44 148.92 21.96 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.795 0.438 . . . . 0.0 109.892 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -116.42 138.22 51.54 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 169.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.9 mt -124.4 99.29 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.18 92.25 6.27 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.051 1.74 . . . . 0.0 108.59 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 26.5 pt -66.67 -35.28 74.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -174.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.5 tp -63.1 -16.08 58.77 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.525 1.53 . . . . 0.0 112.518 -175.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -58.53 -37.68 76.15 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.653 0.66 . . . . 0.0 111.692 176.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -168.82 -52.07 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.228 1.411 . . . . 0.0 108.684 171.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -160.61 -34.72 0.05 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.271 1.828 . . . . 0.0 109.639 174.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.3 pt -142.38 161.01 52.34 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 129.026 2.931 . . . . 0.0 105.466 169.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.03 164.63 29.24 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 121.979 1.786 . . . . 0.0 111.042 176.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -64.18 -35.64 81.45 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.536 0.735 . . . . 0.0 111.126 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.26 117.13 40.29 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 123.989 0.916 . . . . 0.0 109.888 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.05 137.07 25.86 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.293 1.995 . . . . 0.0 110.463 -174.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.13 -22.6 65.98 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.895 0.478 . . . . 0.0 112.035 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -63.52 -30.2 71.35 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.693 0.797 . . . . 0.0 111.341 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -68.21 -43.98 76.8 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.214 0.915 . . . . 0.0 109.328 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -64.26 -39.17 93.39 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.81 0.844 . . . . 0.0 110.596 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.69 -30.91 71.05 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.65 -0.656 . . . . 0.0 110.954 176.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.04 -44.29 56.45 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.442 1.02 . . . . 0.0 111.49 171.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.6 m -64.16 -39.13 93.37 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.657 0.729 . . . . 0.0 110.588 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -62.47 -50.7 70.42 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 118.671 0.669 . . . . 0.0 110.869 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.5 m -66.74 -30.76 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.551 1.069 . . . . 0.0 111.027 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -67.76 -33.03 74.05 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.885 0.766 . . . . 0.0 111.333 175.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.43 -49.66 11.14 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.623 0.769 . . . . 0.0 110.154 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 pp -79.35 -21.46 45.79 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.471 -0.776 . . . . 0.0 112.716 -172.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp . . . . . 0 C--O 1.251 1.181 0 C-N-CA 127.382 2.273 . . . . 0.0 111.822 -179.366 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.83 -177.69 6.28 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.364 1.466 . . . . 0.0 108.962 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -128.13 -26.11 2.9 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.17 0.988 . . . . 0.0 111.476 -173.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.3 mt -130.74 85.98 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.1 m -82.01 115.16 21.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mp -74.28 155.35 38.33 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.5 mt -130.89 104.1 8.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.44 1.496 . . . . 0.0 107.076 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.25 133.14 35.23 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.708 0.803 . . . . 0.0 110.982 -177.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -125.34 86.76 0.36 Allowed Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 107.413 -2.275 . . . . 0.0 107.413 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.16 164.84 31.85 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.435 1.112 . . . . 0.0 111.974 173.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.3 p -135.92 -43.7 0.65 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 127.746 2.418 . . . . 0.0 106.742 169.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.79 -34.96 79.59 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.714 1.206 . . . . 0.0 111.468 173.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.72 -9.47 14.48 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.508 1.528 . . . . 0.0 113.194 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.52 -51.27 59.79 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 119.213 1.506 . . . . 0.0 112.203 -169.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.89 -22.76 63.2 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.566 -0.731 . . . . 0.0 111.231 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.25 -39.88 62.75 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.054 0.843 . . . . 0.0 110.135 176.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -68.47 -43.13 77.64 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.683 -0.636 . . . . 0.0 109.436 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.2 t -64.12 -39.71 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.049 175.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.91 -43.55 98.39 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 119.636 1.107 . . . . 0.0 110.88 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -61.02 -44.27 97.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.431 0.56 . . . . 0.0 110.411 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -60.84 -51.62 68.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.919 0.488 . . . . 0.0 110.541 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.7 mt -61.25 -43.63 98.56 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.463 0.705 . . . . 0.0 110.349 -177.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.21 -43.31 99.09 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.167 0.587 . . . . 0.0 110.294 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.0 -45.41 93.74 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.538 0.608 . . . . 0.0 110.293 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -60.98 -43.04 99.4 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.914 -0.491 . . . . 0.0 110.578 178.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 41.6 mt -64.24 -40.94 97.04 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.781 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.8 -38.22 88.37 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.944 0.793 . . . . 0.0 110.308 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -66.77 -36.74 83.13 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.294 0.497 . . . . 0.0 110.845 175.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.75 -25.46 64.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.283 0.633 . . . . 0.0 111.788 173.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.99 -0.17 14.82 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.331 1.444 . . . . 0.0 113.941 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -81.16 143.41 32.39 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.109 1.455 . . . . 0.0 109.69 -177.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 p -79.47 138.14 37.47 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.1 p -128.38 162.51 26.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.046 0.938 . . . . 0.0 109.979 -173.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -145.75 166.64 25.29 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 170.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.3 m -145.72 101.87 3.61 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 -177.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.85 106.92 18.81 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -175.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -74.93 105.71 6.09 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.53 56.13 26.74 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 118.368 -1.24 . . . . 0.0 115.355 172.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.7 172.8 7.61 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.93 2.42 . . . . 0.0 111.623 172.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.2 mt -128.14 170.23 13.2 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.977 2.111 . . . . 0.0 107.565 169.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 tt -54.49 -34.67 62.03 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.888 0.875 . . . . 0.0 111.737 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.06 -5.24 12.3 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.915 1.286 . . . . 0.0 112.591 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -135.23 17.59 3.42 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.944 1.298 . . . . 0.0 110.577 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -134.35 98.59 13.8 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 125.072 1.349 . . . . 0.0 108.628 -169.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -70.23 154.12 66.15 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.559 2.173 . . . . 0.0 111.961 -176.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.02 7.98 6.42 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.059 1.344 . . . . 0.0 114.452 -170.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.5 m -149.48 125.63 10.71 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.125 0.97 . . . . 0.0 108.444 -170.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.24 -175.74 28.32 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.0 mt -116.41 102.03 13.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -96.88 169.86 9.56 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.51 0.724 . . . . 0.0 109.428 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.6 tp -143.16 101.72 3.86 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.1 t -84.34 138.43 19.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 124.125 0.97 . . . . 0.0 108.793 -174.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mp -135.02 130.55 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.24 136.46 50.13 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.042 0.937 . . . . 0.0 110.366 -168.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 m -106.98 47.97 0.86 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.737 0.815 . . . . 0.0 111.175 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.1 m -33.02 105.83 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.178 2.191 . . . . 0.0 110.808 169.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.96 149.86 46.39 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 169.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -42.02 -35.27 1.61 Allowed Glycine 0 CA--C 1.531 1.031 0 C-N-CA 126.096 1.807 . . . . 0.0 116.437 -169.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.92 -10.64 59.25 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.46 46.45 4.34 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 -169.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -123.37 106.78 10.96 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -178.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.4 mt -65.02 141.0 98.26 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.86 141.19 89.02 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.869 2.379 . . . . 0.0 111.851 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -62.44 -14.97 46.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.911 1.684 . . . . 0.0 113.582 -173.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.72 -25.02 63.65 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.461 -0.774 . . . . 0.0 111.824 177.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 63.5 tp -128.68 -31.77 2.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.973 0.806 . . . . 0.0 112.348 -169.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.7 p -52.27 -34.25 15.22 Favored Pre-proline 0 CA--C 1.553 1.08 0 CA-C-O 116.744 -1.598 . . . . 0.0 114.298 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.15 -37.68 59.02 Favored 'Trans proline' 0 C--N 1.359 1.113 0 C-N-CA 123.296 2.664 . . . . 0.0 114.989 174.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -61.13 -44.39 97.41 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.396 0.544 . . . . 0.0 109.764 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -75.84 -30.47 58.95 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.975 0.51 . . . . 0.0 110.686 -173.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -62.56 -43.15 99.53 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.461 -0.774 . . . . 0.0 109.118 169.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.47 -20.65 66.1 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 118.4 -0.809 . . . . 0.0 112.737 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.16 -55.95 10.51 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.774 1.17 . . . . 0.0 109.051 172.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -64.78 -28.17 69.39 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.015 0.825 . . . . 0.0 111.734 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -67.09 -28.63 68.34 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.475 0.71 . . . . 0.0 111.631 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -123.22 -17.62 6.56 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 -169.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.8 tttp 41.02 58.61 8.54 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.322 1.449 . . . . 0.0 109.633 -168.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -67.19 158.47 56.79 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.803 2.335 . . . . 0.0 111.027 -170.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -81.99 84.46 6.96 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.853 0.861 . . . . 0.0 109.761 177.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 mt -108.95 26.82 10.16 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.642 1.577 . . . . 0.0 109.728 175.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.7 m -60.76 17.1 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 128.548 2.739 . . . . 0.0 116.012 -174.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.52 5.42 1.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.197 1.399 . . . . 0.0 111.909 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.9 t -77.66 137.62 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 169.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -124.02 146.94 48.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 168.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -150.03 166.91 28.27 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.421 -175.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -112.76 157.89 14.64 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 104.674 -3.37 . . . . 0.0 104.674 169.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.77 132.05 20.65 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.944 1.372 . . . . 0.0 110.187 -169.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 56.7 mt -138.39 138.75 42.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.93 150.31 17.63 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 107.864 -2.095 . . . . 0.0 107.864 169.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.7 mt -139.61 136.04 39.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.9 -164.02 30.53 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 176.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.0 m -110.33 104.21 12.97 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.218 1.407 . . . . 0.0 108.494 -175.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -59.68 -12.41 6.88 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.075 1.35 . . . . 0.0 113.056 -174.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -56.73 -32.53 65.63 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.486 1.039 . . . . 0.0 110.94 169.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -83.68 151.7 25.13 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.015 0.926 . . . . 0.0 110.026 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.75 -27.75 65.21 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -175.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.9 m -120.17 28.61 7.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.368 1.067 . . . . 0.0 110.795 -169.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -50.45 -33.82 22.51 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 -169.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 75.7 m -132.29 8.99 4.36 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.474 1.109 . . . . 0.0 110.888 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.09 -38.38 89.29 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 119.302 0.956 . . . . 0.0 112.452 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.16 -8.77 41.48 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.36 -27.45 41.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 119.714 1.143 . . . . 0.0 109.443 170.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.17 -39.16 89.54 Favored 'General case' 0 C--N 1.338 0.106 0 O-C-N 121.591 -0.693 . . . . 0.0 110.479 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -58.94 -49.02 79.42 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.96 -54.54 45.96 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.451 0.3 . . . . 0.0 110.501 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -64.19 -38.21 90.22 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.122 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.47 -36.37 78.88 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 119.396 -0.335 . . . . 0.0 111.192 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -74.5 -33.05 62.73 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.794 0.724 . . . . 0.0 110.909 -175.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.3 mt -69.24 -38.85 78.68 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.686 1.13 . . . . 0.0 109.7 169.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -62.05 -40.66 96.53 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.839 0.745 . . . . 0.0 110.124 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -65.2 -31.27 72.36 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.759 0.824 . . . . 0.0 111.415 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.6 m -77.47 4.71 10.41 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.234 1.013 . . . . 0.0 112.355 172.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.24 -11.55 63.63 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.735 1.159 . . . . 0.0 113.41 172.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.35 -178.21 0.48 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.556 1.178 . . . . 0.0 110.793 173.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.18 138.08 17.15 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.148 -0.97 . . . . 0.0 110.966 169.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.56 168.0 1.29 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.337 1.455 . . . . 0.0 108.512 169.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.6 m -135.16 151.61 50.83 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.3 -120.11 21.31 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -140.68 164.23 30.75 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.769 1.627 . . . . 0.0 106.966 170.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.0 m -83.48 139.18 33.08 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.552 -0.717 . . . . 0.0 109.532 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.4 tp -97.9 149.32 22.52 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.824 1.249 . . . . 0.0 109.893 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -119.36 146.33 45.41 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 169.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.7 mt -133.16 100.06 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -68.21 139.13 56.04 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 169.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.3 pp -129.62 15.54 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.22 1.008 . . . . 0.0 112.26 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.0 tp -128.09 131.87 49.03 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.075 0.852 . . . . 0.0 108.984 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.0 t70 68.01 -30.92 0.18 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.573 2.749 . . . . 0.0 114.146 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -142.76 173.7 11.31 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.446 2.298 . . . . 0.0 107.782 175.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -129.45 -140.51 0.23 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.557 1.943 . . . . 0.0 105.94 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.1 pt -132.9 40.05 0.55 Allowed Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.369 1.467 . . . . 0.0 112.214 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.44 -25.41 55.94 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 121.857 1.705 . . . . 0.0 112.979 -171.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.17 -10.82 59.57 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.054 0.942 . . . . 0.0 112.455 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -153.23 63.75 4.79 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 125.226 1.41 . . . . 0.0 108.466 -174.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -67.17 157.88 59.6 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.065 2.51 . . . . 0.0 112.459 -169.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.88 -33.52 64.67 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.559 0.744 . . . . 0.0 111.473 177.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.35 -40.25 74.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.056 0.942 . . . . 0.0 111.232 178.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -73.87 -42.33 60.93 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.726 -0.609 . . . . 0.0 109.895 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -68.55 -36.47 78.85 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.555 0.342 . . . . 0.0 110.621 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.6 tp -61.19 -39.53 90.53 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.81 0.844 . . . . 0.0 110.203 171.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.36 -48.32 48.38 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.575 1.083 . . . . 0.0 111.33 170.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.2 m -61.97 -41.47 98.05 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 117.645 0.723 . . . . 0.0 110.865 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -62.86 -50.82 69.4 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.481 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.8 m -63.96 -34.23 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 120.115 1.325 . . . . 0.0 110.733 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.0 -21.37 66.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.901 0.88 . . . . 0.0 113.05 176.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.32 -49.77 4.57 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.405 1.002 . . . . 0.0 111.12 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.76 -27.23 64.76 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.376 -173.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt . . . . . 0 C--O 1.252 1.197 0 C-N-CA 128.187 2.595 . . . . 0.0 113.102 175.277 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.05 154.38 42.44 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.939 1.295 . . . . 0.0 108.318 173.416 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -135.87 -25.06 1.27 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.982 1.313 . . . . 0.0 111.036 -179.202 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.7 mt -125.35 80.87 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 169.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.0 m -76.56 114.14 14.96 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.37 155.21 28.52 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.353 1.061 . . . . 0.0 109.233 174.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.1 mt -127.4 93.2 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -174.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -67.02 162.58 21.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.818 1.247 . . . . 0.0 110.158 172.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.78 58.36 0.08 OUTLIER Glycine 0 C--N 1.337 0.615 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -169.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.8 p -135.1 153.03 52.16 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.148 0.979 . . . . 0.0 110.502 170.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 p -99.46 -34.96 10.06 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.963 1.305 . . . . 0.0 109.323 169.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.1 pp -60.72 -25.98 66.83 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.695 1.198 . . . . 0.0 112.502 177.242 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.94 68.6 1.36 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.53 -47.03 0.05 OUTLIER Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 178.793 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.03 -28.62 69.92 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 117.874 0.837 . . . . 0.0 110.737 176.218 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -68.84 -40.46 79.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.094 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -76.75 -37.41 55.99 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 122.72 0.408 . . . . 0.0 110.62 -179.395 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.58 -43.01 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 118.454 0.57 . . . . 0.0 109.474 171.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.19 93.8 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.548 0.613 . . . . 0.0 110.395 177.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.14 -42.4 99.21 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.458 0.572 . . . . 0.0 110.872 178.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -61.81 -50.41 72.41 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.704 0.802 . . . . 0.0 110.165 178.27 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.3 mt -62.18 -39.75 93.72 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.383 0.673 . . . . 0.0 110.655 179.216 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.96 99.3 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.952 0.501 . . . . 0.0 110.6 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.12 -43.61 94.76 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.678 0.672 . . . . 0.0 110.3 178.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -58.27 -45.99 86.84 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.914 -0.492 . . . . 0.0 110.067 175.387 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.6 mt -62.48 -38.83 91.35 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.996 178.027 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.22 -38.51 90.65 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.23 0.923 . . . . 0.0 110.316 177.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.05 -36.74 82.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.54 0.609 . . . . 0.0 110.756 175.087 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.16 -25.28 65.19 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.154 0.581 . . . . 0.0 111.898 173.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.78 0.61 17.57 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.395 1.474 . . . . 0.0 113.998 170.225 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -83.59 149.57 26.48 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.04 1.42 . . . . 0.0 109.91 -178.669 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -87.86 140.18 29.77 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.191 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 p -139.22 165.97 25.76 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.305 1.042 . . . . 0.0 109.812 -169.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -154.42 155.4 34.91 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 169.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.9 p -126.28 84.31 2.26 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -171.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.6 mt -68.12 119.98 13.58 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -174.074 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -75.54 92.36 2.89 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.192 0.997 . . . . 0.0 108.458 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.45 61.79 5.65 Favored Glycine 0 CA--C 1.542 1.772 0 C-N-CA 124.628 1.108 . . . . 0.0 113.929 175.243 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -69.06 177.47 5.07 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.973 3.115 . . . . 0.0 111.875 179.036 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 38.3 mt -107.49 154.21 21.7 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.828 1.251 . . . . 0.0 107.965 169.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.46 -38.83 72.2 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.924 0.889 . . . . 0.0 111.539 -177.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.09 -18.09 63.01 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -75.3 -19.43 59.68 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.601 0.637 . . . . 0.0 111.862 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.1 mt -99.9 143.09 25.83 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 123.983 0.913 . . . . 0.0 110.517 -173.231 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.19 163.19 38.72 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.364 2.043 . . . . 0.0 109.26 169.052 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.81 25.66 0.77 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.521 1.128 . . . . 0.0 111.904 -176.575 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.5 m -155.89 142.2 18.43 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.13 1.372 . . . . 0.0 107.907 177.313 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 150.46 -176.16 29.18 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 178.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -128.92 101.24 6.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 178.002 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -103.14 171.82 7.16 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.202 1.001 . . . . 0.0 108.981 -177.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.2 tp -148.0 117.2 6.87 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 176.403 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.52 135.39 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -169.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.78 119.91 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.0 m -123.04 -174.42 2.94 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.799 1.64 . . . . 0.0 107.793 -174.083 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -144.47 170.26 16.37 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 168.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.452 HG21 ' O ' ' A' ' 97' ' ' THR . 24.1 m -126.24 129.28 48.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -67.17 -29.75 69.53 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 117.92 0.327 . . . . 0.0 111.393 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.94 -38.95 0.32 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.692 0.663 . . . . 0.0 112.805 175.006 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.87 19.15 7.85 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.054 0.942 . . . . 0.0 112.732 -170.054 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.62 -8.07 28.08 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.266 0.936 . . . . 0.0 113.171 174.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.12 121.3 15.32 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.495 1.147 . . . . 0.0 109.834 176.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.9 mt -78.11 142.01 63.44 Favored Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 176.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.75 145.28 86.18 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.602 2.868 . . . . 0.0 112.044 176.511 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.49 -17.73 34.14 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.964 1.706 . . . . 0.0 114.281 -173.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -62.42 -44.8 95.56 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.502 0.721 . . . . 0.0 109.429 178.214 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.2 tp -120.05 -17.58 8.35 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.334 0.654 . . . . 0.0 112.329 -170.008 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.4 p -53.94 -32.87 12.3 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -178.538 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -54.69 -23.99 35.38 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.518 2.146 . . . . 0.0 114.852 171.033 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -61.23 -38.54 87.0 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.33 0.968 . . . . 0.0 110.769 177.611 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -66.98 -37.15 83.71 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.237 0.471 . . . . 0.0 110.474 177.512 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.81 -45.94 69.91 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.392 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.72 -31.19 72.04 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.764 -0.585 . . . . 0.0 112.1 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.9 mt -61.71 -60.72 3.24 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 123.45 0.7 . . . . 0.0 109.405 171.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -71.14 -26.82 63.17 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -171.255 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -67.69 -37.18 81.96 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.686 0.676 . . . . 0.0 110.97 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -105.95 -34.38 7.63 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.96 0.504 . . . . 0.0 111.613 -170.306 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.9 tttp 32.73 59.27 1.47 Allowed Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 127.759 2.424 . . . . 0.0 113.59 -174.265 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -69.95 159.21 54.07 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.73 1.62 . . . . 0.0 110.004 174.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -71.76 127.65 33.23 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 169.306 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 pp -140.54 38.36 1.86 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.862 1.265 . . . . 0.0 110.129 177.698 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.1 m -59.43 24.41 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.856 2.462 . . . . 0.0 115.497 170.256 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.73 3.51 0.97 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.311 1.445 . . . . 0.0 112.184 178.356 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.9 t -87.35 146.11 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 169.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -122.11 146.44 47.21 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 168.093 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -137.63 168.98 18.57 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.009 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -125.43 156.57 19.28 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 104.802 -3.319 . . . . 0.0 104.802 169.007 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.06 123.9 25.29 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.408 1.104 . . . . 0.0 109.986 -169.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.2 mt -132.7 135.48 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.14 162.16 13.65 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 169.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.5 mt -141.71 144.13 26.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -177.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 175.41 166.35 32.91 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 106.743 -2.543 . . . . 0.0 106.743 177.622 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.4 m -73.55 134.53 43.8 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 169.742 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -61.61 -15.21 37.33 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -67.73 -23.95 65.32 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.158 0.983 . . . . 0.0 111.647 173.4 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -62.32 143.23 57.19 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.861 0.864 . . . . 0.0 111.14 -175.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.91 -33.09 75.2 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.426 0.69 . . . . 0.0 111.518 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.452 ' O ' HG21 ' A' ' 56' ' ' THR . 24.6 m -117.21 43.61 2.28 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.68 1.592 . . . . 0.0 108.049 178.707 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -43.96 117.33 1.17 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.73 1.212 . . . . 0.0 110.762 175.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 64.2 m 48.46 33.07 3.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.113 1.765 . . . . 0.0 113.751 -178.345 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.71 -24.9 19.46 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.366 -0.686 . . . . 0.0 112.912 -175.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.416 ' HB2' HG23 ' A' ' 56' ' ' THR . . . -67.44 -21.76 65.54 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.169 1.484 . . . . 0.0 113.807 -169.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 tp -57.99 -26.66 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.497 1.119 . . . . 0.0 110.237 172.65 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -57.94 -38.76 76.54 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.716 -0.615 . . . . 0.0 112.119 -174.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -72.43 -41.14 66.5 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.566 -0.709 . . . . 0.0 110.416 -178.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 45.3 mt -61.39 -47.64 84.89 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.396 0.678 . . . . 0.0 109.53 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -70.31 -36.55 74.39 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.76 -178.524 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.72 96.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.721 -0.656 . . . . 0.0 110.87 -169.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -74.05 -25.57 59.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.159 0.89 . . . . 0.0 111.717 -175.186 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.1 mt -66.23 -48.35 70.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.478 1.49 . . . . 0.0 108.603 169.687 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -61.11 -44.31 97.55 Favored 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 123.634 0.774 . . . . 0.0 109.611 -175.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -72.99 0.31 11.68 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.035 1.734 . . . . 0.0 112.722 178.168 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.3 m -122.72 7.21 9.4 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.55 1.14 . . . . 0.0 111.838 176.393 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 132.43 -34.0 2.57 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 118.547 -1.141 . . . . 0.0 114.598 168.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.22 177.88 0.77 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.715 1.258 . . . . 0.0 112.211 -178.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -149.54 162.18 40.66 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 121.399 -0.813 . . . . 0.0 111.039 169.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.27 165.35 3.58 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.059 1.344 . . . . 0.0 110.119 173.179 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.0 m -145.58 159.69 42.75 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 174.146 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.78 -124.7 32.89 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -172.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -139.33 163.53 32.25 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.3 m -66.06 149.67 49.89 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.7 tp -129.56 150.62 50.82 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.426 1.091 . . . . 0.0 109.259 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.24 142.48 47.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 176.451 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.4 mt -134.75 108.97 11.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -171.467 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -68.15 133.19 48.51 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.85 0.86 . . . . 0.0 110.593 178.229 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.1 pt -125.31 16.46 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 125.537 1.535 . . . . 0.0 111.462 174.029 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.18 -24.15 66.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.779 0.832 . . . . 0.0 110.863 170.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -126.07 161.99 26.35 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.578 1.551 . . . . 0.0 107.972 171.254 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -49.68 -48.97 49.25 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 127.234 2.214 . . . . 0.0 113.26 -169.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -158.74 103.37 1.72 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.686 1.195 . . . . 0.0 107.82 -173.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.3 tp -53.36 137.7 49.78 Favored Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 125.579 1.552 . . . . 0.0 110.077 175.829 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -56.43 169.21 1.73 Allowed 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.701 2.934 . . . . 0.0 114.582 177.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 58.36 -166.21 0.16 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.329 1.852 . . . . 0.0 111.68 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -138.53 69.58 45.77 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.562 1.145 . . . . 0.0 109.142 -178.571 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.29 -23.52 51.73 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.171 1.914 . . . . 0.0 111.533 179.054 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.74 -46.75 88.16 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.458 0.572 . . . . 0.0 109.807 175.401 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -63.99 -41.31 97.54 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.596 0.635 . . . . 0.0 110.993 176.421 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.81 -46.29 88.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.665 0.666 . . . . 0.0 110.632 -177.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -66.32 -35.92 81.6 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 122.68 0.392 . . . . 0.0 111.035 175.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 30.2 tp -62.96 -36.21 82.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.204 177.242 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.62 -47.06 65.08 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 170.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.4 m -64.26 -42.86 96.27 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.43 0.615 . . . . 0.0 110.839 177.021 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -60.27 -52.85 63.5 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.849 178.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.2 m -65.21 -34.0 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 119.94 1.246 . . . . 0.0 110.948 -177.576 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.46 -40.52 95.87 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.55 0.614 . . . . 0.0 111.652 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.5 mt -85.62 -35.63 20.86 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.103 -175.698 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 pp -76.6 -29.35 56.51 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.421 1.01 . . . . 0.0 111.659 177.212 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? . . . . . 0 C--O 1.249 1.026 0 C-N-CA 128.823 2.849 . . . . 0.0 113.695 179.434 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.206 0 N-CA-C 109.807 -0.442 . . . . 10.0 109.807 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -114.15 -24.45 8.97 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.859 1.263 . . . . 10.0 110.686 174.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.8 mt -125.94 89.66 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.146 0 N-CA-C 105.793 -1.929 . . . . 10.0 105.793 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.8 m -74.11 115.34 13.47 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.9 mp -77.27 154.0 33.39 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.701 -1.222 . . . . 10.0 107.701 169.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.8 mt -125.62 83.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 103.084 -2.932 . . . . 10.0 103.084 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 m -69.31 147.52 51.02 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.96 1.304 . . . . 10.0 109.272 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.46 81.59 0.15 Allowed Glycine 0 C--N 1.335 0.511 0 N-CA-C 111.119 -0.792 . . . . 10.0 111.119 -172.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.7 p . . . . . 0 C--O 1.232 0.176 0 CA-C-N 117.859 0.83 . . . . 10.0 110.142 165.954 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.99 0 N-CA-C 112.129 -0.389 . . . . 10.0 112.129 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.76 -31.24 70.14 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 117.899 0.849 . . . . 10.0 111.146 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -66.67 -42.37 86.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.099 0.863 . . . . 10.0 109.477 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -59.2 -53.04 62.84 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.133 0.573 . . . . 10.0 110.113 175.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.98 -40.37 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 119.012 -0.518 . . . . 10.0 110.006 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.54 -46.92 86.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.818 0.736 . . . . 10.0 110.433 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.75 -42.86 99.53 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.339 0.518 . . . . 10.0 110.444 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -62.6 -48.97 77.09 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.211 0.604 . . . . 10.0 110.114 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.439 HD21 ' HB1' ' A' ' 135' ' ' ALA . 23.7 mt -60.81 -43.59 98.0 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 124.029 0.932 . . . . 10.0 111.044 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.84 91.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.195 0.598 . . . . 10.0 110.534 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.02 -47.14 87.79 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.699 0.681 . . . . 10.0 110.281 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -61.59 -40.09 93.56 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 121.804 -0.56 . . . . 10.0 110.759 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.509 HD21 HD11 ' A' ' 139' ' ' LEU . 40.1 mt -64.16 -39.96 95.11 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 119.012 -0.518 . . . . 10.0 110.95 177.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.59 -38.81 92.28 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.847 0.749 . . . . 10.0 110.323 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.83 -33.81 75.5 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.914 0.779 . . . . 10.0 111.197 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.71 -20.58 65.28 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.266 0.626 . . . . 10.0 111.807 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.81 6.47 22.94 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.371 1.463 . . . . 10.0 113.376 171.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -103.28 135.87 44.11 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.196 1.498 . . . . 10.0 108.539 -173.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.8 p -79.69 147.42 31.97 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.024 0.53 . . . . 10.0 110.011 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.8 p -141.97 164.33 30.48 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.776 0.798 . . . . 10.0 111.309 -168.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -151.26 159.59 44.27 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.48 2.312 . . . . 10.0 105.103 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -131.0 61.45 1.63 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.356 1.462 . . . . 10.0 108.446 -171.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 mt -55.64 118.71 4.77 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.759 0.824 . . . . 10.0 108.957 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.21 116.57 16.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.178 -1.415 . . . . 10.0 107.178 171.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.8 50.49 14.78 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.027 -1.43 . . . . 10.0 115.73 167.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -65.3 164.35 26.0 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 CA-C-N 120.352 2.076 . . . . 10.0 110.391 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.7 mt -108.7 163.81 12.92 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.851 0.86 . . . . 10.0 108.754 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.408 HD13 ' C ' ' A' ' 41' ' ' LEU . 3.0 tm? -56.75 -39.99 74.98 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.849 0.86 . . . . 10.0 110.356 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.35 2.1 1.36 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.545 1.138 . . . . 10.0 113.705 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -126.33 17.23 7.7 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.691 1.596 . . . . 10.0 111.263 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.6 mt -132.01 123.43 18.96 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.837 1.255 . . . . 10.0 108.558 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.55 159.45 52.77 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 121.926 1.751 . . . . 10.0 110.565 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.74 11.1 1.82 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.664 1.186 . . . . 10.0 113.963 -174.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.0 m -143.71 138.66 29.02 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.114 1.366 . . . . 10.0 107.944 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.42 -177.7 31.64 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.457 -1.057 . . . . 10.0 110.457 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mt -125.6 96.13 3.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 104.699 -2.334 . . . . 10.0 104.699 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -97.14 175.54 6.26 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.17 0.588 . . . . 10.0 110.605 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.9 tp -150.13 99.09 2.78 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 107.812 -1.181 . . . . 10.0 107.812 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.6 t -83.5 130.82 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.751 -1.203 . . . . 10.0 107.751 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.9 mt -132.75 128.35 57.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.321 -2.103 . . . . 10.0 105.321 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.7 m -137.89 133.16 33.51 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.48 0.488 . . . . 10.0 109.936 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.3 m -62.61 160.67 13.53 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.506 0.669 . . . . 10.0 110.024 157.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.1 m -126.7 117.42 22.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 103.82 -2.659 . . . . 10.0 103.82 171.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -74.54 8.7 2.14 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.7 1.0 . . . . 10.0 113.7 -168.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.99 -22.94 26.66 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.766 1.651 . . . . 10.0 112.221 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.02 8.82 8.67 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.447 1.099 . . . . 10.0 112.505 -172.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.32 -2.86 81.61 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 123.534 0.588 . . . . 10.0 112.895 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -68.26 124.35 23.25 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.031 0.916 . . . . 10.0 108.737 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.9 mt -72.73 142.56 83.62 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 106.388 -1.708 . . . . 10.0 106.388 173.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.78 140.38 93.45 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.217 2.612 . . . . 10.0 111.066 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -60.34 -21.79 62.48 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.558 1.143 . . . . 10.0 113.118 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -50.99 -44.18 60.85 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.235 1.414 . . . . 10.0 111.132 169.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.1 tp -122.45 -19.34 6.43 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.745 0.818 . . . . 10.0 112.439 -168.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.9 p -52.78 -35.06 20.46 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 115.131 1.53 . . . . 10.0 115.131 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -54.73 -24.46 37.83 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.365 2.043 . . . . 10.0 114.577 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -62.02 -36.73 82.45 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.427 1.012 . . . . 10.0 111.027 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -61.16 -42.46 98.61 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.513 0.597 . . . . 10.0 110.205 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -72.01 -45.51 60.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.149 0.58 . . . . 10.0 109.732 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.45 -37.09 82.3 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.312 0.645 . . . . 10.0 111.315 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.8 mt -64.75 -59.44 4.23 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 118.726 -0.654 . . . . 10.0 109.529 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -66.99 -29.42 69.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.113 0.869 . . . . 10.0 112.372 -170.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.72 -34.14 76.28 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.226 0.611 . . . . 10.0 111.257 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -105.74 -27.55 11.23 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.417 0.687 . . . . 10.0 111.862 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt 26.73 62.82 0.56 Allowed Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 128.657 2.783 . . . . 10.0 112.858 -169.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.0 166.91 23.14 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.631 2.22 . . . . 10.0 110.364 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -71.53 120.17 16.73 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.533 -0.914 . . . . 10.0 108.533 165.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.2 mt -124.83 24.37 7.68 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.484 1.514 . . . . 10.0 110.255 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.7 m -63.96 10.8 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 115.803 1.779 . . . . 10.0 115.803 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.33 3.01 4.67 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.849 1.26 . . . . 10.0 112.23 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.1 t -74.66 131.8 34.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.752 -1.573 . . . . 10.0 106.752 165.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -105.31 150.81 24.86 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.29 -1.744 . . . . 10.0 106.29 157.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -145.54 159.36 43.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.273 0.559 . . . . 10.0 111.081 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -113.4 163.14 12.17 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 108.445 -1.862 . . . . 10.0 108.445 162.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.54 130.32 21.6 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.492 1.117 . . . . 10.0 108.299 -172.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 mt -134.78 133.21 54.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 105.866 -1.901 . . . . 10.0 105.866 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -108.65 145.04 16.39 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 108.336 -1.906 . . . . 10.0 108.336 166.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.4 mt -130.52 142.67 43.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.331 -2.1 . . . . 10.0 105.331 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.37 174.36 40.34 Favored Glycine 0 N--CA 1.453 -0.209 0 O-C-N 121.374 -0.829 . . . . 10.0 111.532 169.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.0 m -69.06 104.71 2.2 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.064 -1.088 . . . . 10.0 108.064 168.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -75.74 -10.57 59.55 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.321 0.86 . . . . 10.0 113.321 -163.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -76.62 -12.25 59.98 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.573 1.079 . . . . 10.0 112.236 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -64.17 162.59 14.19 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.185 0.902 . . . . 10.0 111.631 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.75 -34.36 74.32 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.92 0.888 . . . . 10.0 111.924 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 108.505 -0.924 . . . . 10.0 108.505 174.734 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.364 0 CA-C-O 120.685 0.279 . . . . 10.0 110.811 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.5 tp -57.1 -32.31 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.636 1.175 . . . . 10.0 111.691 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -54.96 -38.06 67.28 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.72 0.808 . . . . 10.0 111.933 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.92 -42.25 85.69 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.834 0.453 . . . . 10.0 110.98 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.3 mt -67.68 -49.28 63.6 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.163 -0.68 . . . . 10.0 109.163 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -63.77 -37.9 89.11 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 118.595 -0.717 . . . . 10.0 110.443 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.29 99.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.129 0.877 . . . . 10.0 110.643 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -74.09 -30.36 62.31 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 119.557 1.071 . . . . 10.0 112.043 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.2 mt -61.59 -48.25 81.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.826 1.193 . . . . 10.0 109.315 169.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -59.44 -45.93 90.19 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.724 1.21 . . . . 10.0 110.296 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -62.38 -38.62 90.32 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.822 1.649 . . . . 10.0 111.311 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.0 m -71.81 -11.87 61.01 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.427 1.091 . . . . 10.0 112.632 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.72 -12.64 8.76 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.706 1.146 . . . . 10.0 113.264 169.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.15 169.86 3.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.437 1.118 . . . . 10.0 110.585 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -138.32 145.16 40.85 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.441 -0.787 . . . . 10.0 111.009 168.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -63.18 166.79 5.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.403 -1.271 . . . . 10.0 109.19 172.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.3 m -132.61 153.06 51.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 105.606 -1.998 . . . . 10.0 105.606 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.99 -140.98 47.09 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 110.97 -0.852 . . . . 10.0 110.97 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -133.8 167.69 20.1 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.547 1.539 . . . . 10.0 108.147 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.2 m -82.64 123.22 29.05 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.793 0.837 . . . . 10.0 109.59 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.5 tp -85.48 145.95 27.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 122.636 0.374 . . . . 10.0 110.045 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -110.64 145.4 38.0 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.005 1.722 . . . . 10.0 106.956 169.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.5 mt -140.29 102.92 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.429 -1.693 . . . . 10.0 106.429 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -73.93 135.51 43.26 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.411 -0.589 . . . . 10.0 109.411 173.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.1 pp -128.67 7.75 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.109 0.963 . . . . 10.0 112.805 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.2 tp . . . . . 0 N--CA 1.469 0.489 0 CA-C-N 119.07 0.85 . . . . 10.0 111.3 -177.616 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.439 ' HB1' HD21 ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 110.184 -0.302 . . . . 10.0 110.184 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -56.27 -39.84 73.27 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.987 1.715 . . . . 10.0 112.164 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -67.52 -47.18 70.68 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.01 0.823 . . . . 10.0 109.091 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -61.97 -41.02 97.55 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.389 0.676 . . . . 10.0 110.353 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.509 HD11 HD21 ' A' ' 26' ' ' LEU . 35.3 tp -61.58 -38.99 89.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.802 1.241 . . . . 10.0 110.646 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.07 -50.25 62.74 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.862 -0.895 . . . . 10.0 110.862 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.5 m -60.65 -30.27 69.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.007 0.523 . . . . 10.0 111.786 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -52.87 10.74 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.488 0.715 . . . . 10.0 111.852 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.0 -32.04 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -59.96 -23.53 63.66 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.476 1.111 . . . . 10.0 113.622 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.5 mt -102.06 -44.23 5.52 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 120.139 1.336 . . . . 10.0 111.382 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.95 -27.43 62.78 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.786 -1.102 . . . . 10.0 112.244 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm . . . . . 0 C--O 1.252 1.194 0 C-N-CA 128.672 2.789 . . . . 10.0 113.417 -177.296 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 121.063 0.459 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -76.0 -29.48 58.18 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.136 0.975 . . . . 0.0 110.113 -175.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.8 mt -125.15 74.17 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.1 m -74.81 114.83 13.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.94 155.19 37.69 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 172.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.9 mt -116.95 112.06 37.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 103.829 -2.656 . . . . 0.0 103.829 172.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -113.86 155.55 25.53 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.531 1.532 . . . . 0.0 110.84 -169.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.01 131.21 1.28 Allowed Glycine 0 N--CA 1.448 -0.512 0 O-C-N 121.187 -0.945 . . . . 0.0 111.13 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.0 p . . . . . 0 C--N 1.328 -0.33 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 169.433 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.279 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.79 -27.7 68.47 Favored 'General case' 0 C--O 1.228 -0.075 0 CA-C-N 118.108 0.954 . . . . 0.0 110.702 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -60.48 -27.89 67.92 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.921 0.488 . . . . 0.0 111.029 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -95.89 -51.75 4.34 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.631 0.773 . . . . 0.0 110.426 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.61 -39.22 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.741 -171.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.92 89.08 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.414 1.006 . . . . 0.0 111.04 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -68.24 -41.19 81.57 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.637 0.653 . . . . 0.0 110.144 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -60.45 -49.4 77.73 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.927 0.491 . . . . 0.0 110.276 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.5 mt -60.05 -43.43 95.38 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.523 0.729 . . . . 0.0 110.42 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.83 98.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.976 0.511 . . . . 0.0 110.753 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -66.25 -42.55 88.43 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.129 0.571 . . . . 0.0 110.419 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -59.66 -39.85 85.82 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 121.507 -0.746 . . . . 0.0 111.085 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.513 ' HB2' HG21 ' A' ' 33' ' ' THR . 55.3 mt -68.28 -29.22 67.96 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.98 177.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -65.56 -38.26 89.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.713 1.142 . . . . 0.0 109.875 172.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.81 -39.29 93.34 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.948 0.794 . . . . 0.0 110.496 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.07 -21.83 64.96 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.545 0.738 . . . . 0.0 112.259 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.84 31.09 3.25 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 118.651 -1.083 . . . . 0.0 113.58 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -125.29 148.25 48.78 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.026 1.413 . . . . 0.0 110.055 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 p -71.88 146.28 47.99 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.513 HG21 ' HB2' ' A' ' 26' ' ' LEU . 12.6 p -139.19 160.06 40.68 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.486 0.66 . . . . 0.0 110.956 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -149.64 161.69 41.69 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 p -134.3 81.41 1.91 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -175.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.63 105.57 3.72 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -78.97 102.67 8.44 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.17 56.58 15.03 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-O 118.348 -1.251 . . . . 0.0 114.589 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -69.24 178.3 4.38 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.043 2.495 . . . . 0.0 110.804 171.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.8 mt -125.03 158.08 34.63 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 169.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -53.53 -31.0 44.45 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.237 1.015 . . . . 0.0 111.134 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -62.45 -10.72 12.51 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.353 1.861 . . . . 0.0 112.736 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -133.87 18.67 3.83 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.393 1.077 . . . . 0.0 110.905 -175.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -134.77 106.08 10.68 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.743 1.217 . . . . 0.0 108.881 -169.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.82 161.52 41.4 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.884 2.39 . . . . 0.0 112.969 -170.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.43 7.38 5.47 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.763 1.625 . . . . 0.0 114.934 -171.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.8 m -146.81 129.72 16.29 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.7 -179.86 27.95 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.4 mt -112.94 101.83 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -99.55 168.78 9.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.3 tp -146.83 112.69 5.72 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -98.36 134.45 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -169.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 mp -132.78 125.11 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.8 p -138.6 143.2 39.24 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.945 1.298 . . . . 0.0 107.82 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.1 p -77.04 175.41 9.62 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 169.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 97' ' ' THR . 40.9 m -130.7 123.43 29.29 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 169.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -69.07 -22.2 64.03 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 159.56 -35.53 0.47 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 118.696 0.68 . . . . 0.0 113.37 170.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.78 22.87 8.09 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.124 0.969 . . . . 0.0 112.153 -169.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.75 -1.1 56.67 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 123.936 0.779 . . . . 0.0 113.094 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.5 114.67 8.84 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.301 1.051 . . . . 0.0 109.582 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.7 mt -68.91 147.8 97.86 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 125.643 1.577 . . . . 0.0 107.795 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -56.54 137.61 81.32 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.113 3.209 . . . . 0.0 112.38 175.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -63.93 -22.31 66.86 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -169.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -71.55 -24.42 61.93 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.713 -0.617 . . . . 0.0 111.941 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.6 tp -121.92 -24.76 5.13 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.279 1.032 . . . . 0.0 111.771 -169.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.0 p -55.12 -28.21 3.91 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 116.924 -1.512 . . . . 0.0 114.939 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -53.4 -24.55 28.16 Favored 'Trans proline' 0 C--N 1.354 0.86 0 CA-C-N 122.903 2.073 . . . . 0.0 114.716 169.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -62.02 -43.92 97.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.58 1.082 . . . . 0.0 110.673 175.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -60.96 -40.01 91.7 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.866 0.866 . . . . 0.0 110.101 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -68.77 -48.37 63.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.853 0.461 . . . . 0.0 110.54 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.06 -28.59 67.51 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.464 -0.772 . . . . 0.0 112.37 -176.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.1 mt -67.6 -57.74 5.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.722 -0.656 . . . . 0.0 109.385 171.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -67.25 -29.2 68.77 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.06 0.846 . . . . 0.0 112.071 -171.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.82 -31.0 71.34 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.136 0.574 . . . . 0.0 110.775 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -115.09 -23.21 9.13 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -169.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.4 tttt 37.74 66.11 2.46 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.67 1.588 . . . . 0.0 110.796 -169.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.32 168.82 10.46 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.687 2.258 . . . . 0.0 110.696 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -92.68 107.2 19.04 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 169.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.5 mt -120.02 26.15 9.46 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.262 1.825 . . . . 0.0 110.045 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -61.58 18.62 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.318 1.847 . . . . 0.0 115.424 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.77 3.19 1.84 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.265 1.426 . . . . 0.0 111.855 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.7 t -79.53 140.46 16.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.5 mmm-85 -123.79 138.4 54.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 168.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -134.39 170.87 15.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.895 0.378 . . . . 0.0 110.653 -172.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.14 162.86 23.09 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 105.347 -3.101 . . . . 0.0 105.347 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.428 ' HB1' HD12 ' A' ' 102' ' ' ILE . . . -146.89 124.55 11.81 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.401 1.101 . . . . 0.0 109.446 -170.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.6 mt -133.73 124.27 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -100.7 156.73 19.34 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.4 mt -134.9 139.11 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.17 -151.42 13.74 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.6 m -126.02 135.36 51.71 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.727 1.211 . . . . 0.0 108.517 -175.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -66.72 -10.25 44.95 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.78 -15.03 58.25 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.979 0.809 . . . . 0.0 112.359 171.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -64.32 148.68 49.76 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.381 0.991 . . . . 0.0 110.847 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.65 -34.22 77.7 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.511 0.725 . . . . 0.0 111.392 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.461 ' O ' HG21 ' A' ' 56' ' ' THR . 34.8 m . . . . . 0 CA--C 1.536 0.42 0 C-N-CA 125.73 1.612 . . . . 0.0 107.467 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.438 ' N ' ' HG1' ' A' ' 56' ' ' THR . . . . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.428 HD12 ' HB1' ' A' ' 87' ' ' ALA . 0.1 OUTLIER -59.19 -29.7 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.964 0.905 . . . . 0.0 109.444 178.302 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -54.75 -34.18 62.2 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.104 0.962 . . . . 0.0 112.071 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -81.58 -37.83 27.07 Favored 'General case' 0 C--O 1.232 0.14 0 O-C-N 121.731 -0.606 . . . . 0.0 110.189 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.5 mt -57.89 -50.88 71.81 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -70.58 -32.98 70.57 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.394 -174.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.28 80.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.315 0.507 . . . . 0.0 110.103 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -79.79 -28.88 40.23 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.03 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.0 -45.75 84.25 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.379 1.445 . . . . 0.0 109.578 170.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -71.27 -33.66 69.97 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.469 0.577 . . . . 0.0 111.266 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -61.23 -39.66 91.09 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.178 0.591 . . . . 0.0 110.537 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.6 m -72.03 -7.82 50.98 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.221 1.008 . . . . 0.0 113.13 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.24 -14.93 10.15 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.644 1.116 . . . . 0.0 114.102 169.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.19 173.52 1.94 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.573 1.187 . . . . 0.0 111.341 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -143.83 148.1 35.04 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.019 -1.051 . . . . 0.0 112.153 170.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -58.78 158.55 7.94 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.376 1.87 . . . . 0.0 109.851 173.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.8 m -139.88 163.33 32.94 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.465 1.906 . . . . 0.0 106.087 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.35 -135.25 48.07 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -173.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -146.5 150.18 35.07 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 169.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.2 m -61.76 149.48 39.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.125 1.37 . . . . 0.0 111.176 -171.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.3 tp -129.81 151.21 50.64 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.343 1.057 . . . . 0.0 110.388 -173.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -119.87 150.4 40.51 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 23.5 mm -131.68 100.47 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -78.33 126.47 30.83 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 118.682 -0.675 . . . . 0.0 109.363 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.57 9.46 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.768 0.827 . . . . 0.0 112.152 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.1 tp . . . . . 0 N--CA 1.469 0.479 0 C-N-CA 126.067 1.747 . . . . 0.0 113.685 -174.228 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -56.33 -42.76 78.21 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.261 0.937 . . . . 0.0 112.041 -169.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -69.45 -40.3 77.24 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.999 -0.438 . . . . 0.0 110.453 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -72.36 -35.48 68.51 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.642 0.777 . . . . 0.0 110.58 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.97 -35.14 77.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.459 0.704 . . . . 0.0 109.958 170.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.47 -47.18 57.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.387 0.994 . . . . 0.0 111.177 169.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.8 m -62.59 -38.22 89.28 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 122.081 -0.658 . . . . 0.0 111.132 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -53.48 50.22 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.087 175.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.9 m -62.89 -31.25 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 119.799 1.182 . . . . 0.0 111.188 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -62.82 -27.03 69.04 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.593 -0.718 . . . . 0.0 112.669 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.2 mt -106.37 -37.09 6.63 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.216 0.917 . . . . 0.0 112.93 -176.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 pp -73.03 -12.59 60.98 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.465 1.03 . . . . 0.0 112.171 172.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.018 0 C-N-CA 129.451 3.1 . . . . 0.0 112.645 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.246 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -136.97 -25.37 1.08 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.79 1.236 . . . . 0.0 111.085 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.4 mt -130.52 82.38 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.0 m -75.23 121.15 21.72 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.9 mp -85.41 152.19 23.42 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.312 0.645 . . . . 0.0 109.711 174.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.8 mt -123.49 93.28 2.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 126.294 1.837 . . . . 0.0 106.161 -175.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -72.95 155.7 39.6 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.558 1.143 . . . . 0.0 110.862 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.2 65.17 0.26 Allowed Glycine 0 C--N 1.34 0.801 0 N-CA-C 114.239 0.456 . . . . 0.0 114.239 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.499 ' HG ' ' N ' ' A' ' 14' ' ' GLY . 9.4 t . . . . . 0 N--CA 1.455 -0.211 0 C-N-CA 124.52 1.128 . . . . 0.0 110.595 174.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.499 ' N ' ' HG ' ' A' ' 10' ' ' SER . . . . . . . . 0 CA--C 1.523 0.566 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.448 ' H ' ' HB2' ' A' ' 10' ' ' SER . . . -66.6 -28.25 68.36 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 117.51 0.655 . . . . 0.0 111.231 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -68.62 -44.8 73.5 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -70.55 -46.02 64.33 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.386 0.675 . . . . 0.0 109.94 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.9 t -62.15 -38.52 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 118.451 -0.785 . . . . 0.0 110.101 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.17 97.82 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.693 1.133 . . . . 0.0 110.777 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -63.49 -41.42 98.56 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.594 0.634 . . . . 0.0 110.551 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -63.85 -43.3 96.55 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.941 -0.474 . . . . 0.0 111.125 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.4 mt -63.78 -43.81 95.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.546 0.738 . . . . 0.0 109.666 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.33 -37.8 78.72 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.422 0.689 . . . . 0.0 111.219 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -52.55 -44.68 66.0 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.847 0.748 . . . . 0.0 110.482 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt -68.33 -37.54 80.63 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.834 -0.541 . . . . 0.0 109.813 -175.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.1 mt -68.09 -38.61 82.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.262 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.83 -38.57 89.26 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.361 0.528 . . . . 0.0 110.329 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.04 -37.05 84.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.599 0.636 . . . . 0.0 110.98 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.27 -26.0 66.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.972 0.509 . . . . 0.0 111.67 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.86 -3.88 10.77 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.32 1.438 . . . . 0.0 113.743 169.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -78.9 146.4 33.58 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.924 1.362 . . . . 0.0 109.981 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 p -83.5 146.6 28.28 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 169.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.2 p -134.43 169.29 17.47 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.806 0.842 . . . . 0.0 109.943 -170.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.1 158.73 44.41 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 169.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.4 m -130.42 81.96 2.03 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.9 mt -75.94 116.41 16.61 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -74.88 94.48 2.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.0 57.2 19.41 Favored Glycine 0 CA--C 1.54 1.635 0 CA-C-O 118.797 -1.001 . . . . 0.0 114.437 172.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.35 179.01 4.33 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.338 2.692 . . . . 0.0 111.297 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.8 mt -114.38 151.16 33.52 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 169.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -61.21 -28.89 69.47 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.348 0.659 . . . . 0.0 111.747 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.99 -21.59 63.68 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 175.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -82.89 -7.02 59.7 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.697 0.799 . . . . 0.0 111.812 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.1 mt -113.91 145.07 32.75 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 124.359 1.063 . . . . 0.0 109.989 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -70.15 162.89 40.57 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.758 2.305 . . . . 0.0 110.725 169.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.37 23.65 0.6 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.179 1.392 . . . . 0.0 112.024 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 m -156.37 142.87 18.48 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.352 1.461 . . . . 0.0 107.832 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 150.33 179.98 26.57 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.7 mt -122.24 101.74 10.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -107.12 170.59 7.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.535 1.134 . . . . 0.0 109.051 -175.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.8 tp -149.45 121.88 8.49 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.0 t -111.6 138.3 40.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -169.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -134.43 138.57 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.9 m -139.75 145.34 38.15 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.507 1.123 . . . . 0.0 109.213 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -99.21 95.72 7.27 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.752 0.786 . . . . 0.0 109.911 174.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.467 ' HG1' ' N ' ' A' ' 101' ' ' ALA . 24.3 m -58.54 135.42 57.31 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 169.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.4 p-80 -136.01 41.59 2.65 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.986 1.314 . . . . 0.0 108.961 -174.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.43 -35.37 2.43 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.765 1.65 . . . . 0.0 113.118 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.61 -21.03 66.13 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.058 1.343 . . . . 0.0 113.975 -171.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.11 33.78 64.95 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -172.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -141.42 149.92 41.66 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.319 1.048 . . . . 0.0 108.482 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 62' ' ' ILE . 4.2 mp -69.3 148.2 97.32 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -55.44 153.08 29.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.411 2.741 . . . . 0.0 112.635 169.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.77 -19.14 25.89 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.833 1.253 . . . . 0.0 114.003 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -63.15 -36.63 84.27 Favored 'General case' 0 C--N 1.343 0.289 0 O-C-N 121.801 -0.562 . . . . 0.0 110.591 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.2 tp -127.16 -18.25 4.6 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.883 -169.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.6 p -52.66 -32.43 9.51 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.54 -21.4 18.72 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.131 2.554 . . . . 0.0 115.773 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -56.82 -32.31 65.6 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.187 0.995 . . . . 0.0 110.96 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -62.79 -51.2 68.0 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -62.2 -42.98 99.79 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.027 0.531 . . . . 0.0 109.906 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.11 -27.52 68.43 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.445 0.698 . . . . 0.0 112.591 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 mt -75.94 -20.84 57.62 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.21 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -93.95 -41.78 9.41 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.038 1.29 . . . . 0.0 109.062 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -60.22 -36.54 77.92 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.105 0.962 . . . . 0.0 110.208 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -107.61 -37.11 6.26 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.089 0.555 . . . . 0.0 112.426 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm 27.31 64.3 0.59 Allowed Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 126.853 2.061 . . . . 0.0 113.355 -169.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -59.3 160.52 19.33 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.297 1.998 . . . . 0.0 111.276 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.35 50.72 1.12 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.978 1.311 . . . . 0.0 109.965 173.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.66 34.98 0.1 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.279 1.831 . . . . 0.0 114.168 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -61.75 23.42 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 128.699 2.8 . . . . 0.0 114.745 171.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.06 0.07 1.71 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.886 1.675 . . . . 0.0 111.672 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.6 t -82.47 147.97 5.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 169.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -126.29 141.34 51.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 168.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -140.01 175.38 9.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.225 0.536 . . . . 0.0 110.4 -172.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.07 164.92 26.09 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 106.631 -2.588 . . . . 0.0 106.631 169.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.69 124.89 15.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -169.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.8 mt -133.71 128.08 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 -177.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.66 120.33 5.37 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 107.576 -2.21 . . . . 0.0 107.576 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.9 mt -94.67 152.43 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 169.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 169.81 -144.01 8.26 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 172.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.2 m -132.59 127.69 35.57 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.38 -11.13 60.56 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.699 -0.626 . . . . 0.0 112.124 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.08 -28.44 69.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.513 0.725 . . . . 0.0 111.129 169.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -66.1 145.37 55.91 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 118.87 0.759 . . . . 0.0 109.479 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.98 -35.38 80.52 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 168.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 CA--C 1.544 0.736 0 C-N-CA 128.086 2.554 . . . . 0.0 109.138 169.592 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.467 ' N ' ' HG1' ' A' ' 56' ' ' THR . . . . . . . . 0 N--CA 1.468 0.446 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 tp -56.28 -28.63 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.02 1.728 . . . . 0.0 110.723 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -53.03 -37.46 61.56 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.77 0.828 . . . . 0.0 112.73 -173.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -65.23 -42.19 93.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 118.785 0.72 . . . . 0.0 111.458 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.7 mt -68.76 -50.74 47.95 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -37.06 81.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.729 -170.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.4 -35.48 79.37 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.58 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -72.76 -31.24 64.76 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.471 1.032 . . . . 0.0 111.978 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.2 mt -62.13 -44.8 95.84 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 120.77 1.623 . . . . 0.0 108.749 169.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -61.44 -44.6 96.84 Favored 'General case' 0 C--N 1.335 -0.055 0 C-N-CA 124.037 0.935 . . . . 0.0 110.057 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -65.26 -43.34 91.58 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.917 1.287 . . . . 0.0 110.891 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m -68.07 -27.07 66.18 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 119.204 -0.427 . . . . 0.0 111.286 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.94 -32.69 0.38 Allowed Glycine 0 CA--C 1.529 0.929 0 CA-C-N 118.987 0.812 . . . . 0.0 115.002 169.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.61 177.51 0.52 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.807 1.243 . . . . 0.0 113.498 -171.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -138.49 147.31 43.04 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.689 -0.632 . . . . 0.0 110.687 169.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -64.55 166.45 8.53 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.837 1.255 . . . . 0.0 109.404 175.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 m -137.88 153.06 49.59 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.286 1.834 . . . . 0.0 106.189 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 56.08 -139.1 44.18 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -170.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -137.44 157.02 47.48 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.4 145.98 52.57 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.589 1.156 . . . . 0.0 110.074 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.3 tp -120.42 138.85 53.55 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.563 0.745 . . . . 0.0 109.26 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -101.72 141.3 34.79 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 53.0 mt -130.7 136.21 58.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 175.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -125.78 96.03 4.63 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.567 1.547 . . . . 0.0 109.279 -169.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.4 pp -80.48 -3.98 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 O-C-N 121.433 -0.792 . . . . 0.0 112.668 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.3 tp . . . . . 0 CA--C 1.534 0.361 0 C-N-CA 123.846 0.858 . . . . 0.0 112.124 178.907 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 119.582 -0.247 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.55 -42.07 98.3 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.373 0.669 . . . . 0.0 110.411 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -76.88 -40.94 45.79 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.348 0.659 . . . . 0.0 109.703 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 -64.11 -42.15 96.98 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.928 0.491 . . . . 0.0 110.612 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 15.6 tp -66.57 -27.62 67.87 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.72 -0.612 . . . . 0.0 110.451 174.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.97 -48.37 82.99 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 169.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.6 m -63.68 -35.2 79.77 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.736 -0.861 . . . . 0.0 111.129 175.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 38.4 t90 -63.23 -50.68 69.28 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.211 0.605 . . . . 0.0 110.461 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 32.0 m -68.24 -29.21 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 121.214 -0.929 . . . . 0.0 111.444 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -60.71 -21.6 63.08 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.504 -0.76 . . . . 0.0 112.003 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.2 mt -101.77 -32.01 10.49 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 117.963 -1.018 . . . . 0.0 112.664 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.47 -28.35 66.01 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.471 1.487 . . . . 0.0 111.485 173.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttm . . . . . 0 C--O 1.251 1.167 0 C-N-CA 128.321 2.649 . . . . 0.0 111.596 -177.902 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.222 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -79.36 -31.18 42.87 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.967 0.907 . . . . 0.0 109.898 -172.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.7 mt -122.32 70.02 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.7 m -68.4 116.46 8.99 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.7 mt -86.09 155.09 20.95 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.0 mt -123.14 90.62 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -172.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.6 m -77.62 129.07 35.14 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.153 0.981 . . . . 0.0 110.619 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.0 60.99 0.66 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 124.637 1.113 . . . . 0.0 113.123 -169.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.41 ' HG ' ' N ' ' A' ' 14' ' ' GLY . 91.8 p . . . . . 0 N--CA 1.453 -0.275 0 CA-C-N 117.515 0.658 . . . . 0.0 109.894 169.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.41 ' N ' ' HG ' ' A' ' 10' ' ' SER . . . . . . . . 0 CA--C 1.529 0.915 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.34 -34.01 76.43 Favored 'General case' 0 C--O 1.227 -0.128 0 O-C-N 122.065 -0.667 . . . . 0.0 110.487 175.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.13 -39.84 86.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.676 0.671 . . . . 0.0 110.332 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -66.46 -46.28 76.95 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.996 0.918 . . . . 0.0 109.012 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.99 -49.19 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.88 87.59 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.927 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.57 -44.25 94.64 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.139 0.881 . . . . 0.0 111.101 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -68.91 -41.82 77.68 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.949 -0.469 . . . . 0.0 110.852 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.42 -42.05 98.72 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.66 96.33 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.769 0.828 . . . . 0.0 110.753 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -58.38 -42.87 88.01 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.595 0.634 . . . . 0.0 110.362 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -67.2 -39.61 86.36 Favored 'General case' 0 N--CA 1.461 0.109 0 O-C-N 121.738 -0.601 . . . . 0.0 111.179 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 mt -62.25 -37.64 86.2 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.54 0.609 . . . . 0.0 111.259 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.41 -38.44 87.47 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.092 0.86 . . . . 0.0 110.283 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -66.24 -35.77 81.28 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.609 0.64 . . . . 0.0 110.888 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.6 -26.79 66.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.085 0.554 . . . . 0.0 111.644 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.44 -3.36 10.32 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.269 1.414 . . . . 0.0 113.928 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -81.07 148.31 29.73 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.059 1.43 . . . . 0.0 110.342 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 p -79.05 144.42 34.65 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 169.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.8 p -140.64 163.96 31.48 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.284 0.634 . . . . 0.0 111.036 -176.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -150.47 151.62 32.99 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 105.437 -2.06 . . . . 0.0 105.437 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 p -108.81 73.15 0.85 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.32 104.01 6.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -169.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -73.25 121.54 20.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.15 51.85 29.14 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 117.89 -1.505 . . . . 0.0 116.759 169.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -67.23 175.84 5.35 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 CA-C-N 120.735 2.268 . . . . 0.0 111.368 170.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 mt -128.62 168.94 15.03 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.687 1.595 . . . . 0.0 108.659 171.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.38 -37.74 67.95 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.083 0.953 . . . . 0.0 110.902 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.36 -3.46 14.25 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.15 0.98 . . . . 0.0 113.294 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -125.17 9.33 8.0 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.919 1.288 . . . . 0.0 112.332 -170.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.45 149.78 52.29 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 124.127 0.971 . . . . 0.0 110.552 169.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.31 164.28 29.15 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.745 2.297 . . . . 0.0 111.471 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.67 21.19 0.84 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.204 1.402 . . . . 0.0 112.9 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.6 p -153.12 143.66 22.62 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.575 1.15 . . . . 0.0 108.772 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.19 -176.72 27.82 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.22 93.25 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -96.54 169.18 10.07 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.718 0.807 . . . . 0.0 109.796 -172.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.0 tp -135.39 124.14 23.86 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.73 130.48 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.53 121.04 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.4 m -138.4 133.07 32.4 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.307 0.643 . . . . 0.0 109.41 -169.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -77.13 163.85 26.22 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 169.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.0 m -114.35 119.04 35.58 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -66.69 -30.04 70.19 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.402 0.281 . . . . 0.0 110.965 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.49 -35.09 0.34 Allowed Glycine 0 CA--C 1.526 0.777 0 C-N-CA 123.791 0.71 . . . . 0.0 112.81 171.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.09 23.83 7.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.24 1.016 . . . . 0.0 112.192 -173.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.01 -3.62 60.47 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.196 -0.78 . . . . 0.0 113.098 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.29 149.18 47.66 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.448 1.124 . . . . 0.0 109.71 170.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.7 mt -113.71 144.27 31.11 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 126.043 1.737 . . . . 0.0 107.096 -169.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -48.72 139.94 23.46 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 124.223 3.282 . . . . 0.0 114.381 172.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -59.46 -21.56 60.25 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.634 1.574 . . . . 0.0 113.858 -172.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -67.35 -29.63 69.22 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.305 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.0 tp -127.64 -22.11 3.66 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.607 0.763 . . . . 0.0 112.049 -171.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 92.1 p -53.2 -31.66 8.3 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -52.1 -24.05 18.97 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.203 2.602 . . . . 0.0 115.278 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -58.5 -35.58 72.44 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.162 0.892 . . . . 0.0 110.773 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -62.45 -42.76 99.7 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.779 0.718 . . . . 0.0 110.484 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -68.89 -48.05 64.34 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.354 0.662 . . . . 0.0 109.286 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.28 -35.25 79.91 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 118.969 -0.539 . . . . 0.0 111.788 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.0 mt -65.72 -53.07 45.84 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.777 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -70.03 -28.34 65.39 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.337 0.972 . . . . 0.0 112.035 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.01 -35.03 77.63 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.515 0.598 . . . . 0.0 110.825 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -109.25 -33.64 6.8 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -169.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp 30.53 57.22 0.89 Allowed Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 127.385 2.274 . . . . 0.0 113.119 -172.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -69.3 172.0 12.97 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.169 1.913 . . . . 0.0 110.029 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -71.75 106.66 4.21 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.912 -0.493 . . . . 0.0 110.077 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.1 mt -113.0 20.43 16.37 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.601 1.56 . . . . 0.0 110.899 176.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 m -63.31 19.97 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.957 1.703 . . . . 0.0 115.548 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -135.28 0.1 2.77 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.208 1.403 . . . . 0.0 111.762 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 64.5 t -82.13 133.78 28.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -108.99 142.78 39.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 103.444 -2.798 . . . . 0.0 103.444 168.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -136.41 168.35 19.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 119.13 0.877 . . . . 0.0 111.354 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.16 163.48 23.53 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 105.561 -3.015 . . . . 0.0 105.561 169.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.06 124.4 13.04 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -169.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 52.1 mt -133.38 133.25 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.62 150.47 18.01 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.4 mt -139.79 150.44 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.35 -45.77 0.49 Allowed Glycine 0 C--N 1.33 0.237 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 169.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.2 m 115.01 140.92 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 1 C-N-CA 132.08 4.152 . . . . 0.0 108.056 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -67.81 0.84 2.97 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -63.62 -30.58 71.67 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.719 0.808 . . . . 0.0 109.994 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -70.8 156.43 39.55 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.467 0.707 . . . . 0.0 110.853 174.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.14 -37.5 83.06 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.659 0.783 . . . . 0.0 111.785 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.6 m . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 172.115 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.0 tp -57.93 -28.11 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.755 1.222 . . . . 0.0 110.834 175.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -52.3 -38.68 59.1 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.194 0.997 . . . . 0.0 112.288 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -73.52 -41.12 63.44 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 121.84 -0.537 . . . . 0.0 110.489 -174.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 50.0 mt -64.2 -51.56 63.12 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.17 -38.67 82.31 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -169.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.35 75.23 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 122.049 -0.407 . . . . 0.0 110.576 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -74.13 -31.06 62.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.708 0.685 . . . . 0.0 110.691 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.88 -43.34 96.36 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.429 1.013 . . . . 0.0 108.885 169.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -61.98 -43.79 98.1 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.842 0.457 . . . . 0.0 109.826 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -64.28 -35.92 82.41 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.441 0.696 . . . . 0.0 111.132 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.5 m -71.47 -7.39 47.15 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.164 0.986 . . . . 0.0 112.927 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.85 -17.49 10.85 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.765 1.174 . . . . 0.0 113.787 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.2 171.61 1.29 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.266 1.033 . . . . 0.0 111.158 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -142.5 153.4 43.59 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 121.114 -0.991 . . . . 0.0 111.714 172.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -71.24 156.62 39.33 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.362 174.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 66.2 m -128.0 151.74 48.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.819 2.048 . . . . 0.0 106.675 169.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 62.0 -146.19 49.11 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -172.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -135.44 156.4 48.97 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.647 1.179 . . . . 0.0 108.206 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.66 152.64 45.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.986 1.314 . . . . 0.0 110.462 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.8 tp -129.98 144.17 51.19 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.443 1.097 . . . . 0.0 108.826 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -115.52 153.83 30.46 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 169.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 38.1 mt -134.76 109.14 11.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -172.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -77.63 135.9 38.17 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.555 0.742 . . . . 0.0 109.353 170.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 46.5 pt -129.23 -15.69 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.945 1.698 . . . . 0.0 112.131 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.2 mt . . . . . 0 N--CA 1.467 0.388 0 CA-C-N 119.121 0.873 . . . . 0.0 112.761 -170.06 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.136 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -62.37 -44.61 96.05 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.022 0.529 . . . . 0.0 110.363 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -62.44 -49.77 74.11 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.666 0.386 . . . . 0.0 110.306 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 9.1 t-105 -67.95 -36.25 79.79 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 122.172 -0.33 . . . . 0.0 110.871 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.35 -41.38 93.54 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 118.906 -0.569 . . . . 0.0 110.032 173.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.81 -49.85 60.35 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 173.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.7 m -62.05 -36.6 82.1 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.161 0.584 . . . . 0.0 111.261 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 21.0 t90 -66.36 -53.05 40.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 119.137 -0.459 . . . . 0.0 110.124 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.1 m -66.21 -29.88 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 118.997 0.817 . . . . 0.0 111.514 -176.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -54.36 -25.33 23.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.89 0.876 . . . . 0.0 112.314 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 29.5 mt -100.29 -0.26 38.83 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.255 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.9 pp -124.71 -8.8 7.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.218 1.372 . . . . 0.0 113.59 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 71.8 mttt . . . . . 0 C--O 1.252 1.189 0 CA-C-N 119.542 1.065 . . . . 0.0 110.73 178.256 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -75.72 -30.84 59.41 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.812 0.845 . . . . 0.0 109.949 -171.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.0 mt -124.96 74.71 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 m -74.45 114.1 12.45 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 mp -74.27 155.03 38.68 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.0 mt -122.4 86.53 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 m -81.21 157.14 25.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.44 1.496 . . . . 0.0 111.722 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.0 135.26 1.92 Allowed Glycine 0 N--CA 1.444 -0.795 0 O-C-N 121.204 -0.935 . . . . 0.0 110.934 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 31.2 p . . . . . 0 C--N 1.329 -0.283 0 C-N-CA 123.723 0.809 . . . . 0.0 111.943 169.018 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.696 0 CA-C-O 119.791 -0.449 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.02 -21.17 66.39 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.184 0.992 . . . . 0.0 111.139 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.61 -35.8 77.03 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.206 0.602 . . . . 0.0 110.409 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -71.82 -40.22 69.28 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 122.062 -0.398 . . . . 0.0 110.155 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.97 -39.31 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.98 99.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.273 0.629 . . . . 0.0 110.084 175.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.19 -42.1 98.97 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.741 0.7 . . . . 0.0 110.571 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -61.51 -48.25 81.91 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.429 0.559 . . . . 0.0 110.814 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.0 mt -59.67 -46.3 89.47 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.343 0.657 . . . . 0.0 109.988 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.32 87.19 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.911 0.884 . . . . 0.0 111.397 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 -68.96 -45.52 70.49 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.567 0.747 . . . . 0.0 109.82 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -61.97 -41.3 97.85 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.363 0.528 . . . . 0.0 110.499 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.0 mt -62.72 -37.59 87.14 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.008 0.523 . . . . 0.0 111.396 173.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -67.15 -38.67 85.9 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.692 0.678 . . . . 0.0 110.373 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.54 -35.55 81.18 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.872 0.469 . . . . 0.0 110.839 173.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.89 -28.0 68.63 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.408 0.549 . . . . 0.0 111.335 172.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.39 -8.76 6.23 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.984 1.278 . . . . 0.0 114.155 169.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -80.0 143.76 33.83 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.962 1.381 . . . . 0.0 110.029 -174.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 p -70.95 141.05 51.09 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 169.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.8 p -134.91 159.44 41.43 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.143 0.497 . . . . 0.0 111.624 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -152.18 162.99 40.3 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -135.71 79.29 1.77 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.67 113.56 13.26 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -82.76 110.63 17.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.25 51.97 56.03 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-O 118.018 -1.434 . . . . 0.0 115.613 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -67.49 178.05 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.954 2.436 . . . . 0.0 111.322 170.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.0 mt -131.04 163.61 27.22 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 125.453 1.501 . . . . 0.0 109.56 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.3 tp -59.91 -36.18 76.44 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.656 1.182 . . . . 0.0 111.216 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.63 -3.79 10.04 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -134.56 22.63 3.67 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.783 1.633 . . . . 0.0 110.567 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.3 mt -137.41 123.1 12.93 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 125.286 1.434 . . . . 0.0 108.102 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.41 159.61 48.86 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.201 1.934 . . . . 0.0 110.486 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.02 17.23 1.26 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.586 1.155 . . . . 0.0 113.256 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.1 m -146.02 132.48 19.7 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.477 1.111 . . . . 0.0 108.429 -174.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 153.28 178.53 27.93 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.35 94.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -91.73 168.55 11.39 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.248 0.619 . . . . 0.0 109.402 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.3 tp -146.23 105.92 3.97 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.8 t -91.19 147.77 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -172.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.14 140.71 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 m -151.09 150.85 31.18 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.568 1.147 . . . . 0.0 108.623 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.6 m -69.62 159.29 33.7 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.044 0.45 . . . . 0.0 111.871 174.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.57 63.72 1.51 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 168.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -84.19 23.19 1.1 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.905 1.682 . . . . 0.0 110.855 -169.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.6 -13.48 41.41 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.484 1.04 . . . . 0.0 113.027 -170.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.86 -29.23 63.03 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.729 1.265 . . . . 0.0 112.916 -176.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.417 ' H ' HG21 ' A' ' 97' ' ' THR . . . 60.09 33.12 78.14 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.008 0.814 . . . . 0.0 112.003 -175.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -144.43 149.12 35.52 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.081 1.352 . . . . 0.0 107.683 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.4 mt -64.91 142.12 98.55 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -170.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.39 143.49 93.61 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.187 1.924 . . . . 0.0 110.939 -176.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.29 -28.48 58.88 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -169.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -70.83 -25.18 62.72 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 122.018 -0.426 . . . . 0.0 112.03 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.8 tp -120.5 -23.46 6.1 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.534 1.134 . . . . 0.0 111.832 -169.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 89.0 p -54.58 -30.32 6.67 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -52.21 -24.92 21.9 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.529 2.153 . . . . 0.0 114.598 169.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -60.26 -45.46 93.2 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.412 1.005 . . . . 0.0 110.542 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -64.43 -36.67 84.91 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.91 0.484 . . . . 0.0 110.661 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -65.35 -45.95 82.12 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.15 0.432 . . . . 0.0 110.183 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.51 -41.21 93.44 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.724 -0.61 . . . . 0.0 111.188 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.8 mt -60.42 -52.23 66.12 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.431 0.692 . . . . 0.0 110.334 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -70.92 -27.83 64.06 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.565 0.621 . . . . 0.0 111.505 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.82 -51.59 46.81 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.845 0.748 . . . . 0.0 109.686 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -85.17 -24.01 28.11 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.629 -169.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm 41.71 60.1 8.96 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.143 1.377 . . . . 0.0 111.166 -171.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -68.43 176.62 5.5 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.771 2.981 . . . . 0.0 111.971 -174.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -106.6 107.24 18.16 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 169.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.7 mt -119.62 24.38 10.65 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 126.44 1.896 . . . . 0.0 110.058 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.7 m -52.83 -10.2 0.15 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.89 -1.68 13.8 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.488 1.115 . . . . 0.0 111.222 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.0 t -80.91 141.99 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 168.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.92 146.97 50.81 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 168.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -137.9 171.71 14.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.295 0.569 . . . . 0.0 112.17 -169.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.52 167.48 26.17 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 105.64 -2.984 . . . . 0.0 105.64 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.419 ' HB3' HG23 ' A' ' 120' ' ' THR . . . -147.69 134.41 19.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.653 0.727 . . . . 0.0 109.649 -169.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.7 mm -128.14 132.77 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.05 130.48 9.65 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 173.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -127.37 126.07 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -172.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 171.22 -141.64 6.57 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -169.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.9 m -115.94 99.21 7.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.172 0.989 . . . . 0.0 108.759 -171.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -13.06 57.97 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.295 0.638 . . . . 0.0 112.561 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -56.76 -28.26 60.9 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.969 0.908 . . . . 0.0 111.002 169.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -123.25 -31.56 3.55 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.522 1.129 . . . . 0.0 110.914 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.7 t70 66.57 -16.31 0.13 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 129.608 3.163 . . . . 0.0 114.859 172.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.417 HG21 ' H ' ' A' ' 60' ' ' GLY . 1.8 m . . . . . 0 CA--C 1.552 1.047 0 C-N-CA 126.635 1.974 . . . . 0.0 112.36 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.558 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 tp -141.15 -34.1 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.028 1.331 . . . . 0.0 109.772 172.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -50.97 -36.01 36.7 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.322 1.049 . . . . 0.0 112.492 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -71.68 -55.35 7.88 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.59 -0.694 . . . . 0.0 110.676 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 pp -65.04 -40.51 94.91 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -72.1 -39.25 69.04 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -172.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.69 -30.64 70.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 119.05 -0.5 . . . . 0.0 110.431 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -70.83 -33.56 70.79 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.207 0.912 . . . . 0.0 110.912 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.1 mt -64.0 -40.82 97.21 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.129 1.332 . . . . 0.0 109.235 169.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -63.42 -43.43 97.51 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -63.04 -38.71 92.29 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.708 0.803 . . . . 0.0 110.762 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.6 m -67.9 -10.62 54.68 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.986 0.914 . . . . 0.0 112.75 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.56 -18.17 8.22 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.013 1.292 . . . . 0.0 113.606 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.24 175.79 0.89 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.371 1.086 . . . . 0.0 111.522 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -146.62 159.66 43.17 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.362 -0.836 . . . . 0.0 109.784 169.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -73.46 168.14 19.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.534 1.134 . . . . 0.0 109.473 175.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 m -133.25 145.27 50.37 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 127.105 2.162 . . . . 0.0 106.237 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.58 -133.12 52.8 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -173.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -140.99 160.12 40.75 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.355 1.862 . . . . 0.0 106.149 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.419 HG23 ' HB3' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -61.58 157.89 16.38 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.086 1.354 . . . . 0.0 111.033 -178.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 51.4 tp -126.86 149.84 49.53 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.86 0.864 . . . . 0.0 109.333 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -116.33 147.93 41.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 172.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 25.7 mm -132.89 138.73 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -108.94 133.98 52.21 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.664 1.186 . . . . 0.0 108.802 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.7 pp -127.1 4.96 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.868 1.267 . . . . 0.0 111.273 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.4 tp . . . . . 0 CA--C 1.532 0.253 0 C-N-CA 123.435 0.694 . . . . 0.0 111.872 -177.704 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.299 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.64 -37.83 73.99 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.681 0.792 . . . . 0.0 111.242 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -69.74 -38.57 76.87 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.848 -0.533 . . . . 0.0 110.494 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -65.52 -43.04 91.3 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.619 0.368 . . . . 0.0 110.063 172.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 28.2 tp -60.6 -39.46 88.22 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.3 0.64 . . . . 0.0 110.498 -173.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.15 -48.88 65.7 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.6 m -65.31 -35.98 82.67 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.047 -0.678 . . . . 0.0 111.148 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 17.1 t90 -66.18 -51.16 60.41 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.3 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.0 m -65.78 -28.98 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 119.128 0.876 . . . . 0.0 111.528 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -57.65 -24.23 55.51 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.808 -0.615 . . . . 0.0 112.169 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.5 mt -102.04 3.08 38.41 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 pp -124.6 -10.21 7.36 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.717 1.144 . . . . 0.0 113.24 174.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.249 1.036 0 C-N-CA 125.845 1.658 . . . . 0.0 112.188 -179.958 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.332 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -131.82 -28.43 1.79 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.487 1.515 . . . . 0.0 110.404 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.1 mt -123.93 84.51 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 169.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.5 m -75.94 109.55 9.66 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.74 154.39 38.41 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 89.1 mt -126.85 88.81 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 m -69.55 145.87 52.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.113 1.365 . . . . 0.0 109.933 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.07 49.82 0.66 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.411 0.529 . . . . 0.0 114.064 -169.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.234 0.252 0 C-N-CA 124.677 1.191 . . . . 0.0 108.138 169.408 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.271 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.8 -42.17 95.24 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 122.673 0.389 . . . . 0.0 109.974 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -67.44 -31.8 72.24 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.024 0.93 . . . . 0.0 112.082 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -70.18 -46.66 64.15 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.3 t -68.43 -35.65 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 118.998 -0.525 . . . . 0.0 109.723 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.09 88.09 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 119.026 0.83 . . . . 0.0 110.873 173.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -62.54 -42.02 99.26 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.052 0.842 . . . . 0.0 110.778 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -66.06 -45.7 80.38 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 122.027 -0.42 . . . . 0.0 110.488 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -59.97 -43.54 95.03 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.418 0.687 . . . . 0.0 110.098 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.51 99.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.751 0.82 . . . . 0.0 110.669 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -63.4 -44.18 95.41 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.559 0.618 . . . . 0.0 110.406 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -62.59 -40.44 96.9 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 121.635 -0.665 . . . . 0.0 110.516 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 41.2 mt -63.48 -38.35 90.8 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 118.449 -0.786 . . . . 0.0 111.954 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.95 -38.8 92.15 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.411 1.005 . . . . 0.0 110.358 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -66.47 -35.81 81.2 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.251 0.478 . . . . 0.0 110.872 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.72 -26.37 65.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.163 0.585 . . . . 0.0 111.712 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.44 -2.83 10.37 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.266 1.412 . . . . 0.0 114.137 169.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -82.07 142.91 31.89 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.094 1.447 . . . . 0.0 109.579 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 p -80.97 142.41 33.49 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.1 p -136.94 166.23 24.12 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.575 0.702 . . . . 0.0 110.991 -169.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -150.31 159.53 44.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 169.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 p -128.04 76.62 1.7 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.1 mt -70.54 113.59 7.8 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -76.69 107.29 8.88 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 52.8 52.13 40.64 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-O 118.521 -1.155 . . . . 0.0 115.057 172.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -67.7 177.74 3.88 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.092 2.528 . . . . 0.0 111.13 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.2 mt -127.91 166.84 17.54 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.271 1.428 . . . . 0.0 108.968 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -53.21 -36.85 61.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.489 1.516 . . . . 0.0 112.127 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.46 -7.13 8.88 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.237 1.015 . . . . 0.0 113.415 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -132.14 21.88 4.47 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.778 1.631 . . . . 0.0 110.976 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.2 mt -134.12 112.95 12.35 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.558 1.143 . . . . 0.0 109.273 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -66.34 157.44 60.18 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.35 2.034 . . . . 0.0 111.963 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.33 10.61 26.71 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.757 1.223 . . . . 0.0 114.288 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.7 m -144.4 124.57 13.69 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 150.79 -171.36 30.56 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.8 mp -124.92 99.22 5.89 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -94.23 174.09 7.32 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.722 0.809 . . . . 0.0 109.515 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.6 tp -144.87 98.6 3.21 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.7 138.61 19.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 mt -130.11 148.57 33.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.8 m -146.33 137.64 24.54 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 m -70.54 144.57 51.26 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 168.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 p -85.34 1.96 46.25 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -177.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 45.08 19.61 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 129.537 3.135 . . . . 0.0 114.394 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.58 23.74 29.29 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 120.905 -1.122 . . . . 0.0 113.149 -169.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.82 -9.09 0.41 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.342 1.071 . . . . 0.0 113.515 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.81 34.72 42.2 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 118.862 0.756 . . . . 0.0 111.642 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -140.32 146.93 39.13 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.053 0.941 . . . . 0.0 109.214 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.482 ' H ' HD12 ' A' ' 62' ' ' ILE . 3.6 mp -76.73 146.1 75.84 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -57.42 155.07 32.13 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.951 2.434 . . . . 0.0 111.663 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -59.56 -16.28 24.17 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.115 1.366 . . . . 0.0 114.107 -174.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -64.46 -39.82 94.54 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.519 0.728 . . . . 0.0 111.083 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.2 tp -122.97 -20.64 5.73 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.185 0.594 . . . . 0.0 112.313 -171.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 t -49.2 -39.05 33.4 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.75 -23.78 8.91 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.463 2.775 . . . . 0.0 116.162 172.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -59.94 -37.03 78.33 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.658 1.117 . . . . 0.0 111.16 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -59.03 -42.94 91.4 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.237 0.615 . . . . 0.0 110.34 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -68.65 -48.24 64.51 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.401 0.68 . . . . 0.0 109.79 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.34 84.03 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 118.924 -0.56 . . . . 0.0 112.094 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.6 mt -65.84 -53.82 34.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 118.65 -0.69 . . . . 0.0 109.503 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -69.15 -28.58 66.56 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.162 0.892 . . . . 0.0 111.847 -174.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -66.09 -36.44 83.19 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.709 0.686 . . . . 0.0 110.725 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -107.22 -20.74 13.19 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -169.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm 39.71 60.54 6.31 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.873 1.669 . . . . 0.0 111.057 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.95 167.25 14.38 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.752 2.968 . . . . 0.0 111.997 -174.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -95.52 73.27 3.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.386 1.075 . . . . 0.0 109.332 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.47 16.68 9.82 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.26 1.424 . . . . 0.0 111.517 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.9 m -51.57 10.95 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 129.601 3.161 . . . . 0.0 116.921 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.22 2.18 2.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.168 1.387 . . . . 0.0 112.213 174.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.5 t -80.16 140.87 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 169.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -116.84 151.07 37.31 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 168.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -147.43 170.83 16.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.189 0.904 . . . . 0.0 112.48 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.55 161.16 23.95 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 104.766 -3.334 . . . . 0.0 104.766 169.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.423 ' HB1' HD12 ' A' ' 102' ' ' ILE . . . -140.98 132.88 27.59 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -169.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.2 mt -137.72 126.32 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 -173.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -114.93 121.07 5.2 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.1 mt -123.47 134.32 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 118.232 1.016 . . . . 0.0 108.34 -169.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.02 -164.42 37.96 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.5 m -75.06 75.22 2.25 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 125.621 1.569 . . . . 0.0 109.186 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -65.1 -12.2 48.19 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.448 1.099 . . . . 0.0 113.39 -171.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -65.56 -22.49 66.7 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.379 0.536 . . . . 0.0 111.475 170.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -75.01 174.31 9.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.055 0.942 . . . . 0.0 110.326 175.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.34 -29.9 70.96 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.712 0.805 . . . . 0.0 113.16 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 58.3 m . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -178.866 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.423 HD12 ' HB1' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -66.04 -34.99 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -175.14 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.0 -37.33 63.9 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.279 1.032 . . . . 0.0 112.528 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -63.7 -43.68 95.9 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.202 0.91 . . . . 0.0 111.35 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.3 mt -63.14 -50.43 70.46 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -70.22 -30.44 67.52 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.496 -173.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.01 91.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.481 0.582 . . . . 0.0 109.975 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -75.89 -29.6 58.53 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 117.771 -1.109 . . . . 0.0 112.4 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.26 -45.46 87.99 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 121.059 1.754 . . . . 0.0 109.855 172.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -71.4 -31.95 67.85 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.142 0.428 . . . . 0.0 110.964 -177.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -62.56 -39.47 93.74 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.013 0.37 . . . . 0.0 110.367 169.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.1 m -71.56 -0.53 10.82 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.82 1.248 . . . . 0.0 112.945 172.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.71 -14.31 41.9 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.809 1.195 . . . . 0.0 114.004 169.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.55 171.63 1.91 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.79 1.295 . . . . 0.0 110.839 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -142.81 150.68 40.27 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.993 -1.067 . . . . 0.0 112.237 170.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 17.3 tm0? -70.85 148.18 48.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.738 1.615 . . . . 0.0 108.438 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.3 m -128.22 144.96 51.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.936 1.695 . . . . 0.0 107.53 174.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.02 -127.84 8.68 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -143.98 164.41 30.68 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.993 1.717 . . . . 0.0 107.209 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.7 m -68.12 139.95 56.18 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.3 tp -105.8 150.2 25.77 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.209 1.003 . . . . 0.0 108.662 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.32 136.65 35.06 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.6 mm -135.49 113.81 15.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.176 -1.786 . . . . 0.0 106.176 -170.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -72.07 142.78 49.23 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 169.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.4 pp -128.92 3.62 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.518 1.127 . . . . 0.0 112.378 171.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 tp . . . . . 0 N--CA 1.466 0.374 0 CA-C-N 119.096 0.862 . . . . 0.0 112.351 -172.303 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 119.243 -0.408 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.1 -37.87 89.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.288 0.635 . . . . 0.0 111.252 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -71.46 -41.43 69.4 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.763 -0.586 . . . . 0.0 109.562 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -61.05 -45.15 95.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.62 -43.75 95.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.481 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.31 -45.36 92.87 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -63.97 -36.86 85.37 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.154 0.582 . . . . 0.0 111.168 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -67.91 -54.06 21.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.934 0.894 . . . . 0.0 109.8 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.93 -31.35 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 118.818 0.735 . . . . 0.0 111.141 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.24 -25.09 58.57 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.416 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.5 mt -101.46 -5.84 24.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.038 -0.982 . . . . 0.0 113.293 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.5 pp -120.3 -9.41 9.52 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.308 1.413 . . . . 0.0 113.08 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.251 1.133 0 C-N-CA 125.703 1.601 . . . . 0.0 111.961 178.264 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.38 0 CA-C-O 121.041 0.448 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -135.44 -25.94 1.28 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.765 1.226 . . . . 0.0 110.977 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.8 mt -129.53 84.77 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 169.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.5 m -75.56 115.85 15.67 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 176.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mp -74.35 156.89 36.62 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 171.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.6 mt -126.39 80.22 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.5 m -68.45 153.88 42.91 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.527 1.531 . . . . 0.0 110.561 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.1 100.42 0.19 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 121.656 0.741 . . . . 0.0 109.976 171.523 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.48 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.68 -26.83 64.56 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.483 0.641 . . . . 0.0 110.74 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -69.96 -36.64 75.4 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.328 0.513 . . . . 0.0 110.685 175.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -67.02 -44.28 80.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.735 0.698 . . . . 0.0 109.504 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.65 -39.15 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 119.057 -0.497 . . . . 0.0 109.967 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.88 -41.74 96.58 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.296 0.953 . . . . 0.0 110.987 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -63.32 -42.5 99.0 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.746 0.703 . . . . 0.0 110.553 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -62.02 -45.41 93.7 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.845 -0.534 . . . . 0.0 110.706 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.7 mt -62.06 -41.78 98.5 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.474 0.71 . . . . 0.0 110.464 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.18 -38.24 85.8 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.028 0.531 . . . . 0.0 110.662 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.18 -41.33 90.44 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.425 ' N ' ' HE2' ' A' ' 25' ' ' LYS . 6.8 mmpt? -62.89 -36.34 83.01 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 121.685 -0.634 . . . . 0.0 110.009 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.3 mt -68.45 -37.53 80.31 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 118.965 -0.541 . . . . 0.0 110.984 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -62.9 -42.11 99.67 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.924 0.783 . . . . 0.0 109.974 175.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.93 -37.29 87.16 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.145 0.43 . . . . 0.0 111.012 175.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.16 -22.03 63.96 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.792 0.837 . . . . 0.0 112.186 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.56 28.75 2.89 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.567 -1.13 . . . . 0.0 113.973 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -125.98 137.44 53.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.286 1.543 . . . . 0.0 109.223 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.5 p -76.07 146.85 39.08 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.43 0.633 . . . . 0.0 109.513 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.4 p -135.36 167.63 20.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.781 0.832 . . . . 0.0 110.212 -170.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -150.97 160.75 43.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 169.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.7 78.65 1.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -175.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.09 110.85 4.71 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -93.93 92.02 7.19 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -171.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.51 56.6 12.65 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.931 -0.927 . . . . 0.0 113.071 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.19 -179.14 3.3 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.91 2.407 . . . . 0.0 110.345 170.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.3 mt -114.77 160.16 19.75 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 169.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -55.5 -40.04 71.22 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.781 0.832 . . . . 0.0 111.403 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -64.83 -14.54 59.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.808 0.843 . . . . 0.0 113.198 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -90.76 -2.91 57.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.932 0.893 . . . . 0.0 112.309 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -137.44 154.4 75.26 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.147 0.979 . . . . 0.0 111.179 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.8 163.58 26.1 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.826 2.351 . . . . 0.0 111.77 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.04 18.67 0.99 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.41 1.484 . . . . 0.0 113.22 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.7 m -146.45 136.7 23.7 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.223 1.409 . . . . 0.0 107.887 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.71 -176.2 30.19 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.95 104.28 13.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -104.95 172.85 6.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.199 0.999 . . . . 0.0 109.931 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.6 tp -141.31 100.55 3.82 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 t -79.35 131.57 34.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.9 mt -133.0 127.58 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.2 m -134.29 129.31 35.39 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -170.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.9 m -69.07 160.51 30.89 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.505 169.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.9 m -132.82 109.21 9.48 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -63.28 -24.89 68.07 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.04 0.382 . . . . 0.0 111.956 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.09 -32.24 0.33 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.052 0.834 . . . . 0.0 112.234 171.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.93 30.31 4.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.27 1.028 . . . . 0.0 111.922 -171.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.81 -0.01 59.14 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.376 -0.68 . . . . 0.0 113.641 173.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -69.14 110.82 4.73 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 118.484 1.142 . . . . 0.0 109.982 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 61.2 mt -69.3 141.86 91.76 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 171.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.51 136.76 56.23 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.204 2.602 . . . . 0.0 110.985 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.9 -21.48 43.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.407 1.483 . . . . 0.0 113.237 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -64.87 -34.94 79.58 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.446 0.699 . . . . 0.0 111.454 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 tt -121.76 -22.17 5.88 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.615 0.766 . . . . 0.0 112.306 -169.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 81.7 p -51.13 -34.01 11.51 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-O 116.439 -1.743 . . . . 0.0 115.259 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -52.11 -22.9 15.99 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.989 2.46 . . . . 0.0 115.728 172.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -59.46 -37.21 77.58 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.336 0.971 . . . . 0.0 110.913 175.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -65.21 -42.26 93.69 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.602 0.761 . . . . 0.0 110.179 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -63.35 -50.95 67.95 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.714 0.406 . . . . 0.0 109.997 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.56 -29.21 70.23 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.993 0.815 . . . . 0.0 112.745 -174.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.3 mt -68.69 -57.07 6.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.382 171.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -69.86 -27.46 64.85 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.041 0.837 . . . . 0.0 112.431 -170.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.92 -26.05 61.27 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.123 0.874 . . . . 0.0 111.256 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -109.44 -24.4 11.04 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.573 -173.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt 40.13 59.81 7.05 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.778 1.631 . . . . 0.0 110.577 -169.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.25 167.62 17.94 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.846 2.364 . . . . 0.0 111.068 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -96.53 106.72 19.02 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 169.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.1 mt -118.98 24.93 10.54 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.128 1.771 . . . . 0.0 110.022 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -61.0 20.0 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.524 1.929 . . . . 0.0 115.569 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.13 1.86 1.86 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.35 1.46 . . . . 0.0 111.992 173.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.5 t -84.09 142.66 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -123.42 148.65 45.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 168.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -144.08 171.3 14.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.452 0.644 . . . . 0.0 111.45 -174.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.42 161.54 22.16 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 104.461 -3.456 . . . . 0.0 104.461 168.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.31 124.77 13.93 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -169.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 mt -134.65 133.43 54.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.8 140.03 15.93 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 170.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 mt -138.73 131.47 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -171.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.7 -169.01 41.46 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 120.231 1.378 . . . . 0.0 110.541 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.9 m -79.34 74.17 5.95 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 126.02 1.728 . . . . 0.0 108.223 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -52.6 -33.93 48.57 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.962 1.305 . . . . 0.0 112.211 -173.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -80.84 -12.02 59.5 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.671 1.188 . . . . 0.0 112.349 -174.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -67.49 -52.54 38.03 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 118.978 0.808 . . . . 0.0 111.836 -169.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -162.87 -47.06 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.346 1.058 . . . . 0.0 110.915 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.8 m . . . . . 0 C--O 1.234 0.245 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -174.358 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.6 tp -60.86 -28.21 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.361 1.464 . . . . 0.0 111.163 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -57.22 -40.35 77.34 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -169.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -63.62 -44.35 94.18 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.927 -0.483 . . . . 0.0 111.047 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.9 mt -69.34 -48.61 60.85 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.566 0.747 . . . . 0.0 109.398 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.63 -38.57 87.21 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.56 -37.65 88.27 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.316 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -70.62 -29.16 65.47 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.596 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.6 mt -66.23 -43.05 87.7 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.948 1.704 . . . . 0.0 109.259 170.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -62.71 -42.81 99.83 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 122.732 0.413 . . . . 0.0 109.985 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -60.82 -40.51 92.99 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.207 1.003 . . . . 0.0 110.826 174.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.0 m -70.3 -5.78 30.34 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.478 1.111 . . . . 0.0 113.186 175.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.19 -13.9 21.33 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.53 1.062 . . . . 0.0 113.612 169.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.73 178.97 0.7 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.379 1.089 . . . . 0.0 110.589 174.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -151.73 148.08 27.47 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.873 -1.142 . . . . 0.0 113.204 169.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 39.7 tp60 -56.77 155.94 7.13 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.715 2.006 . . . . 0.0 109.928 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.5 m -141.3 131.96 25.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.57 174.77 17.01 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -169.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -71.55 158.3 36.46 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.625 -0.926 . . . . 0.0 108.963 170.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.88 160.52 20.28 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 169.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 54.2 tp -129.54 148.44 51.44 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.517 -0.739 . . . . 0.0 109.637 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -125.71 147.33 49.4 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 169.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.7 mm -131.66 106.88 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -78.14 134.96 37.59 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 169.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.24 -17.64 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 118.294 0.497 . . . . 0.0 111.699 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.0 tp . . . . . 0 CA--C 1.533 0.322 0 CA-C-N 118.552 0.614 . . . . 0.0 111.274 -171.469 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 111.153 0.057 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -58.63 -33.73 70.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.49 1.116 . . . . 0.0 111.565 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -69.52 -42.08 75.16 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.851 0.75 . . . . 0.0 109.954 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -64.68 -43.88 92.11 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.98 -43.34 99.06 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.354 0.662 . . . . 0.0 110.513 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.71 -44.54 97.8 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.954 0.787 . . . . 0.0 111.513 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -63.47 -35.58 80.93 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.023 -0.692 . . . . 0.0 111.053 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -68.88 -48.51 63.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.918 0.887 . . . . 0.0 110.403 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.15 -32.55 57.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 CA-C-N 119.161 0.891 . . . . 0.0 111.169 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -62.14 -22.23 65.68 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.344 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.1 mt -96.53 -43.8 7.45 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.438 1.017 . . . . 0.0 111.621 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 pp -70.92 -25.41 62.75 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.355 0.98 . . . . 0.0 112.32 -175.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 C--O 1.252 1.209 0 C-N-CA 127.796 2.438 . . . . 0.0 112.02 177.767 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.282 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -137.36 -25.09 1.05 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.69 1.596 . . . . 0.0 110.992 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.8 mt -124.9 79.3 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 169.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.4 m -74.83 117.77 17.05 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.65 151.0 34.5 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.3 mt -116.2 80.34 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 m -71.44 148.34 46.96 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.254 1.422 . . . . 0.0 109.683 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.6 80.7 0.18 Allowed Glycine 0 C--N 1.339 0.735 0 O-C-N 122.237 -0.289 . . . . 0.0 113.794 -169.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.537 ' HG ' ' N ' ' A' ' 14' ' ' GLY . 5.0 t . . . . . 0 N--CA 1.451 -0.402 0 C-N-CA 123.899 0.88 . . . . 0.0 108.734 168.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.537 ' N ' ' HG ' ' A' ' 10' ' ' SER . . . . . . . . 0 CA--C 1.522 0.478 0 CA-C-O 120.026 -0.319 . . . . 0.0 113.109 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.02 -27.97 67.0 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 117.568 0.684 . . . . 0.0 110.972 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -76.33 -22.7 54.6 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.192 -173.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -65.75 -41.6 91.92 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.94 0.791 . . . . 0.0 109.182 169.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.5 t -72.22 -32.76 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 121.822 -0.549 . . . . 0.0 109.937 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.86 87.12 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.409 -0.807 . . . . 0.0 110.277 170.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.07 -38.93 89.56 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.412 0.551 . . . . 0.0 111.157 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -59.23 -46.8 87.51 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.095 0.861 . . . . 0.0 110.032 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.6 mt -65.14 -43.18 92.7 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.799 -0.563 . . . . 0.0 110.103 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.47 -42.61 92.43 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.549 0.74 . . . . 0.0 111.004 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -52.79 -47.43 67.56 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.799 0.84 . . . . 0.0 110.031 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -67.87 -40.9 83.54 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.2 mt -66.41 -39.59 89.09 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 119.259 -0.4 . . . . 0.0 110.641 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -61.12 -46.18 91.63 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.111 0.564 . . . . 0.0 109.655 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -65.5 -34.94 79.45 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.846 0.458 . . . . 0.0 111.34 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.6 -22.36 64.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.877 0.871 . . . . 0.0 112.035 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.25 1.67 23.47 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.656 1.122 . . . . 0.0 113.212 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -74.97 174.74 8.89 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.444 1.122 . . . . 0.0 109.475 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.4 p -122.61 137.32 54.93 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.5 p -132.51 170.32 15.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.135 0.974 . . . . 0.0 110.336 -170.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -153.54 126.1 8.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 104.518 -2.401 . . . . 0.0 104.518 169.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.0 p -82.54 70.63 9.55 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -69.58 113.59 7.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -169.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -72.27 107.98 5.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.261 1.024 . . . . 0.0 108.744 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.82 56.65 15.13 Favored Glycine 0 CA--C 1.539 1.577 0 CA-C-O 118.341 -1.255 . . . . 0.0 115.766 169.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.2 175.71 5.46 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.771 2.314 . . . . 0.0 111.685 173.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.7 mt -128.67 164.35 23.12 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.346 1.458 . . . . 0.0 109.226 174.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.4 tp -62.27 -27.8 69.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.816 1.247 . . . . 0.0 112.169 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.75 -10.38 12.6 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.136 0.974 . . . . 0.0 113.101 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -128.56 19.88 6.19 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.348 1.459 . . . . 0.0 110.872 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.94 97.67 13.61 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.08 1.352 . . . . 0.0 107.886 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.76 165.22 28.45 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.404 2.069 . . . . 0.0 111.774 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.71 4.67 1.8 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.69 1.596 . . . . 0.0 114.788 -175.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.2 m -144.94 133.85 22.47 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.354 1.462 . . . . 0.0 107.276 -175.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.71 175.53 23.54 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.5 mt -114.54 101.83 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -110.42 166.63 10.83 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.573 0.749 . . . . 0.0 108.98 -176.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.8 tp -146.37 99.28 3.2 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 t -79.52 132.31 32.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.793 1.237 . . . . 0.0 107.839 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 mt -135.98 132.29 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.6 m -134.18 133.67 41.23 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -169.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 m -80.08 166.71 21.24 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 169.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.5 m -141.15 112.27 7.29 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 174.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -71.61 -5.25 32.08 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -169.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 160.89 -38.58 0.43 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-N 119.794 1.179 . . . . 0.0 113.761 169.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.22 10.25 3.0 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.273 1.036 . . . . 0.0 113.259 -170.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.62 -14.88 4.71 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.135 0.874 . . . . 0.0 113.289 172.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.07 119.43 6.3 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.353 1.061 . . . . 0.0 111.632 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.4 mt -83.47 132.23 50.27 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -51.13 136.46 45.51 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 124.016 3.144 . . . . 0.0 113.292 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.39 -18.6 62.0 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.283 1.033 . . . . 0.0 113.315 -176.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -73.89 -27.11 60.89 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.413 -0.804 . . . . 0.0 112.179 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.9 tp -121.04 -27.1 5.02 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.283 0.947 . . . . 0.0 111.92 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -46.73 -39.76 17.37 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-O 117.549 -1.215 . . . . 0.0 113.935 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.42 -25.64 14.46 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.502 2.801 . . . . 0.0 116.077 172.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -60.56 -37.5 81.47 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.157 -0.965 . . . . 0.0 110.855 176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -65.71 -43.3 89.54 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.113 0.565 . . . . 0.0 110.9 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.26 -38.04 68.95 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.583 0.629 . . . . 0.0 110.784 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.04 -35.91 80.92 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.726 0.693 . . . . 0.0 111.576 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.9 mt -64.45 -54.41 33.02 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.744 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -69.54 -25.96 64.27 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.147 0.885 . . . . 0.0 111.957 -173.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -68.88 -37.27 78.94 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.86 0.755 . . . . 0.0 110.697 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -105.07 -34.33 8.0 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -169.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm 31.0 57.92 0.98 Allowed Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 127.306 2.242 . . . . 0.0 113.675 -173.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.23 169.83 15.93 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.929 1.753 . . . . 0.0 110.167 174.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -72.04 114.83 10.57 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 169.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.1 mt -119.72 18.74 12.62 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.674 1.59 . . . . 0.0 110.901 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.8 m -57.87 4.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.43 1.22 8.96 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.848 1.204 . . . . 0.0 111.614 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 79.8 t -74.56 131.63 34.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 169.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -107.62 102.73 11.95 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 102.197 -3.26 . . . . 0.0 102.197 168.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -95.88 167.35 11.31 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.803 0.811 . . . . 0.0 108.933 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -123.13 154.46 17.17 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 104.839 -3.305 . . . . 0.0 104.839 169.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.47 122.48 11.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.8 mt -135.68 131.82 50.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -102.26 138.11 13.73 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.9 mt -133.21 153.35 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 165.66 173.4 34.13 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-O 123.278 1.488 . . . . 0.0 110.732 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.1 m -74.48 56.94 0.69 Allowed 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 126.511 1.924 . . . . 0.0 109.952 174.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.14 -52.5 7.23 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.894 2.078 . . . . 0.0 110.978 -174.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -65.14 -11.7 43.07 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.093 0.557 . . . . 0.0 112.498 -171.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -66.27 -50.43 63.73 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.908 0.776 . . . . 0.0 110.184 170.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -171.61 -49.02 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.412 1.485 . . . . 0.0 111.797 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.536 0.44 0 C-N-CA 124.739 1.216 . . . . 0.0 114.02 -169.685 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.8 tp -67.88 -27.87 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.174 0.59 . . . . 0.0 110.841 -176.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -61.02 -43.52 98.76 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 118.354 0.524 . . . . 0.0 111.787 -169.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -65.81 -44.52 85.4 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 122.016 -0.427 . . . . 0.0 110.802 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.9 mt -63.33 -46.66 85.61 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.331 0.652 . . . . 0.0 109.948 -176.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.89 -40.38 75.7 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.997 0.362 . . . . 0.0 110.075 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.31 -35.02 79.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.032 -169.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -74.21 -29.94 61.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.18 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.8 mt -66.62 -41.78 87.84 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.16 1.346 . . . . 0.0 109.02 169.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -61.55 -43.92 97.98 Favored 'General case' 0 N--CA 1.458 -0.062 0 C-N-CA 124.002 0.921 . . . . 0.0 109.343 -177.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -67.5 -36.41 81.01 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.023 0.929 . . . . 0.0 111.347 176.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.1 m -68.84 -2.09 8.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.225 1.01 . . . . 0.0 112.876 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.28 -15.66 30.16 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.32 1.438 . . . . 0.0 113.693 169.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.19 171.95 2.73 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.6 1.2 . . . . 0.0 110.989 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -142.66 154.47 44.37 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.364 -0.835 . . . . 0.0 111.462 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -63.85 161.35 15.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.774 2.029 . . . . 0.0 110.244 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.6 m -133.99 152.85 52.01 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.509 1.923 . . . . 0.0 106.321 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.37 -135.27 51.84 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -169.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -140.47 150.67 44.09 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.8 m -63.22 149.64 44.98 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.269 1.428 . . . . 0.0 110.551 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.9 tp -132.88 147.89 52.3 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.388 1.075 . . . . 0.0 109.084 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -120.06 139.25 52.82 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.221 1.808 . . . . 0.0 106.227 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.8 mt -138.07 107.25 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -67.57 141.13 56.92 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 170.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.3 pt -122.06 -9.66 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.036 1.335 . . . . 0.0 112.1 171.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.4 tp . . . . . 0 C--N 1.343 0.283 0 CA-C-N 119.883 1.22 . . . . 0.0 108.378 176.562 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.408 0 CA-C-O 119.353 -0.356 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -62.15 -38.93 90.89 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.51 0.724 . . . . 0.0 110.908 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -76.13 -49.09 18.29 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -64.67 -33.16 75.28 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.216 -0.303 . . . . 0.0 111.744 -174.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 48.9 tp -56.98 -30.18 63.9 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 118.68 -0.676 . . . . 0.0 111.358 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.92 -45.7 70.34 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 118.841 0.746 . . . . 0.0 111.297 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.9 m -66.77 -30.76 71.05 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 117.492 0.646 . . . . 0.0 111.319 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -72.61 -51.31 20.18 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.532 0.733 . . . . 0.0 110.03 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 31.4 m -66.52 -30.64 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 O-C-N 121.331 -0.855 . . . . 0.0 111.246 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -60.74 -21.25 62.78 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.846 0.859 . . . . 0.0 112.482 175.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 28.8 mt -102.78 -35.93 8.46 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 118.069 -0.967 . . . . 0.0 112.109 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -35.78 79.52 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 120.005 1.275 . . . . 0.0 111.838 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt . . . . . 0 C--O 1.251 1.176 0 C-N-CA 128.658 2.783 . . . . 0.0 113.236 -179.474 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 121.006 0.431 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -134.34 -26.03 1.48 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.122 1.369 . . . . 0.0 110.973 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.6 mt -129.04 82.36 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 169.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.8 m -74.6 121.29 21.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.5 mp -78.98 146.17 33.54 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.5 mt -109.91 82.31 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.4 m -64.1 140.33 58.86 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.014 0.926 . . . . 0.0 110.431 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.57 72.12 0.41 Allowed Glycine 0 C--N 1.339 0.739 0 C-N-CA 123.584 0.611 . . . . 0.0 113.851 -169.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 C--O 1.234 0.238 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 168.51 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.815 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.9 -29.23 69.06 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.542 -0.742 . . . . 0.0 110.644 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -69.88 -35.32 74.56 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.15 0.886 . . . . 0.0 110.231 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -70.91 -41.73 70.88 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.998 0.817 . . . . 0.0 109.784 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.11 -44.81 99.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.87 -36.47 79.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.524 -0.751 . . . . 0.0 111.01 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.82 -41.69 99.42 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.52 1.055 . . . . 0.0 110.7 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -64.57 -48.87 73.4 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.161 0.437 . . . . 0.0 109.962 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.84 -46.11 88.49 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.86 0.464 . . . . 0.0 110.233 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.51 98.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.474 1.11 . . . . 0.0 111.029 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.39 -43.66 96.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.288 0.495 . . . . 0.0 110.355 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -67.45 -34.29 76.88 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.356 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.0 mt -63.99 -37.02 85.9 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 119.381 0.991 . . . . 0.0 111.755 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -63.44 -40.91 98.4 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.586 1.085 . . . . 0.0 110.15 175.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.22 -37.04 86.03 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.296 0.498 . . . . 0.0 111.087 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.84 -21.86 63.33 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.74 0.816 . . . . 0.0 112.256 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.27 26.04 3.32 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.533 -1.148 . . . . 0.0 114.022 170.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -125.88 131.58 52.33 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.244 1.522 . . . . 0.0 108.72 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 p -73.26 147.47 44.56 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.5 p -140.72 169.28 17.94 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.084 0.954 . . . . 0.0 109.588 -169.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -152.5 140.67 20.38 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 169.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.5 p -96.42 68.65 2.57 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.87 119.3 17.9 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -169.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -69.29 99.96 1.26 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.264 1.026 . . . . 0.0 109.665 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.13 54.22 10.04 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.347 1.451 . . . . 0.0 115.549 171.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -60.6 142.97 99.31 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 CA-C-N 120.494 2.147 . . . . 0.0 109.815 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.1 mt -69.23 155.03 41.08 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.75 -34.26 71.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.311 0.644 . . . . 0.0 109.761 169.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -65.58 -9.57 27.83 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.386 1.475 . . . . 0.0 112.909 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -118.06 13.23 13.84 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.007 1.323 . . . . 0.0 111.556 -170.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 pp -141.98 154.78 65.53 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.513 1.125 . . . . 0.0 109.592 171.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.48 161.29 37.57 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.594 2.196 . . . . 0.0 112.07 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.06 18.63 0.48 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.567 1.547 . . . . 0.0 112.931 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.8 t -152.37 133.68 14.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.03 179.39 31.93 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.0 mt -117.25 106.66 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.096 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -107.75 169.07 8.83 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 123.152 0.581 . . . . 0.0 109.516 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.4 tp -142.41 101.04 3.82 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.01 144.09 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.217 -171.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.57 143.42 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 172.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 m -147.24 134.49 20.59 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.402 -0.812 . . . . 0.0 108.876 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.4 m -75.91 160.36 29.99 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 169.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.471 ' HG1' ' N ' ' A' ' 101' ' ' ALA . 90.8 m -128.64 106.22 8.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.778 1.631 . . . . 0.0 106.921 -174.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -67.11 169.82 7.9 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.2 -23.82 34.3 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.754 -1.026 . . . . 0.0 114.947 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.92 11.7 16.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.996 1.318 . . . . 0.0 112.709 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.14 16.97 70.61 Favored Glycine 0 C--N 1.339 0.697 0 O-C-N 121.439 -0.788 . . . . 0.0 113.721 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -66.45 119.99 12.59 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.659 1.23 . . . . 0.0 108.419 170.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.2 mt -70.18 142.58 90.15 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -61.28 144.64 98.74 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.085 2.523 . . . . 0.0 112.065 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -59.01 -21.91 59.8 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.359 1.464 . . . . 0.0 113.598 -173.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.91 -27.97 68.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.38 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 63.6 tp -130.79 -20.72 2.81 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.734 0.814 . . . . 0.0 112.508 -170.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.0 p -53.19 -31.5 7.88 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -53.52 -20.89 17.14 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.014 2.476 . . . . 0.0 115.583 169.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -56.99 -35.65 69.45 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.177 0.898 . . . . 0.0 110.96 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -65.35 -48.83 71.64 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.58 -43.44 98.85 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.605 0.762 . . . . 0.0 110.009 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.57 -29.8 68.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.419 0.688 . . . . 0.0 112.492 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.4 mt -76.68 -29.8 56.48 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.771 176.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -73.62 -46.84 44.43 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.494 1.043 . . . . 0.0 109.115 175.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.11 -25.73 67.9 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.831 0.853 . . . . 0.0 111.837 -171.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -118.14 -25.26 6.71 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 117.974 -1.012 . . . . 0.0 113.167 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? 36.55 59.06 3.51 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 125.026 1.33 . . . . 0.0 110.605 -169.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -68.17 173.84 8.89 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.603 2.869 . . . . 0.0 112.777 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -105.39 107.81 19.0 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.8 mt -117.86 22.32 12.36 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 126.146 1.778 . . . . 0.0 110.675 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 m -57.46 16.05 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.51 2.324 . . . . 0.0 116.549 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.6 0.89 2.08 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.889 1.276 . . . . 0.0 112.309 172.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 94.9 t -75.85 134.56 28.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.9 mmm-85 -121.97 144.46 48.87 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 104.972 -2.232 . . . . 0.0 104.972 168.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -150.84 169.73 20.99 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.861 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -125.37 166.31 18.15 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 105.457 -3.057 . . . . 0.0 105.457 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.81 135.84 22.46 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.831 1.315 . . . . 0.0 111.111 -169.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.1 mm -124.24 130.51 73.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -104.9 135.97 12.85 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 107.691 -2.163 . . . . 0.0 107.691 169.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.2 mt -130.01 152.92 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 161.17 175.66 32.44 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 71.0 m -78.39 91.69 4.5 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 169.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -28.87 62.05 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.472 0.709 . . . . 0.0 112.872 -169.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -73.68 -9.9 59.14 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.49 169.01 11.65 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.161 0.891 . . . . 0.0 110.173 172.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -58.48 -34.52 70.97 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.424 0.69 . . . . 0.0 112.782 -173.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.9 m . . . . . 0 C--O 1.235 0.326 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.508 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.471 ' N ' ' HG1' ' A' ' 56' ' ' THR . . . . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 102' ' ' ILE . 2.1 tp -52.98 -33.34 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 126.075 1.75 . . . . 0.0 110.391 170.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -51.4 -39.18 56.7 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.497 1.119 . . . . 0.0 112.855 -172.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -66.44 -36.5 82.95 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.787 -0.571 . . . . 0.0 111.446 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.2 mt -71.89 -52.07 19.1 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -67.08 -35.81 80.62 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.991 -171.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.32 -38.54 90.47 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -73.25 -30.94 63.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.914 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.05 -46.69 86.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.314 1.415 . . . . 0.0 109.203 169.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -63.37 -41.06 98.79 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 122.417 0.287 . . . . 0.0 110.387 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -63.04 -39.54 95.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.581 0.752 . . . . 0.0 110.524 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.7 m -70.68 -7.11 42.15 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.469 1.108 . . . . 0.0 112.908 174.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.03 -16.9 8.71 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.728 1.156 . . . . 0.0 113.921 169.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.22 172.75 1.35 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.517 1.159 . . . . 0.0 111.277 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -140.87 136.16 32.06 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.499 -0.751 . . . . 0.0 110.904 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -62.43 170.46 2.39 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.973 1.309 . . . . 0.0 109.295 170.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 m -133.67 149.71 51.55 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.419 ' H ' HD12 ' A' ' 145' ' ' LEU . . . 61.87 -136.44 46.37 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.09 157.71 45.79 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 171.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.98 135.76 57.47 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.959 0.904 . . . . 0.0 110.183 -177.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.4 tp -94.08 148.7 21.92 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -123.55 144.41 49.59 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 57.0 mt -136.95 108.82 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -68.03 143.2 55.64 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 169.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.24 9.25 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.024 0.93 . . . . 0.0 112.54 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp . . . . . 0 N--CA 1.467 0.384 0 O-C-N 121.473 -0.767 . . . . 0.0 111.318 178.617 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 118.856 -0.593 . . . . 0.0 111.958 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -54.76 -35.34 63.67 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.011 0.924 . . . . 0.0 111.515 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -65.21 -43.45 91.51 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.679 -0.638 . . . . 0.0 110.188 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -74.28 -35.42 63.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.763 0.825 . . . . 0.0 110.344 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.4 tp -61.94 -36.24 80.81 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.973 0.909 . . . . 0.0 110.742 173.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.76 -47.74 58.01 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.471 1.034 . . . . 0.0 111.102 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 m -61.82 -42.23 98.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.665 0.732 . . . . 0.0 110.778 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -60.44 -49.92 75.65 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.511 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.7 m -65.36 -34.79 72.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 119.866 1.212 . . . . 0.0 110.867 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.79 -22.4 66.98 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.426 0.69 . . . . 0.0 111.679 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.419 HD12 ' H ' ' A' ' 118' ' ' GLY . 7.2 mt -90.67 -57.98 2.64 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.599 1.09 . . . . 0.0 110.141 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.08 -25.79 65.51 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 117.567 -1.206 . . . . 0.0 113.815 -169.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm . . . . . 0 C--O 1.251 1.181 0 C-N-CA 128.046 2.538 . . . . 0.0 113.27 175.249 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 120.913 0.387 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -133.38 -25.58 1.72 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.818 1.247 . . . . 0.0 111.028 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.0 mt -121.37 74.92 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 170.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.1 m -75.35 120.98 21.55 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.8 mt -94.85 151.06 19.55 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 80.3 mt -125.76 84.13 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -169.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.9 m -74.94 151.23 38.89 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.656 0.782 . . . . 0.0 110.35 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.81 118.16 0.8 Allowed Glycine 0 C--N 1.333 0.394 0 N-CA-C 107.576 -2.209 . . . . 0.0 107.576 170.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 122.006 0.908 . . . . 0.0 111.641 -173.625 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.558 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.6 -22.96 64.42 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 117.315 0.557 . . . . 0.0 111.571 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -75.31 -43.8 48.9 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -68.7 -41.8 78.65 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 122.862 0.465 . . . . 0.0 109.748 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.24 -48.84 85.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.244 0.618 . . . . 0.0 109.433 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.17 89.48 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 118.902 0.773 . . . . 0.0 110.667 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.0 -43.0 93.97 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.455 1.025 . . . . 0.0 111.119 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -61.86 -45.11 95.18 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.834 -0.541 . . . . 0.0 110.481 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.5 mt -65.45 -42.21 92.61 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.256 0.622 . . . . 0.0 110.153 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.1 83.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.023 0.929 . . . . 0.0 110.966 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -58.68 -46.8 86.43 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.882 0.765 . . . . 0.0 110.496 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -68.21 -37.46 80.91 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.567 -0.708 . . . . 0.0 110.835 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.3 mt -61.41 -42.04 98.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.279 0.945 . . . . 0.0 111.369 175.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.7 -38.96 84.35 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.642 0.655 . . . . 0.0 110.327 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -64.55 -36.04 82.92 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.46 0.573 . . . . 0.0 110.904 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.01 -23.71 64.13 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.54 0.736 . . . . 0.0 111.973 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.56 -0.77 12.46 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.968 1.271 . . . . 0.0 113.764 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -77.05 174.7 10.35 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.635 1.217 . . . . 0.0 110.61 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.8 p -120.88 140.0 52.41 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 p -136.49 168.98 18.45 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.254 1.022 . . . . 0.0 110.229 -169.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -153.13 155.59 37.03 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 169.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.0 p -119.55 71.55 0.88 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -172.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.3 mt -76.07 118.9 19.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -171.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -91.89 95.48 9.85 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.97 49.47 6.38 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.016 -1.436 . . . . 0.0 115.22 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -68.43 176.27 5.92 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 CA-C-N 120.686 2.243 . . . . 0.0 110.989 169.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.5 mt -130.8 168.4 17.3 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.381 1.472 . . . . 0.0 110.027 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.5 tp -56.06 -27.36 53.1 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.906 1.683 . . . . 0.0 111.881 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -64.18 -12.37 39.62 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.547 1.139 . . . . 0.0 112.593 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -137.09 20.52 3.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.933 1.293 . . . . 0.0 111.377 -173.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.2 mt -135.03 102.81 10.88 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.648 1.179 . . . . 0.0 108.319 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -73.32 169.85 21.3 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.932 2.422 . . . . 0.0 112.21 -176.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.48 8.98 2.42 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.807 1.643 . . . . 0.0 114.767 -171.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -153.15 141.18 20.31 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.929 0.786 . . . . 0.0 109.27 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.14 -178.66 24.63 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -123.3 99.5 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -94.69 176.22 6.36 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.464 0.706 . . . . 0.0 110.155 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.9 tp -140.98 98.67 3.43 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -79.64 129.0 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 mt -127.54 146.21 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.9 m -145.48 141.92 28.77 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.718 -0.614 . . . . 0.0 110.016 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.7 m -91.08 95.11 9.92 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.48 ' HG1' ' N ' ' A' ' 101' ' ' ALA . 44.2 m -70.6 83.2 0.61 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 171.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -79.12 44.23 0.56 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.123 1.769 . . . . 0.0 111.442 -174.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.2 -30.05 2.15 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.33 1.443 . . . . 0.0 114.278 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.61 -21.75 64.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.395 1.078 . . . . 0.0 113.678 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.86 20.37 77.98 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -170.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -130.77 155.46 46.62 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.734 1.614 . . . . 0.0 107.083 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.37 150.07 39.43 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.227 1.411 . . . . 0.0 107.965 -169.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -53.6 139.25 66.99 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.276 2.651 . . . . 0.0 112.321 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -58.35 -23.12 55.84 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.976 1.311 . . . . 0.0 113.71 -171.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -75.21 -21.48 58.63 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.563 -0.732 . . . . 0.0 112.502 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.6 tp -126.84 -23.89 3.6 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.007 0.923 . . . . 0.0 111.902 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 91.9 p -53.72 -29.65 5.02 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-O 117.038 -1.458 . . . . 0.0 114.138 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.34 -23.34 18.2 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.639 2.226 . . . . 0.0 114.958 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -64.52 -39.96 94.74 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 120.104 1.32 . . . . 0.0 110.815 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -60.72 -41.87 96.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.105 0.562 . . . . 0.0 110.085 175.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -66.23 -47.89 72.34 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.076 0.55 . . . . 0.0 110.299 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.85 -41.28 95.83 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 121.794 -0.566 . . . . 0.0 111.362 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.7 mt -62.72 -50.82 69.61 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.888 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -70.3 -29.19 65.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.023 0.829 . . . . 0.0 111.642 -176.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.09 -50.46 47.97 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.768 0.713 . . . . 0.0 109.866 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -84.19 -23.01 30.73 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.349 -173.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.5 tttt 38.45 61.43 4.74 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 126.085 1.754 . . . . 0.0 110.806 -169.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -66.5 169.27 14.5 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.109 2.539 . . . . 0.0 111.363 -174.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -96.69 104.21 16.18 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 169.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.0 mt -118.83 26.6 9.43 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 126.414 1.886 . . . . 0.0 109.818 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.8 m -60.1 15.62 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.815 2.046 . . . . 0.0 116.048 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.85 6.09 1.58 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.039 1.336 . . . . 0.0 111.762 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.1 t -77.58 140.31 17.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -122.67 157.2 32.76 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 168.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -154.16 176.28 12.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.739 0.699 . . . . 0.0 111.77 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.55 162.76 22.17 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 105.593 -3.003 . . . . 0.0 105.593 169.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.68 126.63 19.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -169.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.7 mt -136.04 126.2 41.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -174.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -100.69 152.25 19.08 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.6 mt -134.8 137.98 50.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 175.99 -152.05 12.47 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.6 m -128.19 127.19 42.46 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.381 1.073 . . . . 0.0 109.095 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -67.58 -6.57 20.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.631 0.772 . . . . 0.0 112.09 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.35 -33.12 63.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.094 1.358 . . . . 0.0 111.592 172.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -116.36 155.96 27.56 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.448 1.099 . . . . 0.0 110.805 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.64 -34.46 77.88 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.638 0.775 . . . . 0.0 111.661 -174.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.756 0 C-N-CA 126.472 1.909 . . . . 0.0 111.011 175.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.48 ' N ' ' HG1' ' A' ' 56' ' ' THR . . . . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.33 -34.2 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.781 1.232 . . . . 0.0 109.579 170.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.21 -32.42 68.28 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 123.777 0.831 . . . . 0.0 111.989 -175.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -62.01 -45.41 93.71 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.512 0.596 . . . . 0.0 110.473 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.29 -53.15 61.11 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -72.22 -31.89 66.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.64 -170.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.16 -44.2 92.12 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.99 0.814 . . . . 0.0 109.858 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -74.64 -28.11 60.72 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.199 -0.905 . . . . 0.0 112.281 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.6 -45.01 92.32 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.493 1.497 . . . . 0.0 109.374 169.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -66.27 -39.77 89.66 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 122.182 -0.324 . . . . 0.0 110.473 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -61.05 -40.17 92.62 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.056 0.542 . . . . 0.0 110.511 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.5 m -69.57 -14.27 62.76 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.946 0.898 . . . . 0.0 112.878 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.58 -13.04 6.94 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.048 1.309 . . . . 0.0 113.872 169.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.87 172.6 2.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.579 1.19 . . . . 0.0 111.858 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -145.54 144.1 30.33 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.389 -0.819 . . . . 0.0 111.558 169.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 38.2 tp60 -58.26 154.44 13.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.893 1.677 . . . . 0.0 109.491 172.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.4 m -139.42 134.01 31.8 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.02 176.34 37.71 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -172.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -76.26 164.27 26.22 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.022 -0.693 . . . . 0.0 109.488 172.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.2 164.12 23.38 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 169.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.0 tp -129.84 147.61 51.63 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.246 -0.909 . . . . 0.0 109.704 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.97 142.13 47.69 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 176.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 43.3 mt -138.79 110.87 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -82.88 131.2 35.2 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 123.247 0.619 . . . . 0.0 109.696 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -127.75 14.45 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 125.028 1.331 . . . . 0.0 111.852 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 68.0 tp . . . . . 0 N--CA 1.468 0.467 0 C-N-CA 124.387 1.075 . . . . 0.0 111.449 -177.264 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -60.31 -49.14 78.78 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.428 0.691 . . . . 0.0 110.922 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -79.85 -36.63 36.46 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.787 0.835 . . . . 0.0 110.121 -174.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 86.2 t90 -58.98 -48.45 81.52 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 28.7 tp -67.51 -39.74 85.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 119.057 -0.497 . . . . 0.0 110.6 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.9 -44.73 92.34 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -65.43 -40.54 93.43 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.133 0.573 . . . . 0.0 110.629 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -63.96 -49.78 71.21 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.797 -0.621 . . . . 0.0 110.231 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.06 -34.6 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 119.297 0.953 . . . . 0.0 110.895 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -61.63 -31.62 71.73 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-O 118.848 -0.596 . . . . 0.0 111.8 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.3 mt -86.27 -46.68 10.11 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.219 0.918 . . . . 0.0 111.296 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.05 -24.35 61.52 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.945 0.793 . . . . 0.0 112.404 -172.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.9 mttp . . . . . 0 C--O 1.247 0.926 0 C-N-CA 127.572 2.349 . . . . 0.0 111.652 -179.115 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 120.709 0.29 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -135.98 -25.11 1.25 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.418 1.087 . . . . 0.0 111.453 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.0 mt -130.27 82.74 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 169.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.6 m -75.95 116.9 17.11 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.85 151.88 40.38 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.3 mt -122.31 100.08 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 m -93.73 123.73 37.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.176 0.99 . . . . 0.0 110.121 -172.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.68 60.28 0.62 Allowed Glycine 0 C--N 1.331 0.254 0 N-CA-C 105.972 -2.851 . . . . 0.0 105.972 170.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.449 -0.513 0 C-N-CA 124.576 1.15 . . . . 0.0 111.589 -167.984 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.637 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.88 -28.17 68.76 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 117.433 0.617 . . . . 0.0 111.174 177.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.39 -39.96 58.51 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -65.31 -40.06 93.29 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.3 t -57.32 -51.29 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.134 0.974 . . . . 0.0 109.639 173.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.54 -43.56 98.64 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.961 0.801 . . . . 0.0 111.088 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.73 -45.51 86.17 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.914 0.486 . . . . 0.0 110.735 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -59.8 -48.27 82.36 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.297 1.039 . . . . 0.0 110.221 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.1 mt -59.88 -46.05 90.54 Favored 'General case' 0 N--CA 1.458 -0.054 0 C-N-CA 123.369 0.667 . . . . 0.0 110.242 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.87 -50.64 73.23 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.293 0.497 . . . . 0.0 110.339 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -58.87 -47.63 84.25 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.129 0.571 . . . . 0.0 110.483 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -66.01 -38.32 88.18 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.132 -177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.6 mt -65.78 -39.93 91.46 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 119.63 1.105 . . . . 0.0 110.791 175.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.96 -40.1 95.65 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.916 0.78 . . . . 0.0 110.128 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -65.66 -37.73 87.36 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.406 0.548 . . . . 0.0 111.156 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.92 -22.4 64.16 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.708 0.803 . . . . 0.0 112.136 176.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.14 25.72 3.46 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.636 -1.091 . . . . 0.0 113.821 170.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -127.72 127.73 44.16 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.152 1.476 . . . . 0.0 108.451 -177.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 p -72.68 149.83 43.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 109.835 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.8 p -133.72 170.21 15.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.688 0.756 . . . . 0.0 110.356 -172.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -151.66 162.17 41.45 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 169.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.5 83.04 2.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -177.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.2 mt -71.19 109.99 5.57 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -78.77 108.86 12.51 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.67 50.77 60.98 Favored Glycine 0 CA--C 1.54 1.612 0 CA-C-O 118.159 -1.356 . . . . 0.0 115.367 171.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -67.86 175.57 6.22 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.706 2.271 . . . . 0.0 111.183 173.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.9 mt -123.43 157.01 34.4 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.192 1.397 . . . . 0.0 108.219 170.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.81 -30.47 71.56 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.797 0.839 . . . . 0.0 111.768 -174.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.49 -8.51 14.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.783 0.833 . . . . 0.0 112.897 176.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -118.13 18.28 13.86 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.543 1.537 . . . . 0.0 110.832 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.4 mt -127.06 142.11 42.71 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.751 1.22 . . . . 0.0 109.205 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.05 162.47 41.71 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.539 2.159 . . . . 0.0 109.823 169.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.7 21.33 0.67 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.383 1.073 . . . . 0.0 112.557 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.6 p -156.79 149.76 23.87 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.787 1.235 . . . . 0.0 109.043 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.31 179.28 22.37 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.5 mt -117.62 103.32 14.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -104.82 170.81 7.66 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.043 0.937 . . . . 0.0 109.58 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.4 tp -148.58 106.52 3.71 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.8 t -87.88 137.07 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -173.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.04 126.67 56.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.3 m -135.08 120.37 18.99 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.781 0.432 . . . . 0.0 110.401 -172.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 m -71.94 -172.81 0.91 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 168.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -127.84 141.4 51.57 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -77.16 11.87 1.68 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.608 1.563 . . . . 0.0 111.889 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.05 23.34 76.1 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 120.934 -1.104 . . . . 0.0 111.378 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.2 8.54 2.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.206 1.402 . . . . 0.0 112.151 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.421 ' H ' HG23 ' A' ' 97' ' ' THR . . . 73.59 34.58 56.73 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 119.25 0.932 . . . . 0.0 111.114 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -145.92 152.73 39.9 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.774 1.63 . . . . 0.0 107.802 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 62' ' ' ILE . 4.2 mp -65.9 148.05 98.48 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -52.97 149.67 25.85 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.686 2.924 . . . . 0.0 113.298 169.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -57.21 -16.63 8.6 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.864 1.666 . . . . 0.0 113.663 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -61.99 -39.15 91.2 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.731 0.812 . . . . 0.0 110.8 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.2 tp -126.28 -22.27 4.07 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.5 0.72 . . . . 0.0 112.301 -171.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.9 p -54.37 -31.1 7.92 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-O 117.03 -1.462 . . . . 0.0 114.819 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -52.25 -22.71 16.15 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.147 2.565 . . . . 0.0 115.188 169.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -56.26 -35.64 67.67 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.029 0.932 . . . . 0.0 111.066 175.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -64.06 -40.59 96.6 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 122.991 0.517 . . . . 0.0 110.878 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.75 -46.44 58.46 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.02 -29.41 70.32 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.141 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.67 -63.74 1.09 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 170.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -67.85 -22.61 65.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.682 0.674 . . . . 0.0 112.624 -170.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -70.98 -32.95 69.94 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.602 0.761 . . . . 0.0 111.502 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -114.43 -33.98 5.41 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp 28.05 64.72 0.65 Allowed Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 127.83 2.452 . . . . 0.0 113.086 -169.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -60.57 173.38 2.14 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.695 2.263 . . . . 0.0 111.954 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -75.84 62.59 1.57 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.174 1.39 . . . . 0.0 110.561 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 70.8 mt -73.27 8.33 1.76 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.358 1.463 . . . . 0.0 112.786 -177.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.9 m -45.76 10.31 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.751 1 C-N-CA 132.055 4.142 . . . . 0.0 117.649 170.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.36 3.03 1.71 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.2 1.4 . . . . 0.0 112.172 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.2 t -78.71 137.3 22.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 169.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -119.19 141.5 48.82 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 168.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -148.86 172.46 14.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.111 0.414 . . . . 0.0 111.094 -174.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.67 163.53 24.11 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 105.761 -2.936 . . . . 0.0 105.761 169.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.19 130.37 19.65 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.306 1.053 . . . . 0.0 109.662 -169.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 23.1 mt -134.1 130.92 55.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -118.14 139.65 14.84 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.2 mp -131.44 118.37 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 176.7 -158.37 24.37 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 105.906 -2.878 . . . . 0.0 105.906 -172.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.6 m -96.82 170.14 9.37 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.187 0.995 . . . . 0.0 110.765 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -119.7 -19.76 7.92 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.203 1.001 . . . . 0.0 109.866 169.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -111.57 5.98 19.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.934 2.494 . . . . 0.0 111.089 -169.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -141.58 165.04 28.59 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.186 1.794 . . . . 0.0 109.04 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -59.28 -35.35 73.58 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.827 1.651 . . . . 0.0 113.503 -169.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 60' ' ' GLY . 53.2 m . . . . . 0 CA--C 1.534 0.349 0 CA-C-O 121.881 0.848 . . . . 0.0 109.2 170.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.676 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.9 tp -54.26 -31.41 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.599 1.56 . . . . 0.0 110.969 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -50.91 -35.28 32.26 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.732 1.213 . . . . 0.0 112.962 -170.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -54.27 -51.47 64.47 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.46 0.573 . . . . 0.0 111.353 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.3 mt -68.7 -50.89 47.26 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -172.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -67.58 -35.74 79.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.901 -173.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.84 -41.66 78.22 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.38 -24.97 62.17 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 117.509 -1.234 . . . . 0.0 112.424 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.6 mt -65.86 -52.38 50.82 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.978 1.717 . . . . 0.0 108.951 169.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -68.21 -33.89 75.25 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 122.076 -0.39 . . . . 0.0 110.883 -173.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -76.13 6.55 5.2 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.875 1.27 . . . . 0.0 112.644 172.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.4 m -120.59 15.41 11.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.299 1.44 . . . . 0.0 110.328 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.75 -22.96 27.11 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.623 1.106 . . . . 0.0 113.557 169.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.83 167.92 1.41 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.587 1.194 . . . . 0.0 110.66 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -137.17 136.48 38.25 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 121.461 -0.775 . . . . 0.0 111.351 171.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -60.29 164.58 4.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.056 -1.429 . . . . 0.0 109.525 171.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 m -136.49 157.84 45.85 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 126.371 1.868 . . . . 0.0 106.036 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.434 ' H ' HD12 ' A' ' 145' ' ' LEU . . . 55.7 -128.74 45.65 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 -173.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -144.62 165.81 26.97 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.706 1.203 . . . . 0.0 107.956 169.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.75 154.42 29.71 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.041 0.937 . . . . 0.0 110.438 -178.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 57.0 tp -129.67 143.54 50.87 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.858 0.863 . . . . 0.0 109.576 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -118.15 143.09 46.77 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.4 mt -132.31 100.38 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -69.62 142.01 53.58 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.486 0.714 . . . . 0.0 111.161 -171.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 8.4 pt -105.79 -21.04 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.178 0.991 . . . . 0.0 111.858 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 CA--C 1.53 0.208 0 C-N-CA 123.559 0.744 . . . . 0.0 109.801 -172.155 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 118.885 -0.579 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -65.23 -44.14 89.17 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.039 0.836 . . . . 0.0 110.304 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -62.84 -47.55 82.91 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.126 -0.359 . . . . 0.0 110.266 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -68.69 -33.75 74.5 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.536 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.9 tt -58.74 -40.97 85.37 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.193 0.906 . . . . 0.0 110.184 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.6 -48.25 66.42 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 173.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.4 m -63.96 -41.19 97.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.401 0.601 . . . . 0.0 111.11 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -62.57 -52.51 63.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 117.739 -1.124 . . . . 0.0 110.492 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.7 m -64.71 -34.03 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 120.258 1.39 . . . . 0.0 110.685 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -59.49 -32.77 70.57 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.061 0.846 . . . . 0.0 112.118 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.434 HD12 ' H ' ' A' ' 118' ' ' GLY . 25.9 mt -94.75 -35.85 11.95 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.512 -0.756 . . . . 0.0 112.55 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.7 pp -90.99 -17.3 26.54 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 117.36 -1.305 . . . . 0.0 113.459 -173.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt . . . . . 0 C--O 1.251 1.167 0 CA-C-N 119.572 1.078 . . . . 0.0 112.104 -172.529 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.289 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -140.98 -25.17 0.74 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.435 1.094 . . . . 0.0 111.482 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.7 mt -132.89 83.65 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 173.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.6 m -78.38 116.02 18.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.72 154.25 36.54 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.632 0.773 . . . . 0.0 109.598 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.3 mt -126.49 97.87 4.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.7 m -78.75 156.98 28.6 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.761 0.824 . . . . 0.0 110.097 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.68 89.83 0.09 OUTLIER Glycine 0 C--N 1.333 0.411 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.509 ' HG ' ' N ' ' A' ' 14' ' ' GLY . 23.7 p . . . . . 0 C--O 1.232 0.147 0 CA-C-N 117.462 0.631 . . . . 0.0 110.584 172.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.509 ' N ' ' HG ' ' A' ' 10' ' ' SER . . . . . . . . 0 CA--C 1.526 0.747 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.46 90.3 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.213 1.006 . . . . 0.0 110.229 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.46 -32.44 64.35 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.095 0.407 . . . . 0.0 111.912 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -65.01 -44.9 87.71 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.9 t -60.69 -46.43 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.1 -39.84 79.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.568 0.622 . . . . 0.0 111.344 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.17 -42.8 99.21 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.62 0.645 . . . . 0.0 110.837 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -71.64 -41.96 68.18 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.903 -0.498 . . . . 0.0 110.972 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.86 -44.44 97.02 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.07 -44.31 96.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.432 0.693 . . . . 0.0 110.469 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -58.0 -44.56 87.29 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.458 0.572 . . . . 0.0 110.388 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -62.73 -40.86 98.51 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.762 -0.587 . . . . 0.0 111.285 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 66.3 mt -63.9 -41.34 97.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.943 0.792 . . . . 0.0 111.142 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.24 -40.12 90.02 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.576 0.625 . . . . 0.0 110.378 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.88 -36.0 82.93 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.048 0.539 . . . . 0.0 110.805 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.62 -21.63 63.55 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.379 0.671 . . . . 0.0 112.248 174.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.52 -0.64 14.04 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.844 1.211 . . . . 0.0 113.825 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -79.2 178.94 7.69 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.424 1.112 . . . . 0.0 110.023 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.9 p -124.84 150.31 46.55 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.7 p -137.48 170.26 16.38 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.635 0.774 . . . . 0.0 109.729 -169.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -152.19 161.86 41.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 169.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.39 102.27 6.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.2 mt -80.08 153.57 28.67 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -128.76 102.47 6.57 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.42 52.83 49.33 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.487 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -66.39 174.45 6.2 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.028 2.485 . . . . 0.0 111.588 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.9 mt -129.26 163.47 25.59 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 125.249 1.42 . . . . 0.0 109.191 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.89 -30.4 58.04 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.75 1.22 . . . . 0.0 110.888 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -64.09 -11.18 27.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.314 1.446 . . . . 0.0 112.661 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -136.59 16.88 3.12 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.383 1.073 . . . . 0.0 110.907 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -135.62 101.03 10.95 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.124 1.37 . . . . 0.0 107.866 -169.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.32 164.59 34.8 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.737 2.292 . . . . 0.0 112.139 -171.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.58 7.29 1.94 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.574 1.55 . . . . 0.0 114.575 -173.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.9 m -149.61 139.33 21.75 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.8 178.08 27.06 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.5 mt -119.67 101.75 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 -176.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -114.76 167.69 10.55 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.205 1.002 . . . . 0.0 110.247 -171.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.4 tp -147.7 100.56 3.24 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 175.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.5 t -83.96 141.4 14.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.593 1.157 . . . . 0.0 109.685 -172.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.57 126.54 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.2 m -142.08 130.8 22.77 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.427 0.691 . . . . 0.0 110.656 -169.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.8 m -67.56 168.83 10.3 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.632 0.73 . . . . 0.0 111.358 169.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.573 ' HG1' ' N ' ' A' ' 101' ' ' ALA . 87.2 m -141.27 135.03 30.24 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 129.02 2.928 . . . . 0.0 104.143 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -129.72 146.13 51.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 172.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 36.62 -97.27 0.01 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 127.088 2.28 . . . . 0.0 114.586 176.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.87 9.63 26.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.342 1.457 . . . . 0.0 113.455 -169.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.71 25.46 7.63 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 120.115 1.325 . . . . 0.0 110.837 -175.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.08 110.52 5.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.97 149.84 85.54 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.79 144.82 49.58 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.702 2.268 . . . . 0.0 110.02 -169.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -56.8 -21.01 25.62 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.036 1.334 . . . . 0.0 113.793 -175.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -69.02 -31.62 70.56 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.843 -0.535 . . . . 0.0 111.823 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.5 tp -123.83 -25.31 4.29 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.641 0.777 . . . . 0.0 112.323 -169.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 78.8 p -54.47 -30.82 7.42 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 117.027 -1.464 . . . . 0.0 114.542 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -52.68 -26.11 28.67 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.612 2.208 . . . . 0.0 114.814 169.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -62.21 -40.76 97.19 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.508 1.049 . . . . 0.0 110.238 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -63.74 -37.6 87.95 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.91 0.777 . . . . 0.0 110.354 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -68.65 -44.66 73.65 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.747 0.419 . . . . 0.0 110.377 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.85 -41.67 95.51 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.676 -0.64 . . . . 0.0 110.935 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.2 mt -61.33 -49.35 77.34 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 118.56 -0.734 . . . . 0.0 110.352 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -71.74 -28.55 63.74 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.259 0.936 . . . . 0.0 111.434 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.4 -43.54 77.01 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.562 0.619 . . . . 0.0 110.58 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -99.32 -35.0 10.09 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -169.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.0 ttpp 30.04 57.28 0.81 Allowed Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 127.39 2.276 . . . . 0.0 113.412 -169.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.31 174.76 10.31 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.263 1.975 . . . . 0.0 110.374 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 81' ' ' SER . 13.4 p-10 -76.9 69.64 3.24 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.519 1.528 . . . . 0.0 111.024 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.2 mt -74.13 19.08 0.13 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.843 1.657 . . . . 0.0 112.158 173.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 79' ' ' ASP . 3.1 m -53.18 12.2 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.713 1 C-N-CA 131.786 4.034 . . . . 0.0 116.639 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.14 4.37 0.94 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.176 1.391 . . . . 0.0 112.232 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 79.2 t -74.1 131.36 35.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 169.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 121.14 39.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 169.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -130.44 168.95 16.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.086 0.469 . . . . 0.0 110.56 -173.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -127.62 162.76 21.51 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 104.758 -3.337 . . . . 0.0 104.758 169.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.2 137.63 24.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.139 0.97 . . . . 0.0 110.072 -169.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.5 mt -134.72 127.67 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -175.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.43 146.23 16.42 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 171.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.1 mt -137.11 147.1 27.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.66 166.38 29.47 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 176.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.4 m -81.64 111.18 17.68 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 170.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -64.63 -2.29 2.34 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 -169.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -63.64 -41.83 98.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.771 0.829 . . . . 0.0 110.877 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -75.37 155.24 36.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.963 0.801 . . . . 0.0 110.8 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -55.65 -33.83 64.43 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.835 1.254 . . . . 0.0 114.16 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.402 ' O ' HG21 ' A' ' 56' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.573 ' N ' ' HG1' ' A' ' 56' ' ' THR . . . . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.5 tp -54.87 -27.54 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.078 1.351 . . . . 0.0 110.51 171.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -52.19 -35.37 48.88 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.451 1.1 . . . . 0.0 112.817 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -66.89 -54.27 23.83 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 121.831 -0.543 . . . . 0.0 109.938 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.0 mt -61.56 -48.67 79.93 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.8 0.84 . . . . 0.0 109.456 -175.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.13 -37.87 86.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -173.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.22 -40.43 77.98 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -172.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -71.16 -31.06 67.22 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.584 -0.722 . . . . 0.0 111.504 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.9 mt -62.43 -48.15 80.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.911 1.232 . . . . 0.0 109.57 169.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -64.31 -38.83 92.43 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -65.92 -35.3 80.25 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.055 0.542 . . . . 0.0 111.339 175.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.1 m -71.73 -3.31 21.19 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.337 1.055 . . . . 0.0 112.846 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.72 -12.15 27.59 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.759 1.171 . . . . 0.0 113.201 170.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.59 171.89 1.82 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.441 1.121 . . . . 0.0 110.759 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -139.7 144.69 37.67 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.756 0.789 . . . . 0.0 110.591 169.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -78.75 171.05 15.72 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.167 171.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.46 153.03 41.05 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.916 1.287 . . . . 0.0 107.811 169.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.46 -130.73 37.76 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 172.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -136.91 162.26 33.76 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.3 1.44 . . . . 0.0 107.181 171.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.3 m -69.35 132.42 46.38 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.193 0.597 . . . . 0.0 109.476 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.4 tp -81.1 153.29 27.4 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -125.87 144.14 50.78 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 169.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 40.4 mt -132.63 101.74 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -67.58 138.37 56.39 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 171.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 18.5 pt -128.02 15.98 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 125.313 1.445 . . . . 0.0 111.73 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 N--CA 1.47 0.56 0 C-N-CA 124.413 1.085 . . . . 0.0 111.631 -178.629 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -56.69 -40.55 75.79 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.074 0.95 . . . . 0.0 112.469 -169.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -73.74 -30.82 63.03 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.785 0.721 . . . . 0.0 111.075 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -73.57 -40.23 64.07 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.518 -0.739 . . . . 0.0 109.723 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.4 tp -61.8 -44.29 97.16 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.907 1.283 . . . . 0.0 109.988 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.06 -44.42 93.0 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.682 1.134 . . . . 0.0 111.126 173.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.1 m -62.7 -40.07 95.99 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 122.313 -0.522 . . . . 0.0 110.67 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -63.04 -48.77 77.3 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 117.968 -1.015 . . . . 0.0 111.786 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 28.1 m -65.74 -33.39 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 119.978 1.263 . . . . 0.0 110.949 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.83 -32.84 74.14 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.687 -0.673 . . . . 0.0 111.854 174.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 mt -80.27 -50.9 9.58 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.004 0.82 . . . . 0.0 111.016 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 pp -79.11 -16.45 56.68 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.901 0.773 . . . . 0.0 113.052 -173.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 60.1 mttm . . . . . 0 C--O 1.25 1.129 0 C-N-CA 127.808 2.443 . . . . 0.0 111.949 176.816 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.358 0 CA-C-O 120.74 0.305 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -134.51 -26.84 1.39 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.393 1.077 . . . . 0.0 111.263 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.0 mt -128.9 81.39 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 171.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.7 m -77.46 110.69 12.45 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mp -74.78 155.89 37.13 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.7 mt -127.89 100.63 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 m -70.65 158.1 36.82 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.288 1.435 . . . . 0.0 110.88 177.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.41 59.37 0.23 Allowed Glycine 0 C--N 1.338 0.694 0 O-C-N 121.992 -0.443 . . . . 0.0 112.789 -170.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 CA--C 1.534 0.35 0 C-N-CA 125.17 1.388 . . . . 0.0 107.587 169.312 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.37 0 N-CA-C 107.404 -2.278 . . . . 0.0 107.404 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.15 -32.11 73.64 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 122.983 0.513 . . . . 0.0 111.066 175.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -66.04 -35.24 80.0 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.611 0.764 . . . . 0.0 110.572 176.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -70.64 -47.49 59.75 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -59.58 -40.95 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.31 -48.29 82.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.871 0.76 . . . . 0.0 110.599 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.96 -43.14 99.61 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.189 0.449 . . . . 0.0 110.765 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -66.8 -42.65 85.62 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.847 -0.533 . . . . 0.0 111.078 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.9 mt -65.68 -41.32 92.57 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.639 -0.663 . . . . 0.0 110.267 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.41 -41.04 93.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 119.005 -0.522 . . . . 0.0 110.761 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -55.9 -48.73 75.13 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.64 0.655 . . . . 0.0 110.128 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.18 -37.68 84.11 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 121.786 -0.571 . . . . 0.0 110.69 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.0 mt -62.68 -39.74 94.92 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.665 0.666 . . . . 0.0 111.426 175.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -66.85 -37.03 83.67 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.872 0.76 . . . . 0.0 110.534 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.84 -37.37 86.04 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.66 0.663 . . . . 0.0 110.877 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.02 -25.89 65.61 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.157 0.583 . . . . 0.0 111.661 173.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.88 -3.11 11.81 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.228 1.394 . . . . 0.0 113.88 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -79.85 143.56 34.23 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.863 1.331 . . . . 0.0 109.601 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 p -82.23 144.54 30.6 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 169.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.3 p -135.96 170.7 15.58 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.654 0.781 . . . . 0.0 110.116 -170.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -153.18 161.84 41.98 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 169.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 p -135.44 75.64 1.57 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -173.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.8 mt -66.29 115.87 6.71 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -171.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -76.88 95.34 4.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 53.26 62.69 5.75 Favored Glycine 0 CA--C 1.541 1.693 0 C-N-CA 123.894 0.759 . . . . 0.0 113.491 173.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -68.89 176.34 6.23 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.826 3.018 . . . . 0.0 111.848 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.4 mt -122.74 162.78 21.39 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.318 1.447 . . . . 0.0 107.603 169.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.7 tt -57.03 -35.93 69.87 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.733 0.813 . . . . 0.0 111.328 -176.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.23 -3.51 5.9 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.902 1.281 . . . . 0.0 113.21 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -130.47 16.54 5.43 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.908 1.283 . . . . 0.0 110.406 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -135.73 105.01 9.85 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.104 1.362 . . . . 0.0 108.826 -169.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.71 153.66 72.78 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.603 2.202 . . . . 0.0 112.388 -174.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.57 17.16 2.8 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.274 1.43 . . . . 0.0 113.347 -170.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.7 m -154.75 131.1 10.43 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 120.825 -1.172 . . . . 0.0 108.196 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.88 -173.92 26.9 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.9 mt -122.28 101.62 10.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -174.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -99.3 170.72 8.46 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.952 0.901 . . . . 0.0 109.844 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.3 tp -148.67 101.25 3.19 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 175.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.0 t -84.81 137.54 20.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 123.853 0.861 . . . . 0.0 108.725 -171.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.8 mt -133.73 115.94 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.1 m -130.47 127.7 39.74 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.216 0.606 . . . . 0.0 109.724 -169.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 m -76.85 165.8 24.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.135 0.493 . . . . 0.0 109.868 171.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 m -136.4 99.03 3.98 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.7 -34.05 77.3 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 157.9 155.64 7.62 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 171.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 46.24 32.44 1.49 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.632 1.973 . . . . 0.0 113.978 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.64 5.3 66.89 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.407 -0.663 . . . . 0.0 113.013 174.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.77 92.4 2.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.336 1.068 . . . . 0.0 110.115 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.0 mt -65.12 142.67 98.66 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 169.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.43 148.22 90.71 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.615 2.21 . . . . 0.0 111.497 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -57.91 -17.95 20.01 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.256 1.822 . . . . 0.0 113.785 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -62.06 -42.62 99.38 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.719 0.807 . . . . 0.0 110.401 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.5 tp -117.61 -26.07 6.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.592 0.757 . . . . 0.0 112.51 -169.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 100.0 p -55.92 -31.68 10.57 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 116.87 -1.538 . . . . 0.0 114.994 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -53.2 -25.09 28.56 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.537 2.158 . . . . 0.0 114.938 171.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -61.1 -38.34 85.95 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.262 0.937 . . . . 0.0 111.094 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -62.08 -40.98 97.68 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.679 0.792 . . . . 0.0 110.239 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.78 -46.82 62.19 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.955 0.502 . . . . 0.0 109.927 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.65 -31.34 72.31 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.765 -0.585 . . . . 0.0 112.124 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.4 mt -64.42 -59.98 3.7 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -68.1 -26.43 65.82 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.771 0.714 . . . . 0.0 112.291 -171.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -66.59 -33.85 76.58 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.299 0.64 . . . . 0.0 110.971 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -111.86 -30.48 7.28 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -169.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt 31.8 57.98 1.18 Allowed Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 126.976 2.111 . . . . 0.0 112.365 -169.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -71.37 170.78 17.55 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.367 2.045 . . . . 0.0 109.886 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -73.75 103.29 4.26 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.836 -0.54 . . . . 0.0 110.262 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.1 mt -114.34 23.13 13.09 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.639 1.576 . . . . 0.0 110.491 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.5 m -62.63 19.82 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.535 1.934 . . . . 0.0 115.696 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.18 2.57 1.5 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.321 1.448 . . . . 0.0 111.917 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.8 t -77.84 137.01 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 169.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -121.36 144.76 48.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 168.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -148.11 169.33 20.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.067 0.394 . . . . 0.0 110.186 -176.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.2 167.16 21.32 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 106.156 -2.778 . . . . 0.0 106.156 169.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.39 132.02 28.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.598 0.699 . . . . 0.0 109.79 -169.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.9 mt -132.29 130.76 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.13 146.57 18.83 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.1 mt -138.42 140.66 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -172.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 172.2 179.03 42.83 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.9 m -77.16 123.73 26.83 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 170.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.6 ptt-85 -58.94 -22.91 60.81 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -172.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -84.05 -4.42 58.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.439 0.696 . . . . 0.0 112.525 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.8 m-30 -63.51 162.03 13.47 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.453 1.024 . . . . 0.0 110.352 169.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -60.82 -27.45 68.06 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.653 0.781 . . . . 0.0 112.009 173.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.2 p . . . . . 0 C--O 1.233 0.237 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 172.85 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -30.31 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.796 0.838 . . . . 0.0 109.57 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -55.56 -31.22 61.97 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.4 1.08 . . . . 0.0 112.421 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -62.52 -49.63 74.58 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.783 0.72 . . . . 0.0 109.962 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.5 mt -64.67 -49.09 72.33 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -71.38 -32.62 68.68 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.907 -175.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.43 -44.58 92.88 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.431 1.014 . . . . 0.0 109.474 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -73.35 -27.56 61.57 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.603 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.0 mt -64.33 -46.36 83.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.479 1.49 . . . . 0.0 109.273 169.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -64.97 -39.95 94.26 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 117.855 0.298 . . . . 0.0 110.392 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -62.37 -37.92 87.59 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.546 0.738 . . . . 0.0 110.723 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.6 m -72.8 -12.35 60.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.244 1.018 . . . . 0.0 112.82 173.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 129.36 -17.7 5.56 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.988 1.28 . . . . 0.0 114.32 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.32 173.27 1.59 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.508 1.154 . . . . 0.0 111.958 -175.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -143.1 142.24 31.46 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.264 -0.898 . . . . 0.0 112.066 169.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -63.16 161.48 13.47 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.526 1.93 . . . . 0.0 109.962 176.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.8 m -143.03 149.28 38.03 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.909 1.684 . . . . 0.0 107.031 -176.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.57 -144.06 44.98 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -136.73 149.99 48.16 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 174.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.6 m -64.08 133.49 53.13 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.904 0.882 . . . . 0.0 110.149 -173.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.5 tp -98.92 152.24 19.98 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.69 138.94 39.9 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 29.0 mt -132.04 104.93 8.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 -170.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -67.57 134.54 51.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.17 172.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 6.3 pt -110.05 -8.61 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.78 0.832 . . . . 0.0 111.889 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.1 tp . . . . . 0 C--N 1.34 0.168 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.719 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -55.84 -25.64 42.98 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.06 0.846 . . . . 0.0 113.036 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -74.12 -48.22 30.95 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.023 0.829 . . . . 0.0 109.456 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 6.4 t-105 -68.64 -27.54 66.09 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.213 1.005 . . . . 0.0 111.158 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.1 tp -56.07 -33.74 65.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.22 1.008 . . . . 0.0 111.073 171.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.15 -44.36 88.71 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 174.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.9 m -63.03 -43.2 99.36 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.319 0.56 . . . . 0.0 110.206 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -62.46 -49.61 74.74 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 118.112 -0.947 . . . . 0.0 111.832 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.03 -30.17 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 120.378 1.445 . . . . 0.0 111.405 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -70.03 -20.32 63.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.602 0.637 . . . . 0.0 111.213 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.36 -46.81 4.9 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.132 0.973 . . . . 0.0 110.21 -174.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 pp -75.87 -20.61 57.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.302 -0.856 . . . . 0.0 112.255 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.9 mttp . . . . . 0 C--O 1.25 1.117 0 C-N-CA 127.631 2.372 . . . . 0.0 112.119 179.569 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 120.812 0.339 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -136.42 -26.43 1.11 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.933 1.293 . . . . 0.0 111.226 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.8 mt -125.67 79.49 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 170.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.1 m -74.37 117.65 16.42 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -84.26 154.83 22.76 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.6 mt -126.31 85.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -173.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -71.31 152.24 43.43 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.577 1.151 . . . . 0.0 110.173 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.45 104.26 0.24 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.837 0.827 . . . . 0.0 111.65 177.188 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.759 0 CA-C-O 119.514 -0.603 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.62 -26.26 66.16 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.707 1.254 . . . . 0.0 111.092 -176.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.38 -37.94 89.22 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.273 0.229 . . . . 0.0 110.863 176.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -76.11 -50.26 15.13 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 175.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.99 -47.21 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.402 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.06 98.23 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.029 0.831 . . . . 0.0 110.593 -177.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.63 -42.35 86.89 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.604 0.638 . . . . 0.0 110.64 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -63.36 -43.16 98.48 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.858 0.463 . . . . 0.0 110.628 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.93 -42.94 89.45 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.696 -0.628 . . . . 0.0 109.522 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.15 -37.18 76.66 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.525 0.73 . . . . 0.0 111.674 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -51.73 -47.08 64.18 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.65 0.659 . . . . 0.0 110.227 175.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.9 mmtt -68.36 -39.28 81.87 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.6 mt -65.65 -40.44 92.49 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.581 0.353 . . . . 0.0 110.258 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.27 -40.29 90.01 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.192 -0.432 . . . . 0.0 110.284 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.14 -36.44 84.27 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.703 0.683 . . . . 0.0 111.174 175.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.8 -22.96 65.15 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.475 0.71 . . . . 0.0 112.024 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.71 -0.1 19.98 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.922 1.249 . . . . 0.0 113.326 171.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -75.12 174.91 8.76 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.449 1.124 . . . . 0.0 109.907 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 p -122.47 145.72 48.04 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.2 p -132.52 166.29 22.41 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.662 0.785 . . . . 0.0 110.667 -169.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -152.49 159.4 43.34 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 169.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 p -127.99 80.19 1.94 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -171.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.3 mt -73.21 110.8 7.78 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -84.78 106.28 16.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.74 52.24 54.19 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 118.496 -1.169 . . . . 0.0 114.275 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.53 179.24 3.17 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.315 2.677 . . . . 0.0 111.029 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.4 mt -130.45 168.08 17.58 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.221 1.408 . . . . 0.0 108.528 172.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.78 -35.98 64.39 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.024 1.33 . . . . 0.0 111.697 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.75 -6.94 6.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.14 0.976 . . . . 0.0 113.444 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -129.45 19.07 5.79 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.661 1.584 . . . . 0.0 111.07 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.6 mt -135.75 112.04 10.56 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.803 1.241 . . . . 0.0 108.656 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.28 161.37 45.97 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.182 1.921 . . . . 0.0 111.223 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.69 13.28 1.71 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.185 1.394 . . . . 0.0 113.816 -172.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.4 m -146.92 130.2 16.59 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.487 1.115 . . . . 0.0 108.121 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.53 -176.63 29.86 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.18 99.29 5.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -100.57 173.99 6.29 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.27 1.028 . . . . 0.0 110.013 -173.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.2 tp -143.31 110.16 5.57 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.15 136.68 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.11 119.42 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 176.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.2 m -120.39 132.72 55.38 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.932 0.893 . . . . 0.0 108.894 -175.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.506 ' H ' ' HG3' ' A' ' 63' ' ' PRO . 15.4 m -87.59 50.94 2.09 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.73 0.812 . . . . 0.0 109.937 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -54.13 99.71 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.518 2.327 . . . . 0.0 110.636 -173.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -61.95 130.15 44.26 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.87 20.14 12.6 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.406 1.003 . . . . 0.0 113.843 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 49.97 34.26 7.82 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.105 1.362 . . . . 0.0 111.743 -169.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.58 -0.58 0.33 Allowed Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.518 -1.157 . . . . 0.0 115.132 -169.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -144.02 118.14 9.49 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 119.637 1.718 . . . . 0.0 108.744 171.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.5 mt -68.37 140.79 92.93 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.506 ' HG3' ' H ' ' A' ' 55' ' ' SER . 56.0 Cg_endo -64.17 139.02 64.38 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.975 1.783 . . . . 0.0 110.683 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.86 -19.72 52.84 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.07 1.348 . . . . 0.0 113.674 -173.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -70.88 -31.6 68.31 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.66 -0.65 . . . . 0.0 111.897 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.7 tp -118.14 -25.08 6.76 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.678 0.791 . . . . 0.0 111.753 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.6 t -44.98 -42.24 15.16 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 117.39 -1.29 . . . . 0.0 114.338 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.06 -25.71 13.26 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.81 3.007 . . . . 0.0 116.176 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -59.72 -35.81 75.28 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.19 0.904 . . . . 0.0 111.288 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -58.31 -40.67 82.67 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.225 0.61 . . . . 0.0 110.585 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -72.22 -47.65 48.89 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.912 0.485 . . . . 0.0 109.942 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.43 -35.92 82.49 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.562 0.619 . . . . 0.0 111.725 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.5 mt -66.02 -52.5 48.68 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.772 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -69.88 -25.56 63.76 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.544 1.066 . . . . 0.0 112.224 -174.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.27 -37.25 83.14 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.502 0.592 . . . . 0.0 110.349 177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -107.25 -28.78 9.71 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -169.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.9 mttm 32.27 57.82 1.29 Allowed Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 127.257 2.223 . . . . 0.0 112.556 -172.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.11 171.09 14.35 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.871 2.38 . . . . 0.0 110.66 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -77.23 110.37 11.87 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.576 -0.703 . . . . 0.0 109.357 170.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.5 mt -118.23 19.77 13.38 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.996 1.718 . . . . 0.0 110.951 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.8 m -58.74 11.21 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.857 2.063 . . . . 0.0 116.39 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.16 2.79 4.74 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.626 1.171 . . . . 0.0 111.445 173.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 80.5 t -81.76 140.21 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 169.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -119.51 146.82 45.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 168.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -140.98 171.65 13.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.918 0.866 . . . . 0.0 111.145 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.01 162.6 25.62 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 104.448 -3.461 . . . . 0.0 104.448 169.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.07 132.71 25.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.6 mt -134.17 137.82 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -110.29 152.88 17.25 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 170.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.3 mt -134.31 122.83 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 175.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.62 -155.98 15.2 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.241 -1.943 . . . . 0.0 108.241 -172.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.0 m -102.88 124.17 47.9 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 24.9 ttp180 -69.21 -14.93 63.24 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -69.34 -13.87 62.61 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.461 -0.774 . . . . 0.0 111.274 169.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 52.7 179.93 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 129.732 3.213 . . . . 0.0 115.547 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -156.33 -41.47 0.08 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.214 2.206 . . . . 0.0 107.527 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 92.4 m . . . . . 0 CA--C 1.543 0.683 0 C-N-CA 127.753 2.421 . . . . 0.0 105.659 169.21 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.321 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.686 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -33.28 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 119.251 0.932 . . . . 0.0 109.809 -178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -53.32 -29.59 34.58 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 119.005 -0.521 . . . . 0.0 112.341 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.57 -42.0 95.75 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.617 1.099 . . . . 0.0 111.541 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.41 -51.86 64.03 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -70.08 -35.5 74.23 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.921 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.2 -37.13 86.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.104 0.411 . . . . 0.0 110.846 -172.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -68.79 -34.71 76.0 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.383 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 44.2 mt -65.74 -41.63 91.97 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.258 1.39 . . . . 0.0 109.515 172.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -63.21 -44.63 94.78 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.315 1.046 . . . . 0.0 109.383 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -61.23 -42.26 98.29 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.003 0.921 . . . . 0.0 110.879 172.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.7 m -68.14 -7.0 26.1 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.226 1.01 . . . . 0.0 113.013 177.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.74 -15.15 14.34 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.058 1.313 . . . . 0.0 113.627 169.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.89 169.77 3.06 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.466 1.133 . . . . 0.0 110.776 176.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -142.76 154.01 43.83 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.422 -0.799 . . . . 0.0 111.228 171.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -70.43 155.75 40.27 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.927 171.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 72.8 m -125.95 153.21 44.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.379 1.872 . . . . 0.0 106.931 169.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.94 -144.54 49.05 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -175.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -135.71 152.51 51.24 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.497 1.119 . . . . 0.0 108.25 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.82 150.83 46.86 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.284 1.434 . . . . 0.0 110.427 -176.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.3 tp -130.0 144.97 51.62 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.391 1.076 . . . . 0.0 108.815 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.36 147.42 43.53 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 169.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.3 mt -124.35 106.5 16.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 -175.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -68.09 128.1 35.31 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.077 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -124.49 10.14 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.804 1.242 . . . . 0.0 111.68 174.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 53.2 tp . . . . . 0 CA--C 1.535 0.375 0 C-N-CA 123.051 0.54 . . . . 0.0 111.339 179.225 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -56.61 -44.22 80.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.776 0.83 . . . . 0.0 111.868 -169.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -73.33 -35.04 65.97 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 122.02 -0.425 . . . . 0.0 110.748 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -69.27 -40.36 77.83 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.81 -0.556 . . . . 0.0 109.839 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 48.9 tp -65.13 -39.93 93.75 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.389 0.676 . . . . 0.0 110.194 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.8 -46.4 83.21 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 171.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.6 m -64.54 -34.11 77.48 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.647 0.779 . . . . 0.0 111.299 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -66.14 -53.65 35.11 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.519 0.727 . . . . 0.0 110.051 176.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.5 m -66.06 -25.89 36.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 118.989 0.813 . . . . 0.0 112.182 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -54.98 -25.38 29.46 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.438 0.695 . . . . 0.0 112.276 177.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 27.7 mt -101.56 0.21 36.05 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 pp -127.68 -11.96 5.49 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 120.362 1.437 . . . . 0.0 113.467 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.0 pttp . . . . . 0 C--O 1.249 1.029 0 C-N-CA 124.286 1.034 . . . . 0.0 111.105 177.526 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 121.09 0.471 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -134.23 -26.66 1.46 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.123 1.369 . . . . 0.0 110.941 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.2 mt -124.64 79.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.6 m -74.51 114.38 12.85 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mp -76.6 148.39 37.01 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 170.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.5 mt -116.89 90.6 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -175.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.5 m -80.62 137.7 36.38 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.88 1.272 . . . . 0.0 111.262 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.95 76.62 0.36 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 125.148 1.356 . . . . 0.0 111.839 -170.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 169.421 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.26 0 N-CA-C 108.405 -1.878 . . . . 0.0 108.405 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.0 -35.09 79.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.803 176.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.18 -36.29 83.14 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.436 0.562 . . . . 0.0 110.315 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -73.67 -47.15 41.94 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.9 t -60.91 -43.3 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -46.39 90.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.019 0.528 . . . . 0.0 110.438 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.4 -44.26 96.87 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.623 0.647 . . . . 0.0 110.415 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -63.48 -35.63 81.09 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.743 0.417 . . . . 0.0 111.601 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.5 mt -74.21 -46.8 39.56 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.763 0.825 . . . . 0.0 109.904 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.13 -35.2 71.14 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.402 1.081 . . . . 0.0 111.623 -174.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -48.25 -44.07 32.97 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.161 0.985 . . . . 0.0 111.477 174.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -77.91 -32.85 51.93 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.502 -0.749 . . . . 0.0 109.984 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.0 mt -64.16 -39.25 93.62 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.554 0.616 . . . . 0.0 110.043 174.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -65.41 -41.63 93.39 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.291 0.496 . . . . 0.0 110.249 176.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -64.18 -35.91 82.33 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.552 0.615 . . . . 0.0 111.287 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.88 -22.54 65.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.555 0.742 . . . . 0.0 111.984 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.19 -0.73 16.77 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.913 1.244 . . . . 0.0 113.346 170.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -75.64 174.72 9.38 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.509 1.154 . . . . 0.0 110.074 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 p -120.32 144.08 48.03 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 169.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.5 p -134.88 168.46 19.03 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.653 0.781 . . . . 0.0 110.484 -169.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -151.86 149.93 29.53 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 104.359 -2.459 . . . . 0.0 104.359 169.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -110.96 69.64 0.69 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.43 106.86 5.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -169.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -72.87 118.38 15.74 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.71 54.14 26.28 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 118.124 -1.376 . . . . 0.0 116.187 169.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.45 176.28 4.26 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 CA-C-N 120.328 2.064 . . . . 0.0 110.978 169.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.7 mt -127.33 161.52 28.44 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.093 1.357 . . . . 0.0 107.969 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.37 -27.76 69.29 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.853 0.861 . . . . 0.0 111.315 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -65.22 -7.75 14.36 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.592 1.157 . . . . 0.0 112.435 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -131.4 21.94 4.76 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.731 1.612 . . . . 0.0 110.871 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 65.8 mt -133.81 115.8 13.45 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.919 1.288 . . . . 0.0 107.835 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -70.25 163.89 37.03 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.147 1.898 . . . . 0.0 111.346 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.32 14.8 0.68 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.133 1.373 . . . . 0.0 113.52 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 p -153.46 146.1 24.22 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.221 1.008 . . . . 0.0 109.097 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.22 179.74 23.52 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.53 97.38 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 173.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -95.39 169.48 10.03 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.849 0.86 . . . . 0.0 109.055 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.4 tp -147.89 111.24 4.93 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.5 t -96.93 138.02 23.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -171.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -134.68 133.32 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.5 p -138.46 146.93 42.68 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 m -109.33 79.32 1.2 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.278 1.031 . . . . 0.0 109.508 -172.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.0 m -45.09 114.18 0.69 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.932 1.693 . . . . 0.0 109.873 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -64.52 -22.49 66.98 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -175.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 159.93 -29.29 0.37 Allowed Glycine 0 C--N 1.339 0.717 0 CA-C-O 118.833 -0.982 . . . . 0.0 113.363 169.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.11 29.14 4.07 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.454 1.127 . . . . 0.0 112.309 -170.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.1 4.23 60.04 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.426 -0.652 . . . . 0.0 113.471 175.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -81.97 121.99 27.22 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.265 1.032 . . . . 0.0 109.492 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.8 mt -80.46 142.43 53.99 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -49.85 136.85 35.71 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.031 3.154 . . . . 0.0 112.984 169.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -60.5 -20.99 61.92 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.688 1.195 . . . . 0.0 113.296 -174.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -69.26 -30.43 68.54 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 118.856 -0.592 . . . . 0.0 111.638 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.3 tp -123.34 -22.52 5.07 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.463 0.705 . . . . 0.0 112.105 -169.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.1 t -46.02 -41.08 19.26 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 117.636 -1.173 . . . . 0.0 113.546 173.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -50.96 -26.88 19.45 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.266 2.644 . . . . 0.0 116.005 172.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -62.84 -38.11 89.48 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.791 1.178 . . . . 0.0 110.802 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -63.46 -38.89 92.89 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 118.341 0.519 . . . . 0.0 110.36 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.04 -48.62 65.16 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.34 70.15 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 121.515 -0.741 . . . . 0.0 112.462 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.95 -57.42 6.94 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -69.47 -28.49 66.13 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.887 0.767 . . . . 0.0 112.346 -171.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -76.64 -22.14 54.5 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.745 0.702 . . . . 0.0 111.781 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -118.2 -36.09 3.66 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.748 0.704 . . . . 0.0 112.391 -172.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt 30.59 60.67 1.0 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 127.222 2.209 . . . . 0.0 113.376 -174.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.74 170.8 14.51 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.156 1.904 . . . . 0.0 109.924 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -72.31 111.01 7.14 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.002 0.521 . . . . 0.0 109.925 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.1 mt -118.98 24.5 10.79 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.796 1.638 . . . . 0.0 110.52 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.7 m -63.37 20.89 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.473 1.909 . . . . 0.0 115.872 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.09 2.84 1.75 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.663 1.185 . . . . 0.0 111.967 173.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.7 t -76.97 142.29 14.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 169.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 54.8 mmm-85 -119.76 144.21 47.4 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 168.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -138.25 171.28 14.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.29 0.567 . . . . 0.0 110.66 -174.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.33 165.55 25.45 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 105.553 -3.019 . . . . 0.0 105.553 169.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.32 128.85 15.02 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.677 0.739 . . . . 0.0 109.878 -169.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 37.4 mt -131.11 124.22 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -101.84 95.59 1.35 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.1 mt -79.79 155.19 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 168.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.59 174.43 33.44 Favored Glycine 0 N--CA 1.436 -1.329 0 CA-C-O 123.21 1.45 . . . . 0.0 111.468 169.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.6 m -74.78 73.65 2.07 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 125.98 1.712 . . . . 0.0 109.077 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.92 -27.89 63.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.167 1.387 . . . . 0.0 112.362 -170.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -83.78 -11.34 57.21 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.467 0.707 . . . . 0.0 112.745 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -70.09 -53.55 16.91 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.374 0.988 . . . . 0.0 111.416 -169.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -164.78 -49.41 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.386 1.074 . . . . 0.0 110.755 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.233 0.212 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -172.632 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.563 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.1 tp -59.83 -28.88 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.006 1.323 . . . . 0.0 110.839 173.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.06 -37.66 77.55 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 122.908 0.483 . . . . 0.0 111.176 -174.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -61.81 -53.28 58.01 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.745 0.818 . . . . 0.0 109.819 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.7 mt -62.09 -50.82 70.41 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.66 0.784 . . . . 0.0 109.477 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.47 -41.57 72.57 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -171.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.24 -33.74 72.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 119.118 -0.468 . . . . 0.0 110.236 -170.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.57 -29.78 66.31 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.858 0.753 . . . . 0.0 111.197 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.1 mt -64.41 -44.54 90.95 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.795 1.18 . . . . 0.0 108.777 169.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -59.63 -44.87 93.32 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -177.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -66.46 -37.1 84.38 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 122.739 0.415 . . . . 0.0 110.335 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 31.3 m -68.3 -13.06 61.99 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.833 0.853 . . . . 0.0 112.393 174.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.19 -20.69 3.35 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.745 1.164 . . . . 0.0 113.442 169.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.72 171.02 2.25 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.116 0.958 . . . . 0.0 111.841 -175.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -142.12 141.91 32.72 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.172 -0.955 . . . . 0.0 110.115 173.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -63.85 164.86 9.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.217 1.007 . . . . 0.0 109.997 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.3 m -136.0 148.29 48.35 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.914 2.086 . . . . 0.0 106.197 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.55 -133.64 52.62 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -170.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -141.28 160.58 39.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.273 1.829 . . . . 0.0 106.453 176.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.89 158.72 24.46 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.527 1.131 . . . . 0.0 110.695 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.4 tp -129.85 146.43 51.57 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.392 1.077 . . . . 0.0 108.749 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -120.18 141.98 49.39 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.9 mt -137.84 100.6 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -67.77 130.37 42.78 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 170.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 pp -113.85 -4.1 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 123.875 0.87 . . . . 0.0 111.875 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.4 tp . . . . . 0 CA--C 1.533 0.299 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 168.562 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.339 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -60.77 -41.53 95.71 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.881 0.872 . . . . 0.0 110.828 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -73.19 -40.08 65.06 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 75.7 t90 -60.51 -50.24 74.34 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 52.3 tp -64.94 -40.59 95.26 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 119.148 -0.453 . . . . 0.0 110.164 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.18 -46.83 84.86 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 173.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.5 m -63.99 -37.13 86.31 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.056 0.543 . . . . 0.0 111.071 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -65.97 -51.64 56.71 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.91 0.884 . . . . 0.0 110.286 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.8 m -67.2 -30.88 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 O-C-N 121.24 -0.913 . . . . 0.0 111.379 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -61.82 -20.12 63.29 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.632 0.773 . . . . 0.0 112.376 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.6 mt -101.87 -36.27 8.71 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.787 171.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.71 -37.22 84.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.779 1.172 . . . . 0.0 111.718 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt . . . . . 0 C--O 1.247 0.95 0 C-N-CA 128.604 2.762 . . . . 0.0 113.074 179.839 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.39 0 CA-C-O 120.713 0.292 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -132.84 -27.23 1.69 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.58 1.152 . . . . 0.0 110.962 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.8 mt -124.94 79.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.2 m -75.12 117.82 17.38 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 mt -89.09 156.84 18.57 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.783 0.833 . . . . 0.0 108.812 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.4 mt -126.44 95.32 3.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -171.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.5 m -73.29 146.27 45.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.855 0.862 . . . . 0.0 110.11 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.32 81.94 0.15 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 124.47 1.033 . . . . 0.0 110.833 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.463 ' HG ' ' N ' ' A' ' 14' ' ' GLY . 23.0 t . . . . . 0 N--CA 1.455 -0.176 0 C-N-CA 123.444 0.697 . . . . 0.0 110.025 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.463 ' N ' ' HG ' ' A' ' 10' ' ' SER . . . . . . . . 0 CA--C 1.524 0.611 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.38 -35.47 80.41 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 122.001 -0.705 . . . . 0.0 110.499 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.59 -34.51 69.96 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.095 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -66.43 -46.06 77.77 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.417 0.687 . . . . 0.0 109.238 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.0 t -63.18 -47.75 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.57 -38.41 84.49 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-O 118.823 -0.608 . . . . 0.0 111.007 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.16 -45.23 89.39 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.345 0.975 . . . . 0.0 110.715 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -67.79 -40.04 83.99 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.884 -0.51 . . . . 0.0 110.795 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.3 mt -64.2 -42.51 96.6 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 119.257 -0.402 . . . . 0.0 110.157 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.08 -44.87 96.71 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.549 0.74 . . . . 0.0 110.468 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -58.77 -42.25 88.51 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.225 0.466 . . . . 0.0 110.269 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.5 mmtm -69.94 -39.47 76.08 Favored 'General case' 0 N--CA 1.462 0.142 0 O-C-N 121.682 -0.636 . . . . 0.0 111.726 176.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.6 mt -60.65 -37.12 80.47 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.084 0.856 . . . . 0.0 111.045 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -67.63 -35.75 79.51 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.863 0.756 . . . . 0.0 110.682 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.71 -37.46 84.74 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.092 0.86 . . . . 0.0 110.792 172.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.64 -26.41 67.05 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 122.844 0.457 . . . . 0.0 111.55 173.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.95 -3.28 11.68 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.345 1.45 . . . . 0.0 113.834 169.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -81.08 144.36 31.78 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.91 1.355 . . . . 0.0 109.724 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 p -84.18 144.11 29.19 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 169.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.8 p -135.7 169.33 17.72 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.613 0.765 . . . . 0.0 110.795 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -150.79 161.38 42.76 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 p -131.95 75.73 1.66 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.6 mt -69.23 121.91 17.78 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -171.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -80.51 95.49 6.49 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.64 56.17 26.76 Favored Glycine 0 CA--C 1.541 1.68 0 CA-C-O 118.783 -1.009 . . . . 0.0 113.852 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -69.47 178.84 3.99 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.556 2.838 . . . . 0.0 111.988 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.7 mt -129.04 165.93 20.21 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.44 1.496 . . . . 0.0 109.173 172.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.4 tp -63.2 -26.57 68.86 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.777 1.231 . . . . 0.0 112.288 -173.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.11 -10.15 13.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.052 0.941 . . . . 0.0 113.071 174.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -128.07 18.79 6.55 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.443 1.497 . . . . 0.0 111.068 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.6 mt -135.51 97.93 12.67 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 125.106 1.362 . . . . 0.0 107.756 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.73 165.26 30.21 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.356 2.037 . . . . 0.0 111.731 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.64 5.21 2.57 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.837 1.655 . . . . 0.0 114.71 -171.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.3 m -145.43 131.65 19.48 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.776 1.23 . . . . 0.0 107.997 -173.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.91 -172.23 35.06 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.039 -0.825 . . . . 0.0 111.039 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -129.73 97.26 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 173.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -100.52 172.27 7.22 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.602 0.761 . . . . 0.0 110.014 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.7 tp -138.78 103.17 4.76 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 120.793 -1.192 . . . . 0.0 107.809 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.6 t -80.43 129.34 37.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 mt -129.93 129.12 65.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 172.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -139.26 129.7 25.65 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -170.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.8 m -74.08 164.54 26.49 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.174 0.511 . . . . 0.0 109.981 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.8 m -135.98 138.53 42.37 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 176.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -124.84 10.47 8.3 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -169.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.59 -48.82 0.46 Allowed Glycine 0 C--N 1.34 0.773 0 CA-C-N 119.124 0.874 . . . . 0.0 112.849 169.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.28 24.53 2.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.038 0.935 . . . . 0.0 112.053 -169.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.85 9.67 57.14 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 119.614 -0.548 . . . . 0.0 112.653 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -65.08 122.27 16.65 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.276 1.038 . . . . 0.0 109.089 172.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.8 mt -83.07 145.02 48.36 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.79 138.88 85.59 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.064 2.51 . . . . 0.0 110.897 173.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -59.46 -16.93 27.09 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.914 1.285 . . . . 0.0 113.185 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -67.48 -33.12 74.46 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.259 0.624 . . . . 0.0 111.802 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.7 tp -125.67 -21.16 4.51 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.353 0.661 . . . . 0.0 112.27 -172.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 t -47.4 -40.56 27.72 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 117.618 -1.182 . . . . 0.0 113.736 174.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -50.79 -27.18 19.53 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.162 2.574 . . . . 0.0 115.669 172.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -63.02 -38.38 90.94 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.596 1.089 . . . . 0.0 110.877 177.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -64.22 -37.31 87.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.694 0.679 . . . . 0.0 110.156 177.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -69.49 -50.3 46.62 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.1 -31.73 73.04 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.448 -0.783 . . . . 0.0 112.15 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.5 mt -65.51 -55.53 17.3 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.539 -0.743 . . . . 0.0 109.605 172.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -70.18 -27.67 64.7 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.509 1.05 . . . . 0.0 112.309 -172.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -71.27 -28.41 64.13 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.769 0.713 . . . . 0.0 111.433 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -114.45 -33.69 5.5 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -170.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp 29.97 57.73 0.82 Allowed Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 127.719 2.407 . . . . 0.0 113.415 -172.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -69.41 172.63 11.95 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.125 1.883 . . . . 0.0 110.333 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -70.26 111.74 6.08 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.967 0.507 . . . . 0.0 109.83 171.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 mt -120.45 25.32 9.87 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.978 1.711 . . . . 0.0 110.323 175.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.4 m -63.7 19.9 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -174.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.87 9.44 1.52 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.684 1.194 . . . . 0.0 111.505 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.9 t -80.38 102.19 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 170.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -79.73 147.75 31.78 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 167.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -146.23 172.62 13.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 119.325 0.966 . . . . 0.0 112.019 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -125.66 162.35 19.91 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 105.847 -2.901 . . . . 0.0 105.847 169.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.7 125.93 16.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -170.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.3 mt -136.07 135.43 50.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -114.72 147.15 18.85 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.7 mt -127.83 147.81 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 164.95 157.18 9.49 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.4 m -71.51 120.32 16.93 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 171.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 -60.67 -15.32 27.55 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -64.38 -25.99 68.27 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.495 -0.753 . . . . 0.0 112.21 172.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 -61.76 156.7 19.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.856 0.753 . . . . 0.0 111.761 -177.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -57.45 -41.1 79.86 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.958 0.903 . . . . 0.0 110.784 171.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.8 m . . . . . 0 N--CA 1.446 -0.653 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 175.974 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.775 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 tp -53.91 -31.36 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.438 1.895 . . . . 0.0 110.361 169.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -57.48 -38.45 74.56 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.062 0.545 . . . . 0.0 112.209 -170.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -68.07 -45.67 73.18 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 121.946 -0.471 . . . . 0.0 110.549 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.9 mt -60.81 -49.21 78.41 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.384 0.674 . . . . 0.0 109.182 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -69.74 -33.68 72.79 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.185 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.32 93.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -74.27 -30.5 62.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.949 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.0 mt -62.11 -51.72 66.77 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 119.482 1.037 . . . . 0.0 109.483 170.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -68.29 -32.85 73.29 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.73 -173.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -64.76 -37.33 87.26 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.504 0.322 . . . . 0.0 111.106 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.5 m -71.03 -4.67 26.18 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.316 1.046 . . . . 0.0 112.917 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.79 -16.61 9.5 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.177 1.37 . . . . 0.0 113.249 169.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.69 176.14 0.55 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.037 1.335 . . . . 0.0 111.632 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.62 137.22 15.98 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.723 -1.236 . . . . 0.0 112.649 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -60.66 137.71 58.15 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.566 1.546 . . . . 0.0 108.661 169.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.3 m -121.59 139.24 53.78 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.593 1.957 . . . . 0.0 106.211 171.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.1 175.26 24.79 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.945 0.783 . . . . 0.0 111.668 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -85.47 139.07 31.79 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.924 -0.75 . . . . 0.0 109.366 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.1 m -57.73 152.84 14.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.902 1.681 . . . . 0.0 110.24 174.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 62.9 tp -128.95 149.01 50.98 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.941 0.897 . . . . 0.0 109.939 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -113.16 139.34 48.83 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 17.1 mm -117.6 96.0 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 171.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -67.43 138.37 56.61 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 172.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.0 pt -129.45 13.14 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.673 1.189 . . . . 0.0 111.745 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.4 tp . . . . . 0 N--CA 1.466 0.363 0 C-N-CA 123.452 0.701 . . . . 0.0 110.755 177.409 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.269 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -59.03 -24.29 62.71 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.367 1.467 . . . . 0.0 112.577 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -89.81 -43.49 10.61 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.899 0.772 . . . . 0.0 109.596 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -59.93 -28.92 68.01 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.44 0.696 . . . . 0.0 111.498 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 59.8 tp -51.92 -35.2 44.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.394 1.477 . . . . 0.0 111.872 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.85 -44.61 87.26 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 m -66.76 -30.99 71.34 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.548 0.739 . . . . 0.0 111.145 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -72.32 -55.35 7.27 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.251 0.478 . . . . 0.0 109.798 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.9 m -63.62 -29.53 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 118.498 0.59 . . . . 0.0 111.553 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -54.38 -28.53 43.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.896 0.879 . . . . 0.0 112.458 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 27.4 mt -101.7 -3.49 28.13 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.067 -0.968 . . . . 0.0 113.511 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.6 pp -125.94 -14.63 6.07 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.274 1.397 . . . . 0.0 113.497 -178.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.5 pttt . . . . . 0 C--O 1.25 1.126 0 C-N-CA 123.826 0.85 . . . . 0.0 111.079 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.726 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -140.97 -27.27 0.71 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.823 1.249 . . . . 0.0 111.669 177.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mt -132.96 83.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 171.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 79.6 m -73.99 119.28 17.99 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.55 148.13 35.38 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 172.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 82.7 mt -113.39 78.05 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.9 m -76.13 97.23 4.04 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.237 1.415 . . . . 0.0 109.332 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.03 52.21 0.67 Allowed Glycine 0 N--CA 1.461 0.337 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -172.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.448 -0.569 0 C-N-CA 123.296 0.639 . . . . 0.0 112.549 -167.972 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.592 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.78 -31.78 72.95 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.154 -0.45 . . . . 0.0 110.06 175.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -72.61 -35.38 67.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.816 0.735 . . . . 0.0 111.015 177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -67.11 -39.42 86.68 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.994 0.815 . . . . 0.0 109.229 175.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.87 -47.01 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 118.681 -0.676 . . . . 0.0 109.549 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.96 86.29 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.467 1.031 . . . . 0.0 111.383 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.09 -43.57 91.68 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.14 0.576 . . . . 0.0 110.593 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -64.62 -44.59 90.05 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.541 0.61 . . . . 0.0 110.66 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.3 mt -58.55 -46.97 85.74 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.327 1.051 . . . . 0.0 109.93 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.03 -46.04 89.2 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.303 0.641 . . . . 0.0 110.176 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.02 -42.2 93.84 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.016 0.526 . . . . 0.0 110.082 -179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.403 ' N ' ' HE2' ' A' ' 25' ' ' LYS . 6.1 mmpt? -63.74 -36.89 85.36 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 121.744 -0.598 . . . . 0.0 110.233 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.94 -38.71 76.26 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 118.66 0.664 . . . . 0.0 111.013 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.07 -43.35 99.02 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.727 0.694 . . . . 0.0 109.398 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.04 -38.99 92.65 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.078 0.551 . . . . 0.0 111.104 176.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.38 -21.43 64.7 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.624 0.77 . . . . 0.0 112.203 176.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.95 28.71 3.54 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.758 -1.023 . . . . 0.0 113.623 170.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -124.96 133.77 52.89 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.977 1.388 . . . . 0.0 108.924 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 p -75.79 140.6 42.43 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.282 0.563 . . . . 0.0 109.7 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.1 p -131.01 168.55 17.18 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.35 1.06 . . . . 0.0 110.6 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -154.45 128.0 8.6 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 169.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 p -82.59 65.09 7.55 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.007 1.323 . . . . 0.0 108.248 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.1 121.36 15.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -169.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.0 107.23 4.61 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -173.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 37.36 56.59 1.5 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 127.642 2.544 . . . . 0.0 115.789 173.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -62.47 148.66 92.97 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 120.222 2.011 . . . . 0.0 110.63 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mt -98.62 171.06 8.37 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 124.233 1.013 . . . . 0.0 110.551 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -52.92 -38.78 62.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.425 1.49 . . . . 0.0 111.282 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.74 -6.0 18.86 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.45 1.1 . . . . 0.0 112.68 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -135.27 20.38 3.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.986 1.714 . . . . 0.0 110.924 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.2 mt -134.11 108.73 11.54 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 125.133 1.373 . . . . 0.0 107.607 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.2 160.42 48.94 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.889 1.726 . . . . 0.0 110.631 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.6 7.13 2.58 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.742 1.217 . . . . 0.0 114.098 -172.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.2 m -147.52 142.13 26.59 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -176.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.16 -177.85 29.73 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.5 101.31 8.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -109.04 170.23 8.18 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.991 0.916 . . . . 0.0 109.914 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.8 tp -144.73 106.95 4.34 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.1 t -81.79 139.58 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 124.059 0.944 . . . . 0.0 108.864 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 mp -133.34 143.45 39.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.2 m -148.46 143.91 27.04 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.192 -0.943 . . . . 0.0 110.195 176.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -69.37 150.62 47.1 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.0 m -116.43 91.59 3.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -56.66 -32.19 65.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.53 0.732 . . . . 0.0 111.714 -176.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 150.82 -29.96 1.02 Allowed Glycine 0 C--N 1.34 0.763 0 C-N-CA 123.892 0.758 . . . . 0.0 112.628 169.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.96 25.29 7.36 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.421 1.088 . . . . 0.0 111.948 -170.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.12 5.94 86.99 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-O 119.363 -0.687 . . . . 0.0 112.921 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -72.96 146.94 45.67 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 169.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.3 mt -126.03 139.69 34.99 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -172.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -51.73 138.19 50.29 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.055 2.503 . . . . 0.0 113.304 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -57.71 -12.69 3.15 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.717 1.607 . . . . 0.0 113.198 174.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -54.96 -42.59 72.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.178 1.391 . . . . 0.0 109.732 172.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.3 tp -133.64 -21.45 1.97 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -171.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 91.5 p -52.48 -33.12 11.05 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -172.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -53.68 -23.09 24.83 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.803 2.335 . . . . 0.0 115.153 171.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -59.56 -36.59 76.5 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.571 1.078 . . . . 0.0 111.441 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -61.35 -43.0 99.61 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.186 0.448 . . . . 0.0 110.047 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -68.74 -47.09 67.18 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.167 0.587 . . . . 0.0 109.864 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.36 -36.74 83.65 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.865 -0.522 . . . . 0.0 112.03 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.3 mt -67.91 -51.31 49.34 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 118.515 -0.755 . . . . 0.0 109.537 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -68.76 -28.02 66.42 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.435 1.016 . . . . 0.0 111.886 -174.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.2 -39.23 86.32 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.749 0.704 . . . . 0.0 110.483 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -100.17 -22.8 15.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.891 -0.576 . . . . 0.0 112.43 -170.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt 40.03 56.97 7.2 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.997 1.719 . . . . 0.0 110.691 -169.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.88 143.02 78.19 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.354 2.036 . . . . 0.0 110.883 -169.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -81.85 64.22 6.45 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.655 1.182 . . . . 0.0 108.731 174.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.75 -56.01 10.88 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.6 m 50.55 19.97 0.64 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 169.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -157.38 -0.63 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 80.9 t -71.56 139.26 20.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -115.05 135.11 54.57 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 169.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -139.81 173.17 11.79 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.116 0.96 . . . . 0.0 112.298 -170.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -133.63 163.4 24.43 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 106.079 -2.808 . . . . 0.0 106.079 169.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.45 123.86 7.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.218 1.009 . . . . 0.0 108.413 -169.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 29.7 mt -139.53 139.93 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.47 138.91 11.81 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 169.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.68 128.59 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 162.96 -149.74 17.85 Favored Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 172.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.3 m -85.45 55.87 3.7 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 126.144 1.778 . . . . 0.0 110.956 -169.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -53.14 -37.01 61.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.836 0.855 . . . . 0.0 112.344 -173.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.0 -16.97 64.02 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.641 0.776 . . . . 0.0 112.87 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -63.18 -47.37 82.91 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.806 0.73 . . . . 0.0 111.483 -174.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -162.76 -43.07 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.4 m . . . . . 0 CA--C 1.531 0.234 0 C-N-CA 124.062 0.945 . . . . 0.0 108.874 -169.964 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.6 tp -127.6 -34.0 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.292 1.037 . . . . 0.0 110.002 169.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -55.17 -36.91 66.36 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.41 0.684 . . . . 0.0 111.823 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.41 -54.57 45.52 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.569 0.622 . . . . 0.0 110.902 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 50.4 mt -66.26 -49.35 67.45 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -173.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.17 -35.98 74.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -171.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.84 82.78 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.86 -0.591 . . . . 0.0 110.107 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -69.13 -31.25 69.8 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.239 0.927 . . . . 0.0 112.437 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.7 mt -64.24 -42.37 96.56 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.645 1.566 . . . . 0.0 109.447 169.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -61.93 -41.4 97.91 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.504 0.722 . . . . 0.0 110.133 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -64.4 -36.44 84.15 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.056 1.342 . . . . 0.0 111.012 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.1 m -72.79 7.8 1.8 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.076 1.35 . . . . 0.0 112.849 172.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.27 -8.11 80.55 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.898 1.237 . . . . 0.0 113.353 171.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.13 167.75 4.75 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.421 1.111 . . . . 0.0 110.043 170.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -142.7 151.93 41.84 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.267 -0.896 . . . . 0.0 111.957 176.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -56.39 163.71 1.62 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.375 1.47 . . . . 0.0 110.147 169.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.72 37.69 2.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.381 1.086 . . . . 0.0 109.604 -177.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 155.52 -167.48 33.04 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.558 2.028 . . . . 0.0 108.046 -169.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.75 154.68 20.76 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 117.925 0.863 . . . . 0.0 109.007 169.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.7 m -67.61 158.21 32.64 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.0 tp -132.41 152.34 51.51 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.563 0.745 . . . . 0.0 109.141 172.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -137.4 146.46 44.46 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 169.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.8 mt -134.14 103.31 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -169.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -75.8 141.8 42.44 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -130.9 4.86 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.2 tp . . . . . 0 C--N 1.347 0.462 0 CA-C-N 119.923 1.238 . . . . 0.0 111.374 -169.977 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 119.078 -0.486 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.5 -42.99 86.56 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.717 0.69 . . . . 0.0 110.647 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.19 -40.51 78.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.867 0.467 . . . . 0.0 110.127 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -67.05 -37.78 84.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.06 175.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.03 -42.92 93.89 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.629 1.104 . . . . 0.0 109.941 177.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.84 -43.9 87.21 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 171.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.0 m -63.82 -41.48 97.85 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.177 -0.602 . . . . 0.0 110.836 176.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -49.01 79.32 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.674 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.7 m -66.57 -31.75 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 120.431 1.468 . . . . 0.0 111.634 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -67.97 -18.91 64.88 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.628 0.649 . . . . 0.0 111.794 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.37 -47.2 4.77 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.809 1.244 . . . . 0.0 110.25 -176.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.6 pp -74.55 -23.51 58.8 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.077 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 C--O 1.246 0.88 0 C-N-CA 127.73 2.412 . . . . 0.0 112.15 177.932 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.261 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -136.95 -25.1 1.1 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.045 1.338 . . . . 0.0 111.215 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.9 mt -128.83 82.1 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 169.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 m -76.6 117.94 18.75 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.76 149.74 39.64 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 171.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 68.9 mt -117.18 95.14 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 104.743 -2.318 . . . . 0.0 104.743 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.4 m -85.59 89.49 7.73 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.283 1.833 . . . . 0.0 110.847 -169.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.64 57.09 4.76 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -167.627 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 111.424 -0.671 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.09 -29.66 68.73 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.241 0.52 . . . . 0.0 110.091 172.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -80.88 -30.32 35.57 Favored 'General case' 0 N--CA 1.462 0.162 0 O-C-N 121.962 -0.461 . . . . 0.0 111.601 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -66.79 -40.54 88.17 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.094 0.861 . . . . 0.0 108.931 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.07 -42.36 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 118.675 -0.679 . . . . 0.0 109.849 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.85 85.12 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.539 1.063 . . . . 0.0 111.149 176.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -65.04 -43.03 93.68 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.192 0.597 . . . . 0.0 110.654 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -61.2 -47.22 87.12 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.417 0.553 . . . . 0.0 110.875 176.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.5 mt -59.34 -47.67 84.55 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.541 0.737 . . . . 0.0 109.374 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.5 93.58 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.586 0.754 . . . . 0.0 110.808 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 -58.93 -41.49 87.44 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.404 0.547 . . . . 0.0 110.435 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.44 -30.76 66.43 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.011 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 70.5 mt -65.76 -40.0 91.63 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 119.91 1.232 . . . . 0.0 111.62 170.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -60.09 -43.92 95.18 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.868 0.758 . . . . 0.0 109.321 177.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.41 -38.06 88.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.206 0.602 . . . . 0.0 111.311 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.86 -21.43 64.27 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.739 0.816 . . . . 0.0 112.275 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.29 28.49 3.79 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.375 171.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -126.52 129.39 48.53 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.804 1.302 . . . . 0.0 107.96 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 p -75.37 148.11 39.49 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.8 p -134.02 170.17 16.04 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.757 0.789 . . . . 0.0 111.393 -171.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -152.6 161.96 41.87 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 169.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.49 78.5 1.81 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.7 mt -69.66 113.6 7.08 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.429 ' CD2' HD22 ' A' ' 65' ' ' ASN . 43.0 t60 -73.35 106.23 5.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 52.51 55.68 21.39 Favored Glycine 0 CA--C 1.541 1.685 0 CA-C-O 118.58 -1.122 . . . . 0.0 115.575 172.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -69.26 175.33 7.83 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.161 2.574 . . . . 0.0 111.722 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.6 mt -131.69 171.28 13.67 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 126.06 1.744 . . . . 0.0 110.152 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.87 -38.26 55.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.051 1.74 . . . . 0.0 111.857 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.62 -8.56 14.77 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -133.99 18.41 3.79 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.144 1.778 . . . . 0.0 110.87 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.9 mt -134.27 98.29 14.14 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 125.223 1.409 . . . . 0.0 107.704 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.14 163.5 35.8 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.157 1.905 . . . . 0.0 110.857 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.79 3.03 4.53 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -170.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.4 m -147.68 136.96 22.39 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.654 1.182 . . . . 0.0 107.894 -171.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.1 177.26 25.62 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.5 mt -113.71 102.43 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -101.21 168.68 9.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.341 0.656 . . . . 0.0 109.43 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.0 tp -144.59 100.42 3.52 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.4 t -79.49 140.78 16.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 123.553 0.741 . . . . 0.0 109.015 -174.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.3 mp -132.31 135.97 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 171.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.3 m -126.0 137.95 53.7 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.284 0.633 . . . . 0.0 111.369 173.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.4 m -69.87 160.25 32.16 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 168.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.59 89.14 2.19 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -78.63 42.28 0.44 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.767 1.227 . . . . 0.0 112.053 -171.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.57 -39.56 1.95 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.103 1.335 . . . . 0.0 113.422 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.62 -21.35 59.51 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.124 0.969 . . . . 0.0 112.971 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.35 9.13 80.04 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.767 -1.018 . . . . 0.0 113.539 -176.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -75.92 152.54 37.08 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.83 1.315 . . . . 0.0 110.756 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.1 mt -65.98 142.89 98.23 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.325 1.45 . . . . 0.0 108.567 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -57.95 125.99 20.31 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.937 3.091 . . . . 0.0 111.714 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -56.75 -27.09 58.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.656 1.182 . . . . 0.0 114.134 -173.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.429 HD22 ' CD2' ' A' ' 37' ' ' HIS . 10.2 p-10 -73.23 -19.18 61.14 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.817 -0.552 . . . . 0.0 112.43 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.4 tp -127.29 -23.03 3.6 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.125 1.37 . . . . 0.0 111.175 -171.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.2 p -53.94 -31.66 9.04 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-O 116.832 -1.556 . . . . 0.0 114.832 -176.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -52.54 -23.57 19.78 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.481 2.121 . . . . 0.0 114.929 169.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.46 -35.92 78.95 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.952 1.251 . . . . 0.0 111.675 175.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -59.32 -43.07 92.73 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.331 0.514 . . . . 0.0 109.777 176.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.9 -48.47 58.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.929 0.492 . . . . 0.0 109.8 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.38 -31.56 72.73 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.891 0.769 . . . . 0.0 112.54 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.1 mt -68.6 -54.65 15.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.952 0.796 . . . . 0.0 109.404 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -68.89 -29.52 67.82 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.336 0.971 . . . . 0.0 112.264 -171.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -73.24 -24.16 60.44 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.786 0.721 . . . . 0.0 111.32 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -112.86 -23.64 10.0 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.865 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt 39.31 64.67 3.84 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.936 1.694 . . . . 0.0 109.807 -169.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.88 -4.68 13.87 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.295 2.663 . . . . 0.0 115.534 -169.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.7 t70 50.57 51.99 15.76 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.172 1.389 . . . . 0.0 111.592 171.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.3 mt -58.92 -46.48 87.85 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.443 1.497 . . . . 0.0 110.494 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.8 m 54.86 15.44 1.13 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 172.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -153.92 2.03 0.24 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.704 1.138 . . . . 0.0 113.857 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 79.7 t -72.56 138.12 22.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 169.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -119.96 140.32 51.11 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 104.262 -2.496 . . . . 0.0 104.262 168.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -149.69 169.91 19.92 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.364 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.42 166.65 20.9 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 105.662 -2.975 . . . . 0.0 105.662 169.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.64 135.84 23.87 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.373 1.087 . . . . 0.0 109.723 -169.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.2 mt -135.9 137.36 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -175.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.18 135.18 11.18 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 170.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.9 mt -139.57 131.13 33.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 164.96 -159.85 33.02 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 120.425 1.466 . . . . 0.0 110.369 171.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.6 m -76.33 47.45 0.47 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 127.727 2.411 . . . . 0.0 111.106 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 57.1 mtt-85 -66.57 -15.9 63.76 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.149 -0.969 . . . . 0.0 112.879 -170.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.63 -28.38 69.86 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.21 0.604 . . . . 0.0 112.051 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -66.42 -57.32 7.65 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 123.292 0.637 . . . . 0.0 110.466 -171.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -169.01 -66.33 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.263 1.425 . . . . 0.0 108.636 172.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.9 p . . . . . 0 CA--C 1.551 0.987 0 C-N-CA 127.413 2.285 . . . . 0.0 114.308 -174.516 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.09 -33.16 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -61.06 -37.77 83.83 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.957 0.903 . . . . 0.0 111.971 -172.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -68.38 -42.77 78.61 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.725 -0.609 . . . . 0.0 111.081 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.77 -50.05 73.91 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.55 -32.93 73.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 119.438 -0.315 . . . . 0.0 111.023 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.77 99.59 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -74.57 -29.2 61.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.279 -0.867 . . . . 0.0 112.259 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.1 mt -62.82 -47.91 81.38 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.191 1.359 . . . . 0.0 109.234 170.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -66.07 -36.62 83.7 Favored 'General case' 0 N--CA 1.46 0.054 0 C-N-CA 122.415 0.286 . . . . 0.0 110.829 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -63.38 -38.36 90.85 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.134 0.574 . . . . 0.0 110.7 173.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.2 m -74.46 11.77 0.92 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.661 1.184 . . . . 0.0 112.499 171.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.35 -5.52 84.64 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 120.78 -1.2 . . . . 0.0 113.857 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.9 169.39 2.6 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.0 1.4 . . . . 0.0 110.092 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -141.74 139.74 32.93 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.602 -0.686 . . . . 0.0 110.966 169.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -64.94 170.61 4.15 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.049 1.339 . . . . 0.0 109.461 175.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.1 m -140.15 152.72 46.29 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.39 -132.99 42.03 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -144.07 154.85 43.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.77 129.78 42.02 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.119 0.968 . . . . 0.0 109.958 -177.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.2 tp -91.36 142.39 27.74 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -129.71 139.46 51.33 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.2 mt -138.99 100.4 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -73.43 133.43 43.73 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 169.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -128.91 8.12 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.844 0.747 . . . . 0.0 112.538 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.5 tp . . . . . 0 N--CA 1.468 0.456 0 CA-C-N 118.941 0.792 . . . . 0.0 111.654 -178.479 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.218 0 CA-C-O 119.541 -0.266 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.29 -34.19 77.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.217 0.607 . . . . 0.0 111.563 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -79.42 -36.6 38.78 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.419 0.554 . . . . 0.0 109.756 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -66.83 -40.0 87.83 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.771 -0.581 . . . . 0.0 110.046 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.1 tp -64.77 -42.33 95.19 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.51 1.124 . . . . 0.0 110.575 174.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.52 -43.98 85.59 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.43 1.014 . . . . 0.0 110.985 172.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.8 m -63.98 -41.11 97.64 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.292 0.637 . . . . 0.0 110.568 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -52.01 66.68 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.406 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.1 m -61.79 -35.07 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 119.793 1.179 . . . . 0.0 110.796 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -61.92 -24.35 66.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.55 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.2 mt -91.64 -47.77 7.2 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.739 1.154 . . . . 0.0 111.04 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.7 pp -80.24 -10.94 59.77 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -172.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.4 pttm . . . . . 0 C--O 1.249 1.053 0 C-N-CA 125.463 1.505 . . . . 0.0 112.778 -177.565 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.299 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -136.37 -26.64 1.11 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.276 1.43 . . . . 0.0 111.038 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.0 mt -122.91 77.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 169.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -74.74 116.33 15.33 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.2 mt -87.84 155.93 19.64 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.3 mt -125.62 95.12 3.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -170.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 m -90.07 153.03 20.87 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.086 1.754 . . . . 0.0 111.022 -175.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.18 128.95 1.15 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 107.558 -2.217 . . . . 0.0 107.558 173.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.204 0 CA-C-O 121.565 0.698 . . . . 0.0 112.305 -172.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.648 0 CA-C-O 118.611 -1.105 . . . . 0.0 112.948 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.23 -32.42 73.83 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.037 1.919 . . . . 0.0 110.746 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.67 -39.34 93.5 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.494 0.318 . . . . 0.0 110.848 176.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -70.55 -48.03 57.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -61.35 -43.1 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.52 -48.15 83.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 118.73 0.696 . . . . 0.0 110.101 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.51 -43.33 94.43 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.663 0.665 . . . . 0.0 110.986 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -63.53 -38.44 91.16 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.813 0.845 . . . . 0.0 111.252 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.6 mt -74.53 -41.25 60.94 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.266 0.626 . . . . 0.0 110.275 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.89 -40.32 80.0 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 123.438 0.695 . . . . 0.0 110.84 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -52.51 -46.35 66.64 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.608 0.763 . . . . 0.0 110.638 175.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -68.0 -39.21 83.26 Favored 'General case' 0 N--CA 1.46 0.064 0 O-C-N 121.84 -0.538 . . . . 0.0 110.259 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.8 mt -66.34 -39.84 89.46 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 119.506 -0.283 . . . . 0.0 110.705 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.81 -40.44 91.88 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.409 0.549 . . . . 0.0 110.18 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -64.78 -36.19 83.51 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.33 0.514 . . . . 0.0 111.018 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.94 -23.98 64.22 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.46 0.704 . . . . 0.0 111.994 174.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.86 -0.62 13.53 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.902 1.239 . . . . 0.0 113.741 170.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -75.67 174.75 9.36 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.737 1.268 . . . . 0.0 110.305 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.9 p -119.16 144.01 46.91 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 170.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -135.64 167.69 20.66 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.063 0.945 . . . . 0.0 109.934 -169.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -153.07 160.23 42.92 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 169.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 p -124.88 72.19 1.21 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.0 mt -69.05 114.38 7.28 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -173.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -81.89 110.0 16.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.85 46.62 93.22 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-O 117.943 -1.476 . . . . 0.0 115.926 172.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -69.09 173.36 10.48 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 121.031 2.415 . . . . 0.0 110.267 169.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 mp -131.34 175.68 8.93 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.285 1.434 . . . . 0.0 108.036 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.408 HD21 ' HG3' ' A' ' 78' ' ' PRO . 45.3 tp -55.77 -32.02 63.08 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.284 1.034 . . . . 0.0 111.052 175.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.83 -7.5 11.43 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.068 0.947 . . . . 0.0 112.717 178.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -134.19 18.08 3.74 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.42 1.488 . . . . 0.0 111.336 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.7 mt -137.27 113.57 9.58 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.702 1.201 . . . . 0.0 108.422 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.78 164.14 36.63 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.366 2.044 . . . . 0.0 111.428 -178.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.6 20.46 1.12 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.163 1.385 . . . . 0.0 112.951 -171.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.8 m -153.94 139.1 17.43 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 120.999 -1.063 . . . . 0.0 108.41 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.42 -178.14 27.14 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.18 101.05 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -102.82 175.28 5.54 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.29 1.036 . . . . 0.0 110.462 -173.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.6 tp -145.66 108.3 4.48 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.4 t -86.56 131.65 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.6 mt -130.67 131.63 64.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.9 m -149.47 142.02 24.4 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.643 0.777 . . . . 0.0 109.192 -169.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.8 m -73.68 160.6 31.33 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 m -115.54 5.77 14.5 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.757 0.789 . . . . 0.0 112.678 -175.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 41.53 22.9 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 129.279 3.031 . . . . 0.0 114.181 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.89 19.31 29.12 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.462 -1.188 . . . . 0.0 114.562 -170.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.35 -13.32 0.13 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.491 1.646 . . . . 0.0 115.115 -169.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.43 -1.83 53.64 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 119.454 1.025 . . . . 0.0 113.081 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.96 155.87 38.18 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 169.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.9 mt -122.91 144.38 42.86 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.028 1.331 . . . . 0.0 107.863 -169.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.99 124.74 4.93 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.606 3.538 . . . . 0.0 113.62 172.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.5 -24.22 65.13 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.94 0.896 . . . . 0.0 113.066 -174.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -73.9 -22.46 59.69 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.0 tp -122.69 -29.9 3.95 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.152 0.981 . . . . 0.0 111.372 -170.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 t -45.75 -41.76 20.39 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.537 1.535 . . . . 0.0 113.684 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -51.16 -23.01 12.05 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.301 2.667 . . . . 0.0 116.122 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -56.76 -38.21 72.12 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.68 1.127 . . . . 0.0 111.027 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -58.23 -43.81 87.92 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.101 0.96 . . . . 0.0 110.458 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -72.48 -45.71 58.22 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.05 0.54 . . . . 0.0 109.841 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.62 -33.95 77.09 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 118.874 -0.584 . . . . 0.0 112.058 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.3 mt -63.85 -57.87 8.52 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -68.85 -27.24 65.64 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.829 0.741 . . . . 0.0 112.197 -172.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.06 -37.34 87.22 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.576 0.625 . . . . 0.0 110.615 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -105.65 -30.81 9.24 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -170.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.7 tttm 29.27 60.86 0.79 Allowed Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 128.019 2.528 . . . . 0.0 113.692 -174.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.408 ' HG3' HD21 ' A' ' 41' ' ' LEU . 83.3 Cg_endo -68.09 170.08 15.21 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.711 1.608 . . . . 0.0 110.089 172.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -74.23 110.99 8.96 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.2 mt -114.58 20.24 15.48 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.418 1.487 . . . . 0.0 110.948 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.8 m -62.15 19.35 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.994 1.718 . . . . 0.0 115.558 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.12 -0.8 2.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.338 1.455 . . . . 0.0 111.861 174.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 68.0 t -81.41 142.92 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 169.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -122.63 146.72 47.2 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 168.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -143.9 172.37 12.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.588 0.709 . . . . 0.0 110.803 -173.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.68 166.95 23.36 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 107.983 -2.047 . . . . 0.0 107.983 169.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.9 134.8 17.81 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -169.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.9 mt -138.68 128.82 33.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -177.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -104.32 104.59 2.45 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 107.983 -2.047 . . . . 0.0 107.983 173.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.3 mt -84.33 128.56 38.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.798 -1.926 . . . . 0.0 105.798 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.55 -146.48 6.06 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 -172.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.2 m -161.7 149.08 14.54 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.653 1.181 . . . . 0.0 110.36 171.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -64.7 -17.18 63.86 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.81 -36.55 84.7 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.207 0.603 . . . . 0.0 109.91 175.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -74.01 158.26 34.66 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.429 0.633 . . . . 0.0 110.708 176.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.49 -19.07 62.25 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.668 0.787 . . . . 0.0 112.523 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.4 m . . . . . 0 CA--C 1.536 0.442 0 C-N-CA 124.445 1.098 . . . . 0.0 108.997 -172.495 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.393 0 N-CA-C 110.654 -0.128 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.2 tp -60.92 -31.07 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.735 0.814 . . . . 0.0 109.693 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -51.43 -38.17 52.27 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.131 0.972 . . . . 0.0 112.165 177.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -71.84 -47.87 50.03 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.972 0.806 . . . . 0.0 109.961 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.3 mt -59.58 -48.34 82.05 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.299 0.64 . . . . 0.0 109.781 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -68.98 -37.66 78.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.1 85.92 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 118.564 -0.731 . . . . 0.0 110.508 -171.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -72.02 -28.26 63.26 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.309 0.958 . . . . 0.0 112.699 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.51 -43.88 84.04 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.571 1.532 . . . . 0.0 108.498 169.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -61.11 -44.3 97.56 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.2 1.0 . . . . 0.0 109.977 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -66.14 -35.25 80.0 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.988 1.715 . . . . 0.0 111.281 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 44.4 m -73.65 -8.13 54.77 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.786 0.834 . . . . 0.0 112.675 173.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.42 -18.13 8.85 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.797 1.189 . . . . 0.0 113.935 169.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.66 171.97 2.38 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.294 1.047 . . . . 0.0 111.286 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -144.32 155.44 43.81 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.972 -1.08 . . . . 0.0 112.287 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -56.44 168.12 0.6 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.948 1.699 . . . . 0.0 110.581 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 m -134.02 37.92 3.2 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.211 1.004 . . . . 0.0 110.266 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 139.6 -168.95 24.79 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 126.945 2.212 . . . . 0.0 110.245 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -89.84 143.32 26.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 117.928 0.864 . . . . 0.0 110.858 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.1 m -58.32 137.91 56.82 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.914 1.686 . . . . 0.0 111.447 -176.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 35.9 tp -91.44 148.92 21.96 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.795 0.438 . . . . 0.0 109.892 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -116.42 138.22 51.54 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 169.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.9 mt -124.4 99.29 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.18 92.25 6.27 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.051 1.74 . . . . 0.0 108.59 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 26.5 pt -66.67 -35.28 74.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -174.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.5 tp . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 125.525 1.53 . . . . 0.0 112.518 -175.586 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -63.52 -30.2 71.35 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.693 0.797 . . . . 0.0 111.341 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -68.21 -43.98 76.8 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.214 0.915 . . . . 0.0 109.328 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -64.26 -39.17 93.39 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.81 0.844 . . . . 0.0 110.596 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.69 -30.91 71.05 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.65 -0.656 . . . . 0.0 110.954 176.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.04 -44.29 56.45 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.442 1.02 . . . . 0.0 111.49 171.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.6 m -64.16 -39.13 93.37 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.657 0.729 . . . . 0.0 110.588 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -62.47 -50.7 70.42 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 118.671 0.669 . . . . 0.0 110.869 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.5 m -66.74 -30.76 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.551 1.069 . . . . 0.0 111.027 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -67.76 -33.03 74.05 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.885 0.766 . . . . 0.0 111.333 175.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.43 -49.66 11.14 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.623 0.769 . . . . 0.0 110.154 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 pp -79.35 -21.46 45.79 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.471 -0.776 . . . . 0.0 112.716 -172.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp . . . . . 0 C--O 1.251 1.181 0 C-N-CA 127.382 2.273 . . . . 0.0 111.822 -179.366 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -128.13 -26.11 2.9 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.17 0.988 . . . . 0.0 111.476 -173.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.3 mt -130.74 85.98 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.1 m -82.01 115.16 21.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mp -74.28 155.35 38.33 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.5 mt -130.89 104.1 8.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.44 1.496 . . . . 0.0 107.076 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.25 133.14 35.23 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.708 0.803 . . . . 0.0 110.982 -177.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -125.34 86.76 0.36 Allowed Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 107.413 -2.275 . . . . 0.0 107.413 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 122.435 1.112 . . . . 0.0 111.974 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 N-CA-C 112.203 -0.359 . . . . 0.0 112.203 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.89 -22.76 63.2 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.566 -0.731 . . . . 0.0 111.231 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.25 -39.88 62.75 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.054 0.843 . . . . 0.0 110.135 176.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -68.47 -43.13 77.64 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.683 -0.636 . . . . 0.0 109.436 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.2 t -64.12 -39.71 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.049 175.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.91 -43.55 98.39 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 119.636 1.107 . . . . 0.0 110.88 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -61.02 -44.27 97.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.431 0.56 . . . . 0.0 110.411 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -60.84 -51.62 68.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.919 0.488 . . . . 0.0 110.541 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.7 mt -61.25 -43.63 98.56 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.463 0.705 . . . . 0.0 110.349 -177.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.21 -43.31 99.09 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.167 0.587 . . . . 0.0 110.294 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.0 -45.41 93.74 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.538 0.608 . . . . 0.0 110.293 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -60.98 -43.04 99.4 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.914 -0.491 . . . . 0.0 110.578 178.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 41.6 mt -64.24 -40.94 97.04 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.781 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.8 -38.22 88.37 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.944 0.793 . . . . 0.0 110.308 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -66.77 -36.74 83.13 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.294 0.497 . . . . 0.0 110.845 175.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.75 -25.46 64.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.283 0.633 . . . . 0.0 111.788 173.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.99 -0.17 14.82 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.331 1.444 . . . . 0.0 113.941 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -81.16 143.41 32.39 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.109 1.455 . . . . 0.0 109.69 -177.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 p -79.47 138.14 37.47 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.1 p -128.38 162.51 26.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.046 0.938 . . . . 0.0 109.979 -173.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -145.75 166.64 25.29 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 170.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.3 m -145.72 101.87 3.61 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 -177.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.85 106.92 18.81 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -175.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -74.93 105.71 6.09 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.53 56.13 26.74 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 118.368 -1.24 . . . . 0.0 115.355 172.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.7 172.8 7.61 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.93 2.42 . . . . 0.0 111.623 172.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.2 mt -128.14 170.23 13.2 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.977 2.111 . . . . 0.0 107.565 169.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 tt -54.49 -34.67 62.03 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.888 0.875 . . . . 0.0 111.737 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.06 -5.24 12.3 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.915 1.286 . . . . 0.0 112.591 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -135.23 17.59 3.42 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.944 1.298 . . . . 0.0 110.577 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -134.35 98.59 13.8 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 125.072 1.349 . . . . 0.0 108.628 -169.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -70.23 154.12 66.15 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.559 2.173 . . . . 0.0 111.961 -176.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.02 7.98 6.42 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.059 1.344 . . . . 0.0 114.452 -170.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.5 m -149.48 125.63 10.71 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.125 0.97 . . . . 0.0 108.444 -170.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.24 -175.74 28.32 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.0 mt -116.41 102.03 13.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -96.88 169.86 9.56 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.51 0.724 . . . . 0.0 109.428 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.6 tp -143.16 101.72 3.86 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.1 t -84.34 138.43 19.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 124.125 0.97 . . . . 0.0 108.793 -174.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mp -135.02 130.55 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.24 136.46 50.13 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.042 0.937 . . . . 0.0 110.366 -168.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 m -106.98 47.97 0.86 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.737 0.815 . . . . 0.0 111.175 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.1 m -33.02 105.83 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.178 2.191 . . . . 0.0 110.808 169.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.96 149.86 46.39 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 169.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -42.02 -35.27 1.61 Allowed Glycine 0 CA--C 1.531 1.031 0 C-N-CA 126.096 1.807 . . . . 0.0 116.437 -169.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.92 -10.64 59.25 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.46 46.45 4.34 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 -169.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -123.37 106.78 10.96 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -178.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.4 mt -65.02 141.0 98.26 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.86 141.19 89.02 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.869 2.379 . . . . 0.0 111.851 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -62.44 -14.97 46.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.911 1.684 . . . . 0.0 113.582 -173.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.72 -25.02 63.65 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.461 -0.774 . . . . 0.0 111.824 177.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 63.5 tp -128.68 -31.77 2.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.973 0.806 . . . . 0.0 112.348 -169.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.7 p -52.27 -34.25 15.22 Favored Pre-proline 0 CA--C 1.553 1.08 0 CA-C-O 116.744 -1.598 . . . . 0.0 114.298 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.15 -37.68 59.02 Favored 'Trans proline' 0 C--N 1.359 1.113 0 C-N-CA 123.296 2.664 . . . . 0.0 114.989 174.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -61.13 -44.39 97.41 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.396 0.544 . . . . 0.0 109.764 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -75.84 -30.47 58.95 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.975 0.51 . . . . 0.0 110.686 -173.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -62.56 -43.15 99.53 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.461 -0.774 . . . . 0.0 109.118 169.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.47 -20.65 66.1 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 118.4 -0.809 . . . . 0.0 112.737 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.16 -55.95 10.51 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.774 1.17 . . . . 0.0 109.051 172.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -64.78 -28.17 69.39 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.015 0.825 . . . . 0.0 111.734 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -67.09 -28.63 68.34 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.475 0.71 . . . . 0.0 111.631 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -123.22 -17.62 6.56 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 -169.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.8 tttp 41.02 58.61 8.54 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.322 1.449 . . . . 0.0 109.633 -168.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -67.19 158.47 56.79 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.803 2.335 . . . . 0.0 111.027 -170.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -81.99 84.46 6.96 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.853 0.861 . . . . 0.0 109.761 177.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 mt -108.95 26.82 10.16 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.642 1.577 . . . . 0.0 109.728 175.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.7 m -60.76 17.1 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 128.548 2.739 . . . . 0.0 116.012 -174.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.52 5.42 1.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.197 1.399 . . . . 0.0 111.909 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.9 t -77.66 137.62 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 169.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -124.02 146.94 48.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 168.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -150.03 166.91 28.27 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.421 -175.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -112.76 157.89 14.64 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 104.674 -3.37 . . . . 0.0 104.674 169.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.77 132.05 20.65 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.944 1.372 . . . . 0.0 110.187 -169.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 56.7 mt -138.39 138.75 42.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.93 150.31 17.63 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 107.864 -2.095 . . . . 0.0 107.864 169.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.7 mt -139.61 136.04 39.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.9 -164.02 30.53 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 176.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.0 m -110.33 104.21 12.97 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.218 1.407 . . . . 0.0 108.494 -175.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -59.68 -12.41 6.88 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.075 1.35 . . . . 0.0 113.056 -174.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -56.73 -32.53 65.63 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.486 1.039 . . . . 0.0 110.94 169.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -83.68 151.7 25.13 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.015 0.926 . . . . 0.0 110.026 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.75 -27.75 65.21 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -175.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 CA--C 1.537 0.47 0 C-N-CA 124.368 1.067 . . . . 0.0 110.795 -169.592 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.36 -27.45 41.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 119.714 1.143 . . . . 0.0 109.443 170.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.17 -39.16 89.54 Favored 'General case' 0 C--N 1.338 0.106 0 O-C-N 121.591 -0.693 . . . . 0.0 110.479 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -58.94 -49.02 79.42 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.96 -54.54 45.96 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.451 0.3 . . . . 0.0 110.501 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -64.19 -38.21 90.22 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.122 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.47 -36.37 78.88 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 119.396 -0.335 . . . . 0.0 111.192 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -74.5 -33.05 62.73 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.794 0.724 . . . . 0.0 110.909 -175.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.3 mt -69.24 -38.85 78.68 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.686 1.13 . . . . 0.0 109.7 169.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -62.05 -40.66 96.53 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.839 0.745 . . . . 0.0 110.124 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -65.2 -31.27 72.36 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.759 0.824 . . . . 0.0 111.415 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.6 m -77.47 4.71 10.41 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.234 1.013 . . . . 0.0 112.355 172.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.24 -11.55 63.63 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.735 1.159 . . . . 0.0 113.41 172.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.35 -178.21 0.48 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.556 1.178 . . . . 0.0 110.793 173.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.18 138.08 17.15 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.148 -0.97 . . . . 0.0 110.966 169.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.56 168.0 1.29 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.337 1.455 . . . . 0.0 108.512 169.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.6 m -135.16 151.61 50.83 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.3 -120.11 21.31 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -140.68 164.23 30.75 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.769 1.627 . . . . 0.0 106.966 170.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.0 m -83.48 139.18 33.08 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.552 -0.717 . . . . 0.0 109.532 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.4 tp -97.9 149.32 22.52 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.824 1.249 . . . . 0.0 109.893 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -119.36 146.33 45.41 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 169.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.7 mt -133.16 100.06 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -68.21 139.13 56.04 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 169.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.3 pp -129.62 15.54 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.22 1.008 . . . . 0.0 112.26 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.0 tp . . . . . 0 C--N 1.342 0.24 0 CA-C-N 119.075 0.852 . . . . 0.0 108.984 176.963 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 119.226 -0.416 . . . . 0.0 111.473 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.35 -40.25 74.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.056 0.942 . . . . 0.0 111.232 178.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -73.87 -42.33 60.93 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.726 -0.609 . . . . 0.0 109.895 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -68.55 -36.47 78.85 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.555 0.342 . . . . 0.0 110.621 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.6 tp -61.19 -39.53 90.53 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.81 0.844 . . . . 0.0 110.203 171.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.36 -48.32 48.38 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.575 1.083 . . . . 0.0 111.33 170.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.2 m -61.97 -41.47 98.05 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 117.645 0.723 . . . . 0.0 110.865 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -62.86 -50.82 69.4 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.481 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.8 m -63.96 -34.23 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 120.115 1.325 . . . . 0.0 110.733 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.0 -21.37 66.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.901 0.88 . . . . 0.0 113.05 176.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.32 -49.77 4.57 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.405 1.002 . . . . 0.0 111.12 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.76 -27.23 64.76 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.376 -173.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt . . . . . 0 C--O 1.252 1.197 0 C-N-CA 128.187 2.595 . . . . 0.0 113.102 175.277 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.197 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -135.87 -25.06 1.27 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.982 1.313 . . . . 0.0 111.036 -179.202 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.7 mt -125.35 80.87 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 169.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.0 m -76.56 114.14 14.96 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.37 155.21 28.52 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.353 1.061 . . . . 0.0 109.233 174.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.1 mt -127.4 93.2 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -174.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -67.02 162.58 21.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.818 1.247 . . . . 0.0 110.158 172.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.78 58.36 0.08 OUTLIER Glycine 0 C--N 1.337 0.615 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -169.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 C--N 1.331 -0.215 0 C-N-CA 124.148 0.979 . . . . 0.0 110.502 170.947 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.603 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.03 -28.62 69.92 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 117.874 0.837 . . . . 0.0 110.737 176.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -68.84 -40.46 79.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -76.75 -37.41 55.99 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 122.72 0.408 . . . . 0.0 110.62 -179.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.58 -43.01 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 118.454 0.57 . . . . 0.0 109.474 171.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.19 93.8 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.548 0.613 . . . . 0.0 110.395 177.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.14 -42.4 99.21 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.458 0.572 . . . . 0.0 110.872 178.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -61.81 -50.41 72.41 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.704 0.802 . . . . 0.0 110.165 178.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.3 mt -62.18 -39.75 93.72 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.383 0.673 . . . . 0.0 110.655 179.216 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.96 99.3 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.952 0.501 . . . . 0.0 110.6 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.12 -43.61 94.76 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.678 0.672 . . . . 0.0 110.3 178.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -58.27 -45.99 86.84 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.914 -0.492 . . . . 0.0 110.067 175.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.6 mt -62.48 -38.83 91.35 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.996 178.027 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.22 -38.51 90.65 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.23 0.923 . . . . 0.0 110.316 177.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.05 -36.74 82.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.54 0.609 . . . . 0.0 110.756 175.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.16 -25.28 65.19 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.154 0.581 . . . . 0.0 111.898 173.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.78 0.61 17.57 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.395 1.474 . . . . 0.0 113.998 170.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -83.59 149.57 26.48 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.04 1.42 . . . . 0.0 109.91 -178.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -87.86 140.18 29.77 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 p -139.22 165.97 25.76 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.305 1.042 . . . . 0.0 109.812 -169.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -154.42 155.4 34.91 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 169.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.9 p -126.28 84.31 2.26 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -171.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.6 mt -68.12 119.98 13.58 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -174.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -75.54 92.36 2.89 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.192 0.997 . . . . 0.0 108.458 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.45 61.79 5.65 Favored Glycine 0 CA--C 1.542 1.772 0 C-N-CA 124.628 1.108 . . . . 0.0 113.929 175.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -69.06 177.47 5.07 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.973 3.115 . . . . 0.0 111.875 179.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 38.3 mt -107.49 154.21 21.7 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.828 1.251 . . . . 0.0 107.965 169.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.46 -38.83 72.2 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.924 0.889 . . . . 0.0 111.539 -177.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.09 -18.09 63.01 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -75.3 -19.43 59.68 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.601 0.637 . . . . 0.0 111.862 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.1 mt -99.9 143.09 25.83 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 123.983 0.913 . . . . 0.0 110.517 -173.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.19 163.19 38.72 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.364 2.043 . . . . 0.0 109.26 169.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.81 25.66 0.77 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.521 1.128 . . . . 0.0 111.904 -176.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.5 m -155.89 142.2 18.43 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.13 1.372 . . . . 0.0 107.907 177.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 150.46 -176.16 29.18 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 178.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -128.92 101.24 6.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 178.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -103.14 171.82 7.16 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.202 1.001 . . . . 0.0 108.981 -177.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.2 tp -148.0 117.2 6.87 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 176.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.52 135.39 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -169.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.78 119.91 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.0 m -123.04 -174.42 2.94 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.799 1.64 . . . . 0.0 107.793 -174.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -144.47 170.26 16.37 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 168.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.452 HG21 ' O ' ' A' ' 97' ' ' THR . 24.1 m -126.24 129.28 48.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -67.17 -29.75 69.53 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 117.92 0.327 . . . . 0.0 111.393 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.94 -38.95 0.32 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.692 0.663 . . . . 0.0 112.805 175.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.87 19.15 7.85 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.054 0.942 . . . . 0.0 112.732 -170.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.62 -8.07 28.08 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.266 0.936 . . . . 0.0 113.171 174.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.12 121.3 15.32 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.495 1.147 . . . . 0.0 109.834 176.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.9 mt -78.11 142.01 63.44 Favored Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 176.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.75 145.28 86.18 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.602 2.868 . . . . 0.0 112.044 176.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.49 -17.73 34.14 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.964 1.706 . . . . 0.0 114.281 -173.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -62.42 -44.8 95.56 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.502 0.721 . . . . 0.0 109.429 178.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.2 tp -120.05 -17.58 8.35 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.334 0.654 . . . . 0.0 112.329 -170.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.4 p -53.94 -32.87 12.3 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -178.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -54.69 -23.99 35.38 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.518 2.146 . . . . 0.0 114.852 171.033 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -61.23 -38.54 87.0 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.33 0.968 . . . . 0.0 110.769 177.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -66.98 -37.15 83.71 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.237 0.471 . . . . 0.0 110.474 177.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.81 -45.94 69.91 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.72 -31.19 72.04 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.764 -0.585 . . . . 0.0 112.1 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.9 mt -61.71 -60.72 3.24 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 123.45 0.7 . . . . 0.0 109.405 171.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -71.14 -26.82 63.17 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -171.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -67.69 -37.18 81.96 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.686 0.676 . . . . 0.0 110.97 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -105.95 -34.38 7.63 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.96 0.504 . . . . 0.0 111.613 -170.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.9 tttp 32.73 59.27 1.47 Allowed Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 127.759 2.424 . . . . 0.0 113.59 -174.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -69.95 159.21 54.07 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.73 1.62 . . . . 0.0 110.004 174.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -71.76 127.65 33.23 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 169.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 pp -140.54 38.36 1.86 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.862 1.265 . . . . 0.0 110.129 177.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.1 m -59.43 24.41 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.856 2.462 . . . . 0.0 115.497 170.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.73 3.51 0.97 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.311 1.445 . . . . 0.0 112.184 178.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.9 t -87.35 146.11 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 169.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -122.11 146.44 47.21 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 168.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -137.63 168.98 18.57 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -125.43 156.57 19.28 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 104.802 -3.319 . . . . 0.0 104.802 169.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.06 123.9 25.29 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.408 1.104 . . . . 0.0 109.986 -169.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.2 mt -132.7 135.48 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.14 162.16 13.65 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 169.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.5 mt -141.71 144.13 26.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -177.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 175.41 166.35 32.91 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 106.743 -2.543 . . . . 0.0 106.743 177.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.4 m -73.55 134.53 43.8 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 169.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -61.61 -15.21 37.33 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -67.73 -23.95 65.32 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.158 0.983 . . . . 0.0 111.647 173.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -62.32 143.23 57.19 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.861 0.864 . . . . 0.0 111.14 -175.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.91 -33.09 75.2 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.426 0.69 . . . . 0.0 111.518 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.452 ' O ' HG21 ' A' ' 56' ' ' THR . 24.6 m . . . . . 0 CA--C 1.539 0.535 0 C-N-CA 125.68 1.592 . . . . 0.0 108.049 178.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.44 ' N ' ' HG1' ' A' ' 56' ' ' THR . . . . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 tp -57.99 -26.66 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.497 1.119 . . . . 0.0 110.237 172.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -57.94 -38.76 76.54 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.716 -0.615 . . . . 0.0 112.119 -174.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -72.43 -41.14 66.5 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.566 -0.709 . . . . 0.0 110.416 -178.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 45.3 mt -61.39 -47.64 84.89 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.396 0.678 . . . . 0.0 109.53 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -70.31 -36.55 74.39 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.76 -178.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.72 96.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.721 -0.656 . . . . 0.0 110.87 -169.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -74.05 -25.57 59.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.159 0.89 . . . . 0.0 111.717 -175.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.1 mt -66.23 -48.35 70.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.478 1.49 . . . . 0.0 108.603 169.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -61.11 -44.31 97.55 Favored 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 123.634 0.774 . . . . 0.0 109.611 -175.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -72.99 0.31 11.68 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.035 1.734 . . . . 0.0 112.722 178.168 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.3 m -122.72 7.21 9.4 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.55 1.14 . . . . 0.0 111.838 176.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 132.43 -34.0 2.57 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 118.547 -1.141 . . . . 0.0 114.598 168.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.22 177.88 0.77 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.715 1.258 . . . . 0.0 112.211 -178.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -149.54 162.18 40.66 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 121.399 -0.813 . . . . 0.0 111.039 169.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.27 165.35 3.58 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.059 1.344 . . . . 0.0 110.119 173.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.0 m -145.58 159.69 42.75 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 174.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.78 -124.7 32.89 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -172.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -139.33 163.53 32.25 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.3 m -66.06 149.67 49.89 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.7 tp -129.56 150.62 50.82 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.426 1.091 . . . . 0.0 109.259 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.24 142.48 47.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 176.451 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.4 mt -134.75 108.97 11.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -171.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -68.15 133.19 48.51 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.85 0.86 . . . . 0.0 110.593 178.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.1 pt -125.31 16.46 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 125.537 1.535 . . . . 0.0 111.462 174.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.0 tp . . . . . 0 N--CA 1.47 0.564 0 C-N-CA 123.779 0.832 . . . . 0.0 110.863 170.955 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 119.047 -0.501 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -63.99 -41.31 97.54 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.596 0.635 . . . . 0.0 110.993 176.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.81 -46.29 88.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.665 0.666 . . . . 0.0 110.632 -177.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -66.32 -35.92 81.6 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 122.68 0.392 . . . . 0.0 111.035 175.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 30.2 tp -62.96 -36.21 82.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.204 177.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.62 -47.06 65.08 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 170.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.4 m -64.26 -42.86 96.27 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.43 0.615 . . . . 0.0 110.839 177.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -60.27 -52.85 63.5 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.849 178.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.2 m -65.21 -34.0 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 119.94 1.246 . . . . 0.0 110.948 -177.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.46 -40.52 95.87 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.55 0.614 . . . . 0.0 111.652 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.5 mt -85.62 -35.63 20.86 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.103 -175.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 pp -76.6 -29.35 56.51 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.421 1.01 . . . . 0.0 111.659 177.212 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? . . . . . 0 C--O 1.249 1.026 0 C-N-CA 128.823 2.849 . . . . 0.0 113.695 179.434 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttt . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 110.078 -0.341 . . . . 10.0 110.078 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.06 156.85 20.7 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.703 1.201 . . . . 10.0 109.807 176.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -114.15 -24.45 8.97 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.859 1.263 . . . . 10.0 110.686 174.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.8 mt -125.94 89.66 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.146 0 N-CA-C 105.793 -1.929 . . . . 10.0 105.793 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.8 m -74.11 115.34 13.47 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.9 mp -77.27 154.0 33.39 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.701 -1.222 . . . . 10.0 107.701 169.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.8 mt -125.62 83.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 103.084 -2.932 . . . . 10.0 103.084 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 m -69.31 147.52 51.02 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.96 1.304 . . . . 10.0 109.272 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.46 81.59 0.15 Allowed Glycine 0 C--N 1.335 0.511 0 N-CA-C 111.119 -0.792 . . . . 10.0 111.119 -172.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.7 p -147.37 155.95 42.45 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.859 0.83 . . . . 10.0 110.142 165.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 p -91.43 -37.08 13.41 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.986 1.314 . . . . 10.0 109.361 168.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -38.47 76.87 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.708 0.803 . . . . 10.0 111.116 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 112.16 -5.68 26.99 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.541 1.067 . . . . 10.0 112.916 -173.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.67 -42.99 98.12 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 119.406 1.603 . . . . 10.0 112.129 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.76 -31.24 70.14 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 117.899 0.849 . . . . 10.0 111.146 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -66.67 -42.37 86.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.099 0.863 . . . . 10.0 109.477 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -59.2 -53.04 62.84 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.133 0.573 . . . . 10.0 110.113 175.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.98 -40.37 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 119.012 -0.518 . . . . 10.0 110.006 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.54 -46.92 86.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.818 0.736 . . . . 10.0 110.433 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.75 -42.86 99.53 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.339 0.518 . . . . 10.0 110.444 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -62.6 -48.97 77.09 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.211 0.604 . . . . 10.0 110.114 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.439 HD21 ' HB1' ' A' ' 135' ' ' ALA . 23.7 mt -60.81 -43.59 98.0 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 124.029 0.932 . . . . 10.0 111.044 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.84 91.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.195 0.598 . . . . 10.0 110.534 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.02 -47.14 87.79 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.699 0.681 . . . . 10.0 110.281 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -61.59 -40.09 93.56 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 121.804 -0.56 . . . . 10.0 110.759 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.509 HD21 HD11 ' A' ' 139' ' ' LEU . 40.1 mt -64.16 -39.96 95.11 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 119.012 -0.518 . . . . 10.0 110.95 177.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.59 -38.81 92.28 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.847 0.749 . . . . 10.0 110.323 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.83 -33.81 75.5 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.914 0.779 . . . . 10.0 111.197 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.71 -20.58 65.28 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.266 0.626 . . . . 10.0 111.807 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.81 6.47 22.94 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.371 1.463 . . . . 10.0 113.376 171.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -103.28 135.87 44.11 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.196 1.498 . . . . 10.0 108.539 -173.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.8 p -79.69 147.42 31.97 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.024 0.53 . . . . 10.0 110.011 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.8 p -141.97 164.33 30.48 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.776 0.798 . . . . 10.0 111.309 -168.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -151.26 159.59 44.27 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.48 2.312 . . . . 10.0 105.103 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -131.0 61.45 1.63 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.356 1.462 . . . . 10.0 108.446 -171.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 mt -55.64 118.71 4.77 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.759 0.824 . . . . 10.0 108.957 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.21 116.57 16.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.178 -1.415 . . . . 10.0 107.178 171.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.8 50.49 14.78 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.027 -1.43 . . . . 10.0 115.73 167.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -65.3 164.35 26.0 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 CA-C-N 120.352 2.076 . . . . 10.0 110.391 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.7 mt -108.7 163.81 12.92 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.851 0.86 . . . . 10.0 108.754 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.408 HD13 ' C ' ' A' ' 41' ' ' LEU . 3.0 tm? -56.75 -39.99 74.98 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.849 0.86 . . . . 10.0 110.356 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.35 2.1 1.36 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.545 1.138 . . . . 10.0 113.705 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -126.33 17.23 7.7 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.691 1.596 . . . . 10.0 111.263 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.6 mt -132.01 123.43 18.96 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.837 1.255 . . . . 10.0 108.558 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.55 159.45 52.77 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 121.926 1.751 . . . . 10.0 110.565 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.74 11.1 1.82 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.664 1.186 . . . . 10.0 113.963 -174.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.0 m -143.71 138.66 29.02 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.114 1.366 . . . . 10.0 107.944 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.42 -177.7 31.64 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.457 -1.057 . . . . 10.0 110.457 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mt -125.6 96.13 3.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 104.699 -2.334 . . . . 10.0 104.699 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -97.14 175.54 6.26 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.17 0.588 . . . . 10.0 110.605 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.9 tp -150.13 99.09 2.78 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 107.812 -1.181 . . . . 10.0 107.812 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.6 t -83.5 130.82 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.751 -1.203 . . . . 10.0 107.751 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.9 mt -132.75 128.35 57.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.321 -2.103 . . . . 10.0 105.321 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.7 m -137.89 133.16 33.51 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.48 0.488 . . . . 10.0 109.936 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.3 m -62.61 160.67 13.53 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.506 0.669 . . . . 10.0 110.024 157.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.1 m -126.7 117.42 22.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 103.82 -2.659 . . . . 10.0 103.82 171.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -74.54 8.7 2.14 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.7 1.0 . . . . 10.0 113.7 -168.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.99 -22.94 26.66 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.766 1.651 . . . . 10.0 112.221 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.02 8.82 8.67 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.447 1.099 . . . . 10.0 112.505 -172.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.32 -2.86 81.61 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 123.534 0.588 . . . . 10.0 112.895 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -68.26 124.35 23.25 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.031 0.916 . . . . 10.0 108.737 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.9 mt -72.73 142.56 83.62 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 106.388 -1.708 . . . . 10.0 106.388 173.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.78 140.38 93.45 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.217 2.612 . . . . 10.0 111.066 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -60.34 -21.79 62.48 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.558 1.143 . . . . 10.0 113.118 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -50.99 -44.18 60.85 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.235 1.414 . . . . 10.0 111.132 169.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.1 tp -122.45 -19.34 6.43 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.745 0.818 . . . . 10.0 112.439 -168.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.9 p -52.78 -35.06 20.46 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 115.131 1.53 . . . . 10.0 115.131 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -54.73 -24.46 37.83 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.365 2.043 . . . . 10.0 114.577 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -62.02 -36.73 82.45 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.427 1.012 . . . . 10.0 111.027 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -61.16 -42.46 98.61 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.513 0.597 . . . . 10.0 110.205 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -72.01 -45.51 60.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.149 0.58 . . . . 10.0 109.732 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.45 -37.09 82.3 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.312 0.645 . . . . 10.0 111.315 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.8 mt -64.75 -59.44 4.23 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 118.726 -0.654 . . . . 10.0 109.529 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -66.99 -29.42 69.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.113 0.869 . . . . 10.0 112.372 -170.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.72 -34.14 76.28 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.226 0.611 . . . . 10.0 111.257 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -105.74 -27.55 11.23 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.417 0.687 . . . . 10.0 111.862 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt 26.73 62.82 0.56 Allowed Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 128.657 2.783 . . . . 10.0 112.858 -169.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.0 166.91 23.14 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.631 2.22 . . . . 10.0 110.364 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -71.53 120.17 16.73 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.533 -0.914 . . . . 10.0 108.533 165.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.2 mt -124.83 24.37 7.68 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.484 1.514 . . . . 10.0 110.255 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.7 m -63.96 10.8 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 115.803 1.779 . . . . 10.0 115.803 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.33 3.01 4.67 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.849 1.26 . . . . 10.0 112.23 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.1 t -74.66 131.8 34.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.752 -1.573 . . . . 10.0 106.752 165.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -105.31 150.81 24.86 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.29 -1.744 . . . . 10.0 106.29 157.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -145.54 159.36 43.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.273 0.559 . . . . 10.0 111.081 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -113.4 163.14 12.17 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 108.445 -1.862 . . . . 10.0 108.445 162.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.54 130.32 21.6 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.492 1.117 . . . . 10.0 108.299 -172.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 mt -134.78 133.21 54.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 105.866 -1.901 . . . . 10.0 105.866 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -108.65 145.04 16.39 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 108.336 -1.906 . . . . 10.0 108.336 166.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.4 mt -130.52 142.67 43.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.331 -2.1 . . . . 10.0 105.331 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.37 174.36 40.34 Favored Glycine 0 N--CA 1.453 -0.209 0 O-C-N 121.374 -0.829 . . . . 10.0 111.532 169.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.0 m -69.06 104.71 2.2 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.064 -1.088 . . . . 10.0 108.064 168.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -75.74 -10.57 59.55 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.321 0.86 . . . . 10.0 113.321 -163.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -76.62 -12.25 59.98 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.573 1.079 . . . . 10.0 112.236 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -64.17 162.59 14.19 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.185 0.902 . . . . 10.0 111.631 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.75 -34.36 74.32 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.92 0.888 . . . . 10.0 111.924 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.3 m -109.14 146.63 33.77 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.505 -0.924 . . . . 10.0 108.505 174.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -153.04 64.27 0.77 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 106.446 -1.687 . . . . 10.0 106.446 -129.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 83.7 m 54.19 38.59 29.51 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.177 0.991 . . . . 10.0 111.255 -169.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.41 -12.1 49.41 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.814 -0.992 . . . . 10.0 112.789 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.31 -41.77 98.97 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.446 1.623 . . . . 10.0 110.811 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.5 tp -57.1 -32.31 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.636 1.175 . . . . 10.0 111.691 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -54.96 -38.06 67.28 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.72 0.808 . . . . 10.0 111.933 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.92 -42.25 85.69 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.834 0.453 . . . . 10.0 110.98 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.3 mt -67.68 -49.28 63.6 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.163 -0.68 . . . . 10.0 109.163 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -63.77 -37.9 89.11 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 118.595 -0.717 . . . . 10.0 110.443 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.29 99.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.129 0.877 . . . . 10.0 110.643 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -74.09 -30.36 62.31 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 119.557 1.071 . . . . 10.0 112.043 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.2 mt -61.59 -48.25 81.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.826 1.193 . . . . 10.0 109.315 169.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -59.44 -45.93 90.19 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.724 1.21 . . . . 10.0 110.296 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -62.38 -38.62 90.32 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.822 1.649 . . . . 10.0 111.311 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.0 m -71.81 -11.87 61.01 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.427 1.091 . . . . 10.0 112.632 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.72 -12.64 8.76 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.706 1.146 . . . . 10.0 113.264 169.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.15 169.86 3.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.437 1.118 . . . . 10.0 110.585 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -138.32 145.16 40.85 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.441 -0.787 . . . . 10.0 111.009 168.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -63.18 166.79 5.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.403 -1.271 . . . . 10.0 109.19 172.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.3 m -132.61 153.06 51.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 105.606 -1.998 . . . . 10.0 105.606 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.99 -140.98 47.09 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 110.97 -0.852 . . . . 10.0 110.97 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -133.8 167.69 20.1 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.547 1.539 . . . . 10.0 108.147 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.2 m -82.64 123.22 29.05 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.793 0.837 . . . . 10.0 109.59 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.5 tp -85.48 145.95 27.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 122.636 0.374 . . . . 10.0 110.045 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -110.64 145.4 38.0 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.005 1.722 . . . . 10.0 106.956 169.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.473 HG23 ' CG2' ' A' ' 130' ' ' ILE . 13.5 mt -140.29 102.92 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.429 -1.693 . . . . 10.0 106.429 -176.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -73.93 135.51 43.26 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.411 -0.589 . . . . 10.0 109.411 173.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.1 pp -128.67 7.75 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.109 0.963 . . . . 10.0 112.805 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.2 tp -67.55 -54.1 22.75 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.07 0.85 . . . . 10.0 111.3 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.2 -48.69 3.15 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.917 0.887 . . . . 10.0 109.293 -164.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -109.72 -177.05 3.17 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.746 1.618 . . . . 10.0 108.886 173.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -123.98 49.54 1.75 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.324 1.849 . . . . 10.0 107.707 -171.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.473 ' CG2' HG23 ' A' ' 123' ' ' ILE 0.296 1.5 pt 51.72 129.46 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 128.668 2.787 . . . . 10.0 113.211 -140.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -85.15 -52.92 0.03 OUTLIER 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.118 1.879 . . . . 10.0 113.316 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -148.31 -13.57 0.35 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.012 1.116 . . . . 10.0 114.012 -141.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -121.59 83.76 41.89 Favored Pre-proline 0 N--CA 1.467 0.403 0 N-CA-C 108.039 -1.097 . . . . 10.0 108.039 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -47.25 141.84 12.92 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 123.74 2.96 . . . . 10.0 112.819 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.439 ' HB1' HD21 ' A' ' 22' ' ' LEU . . . -57.68 -25.58 60.46 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.184 162.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -56.27 -39.84 73.27 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.987 1.715 . . . . 10.0 112.164 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -67.52 -47.18 70.68 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.01 0.823 . . . . 10.0 109.091 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -61.97 -41.02 97.55 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.389 0.676 . . . . 10.0 110.353 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.509 HD11 HD21 ' A' ' 26' ' ' LEU . 35.3 tp -61.58 -38.99 89.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.802 1.241 . . . . 10.0 110.646 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.07 -50.25 62.74 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.862 -0.895 . . . . 10.0 110.862 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.5 m -60.65 -30.27 69.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.007 0.523 . . . . 10.0 111.786 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -52.87 10.74 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.488 0.715 . . . . 10.0 111.852 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.0 -32.04 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -59.96 -23.53 63.66 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.476 1.111 . . . . 10.0 113.622 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.5 mt -102.06 -44.23 5.52 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 120.139 1.336 . . . . 10.0 111.382 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.95 -27.43 62.78 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.786 -1.102 . . . . 10.0 112.244 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm . . . . . 0 C--O 1.252 1.194 0 C-N-CA 128.672 2.789 . . . . 10.0 113.417 -177.296 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.2 ttm . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.99 164.27 22.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.847 0.859 . . . . 0.0 111.193 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -76.0 -29.48 58.18 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.136 0.975 . . . . 0.0 110.113 -175.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.8 mt -125.15 74.17 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.1 m -74.81 114.83 13.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.94 155.19 37.69 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 172.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.9 mt -116.95 112.06 37.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 103.829 -2.656 . . . . 0.0 103.829 172.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -113.86 155.55 25.53 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.531 1.532 . . . . 0.0 110.84 -169.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.01 131.21 1.28 Allowed Glycine 0 N--CA 1.448 -0.512 0 O-C-N 121.187 -0.945 . . . . 0.0 111.13 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.0 p -158.15 108.65 2.14 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 169.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.441 ' H ' ' HB3' ' A' ' 63' ' ' PRO . 1.1 p -71.15 -37.09 72.24 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.806 0.442 . . . . 0.0 110.319 175.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 pp -70.68 -34.46 72.01 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.418 0.287 . . . . 0.0 111.513 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 124.57 160.66 10.83 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.82 1.676 . . . . 0.0 109.516 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.98 -55.93 0.69 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 125.027 1.299 . . . . 0.0 111.348 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.79 -27.7 68.47 Favored 'General case' 0 C--O 1.228 -0.075 0 CA-C-N 118.108 0.954 . . . . 0.0 110.702 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -60.48 -27.89 67.92 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.921 0.488 . . . . 0.0 111.029 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -95.89 -51.75 4.34 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.631 0.773 . . . . 0.0 110.426 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.61 -39.22 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.741 -171.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.92 89.08 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.414 1.006 . . . . 0.0 111.04 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -68.24 -41.19 81.57 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.637 0.653 . . . . 0.0 110.144 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -60.45 -49.4 77.73 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.927 0.491 . . . . 0.0 110.276 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.5 mt -60.05 -43.43 95.38 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.523 0.729 . . . . 0.0 110.42 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.83 98.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.976 0.511 . . . . 0.0 110.753 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -66.25 -42.55 88.43 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.129 0.571 . . . . 0.0 110.419 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -59.66 -39.85 85.82 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 121.507 -0.746 . . . . 0.0 111.085 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.513 ' HB2' HG21 ' A' ' 33' ' ' THR . 55.3 mt -68.28 -29.22 67.96 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.98 177.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -65.56 -38.26 89.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.713 1.142 . . . . 0.0 109.875 172.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.81 -39.29 93.34 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.948 0.794 . . . . 0.0 110.496 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.07 -21.83 64.96 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.545 0.738 . . . . 0.0 112.259 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.84 31.09 3.25 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 118.651 -1.083 . . . . 0.0 113.58 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -125.29 148.25 48.78 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.026 1.413 . . . . 0.0 110.055 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 p -71.88 146.28 47.99 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.513 HG21 ' HB2' ' A' ' 26' ' ' LEU . 12.6 p -139.19 160.06 40.68 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.486 0.66 . . . . 0.0 110.956 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -149.64 161.69 41.69 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 p -134.3 81.41 1.91 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -175.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.63 105.57 3.72 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -78.97 102.67 8.44 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.17 56.58 15.03 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-O 118.348 -1.251 . . . . 0.0 114.589 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -69.24 178.3 4.38 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.043 2.495 . . . . 0.0 110.804 171.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.8 mt -125.03 158.08 34.63 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 169.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -53.53 -31.0 44.45 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.237 1.015 . . . . 0.0 111.134 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -62.45 -10.72 12.51 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.353 1.861 . . . . 0.0 112.736 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -133.87 18.67 3.83 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.393 1.077 . . . . 0.0 110.905 -175.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -134.77 106.08 10.68 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.743 1.217 . . . . 0.0 108.881 -169.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.82 161.52 41.4 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.884 2.39 . . . . 0.0 112.969 -170.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.43 7.38 5.47 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.763 1.625 . . . . 0.0 114.934 -171.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.8 m -146.81 129.72 16.29 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.7 -179.86 27.95 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.4 mt -112.94 101.83 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -99.55 168.78 9.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.3 tp -146.83 112.69 5.72 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -98.36 134.45 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -169.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 mp -132.78 125.11 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.8 p -138.6 143.2 39.24 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.945 1.298 . . . . 0.0 107.82 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.1 p -77.04 175.41 9.62 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 169.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 97' ' ' THR . 40.9 m -130.7 123.43 29.29 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 169.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -69.07 -22.2 64.03 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 159.56 -35.53 0.47 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 118.696 0.68 . . . . 0.0 113.37 170.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.78 22.87 8.09 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.124 0.969 . . . . 0.0 112.153 -169.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.75 -1.1 56.67 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 123.936 0.779 . . . . 0.0 113.094 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -70.5 114.67 8.84 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.301 1.051 . . . . 0.0 109.582 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.7 mt -68.91 147.8 97.86 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 125.643 1.577 . . . . 0.0 107.795 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.441 ' HB3' ' H ' ' A' ' 11' ' ' THR . 27.0 Cg_endo -56.54 137.61 81.32 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.113 3.209 . . . . 0.0 112.38 175.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -63.93 -22.31 66.86 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -169.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -71.55 -24.42 61.93 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.713 -0.617 . . . . 0.0 111.941 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.6 tp -121.92 -24.76 5.13 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.279 1.032 . . . . 0.0 111.771 -169.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.0 p -55.12 -28.21 3.91 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 116.924 -1.512 . . . . 0.0 114.939 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -53.4 -24.55 28.16 Favored 'Trans proline' 0 C--N 1.354 0.86 0 CA-C-N 122.903 2.073 . . . . 0.0 114.716 169.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -62.02 -43.92 97.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.58 1.082 . . . . 0.0 110.673 175.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -60.96 -40.01 91.7 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.866 0.866 . . . . 0.0 110.101 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -68.77 -48.37 63.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.853 0.461 . . . . 0.0 110.54 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.06 -28.59 67.51 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.464 -0.772 . . . . 0.0 112.37 -176.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.1 mt -67.6 -57.74 5.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.722 -0.656 . . . . 0.0 109.385 171.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -67.25 -29.2 68.77 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.06 0.846 . . . . 0.0 112.071 -171.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.82 -31.0 71.34 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.136 0.574 . . . . 0.0 110.775 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -115.09 -23.21 9.13 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -169.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.4 tttt 37.74 66.11 2.46 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.67 1.588 . . . . 0.0 110.796 -169.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.32 168.82 10.46 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.687 2.258 . . . . 0.0 110.696 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -92.68 107.2 19.04 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 169.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.5 mt -120.02 26.15 9.46 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.262 1.825 . . . . 0.0 110.045 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -61.58 18.62 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.318 1.847 . . . . 0.0 115.424 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.77 3.19 1.84 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.265 1.426 . . . . 0.0 111.855 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.7 t -79.53 140.46 16.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.5 mmm-85 -123.79 138.4 54.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 168.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -134.39 170.87 15.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.895 0.378 . . . . 0.0 110.653 -172.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.14 162.86 23.09 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 105.347 -3.101 . . . . 0.0 105.347 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.428 ' HB1' HD12 ' A' ' 102' ' ' ILE . . . -146.89 124.55 11.81 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.401 1.101 . . . . 0.0 109.446 -170.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.6 mt -133.73 124.27 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -100.7 156.73 19.34 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.4 mt -134.9 139.11 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.17 -151.42 13.74 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.6 m -126.02 135.36 51.71 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.727 1.211 . . . . 0.0 108.517 -175.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -66.72 -10.25 44.95 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.78 -15.03 58.25 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.979 0.809 . . . . 0.0 112.359 171.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -64.32 148.68 49.76 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.381 0.991 . . . . 0.0 110.847 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.65 -34.22 77.7 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.511 0.725 . . . . 0.0 111.392 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.461 ' O ' HG21 ' A' ' 56' ' ' THR . 34.8 m -119.32 51.15 1.16 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.73 1.612 . . . . 0.0 107.467 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -45.18 113.69 0.61 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.629 1.172 . . . . 0.0 110.825 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.4 m 48.32 34.35 4.54 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.326 1.451 . . . . 0.0 112.84 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.53 -16.19 29.94 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 118.985 -0.897 . . . . 0.0 113.115 -170.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.412 ' HB2' HG23 ' A' ' 56' ' ' THR . . . -64.57 -25.94 68.19 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.588 1.694 . . . . 0.0 112.893 -174.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.428 HD12 ' HB1' ' A' ' 87' ' ' ALA . 0.1 OUTLIER -59.19 -29.7 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.964 0.905 . . . . 0.0 109.444 178.302 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -54.75 -34.18 62.2 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.104 0.962 . . . . 0.0 112.071 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -81.58 -37.83 27.07 Favored 'General case' 0 C--O 1.232 0.14 0 O-C-N 121.731 -0.606 . . . . 0.0 110.189 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.5 mt -57.89 -50.88 71.81 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -70.58 -32.98 70.57 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.394 -174.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.28 80.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.315 0.507 . . . . 0.0 110.103 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -79.79 -28.88 40.23 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.03 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.0 -45.75 84.25 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.379 1.445 . . . . 0.0 109.578 170.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -71.27 -33.66 69.97 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.469 0.577 . . . . 0.0 111.266 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -61.23 -39.66 91.09 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.178 0.591 . . . . 0.0 110.537 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.6 m -72.03 -7.82 50.98 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.221 1.008 . . . . 0.0 113.13 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.24 -14.93 10.15 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.644 1.116 . . . . 0.0 114.102 169.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.19 173.52 1.94 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.573 1.187 . . . . 0.0 111.341 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -143.83 148.1 35.04 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.019 -1.051 . . . . 0.0 112.153 170.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -58.78 158.55 7.94 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.376 1.87 . . . . 0.0 109.851 173.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.8 m -139.88 163.33 32.94 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.465 1.906 . . . . 0.0 106.087 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.35 -135.25 48.07 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -173.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -146.5 150.18 35.07 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 169.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.2 m -61.76 149.48 39.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.125 1.37 . . . . 0.0 111.176 -171.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.3 tp -129.81 151.21 50.64 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.343 1.057 . . . . 0.0 110.388 -173.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -119.87 150.4 40.51 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 23.5 mm -131.68 100.47 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -78.33 126.47 30.83 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 118.682 -0.675 . . . . 0.0 109.363 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.57 9.46 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.768 0.827 . . . . 0.0 112.152 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.1 tp -45.54 -38.23 6.19 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.067 1.747 . . . . 0.0 113.685 -174.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -135.86 41.38 2.69 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.377 1.071 . . . . 0.0 109.768 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 47.4 m80 49.57 44.29 24.26 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.343 1.457 . . . . 0.0 110.327 -169.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -72.28 -8.2 53.58 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.62 1.968 . . . . 0.0 114.636 -169.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.5 pt -50.4 -36.89 24.52 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 -172.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.9 -7.34 20.9 Favored 'Trans proline' 0 C--N 1.356 0.942 0 CA-C-N 124.047 2.481 . . . . 0.0 113.012 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -68.25 -27.16 66.1 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.311 0.96 . . . . 0.0 110.297 171.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -152.87 72.02 7.21 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.806 1.242 . . . . 0.0 109.461 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.31 150.23 81.2 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.796 2.331 . . . . 0.0 111.131 -173.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.87 -16.66 63.28 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -56.33 -42.76 78.21 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.261 0.937 . . . . 0.0 112.041 -169.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -69.45 -40.3 77.24 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.999 -0.438 . . . . 0.0 110.453 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -72.36 -35.48 68.51 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.642 0.777 . . . . 0.0 110.58 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.97 -35.14 77.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.459 0.704 . . . . 0.0 109.958 170.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.47 -47.18 57.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.387 0.994 . . . . 0.0 111.177 169.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.8 m -62.59 -38.22 89.28 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 122.081 -0.658 . . . . 0.0 111.132 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -53.48 50.22 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.087 175.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.9 m -62.89 -31.25 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 119.799 1.182 . . . . 0.0 111.188 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -62.82 -27.03 69.04 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.593 -0.718 . . . . 0.0 112.669 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.2 mt -106.37 -37.09 6.63 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.216 0.917 . . . . 0.0 112.93 -176.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 pp -73.03 -12.59 60.98 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.465 1.03 . . . . 0.0 112.171 172.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.018 0 C-N-CA 129.451 3.1 . . . . 0.0 112.645 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.08 157.98 43.79 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.847 1.259 . . . . 0.0 108.663 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -136.97 -25.37 1.08 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.79 1.236 . . . . 0.0 111.085 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.4 mt -130.52 82.38 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.0 m -75.23 121.15 21.72 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.9 mp -85.41 152.19 23.42 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.312 0.645 . . . . 0.0 109.711 174.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.8 mt -123.49 93.28 2.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 126.294 1.837 . . . . 0.0 106.161 -175.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -72.95 155.7 39.6 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.558 1.143 . . . . 0.0 110.862 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.2 65.17 0.26 Allowed Glycine 0 C--N 1.34 0.801 0 N-CA-C 114.239 0.456 . . . . 0.0 114.239 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.448 ' HB2' ' H ' ' A' ' 15' ' ' ALA . 9.4 t -139.71 144.74 37.68 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.52 1.128 . . . . 0.0 110.595 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 p -88.24 -46.04 9.57 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.05 1.34 . . . . 0.0 109.146 169.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.569 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -68.04 -29.38 68.35 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.272 1.029 . . . . 0.0 111.705 179.212 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.41 -0.3 16.21 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.29 0.948 . . . . 0.0 113.491 170.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.67 -54.07 40.07 Favored Glycine 0 C--N 1.337 0.63 0 CA-C-N 118.937 1.369 . . . . 0.0 110.956 -173.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.448 ' H ' ' HB2' ' A' ' 10' ' ' SER . . . -66.6 -28.25 68.36 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 117.51 0.655 . . . . 0.0 111.231 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -68.62 -44.8 73.5 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -70.55 -46.02 64.33 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.386 0.675 . . . . 0.0 109.94 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.9 t -62.15 -38.52 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 118.451 -0.785 . . . . 0.0 110.101 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.17 97.82 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.693 1.133 . . . . 0.0 110.777 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -63.49 -41.42 98.56 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.594 0.634 . . . . 0.0 110.551 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -63.85 -43.3 96.55 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.941 -0.474 . . . . 0.0 111.125 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.4 mt -63.78 -43.81 95.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.546 0.738 . . . . 0.0 109.666 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.33 -37.8 78.72 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.422 0.689 . . . . 0.0 111.219 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -52.55 -44.68 66.0 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.847 0.748 . . . . 0.0 110.482 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt -68.33 -37.54 80.63 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.834 -0.541 . . . . 0.0 109.813 -175.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.1 mt -68.09 -38.61 82.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.262 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.83 -38.57 89.26 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.361 0.528 . . . . 0.0 110.329 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.04 -37.05 84.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.599 0.636 . . . . 0.0 110.98 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.27 -26.0 66.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.972 0.509 . . . . 0.0 111.67 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.86 -3.88 10.77 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.32 1.438 . . . . 0.0 113.743 169.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -78.9 146.4 33.58 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.924 1.362 . . . . 0.0 109.981 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 p -83.5 146.6 28.28 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 169.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.2 p -134.43 169.29 17.47 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.806 0.842 . . . . 0.0 109.943 -170.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.1 158.73 44.41 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 169.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.4 m -130.42 81.96 2.03 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.9 mt -75.94 116.41 16.61 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -74.88 94.48 2.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.0 57.2 19.41 Favored Glycine 0 CA--C 1.54 1.635 0 CA-C-O 118.797 -1.001 . . . . 0.0 114.437 172.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.35 179.01 4.33 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.338 2.692 . . . . 0.0 111.297 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.8 mt -114.38 151.16 33.52 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 169.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -61.21 -28.89 69.47 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.348 0.659 . . . . 0.0 111.747 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.99 -21.59 63.68 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 175.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -82.89 -7.02 59.7 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.697 0.799 . . . . 0.0 111.812 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.1 mt -113.91 145.07 32.75 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 124.359 1.063 . . . . 0.0 109.989 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -70.15 162.89 40.57 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.758 2.305 . . . . 0.0 110.725 169.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.37 23.65 0.6 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.179 1.392 . . . . 0.0 112.024 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 m -156.37 142.87 18.48 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.352 1.461 . . . . 0.0 107.832 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 150.33 179.98 26.57 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.7 mt -122.24 101.74 10.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -107.12 170.59 7.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.535 1.134 . . . . 0.0 109.051 -175.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.8 tp -149.45 121.88 8.49 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.0 t -111.6 138.3 40.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -169.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -134.43 138.57 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.9 m -139.75 145.34 38.15 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.507 1.123 . . . . 0.0 109.213 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -99.21 95.72 7.27 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.752 0.786 . . . . 0.0 109.911 174.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.3 m -58.54 135.42 57.31 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 169.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.4 p-80 -136.01 41.59 2.65 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.986 1.314 . . . . 0.0 108.961 -174.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.43 -35.37 2.43 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.765 1.65 . . . . 0.0 113.118 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.61 -21.03 66.13 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.058 1.343 . . . . 0.0 113.975 -171.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.11 33.78 64.95 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -172.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -141.42 149.92 41.66 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.319 1.048 . . . . 0.0 108.482 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 62' ' ' ILE . 4.2 mp -69.3 148.2 97.32 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -55.44 153.08 29.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.411 2.741 . . . . 0.0 112.635 169.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.77 -19.14 25.89 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.833 1.253 . . . . 0.0 114.003 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -63.15 -36.63 84.27 Favored 'General case' 0 C--N 1.343 0.289 0 O-C-N 121.801 -0.562 . . . . 0.0 110.591 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.2 tp -127.16 -18.25 4.6 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.883 -169.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.6 p -52.66 -32.43 9.51 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.54 -21.4 18.72 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.131 2.554 . . . . 0.0 115.773 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -56.82 -32.31 65.6 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.187 0.995 . . . . 0.0 110.96 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -62.79 -51.2 68.0 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -62.2 -42.98 99.79 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.027 0.531 . . . . 0.0 109.906 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.11 -27.52 68.43 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.445 0.698 . . . . 0.0 112.591 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 mt -75.94 -20.84 57.62 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.21 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -93.95 -41.78 9.41 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.038 1.29 . . . . 0.0 109.062 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -60.22 -36.54 77.92 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.105 0.962 . . . . 0.0 110.208 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -107.61 -37.11 6.26 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.089 0.555 . . . . 0.0 112.426 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm 27.31 64.3 0.59 Allowed Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 126.853 2.061 . . . . 0.0 113.355 -169.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -59.3 160.52 19.33 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.297 1.998 . . . . 0.0 111.276 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.35 50.72 1.12 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.978 1.311 . . . . 0.0 109.965 173.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.66 34.98 0.1 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.279 1.831 . . . . 0.0 114.168 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -61.75 23.42 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 128.699 2.8 . . . . 0.0 114.745 171.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.06 0.07 1.71 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.886 1.675 . . . . 0.0 111.672 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.6 t -82.47 147.97 5.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 169.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -126.29 141.34 51.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 168.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -140.01 175.38 9.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.225 0.536 . . . . 0.0 110.4 -172.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.07 164.92 26.09 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 106.631 -2.588 . . . . 0.0 106.631 169.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.69 124.89 15.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -169.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.8 mt -133.71 128.08 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 -177.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.66 120.33 5.37 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 107.576 -2.21 . . . . 0.0 107.576 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.9 mt -94.67 152.43 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 169.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 169.81 -144.01 8.26 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 172.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.2 m -132.59 127.69 35.57 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.38 -11.13 60.56 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.699 -0.626 . . . . 0.0 112.124 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.08 -28.44 69.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.513 0.725 . . . . 0.0 111.129 169.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -66.1 145.37 55.91 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 118.87 0.759 . . . . 0.0 109.479 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.98 -35.38 80.52 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 168.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.6 m -73.33 61.81 0.67 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.086 2.554 . . . . 0.0 109.138 169.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -67.52 83.36 0.17 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.111 -0.993 . . . . 0.0 112.236 -172.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 2.0 m 48.93 63.88 1.94 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.084 2.154 . . . . 0.0 112.158 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.22 6.65 2.81 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.416 -1.213 . . . . 0.0 114.701 -169.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.85 -26.23 65.67 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.098 1.949 . . . . 0.0 112.822 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 tp -56.28 -28.63 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.02 1.728 . . . . 0.0 110.723 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -53.03 -37.46 61.56 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.77 0.828 . . . . 0.0 112.73 -173.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -65.23 -42.19 93.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 118.785 0.72 . . . . 0.0 111.458 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.7 mt -68.76 -50.74 47.95 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -37.06 81.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.729 -170.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.4 -35.48 79.37 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.58 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -72.76 -31.24 64.76 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.471 1.032 . . . . 0.0 111.978 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.2 mt -62.13 -44.8 95.84 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 120.77 1.623 . . . . 0.0 108.749 169.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -61.44 -44.6 96.84 Favored 'General case' 0 C--N 1.335 -0.055 0 C-N-CA 124.037 0.935 . . . . 0.0 110.057 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -65.26 -43.34 91.58 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.917 1.287 . . . . 0.0 110.891 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m -68.07 -27.07 66.18 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 119.204 -0.427 . . . . 0.0 111.286 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.94 -32.69 0.38 Allowed Glycine 0 CA--C 1.529 0.929 0 CA-C-N 118.987 0.812 . . . . 0.0 115.002 169.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.61 177.51 0.52 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.807 1.243 . . . . 0.0 113.498 -171.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -138.49 147.31 43.04 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.689 -0.632 . . . . 0.0 110.687 169.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -64.55 166.45 8.53 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.837 1.255 . . . . 0.0 109.404 175.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 m -137.88 153.06 49.59 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.286 1.834 . . . . 0.0 106.189 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 56.08 -139.1 44.18 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -170.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -137.44 157.02 47.48 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.4 145.98 52.57 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.589 1.156 . . . . 0.0 110.074 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.3 tp -120.42 138.85 53.55 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.563 0.745 . . . . 0.0 109.26 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -101.72 141.3 34.79 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 53.0 mt -130.7 136.21 58.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 175.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -125.78 96.03 4.63 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.567 1.547 . . . . 0.0 109.279 -169.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.4 pp -80.48 -3.98 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 O-C-N 121.433 -0.792 . . . . 0.0 112.668 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.3 tp -71.37 -33.32 69.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.846 0.858 . . . . 0.0 112.124 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -149.71 -130.54 0.05 Allowed 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -169.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -54.73 130.95 42.55 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 120.279 1.399 . . . . 0.0 108.12 169.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -65.09 -16.99 64.08 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -169.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 pp -139.25 158.69 68.63 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.629 1.171 . . . . 0.0 109.587 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.8 -39.69 4.31 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.816 1.677 . . . . 0.0 112.603 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -155.51 -16.32 0.11 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -169.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -150.85 131.0 6.91 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.175 1.352 . . . . 0.0 109.831 -170.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -50.95 144.79 26.48 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.296 3.33 . . . . 0.0 114.079 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.37 -34.95 69.37 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.644 0.378 . . . . 0.0 110.946 171.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.55 -42.07 98.3 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.373 0.669 . . . . 0.0 110.411 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -76.88 -40.94 45.79 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.348 0.659 . . . . 0.0 109.703 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 -64.11 -42.15 96.98 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.928 0.491 . . . . 0.0 110.612 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 15.6 tp -66.57 -27.62 67.87 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.72 -0.612 . . . . 0.0 110.451 174.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.97 -48.37 82.99 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 169.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.6 m -63.68 -35.2 79.77 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.736 -0.861 . . . . 0.0 111.129 175.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 38.4 t90 -63.23 -50.68 69.28 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.211 0.605 . . . . 0.0 110.461 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 32.0 m -68.24 -29.21 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 121.214 -0.929 . . . . 0.0 111.444 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -60.71 -21.6 63.08 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.504 -0.76 . . . . 0.0 112.003 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.2 mt -101.77 -32.01 10.49 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 117.963 -1.018 . . . . 0.0 112.664 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.47 -28.35 66.01 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.471 1.487 . . . . 0.0 111.485 173.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttm . . . . . 0 C--O 1.251 1.167 0 C-N-CA 128.321 2.649 . . . . 0.0 111.596 -177.902 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.8 ttm . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.0 159.55 43.78 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.179 1.392 . . . . 0.0 108.499 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -79.36 -31.18 42.87 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.967 0.907 . . . . 0.0 109.898 -172.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.7 mt -122.32 70.02 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.7 m -68.4 116.46 8.99 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.7 mt -86.09 155.09 20.95 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.0 mt -123.14 90.62 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -172.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.6 m -77.62 129.07 35.14 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.153 0.981 . . . . 0.0 110.619 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.0 60.99 0.66 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 124.637 1.113 . . . . 0.0 113.123 -169.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.8 p -144.94 144.0 30.84 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 117.515 0.658 . . . . 0.0 109.894 169.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 p -79.98 -43.61 21.71 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.781 1.232 . . . . 0.0 108.746 169.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.518 ' H ' HD23 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -63.88 -27.1 68.93 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.521 1.528 . . . . 0.0 113.289 178.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.29 7.24 57.26 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.379 0.99 . . . . 0.0 113.559 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.83 -44.58 95.96 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 119.406 1.603 . . . . 0.0 110.844 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.34 -34.01 76.43 Favored 'General case' 0 C--O 1.227 -0.128 0 O-C-N 122.065 -0.667 . . . . 0.0 110.487 175.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.13 -39.84 86.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.676 0.671 . . . . 0.0 110.332 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -66.46 -46.28 76.95 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.996 0.918 . . . . 0.0 109.012 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.99 -49.19 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.88 87.59 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.927 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.57 -44.25 94.64 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.139 0.881 . . . . 0.0 111.101 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -68.91 -41.82 77.68 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.949 -0.469 . . . . 0.0 110.852 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.42 -42.05 98.72 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.66 96.33 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.769 0.828 . . . . 0.0 110.753 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -58.38 -42.87 88.01 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.595 0.634 . . . . 0.0 110.362 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -67.2 -39.61 86.36 Favored 'General case' 0 N--CA 1.461 0.109 0 O-C-N 121.738 -0.601 . . . . 0.0 111.179 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 mt -62.25 -37.64 86.2 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.54 0.609 . . . . 0.0 111.259 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.41 -38.44 87.47 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.092 0.86 . . . . 0.0 110.283 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -66.24 -35.77 81.28 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.609 0.64 . . . . 0.0 110.888 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.6 -26.79 66.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.085 0.554 . . . . 0.0 111.644 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.44 -3.36 10.32 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.269 1.414 . . . . 0.0 113.928 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -81.07 148.31 29.73 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.059 1.43 . . . . 0.0 110.342 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 p -79.05 144.42 34.65 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 169.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.8 p -140.64 163.96 31.48 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.284 0.634 . . . . 0.0 111.036 -176.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -150.47 151.62 32.99 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 105.437 -2.06 . . . . 0.0 105.437 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 p -108.81 73.15 0.85 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.32 104.01 6.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -169.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -73.25 121.54 20.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.15 51.85 29.14 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 117.89 -1.505 . . . . 0.0 116.759 169.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -67.23 175.84 5.35 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 CA-C-N 120.735 2.268 . . . . 0.0 111.368 170.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 mt -128.62 168.94 15.03 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.687 1.595 . . . . 0.0 108.659 171.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.38 -37.74 67.95 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.083 0.953 . . . . 0.0 110.902 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.36 -3.46 14.25 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.15 0.98 . . . . 0.0 113.294 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -125.17 9.33 8.0 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.919 1.288 . . . . 0.0 112.332 -170.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.45 149.78 52.29 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 124.127 0.971 . . . . 0.0 110.552 169.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.31 164.28 29.15 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.745 2.297 . . . . 0.0 111.471 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.67 21.19 0.84 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.204 1.402 . . . . 0.0 112.9 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.6 p -153.12 143.66 22.62 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.575 1.15 . . . . 0.0 108.772 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.19 -176.72 27.82 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.22 93.25 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -96.54 169.18 10.07 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.718 0.807 . . . . 0.0 109.796 -172.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.0 tp -135.39 124.14 23.86 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.73 130.48 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.53 121.04 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.4 m -138.4 133.07 32.4 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.307 0.643 . . . . 0.0 109.41 -169.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -77.13 163.85 26.22 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 169.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.0 m -114.35 119.04 35.58 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -66.69 -30.04 70.19 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.402 0.281 . . . . 0.0 110.965 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.49 -35.09 0.34 Allowed Glycine 0 CA--C 1.526 0.777 0 C-N-CA 123.791 0.71 . . . . 0.0 112.81 171.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.09 23.83 7.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.24 1.016 . . . . 0.0 112.192 -173.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.01 -3.62 60.47 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.196 -0.78 . . . . 0.0 113.098 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.29 149.18 47.66 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.448 1.124 . . . . 0.0 109.71 170.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.7 mt -113.71 144.27 31.11 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 126.043 1.737 . . . . 0.0 107.096 -169.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -48.72 139.94 23.46 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 124.223 3.282 . . . . 0.0 114.381 172.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -59.46 -21.56 60.25 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.634 1.574 . . . . 0.0 113.858 -172.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -67.35 -29.63 69.22 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.305 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.0 tp -127.64 -22.11 3.66 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.607 0.763 . . . . 0.0 112.049 -171.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 92.1 p -53.2 -31.66 8.3 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -52.1 -24.05 18.97 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.203 2.602 . . . . 0.0 115.278 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -58.5 -35.58 72.44 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.162 0.892 . . . . 0.0 110.773 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -62.45 -42.76 99.7 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.779 0.718 . . . . 0.0 110.484 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -68.89 -48.05 64.34 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.354 0.662 . . . . 0.0 109.286 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.28 -35.25 79.91 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 118.969 -0.539 . . . . 0.0 111.788 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.0 mt -65.72 -53.07 45.84 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.777 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -70.03 -28.34 65.39 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.337 0.972 . . . . 0.0 112.035 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.01 -35.03 77.63 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.515 0.598 . . . . 0.0 110.825 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -109.25 -33.64 6.8 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -169.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp 30.53 57.22 0.89 Allowed Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 127.385 2.274 . . . . 0.0 113.119 -172.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -69.3 172.0 12.97 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.169 1.913 . . . . 0.0 110.029 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -71.75 106.66 4.21 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.912 -0.493 . . . . 0.0 110.077 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.1 mt -113.0 20.43 16.37 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.601 1.56 . . . . 0.0 110.899 176.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 m -63.31 19.97 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.957 1.703 . . . . 0.0 115.548 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -135.28 0.1 2.77 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.208 1.403 . . . . 0.0 111.762 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 64.5 t -82.13 133.78 28.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -108.99 142.78 39.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 103.444 -2.798 . . . . 0.0 103.444 168.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -136.41 168.35 19.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 119.13 0.877 . . . . 0.0 111.354 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.16 163.48 23.53 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 105.561 -3.015 . . . . 0.0 105.561 169.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.06 124.4 13.04 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -169.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 52.1 mt -133.38 133.25 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.62 150.47 18.01 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.4 mt -139.79 150.44 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.35 -45.77 0.49 Allowed Glycine 0 C--N 1.33 0.237 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 169.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.2 m 115.01 140.92 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 1 C-N-CA 132.08 4.152 . . . . 0.0 108.056 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -67.81 0.84 2.97 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -63.62 -30.58 71.67 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.719 0.808 . . . . 0.0 109.994 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -70.8 156.43 39.55 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.467 0.707 . . . . 0.0 110.853 174.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.14 -37.5 83.06 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.659 0.783 . . . . 0.0 111.785 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.6 m -96.49 121.7 38.59 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 172.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -74.23 69.76 1.58 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.857 1.663 . . . . 0.0 111.783 -171.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 40.8 m 51.36 32.28 8.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.712 1.205 . . . . 0.0 111.823 -174.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.37 -0.87 79.25 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-O 118.301 -1.277 . . . . 0.0 115.051 -169.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.98 -26.79 67.81 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.4 2.1 . . . . 0.0 113.519 -173.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.0 tp -57.93 -28.11 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.755 1.222 . . . . 0.0 110.834 175.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -52.3 -38.68 59.1 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.194 0.997 . . . . 0.0 112.288 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -73.52 -41.12 63.44 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 121.84 -0.537 . . . . 0.0 110.489 -174.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 50.0 mt -64.2 -51.56 63.12 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.17 -38.67 82.31 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -169.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.35 75.23 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 122.049 -0.407 . . . . 0.0 110.576 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -74.13 -31.06 62.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.708 0.685 . . . . 0.0 110.691 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.88 -43.34 96.36 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.429 1.013 . . . . 0.0 108.885 169.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -61.98 -43.79 98.1 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.842 0.457 . . . . 0.0 109.826 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -64.28 -35.92 82.41 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.441 0.696 . . . . 0.0 111.132 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.5 m -71.47 -7.39 47.15 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.164 0.986 . . . . 0.0 112.927 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.85 -17.49 10.85 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.765 1.174 . . . . 0.0 113.787 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.2 171.61 1.29 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.266 1.033 . . . . 0.0 111.158 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -142.5 153.4 43.59 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 121.114 -0.991 . . . . 0.0 111.714 172.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -71.24 156.62 39.33 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.362 174.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 66.2 m -128.0 151.74 48.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.819 2.048 . . . . 0.0 106.675 169.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 62.0 -146.19 49.11 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -172.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -135.44 156.4 48.97 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.647 1.179 . . . . 0.0 108.206 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.66 152.64 45.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.986 1.314 . . . . 0.0 110.462 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.8 tp -129.98 144.17 51.19 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.443 1.097 . . . . 0.0 108.826 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -115.52 153.83 30.46 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 169.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 38.1 mt -134.76 109.14 11.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -172.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -77.63 135.9 38.17 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.555 0.742 . . . . 0.0 109.353 170.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 46.5 pt -129.23 -15.69 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.945 1.698 . . . . 0.0 112.131 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.2 mt -94.72 -19.51 20.33 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.121 0.873 . . . . 0.0 112.761 -170.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -144.82 -54.14 0.31 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.407 1.003 . . . . 0.0 111.97 -173.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -74.34 -37.17 63.61 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 20.8 t0 41.86 64.29 1.11 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.618 1.567 . . . . 0.0 110.095 -171.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.3 tt -44.12 130.46 4.44 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 126.043 1.737 . . . . 0.0 112.978 -169.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.55 170.57 1.77 Allowed 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.88 3.053 . . . . 0.0 114.606 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -73.83 -29.21 62.02 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.299 1.04 . . . . 0.0 111.443 175.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -54.89 -49.42 91.95 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.39 -26.28 35.05 Favored 'Trans proline' 0 C--N 1.351 0.663 0 CA-C-N 121.52 1.579 . . . . 0.0 112.641 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.59 86.88 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 120.134 1.334 . . . . 0.0 109.319 173.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -62.37 -44.61 96.05 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.022 0.529 . . . . 0.0 110.363 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -62.44 -49.77 74.11 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.666 0.386 . . . . 0.0 110.306 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 9.1 t-105 -67.95 -36.25 79.79 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 122.172 -0.33 . . . . 0.0 110.871 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.35 -41.38 93.54 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 118.906 -0.569 . . . . 0.0 110.032 173.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.81 -49.85 60.35 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 173.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.7 m -62.05 -36.6 82.1 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.161 0.584 . . . . 0.0 111.261 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 21.0 t90 -66.36 -53.05 40.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 119.137 -0.459 . . . . 0.0 110.124 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.1 m -66.21 -29.88 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 118.997 0.817 . . . . 0.0 111.514 -176.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -54.36 -25.33 23.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.89 0.876 . . . . 0.0 112.314 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 29.5 mt -100.29 -0.26 38.83 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.255 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.9 pp -124.71 -8.8 7.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.218 1.372 . . . . 0.0 113.59 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 71.8 mttt . . . . . 0 C--O 1.252 1.189 0 CA-C-N 119.542 1.065 . . . . 0.0 110.73 178.256 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.4 mtt . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.869 0.366 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.08 161.49 24.36 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 170.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -75.72 -30.84 59.41 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.812 0.845 . . . . 0.0 109.949 -171.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.0 mt -124.96 74.71 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 m -74.45 114.1 12.45 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 mp -74.27 155.03 38.68 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.0 mt -122.4 86.53 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 m -81.21 157.14 25.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.44 1.496 . . . . 0.0 111.722 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.0 135.26 1.92 Allowed Glycine 0 N--CA 1.444 -0.795 0 O-C-N 121.204 -0.935 . . . . 0.0 110.934 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 31.2 p -152.97 154.51 35.13 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.723 0.809 . . . . 0.0 111.943 169.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 p -71.79 -44.71 63.5 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.472 0.709 . . . . 0.0 109.749 169.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.468 ' H ' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -64.07 -25.32 68.05 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.899 0.88 . . . . 0.0 112.798 178.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.55 40.16 59.8 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -129.02 -19.58 1.57 Allowed Glycine 0 CA--C 1.525 0.696 0 C-N-CA 125.031 1.301 . . . . 0.0 112.11 -175.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.02 -21.17 66.39 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.184 0.992 . . . . 0.0 111.139 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.61 -35.8 77.03 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.206 0.602 . . . . 0.0 110.409 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -71.82 -40.22 69.28 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 122.062 -0.398 . . . . 0.0 110.155 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.97 -39.31 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.98 99.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.273 0.629 . . . . 0.0 110.084 175.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.19 -42.1 98.97 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.741 0.7 . . . . 0.0 110.571 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -61.51 -48.25 81.91 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.429 0.559 . . . . 0.0 110.814 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.0 mt -59.67 -46.3 89.47 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.343 0.657 . . . . 0.0 109.988 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.32 87.19 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.911 0.884 . . . . 0.0 111.397 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 -68.96 -45.52 70.49 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.567 0.747 . . . . 0.0 109.82 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -61.97 -41.3 97.85 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.363 0.528 . . . . 0.0 110.499 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.0 mt -62.72 -37.59 87.14 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.008 0.523 . . . . 0.0 111.396 173.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -67.15 -38.67 85.9 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.692 0.678 . . . . 0.0 110.373 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.54 -35.55 81.18 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.872 0.469 . . . . 0.0 110.839 173.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.89 -28.0 68.63 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.408 0.549 . . . . 0.0 111.335 172.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.39 -8.76 6.23 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.984 1.278 . . . . 0.0 114.155 169.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -80.0 143.76 33.83 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.962 1.381 . . . . 0.0 110.029 -174.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 p -70.95 141.05 51.09 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 169.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.8 p -134.91 159.44 41.43 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.143 0.497 . . . . 0.0 111.624 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -152.18 162.99 40.3 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -135.71 79.29 1.77 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.67 113.56 13.26 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -82.76 110.63 17.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.25 51.97 56.03 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-O 118.018 -1.434 . . . . 0.0 115.613 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -67.49 178.05 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.954 2.436 . . . . 0.0 111.322 170.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.0 mt -131.04 163.61 27.22 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 125.453 1.501 . . . . 0.0 109.56 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.3 tp -59.91 -36.18 76.44 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.656 1.182 . . . . 0.0 111.216 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -67.63 -3.79 10.04 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -134.56 22.63 3.67 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.783 1.633 . . . . 0.0 110.567 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.3 mt -137.41 123.1 12.93 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 125.286 1.434 . . . . 0.0 108.102 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.41 159.61 48.86 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.201 1.934 . . . . 0.0 110.486 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.02 17.23 1.26 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.586 1.155 . . . . 0.0 113.256 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.1 m -146.02 132.48 19.7 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.477 1.111 . . . . 0.0 108.429 -174.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 153.28 178.53 27.93 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.35 94.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -91.73 168.55 11.39 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.248 0.619 . . . . 0.0 109.402 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.3 tp -146.23 105.92 3.97 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.8 t -91.19 147.77 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -172.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.14 140.71 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 m -151.09 150.85 31.18 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.568 1.147 . . . . 0.0 108.623 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.6 m -69.62 159.29 33.7 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.044 0.45 . . . . 0.0 111.871 174.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.57 63.72 1.51 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 168.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -84.19 23.19 1.1 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.905 1.682 . . . . 0.0 110.855 -169.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.6 -13.48 41.41 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.484 1.04 . . . . 0.0 113.027 -170.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.86 -29.23 63.03 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.729 1.265 . . . . 0.0 112.916 -176.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.417 ' H ' HG21 ' A' ' 97' ' ' THR . . . 60.09 33.12 78.14 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.008 0.814 . . . . 0.0 112.003 -175.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -144.43 149.12 35.52 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.081 1.352 . . . . 0.0 107.683 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.4 mt -64.91 142.12 98.55 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -170.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.39 143.49 93.61 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.187 1.924 . . . . 0.0 110.939 -176.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.29 -28.48 58.88 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -169.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -70.83 -25.18 62.72 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 122.018 -0.426 . . . . 0.0 112.03 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.8 tp -120.5 -23.46 6.1 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.534 1.134 . . . . 0.0 111.832 -169.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 89.0 p -54.58 -30.32 6.67 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -52.21 -24.92 21.9 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.529 2.153 . . . . 0.0 114.598 169.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -60.26 -45.46 93.2 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.412 1.005 . . . . 0.0 110.542 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -64.43 -36.67 84.91 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.91 0.484 . . . . 0.0 110.661 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -65.35 -45.95 82.12 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.15 0.432 . . . . 0.0 110.183 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.51 -41.21 93.44 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.724 -0.61 . . . . 0.0 111.188 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.8 mt -60.42 -52.23 66.12 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.431 0.692 . . . . 0.0 110.334 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -70.92 -27.83 64.06 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.565 0.621 . . . . 0.0 111.505 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.82 -51.59 46.81 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.845 0.748 . . . . 0.0 109.686 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -85.17 -24.01 28.11 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.629 -169.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm 41.71 60.1 8.96 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.143 1.377 . . . . 0.0 111.166 -171.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -68.43 176.62 5.5 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.771 2.981 . . . . 0.0 111.971 -174.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -106.6 107.24 18.16 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 169.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.7 mt -119.62 24.38 10.65 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 126.44 1.896 . . . . 0.0 110.058 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.7 m -52.83 -10.2 0.15 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.89 -1.68 13.8 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.488 1.115 . . . . 0.0 111.222 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.0 t -80.91 141.99 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 168.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.92 146.97 50.81 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 168.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -137.9 171.71 14.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.295 0.569 . . . . 0.0 112.17 -169.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.52 167.48 26.17 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 105.64 -2.984 . . . . 0.0 105.64 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.419 ' HB3' HG23 ' A' ' 120' ' ' THR . . . -147.69 134.41 19.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.653 0.727 . . . . 0.0 109.649 -169.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.7 mm -128.14 132.77 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.05 130.48 9.65 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 173.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -127.37 126.07 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -172.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 171.22 -141.64 6.57 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -169.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.9 m -115.94 99.21 7.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.172 0.989 . . . . 0.0 108.759 -171.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -13.06 57.97 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.295 0.638 . . . . 0.0 112.561 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -56.76 -28.26 60.9 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.969 0.908 . . . . 0.0 111.002 169.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -123.25 -31.56 3.55 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.522 1.129 . . . . 0.0 110.914 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.7 t70 66.57 -16.31 0.13 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 129.608 3.163 . . . . 0.0 114.859 172.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.417 HG21 ' H ' ' A' ' 60' ' ' GLY . 1.8 m 59.78 171.66 0.08 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.635 1.974 . . . . 0.0 112.36 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.411 ' H ' HG22 ' A' ' 97' ' ' THR . 33.7 t80 -74.08 -2.59 25.03 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.634 -1.291 . . . . 0.0 113.027 -177.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 60.2 m 63.14 1.7 0.94 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.982 2.113 . . . . 0.0 115.046 -177.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -48.8 -32.41 11.24 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.762 1.172 . . . . 0.0 112.17 169.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.36 -5.39 1.13 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.84 2.056 . . . . 0.0 115.537 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 tp -141.15 -34.1 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.028 1.331 . . . . 0.0 109.772 172.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -50.97 -36.01 36.7 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.322 1.049 . . . . 0.0 112.492 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -71.68 -55.35 7.88 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.59 -0.694 . . . . 0.0 110.676 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 pp -65.04 -40.51 94.91 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -72.1 -39.25 69.04 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -172.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.69 -30.64 70.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 119.05 -0.5 . . . . 0.0 110.431 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -70.83 -33.56 70.79 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.207 0.912 . . . . 0.0 110.912 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.1 mt -64.0 -40.82 97.21 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.129 1.332 . . . . 0.0 109.235 169.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -63.42 -43.43 97.51 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -63.04 -38.71 92.29 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.708 0.803 . . . . 0.0 110.762 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.6 m -67.9 -10.62 54.68 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.986 0.914 . . . . 0.0 112.75 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.56 -18.17 8.22 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.013 1.292 . . . . 0.0 113.606 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.24 175.79 0.89 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.371 1.086 . . . . 0.0 111.522 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -146.62 159.66 43.17 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.362 -0.836 . . . . 0.0 109.784 169.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -73.46 168.14 19.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.534 1.134 . . . . 0.0 109.473 175.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 m -133.25 145.27 50.37 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 127.105 2.162 . . . . 0.0 106.237 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.58 -133.12 52.8 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -173.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -140.99 160.12 40.75 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.355 1.862 . . . . 0.0 106.149 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.419 HG23 ' HB3' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -61.58 157.89 16.38 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.086 1.354 . . . . 0.0 111.033 -178.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 51.4 tp -126.86 149.84 49.53 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.86 0.864 . . . . 0.0 109.333 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -116.33 147.93 41.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 172.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 25.7 mm -132.89 138.73 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -108.94 133.98 52.21 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.664 1.186 . . . . 0.0 108.802 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.7 pp -127.1 4.96 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.868 1.267 . . . . 0.0 111.273 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.4 tp -65.57 -37.13 85.79 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.435 0.694 . . . . 0.0 111.872 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -153.03 -42.18 0.1 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -169.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -144.53 140.83 29.09 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.365 1.066 . . . . 0.0 109.398 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -85.6 58.53 5.1 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.156 2.182 . . . . 0.0 110.775 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 35.61 52.83 1.8 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 127.414 2.286 . . . . 0.0 115.031 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.11 -22.62 67.45 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.288 1.992 . . . . 0.0 113.086 -172.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -77.72 -13.55 59.86 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.086 0.954 . . . . 0.0 112.677 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -152.82 65.5 5.78 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.688 1.195 . . . . 0.0 110.096 -172.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.82 154.13 75.22 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.896 2.397 . . . . 0.0 111.835 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.87 -21.75 63.59 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.996 0.918 . . . . 0.0 113.212 -175.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.64 -37.83 73.99 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.681 0.792 . . . . 0.0 111.242 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -69.74 -38.57 76.87 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.848 -0.533 . . . . 0.0 110.494 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -65.52 -43.04 91.3 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.619 0.368 . . . . 0.0 110.063 172.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 28.2 tp -60.6 -39.46 88.22 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.3 0.64 . . . . 0.0 110.498 -173.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.15 -48.88 65.7 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.6 m -65.31 -35.98 82.67 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.047 -0.678 . . . . 0.0 111.148 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 17.1 t90 -66.18 -51.16 60.41 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.3 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.0 m -65.78 -28.98 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 119.128 0.876 . . . . 0.0 111.528 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -57.65 -24.23 55.51 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.808 -0.615 . . . . 0.0 112.169 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.5 mt -102.04 3.08 38.41 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 pp -124.6 -10.21 7.36 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.717 1.144 . . . . 0.0 113.24 174.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.249 1.036 0 C-N-CA 125.845 1.658 . . . . 0.0 112.188 -179.958 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.83 162.67 36.22 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.821 1.248 . . . . 0.0 109.15 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -131.82 -28.43 1.79 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.487 1.515 . . . . 0.0 110.404 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.1 mt -123.93 84.51 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 169.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.5 m -75.94 109.55 9.66 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.74 154.39 38.41 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 89.1 mt -126.85 88.81 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 m -69.55 145.87 52.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.113 1.365 . . . . 0.0 109.933 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.07 49.82 0.66 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.411 0.529 . . . . 0.0 114.064 -169.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.8 p -125.03 160.2 29.57 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.677 1.191 . . . . 0.0 108.138 169.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.59 -31.22 18.72 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.155 0.982 . . . . 0.0 112.138 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 pp -140.57 -30.29 0.66 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -171.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.21 153.97 11.97 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.09 -78.59 0.38 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 126.055 1.788 . . . . 0.0 109.192 170.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.8 -42.17 95.24 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 122.673 0.389 . . . . 0.0 109.974 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -67.44 -31.8 72.24 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.024 0.93 . . . . 0.0 112.082 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -70.18 -46.66 64.15 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.3 t -68.43 -35.65 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 118.998 -0.525 . . . . 0.0 109.723 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.09 88.09 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 119.026 0.83 . . . . 0.0 110.873 173.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -62.54 -42.02 99.26 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.052 0.842 . . . . 0.0 110.778 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -66.06 -45.7 80.38 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 122.027 -0.42 . . . . 0.0 110.488 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -59.97 -43.54 95.03 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.418 0.687 . . . . 0.0 110.098 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.51 99.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.751 0.82 . . . . 0.0 110.669 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -63.4 -44.18 95.41 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.559 0.618 . . . . 0.0 110.406 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -62.59 -40.44 96.9 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 121.635 -0.665 . . . . 0.0 110.516 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 41.2 mt -63.48 -38.35 90.8 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 118.449 -0.786 . . . . 0.0 111.954 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.95 -38.8 92.15 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.411 1.005 . . . . 0.0 110.358 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -66.47 -35.81 81.2 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.251 0.478 . . . . 0.0 110.872 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.72 -26.37 65.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.163 0.585 . . . . 0.0 111.712 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.44 -2.83 10.37 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.266 1.412 . . . . 0.0 114.137 169.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -82.07 142.91 31.89 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.094 1.447 . . . . 0.0 109.579 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 p -80.97 142.41 33.49 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.1 p -136.94 166.23 24.12 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.575 0.702 . . . . 0.0 110.991 -169.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -150.31 159.53 44.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 169.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 p -128.04 76.62 1.7 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.1 mt -70.54 113.59 7.8 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -76.69 107.29 8.88 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 52.8 52.13 40.64 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-O 118.521 -1.155 . . . . 0.0 115.057 172.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -67.7 177.74 3.88 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.092 2.528 . . . . 0.0 111.13 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.2 mt -127.91 166.84 17.54 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.271 1.428 . . . . 0.0 108.968 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -53.21 -36.85 61.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.489 1.516 . . . . 0.0 112.127 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.46 -7.13 8.88 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.237 1.015 . . . . 0.0 113.415 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -132.14 21.88 4.47 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.778 1.631 . . . . 0.0 110.976 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.2 mt -134.12 112.95 12.35 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.558 1.143 . . . . 0.0 109.273 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -66.34 157.44 60.18 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.35 2.034 . . . . 0.0 111.963 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.33 10.61 26.71 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.757 1.223 . . . . 0.0 114.288 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.7 m -144.4 124.57 13.69 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 150.79 -171.36 30.56 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.8 mp -124.92 99.22 5.89 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -94.23 174.09 7.32 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.722 0.809 . . . . 0.0 109.515 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.6 tp -144.87 98.6 3.21 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.7 138.61 19.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 mt -130.11 148.57 33.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.8 m -146.33 137.64 24.54 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 m -70.54 144.57 51.26 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 168.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 p -85.34 1.96 46.25 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -177.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 45.08 19.61 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 129.537 3.135 . . . . 0.0 114.394 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.58 23.74 29.29 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 120.905 -1.122 . . . . 0.0 113.149 -169.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.82 -9.09 0.41 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.342 1.071 . . . . 0.0 113.515 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.81 34.72 42.2 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 118.862 0.756 . . . . 0.0 111.642 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -140.32 146.93 39.13 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.053 0.941 . . . . 0.0 109.214 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.482 ' H ' HD12 ' A' ' 62' ' ' ILE . 3.6 mp -76.73 146.1 75.84 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -57.42 155.07 32.13 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.951 2.434 . . . . 0.0 111.663 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -59.56 -16.28 24.17 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.115 1.366 . . . . 0.0 114.107 -174.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -64.46 -39.82 94.54 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.519 0.728 . . . . 0.0 111.083 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.2 tp -122.97 -20.64 5.73 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.185 0.594 . . . . 0.0 112.313 -171.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 t -49.2 -39.05 33.4 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.75 -23.78 8.91 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.463 2.775 . . . . 0.0 116.162 172.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -59.94 -37.03 78.33 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.658 1.117 . . . . 0.0 111.16 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -59.03 -42.94 91.4 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.237 0.615 . . . . 0.0 110.34 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -68.65 -48.24 64.51 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.401 0.68 . . . . 0.0 109.79 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.34 84.03 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 118.924 -0.56 . . . . 0.0 112.094 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.6 mt -65.84 -53.82 34.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 118.65 -0.69 . . . . 0.0 109.503 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -69.15 -28.58 66.56 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.162 0.892 . . . . 0.0 111.847 -174.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -66.09 -36.44 83.19 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.709 0.686 . . . . 0.0 110.725 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -107.22 -20.74 13.19 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -169.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm 39.71 60.54 6.31 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.873 1.669 . . . . 0.0 111.057 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.95 167.25 14.38 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.752 2.968 . . . . 0.0 111.997 -174.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -95.52 73.27 3.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.386 1.075 . . . . 0.0 109.332 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.47 16.68 9.82 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.26 1.424 . . . . 0.0 111.517 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.9 m -51.57 10.95 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 129.601 3.161 . . . . 0.0 116.921 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.22 2.18 2.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.168 1.387 . . . . 0.0 112.213 174.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.5 t -80.16 140.87 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 169.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -116.84 151.07 37.31 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 168.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -147.43 170.83 16.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.189 0.904 . . . . 0.0 112.48 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.55 161.16 23.95 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 104.766 -3.334 . . . . 0.0 104.766 169.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.423 ' HB1' HD12 ' A' ' 102' ' ' ILE . . . -140.98 132.88 27.59 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -169.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.2 mt -137.72 126.32 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 -173.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -114.93 121.07 5.2 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.1 mt -123.47 134.32 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 118.232 1.016 . . . . 0.0 108.34 -169.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.02 -164.42 37.96 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.5 m -75.06 75.22 2.25 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 125.621 1.569 . . . . 0.0 109.186 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -65.1 -12.2 48.19 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.448 1.099 . . . . 0.0 113.39 -171.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -65.56 -22.49 66.7 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.379 0.536 . . . . 0.0 111.475 170.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -75.01 174.31 9.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.055 0.942 . . . . 0.0 110.326 175.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.34 -29.9 70.96 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.712 0.805 . . . . 0.0 113.16 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 58.3 m -69.34 132.47 46.46 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -114.13 -59.57 2.0 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.295 0.638 . . . . 0.0 111.338 -175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 63.9 m -145.71 6.89 1.08 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.535 1.134 . . . . 0.0 112.413 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.6 -33.93 48.95 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 119.165 0.893 . . . . 0.0 114.22 -169.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.42 -59.59 4.17 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 117.949 0.875 . . . . 0.0 110.621 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.423 HD12 ' HB1' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -66.04 -34.99 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -175.14 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.0 -37.33 63.9 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.279 1.032 . . . . 0.0 112.528 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -63.7 -43.68 95.9 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.202 0.91 . . . . 0.0 111.35 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.3 mt -63.14 -50.43 70.46 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -70.22 -30.44 67.52 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.496 -173.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.01 91.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.481 0.582 . . . . 0.0 109.975 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -75.89 -29.6 58.53 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 117.771 -1.109 . . . . 0.0 112.4 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.26 -45.46 87.99 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 121.059 1.754 . . . . 0.0 109.855 172.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -71.4 -31.95 67.85 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.142 0.428 . . . . 0.0 110.964 -177.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -62.56 -39.47 93.74 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.013 0.37 . . . . 0.0 110.367 169.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.1 m -71.56 -0.53 10.82 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.82 1.248 . . . . 0.0 112.945 172.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.71 -14.31 41.9 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.809 1.195 . . . . 0.0 114.004 169.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.55 171.63 1.91 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.79 1.295 . . . . 0.0 110.839 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -142.81 150.68 40.27 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.993 -1.067 . . . . 0.0 112.237 170.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 17.3 tm0? -70.85 148.18 48.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.738 1.615 . . . . 0.0 108.438 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.3 m -128.22 144.96 51.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.936 1.695 . . . . 0.0 107.53 174.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.02 -127.84 8.68 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -143.98 164.41 30.68 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.993 1.717 . . . . 0.0 107.209 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.7 m -68.12 139.95 56.18 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.3 tp -105.8 150.2 25.77 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.209 1.003 . . . . 0.0 108.662 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.32 136.65 35.06 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.6 mm -135.49 113.81 15.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.176 -1.786 . . . . 0.0 106.176 -170.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -72.07 142.78 49.23 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 169.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.4 pp -128.92 3.62 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.518 1.127 . . . . 0.0 112.378 171.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 tp -64.55 -39.6 94.06 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.096 0.862 . . . . 0.0 112.351 -172.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -142.68 -7.39 0.86 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -169.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -150.12 155.27 39.51 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.392 1.477 . . . . 0.0 107.693 177.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -72.86 -34.45 66.74 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -169.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.1 pt -147.32 155.32 46.26 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 126.146 1.779 . . . . 0.0 108.317 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.85 174.69 10.08 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.762 2.308 . . . . 0.0 110.677 169.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.9 mp0 -70.95 24.32 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.044 2.138 . . . . 0.0 112.538 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -142.28 80.64 14.72 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 127.004 2.122 . . . . 0.0 106.726 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.99 151.03 28.64 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.781 2.987 . . . . 0.0 114.098 -169.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.12 -31.68 65.56 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.539 174.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.1 -37.87 89.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.288 0.635 . . . . 0.0 111.252 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -71.46 -41.43 69.4 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.763 -0.586 . . . . 0.0 109.562 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -61.05 -45.15 95.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.62 -43.75 95.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.481 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.31 -45.36 92.87 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -63.97 -36.86 85.37 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.154 0.582 . . . . 0.0 111.168 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -67.91 -54.06 21.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.934 0.894 . . . . 0.0 109.8 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.93 -31.35 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 118.818 0.735 . . . . 0.0 111.141 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.24 -25.09 58.57 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.416 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.5 mt -101.46 -5.84 24.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.038 -0.982 . . . . 0.0 113.293 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.5 pp -120.3 -9.41 9.52 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.308 1.413 . . . . 0.0 113.08 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.251 1.133 0 C-N-CA 125.703 1.601 . . . . 0.0 111.961 178.264 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tmm? . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.16 158.03 14.75 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.72 -0.613 . . . . 0.0 110.776 172.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -135.44 -25.94 1.28 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.765 1.226 . . . . 0.0 110.977 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.8 mt -129.53 84.77 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 169.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.5 m -75.56 115.85 15.67 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 176.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mp -74.35 156.89 36.62 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 171.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.6 mt -126.39 80.22 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.5 m -68.45 153.88 42.91 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.527 1.531 . . . . 0.0 110.561 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.1 100.42 0.19 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -150.12 170.56 18.63 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.656 0.741 . . . . 0.0 109.976 171.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -133.42 -41.4 0.87 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 127.213 2.205 . . . . 0.0 107.344 171.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.71 -33.84 76.54 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.815 0.846 . . . . 0.0 110.64 169.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.44 -8.46 52.21 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.134 1.35 . . . . 0.0 112.754 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.67 -45.17 67.38 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 118.484 1.142 . . . . 0.0 110.684 -173.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.68 -26.83 64.56 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.483 0.641 . . . . 0.0 110.74 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -69.96 -36.64 75.4 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.328 0.513 . . . . 0.0 110.685 175.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -67.02 -44.28 80.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.735 0.698 . . . . 0.0 109.504 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.65 -39.15 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 119.057 -0.497 . . . . 0.0 109.967 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.88 -41.74 96.58 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.296 0.953 . . . . 0.0 110.987 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -63.32 -42.5 99.0 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.746 0.703 . . . . 0.0 110.553 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -62.02 -45.41 93.7 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.845 -0.534 . . . . 0.0 110.706 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.7 mt -62.06 -41.78 98.5 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.474 0.71 . . . . 0.0 110.464 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.18 -38.24 85.8 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.028 0.531 . . . . 0.0 110.662 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.18 -41.33 90.44 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.425 ' N ' ' HE2' ' A' ' 25' ' ' LYS . 6.8 mmpt? -62.89 -36.34 83.01 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 121.685 -0.634 . . . . 0.0 110.009 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.3 mt -68.45 -37.53 80.31 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 118.965 -0.541 . . . . 0.0 110.984 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -62.9 -42.11 99.67 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.924 0.783 . . . . 0.0 109.974 175.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.93 -37.29 87.16 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.145 0.43 . . . . 0.0 111.012 175.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.16 -22.03 63.96 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.792 0.837 . . . . 0.0 112.186 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.56 28.75 2.89 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.567 -1.13 . . . . 0.0 113.973 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -125.98 137.44 53.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.286 1.543 . . . . 0.0 109.223 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.5 p -76.07 146.85 39.08 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.43 0.633 . . . . 0.0 109.513 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.4 p -135.36 167.63 20.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.781 0.832 . . . . 0.0 110.212 -170.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -150.97 160.75 43.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 169.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.7 78.65 1.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -175.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.09 110.85 4.71 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -93.93 92.02 7.19 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -171.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.51 56.6 12.65 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.931 -0.927 . . . . 0.0 113.071 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.19 -179.14 3.3 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.91 2.407 . . . . 0.0 110.345 170.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.3 mt -114.77 160.16 19.75 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 169.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -55.5 -40.04 71.22 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.781 0.832 . . . . 0.0 111.403 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -64.83 -14.54 59.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.808 0.843 . . . . 0.0 113.198 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -90.76 -2.91 57.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.932 0.893 . . . . 0.0 112.309 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -137.44 154.4 75.26 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.147 0.979 . . . . 0.0 111.179 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.8 163.58 26.1 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.826 2.351 . . . . 0.0 111.77 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.04 18.67 0.99 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.41 1.484 . . . . 0.0 113.22 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.7 m -146.45 136.7 23.7 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.223 1.409 . . . . 0.0 107.887 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.71 -176.2 30.19 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.95 104.28 13.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -104.95 172.85 6.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.199 0.999 . . . . 0.0 109.931 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.6 tp -141.31 100.55 3.82 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 t -79.35 131.57 34.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.9 mt -133.0 127.58 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.2 m -134.29 129.31 35.39 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -170.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.9 m -69.07 160.51 30.89 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.505 169.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.9 m -132.82 109.21 9.48 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -63.28 -24.89 68.07 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.04 0.382 . . . . 0.0 111.956 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.09 -32.24 0.33 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.052 0.834 . . . . 0.0 112.234 171.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.93 30.31 4.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.27 1.028 . . . . 0.0 111.922 -171.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.81 -0.01 59.14 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.376 -0.68 . . . . 0.0 113.641 173.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -69.14 110.82 4.73 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 118.484 1.142 . . . . 0.0 109.982 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 61.2 mt -69.3 141.86 91.76 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 171.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.51 136.76 56.23 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.204 2.602 . . . . 0.0 110.985 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.9 -21.48 43.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.407 1.483 . . . . 0.0 113.237 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -64.87 -34.94 79.58 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.446 0.699 . . . . 0.0 111.454 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 tt -121.76 -22.17 5.88 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.615 0.766 . . . . 0.0 112.306 -169.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 81.7 p -51.13 -34.01 11.51 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-O 116.439 -1.743 . . . . 0.0 115.259 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -52.11 -22.9 15.99 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.989 2.46 . . . . 0.0 115.728 172.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -59.46 -37.21 77.58 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.336 0.971 . . . . 0.0 110.913 175.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -65.21 -42.26 93.69 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.602 0.761 . . . . 0.0 110.179 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -63.35 -50.95 67.95 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.714 0.406 . . . . 0.0 109.997 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.56 -29.21 70.23 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.993 0.815 . . . . 0.0 112.745 -174.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.3 mt -68.69 -57.07 6.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.382 171.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -69.86 -27.46 64.85 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.041 0.837 . . . . 0.0 112.431 -170.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.92 -26.05 61.27 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.123 0.874 . . . . 0.0 111.256 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -109.44 -24.4 11.04 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.573 -173.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt 40.13 59.81 7.05 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.778 1.631 . . . . 0.0 110.577 -169.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.25 167.62 17.94 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.846 2.364 . . . . 0.0 111.068 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -96.53 106.72 19.02 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 169.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.1 mt -118.98 24.93 10.54 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.128 1.771 . . . . 0.0 110.022 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -61.0 20.0 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.524 1.929 . . . . 0.0 115.569 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.13 1.86 1.86 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.35 1.46 . . . . 0.0 111.992 173.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.5 t -84.09 142.66 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -123.42 148.65 45.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 168.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -144.08 171.3 14.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.452 0.644 . . . . 0.0 111.45 -174.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.42 161.54 22.16 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 104.461 -3.456 . . . . 0.0 104.461 168.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.31 124.77 13.93 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -169.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 mt -134.65 133.43 54.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.8 140.03 15.93 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 170.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 mt -138.73 131.47 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -171.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.7 -169.01 41.46 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 120.231 1.378 . . . . 0.0 110.541 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.9 m -79.34 74.17 5.95 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 126.02 1.728 . . . . 0.0 108.223 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -52.6 -33.93 48.57 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.962 1.305 . . . . 0.0 112.211 -173.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -80.84 -12.02 59.5 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.671 1.188 . . . . 0.0 112.349 -174.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -67.49 -52.54 38.03 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 118.978 0.808 . . . . 0.0 111.836 -169.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -162.87 -47.06 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.346 1.058 . . . . 0.0 110.915 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.8 m -115.93 131.44 56.94 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -79.7 59.49 3.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.83 1.252 . . . . 0.0 111.434 -169.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 72.1 m 48.28 38.3 10.0 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.646 1.578 . . . . 0.0 112.613 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.02 -0.17 78.08 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 118.673 -1.07 . . . . 0.0 113.55 -172.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.17 -20.52 66.06 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.795 1.797 . . . . 0.0 113.161 -171.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.6 tp -60.86 -28.21 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.361 1.464 . . . . 0.0 111.163 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -57.22 -40.35 77.34 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -169.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -63.62 -44.35 94.18 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.927 -0.483 . . . . 0.0 111.047 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.9 mt -69.34 -48.61 60.85 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.566 0.747 . . . . 0.0 109.398 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.63 -38.57 87.21 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.56 -37.65 88.27 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.316 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -70.62 -29.16 65.47 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.596 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.6 mt -66.23 -43.05 87.7 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.948 1.704 . . . . 0.0 109.259 170.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -62.71 -42.81 99.83 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 122.732 0.413 . . . . 0.0 109.985 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -60.82 -40.51 92.99 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.207 1.003 . . . . 0.0 110.826 174.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.0 m -70.3 -5.78 30.34 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.478 1.111 . . . . 0.0 113.186 175.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.19 -13.9 21.33 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.53 1.062 . . . . 0.0 113.612 169.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.73 178.97 0.7 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.379 1.089 . . . . 0.0 110.589 174.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -151.73 148.08 27.47 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.873 -1.142 . . . . 0.0 113.204 169.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 39.7 tp60 -56.77 155.94 7.13 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.715 2.006 . . . . 0.0 109.928 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.5 m -141.3 131.96 25.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.57 174.77 17.01 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -169.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -71.55 158.3 36.46 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.625 -0.926 . . . . 0.0 108.963 170.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.88 160.52 20.28 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 169.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 54.2 tp -129.54 148.44 51.44 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.517 -0.739 . . . . 0.0 109.637 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -125.71 147.33 49.4 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 169.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.7 mm -131.66 106.88 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -78.14 134.96 37.59 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 169.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.24 -17.64 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 118.294 0.497 . . . . 0.0 111.699 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.0 tp -67.67 -34.46 76.98 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.552 0.614 . . . . 0.0 111.274 -171.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -73.77 -50.83 18.73 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -159.76 34.84 0.19 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.387 0.675 . . . . 0.0 111.018 -171.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.1 t70 67.87 -25.16 0.12 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.454 2.302 . . . . 0.0 114.738 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.0 pt -145.18 160.06 47.17 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 127.757 2.423 . . . . 0.0 107.673 171.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.66 170.31 16.76 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.536 2.157 . . . . 0.0 110.225 169.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.32 -36.98 85.88 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.17 0.588 . . . . 0.0 110.808 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -69.61 115.82 36.85 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.293 1.037 . . . . 0.0 109.91 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.23 138.02 78.65 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.559 2.173 . . . . 0.0 111.767 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.89 -28.67 67.75 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 122.704 0.402 . . . . 0.0 111.153 172.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -58.63 -33.73 70.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.49 1.116 . . . . 0.0 111.565 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -69.52 -42.08 75.16 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.851 0.75 . . . . 0.0 109.954 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -64.68 -43.88 92.11 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.98 -43.34 99.06 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.354 0.662 . . . . 0.0 110.513 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.71 -44.54 97.8 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.954 0.787 . . . . 0.0 111.513 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -63.47 -35.58 80.93 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.023 -0.692 . . . . 0.0 111.053 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -68.88 -48.51 63.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.918 0.887 . . . . 0.0 110.403 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.15 -32.55 57.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 CA-C-N 119.161 0.891 . . . . 0.0 111.169 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -62.14 -22.23 65.68 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.344 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.1 mt -96.53 -43.8 7.45 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.438 1.017 . . . . 0.0 111.621 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 pp -70.92 -25.41 62.75 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.355 0.98 . . . . 0.0 112.32 -175.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 C--O 1.252 1.209 0 C-N-CA 127.796 2.438 . . . . 0.0 112.02 177.767 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.07 158.67 43.75 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.625 1.17 . . . . 0.0 108.589 172.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -137.36 -25.09 1.05 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.69 1.596 . . . . 0.0 110.992 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.8 mt -124.9 79.3 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 169.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.4 m -74.83 117.77 17.05 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.65 151.0 34.5 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.3 mt -116.2 80.34 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 m -71.44 148.34 46.96 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.254 1.422 . . . . 0.0 109.683 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.6 80.7 0.18 Allowed Glycine 0 C--N 1.339 0.735 0 O-C-N 122.237 -0.289 . . . . 0.0 113.794 -169.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 t -150.44 134.37 16.83 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.899 0.88 . . . . 0.0 108.734 168.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -78.24 -38.48 42.86 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 169.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.6 mt -73.83 -41.24 62.58 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.754 0.822 . . . . 0.0 110.635 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.37 -8.42 11.2 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.392 1.472 . . . . 0.0 112.634 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.79 -57.98 14.13 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 125.545 1.545 . . . . 0.0 113.109 -169.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.02 -27.97 67.0 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 117.568 0.684 . . . . 0.0 110.972 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -76.33 -22.7 54.6 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.192 -173.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -65.75 -41.6 91.92 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.94 0.791 . . . . 0.0 109.182 169.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.5 t -72.22 -32.76 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 121.822 -0.549 . . . . 0.0 109.937 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.86 87.12 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.409 -0.807 . . . . 0.0 110.277 170.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.07 -38.93 89.56 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.412 0.551 . . . . 0.0 111.157 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -59.23 -46.8 87.51 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.095 0.861 . . . . 0.0 110.032 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.6 mt -65.14 -43.18 92.7 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.799 -0.563 . . . . 0.0 110.103 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.47 -42.61 92.43 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.549 0.74 . . . . 0.0 111.004 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -52.79 -47.43 67.56 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.799 0.84 . . . . 0.0 110.031 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -67.87 -40.9 83.54 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.2 mt -66.41 -39.59 89.09 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 119.259 -0.4 . . . . 0.0 110.641 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -61.12 -46.18 91.63 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.111 0.564 . . . . 0.0 109.655 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -65.5 -34.94 79.45 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.846 0.458 . . . . 0.0 111.34 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.6 -22.36 64.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.877 0.871 . . . . 0.0 112.035 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.25 1.67 23.47 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.656 1.122 . . . . 0.0 113.212 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -74.97 174.74 8.89 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.444 1.122 . . . . 0.0 109.475 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.4 p -122.61 137.32 54.93 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.5 p -132.51 170.32 15.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.135 0.974 . . . . 0.0 110.336 -170.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -153.54 126.1 8.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 104.518 -2.401 . . . . 0.0 104.518 169.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.0 p -82.54 70.63 9.55 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -69.58 113.59 7.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -169.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -72.27 107.98 5.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.261 1.024 . . . . 0.0 108.744 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.82 56.65 15.13 Favored Glycine 0 CA--C 1.539 1.577 0 CA-C-O 118.341 -1.255 . . . . 0.0 115.766 169.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.2 175.71 5.46 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.771 2.314 . . . . 0.0 111.685 173.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.7 mt -128.67 164.35 23.12 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.346 1.458 . . . . 0.0 109.226 174.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.4 tp -62.27 -27.8 69.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.816 1.247 . . . . 0.0 112.169 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.75 -10.38 12.6 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.136 0.974 . . . . 0.0 113.101 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -128.56 19.88 6.19 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.348 1.459 . . . . 0.0 110.872 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.94 97.67 13.61 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.08 1.352 . . . . 0.0 107.886 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.76 165.22 28.45 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.404 2.069 . . . . 0.0 111.774 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.71 4.67 1.8 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.69 1.596 . . . . 0.0 114.788 -175.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.2 m -144.94 133.85 22.47 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.354 1.462 . . . . 0.0 107.276 -175.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.71 175.53 23.54 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.5 mt -114.54 101.83 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -110.42 166.63 10.83 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.573 0.749 . . . . 0.0 108.98 -176.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.8 tp -146.37 99.28 3.2 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 t -79.52 132.31 32.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.793 1.237 . . . . 0.0 107.839 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 mt -135.98 132.29 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.6 m -134.18 133.67 41.23 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -169.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 m -80.08 166.71 21.24 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 169.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.5 m -141.15 112.27 7.29 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 174.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -71.61 -5.25 32.08 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -169.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 160.89 -38.58 0.43 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-N 119.794 1.179 . . . . 0.0 113.761 169.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.22 10.25 3.0 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.273 1.036 . . . . 0.0 113.259 -170.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.62 -14.88 4.71 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.135 0.874 . . . . 0.0 113.289 172.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.07 119.43 6.3 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.353 1.061 . . . . 0.0 111.632 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.4 mt -83.47 132.23 50.27 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -51.13 136.46 45.51 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 124.016 3.144 . . . . 0.0 113.292 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.39 -18.6 62.0 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.283 1.033 . . . . 0.0 113.315 -176.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -73.89 -27.11 60.89 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.413 -0.804 . . . . 0.0 112.179 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.9 tp -121.04 -27.1 5.02 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.283 0.947 . . . . 0.0 111.92 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -46.73 -39.76 17.37 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-O 117.549 -1.215 . . . . 0.0 113.935 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.42 -25.64 14.46 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.502 2.801 . . . . 0.0 116.077 172.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -60.56 -37.5 81.47 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.157 -0.965 . . . . 0.0 110.855 176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -65.71 -43.3 89.54 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.113 0.565 . . . . 0.0 110.9 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.26 -38.04 68.95 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.583 0.629 . . . . 0.0 110.784 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.04 -35.91 80.92 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.726 0.693 . . . . 0.0 111.576 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.9 mt -64.45 -54.41 33.02 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.744 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -69.54 -25.96 64.27 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.147 0.885 . . . . 0.0 111.957 -173.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -68.88 -37.27 78.94 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.86 0.755 . . . . 0.0 110.697 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -105.07 -34.33 8.0 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -169.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm 31.0 57.92 0.98 Allowed Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 127.306 2.242 . . . . 0.0 113.675 -173.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.23 169.83 15.93 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.929 1.753 . . . . 0.0 110.167 174.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -72.04 114.83 10.57 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 169.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.1 mt -119.72 18.74 12.62 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.674 1.59 . . . . 0.0 110.901 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.8 m -57.87 4.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.43 1.22 8.96 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.848 1.204 . . . . 0.0 111.614 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 79.8 t -74.56 131.63 34.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 169.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -107.62 102.73 11.95 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 102.197 -3.26 . . . . 0.0 102.197 168.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -95.88 167.35 11.31 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.803 0.811 . . . . 0.0 108.933 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -123.13 154.46 17.17 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 104.839 -3.305 . . . . 0.0 104.839 169.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.47 122.48 11.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.8 mt -135.68 131.82 50.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -102.26 138.11 13.73 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.9 mt -133.21 153.35 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 165.66 173.4 34.13 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-O 123.278 1.488 . . . . 0.0 110.732 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.1 m -74.48 56.94 0.69 Allowed 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 126.511 1.924 . . . . 0.0 109.952 174.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.14 -52.5 7.23 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.894 2.078 . . . . 0.0 110.978 -174.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -65.14 -11.7 43.07 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.093 0.557 . . . . 0.0 112.498 -171.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -66.27 -50.43 63.73 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.908 0.776 . . . . 0.0 110.184 170.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -171.61 -49.02 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.412 1.485 . . . . 0.0 111.797 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.5 t -58.65 166.22 1.93 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.739 1.216 . . . . 0.0 114.02 -169.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -112.96 43.39 1.7 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 169.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 16.4 m 45.0 52.9 8.03 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.486 1.914 . . . . 0.0 110.379 -169.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -69.7 -14.36 69.87 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.718 -169.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.38 -36.45 71.26 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.486 1.643 . . . . 0.0 113.784 -169.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.8 tp -67.88 -27.87 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.174 0.59 . . . . 0.0 110.841 -176.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -61.02 -43.52 98.76 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 118.354 0.524 . . . . 0.0 111.787 -169.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -65.81 -44.52 85.4 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 122.016 -0.427 . . . . 0.0 110.802 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.9 mt -63.33 -46.66 85.61 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.331 0.652 . . . . 0.0 109.948 -176.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.89 -40.38 75.7 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.997 0.362 . . . . 0.0 110.075 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.31 -35.02 79.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.032 -169.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -74.21 -29.94 61.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.18 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.8 mt -66.62 -41.78 87.84 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.16 1.346 . . . . 0.0 109.02 169.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -61.55 -43.92 97.98 Favored 'General case' 0 N--CA 1.458 -0.062 0 C-N-CA 124.002 0.921 . . . . 0.0 109.343 -177.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -67.5 -36.41 81.01 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.023 0.929 . . . . 0.0 111.347 176.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.1 m -68.84 -2.09 8.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.225 1.01 . . . . 0.0 112.876 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.28 -15.66 30.16 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.32 1.438 . . . . 0.0 113.693 169.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.19 171.95 2.73 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.6 1.2 . . . . 0.0 110.989 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -142.66 154.47 44.37 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.364 -0.835 . . . . 0.0 111.462 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -63.85 161.35 15.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.774 2.029 . . . . 0.0 110.244 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.6 m -133.99 152.85 52.01 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.509 1.923 . . . . 0.0 106.321 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.37 -135.27 51.84 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -169.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -140.47 150.67 44.09 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.8 m -63.22 149.64 44.98 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.269 1.428 . . . . 0.0 110.551 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.9 tp -132.88 147.89 52.3 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.388 1.075 . . . . 0.0 109.084 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -120.06 139.25 52.82 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.221 1.808 . . . . 0.0 106.227 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.8 mt -138.07 107.25 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.419 HD22 ' CD2' ' A' ' 128' ' ' HIS . 41.8 t30 -67.57 141.13 56.92 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 170.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.3 pt -122.06 -9.66 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.036 1.335 . . . . 0.0 112.1 171.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.4 tp -71.69 115.29 10.71 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 119.883 1.22 . . . . 0.0 108.378 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.1 t70 56.17 31.63 18.68 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.898 1.679 . . . . 0.0 112.367 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.419 ' CD2' HD22 ' A' ' 124' ' ' ASN . 5.4 m170 -128.35 155.16 45.11 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.028 1.731 . . . . 0.0 107.924 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -143.17 12.77 1.8 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.596 1.158 . . . . 0.0 111.853 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 42.4 pt 34.91 56.51 2.17 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 127.284 2.234 . . . . 0.0 114.398 -175.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.5 -26.28 54.88 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.331 2.02 . . . . 0.0 112.612 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -77.69 -7.64 56.77 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.412 1.085 . . . . 0.0 111.288 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 36.7 t0 37.94 57.89 4.72 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 127.883 2.473 . . . . 0.0 113.715 -169.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -55.97 -24.15 46.87 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 123.532 2.821 . . . . 0.0 114.577 -173.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.87 -34.11 62.61 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.876 0.87 . . . . 0.0 111.34 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -62.15 -38.93 90.89 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.51 0.724 . . . . 0.0 110.908 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -76.13 -49.09 18.29 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -64.67 -33.16 75.28 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.216 -0.303 . . . . 0.0 111.744 -174.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 48.9 tp -56.98 -30.18 63.9 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 118.68 -0.676 . . . . 0.0 111.358 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.92 -45.7 70.34 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 118.841 0.746 . . . . 0.0 111.297 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.9 m -66.77 -30.76 71.05 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 117.492 0.646 . . . . 0.0 111.319 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -72.61 -51.31 20.18 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.532 0.733 . . . . 0.0 110.03 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 31.4 m -66.52 -30.64 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 O-C-N 121.331 -0.855 . . . . 0.0 111.246 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -60.74 -21.25 62.78 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.846 0.859 . . . . 0.0 112.482 175.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 28.8 mt -102.78 -35.93 8.46 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 118.069 -0.967 . . . . 0.0 112.109 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -35.78 79.52 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 120.005 1.275 . . . . 0.0 111.838 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt . . . . . 0 C--O 1.251 1.176 0 C-N-CA 128.658 2.783 . . . . 0.0 113.236 -179.474 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 ttm . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.7 158.62 24.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.887 0.475 . . . . 0.0 110.957 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -134.34 -26.03 1.48 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.122 1.369 . . . . 0.0 110.973 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.6 mt -129.04 82.36 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 169.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.8 m -74.6 121.29 21.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.5 mp -78.98 146.17 33.54 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.5 mt -109.91 82.31 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.4 m -64.1 140.33 58.86 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.014 0.926 . . . . 0.0 110.431 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.57 72.12 0.41 Allowed Glycine 0 C--N 1.339 0.739 0 C-N-CA 123.584 0.611 . . . . 0.0 113.851 -169.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 99.5 p -152.16 148.55 27.76 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 168.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -80.43 -44.03 19.98 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.911 0.885 . . . . 0.0 108.886 169.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.492 ' H ' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -64.91 -27.34 68.78 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.133 1.373 . . . . 0.0 113.698 -179.106 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.15 0.19 57.19 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.489 1.042 . . . . 0.0 113.064 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.15 -43.13 98.68 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 119.178 1.489 . . . . 0.0 111.204 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.9 -29.23 69.06 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.542 -0.742 . . . . 0.0 110.644 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -69.88 -35.32 74.56 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.15 0.886 . . . . 0.0 110.231 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -70.91 -41.73 70.88 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.998 0.817 . . . . 0.0 109.784 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.11 -44.81 99.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.87 -36.47 79.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.524 -0.751 . . . . 0.0 111.01 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.82 -41.69 99.42 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.52 1.055 . . . . 0.0 110.7 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -64.57 -48.87 73.4 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.161 0.437 . . . . 0.0 109.962 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.84 -46.11 88.49 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.86 0.464 . . . . 0.0 110.233 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.51 98.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.474 1.11 . . . . 0.0 111.029 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.39 -43.66 96.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.288 0.495 . . . . 0.0 110.355 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -67.45 -34.29 76.88 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.356 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.0 mt -63.99 -37.02 85.9 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 119.381 0.991 . . . . 0.0 111.755 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -63.44 -40.91 98.4 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.586 1.085 . . . . 0.0 110.15 175.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.22 -37.04 86.03 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.296 0.498 . . . . 0.0 111.087 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.84 -21.86 63.33 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.74 0.816 . . . . 0.0 112.256 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.27 26.04 3.32 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.533 -1.148 . . . . 0.0 114.022 170.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -125.88 131.58 52.33 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.244 1.522 . . . . 0.0 108.72 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 p -73.26 147.47 44.56 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.5 p -140.72 169.28 17.94 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.084 0.954 . . . . 0.0 109.588 -169.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -152.5 140.67 20.38 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 169.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.5 p -96.42 68.65 2.57 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.87 119.3 17.9 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -169.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -69.29 99.96 1.26 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.264 1.026 . . . . 0.0 109.665 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.13 54.22 10.04 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.347 1.451 . . . . 0.0 115.549 171.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -60.6 142.97 99.31 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 CA-C-N 120.494 2.147 . . . . 0.0 109.815 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.1 mt -69.23 155.03 41.08 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.75 -34.26 71.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.311 0.644 . . . . 0.0 109.761 169.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -65.58 -9.57 27.83 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.386 1.475 . . . . 0.0 112.909 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -118.06 13.23 13.84 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.007 1.323 . . . . 0.0 111.556 -170.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 pp -141.98 154.78 65.53 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.513 1.125 . . . . 0.0 109.592 171.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.48 161.29 37.57 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.594 2.196 . . . . 0.0 112.07 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.06 18.63 0.48 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.567 1.547 . . . . 0.0 112.931 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.8 t -152.37 133.68 14.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.03 179.39 31.93 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.0 mt -117.25 106.66 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.096 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -107.75 169.07 8.83 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 123.152 0.581 . . . . 0.0 109.516 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.4 tp -142.41 101.04 3.82 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.01 144.09 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.217 -171.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.57 143.42 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 172.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 m -147.24 134.49 20.59 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.402 -0.812 . . . . 0.0 108.876 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.4 m -75.91 160.36 29.99 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 169.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.8 m -128.64 106.22 8.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.778 1.631 . . . . 0.0 106.921 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -67.11 169.82 7.9 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.2 -23.82 34.3 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.754 -1.026 . . . . 0.0 114.947 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.92 11.7 16.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.996 1.318 . . . . 0.0 112.709 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.14 16.97 70.61 Favored Glycine 0 C--N 1.339 0.697 0 O-C-N 121.439 -0.788 . . . . 0.0 113.721 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -66.45 119.99 12.59 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.659 1.23 . . . . 0.0 108.419 170.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.2 mt -70.18 142.58 90.15 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -61.28 144.64 98.74 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.085 2.523 . . . . 0.0 112.065 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -59.01 -21.91 59.8 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.359 1.464 . . . . 0.0 113.598 -173.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.91 -27.97 68.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.38 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 63.6 tp -130.79 -20.72 2.81 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.734 0.814 . . . . 0.0 112.508 -170.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.0 p -53.19 -31.5 7.88 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -53.52 -20.89 17.14 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.014 2.476 . . . . 0.0 115.583 169.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -56.99 -35.65 69.45 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.177 0.898 . . . . 0.0 110.96 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -65.35 -48.83 71.64 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.58 -43.44 98.85 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.605 0.762 . . . . 0.0 110.009 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.57 -29.8 68.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.419 0.688 . . . . 0.0 112.492 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.4 mt -76.68 -29.8 56.48 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.771 176.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -73.62 -46.84 44.43 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.494 1.043 . . . . 0.0 109.115 175.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.11 -25.73 67.9 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.831 0.853 . . . . 0.0 111.837 -171.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -118.14 -25.26 6.71 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 117.974 -1.012 . . . . 0.0 113.167 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? 36.55 59.06 3.51 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 125.026 1.33 . . . . 0.0 110.605 -169.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -68.17 173.84 8.89 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.603 2.869 . . . . 0.0 112.777 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -105.39 107.81 19.0 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.8 mt -117.86 22.32 12.36 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 126.146 1.778 . . . . 0.0 110.675 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 m -57.46 16.05 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.51 2.324 . . . . 0.0 116.549 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.6 0.89 2.08 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.889 1.276 . . . . 0.0 112.309 172.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 94.9 t -75.85 134.56 28.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.9 mmm-85 -121.97 144.46 48.87 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 104.972 -2.232 . . . . 0.0 104.972 168.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -150.84 169.73 20.99 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.861 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -125.37 166.31 18.15 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 105.457 -3.057 . . . . 0.0 105.457 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.81 135.84 22.46 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.831 1.315 . . . . 0.0 111.111 -169.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.1 mm -124.24 130.51 73.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -104.9 135.97 12.85 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 107.691 -2.163 . . . . 0.0 107.691 169.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.2 mt -130.01 152.92 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 161.17 175.66 32.44 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 71.0 m -78.39 91.69 4.5 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 169.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -28.87 62.05 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.472 0.709 . . . . 0.0 112.872 -169.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -73.68 -9.9 59.14 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.49 169.01 11.65 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.161 0.891 . . . . 0.0 110.173 172.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -58.48 -34.52 70.97 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.424 0.69 . . . . 0.0 112.782 -173.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.9 m -101.13 107.85 19.38 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -64.99 153.65 40.03 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 35.1 m -41.38 106.82 0.06 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.511 2.324 . . . . 0.0 110.434 177.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.81 3.3 0.02 OUTLIER Glycine 0 CA--C 1.523 0.569 0 CA-C-O 117.938 -1.479 . . . . 0.0 115.659 -170.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.22 -18.44 63.52 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.807 2.304 . . . . 0.0 112.591 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 102' ' ' ILE . 2.1 tp -52.98 -33.34 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 126.075 1.75 . . . . 0.0 110.391 170.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -51.4 -39.18 56.7 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.497 1.119 . . . . 0.0 112.855 -172.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -66.44 -36.5 82.95 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.787 -0.571 . . . . 0.0 111.446 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.2 mt -71.89 -52.07 19.1 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -67.08 -35.81 80.62 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.991 -171.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.32 -38.54 90.47 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -73.25 -30.94 63.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.914 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.05 -46.69 86.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.314 1.415 . . . . 0.0 109.203 169.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -63.37 -41.06 98.79 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 122.417 0.287 . . . . 0.0 110.387 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -63.04 -39.54 95.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.581 0.752 . . . . 0.0 110.524 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.7 m -70.68 -7.11 42.15 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.469 1.108 . . . . 0.0 112.908 174.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.03 -16.9 8.71 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.728 1.156 . . . . 0.0 113.921 169.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.22 172.75 1.35 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.517 1.159 . . . . 0.0 111.277 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -140.87 136.16 32.06 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.499 -0.751 . . . . 0.0 110.904 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -62.43 170.46 2.39 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.973 1.309 . . . . 0.0 109.295 170.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 m -133.67 149.71 51.55 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.419 ' H ' HD12 ' A' ' 145' ' ' LEU . . . 61.87 -136.44 46.37 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.09 157.71 45.79 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 171.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.98 135.76 57.47 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.959 0.904 . . . . 0.0 110.183 -177.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.4 tp -94.08 148.7 21.92 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -123.55 144.41 49.59 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 57.0 mt -136.95 108.82 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -68.03 143.2 55.64 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 169.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.24 9.25 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.024 0.93 . . . . 0.0 112.54 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp -61.19 -39.65 90.98 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 121.473 -0.767 . . . . 0.0 111.318 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -149.13 35.78 0.75 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.557 1.143 . . . . 0.0 109.688 -175.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -153.77 151.76 29.95 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.785 1.634 . . . . 0.0 107.581 -172.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -154.5 42.19 0.49 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.402 1.081 . . . . 0.0 110.298 -172.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.0 pt 39.25 49.88 2.56 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 126.895 2.078 . . . . 0.0 115.22 -175.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -61.86 136.1 59.7 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.783 1.656 . . . . 0.0 109.342 174.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 59.4 18.82 7.14 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.375 1.47 . . . . 0.0 112.76 -173.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.6 t0 38.21 67.6 2.07 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 127.891 2.476 . . . . 0.0 114.771 173.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.92 -18.1 56.83 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.93 2.42 . . . . 0.0 112.939 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.25 -20.72 60.15 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.429 0.692 . . . . 0.0 111.958 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -54.76 -35.34 63.67 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.011 0.924 . . . . 0.0 111.515 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -65.21 -43.45 91.51 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.679 -0.638 . . . . 0.0 110.188 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -74.28 -35.42 63.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.763 0.825 . . . . 0.0 110.344 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.4 tp -61.94 -36.24 80.81 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.973 0.909 . . . . 0.0 110.742 173.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.76 -47.74 58.01 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.471 1.034 . . . . 0.0 111.102 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 m -61.82 -42.23 98.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.665 0.732 . . . . 0.0 110.778 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -60.44 -49.92 75.65 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.511 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.7 m -65.36 -34.79 72.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 119.866 1.212 . . . . 0.0 110.867 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.79 -22.4 66.98 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.426 0.69 . . . . 0.0 111.679 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.419 HD12 ' H ' ' A' ' 118' ' ' GLY . 7.2 mt -90.67 -57.98 2.64 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.599 1.09 . . . . 0.0 110.141 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.08 -25.79 65.51 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 117.567 -1.206 . . . . 0.0 113.815 -169.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm . . . . . 0 C--O 1.251 1.181 0 C-N-CA 128.046 2.538 . . . . 0.0 113.27 175.249 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.88 152.73 42.24 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.979 -0.451 . . . . 0.0 110.37 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -133.38 -25.58 1.72 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.818 1.247 . . . . 0.0 111.028 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.0 mt -121.37 74.92 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 170.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.1 m -75.35 120.98 21.55 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.8 mt -94.85 151.06 19.55 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 80.3 mt -125.76 84.13 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -169.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.9 m -74.94 151.23 38.89 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.656 0.782 . . . . 0.0 110.35 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.81 118.16 0.8 Allowed Glycine 0 C--N 1.333 0.394 0 N-CA-C 107.576 -2.209 . . . . 0.0 107.576 170.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.3 t -148.54 149.11 31.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.006 0.908 . . . . 0.0 111.641 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 p -73.54 -30.23 62.94 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.036 1.735 . . . . 0.0 110.938 169.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 pp -122.95 -25.74 4.53 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -169.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.91 1.92 10.45 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.238 1.399 . . . . 0.0 112.917 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.34 -40.77 99.09 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 118.867 1.333 . . . . 0.0 111.039 -172.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.6 -22.96 64.42 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 117.315 0.557 . . . . 0.0 111.571 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -75.31 -43.8 48.9 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -68.7 -41.8 78.65 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 122.862 0.465 . . . . 0.0 109.748 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.24 -48.84 85.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.244 0.618 . . . . 0.0 109.433 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.17 89.48 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 118.902 0.773 . . . . 0.0 110.667 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.0 -43.0 93.97 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.455 1.025 . . . . 0.0 111.119 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -61.86 -45.11 95.18 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.834 -0.541 . . . . 0.0 110.481 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.5 mt -65.45 -42.21 92.61 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.256 0.622 . . . . 0.0 110.153 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.1 83.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.023 0.929 . . . . 0.0 110.966 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -58.68 -46.8 86.43 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.882 0.765 . . . . 0.0 110.496 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -68.21 -37.46 80.91 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.567 -0.708 . . . . 0.0 110.835 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.3 mt -61.41 -42.04 98.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.279 0.945 . . . . 0.0 111.369 175.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.7 -38.96 84.35 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.642 0.655 . . . . 0.0 110.327 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -64.55 -36.04 82.92 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.46 0.573 . . . . 0.0 110.904 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.01 -23.71 64.13 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.54 0.736 . . . . 0.0 111.973 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.56 -0.77 12.46 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.968 1.271 . . . . 0.0 113.764 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -77.05 174.7 10.35 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.635 1.217 . . . . 0.0 110.61 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.8 p -120.88 140.0 52.41 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 p -136.49 168.98 18.45 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.254 1.022 . . . . 0.0 110.229 -169.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -153.13 155.59 37.03 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 169.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.0 p -119.55 71.55 0.88 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -172.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.3 mt -76.07 118.9 19.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -171.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -91.89 95.48 9.85 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.97 49.47 6.38 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.016 -1.436 . . . . 0.0 115.22 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -68.43 176.27 5.92 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 CA-C-N 120.686 2.243 . . . . 0.0 110.989 169.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.5 mt -130.8 168.4 17.3 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.381 1.472 . . . . 0.0 110.027 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.5 tp -56.06 -27.36 53.1 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.906 1.683 . . . . 0.0 111.881 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -64.18 -12.37 39.62 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.547 1.139 . . . . 0.0 112.593 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -137.09 20.52 3.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.933 1.293 . . . . 0.0 111.377 -173.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.2 mt -135.03 102.81 10.88 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.648 1.179 . . . . 0.0 108.319 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -73.32 169.85 21.3 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.932 2.422 . . . . 0.0 112.21 -176.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.48 8.98 2.42 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.807 1.643 . . . . 0.0 114.767 -171.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -153.15 141.18 20.31 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.929 0.786 . . . . 0.0 109.27 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.14 -178.66 24.63 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -123.3 99.5 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -94.69 176.22 6.36 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.464 0.706 . . . . 0.0 110.155 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.9 tp -140.98 98.67 3.43 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -79.64 129.0 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 mt -127.54 146.21 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.9 m -145.48 141.92 28.77 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.718 -0.614 . . . . 0.0 110.016 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.7 m -91.08 95.11 9.92 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.2 m -70.6 83.2 0.61 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 171.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -79.12 44.23 0.56 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.123 1.769 . . . . 0.0 111.442 -174.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.2 -30.05 2.15 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.33 1.443 . . . . 0.0 114.278 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.61 -21.75 64.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.395 1.078 . . . . 0.0 113.678 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.86 20.37 77.98 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -170.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -130.77 155.46 46.62 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.734 1.614 . . . . 0.0 107.083 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.37 150.07 39.43 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.227 1.411 . . . . 0.0 107.965 -169.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -53.6 139.25 66.99 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.276 2.651 . . . . 0.0 112.321 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -58.35 -23.12 55.84 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.976 1.311 . . . . 0.0 113.71 -171.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -75.21 -21.48 58.63 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.563 -0.732 . . . . 0.0 112.502 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.6 tp -126.84 -23.89 3.6 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.007 0.923 . . . . 0.0 111.902 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 91.9 p -53.72 -29.65 5.02 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-O 117.038 -1.458 . . . . 0.0 114.138 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.34 -23.34 18.2 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.639 2.226 . . . . 0.0 114.958 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -64.52 -39.96 94.74 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 120.104 1.32 . . . . 0.0 110.815 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -60.72 -41.87 96.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.105 0.562 . . . . 0.0 110.085 175.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -66.23 -47.89 72.34 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.076 0.55 . . . . 0.0 110.299 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.85 -41.28 95.83 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 121.794 -0.566 . . . . 0.0 111.362 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.7 mt -62.72 -50.82 69.61 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.888 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -70.3 -29.19 65.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.023 0.829 . . . . 0.0 111.642 -176.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.09 -50.46 47.97 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.768 0.713 . . . . 0.0 109.866 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -84.19 -23.01 30.73 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.349 -173.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.5 tttt 38.45 61.43 4.74 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 126.085 1.754 . . . . 0.0 110.806 -169.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -66.5 169.27 14.5 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.109 2.539 . . . . 0.0 111.363 -174.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -96.69 104.21 16.18 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 169.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.0 mt -118.83 26.6 9.43 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 126.414 1.886 . . . . 0.0 109.818 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.8 m -60.1 15.62 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.815 2.046 . . . . 0.0 116.048 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.85 6.09 1.58 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.039 1.336 . . . . 0.0 111.762 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.1 t -77.58 140.31 17.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -122.67 157.2 32.76 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 168.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -154.16 176.28 12.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.739 0.699 . . . . 0.0 111.77 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.55 162.76 22.17 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 105.593 -3.003 . . . . 0.0 105.593 169.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.68 126.63 19.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -169.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.7 mt -136.04 126.2 41.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -174.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -100.69 152.25 19.08 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.6 mt -134.8 137.98 50.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 175.99 -152.05 12.47 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.6 m -128.19 127.19 42.46 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.381 1.073 . . . . 0.0 109.095 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -67.58 -6.57 20.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.631 0.772 . . . . 0.0 112.09 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.35 -33.12 63.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.094 1.358 . . . . 0.0 111.592 172.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -116.36 155.96 27.56 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.448 1.099 . . . . 0.0 110.805 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.64 -34.46 77.88 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.638 0.775 . . . . 0.0 111.661 -174.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.06 38.07 0.1 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.472 1.909 . . . . 0.0 111.011 175.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -49.06 -49.35 41.85 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.721 1.608 . . . . 0.0 111.2 -172.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 67.0 m -152.29 135.25 15.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.55 -27.9 0.09 OUTLIER Glycine 0 CA--C 1.522 0.487 0 CA-C-O 118.946 -0.919 . . . . 0.0 114.595 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.19 -18.38 65.31 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.491 1.645 . . . . 0.0 112.099 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.33 -34.2 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.781 1.232 . . . . 0.0 109.579 170.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.21 -32.42 68.28 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 123.777 0.831 . . . . 0.0 111.989 -175.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -62.01 -45.41 93.71 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.512 0.596 . . . . 0.0 110.473 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.29 -53.15 61.11 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -72.22 -31.89 66.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.64 -170.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.16 -44.2 92.12 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.99 0.814 . . . . 0.0 109.858 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -74.64 -28.11 60.72 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.199 -0.905 . . . . 0.0 112.281 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.6 -45.01 92.32 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.493 1.497 . . . . 0.0 109.374 169.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -66.27 -39.77 89.66 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 122.182 -0.324 . . . . 0.0 110.473 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -61.05 -40.17 92.62 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.056 0.542 . . . . 0.0 110.511 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.5 m -69.57 -14.27 62.76 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.946 0.898 . . . . 0.0 112.878 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.58 -13.04 6.94 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.048 1.309 . . . . 0.0 113.872 169.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.87 172.6 2.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.579 1.19 . . . . 0.0 111.858 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -145.54 144.1 30.33 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.389 -0.819 . . . . 0.0 111.558 169.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 38.2 tp60 -58.26 154.44 13.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.893 1.677 . . . . 0.0 109.491 172.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.4 m -139.42 134.01 31.8 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.02 176.34 37.71 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -172.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -76.26 164.27 26.22 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.022 -0.693 . . . . 0.0 109.488 172.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.2 164.12 23.38 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 169.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.0 tp -129.84 147.61 51.63 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.246 -0.909 . . . . 0.0 109.704 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.97 142.13 47.69 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 176.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 43.3 mt -138.79 110.87 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -82.88 131.2 35.2 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 123.247 0.619 . . . . 0.0 109.696 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -127.75 14.45 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 125.028 1.331 . . . . 0.0 111.852 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 68.0 tp -53.41 -46.42 69.74 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.387 1.075 . . . . 0.0 111.449 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -165.7 -52.71 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 125.828 1.651 . . . . 0.0 107.673 176.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.44 101.96 4.3 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -71.97 71.3 0.8 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.345 1.858 . . . . 0.0 109.941 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.293 17.8 tt 24.11 74.12 0.29 Allowed Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 129.395 3.078 . . . . 0.0 114.156 -173.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.79 -21.79 16.05 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.381 3.387 . . . . 0.0 116.111 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.56 -22.45 65.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.186 0.994 . . . . 0.0 111.826 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.8 t0 41.72 58.17 9.64 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 127.436 2.294 . . . . 0.0 113.315 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.09 -13.26 36.03 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.948 2.432 . . . . 0.0 113.287 -174.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.22 -34.56 64.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.884 0.874 . . . . 0.0 112.135 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -60.31 -49.14 78.78 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.428 0.691 . . . . 0.0 110.922 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -79.85 -36.63 36.46 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.787 0.835 . . . . 0.0 110.121 -174.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 86.2 t90 -58.98 -48.45 81.52 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 28.7 tp -67.51 -39.74 85.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 119.057 -0.497 . . . . 0.0 110.6 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.9 -44.73 92.34 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -65.43 -40.54 93.43 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.133 0.573 . . . . 0.0 110.629 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -63.96 -49.78 71.21 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.797 -0.621 . . . . 0.0 110.231 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.06 -34.6 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 119.297 0.953 . . . . 0.0 110.895 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -61.63 -31.62 71.73 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-O 118.848 -0.596 . . . . 0.0 111.8 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.3 mt -86.27 -46.68 10.11 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.219 0.918 . . . . 0.0 111.296 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.05 -24.35 61.52 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.945 0.793 . . . . 0.0 112.404 -172.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.9 mttp . . . . . 0 C--O 1.247 0.926 0 C-N-CA 127.572 2.349 . . . . 0.0 111.652 -179.115 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.41 159.57 29.2 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.931 0.493 . . . . 0.0 110.584 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -135.98 -25.11 1.25 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.418 1.087 . . . . 0.0 111.453 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.0 mt -130.27 82.74 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 169.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.6 m -75.95 116.9 17.11 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.85 151.88 40.38 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.3 mt -122.31 100.08 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 m -93.73 123.73 37.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.176 0.99 . . . . 0.0 110.121 -172.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.68 60.28 0.62 Allowed Glycine 0 C--N 1.331 0.254 0 N-CA-C 105.972 -2.851 . . . . 0.0 105.972 170.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.1 m -115.09 134.7 54.94 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.576 1.15 . . . . 0.0 111.589 -167.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.5 p -139.06 -31.06 0.72 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.272 1.429 . . . . 0.0 111.786 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.69 -4.73 13.01 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.218 1.407 . . . . 0.0 113.708 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.52 -48.01 3.75 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.387 0.994 . . . . 0.0 110.877 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.19 -44.93 96.07 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 118.168 0.984 . . . . 0.0 110.807 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.88 -28.17 68.76 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 117.433 0.617 . . . . 0.0 111.174 177.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.39 -39.96 58.51 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -65.31 -40.06 93.29 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.3 t -57.32 -51.29 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.134 0.974 . . . . 0.0 109.639 173.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.54 -43.56 98.64 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.961 0.801 . . . . 0.0 111.088 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.73 -45.51 86.17 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.914 0.486 . . . . 0.0 110.735 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -59.8 -48.27 82.36 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.297 1.039 . . . . 0.0 110.221 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.1 mt -59.88 -46.05 90.54 Favored 'General case' 0 N--CA 1.458 -0.054 0 C-N-CA 123.369 0.667 . . . . 0.0 110.242 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.87 -50.64 73.23 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.293 0.497 . . . . 0.0 110.339 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -58.87 -47.63 84.25 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.129 0.571 . . . . 0.0 110.483 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -66.01 -38.32 88.18 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.132 -177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.6 mt -65.78 -39.93 91.46 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 119.63 1.105 . . . . 0.0 110.791 175.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.96 -40.1 95.65 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.916 0.78 . . . . 0.0 110.128 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -65.66 -37.73 87.36 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.406 0.548 . . . . 0.0 111.156 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.92 -22.4 64.16 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.708 0.803 . . . . 0.0 112.136 176.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.14 25.72 3.46 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.636 -1.091 . . . . 0.0 113.821 170.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -127.72 127.73 44.16 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.152 1.476 . . . . 0.0 108.451 -177.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 p -72.68 149.83 43.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 109.835 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.8 p -133.72 170.21 15.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.688 0.756 . . . . 0.0 110.356 -172.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -151.66 162.17 41.45 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 169.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.5 83.04 2.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -177.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.2 mt -71.19 109.99 5.57 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -78.77 108.86 12.51 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.67 50.77 60.98 Favored Glycine 0 CA--C 1.54 1.612 0 CA-C-O 118.159 -1.356 . . . . 0.0 115.367 171.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -67.86 175.57 6.22 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.706 2.271 . . . . 0.0 111.183 173.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.9 mt -123.43 157.01 34.4 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.192 1.397 . . . . 0.0 108.219 170.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.81 -30.47 71.56 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.797 0.839 . . . . 0.0 111.768 -174.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.49 -8.51 14.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.783 0.833 . . . . 0.0 112.897 176.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -118.13 18.28 13.86 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.543 1.537 . . . . 0.0 110.832 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.4 mt -127.06 142.11 42.71 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.751 1.22 . . . . 0.0 109.205 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.05 162.47 41.71 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.539 2.159 . . . . 0.0 109.823 169.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.7 21.33 0.67 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.383 1.073 . . . . 0.0 112.557 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.6 p -156.79 149.76 23.87 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.787 1.235 . . . . 0.0 109.043 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.31 179.28 22.37 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.5 mt -117.62 103.32 14.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -104.82 170.81 7.66 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.043 0.937 . . . . 0.0 109.58 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.4 tp -148.58 106.52 3.71 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.8 t -87.88 137.07 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -173.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.04 126.67 56.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.3 m -135.08 120.37 18.99 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.781 0.432 . . . . 0.0 110.401 -172.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 m -71.94 -172.81 0.91 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 168.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -127.84 141.4 51.57 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -77.16 11.87 1.68 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.608 1.563 . . . . 0.0 111.889 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.05 23.34 76.1 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 120.934 -1.104 . . . . 0.0 111.378 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.2 8.54 2.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.206 1.402 . . . . 0.0 112.151 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.421 ' H ' HG23 ' A' ' 97' ' ' THR . . . 73.59 34.58 56.73 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 119.25 0.932 . . . . 0.0 111.114 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -145.92 152.73 39.9 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.774 1.63 . . . . 0.0 107.802 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 62' ' ' ILE . 4.2 mp -65.9 148.05 98.48 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -52.97 149.67 25.85 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.686 2.924 . . . . 0.0 113.298 169.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -57.21 -16.63 8.6 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.864 1.666 . . . . 0.0 113.663 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -61.99 -39.15 91.2 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.731 0.812 . . . . 0.0 110.8 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.2 tp -126.28 -22.27 4.07 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.5 0.72 . . . . 0.0 112.301 -171.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.9 p -54.37 -31.1 7.92 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-O 117.03 -1.462 . . . . 0.0 114.819 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -52.25 -22.71 16.15 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.147 2.565 . . . . 0.0 115.188 169.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -56.26 -35.64 67.67 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.029 0.932 . . . . 0.0 111.066 175.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -64.06 -40.59 96.6 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 122.991 0.517 . . . . 0.0 110.878 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.75 -46.44 58.46 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.02 -29.41 70.32 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.141 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.67 -63.74 1.09 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 170.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -67.85 -22.61 65.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.682 0.674 . . . . 0.0 112.624 -170.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -70.98 -32.95 69.94 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.602 0.761 . . . . 0.0 111.502 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -114.43 -33.98 5.41 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp 28.05 64.72 0.65 Allowed Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 127.83 2.452 . . . . 0.0 113.086 -169.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -60.57 173.38 2.14 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.695 2.263 . . . . 0.0 111.954 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -75.84 62.59 1.57 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.174 1.39 . . . . 0.0 110.561 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 70.8 mt -73.27 8.33 1.76 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.358 1.463 . . . . 0.0 112.786 -177.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.9 m -45.76 10.31 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.751 1 C-N-CA 132.055 4.142 . . . . 0.0 117.649 170.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.36 3.03 1.71 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.2 1.4 . . . . 0.0 112.172 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.2 t -78.71 137.3 22.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 169.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -119.19 141.5 48.82 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 168.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -148.86 172.46 14.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.111 0.414 . . . . 0.0 111.094 -174.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.67 163.53 24.11 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 105.761 -2.936 . . . . 0.0 105.761 169.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.19 130.37 19.65 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.306 1.053 . . . . 0.0 109.662 -169.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 23.1 mt -134.1 130.92 55.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -118.14 139.65 14.84 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.2 mp -131.44 118.37 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 176.7 -158.37 24.37 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 105.906 -2.878 . . . . 0.0 105.906 -172.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.6 m -96.82 170.14 9.37 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.187 0.995 . . . . 0.0 110.765 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -119.7 -19.76 7.92 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.203 1.001 . . . . 0.0 109.866 169.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -111.57 5.98 19.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.934 2.494 . . . . 0.0 111.089 -169.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -141.58 165.04 28.59 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.186 1.794 . . . . 0.0 109.04 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -59.28 -35.35 73.58 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.827 1.651 . . . . 0.0 113.503 -169.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 60' ' ' GLY . 53.2 m -74.73 76.55 2.07 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.881 0.848 . . . . 0.0 109.2 170.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -61.61 134.81 57.25 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 173.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 3.5 p -55.81 -21.55 20.05 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.575 1.55 . . . . 0.0 112.976 174.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.51 3.81 3.31 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.07 -1.406 . . . . 0.0 115.087 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.09 -22.85 6.67 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 120.323 2.062 . . . . 0.0 113.867 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.9 tp -54.26 -31.41 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.599 1.56 . . . . 0.0 110.969 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -50.91 -35.28 32.26 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.732 1.213 . . . . 0.0 112.962 -170.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -54.27 -51.47 64.47 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.46 0.573 . . . . 0.0 111.353 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.3 mt -68.7 -50.89 47.26 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -172.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -67.58 -35.74 79.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.901 -173.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.84 -41.66 78.22 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.38 -24.97 62.17 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 117.509 -1.234 . . . . 0.0 112.424 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.6 mt -65.86 -52.38 50.82 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.978 1.717 . . . . 0.0 108.951 169.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -68.21 -33.89 75.25 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 122.076 -0.39 . . . . 0.0 110.883 -173.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -76.13 6.55 5.2 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.875 1.27 . . . . 0.0 112.644 172.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.4 m -120.59 15.41 11.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.299 1.44 . . . . 0.0 110.328 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.75 -22.96 27.11 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.623 1.106 . . . . 0.0 113.557 169.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.83 167.92 1.41 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.587 1.194 . . . . 0.0 110.66 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -137.17 136.48 38.25 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 121.461 -0.775 . . . . 0.0 111.351 171.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -60.29 164.58 4.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.056 -1.429 . . . . 0.0 109.525 171.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 m -136.49 157.84 45.85 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 126.371 1.868 . . . . 0.0 106.036 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.434 ' H ' HD12 ' A' ' 145' ' ' LEU . . . 55.7 -128.74 45.65 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 -173.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -144.62 165.81 26.97 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.706 1.203 . . . . 0.0 107.956 169.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.75 154.42 29.71 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.041 0.937 . . . . 0.0 110.438 -178.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 57.0 tp -129.67 143.54 50.87 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.858 0.863 . . . . 0.0 109.576 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -118.15 143.09 46.77 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.4 mt -132.31 100.38 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -69.62 142.01 53.58 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.486 0.714 . . . . 0.0 111.161 -171.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 8.4 pt -105.79 -21.04 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.178 0.991 . . . . 0.0 111.858 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.03 -35.95 81.02 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.559 0.744 . . . . 0.0 109.801 -172.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -146.66 151.89 37.98 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.429 1.491 . . . . 0.0 109.082 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 64.78 -36.89 0.21 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 129.678 3.191 . . . . 0.0 115.568 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.9 t70 64.98 -44.08 0.33 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 129.068 2.947 . . . . 0.0 115.088 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.264 11.7 tt 25.13 64.46 0.45 Allowed Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 130.098 3.359 . . . . 0.0 115.558 169.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -79.42 15.5 1.57 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 123.488 2.792 . . . . 0.0 114.407 -169.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -136.49 -58.36 0.74 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.126 1.33 . . . . 0.0 112.301 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.63 -48.6 92.87 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -169.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.04 -39.12 83.22 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 121.864 1.709 . . . . 0.0 112.013 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.93 -39.77 90.8 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.885 -0.579 . . . . 0.0 110.348 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -65.23 -44.14 89.17 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.039 0.836 . . . . 0.0 110.304 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -62.84 -47.55 82.91 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.126 -0.359 . . . . 0.0 110.266 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -68.69 -33.75 74.5 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.536 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.9 tt -58.74 -40.97 85.37 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.193 0.906 . . . . 0.0 110.184 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.6 -48.25 66.42 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 173.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.4 m -63.96 -41.19 97.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.401 0.601 . . . . 0.0 111.11 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -62.57 -52.51 63.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 117.739 -1.124 . . . . 0.0 110.492 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.7 m -64.71 -34.03 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 120.258 1.39 . . . . 0.0 110.685 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -59.49 -32.77 70.57 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.061 0.846 . . . . 0.0 112.118 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.434 HD12 ' H ' ' A' ' 118' ' ' GLY . 25.9 mt -94.75 -35.85 11.95 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.512 -0.756 . . . . 0.0 112.55 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.7 pp -90.99 -17.3 26.54 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 117.36 -1.305 . . . . 0.0 113.459 -173.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt . . . . . 0 C--O 1.251 1.167 0 CA-C-N 119.572 1.078 . . . . 0.0 112.104 -172.529 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.49 157.17 43.71 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.999 1.32 . . . . 0.0 108.069 171.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -140.98 -25.17 0.74 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.435 1.094 . . . . 0.0 111.482 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.7 mt -132.89 83.65 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 173.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.6 m -78.38 116.02 18.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.72 154.25 36.54 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.632 0.773 . . . . 0.0 109.598 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.3 mt -126.49 97.87 4.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.7 m -78.75 156.98 28.6 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.761 0.824 . . . . 0.0 110.097 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.68 89.83 0.09 OUTLIER Glycine 0 C--N 1.333 0.411 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.7 p -153.89 128.15 9.1 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 117.462 0.631 . . . . 0.0 110.584 172.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.25 -32.06 72.84 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 168.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.5 mt -69.55 -14.15 62.7 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.309 1.444 . . . . 0.0 112.915 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.65 14.9 75.38 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-N 118.989 0.813 . . . . 0.0 113.537 -175.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.7 -38.48 8.1 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 118.657 1.229 . . . . 0.0 111.497 -175.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.46 90.3 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.213 1.006 . . . . 0.0 110.229 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.46 -32.44 64.35 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.095 0.407 . . . . 0.0 111.912 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -65.01 -44.9 87.71 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.9 t -60.69 -46.43 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.1 -39.84 79.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.568 0.622 . . . . 0.0 111.344 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.17 -42.8 99.21 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.62 0.645 . . . . 0.0 110.837 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -71.64 -41.96 68.18 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.903 -0.498 . . . . 0.0 110.972 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.86 -44.44 97.02 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.07 -44.31 96.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.432 0.693 . . . . 0.0 110.469 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -58.0 -44.56 87.29 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.458 0.572 . . . . 0.0 110.388 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -62.73 -40.86 98.51 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.762 -0.587 . . . . 0.0 111.285 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 66.3 mt -63.9 -41.34 97.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.943 0.792 . . . . 0.0 111.142 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.24 -40.12 90.02 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.576 0.625 . . . . 0.0 110.378 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.88 -36.0 82.93 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.048 0.539 . . . . 0.0 110.805 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.62 -21.63 63.55 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.379 0.671 . . . . 0.0 112.248 174.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.52 -0.64 14.04 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.844 1.211 . . . . 0.0 113.825 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -79.2 178.94 7.69 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.424 1.112 . . . . 0.0 110.023 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.9 p -124.84 150.31 46.55 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.7 p -137.48 170.26 16.38 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.635 0.774 . . . . 0.0 109.729 -169.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -152.19 161.86 41.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 169.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.39 102.27 6.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.2 mt -80.08 153.57 28.67 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -128.76 102.47 6.57 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.42 52.83 49.33 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.487 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -66.39 174.45 6.2 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.028 2.485 . . . . 0.0 111.588 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.9 mt -129.26 163.47 25.59 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 125.249 1.42 . . . . 0.0 109.191 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.89 -30.4 58.04 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.75 1.22 . . . . 0.0 110.888 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -64.09 -11.18 27.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.314 1.446 . . . . 0.0 112.661 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -136.59 16.88 3.12 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.383 1.073 . . . . 0.0 110.907 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -135.62 101.03 10.95 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.124 1.37 . . . . 0.0 107.866 -169.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.32 164.59 34.8 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.737 2.292 . . . . 0.0 112.139 -171.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.58 7.29 1.94 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.574 1.55 . . . . 0.0 114.575 -173.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.9 m -149.61 139.33 21.75 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.8 178.08 27.06 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.5 mt -119.67 101.75 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 -176.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -114.76 167.69 10.55 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.205 1.002 . . . . 0.0 110.247 -171.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.4 tp -147.7 100.56 3.24 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 175.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.5 t -83.96 141.4 14.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.593 1.157 . . . . 0.0 109.685 -172.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.57 126.54 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.2 m -142.08 130.8 22.77 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.427 0.691 . . . . 0.0 110.656 -169.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.8 m -67.56 168.83 10.3 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.632 0.73 . . . . 0.0 111.358 169.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 97' ' ' THR . 87.2 m -141.27 135.03 30.24 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 129.02 2.928 . . . . 0.0 104.143 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -129.72 146.13 51.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 172.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 36.62 -97.27 0.01 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 127.088 2.28 . . . . 0.0 114.586 176.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.87 9.63 26.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.342 1.457 . . . . 0.0 113.455 -169.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.71 25.46 7.63 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 120.115 1.325 . . . . 0.0 110.837 -175.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.08 110.52 5.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.97 149.84 85.54 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.79 144.82 49.58 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.702 2.268 . . . . 0.0 110.02 -169.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -56.8 -21.01 25.62 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.036 1.334 . . . . 0.0 113.793 -175.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -69.02 -31.62 70.56 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.843 -0.535 . . . . 0.0 111.823 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.5 tp -123.83 -25.31 4.29 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.641 0.777 . . . . 0.0 112.323 -169.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 78.8 p -54.47 -30.82 7.42 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 117.027 -1.464 . . . . 0.0 114.542 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -52.68 -26.11 28.67 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.612 2.208 . . . . 0.0 114.814 169.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -62.21 -40.76 97.19 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.508 1.049 . . . . 0.0 110.238 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -63.74 -37.6 87.95 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.91 0.777 . . . . 0.0 110.354 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -68.65 -44.66 73.65 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.747 0.419 . . . . 0.0 110.377 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.85 -41.67 95.51 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.676 -0.64 . . . . 0.0 110.935 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.2 mt -61.33 -49.35 77.34 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 118.56 -0.734 . . . . 0.0 110.352 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -71.74 -28.55 63.74 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.259 0.936 . . . . 0.0 111.434 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.4 -43.54 77.01 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.562 0.619 . . . . 0.0 110.58 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -99.32 -35.0 10.09 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -169.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.0 ttpp 30.04 57.28 0.81 Allowed Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 127.39 2.276 . . . . 0.0 113.412 -169.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.31 174.76 10.31 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.263 1.975 . . . . 0.0 110.374 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 81' ' ' SER . 13.4 p-10 -76.9 69.64 3.24 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.519 1.528 . . . . 0.0 111.024 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.2 mt -74.13 19.08 0.13 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.843 1.657 . . . . 0.0 112.158 173.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 79' ' ' ASP . 3.1 m -53.18 12.2 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.713 1 C-N-CA 131.786 4.034 . . . . 0.0 116.639 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.14 4.37 0.94 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.176 1.391 . . . . 0.0 112.232 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 79.2 t -74.1 131.36 35.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 169.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 121.14 39.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 169.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -130.44 168.95 16.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.086 0.469 . . . . 0.0 110.56 -173.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -127.62 162.76 21.51 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 104.758 -3.337 . . . . 0.0 104.758 169.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.2 137.63 24.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.139 0.97 . . . . 0.0 110.072 -169.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.5 mt -134.72 127.67 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -175.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.43 146.23 16.42 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 171.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.1 mt -137.11 147.1 27.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.66 166.38 29.47 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 176.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.4 m -81.64 111.18 17.68 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 170.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -64.63 -2.29 2.34 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 -169.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -63.64 -41.83 98.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.771 0.829 . . . . 0.0 110.877 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -75.37 155.24 36.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.963 0.801 . . . . 0.0 110.8 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -55.65 -33.83 64.43 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.835 1.254 . . . . 0.0 114.16 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.402 ' O ' HG21 ' A' ' 56' ' ' THR . 0.3 OUTLIER -95.89 11.66 33.02 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.7 p90 22.44 -83.29 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 130.373 3.469 . . . . 0.0 114.885 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 60.6 m -140.37 38.06 1.89 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.517 1.927 . . . . 0.0 108.88 -173.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.68 -6.19 30.9 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 118.246 -1.308 . . . . 0.0 115.652 -169.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.06 -19.05 65.8 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.754 2.277 . . . . 0.0 113.236 -176.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.5 tp -54.87 -27.54 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.078 1.351 . . . . 0.0 110.51 171.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -52.19 -35.37 48.88 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.451 1.1 . . . . 0.0 112.817 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -66.89 -54.27 23.83 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 121.831 -0.543 . . . . 0.0 109.938 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.0 mt -61.56 -48.67 79.93 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.8 0.84 . . . . 0.0 109.456 -175.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.13 -37.87 86.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -173.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.22 -40.43 77.98 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -172.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -71.16 -31.06 67.22 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.584 -0.722 . . . . 0.0 111.504 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.9 mt -62.43 -48.15 80.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.911 1.232 . . . . 0.0 109.57 169.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -64.31 -38.83 92.43 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -65.92 -35.3 80.25 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.055 0.542 . . . . 0.0 111.339 175.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.1 m -71.73 -3.31 21.19 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.337 1.055 . . . . 0.0 112.846 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.72 -12.15 27.59 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.759 1.171 . . . . 0.0 113.201 170.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.59 171.89 1.82 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.441 1.121 . . . . 0.0 110.759 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -139.7 144.69 37.67 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.756 0.789 . . . . 0.0 110.591 169.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -78.75 171.05 15.72 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.167 171.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.46 153.03 41.05 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.916 1.287 . . . . 0.0 107.811 169.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.46 -130.73 37.76 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 172.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -136.91 162.26 33.76 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.3 1.44 . . . . 0.0 107.181 171.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.3 m -69.35 132.42 46.38 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.193 0.597 . . . . 0.0 109.476 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.4 tp -81.1 153.29 27.4 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -125.87 144.14 50.78 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 169.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 40.4 mt -132.63 101.74 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -67.58 138.37 56.39 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 171.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 18.5 pt -128.02 15.98 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 125.313 1.445 . . . . 0.0 111.73 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.05 -42.77 69.61 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.413 1.085 . . . . 0.0 111.631 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -147.13 -54.75 0.23 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.85 0.46 . . . . 0.0 111.255 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -70.64 148.86 47.62 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 171.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -71.27 -29.69 65.38 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.404 0.682 . . . . 0.0 112.269 -176.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 31.4 pt -143.48 155.41 60.66 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 127.055 2.142 . . . . 0.0 107.298 174.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -67.4 174.51 7.14 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.514 2.143 . . . . 0.0 111.273 174.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.85 11.98 0.12 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.203 1.801 . . . . 0.0 114.172 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -138.96 110.37 7.85 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 126.159 1.783 . . . . 0.0 107.039 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -71.73 157.95 54.33 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.597 2.198 . . . . 0.0 111.707 -171.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.95 -21.03 66.4 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -56.69 -40.55 75.79 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.074 0.95 . . . . 0.0 112.469 -169.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -73.74 -30.82 63.03 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.785 0.721 . . . . 0.0 111.075 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -73.57 -40.23 64.07 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.518 -0.739 . . . . 0.0 109.723 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.4 tp -61.8 -44.29 97.16 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.907 1.283 . . . . 0.0 109.988 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.06 -44.42 93.0 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.682 1.134 . . . . 0.0 111.126 173.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.1 m -62.7 -40.07 95.99 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 122.313 -0.522 . . . . 0.0 110.67 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -63.04 -48.77 77.3 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 117.968 -1.015 . . . . 0.0 111.786 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 28.1 m -65.74 -33.39 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 119.978 1.263 . . . . 0.0 110.949 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.83 -32.84 74.14 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.687 -0.673 . . . . 0.0 111.854 174.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 mt -80.27 -50.9 9.58 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.004 0.82 . . . . 0.0 111.016 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 pp -79.11 -16.45 56.68 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.901 0.773 . . . . 0.0 113.052 -173.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 60.1 mttm . . . . . 0 C--O 1.25 1.129 0 C-N-CA 127.808 2.443 . . . . 0.0 111.949 176.816 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.39 155.5 25.08 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 122.027 -0.42 . . . . 0.0 110.282 171.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -134.51 -26.84 1.39 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.393 1.077 . . . . 0.0 111.263 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.0 mt -128.9 81.39 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 171.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.7 m -77.46 110.69 12.45 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mp -74.78 155.89 37.13 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.7 mt -127.89 100.63 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 m -70.65 158.1 36.82 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.288 1.435 . . . . 0.0 110.88 177.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.41 59.37 0.23 Allowed Glycine 0 C--N 1.338 0.694 0 O-C-N 121.992 -0.443 . . . . 0.0 112.789 -170.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.4 p -128.4 169.56 14.13 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.17 1.388 . . . . 0.0 107.587 169.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.5 p -72.92 -45.66 56.87 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.779 0.832 . . . . 0.0 111.012 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 pp -144.25 -27.6 0.51 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.314 1.045 . . . . 0.0 113.023 -169.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.78 154.74 15.83 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 107.744 -2.142 . . . . 0.0 107.744 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.69 -85.31 0.26 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 107.404 -2.278 . . . . 0.0 107.404 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.15 -32.11 73.64 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 122.983 0.513 . . . . 0.0 111.066 175.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -66.04 -35.24 80.0 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.611 0.764 . . . . 0.0 110.572 176.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -70.64 -47.49 59.75 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -59.58 -40.95 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.31 -48.29 82.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.871 0.76 . . . . 0.0 110.599 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.96 -43.14 99.61 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.189 0.449 . . . . 0.0 110.765 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -66.8 -42.65 85.62 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.847 -0.533 . . . . 0.0 111.078 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.9 mt -65.68 -41.32 92.57 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.639 -0.663 . . . . 0.0 110.267 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.41 -41.04 93.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 119.005 -0.522 . . . . 0.0 110.761 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -55.9 -48.73 75.13 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.64 0.655 . . . . 0.0 110.128 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.18 -37.68 84.11 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 121.786 -0.571 . . . . 0.0 110.69 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.0 mt -62.68 -39.74 94.92 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.665 0.666 . . . . 0.0 111.426 175.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -66.85 -37.03 83.67 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.872 0.76 . . . . 0.0 110.534 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.84 -37.37 86.04 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.66 0.663 . . . . 0.0 110.877 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.02 -25.89 65.61 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.157 0.583 . . . . 0.0 111.661 173.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.88 -3.11 11.81 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.228 1.394 . . . . 0.0 113.88 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -79.85 143.56 34.23 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.863 1.331 . . . . 0.0 109.601 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 p -82.23 144.54 30.6 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 169.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.3 p -135.96 170.7 15.58 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.654 0.781 . . . . 0.0 110.116 -170.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -153.18 161.84 41.98 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 169.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 p -135.44 75.64 1.57 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -173.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.8 mt -66.29 115.87 6.71 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -171.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -76.88 95.34 4.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 53.26 62.69 5.75 Favored Glycine 0 CA--C 1.541 1.693 0 C-N-CA 123.894 0.759 . . . . 0.0 113.491 173.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -68.89 176.34 6.23 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.826 3.018 . . . . 0.0 111.848 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.4 mt -122.74 162.78 21.39 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.318 1.447 . . . . 0.0 107.603 169.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.7 tt -57.03 -35.93 69.87 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.733 0.813 . . . . 0.0 111.328 -176.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.23 -3.51 5.9 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.902 1.281 . . . . 0.0 113.21 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -130.47 16.54 5.43 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.908 1.283 . . . . 0.0 110.406 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -135.73 105.01 9.85 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.104 1.362 . . . . 0.0 108.826 -169.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.71 153.66 72.78 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.603 2.202 . . . . 0.0 112.388 -174.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.57 17.16 2.8 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.274 1.43 . . . . 0.0 113.347 -170.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.7 m -154.75 131.1 10.43 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 120.825 -1.172 . . . . 0.0 108.196 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.88 -173.92 26.9 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.9 mt -122.28 101.62 10.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -174.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -99.3 170.72 8.46 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.952 0.901 . . . . 0.0 109.844 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.3 tp -148.67 101.25 3.19 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 175.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.0 t -84.81 137.54 20.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 123.853 0.861 . . . . 0.0 108.725 -171.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.8 mt -133.73 115.94 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.1 m -130.47 127.7 39.74 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.216 0.606 . . . . 0.0 109.724 -169.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 m -76.85 165.8 24.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.135 0.493 . . . . 0.0 109.868 171.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 m -136.4 99.03 3.98 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.7 -34.05 77.3 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 157.9 155.64 7.62 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 171.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 46.24 32.44 1.49 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.632 1.973 . . . . 0.0 113.978 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.64 5.3 66.89 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.407 -0.663 . . . . 0.0 113.013 174.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.77 92.4 2.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.336 1.068 . . . . 0.0 110.115 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.0 mt -65.12 142.67 98.66 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 169.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.43 148.22 90.71 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.615 2.21 . . . . 0.0 111.497 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -57.91 -17.95 20.01 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.256 1.822 . . . . 0.0 113.785 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -62.06 -42.62 99.38 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.719 0.807 . . . . 0.0 110.401 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.5 tp -117.61 -26.07 6.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.592 0.757 . . . . 0.0 112.51 -169.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 100.0 p -55.92 -31.68 10.57 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 116.87 -1.538 . . . . 0.0 114.994 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -53.2 -25.09 28.56 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.537 2.158 . . . . 0.0 114.938 171.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -61.1 -38.34 85.95 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.262 0.937 . . . . 0.0 111.094 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -62.08 -40.98 97.68 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.679 0.792 . . . . 0.0 110.239 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.78 -46.82 62.19 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.955 0.502 . . . . 0.0 109.927 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.65 -31.34 72.31 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.765 -0.585 . . . . 0.0 112.124 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.4 mt -64.42 -59.98 3.7 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -68.1 -26.43 65.82 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.771 0.714 . . . . 0.0 112.291 -171.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -66.59 -33.85 76.58 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.299 0.64 . . . . 0.0 110.971 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -111.86 -30.48 7.28 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -169.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt 31.8 57.98 1.18 Allowed Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 126.976 2.111 . . . . 0.0 112.365 -169.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -71.37 170.78 17.55 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.367 2.045 . . . . 0.0 109.886 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -73.75 103.29 4.26 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.836 -0.54 . . . . 0.0 110.262 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.1 mt -114.34 23.13 13.09 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.639 1.576 . . . . 0.0 110.491 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.5 m -62.63 19.82 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.535 1.934 . . . . 0.0 115.696 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.18 2.57 1.5 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.321 1.448 . . . . 0.0 111.917 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.8 t -77.84 137.01 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 169.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -121.36 144.76 48.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 168.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -148.11 169.33 20.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.067 0.394 . . . . 0.0 110.186 -176.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.2 167.16 21.32 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 106.156 -2.778 . . . . 0.0 106.156 169.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.39 132.02 28.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.598 0.699 . . . . 0.0 109.79 -169.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.9 mt -132.29 130.76 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.13 146.57 18.83 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.1 mt -138.42 140.66 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -172.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 172.2 179.03 42.83 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.9 m -77.16 123.73 26.83 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 170.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.41 ' HA ' ' CG ' ' A' ' 98' ' ' PHE . 31.6 ptt-85 -58.94 -22.91 60.81 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -172.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -84.05 -4.42 58.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.439 0.696 . . . . 0.0 112.525 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.8 m-30 -63.51 162.03 13.47 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.453 1.024 . . . . 0.0 110.352 169.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -60.82 -27.45 68.06 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.653 0.781 . . . . 0.0 112.009 173.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.2 p -143.59 137.41 28.34 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 172.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.41 ' CG ' ' HA ' ' A' ' 93' ' ' ARG . 4.0 p90 -133.92 1.06 3.26 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.085 0.857 . . . . 0.0 112.556 173.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 7.0 p -159.8 -37.26 0.06 Allowed 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -54.26 -22.99 24.1 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.455 1.026 . . . . 0.0 113.882 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.16 -28.53 40.82 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.502 1.121 . . . . 0.0 113.161 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -30.31 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.796 0.838 . . . . 0.0 109.57 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -55.56 -31.22 61.97 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.4 1.08 . . . . 0.0 112.421 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -62.52 -49.63 74.58 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.783 0.72 . . . . 0.0 109.962 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.5 mt -64.67 -49.09 72.33 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -71.38 -32.62 68.68 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.907 -175.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.43 -44.58 92.88 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.431 1.014 . . . . 0.0 109.474 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -73.35 -27.56 61.57 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.603 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.0 mt -64.33 -46.36 83.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.479 1.49 . . . . 0.0 109.273 169.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -64.97 -39.95 94.26 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 117.855 0.298 . . . . 0.0 110.392 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -62.37 -37.92 87.59 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.546 0.738 . . . . 0.0 110.723 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.6 m -72.8 -12.35 60.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.244 1.018 . . . . 0.0 112.82 173.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 129.36 -17.7 5.56 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.988 1.28 . . . . 0.0 114.32 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.32 173.27 1.59 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.508 1.154 . . . . 0.0 111.958 -175.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -143.1 142.24 31.46 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.264 -0.898 . . . . 0.0 112.066 169.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -63.16 161.48 13.47 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.526 1.93 . . . . 0.0 109.962 176.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.8 m -143.03 149.28 38.03 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.909 1.684 . . . . 0.0 107.031 -176.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.57 -144.06 44.98 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -136.73 149.99 48.16 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 174.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.6 m -64.08 133.49 53.13 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.904 0.882 . . . . 0.0 110.149 -173.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.5 tp -98.92 152.24 19.98 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.69 138.94 39.9 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 29.0 mt -132.04 104.93 8.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 -170.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -67.57 134.54 51.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.17 172.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 6.3 pt -110.05 -8.61 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.78 0.832 . . . . 0.0 111.889 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.1 tp -79.35 83.71 5.35 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -151.91 -45.83 0.11 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.435 1.494 . . . . 0.0 108.186 170.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -160.28 -56.42 0.06 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 169.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -163.97 -141.54 0.06 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 102.607 -3.109 . . . . 0.0 102.607 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.1 pt -129.44 70.77 81.99 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.641 1.576 . . . . 0.0 108.063 169.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.58 -5.68 17.27 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.083 2.522 . . . . 0.0 112.376 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -143.73 159.19 42.94 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.665 2.386 . . . . 0.0 105.455 174.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -140.04 115.38 7.86 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.133 0.973 . . . . 0.0 110.089 -174.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.36 -4.59 14.36 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.353 2.702 . . . . 0.0 113.758 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.0 -21.25 58.65 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.045 1.293 . . . . 0.0 113.248 -172.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -55.84 -25.64 42.98 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.06 0.846 . . . . 0.0 113.036 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -74.12 -48.22 30.95 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.023 0.829 . . . . 0.0 109.456 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 6.4 t-105 -68.64 -27.54 66.09 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.213 1.005 . . . . 0.0 111.158 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.1 tp -56.07 -33.74 65.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.22 1.008 . . . . 0.0 111.073 171.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.15 -44.36 88.71 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 174.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.9 m -63.03 -43.2 99.36 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.319 0.56 . . . . 0.0 110.206 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -62.46 -49.61 74.74 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 118.112 -0.947 . . . . 0.0 111.832 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.03 -30.17 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 120.378 1.445 . . . . 0.0 111.405 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -70.03 -20.32 63.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.602 0.637 . . . . 0.0 111.213 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.36 -46.81 4.9 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.132 0.973 . . . . 0.0 110.21 -174.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 pp -75.87 -20.61 57.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.302 -0.856 . . . . 0.0 112.255 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.9 mttp . . . . . 0 C--O 1.25 1.117 0 C-N-CA 127.631 2.372 . . . . 0.0 112.119 179.569 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.44 158.75 23.01 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.08 0.855 . . . . 0.0 110.767 175.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -136.42 -26.43 1.11 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.933 1.293 . . . . 0.0 111.226 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.8 mt -125.67 79.49 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 170.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.1 m -74.37 117.65 16.42 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -84.26 154.83 22.76 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.6 mt -126.31 85.4 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -173.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -71.31 152.24 43.43 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.577 1.151 . . . . 0.0 110.173 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.45 104.26 0.24 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 t -147.45 168.11 22.72 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.837 0.827 . . . . 0.0 111.65 177.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p -139.85 -42.44 0.43 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 127.68 2.392 . . . . 0.0 107.141 170.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.47 -30.61 71.64 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 123.845 0.858 . . . . 0.0 112.101 172.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.96 34.45 3.74 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.486 1.041 . . . . 0.0 112.741 174.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.89 -43.87 2.02 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 118.026 0.913 . . . . 0.0 112.326 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.62 -26.26 66.16 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.707 1.254 . . . . 0.0 111.092 -176.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.38 -37.94 89.22 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.273 0.229 . . . . 0.0 110.863 176.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -76.11 -50.26 15.13 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 175.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.99 -47.21 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.402 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.06 98.23 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.029 0.831 . . . . 0.0 110.593 -177.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.63 -42.35 86.89 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.604 0.638 . . . . 0.0 110.64 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -63.36 -43.16 98.48 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.858 0.463 . . . . 0.0 110.628 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.93 -42.94 89.45 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.696 -0.628 . . . . 0.0 109.522 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.15 -37.18 76.66 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.525 0.73 . . . . 0.0 111.674 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -51.73 -47.08 64.18 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.65 0.659 . . . . 0.0 110.227 175.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.9 mmtt -68.36 -39.28 81.87 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.6 mt -65.65 -40.44 92.49 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.581 0.353 . . . . 0.0 110.258 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.27 -40.29 90.01 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.192 -0.432 . . . . 0.0 110.284 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.14 -36.44 84.27 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.703 0.683 . . . . 0.0 111.174 175.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.8 -22.96 65.15 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.475 0.71 . . . . 0.0 112.024 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.71 -0.1 19.98 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.922 1.249 . . . . 0.0 113.326 171.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -75.12 174.91 8.76 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.449 1.124 . . . . 0.0 109.907 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 p -122.47 145.72 48.04 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.2 p -132.52 166.29 22.41 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.662 0.785 . . . . 0.0 110.667 -169.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -152.49 159.4 43.34 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 169.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 p -127.99 80.19 1.94 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -171.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.3 mt -73.21 110.8 7.78 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -84.78 106.28 16.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.74 52.24 54.19 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 118.496 -1.169 . . . . 0.0 114.275 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.53 179.24 3.17 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.315 2.677 . . . . 0.0 111.029 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.4 mt -130.45 168.08 17.58 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.221 1.408 . . . . 0.0 108.528 172.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.78 -35.98 64.39 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.024 1.33 . . . . 0.0 111.697 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.75 -6.94 6.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.14 0.976 . . . . 0.0 113.444 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -129.45 19.07 5.79 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.661 1.584 . . . . 0.0 111.07 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.6 mt -135.75 112.04 10.56 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.803 1.241 . . . . 0.0 108.656 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.28 161.37 45.97 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.182 1.921 . . . . 0.0 111.223 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.69 13.28 1.71 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.185 1.394 . . . . 0.0 113.816 -172.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.4 m -146.92 130.2 16.59 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.487 1.115 . . . . 0.0 108.121 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.53 -176.63 29.86 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.18 99.29 5.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -100.57 173.99 6.29 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.27 1.028 . . . . 0.0 110.013 -173.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.2 tp -143.31 110.16 5.57 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.15 136.68 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.11 119.42 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 176.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.2 m -120.39 132.72 55.38 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.932 0.893 . . . . 0.0 108.894 -175.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.506 ' H ' ' HG3' ' A' ' 63' ' ' PRO . 15.4 m -87.59 50.94 2.09 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.73 0.812 . . . . 0.0 109.937 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -54.13 99.71 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.518 2.327 . . . . 0.0 110.636 -173.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -61.95 130.15 44.26 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.87 20.14 12.6 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.406 1.003 . . . . 0.0 113.843 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 49.97 34.26 7.82 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.105 1.362 . . . . 0.0 111.743 -169.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.58 -0.58 0.33 Allowed Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.518 -1.157 . . . . 0.0 115.132 -169.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -144.02 118.14 9.49 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 119.637 1.718 . . . . 0.0 108.744 171.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.5 mt -68.37 140.79 92.93 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.506 ' HG3' ' H ' ' A' ' 55' ' ' SER . 56.0 Cg_endo -64.17 139.02 64.38 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.975 1.783 . . . . 0.0 110.683 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.86 -19.72 52.84 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.07 1.348 . . . . 0.0 113.674 -173.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -70.88 -31.6 68.31 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.66 -0.65 . . . . 0.0 111.897 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.7 tp -118.14 -25.08 6.76 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.678 0.791 . . . . 0.0 111.753 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.6 t -44.98 -42.24 15.16 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 117.39 -1.29 . . . . 0.0 114.338 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.06 -25.71 13.26 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.81 3.007 . . . . 0.0 116.176 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -59.72 -35.81 75.28 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.19 0.904 . . . . 0.0 111.288 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -58.31 -40.67 82.67 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.225 0.61 . . . . 0.0 110.585 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -72.22 -47.65 48.89 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.912 0.485 . . . . 0.0 109.942 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.43 -35.92 82.49 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.562 0.619 . . . . 0.0 111.725 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.5 mt -66.02 -52.5 48.68 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.772 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -69.88 -25.56 63.76 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.544 1.066 . . . . 0.0 112.224 -174.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.27 -37.25 83.14 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.502 0.592 . . . . 0.0 110.349 177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -107.25 -28.78 9.71 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.626 0.972 . . . . 0.0 113.626 -169.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.9 mttm 32.27 57.82 1.29 Allowed Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 127.257 2.223 . . . . 0.0 112.556 -172.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.11 171.09 14.35 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.871 2.38 . . . . 0.0 110.66 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -77.23 110.37 11.87 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.576 -0.703 . . . . 0.0 109.357 170.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.5 mt -118.23 19.77 13.38 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.996 1.718 . . . . 0.0 110.951 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.8 m -58.74 11.21 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.857 2.063 . . . . 0.0 116.39 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.16 2.79 4.74 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.626 1.171 . . . . 0.0 111.445 173.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 80.5 t -81.76 140.21 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 169.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -119.51 146.82 45.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 168.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -140.98 171.65 13.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.918 0.866 . . . . 0.0 111.145 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.01 162.6 25.62 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 104.448 -3.461 . . . . 0.0 104.448 169.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.07 132.71 25.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.6 mt -134.17 137.82 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -110.29 152.88 17.25 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 170.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.3 mt -134.31 122.83 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 175.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.62 -155.98 15.2 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.241 -1.943 . . . . 0.0 108.241 -172.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.0 m -102.88 124.17 47.9 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 24.9 ttp180 -69.21 -14.93 63.24 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -69.34 -13.87 62.61 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.461 -0.774 . . . . 0.0 111.274 169.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 52.7 179.93 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 129.732 3.213 . . . . 0.0 115.547 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -156.33 -41.47 0.08 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.214 2.206 . . . . 0.0 107.527 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 92.4 m -122.15 170.53 9.78 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.753 2.421 . . . . 0.0 105.659 169.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -124.41 53.77 1.41 Allowed 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.327 -0.858 . . . . 0.0 111.338 -169.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 24.2 m 72.35 5.26 5.24 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.72 2.008 . . . . 0.0 114.75 169.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.66 -27.76 55.57 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 118.865 0.757 . . . . 0.0 112.446 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.71 -55.45 15.03 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.058 0.929 . . . . 0.0 111.686 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -33.28 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 119.251 0.932 . . . . 0.0 109.809 -178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -53.32 -29.59 34.58 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 119.005 -0.521 . . . . 0.0 112.341 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.57 -42.0 95.75 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.617 1.099 . . . . 0.0 111.541 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.41 -51.86 64.03 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -70.08 -35.5 74.23 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.921 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.2 -37.13 86.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.104 0.411 . . . . 0.0 110.846 -172.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -68.79 -34.71 76.0 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.383 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 44.2 mt -65.74 -41.63 91.97 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.258 1.39 . . . . 0.0 109.515 172.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -63.21 -44.63 94.78 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.315 1.046 . . . . 0.0 109.383 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -61.23 -42.26 98.29 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.003 0.921 . . . . 0.0 110.879 172.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.7 m -68.14 -7.0 26.1 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.226 1.01 . . . . 0.0 113.013 177.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.74 -15.15 14.34 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.058 1.313 . . . . 0.0 113.627 169.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.89 169.77 3.06 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.466 1.133 . . . . 0.0 110.776 176.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -142.76 154.01 43.83 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.422 -0.799 . . . . 0.0 111.228 171.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -70.43 155.75 40.27 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.927 171.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 72.8 m -125.95 153.21 44.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.379 1.872 . . . . 0.0 106.931 169.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.94 -144.54 49.05 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -175.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -135.71 152.51 51.24 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.497 1.119 . . . . 0.0 108.25 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.82 150.83 46.86 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.284 1.434 . . . . 0.0 110.427 -176.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.3 tp -130.0 144.97 51.62 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.391 1.076 . . . . 0.0 108.815 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.36 147.42 43.53 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 169.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.3 mt -124.35 106.5 16.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 -175.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -68.09 128.1 35.31 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.077 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -124.49 10.14 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.804 1.242 . . . . 0.0 111.68 174.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 53.2 tp -58.96 -37.46 76.84 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.051 0.54 . . . . 0.0 111.339 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -158.03 -42.34 0.06 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.528 0.731 . . . . 0.0 112.097 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -77.43 -8.55 57.91 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -170.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.6 t70 65.97 -19.02 0.1 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 128.232 2.613 . . . . 0.0 115.532 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.5 pt -141.83 166.83 19.23 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 127.997 2.519 . . . . 0.0 107.169 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -59.33 179.68 0.22 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.353 2.036 . . . . 0.0 111.672 169.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.48 -2.02 4.2 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.95 0.9 . . . . 0.0 113.254 173.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -147.04 129.93 7.94 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 126.786 2.034 . . . . 0.0 107.1 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.6 158.16 58.14 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.548 2.165 . . . . 0.0 112.306 -172.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.86 -17.73 64.85 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -174.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -56.61 -44.22 80.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.776 0.83 . . . . 0.0 111.868 -169.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -73.33 -35.04 65.97 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 122.02 -0.425 . . . . 0.0 110.748 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -69.27 -40.36 77.83 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.81 -0.556 . . . . 0.0 109.839 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 48.9 tp -65.13 -39.93 93.75 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.389 0.676 . . . . 0.0 110.194 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.8 -46.4 83.21 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 171.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.6 m -64.54 -34.11 77.48 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.647 0.779 . . . . 0.0 111.299 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -66.14 -53.65 35.11 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.519 0.727 . . . . 0.0 110.051 176.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.5 m -66.06 -25.89 36.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 118.989 0.813 . . . . 0.0 112.182 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -54.98 -25.38 29.46 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.438 0.695 . . . . 0.0 112.276 177.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 27.7 mt -101.56 0.21 36.05 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 pp -127.68 -11.96 5.49 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 120.362 1.437 . . . . 0.0 113.467 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.0 pttp . . . . . 0 C--O 1.249 1.029 0 C-N-CA 124.286 1.034 . . . . 0.0 111.105 177.526 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.73 156.37 30.68 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.033 0.533 . . . . 0.0 110.904 176.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -134.23 -26.66 1.46 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.123 1.369 . . . . 0.0 110.941 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.2 mt -124.64 79.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.6 m -74.51 114.38 12.85 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mp -76.6 148.39 37.01 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 170.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.5 mt -116.89 90.6 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -175.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.5 m -80.62 137.7 36.38 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.88 1.272 . . . . 0.0 111.262 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.95 76.62 0.36 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 125.148 1.356 . . . . 0.0 111.839 -170.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 p -146.18 145.25 30.39 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 169.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.28 -32.13 62.79 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.0 0.92 . . . . 0.0 111.967 -177.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 pp -132.5 -31.89 1.35 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.866 0.866 . . . . 0.0 112.577 -174.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.98 157.55 10.59 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 107.99 -2.044 . . . . 0.0 107.99 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 139.13 -73.43 0.41 Allowed Glycine 0 CA--C 1.518 0.26 0 N-CA-C 108.405 -1.878 . . . . 0.0 108.405 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.0 -35.09 79.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.803 176.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.18 -36.29 83.14 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.436 0.562 . . . . 0.0 110.315 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -73.67 -47.15 41.94 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.9 t -60.91 -43.3 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -46.39 90.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.019 0.528 . . . . 0.0 110.438 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.4 -44.26 96.87 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.623 0.647 . . . . 0.0 110.415 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -63.48 -35.63 81.09 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.743 0.417 . . . . 0.0 111.601 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.5 mt -74.21 -46.8 39.56 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.763 0.825 . . . . 0.0 109.904 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.13 -35.2 71.14 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.402 1.081 . . . . 0.0 111.623 -174.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -48.25 -44.07 32.97 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.161 0.985 . . . . 0.0 111.477 174.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -77.91 -32.85 51.93 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.502 -0.749 . . . . 0.0 109.984 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.0 mt -64.16 -39.25 93.62 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.554 0.616 . . . . 0.0 110.043 174.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -65.41 -41.63 93.39 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.291 0.496 . . . . 0.0 110.249 176.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -64.18 -35.91 82.33 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.552 0.615 . . . . 0.0 111.287 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.88 -22.54 65.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.555 0.742 . . . . 0.0 111.984 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.19 -0.73 16.77 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.913 1.244 . . . . 0.0 113.346 170.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -75.64 174.72 9.38 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.509 1.154 . . . . 0.0 110.074 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 p -120.32 144.08 48.03 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 169.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.5 p -134.88 168.46 19.03 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.653 0.781 . . . . 0.0 110.484 -169.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -151.86 149.93 29.53 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 104.359 -2.459 . . . . 0.0 104.359 169.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -110.96 69.64 0.69 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.43 106.86 5.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -169.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -72.87 118.38 15.74 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.71 54.14 26.28 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 118.124 -1.376 . . . . 0.0 116.187 169.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.45 176.28 4.26 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 CA-C-N 120.328 2.064 . . . . 0.0 110.978 169.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.7 mt -127.33 161.52 28.44 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.093 1.357 . . . . 0.0 107.969 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.37 -27.76 69.29 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.853 0.861 . . . . 0.0 111.315 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -65.22 -7.75 14.36 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.592 1.157 . . . . 0.0 112.435 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -131.4 21.94 4.76 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.731 1.612 . . . . 0.0 110.871 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 65.8 mt -133.81 115.8 13.45 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.919 1.288 . . . . 0.0 107.835 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -70.25 163.89 37.03 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.147 1.898 . . . . 0.0 111.346 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.32 14.8 0.68 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.133 1.373 . . . . 0.0 113.52 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 p -153.46 146.1 24.22 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.221 1.008 . . . . 0.0 109.097 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.22 179.74 23.52 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.53 97.38 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 173.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -95.39 169.48 10.03 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.849 0.86 . . . . 0.0 109.055 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.4 tp -147.89 111.24 4.93 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.5 t -96.93 138.02 23.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -171.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -134.68 133.32 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.5 p -138.46 146.93 42.68 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 m -109.33 79.32 1.2 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.278 1.031 . . . . 0.0 109.508 -172.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.0 m -45.09 114.18 0.69 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.932 1.693 . . . . 0.0 109.873 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -64.52 -22.49 66.98 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -175.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 159.93 -29.29 0.37 Allowed Glycine 0 C--N 1.339 0.717 0 CA-C-O 118.833 -0.982 . . . . 0.0 113.363 169.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.11 29.14 4.07 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.454 1.127 . . . . 0.0 112.309 -170.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.1 4.23 60.04 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.426 -0.652 . . . . 0.0 113.471 175.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -81.97 121.99 27.22 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.265 1.032 . . . . 0.0 109.492 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.8 mt -80.46 142.43 53.99 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -49.85 136.85 35.71 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.031 3.154 . . . . 0.0 112.984 169.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -60.5 -20.99 61.92 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.688 1.195 . . . . 0.0 113.296 -174.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -69.26 -30.43 68.54 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 118.856 -0.592 . . . . 0.0 111.638 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.3 tp -123.34 -22.52 5.07 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.463 0.705 . . . . 0.0 112.105 -169.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.1 t -46.02 -41.08 19.26 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 117.636 -1.173 . . . . 0.0 113.546 173.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -50.96 -26.88 19.45 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.266 2.644 . . . . 0.0 116.005 172.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -62.84 -38.11 89.48 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.791 1.178 . . . . 0.0 110.802 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -63.46 -38.89 92.89 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 118.341 0.519 . . . . 0.0 110.36 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.04 -48.62 65.16 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.34 70.15 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 121.515 -0.741 . . . . 0.0 112.462 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.95 -57.42 6.94 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -69.47 -28.49 66.13 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.887 0.767 . . . . 0.0 112.346 -171.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -76.64 -22.14 54.5 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.745 0.702 . . . . 0.0 111.781 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -118.2 -36.09 3.66 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.748 0.704 . . . . 0.0 112.391 -172.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt 30.59 60.67 1.0 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 127.222 2.209 . . . . 0.0 113.376 -174.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.74 170.8 14.51 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.156 1.904 . . . . 0.0 109.924 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -72.31 111.01 7.14 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.002 0.521 . . . . 0.0 109.925 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.1 mt -118.98 24.5 10.79 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.796 1.638 . . . . 0.0 110.52 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.7 m -63.37 20.89 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.473 1.909 . . . . 0.0 115.872 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.09 2.84 1.75 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.663 1.185 . . . . 0.0 111.967 173.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.7 t -76.97 142.29 14.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 169.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 54.8 mmm-85 -119.76 144.21 47.4 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 168.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -138.25 171.28 14.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.29 0.567 . . . . 0.0 110.66 -174.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.33 165.55 25.45 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 105.553 -3.019 . . . . 0.0 105.553 169.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.32 128.85 15.02 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.677 0.739 . . . . 0.0 109.878 -169.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 37.4 mt -131.11 124.22 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -101.84 95.59 1.35 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.1 mt -79.79 155.19 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 168.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.59 174.43 33.44 Favored Glycine 0 N--CA 1.436 -1.329 0 CA-C-O 123.21 1.45 . . . . 0.0 111.468 169.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.6 m -74.78 73.65 2.07 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 125.98 1.712 . . . . 0.0 109.077 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.92 -27.89 63.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.167 1.387 . . . . 0.0 112.362 -170.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -83.78 -11.34 57.21 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.467 0.707 . . . . 0.0 112.745 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -70.09 -53.55 16.91 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.374 0.988 . . . . 0.0 111.416 -169.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -164.78 -49.41 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.386 1.074 . . . . 0.0 110.755 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.5 m -109.72 133.9 52.61 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -172.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -82.04 61.18 5.2 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.374 1.07 . . . . 0.0 109.816 -172.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 13.5 m 46.62 50.05 13.28 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.349 1.86 . . . . 0.0 111.838 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.74 -2.11 61.5 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 118.572 -1.127 . . . . 0.0 113.208 -173.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.35 -21.75 66.73 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.942 1.871 . . . . 0.0 112.25 -175.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.1 tp -59.83 -28.88 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.006 1.323 . . . . 0.0 110.839 173.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.06 -37.66 77.55 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 122.908 0.483 . . . . 0.0 111.176 -174.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -61.81 -53.28 58.01 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.745 0.818 . . . . 0.0 109.819 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.7 mt -62.09 -50.82 70.41 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.66 0.784 . . . . 0.0 109.477 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.47 -41.57 72.57 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -171.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.24 -33.74 72.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 119.118 -0.468 . . . . 0.0 110.236 -170.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.57 -29.78 66.31 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.858 0.753 . . . . 0.0 111.197 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.1 mt -64.41 -44.54 90.95 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.795 1.18 . . . . 0.0 108.777 169.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -59.63 -44.87 93.32 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -177.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -66.46 -37.1 84.38 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 122.739 0.415 . . . . 0.0 110.335 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 31.3 m -68.3 -13.06 61.99 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.833 0.853 . . . . 0.0 112.393 174.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.19 -20.69 3.35 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.745 1.164 . . . . 0.0 113.442 169.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.72 171.02 2.25 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.116 0.958 . . . . 0.0 111.841 -175.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -142.12 141.91 32.72 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.172 -0.955 . . . . 0.0 110.115 173.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -63.85 164.86 9.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.217 1.007 . . . . 0.0 109.997 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.3 m -136.0 148.29 48.35 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.914 2.086 . . . . 0.0 106.197 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.55 -133.64 52.62 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -170.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -141.28 160.58 39.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.273 1.829 . . . . 0.0 106.453 176.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.89 158.72 24.46 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.527 1.131 . . . . 0.0 110.695 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.4 tp -129.85 146.43 51.57 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.392 1.077 . . . . 0.0 108.749 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -120.18 141.98 49.39 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.9 mt -137.84 100.6 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -67.77 130.37 42.78 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 170.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 pp -113.85 -4.1 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 123.875 0.87 . . . . 0.0 111.875 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.4 tp -88.47 61.31 6.07 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 168.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -142.9 -172.76 3.73 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.438 1.895 . . . . 0.0 108.996 -168.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -56.87 -43.41 81.19 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 169.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -161.76 -50.98 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.855 1.262 . . . . 0.0 109.555 169.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.4 pt -149.83 163.38 24.95 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 128.013 2.525 . . . . 0.0 107.667 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.46 164.39 23.57 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.394 2.062 . . . . 0.0 111.072 169.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -74.31 -12.47 60.55 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.74 0.816 . . . . 0.0 112.385 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -58.69 124.48 72.89 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 124.118 0.967 . . . . 0.0 110.852 -177.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.14 114.85 4.13 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.728 2.285 . . . . 0.0 111.232 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.28 -27.97 62.58 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.193 0.597 . . . . 0.0 111.428 171.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -60.77 -41.53 95.71 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.881 0.872 . . . . 0.0 110.828 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -73.19 -40.08 65.06 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 75.7 t90 -60.51 -50.24 74.34 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 52.3 tp -64.94 -40.59 95.26 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 119.148 -0.453 . . . . 0.0 110.164 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.18 -46.83 84.86 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 173.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.5 m -63.99 -37.13 86.31 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.056 0.543 . . . . 0.0 111.071 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -65.97 -51.64 56.71 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.91 0.884 . . . . 0.0 110.286 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.8 m -67.2 -30.88 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 O-C-N 121.24 -0.913 . . . . 0.0 111.379 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -61.82 -20.12 63.29 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.632 0.773 . . . . 0.0 112.376 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.6 mt -101.87 -36.27 8.71 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.787 171.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.71 -37.22 84.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.779 1.172 . . . . 0.0 111.718 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt . . . . . 0 C--O 1.247 0.95 0 C-N-CA 128.604 2.762 . . . . 0.0 113.074 179.839 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.78 154.74 28.78 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 122.104 -0.373 . . . . 0.0 110.278 171.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -132.84 -27.23 1.69 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.58 1.152 . . . . 0.0 110.962 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.8 mt -124.94 79.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.2 m -75.12 117.82 17.38 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 mt -89.09 156.84 18.57 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.783 0.833 . . . . 0.0 108.812 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.4 mt -126.44 95.32 3.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -171.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.5 m -73.29 146.27 45.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.855 0.862 . . . . 0.0 110.11 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.32 81.94 0.15 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 124.47 1.033 . . . . 0.0 110.833 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.0 t -154.87 141.69 19.08 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.444 0.697 . . . . 0.0 110.025 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 p -86.37 -35.9 19.52 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.956 1.302 . . . . 0.0 108.503 168.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.5 mt -68.46 -29.76 68.47 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.205 1.402 . . . . 0.0 111.167 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.31 17.61 33.67 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.355 0.978 . . . . 0.0 112.219 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.82 -41.96 9.31 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 118.52 1.16 . . . . 0.0 110.666 -176.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.38 -35.47 80.41 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 122.001 -0.705 . . . . 0.0 110.499 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.59 -34.51 69.96 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.095 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -66.43 -46.06 77.77 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.417 0.687 . . . . 0.0 109.238 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.0 t -63.18 -47.75 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.57 -38.41 84.49 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-O 118.823 -0.608 . . . . 0.0 111.007 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.16 -45.23 89.39 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.345 0.975 . . . . 0.0 110.715 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -67.79 -40.04 83.99 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.884 -0.51 . . . . 0.0 110.795 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.3 mt -64.2 -42.51 96.6 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 119.257 -0.402 . . . . 0.0 110.157 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.08 -44.87 96.71 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.549 0.74 . . . . 0.0 110.468 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -58.77 -42.25 88.51 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.225 0.466 . . . . 0.0 110.269 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.5 mmtm -69.94 -39.47 76.08 Favored 'General case' 0 N--CA 1.462 0.142 0 O-C-N 121.682 -0.636 . . . . 0.0 111.726 176.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.6 mt -60.65 -37.12 80.47 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.084 0.856 . . . . 0.0 111.045 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -67.63 -35.75 79.51 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.863 0.756 . . . . 0.0 110.682 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.71 -37.46 84.74 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.092 0.86 . . . . 0.0 110.792 172.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.64 -26.41 67.05 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 122.844 0.457 . . . . 0.0 111.55 173.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.95 -3.28 11.68 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.345 1.45 . . . . 0.0 113.834 169.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -81.08 144.36 31.78 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.91 1.355 . . . . 0.0 109.724 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 p -84.18 144.11 29.19 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 169.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.8 p -135.7 169.33 17.72 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.613 0.765 . . . . 0.0 110.795 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -150.79 161.38 42.76 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 p -131.95 75.73 1.66 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.6 mt -69.23 121.91 17.78 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -171.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -80.51 95.49 6.49 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.64 56.17 26.76 Favored Glycine 0 CA--C 1.541 1.68 0 CA-C-O 118.783 -1.009 . . . . 0.0 113.852 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -69.47 178.84 3.99 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.556 2.838 . . . . 0.0 111.988 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.7 mt -129.04 165.93 20.21 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.44 1.496 . . . . 0.0 109.173 172.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.4 tp -63.2 -26.57 68.86 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.777 1.231 . . . . 0.0 112.288 -173.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.11 -10.15 13.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.052 0.941 . . . . 0.0 113.071 174.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -128.07 18.79 6.55 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.443 1.497 . . . . 0.0 111.068 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.6 mt -135.51 97.93 12.67 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 125.106 1.362 . . . . 0.0 107.756 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.73 165.26 30.21 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.356 2.037 . . . . 0.0 111.731 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.64 5.21 2.57 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.837 1.655 . . . . 0.0 114.71 -171.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.3 m -145.43 131.65 19.48 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.776 1.23 . . . . 0.0 107.997 -173.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.91 -172.23 35.06 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.039 -0.825 . . . . 0.0 111.039 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -129.73 97.26 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 173.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -100.52 172.27 7.22 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.602 0.761 . . . . 0.0 110.014 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.7 tp -138.78 103.17 4.76 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 120.793 -1.192 . . . . 0.0 107.809 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.6 t -80.43 129.34 37.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 mt -129.93 129.12 65.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 172.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -139.26 129.7 25.65 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -170.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.8 m -74.08 164.54 26.49 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.174 0.511 . . . . 0.0 109.981 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.8 m -135.98 138.53 42.37 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 176.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -124.84 10.47 8.3 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -169.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.59 -48.82 0.46 Allowed Glycine 0 C--N 1.34 0.773 0 CA-C-N 119.124 0.874 . . . . 0.0 112.849 169.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.28 24.53 2.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.038 0.935 . . . . 0.0 112.053 -169.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.85 9.67 57.14 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 119.614 -0.548 . . . . 0.0 112.653 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -65.08 122.27 16.65 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.276 1.038 . . . . 0.0 109.089 172.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.8 mt -83.07 145.02 48.36 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.79 138.88 85.59 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.064 2.51 . . . . 0.0 110.897 173.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -59.46 -16.93 27.09 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.914 1.285 . . . . 0.0 113.185 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -67.48 -33.12 74.46 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.259 0.624 . . . . 0.0 111.802 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.7 tp -125.67 -21.16 4.51 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.353 0.661 . . . . 0.0 112.27 -172.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 t -47.4 -40.56 27.72 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 117.618 -1.182 . . . . 0.0 113.736 174.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -50.79 -27.18 19.53 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.162 2.574 . . . . 0.0 115.669 172.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -63.02 -38.38 90.94 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.596 1.089 . . . . 0.0 110.877 177.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -64.22 -37.31 87.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.694 0.679 . . . . 0.0 110.156 177.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -69.49 -50.3 46.62 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.1 -31.73 73.04 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.448 -0.783 . . . . 0.0 112.15 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.5 mt -65.51 -55.53 17.3 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.539 -0.743 . . . . 0.0 109.605 172.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -70.18 -27.67 64.7 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.509 1.05 . . . . 0.0 112.309 -172.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -71.27 -28.41 64.13 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.769 0.713 . . . . 0.0 111.433 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -114.45 -33.69 5.5 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -170.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp 29.97 57.73 0.82 Allowed Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 127.719 2.407 . . . . 0.0 113.415 -172.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -69.41 172.63 11.95 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.125 1.883 . . . . 0.0 110.333 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -70.26 111.74 6.08 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.967 0.507 . . . . 0.0 109.83 171.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 mt -120.45 25.32 9.87 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.978 1.711 . . . . 0.0 110.323 175.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.4 m -63.7 19.9 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -174.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.87 9.44 1.52 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.684 1.194 . . . . 0.0 111.505 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.9 t -80.38 102.19 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 170.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -79.73 147.75 31.78 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 167.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -146.23 172.62 13.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 119.325 0.966 . . . . 0.0 112.019 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -125.66 162.35 19.91 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 105.847 -2.901 . . . . 0.0 105.847 169.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.7 125.93 16.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -170.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.3 mt -136.07 135.43 50.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -114.72 147.15 18.85 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.7 mt -127.83 147.81 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 164.95 157.18 9.49 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.4 m -71.51 120.32 16.93 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 171.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 -60.67 -15.32 27.55 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -64.38 -25.99 68.27 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.495 -0.753 . . . . 0.0 112.21 172.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 -61.76 156.7 19.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.856 0.753 . . . . 0.0 111.761 -177.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -57.45 -41.1 79.86 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.958 0.903 . . . . 0.0 110.784 171.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.8 m -131.01 126.57 36.29 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -139.42 150.11 44.87 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -177.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 57.9 m 42.91 39.5 1.78 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.868 1.267 . . . . 0.0 113.131 177.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.03 -11.76 0.4 Allowed Glycine 0 C--N 1.338 0.64 0 CA-C-O 118.752 -1.027 . . . . 0.0 114.057 -169.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.72 -18.81 65.35 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.622 1.711 . . . . 0.0 112.013 174.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 tp -53.91 -31.36 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.438 1.895 . . . . 0.0 110.361 169.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -57.48 -38.45 74.56 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.062 0.545 . . . . 0.0 112.209 -170.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -68.07 -45.67 73.18 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 121.946 -0.471 . . . . 0.0 110.549 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.9 mt -60.81 -49.21 78.41 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.384 0.674 . . . . 0.0 109.182 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -69.74 -33.68 72.79 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.185 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.32 93.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -74.27 -30.5 62.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.949 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.0 mt -62.11 -51.72 66.77 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 119.482 1.037 . . . . 0.0 109.483 170.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -68.29 -32.85 73.29 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.73 -173.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -64.76 -37.33 87.26 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.504 0.322 . . . . 0.0 111.106 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.5 m -71.03 -4.67 26.18 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.316 1.046 . . . . 0.0 112.917 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.79 -16.61 9.5 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.177 1.37 . . . . 0.0 113.249 169.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.69 176.14 0.55 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.037 1.335 . . . . 0.0 111.632 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.62 137.22 15.98 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.723 -1.236 . . . . 0.0 112.649 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -60.66 137.71 58.15 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.566 1.546 . . . . 0.0 108.661 169.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.3 m -121.59 139.24 53.78 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.593 1.957 . . . . 0.0 106.211 171.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.1 175.26 24.79 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.945 0.783 . . . . 0.0 111.668 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -85.47 139.07 31.79 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.924 -0.75 . . . . 0.0 109.366 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.1 m -57.73 152.84 14.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.902 1.681 . . . . 0.0 110.24 174.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 62.9 tp -128.95 149.01 50.98 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.941 0.897 . . . . 0.0 109.939 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -113.16 139.34 48.83 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 17.1 mm -117.6 96.0 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 171.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -67.43 138.37 56.61 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 172.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.0 pt -129.45 13.14 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.673 1.189 . . . . 0.0 111.745 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.4 tp -58.29 -45.72 87.42 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.452 0.701 . . . . 0.0 110.755 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -164.63 -48.81 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.978 1.311 . . . . 0.0 109.327 177.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.61 69.84 3.06 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.755 1.222 . . . . 0.0 109.169 175.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -66.57 73.74 0.09 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.273 2.229 . . . . 0.0 110.367 171.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.253 34.4 pt 36.91 56.0 3.39 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 128.127 2.571 . . . . 0.0 114.918 -177.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -70.05 -11.57 30.7 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.998 2.465 . . . . 0.0 112.346 175.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -144.17 157.86 44.06 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.026 2.13 . . . . 0.0 106.135 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.2 t70 41.46 61.81 7.53 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.871 1.669 . . . . 0.0 113.532 -169.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -54.82 158.3 11.2 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.206 2.604 . . . . 0.0 113.389 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.52 -36.58 69.36 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.629 0.372 . . . . 0.0 110.369 171.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -59.03 -24.29 62.71 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.367 1.467 . . . . 0.0 112.577 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -89.81 -43.49 10.61 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.899 0.772 . . . . 0.0 109.596 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -59.93 -28.92 68.01 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.44 0.696 . . . . 0.0 111.498 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 59.8 tp -51.92 -35.2 44.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.394 1.477 . . . . 0.0 111.872 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.85 -44.61 87.26 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 m -66.76 -30.99 71.34 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.548 0.739 . . . . 0.0 111.145 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -72.32 -55.35 7.27 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.251 0.478 . . . . 0.0 109.798 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.9 m -63.62 -29.53 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 118.498 0.59 . . . . 0.0 111.553 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -54.38 -28.53 43.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.896 0.879 . . . . 0.0 112.458 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 27.4 mt -101.7 -3.49 28.13 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.067 -0.968 . . . . 0.0 113.511 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.6 pp -125.94 -14.63 6.07 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.274 1.397 . . . . 0.0 113.497 -178.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.5 pttt . . . . . 0 C--O 1.25 1.126 0 C-N-CA 123.826 0.85 . . . . 0.0 111.079 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.59 -161.03 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.86 1.664 . . . . 0.0 112.542 -174.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -140.97 -27.27 0.71 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.823 1.249 . . . . 0.0 111.669 177.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mt -132.96 83.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 171.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 79.6 m -73.99 119.28 17.99 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.55 148.13 35.38 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 172.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 82.7 mt -113.39 78.05 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.9 m -76.13 97.23 4.04 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.237 1.415 . . . . 0.0 109.332 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.03 52.21 0.67 Allowed Glycine 0 N--CA 1.461 0.337 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -172.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.3 m -127.76 164.53 21.95 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.296 0.639 . . . . 0.0 112.549 -167.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.2 p -146.9 -30.59 0.35 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.03 1.332 . . . . 0.0 112.916 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 70.7 mt -64.17 -20.02 65.71 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -171.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.62 -43.67 1.63 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 125.374 1.464 . . . . 0.0 110.429 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.29 -42.61 90.25 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 -176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.78 -31.78 72.95 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.154 -0.45 . . . . 0.0 110.06 175.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -72.61 -35.38 67.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.816 0.735 . . . . 0.0 111.015 177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -67.11 -39.42 86.68 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.994 0.815 . . . . 0.0 109.229 175.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.87 -47.01 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 118.681 -0.676 . . . . 0.0 109.549 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.96 86.29 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.467 1.031 . . . . 0.0 111.383 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.09 -43.57 91.68 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.14 0.576 . . . . 0.0 110.593 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -64.62 -44.59 90.05 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.541 0.61 . . . . 0.0 110.66 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.3 mt -58.55 -46.97 85.74 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.327 1.051 . . . . 0.0 109.93 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.03 -46.04 89.2 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.303 0.641 . . . . 0.0 110.176 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.02 -42.2 93.84 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.016 0.526 . . . . 0.0 110.082 -179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.403 ' N ' ' HE2' ' A' ' 25' ' ' LYS . 6.1 mmpt? -63.74 -36.89 85.36 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 121.744 -0.598 . . . . 0.0 110.233 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.94 -38.71 76.26 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 118.66 0.664 . . . . 0.0 111.013 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.07 -43.35 99.02 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.727 0.694 . . . . 0.0 109.398 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.04 -38.99 92.65 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.078 0.551 . . . . 0.0 111.104 176.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.38 -21.43 64.7 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.624 0.77 . . . . 0.0 112.203 176.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.95 28.71 3.54 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.758 -1.023 . . . . 0.0 113.623 170.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -124.96 133.77 52.89 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.977 1.388 . . . . 0.0 108.924 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 p -75.79 140.6 42.43 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.282 0.563 . . . . 0.0 109.7 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.1 p -131.01 168.55 17.18 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.35 1.06 . . . . 0.0 110.6 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -154.45 128.0 8.6 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 169.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 p -82.59 65.09 7.55 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.007 1.323 . . . . 0.0 108.248 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.1 121.36 15.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -169.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.0 107.23 4.61 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -173.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 37.36 56.59 1.5 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 127.642 2.544 . . . . 0.0 115.789 173.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -62.47 148.66 92.97 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 120.222 2.011 . . . . 0.0 110.63 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mt -98.62 171.06 8.37 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 124.233 1.013 . . . . 0.0 110.551 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -52.92 -38.78 62.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.425 1.49 . . . . 0.0 111.282 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.74 -6.0 18.86 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.45 1.1 . . . . 0.0 112.68 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -135.27 20.38 3.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.986 1.714 . . . . 0.0 110.924 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.2 mt -134.11 108.73 11.54 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 125.133 1.373 . . . . 0.0 107.607 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.2 160.42 48.94 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.889 1.726 . . . . 0.0 110.631 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.6 7.13 2.58 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.742 1.217 . . . . 0.0 114.098 -172.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.2 m -147.52 142.13 26.59 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -176.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.16 -177.85 29.73 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.5 101.31 8.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -109.04 170.23 8.18 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.991 0.916 . . . . 0.0 109.914 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.8 tp -144.73 106.95 4.34 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.1 t -81.79 139.58 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 124.059 0.944 . . . . 0.0 108.864 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 mp -133.34 143.45 39.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.2 m -148.46 143.91 27.04 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.192 -0.943 . . . . 0.0 110.195 176.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -69.37 150.62 47.1 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.0 m -116.43 91.59 3.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -56.66 -32.19 65.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.53 0.732 . . . . 0.0 111.714 -176.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 150.82 -29.96 1.02 Allowed Glycine 0 C--N 1.34 0.763 0 C-N-CA 123.892 0.758 . . . . 0.0 112.628 169.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.96 25.29 7.36 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.421 1.088 . . . . 0.0 111.948 -170.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.12 5.94 86.99 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-O 119.363 -0.687 . . . . 0.0 112.921 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -72.96 146.94 45.67 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 169.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.3 mt -126.03 139.69 34.99 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -172.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -51.73 138.19 50.29 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.055 2.503 . . . . 0.0 113.304 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -57.71 -12.69 3.15 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.717 1.607 . . . . 0.0 113.198 174.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -54.96 -42.59 72.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.178 1.391 . . . . 0.0 109.732 172.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.3 tp -133.64 -21.45 1.97 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -171.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 91.5 p -52.48 -33.12 11.05 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -172.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -53.68 -23.09 24.83 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.803 2.335 . . . . 0.0 115.153 171.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -59.56 -36.59 76.5 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.571 1.078 . . . . 0.0 111.441 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -61.35 -43.0 99.61 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.186 0.448 . . . . 0.0 110.047 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -68.74 -47.09 67.18 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.167 0.587 . . . . 0.0 109.864 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.36 -36.74 83.65 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.865 -0.522 . . . . 0.0 112.03 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.3 mt -67.91 -51.31 49.34 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 118.515 -0.755 . . . . 0.0 109.537 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -68.76 -28.02 66.42 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.435 1.016 . . . . 0.0 111.886 -174.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.2 -39.23 86.32 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.749 0.704 . . . . 0.0 110.483 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -100.17 -22.8 15.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.891 -0.576 . . . . 0.0 112.43 -170.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt 40.03 56.97 7.2 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.997 1.719 . . . . 0.0 110.691 -169.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.88 143.02 78.19 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.354 2.036 . . . . 0.0 110.883 -169.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -81.85 64.22 6.45 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.655 1.182 . . . . 0.0 108.731 174.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.75 -56.01 10.88 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.6 m 50.55 19.97 0.64 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 169.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -157.38 -0.63 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 80.9 t -71.56 139.26 20.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -115.05 135.11 54.57 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 169.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -139.81 173.17 11.79 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.116 0.96 . . . . 0.0 112.298 -170.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -133.63 163.4 24.43 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 106.079 -2.808 . . . . 0.0 106.079 169.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.45 123.86 7.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.218 1.009 . . . . 0.0 108.413 -169.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 29.7 mt -139.53 139.93 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.47 138.91 11.81 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 169.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.68 128.59 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 162.96 -149.74 17.85 Favored Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 172.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.3 m -85.45 55.87 3.7 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 126.144 1.778 . . . . 0.0 110.956 -169.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -53.14 -37.01 61.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.836 0.855 . . . . 0.0 112.344 -173.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.0 -16.97 64.02 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.641 0.776 . . . . 0.0 112.87 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -63.18 -47.37 82.91 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.806 0.73 . . . . 0.0 111.483 -174.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -162.76 -43.07 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.4 m -128.0 132.55 49.14 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.062 0.945 . . . . 0.0 108.874 -169.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -106.98 -2.38 21.23 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -169.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 20.3 p -155.17 -25.65 0.11 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -47.65 -38.01 14.52 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.726 1.155 . . . . 0.0 114.303 -172.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.33 -8.7 19.44 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.6 tp -127.6 -34.0 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.292 1.037 . . . . 0.0 110.002 169.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -55.17 -36.91 66.36 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.41 0.684 . . . . 0.0 111.823 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.41 -54.57 45.52 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.569 0.622 . . . . 0.0 110.902 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 50.4 mt -66.26 -49.35 67.45 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -173.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.17 -35.98 74.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -171.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.72 -37.84 82.78 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.86 -0.591 . . . . 0.0 110.107 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -69.13 -31.25 69.8 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.239 0.927 . . . . 0.0 112.437 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.7 mt -64.24 -42.37 96.56 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.645 1.566 . . . . 0.0 109.447 169.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -61.93 -41.4 97.91 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.504 0.722 . . . . 0.0 110.133 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -64.4 -36.44 84.15 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.056 1.342 . . . . 0.0 111.012 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.1 m -72.79 7.8 1.8 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.076 1.35 . . . . 0.0 112.849 172.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.27 -8.11 80.55 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.898 1.237 . . . . 0.0 113.353 171.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.13 167.75 4.75 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.421 1.111 . . . . 0.0 110.043 170.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -142.7 151.93 41.84 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.267 -0.896 . . . . 0.0 111.957 176.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -56.39 163.71 1.62 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.375 1.47 . . . . 0.0 110.147 169.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.72 37.69 2.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.381 1.086 . . . . 0.0 109.604 -177.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 155.52 -167.48 33.04 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.558 2.028 . . . . 0.0 108.046 -169.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.75 154.68 20.76 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 117.925 0.863 . . . . 0.0 109.007 169.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.7 m -67.61 158.21 32.64 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.0 tp -132.41 152.34 51.51 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.563 0.745 . . . . 0.0 109.141 172.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -137.4 146.46 44.46 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 169.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.8 mt -134.14 103.31 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -169.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -75.8 141.8 42.44 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -130.9 4.86 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.2 tp -74.66 -67.85 0.59 Allowed 'General case' 0 C--N 1.347 0.462 0 CA-C-N 119.923 1.238 . . . . 0.0 111.374 -169.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -72.56 -27.6 62.3 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.653 0.661 . . . . 0.0 112.673 -177.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -149.37 153.83 38.01 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 124.328 1.051 . . . . 0.0 110.224 -169.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -82.06 6.72 15.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.275 1.43 . . . . 0.0 112.932 -175.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.315 14.2 tt 39.27 62.06 5.2 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 127.509 2.324 . . . . 0.0 113.197 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.32 -10.27 25.33 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.237 2.625 . . . . 0.0 113.587 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.32 -21.16 65.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.871 0.869 . . . . 0.0 111.457 169.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.8 t0 41.11 62.93 6.31 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.315 2.246 . . . . 0.0 113.88 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -63.96 -17.26 59.13 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.014 2.476 . . . . 0.0 113.115 -174.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.79 -38.51 61.23 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.715 0.806 . . . . 0.0 111.463 176.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.5 -42.99 86.56 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.717 0.69 . . . . 0.0 110.647 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.19 -40.51 78.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.867 0.467 . . . . 0.0 110.127 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -67.05 -37.78 84.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.06 175.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.03 -42.92 93.89 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.629 1.104 . . . . 0.0 109.941 177.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.84 -43.9 87.21 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 171.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.0 m -63.82 -41.48 97.85 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.177 -0.602 . . . . 0.0 110.836 176.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -49.01 79.32 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.674 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.7 m -66.57 -31.75 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 120.431 1.468 . . . . 0.0 111.634 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -67.97 -18.91 64.88 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.628 0.649 . . . . 0.0 111.794 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.37 -47.2 4.77 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.809 1.244 . . . . 0.0 110.25 -176.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.6 pp -74.55 -23.51 58.8 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.077 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 C--O 1.246 0.88 0 C-N-CA 127.73 2.412 . . . . 0.0 112.15 177.932 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.52 159.66 42.77 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.892 1.277 . . . . 0.0 108.81 176.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -136.95 -25.1 1.1 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.045 1.338 . . . . 0.0 111.215 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.9 mt -128.83 82.1 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 169.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 m -76.6 117.94 18.75 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.76 149.74 39.64 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 171.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 68.9 mt -117.18 95.14 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 104.743 -2.318 . . . . 0.0 104.743 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.4 m -85.59 89.49 7.73 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.283 1.833 . . . . 0.0 110.847 -169.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.64 57.09 4.76 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.9 m -105.23 58.57 0.68 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -167.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 p -60.6 -36.5 78.71 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.065 0.546 . . . . 0.0 111.248 171.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.9 mt -65.84 -19.51 65.91 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.53 -41.31 1.39 Allowed Glycine 0 CA--C 1.532 1.106 0 CA-C-N 119.418 1.008 . . . . 0.0 112.328 -174.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.93 -36.3 93.24 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 118.502 1.151 . . . . 0.0 111.424 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.09 -29.66 68.73 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.241 0.52 . . . . 0.0 110.091 172.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -80.88 -30.32 35.57 Favored 'General case' 0 N--CA 1.462 0.162 0 O-C-N 121.962 -0.461 . . . . 0.0 111.601 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -66.79 -40.54 88.17 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.094 0.861 . . . . 0.0 108.931 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.07 -42.36 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 118.675 -0.679 . . . . 0.0 109.849 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.85 85.12 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.539 1.063 . . . . 0.0 111.149 176.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -65.04 -43.03 93.68 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.192 0.597 . . . . 0.0 110.654 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -61.2 -47.22 87.12 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.417 0.553 . . . . 0.0 110.875 176.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.5 mt -59.34 -47.67 84.55 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.541 0.737 . . . . 0.0 109.374 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.5 93.58 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.586 0.754 . . . . 0.0 110.808 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 -58.93 -41.49 87.44 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.404 0.547 . . . . 0.0 110.435 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.44 -30.76 66.43 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.011 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 70.5 mt -65.76 -40.0 91.63 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 119.91 1.232 . . . . 0.0 111.62 170.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -60.09 -43.92 95.18 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.868 0.758 . . . . 0.0 109.321 177.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.41 -38.06 88.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.206 0.602 . . . . 0.0 111.311 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.86 -21.43 64.27 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.739 0.816 . . . . 0.0 112.275 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.29 28.49 3.79 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.375 171.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -126.52 129.39 48.53 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.804 1.302 . . . . 0.0 107.96 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 p -75.37 148.11 39.49 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.8 p -134.02 170.17 16.04 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.757 0.789 . . . . 0.0 111.393 -171.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -152.6 161.96 41.87 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 169.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.49 78.5 1.81 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.7 mt -69.66 113.6 7.08 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.429 ' CD2' HD22 ' A' ' 65' ' ' ASN . 43.0 t60 -73.35 106.23 5.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 52.51 55.68 21.39 Favored Glycine 0 CA--C 1.541 1.685 0 CA-C-O 118.58 -1.122 . . . . 0.0 115.575 172.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -69.26 175.33 7.83 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.161 2.574 . . . . 0.0 111.722 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.6 mt -131.69 171.28 13.67 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 126.06 1.744 . . . . 0.0 110.152 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.87 -38.26 55.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.051 1.74 . . . . 0.0 111.857 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.62 -8.56 14.77 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -133.99 18.41 3.79 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.144 1.778 . . . . 0.0 110.87 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.9 mt -134.27 98.29 14.14 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 125.223 1.409 . . . . 0.0 107.704 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.14 163.5 35.8 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.157 1.905 . . . . 0.0 110.857 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.79 3.03 4.53 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -170.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.4 m -147.68 136.96 22.39 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.654 1.182 . . . . 0.0 107.894 -171.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.1 177.26 25.62 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.5 mt -113.71 102.43 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -101.21 168.68 9.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.341 0.656 . . . . 0.0 109.43 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.0 tp -144.59 100.42 3.52 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.4 t -79.49 140.78 16.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 123.553 0.741 . . . . 0.0 109.015 -174.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.3 mp -132.31 135.97 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 171.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.3 m -126.0 137.95 53.7 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.284 0.633 . . . . 0.0 111.369 173.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.4 m -69.87 160.25 32.16 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 168.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.59 89.14 2.19 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -78.63 42.28 0.44 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.767 1.227 . . . . 0.0 112.053 -171.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.57 -39.56 1.95 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.103 1.335 . . . . 0.0 113.422 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.62 -21.35 59.51 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.124 0.969 . . . . 0.0 112.971 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.35 9.13 80.04 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.767 -1.018 . . . . 0.0 113.539 -176.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -75.92 152.54 37.08 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.83 1.315 . . . . 0.0 110.756 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.1 mt -65.98 142.89 98.23 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.325 1.45 . . . . 0.0 108.567 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -57.95 125.99 20.31 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.937 3.091 . . . . 0.0 111.714 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -56.75 -27.09 58.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.656 1.182 . . . . 0.0 114.134 -173.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.429 HD22 ' CD2' ' A' ' 37' ' ' HIS . 10.2 p-10 -73.23 -19.18 61.14 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.817 -0.552 . . . . 0.0 112.43 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.4 tp -127.29 -23.03 3.6 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.125 1.37 . . . . 0.0 111.175 -171.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.2 p -53.94 -31.66 9.04 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-O 116.832 -1.556 . . . . 0.0 114.832 -176.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -52.54 -23.57 19.78 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.481 2.121 . . . . 0.0 114.929 169.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.46 -35.92 78.95 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.952 1.251 . . . . 0.0 111.675 175.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -59.32 -43.07 92.73 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.331 0.514 . . . . 0.0 109.777 176.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.9 -48.47 58.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.929 0.492 . . . . 0.0 109.8 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.38 -31.56 72.73 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.891 0.769 . . . . 0.0 112.54 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.1 mt -68.6 -54.65 15.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.952 0.796 . . . . 0.0 109.404 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -68.89 -29.52 67.82 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.336 0.971 . . . . 0.0 112.264 -171.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -73.24 -24.16 60.44 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.786 0.721 . . . . 0.0 111.32 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -112.86 -23.64 10.0 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.865 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt 39.31 64.67 3.84 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.936 1.694 . . . . 0.0 109.807 -169.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.88 -4.68 13.87 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.295 2.663 . . . . 0.0 115.534 -169.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.7 t70 50.57 51.99 15.76 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.172 1.389 . . . . 0.0 111.592 171.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.3 mt -58.92 -46.48 87.85 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.443 1.497 . . . . 0.0 110.494 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.8 m 54.86 15.44 1.13 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 172.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -153.92 2.03 0.24 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.704 1.138 . . . . 0.0 113.857 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 79.7 t -72.56 138.12 22.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 169.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -119.96 140.32 51.11 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 104.262 -2.496 . . . . 0.0 104.262 168.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -149.69 169.91 19.92 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.364 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.42 166.65 20.9 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 105.662 -2.975 . . . . 0.0 105.662 169.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.64 135.84 23.87 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.373 1.087 . . . . 0.0 109.723 -169.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.2 mt -135.9 137.36 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -175.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.18 135.18 11.18 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 170.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.9 mt -139.57 131.13 33.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 164.96 -159.85 33.02 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 120.425 1.466 . . . . 0.0 110.369 171.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.6 m -76.33 47.45 0.47 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 127.727 2.411 . . . . 0.0 111.106 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 57.1 mtt-85 -66.57 -15.9 63.76 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.149 -0.969 . . . . 0.0 112.879 -170.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.63 -28.38 69.86 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.21 0.604 . . . . 0.0 112.051 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -66.42 -57.32 7.65 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 123.292 0.637 . . . . 0.0 110.466 -171.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -169.01 -66.33 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.263 1.425 . . . . 0.0 108.636 172.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.9 p 49.21 -177.99 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 127.413 2.285 . . . . 0.0 114.308 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -151.82 5.45 0.43 Allowed 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.116 -0.99 . . . . 0.0 112.742 -171.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 63.7 m 56.55 -11.51 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 127.402 2.281 . . . . 0.0 116.353 -170.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -45.35 -35.02 4.97 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 126.154 1.835 . . . . 0.0 112.88 173.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.34 -25.8 6.56 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.123 1.769 . . . . 0.0 114.641 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.09 -33.16 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -61.06 -37.77 83.83 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.957 0.903 . . . . 0.0 111.971 -172.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -68.38 -42.77 78.61 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.725 -0.609 . . . . 0.0 111.081 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.77 -50.05 73.91 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.55 -32.93 73.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 119.438 -0.315 . . . . 0.0 111.023 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.77 99.59 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -74.57 -29.2 61.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.279 -0.867 . . . . 0.0 112.259 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.1 mt -62.82 -47.91 81.38 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.191 1.359 . . . . 0.0 109.234 170.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -66.07 -36.62 83.7 Favored 'General case' 0 N--CA 1.46 0.054 0 C-N-CA 122.415 0.286 . . . . 0.0 110.829 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -63.38 -38.36 90.85 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.134 0.574 . . . . 0.0 110.7 173.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.2 m -74.46 11.77 0.92 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.661 1.184 . . . . 0.0 112.499 171.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.35 -5.52 84.64 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 120.78 -1.2 . . . . 0.0 113.857 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.9 169.39 2.6 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.0 1.4 . . . . 0.0 110.092 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -141.74 139.74 32.93 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.602 -0.686 . . . . 0.0 110.966 169.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -64.94 170.61 4.15 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.049 1.339 . . . . 0.0 109.461 175.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.1 m -140.15 152.72 46.29 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.39 -132.99 42.03 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -144.07 154.85 43.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.77 129.78 42.02 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.119 0.968 . . . . 0.0 109.958 -177.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.2 tp -91.36 142.39 27.74 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -129.71 139.46 51.33 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.2 mt -138.99 100.4 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -73.43 133.43 43.73 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 169.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -128.91 8.12 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.844 0.747 . . . . 0.0 112.538 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.5 tp -55.71 -32.37 63.27 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.941 0.792 . . . . 0.0 111.654 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -137.07 47.68 2.11 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.032 1.333 . . . . 0.0 109.252 172.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 44.39 40.27 3.68 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.72 2.008 . . . . 0.0 113.059 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -80.36 49.82 1.19 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.212 2.205 . . . . 0.0 112.128 -171.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.4 pt -54.28 149.33 19.96 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.437 1.095 . . . . 0.0 110.938 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.06 162.87 30.9 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.783 2.322 . . . . 0.0 112.498 -175.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -73.74 -1.14 17.95 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.423 1.489 . . . . 0.0 112.879 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -125.88 111.18 24.76 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 173.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -53.56 152.68 20.53 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.553 2.836 . . . . 0.0 114.517 -169.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.3 -37.49 62.27 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.417 0.687 . . . . 0.0 110.775 170.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.29 -34.19 77.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.217 0.607 . . . . 0.0 111.563 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -79.42 -36.6 38.78 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.419 0.554 . . . . 0.0 109.756 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -66.83 -40.0 87.83 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.771 -0.581 . . . . 0.0 110.046 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.1 tp -64.77 -42.33 95.19 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.51 1.124 . . . . 0.0 110.575 174.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.52 -43.98 85.59 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.43 1.014 . . . . 0.0 110.985 172.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.8 m -63.98 -41.11 97.64 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.292 0.637 . . . . 0.0 110.568 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -52.01 66.68 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.406 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.1 m -61.79 -35.07 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 119.793 1.179 . . . . 0.0 110.796 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -61.92 -24.35 66.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.55 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.2 mt -91.64 -47.77 7.2 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.739 1.154 . . . . 0.0 111.04 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.7 pp -80.24 -10.94 59.77 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -172.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.4 pttm . . . . . 0 C--O 1.249 1.053 0 C-N-CA 125.463 1.505 . . . . 0.0 112.778 -177.565 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.58 157.31 43.51 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.741 1.217 . . . . 0.0 108.614 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -136.37 -26.64 1.11 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.276 1.43 . . . . 0.0 111.038 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.0 mt -122.91 77.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 169.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -74.74 116.33 15.33 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.2 mt -87.84 155.93 19.64 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.3 mt -125.62 95.12 3.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -170.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 m -90.07 153.03 20.87 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.086 1.754 . . . . 0.0 111.022 -175.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.18 128.95 1.15 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 107.558 -2.217 . . . . 0.0 107.558 173.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.75 155.36 41.62 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.565 0.698 . . . . 0.0 112.305 -172.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 p -129.7 -34.57 1.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.853 2.061 . . . . 0.0 108.656 169.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt -67.1 -20.76 65.85 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.083 0.553 . . . . 0.0 110.57 169.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.18 35.4 18.05 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.05 -24.15 0.99 Allowed Glycine 0 CA--C 1.524 0.648 0 CA-C-O 118.611 -1.105 . . . . 0.0 112.948 -173.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.23 -32.42 73.83 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.037 1.919 . . . . 0.0 110.746 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.67 -39.34 93.5 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.494 0.318 . . . . 0.0 110.848 176.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -70.55 -48.03 57.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -61.35 -43.1 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.52 -48.15 83.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 118.73 0.696 . . . . 0.0 110.101 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.51 -43.33 94.43 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.663 0.665 . . . . 0.0 110.986 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -63.53 -38.44 91.16 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.813 0.845 . . . . 0.0 111.252 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.6 mt -74.53 -41.25 60.94 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.266 0.626 . . . . 0.0 110.275 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.89 -40.32 80.0 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 123.438 0.695 . . . . 0.0 110.84 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -52.51 -46.35 66.64 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.608 0.763 . . . . 0.0 110.638 175.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -68.0 -39.21 83.26 Favored 'General case' 0 N--CA 1.46 0.064 0 O-C-N 121.84 -0.538 . . . . 0.0 110.259 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.8 mt -66.34 -39.84 89.46 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 119.506 -0.283 . . . . 0.0 110.705 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.81 -40.44 91.88 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.409 0.549 . . . . 0.0 110.18 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -64.78 -36.19 83.51 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.33 0.514 . . . . 0.0 111.018 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.94 -23.98 64.22 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.46 0.704 . . . . 0.0 111.994 174.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.86 -0.62 13.53 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.902 1.239 . . . . 0.0 113.741 170.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -75.67 174.75 9.36 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.737 1.268 . . . . 0.0 110.305 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.9 p -119.16 144.01 46.91 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 170.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -135.64 167.69 20.66 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.063 0.945 . . . . 0.0 109.934 -169.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -153.07 160.23 42.92 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 169.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 p -124.88 72.19 1.21 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.0 mt -69.05 114.38 7.28 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -173.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -81.89 110.0 16.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.85 46.62 93.22 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-O 117.943 -1.476 . . . . 0.0 115.926 172.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -69.09 173.36 10.48 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 121.031 2.415 . . . . 0.0 110.267 169.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 mp -131.34 175.68 8.93 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.285 1.434 . . . . 0.0 108.036 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.408 HD21 ' HG3' ' A' ' 78' ' ' PRO . 45.3 tp -55.77 -32.02 63.08 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.284 1.034 . . . . 0.0 111.052 175.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.83 -7.5 11.43 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.068 0.947 . . . . 0.0 112.717 178.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -134.19 18.08 3.74 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.42 1.488 . . . . 0.0 111.336 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.7 mt -137.27 113.57 9.58 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.702 1.201 . . . . 0.0 108.422 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.78 164.14 36.63 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.366 2.044 . . . . 0.0 111.428 -178.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.6 20.46 1.12 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.163 1.385 . . . . 0.0 112.951 -171.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.8 m -153.94 139.1 17.43 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 120.999 -1.063 . . . . 0.0 108.41 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.42 -178.14 27.14 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.18 101.05 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -102.82 175.28 5.54 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.29 1.036 . . . . 0.0 110.462 -173.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.6 tp -145.66 108.3 4.48 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.4 t -86.56 131.65 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.6 mt -130.67 131.63 64.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.9 m -149.47 142.02 24.4 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.643 0.777 . . . . 0.0 109.192 -169.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.8 m -73.68 160.6 31.33 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 m -115.54 5.77 14.5 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.757 0.789 . . . . 0.0 112.678 -175.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 41.53 22.9 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 129.279 3.031 . . . . 0.0 114.181 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.89 19.31 29.12 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.462 -1.188 . . . . 0.0 114.562 -170.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.35 -13.32 0.13 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.491 1.646 . . . . 0.0 115.115 -169.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.43 -1.83 53.64 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 119.454 1.025 . . . . 0.0 113.081 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.96 155.87 38.18 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 169.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.9 mt -122.91 144.38 42.86 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.028 1.331 . . . . 0.0 107.863 -169.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.99 124.74 4.93 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.606 3.538 . . . . 0.0 113.62 172.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.5 -24.22 65.13 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.94 0.896 . . . . 0.0 113.066 -174.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -73.9 -22.46 59.69 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.0 tp -122.69 -29.9 3.95 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.152 0.981 . . . . 0.0 111.372 -170.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 t -45.75 -41.76 20.39 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.537 1.535 . . . . 0.0 113.684 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -51.16 -23.01 12.05 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.301 2.667 . . . . 0.0 116.122 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -56.76 -38.21 72.12 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.68 1.127 . . . . 0.0 111.027 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -58.23 -43.81 87.92 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.101 0.96 . . . . 0.0 110.458 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -72.48 -45.71 58.22 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.05 0.54 . . . . 0.0 109.841 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.62 -33.95 77.09 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 118.874 -0.584 . . . . 0.0 112.058 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.3 mt -63.85 -57.87 8.52 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -68.85 -27.24 65.64 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.829 0.741 . . . . 0.0 112.197 -172.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.06 -37.34 87.22 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.576 0.625 . . . . 0.0 110.615 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -105.65 -30.81 9.24 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -170.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.7 tttm 29.27 60.86 0.79 Allowed Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 128.019 2.528 . . . . 0.0 113.692 -174.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.408 ' HG3' HD21 ' A' ' 41' ' ' LEU . 83.3 Cg_endo -68.09 170.08 15.21 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.711 1.608 . . . . 0.0 110.089 172.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -74.23 110.99 8.96 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.2 mt -114.58 20.24 15.48 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.418 1.487 . . . . 0.0 110.948 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.8 m -62.15 19.35 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.994 1.718 . . . . 0.0 115.558 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.12 -0.8 2.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.338 1.455 . . . . 0.0 111.861 174.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 68.0 t -81.41 142.92 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 169.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -122.63 146.72 47.2 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 168.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -143.9 172.37 12.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.588 0.709 . . . . 0.0 110.803 -173.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.68 166.95 23.36 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 107.983 -2.047 . . . . 0.0 107.983 169.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.9 134.8 17.81 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -169.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.9 mt -138.68 128.82 33.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -177.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -104.32 104.59 2.45 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 107.983 -2.047 . . . . 0.0 107.983 173.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.3 mt -84.33 128.56 38.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.798 -1.926 . . . . 0.0 105.798 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.55 -146.48 6.06 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 -172.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.2 m -161.7 149.08 14.54 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.653 1.181 . . . . 0.0 110.36 171.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -64.7 -17.18 63.86 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.81 -36.55 84.7 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.207 0.603 . . . . 0.0 109.91 175.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -74.01 158.26 34.66 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.429 0.633 . . . . 0.0 110.708 176.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.49 -19.07 62.25 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.668 0.787 . . . . 0.0 112.523 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.4 m -110.79 139.63 45.93 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.445 1.098 . . . . 0.0 108.997 -172.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -117.41 -45.21 2.73 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.884 0.874 . . . . 0.0 111.126 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.2 m -136.35 -0.48 2.44 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.942 0.897 . . . . 0.0 113.172 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.77 -16.31 30.43 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 120.176 1.353 . . . . 0.0 115.087 -171.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.22 -59.49 2.62 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.477 1.139 . . . . 0.0 110.654 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.2 tp -60.92 -31.07 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.735 0.814 . . . . 0.0 109.693 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -51.43 -38.17 52.27 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.131 0.972 . . . . 0.0 112.165 177.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -71.84 -47.87 50.03 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.972 0.806 . . . . 0.0 109.961 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.3 mt -59.58 -48.34 82.05 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.299 0.64 . . . . 0.0 109.781 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -68.98 -37.66 78.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.1 85.92 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 118.564 -0.731 . . . . 0.0 110.508 -171.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -72.02 -28.26 63.26 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.309 0.958 . . . . 0.0 112.699 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.51 -43.88 84.04 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.571 1.532 . . . . 0.0 108.498 169.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -61.11 -44.3 97.56 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.2 1.0 . . . . 0.0 109.977 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -66.14 -35.25 80.0 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.988 1.715 . . . . 0.0 111.281 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 44.4 m -73.65 -8.13 54.77 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.786 0.834 . . . . 0.0 112.675 173.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.42 -18.13 8.85 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.797 1.189 . . . . 0.0 113.935 169.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.66 171.97 2.38 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.294 1.047 . . . . 0.0 111.286 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -144.32 155.44 43.81 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.972 -1.08 . . . . 0.0 112.287 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -56.44 168.12 0.6 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.948 1.699 . . . . 0.0 110.581 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 m -134.02 37.92 3.2 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.211 1.004 . . . . 0.0 110.266 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 139.6 -168.95 24.79 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 126.945 2.212 . . . . 0.0 110.245 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -89.84 143.32 26.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 117.928 0.864 . . . . 0.0 110.858 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.1 m -58.32 137.91 56.82 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.914 1.686 . . . . 0.0 111.447 -176.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 35.9 tp -91.44 148.92 21.96 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.795 0.438 . . . . 0.0 109.892 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -116.42 138.22 51.54 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 169.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.9 mt -124.4 99.29 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.18 92.25 6.27 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.051 1.74 . . . . 0.0 108.59 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 26.5 pt -66.67 -35.28 74.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -174.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.5 tp -63.1 -16.08 58.77 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.525 1.53 . . . . 0.0 112.518 -175.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -58.53 -37.68 76.15 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.653 0.66 . . . . 0.0 111.692 176.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -168.82 -52.07 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.228 1.411 . . . . 0.0 108.684 171.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -160.61 -34.72 0.05 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.271 1.828 . . . . 0.0 109.639 174.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.3 pt -142.38 161.01 52.34 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 129.026 2.931 . . . . 0.0 105.466 169.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.03 164.63 29.24 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 121.979 1.786 . . . . 0.0 111.042 176.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -64.18 -35.64 81.45 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.536 0.735 . . . . 0.0 111.126 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.26 117.13 40.29 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 123.989 0.916 . . . . 0.0 109.888 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.05 137.07 25.86 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.293 1.995 . . . . 0.0 110.463 -174.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.13 -22.6 65.98 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.895 0.478 . . . . 0.0 112.035 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -63.52 -30.2 71.35 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.693 0.797 . . . . 0.0 111.341 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -68.21 -43.98 76.8 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.214 0.915 . . . . 0.0 109.328 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -64.26 -39.17 93.39 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.81 0.844 . . . . 0.0 110.596 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.69 -30.91 71.05 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.65 -0.656 . . . . 0.0 110.954 176.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.04 -44.29 56.45 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.442 1.02 . . . . 0.0 111.49 171.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.6 m -64.16 -39.13 93.37 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.657 0.729 . . . . 0.0 110.588 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -62.47 -50.7 70.42 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 118.671 0.669 . . . . 0.0 110.869 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.5 m -66.74 -30.76 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.551 1.069 . . . . 0.0 111.027 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -67.76 -33.03 74.05 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.885 0.766 . . . . 0.0 111.333 175.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.43 -49.66 11.14 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.623 0.769 . . . . 0.0 110.154 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 pp -79.35 -21.46 45.79 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.471 -0.776 . . . . 0.0 112.716 -172.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp . . . . . 0 C--O 1.251 1.181 0 C-N-CA 127.382 2.273 . . . . 0.0 111.822 -179.366 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.83 -177.69 6.28 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.364 1.466 . . . . 0.0 108.962 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -128.13 -26.11 2.9 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.17 0.988 . . . . 0.0 111.476 -173.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.3 mt -130.74 85.98 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.1 m -82.01 115.16 21.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mp -74.28 155.35 38.33 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.5 mt -130.89 104.1 8.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.44 1.496 . . . . 0.0 107.076 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.25 133.14 35.23 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.708 0.803 . . . . 0.0 110.982 -177.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -125.34 86.76 0.36 Allowed Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 107.413 -2.275 . . . . 0.0 107.413 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.16 164.84 31.85 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.435 1.112 . . . . 0.0 111.974 173.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.3 p -135.92 -43.7 0.65 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 127.746 2.418 . . . . 0.0 106.742 169.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.79 -34.96 79.59 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.714 1.206 . . . . 0.0 111.468 173.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.72 -9.47 14.48 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.508 1.528 . . . . 0.0 113.194 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.52 -51.27 59.79 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 119.213 1.506 . . . . 0.0 112.203 -169.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.89 -22.76 63.2 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.566 -0.731 . . . . 0.0 111.231 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.25 -39.88 62.75 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.054 0.843 . . . . 0.0 110.135 176.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -68.47 -43.13 77.64 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.683 -0.636 . . . . 0.0 109.436 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.2 t -64.12 -39.71 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.049 175.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.91 -43.55 98.39 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 119.636 1.107 . . . . 0.0 110.88 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -61.02 -44.27 97.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.431 0.56 . . . . 0.0 110.411 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -60.84 -51.62 68.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.919 0.488 . . . . 0.0 110.541 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.7 mt -61.25 -43.63 98.56 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.463 0.705 . . . . 0.0 110.349 -177.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.21 -43.31 99.09 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.167 0.587 . . . . 0.0 110.294 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.0 -45.41 93.74 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.538 0.608 . . . . 0.0 110.293 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -60.98 -43.04 99.4 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.914 -0.491 . . . . 0.0 110.578 178.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 41.6 mt -64.24 -40.94 97.04 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.781 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.8 -38.22 88.37 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.944 0.793 . . . . 0.0 110.308 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -66.77 -36.74 83.13 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.294 0.497 . . . . 0.0 110.845 175.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.75 -25.46 64.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.283 0.633 . . . . 0.0 111.788 173.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.99 -0.17 14.82 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.331 1.444 . . . . 0.0 113.941 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -81.16 143.41 32.39 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.109 1.455 . . . . 0.0 109.69 -177.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 p -79.47 138.14 37.47 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.1 p -128.38 162.51 26.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.046 0.938 . . . . 0.0 109.979 -173.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -145.75 166.64 25.29 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 170.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.3 m -145.72 101.87 3.61 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 -177.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.85 106.92 18.81 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -175.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -74.93 105.71 6.09 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.53 56.13 26.74 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 118.368 -1.24 . . . . 0.0 115.355 172.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.7 172.8 7.61 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.93 2.42 . . . . 0.0 111.623 172.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.2 mt -128.14 170.23 13.2 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.977 2.111 . . . . 0.0 107.565 169.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 tt -54.49 -34.67 62.03 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.888 0.875 . . . . 0.0 111.737 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.06 -5.24 12.3 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.915 1.286 . . . . 0.0 112.591 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -135.23 17.59 3.42 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.944 1.298 . . . . 0.0 110.577 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -134.35 98.59 13.8 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 125.072 1.349 . . . . 0.0 108.628 -169.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -70.23 154.12 66.15 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.559 2.173 . . . . 0.0 111.961 -176.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.02 7.98 6.42 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.059 1.344 . . . . 0.0 114.452 -170.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.5 m -149.48 125.63 10.71 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.125 0.97 . . . . 0.0 108.444 -170.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.24 -175.74 28.32 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.0 mt -116.41 102.03 13.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -96.88 169.86 9.56 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.51 0.724 . . . . 0.0 109.428 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.6 tp -143.16 101.72 3.86 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.1 t -84.34 138.43 19.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 124.125 0.97 . . . . 0.0 108.793 -174.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mp -135.02 130.55 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.24 136.46 50.13 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.042 0.937 . . . . 0.0 110.366 -168.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 m -106.98 47.97 0.86 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.737 0.815 . . . . 0.0 111.175 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.1 m -33.02 105.83 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.178 2.191 . . . . 0.0 110.808 169.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.96 149.86 46.39 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 169.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -42.02 -35.27 1.61 Allowed Glycine 0 CA--C 1.531 1.031 0 C-N-CA 126.096 1.807 . . . . 0.0 116.437 -169.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.92 -10.64 59.25 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.46 46.45 4.34 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 -169.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -123.37 106.78 10.96 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -178.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.4 mt -65.02 141.0 98.26 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.86 141.19 89.02 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.869 2.379 . . . . 0.0 111.851 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -62.44 -14.97 46.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.911 1.684 . . . . 0.0 113.582 -173.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.72 -25.02 63.65 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.461 -0.774 . . . . 0.0 111.824 177.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 63.5 tp -128.68 -31.77 2.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.973 0.806 . . . . 0.0 112.348 -169.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.7 p -52.27 -34.25 15.22 Favored Pre-proline 0 CA--C 1.553 1.08 0 CA-C-O 116.744 -1.598 . . . . 0.0 114.298 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.15 -37.68 59.02 Favored 'Trans proline' 0 C--N 1.359 1.113 0 C-N-CA 123.296 2.664 . . . . 0.0 114.989 174.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -61.13 -44.39 97.41 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.396 0.544 . . . . 0.0 109.764 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -75.84 -30.47 58.95 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.975 0.51 . . . . 0.0 110.686 -173.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -62.56 -43.15 99.53 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.461 -0.774 . . . . 0.0 109.118 169.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.47 -20.65 66.1 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 118.4 -0.809 . . . . 0.0 112.737 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.16 -55.95 10.51 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.774 1.17 . . . . 0.0 109.051 172.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -64.78 -28.17 69.39 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.015 0.825 . . . . 0.0 111.734 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -67.09 -28.63 68.34 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.475 0.71 . . . . 0.0 111.631 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -123.22 -17.62 6.56 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 -169.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.8 tttp 41.02 58.61 8.54 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.322 1.449 . . . . 0.0 109.633 -168.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -67.19 158.47 56.79 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.803 2.335 . . . . 0.0 111.027 -170.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -81.99 84.46 6.96 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.853 0.861 . . . . 0.0 109.761 177.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 mt -108.95 26.82 10.16 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.642 1.577 . . . . 0.0 109.728 175.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.7 m -60.76 17.1 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 128.548 2.739 . . . . 0.0 116.012 -174.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.52 5.42 1.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.197 1.399 . . . . 0.0 111.909 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.9 t -77.66 137.62 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 169.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -124.02 146.94 48.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 168.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -150.03 166.91 28.27 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.421 -175.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -112.76 157.89 14.64 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 104.674 -3.37 . . . . 0.0 104.674 169.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.77 132.05 20.65 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.944 1.372 . . . . 0.0 110.187 -169.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 56.7 mt -138.39 138.75 42.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.93 150.31 17.63 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 107.864 -2.095 . . . . 0.0 107.864 169.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.7 mt -139.61 136.04 39.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.9 -164.02 30.53 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 176.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.0 m -110.33 104.21 12.97 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.218 1.407 . . . . 0.0 108.494 -175.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -59.68 -12.41 6.88 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.075 1.35 . . . . 0.0 113.056 -174.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -56.73 -32.53 65.63 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.486 1.039 . . . . 0.0 110.94 169.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -83.68 151.7 25.13 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.015 0.926 . . . . 0.0 110.026 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.75 -27.75 65.21 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -175.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.9 m -120.17 28.61 7.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.368 1.067 . . . . 0.0 110.795 -169.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -50.45 -33.82 22.51 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 -169.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 75.7 m -132.29 8.99 4.36 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.474 1.109 . . . . 0.0 110.888 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.09 -38.38 89.29 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 119.302 0.956 . . . . 0.0 112.452 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.16 -8.77 41.48 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.36 -27.45 41.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 119.714 1.143 . . . . 0.0 109.443 170.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.17 -39.16 89.54 Favored 'General case' 0 C--N 1.338 0.106 0 O-C-N 121.591 -0.693 . . . . 0.0 110.479 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -58.94 -49.02 79.42 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.96 -54.54 45.96 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.451 0.3 . . . . 0.0 110.501 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -64.19 -38.21 90.22 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.122 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.47 -36.37 78.88 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 119.396 -0.335 . . . . 0.0 111.192 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -74.5 -33.05 62.73 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.794 0.724 . . . . 0.0 110.909 -175.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.3 mt -69.24 -38.85 78.68 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.686 1.13 . . . . 0.0 109.7 169.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -62.05 -40.66 96.53 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.839 0.745 . . . . 0.0 110.124 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -65.2 -31.27 72.36 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.759 0.824 . . . . 0.0 111.415 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.6 m -77.47 4.71 10.41 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.234 1.013 . . . . 0.0 112.355 172.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.24 -11.55 63.63 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.735 1.159 . . . . 0.0 113.41 172.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.35 -178.21 0.48 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.556 1.178 . . . . 0.0 110.793 173.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.18 138.08 17.15 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.148 -0.97 . . . . 0.0 110.966 169.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.56 168.0 1.29 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.337 1.455 . . . . 0.0 108.512 169.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.6 m -135.16 151.61 50.83 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.3 -120.11 21.31 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -140.68 164.23 30.75 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.769 1.627 . . . . 0.0 106.966 170.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.0 m -83.48 139.18 33.08 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.552 -0.717 . . . . 0.0 109.532 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.4 tp -97.9 149.32 22.52 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.824 1.249 . . . . 0.0 109.893 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -119.36 146.33 45.41 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 169.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.7 mt -133.16 100.06 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -68.21 139.13 56.04 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 169.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.3 pp -129.62 15.54 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.22 1.008 . . . . 0.0 112.26 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.0 tp -128.09 131.87 49.03 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.075 0.852 . . . . 0.0 108.984 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.0 t70 68.01 -30.92 0.18 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.573 2.749 . . . . 0.0 114.146 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -142.76 173.7 11.31 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.446 2.298 . . . . 0.0 107.782 175.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -129.45 -140.51 0.23 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.557 1.943 . . . . 0.0 105.94 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.1 pt -132.9 40.05 0.55 Allowed Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.369 1.467 . . . . 0.0 112.214 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.44 -25.41 55.94 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 121.857 1.705 . . . . 0.0 112.979 -171.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.17 -10.82 59.57 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.054 0.942 . . . . 0.0 112.455 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -153.23 63.75 4.79 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 125.226 1.41 . . . . 0.0 108.466 -174.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -67.17 157.88 59.6 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.065 2.51 . . . . 0.0 112.459 -169.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.88 -33.52 64.67 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.559 0.744 . . . . 0.0 111.473 177.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.35 -40.25 74.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.056 0.942 . . . . 0.0 111.232 178.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -73.87 -42.33 60.93 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.726 -0.609 . . . . 0.0 109.895 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -68.55 -36.47 78.85 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.555 0.342 . . . . 0.0 110.621 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.6 tp -61.19 -39.53 90.53 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.81 0.844 . . . . 0.0 110.203 171.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.36 -48.32 48.38 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.575 1.083 . . . . 0.0 111.33 170.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.2 m -61.97 -41.47 98.05 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 117.645 0.723 . . . . 0.0 110.865 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -62.86 -50.82 69.4 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.481 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.8 m -63.96 -34.23 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 120.115 1.325 . . . . 0.0 110.733 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.0 -21.37 66.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.901 0.88 . . . . 0.0 113.05 176.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.32 -49.77 4.57 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.405 1.002 . . . . 0.0 111.12 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.76 -27.23 64.76 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.376 -173.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt . . . . . 0 C--O 1.252 1.197 0 C-N-CA 128.187 2.595 . . . . 0.0 113.102 175.277 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.05 154.38 42.44 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.939 1.295 . . . . 0.0 108.318 173.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -135.87 -25.06 1.27 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.982 1.313 . . . . 0.0 111.036 -179.202 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.7 mt -125.35 80.87 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 169.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.0 m -76.56 114.14 14.96 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.37 155.21 28.52 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.353 1.061 . . . . 0.0 109.233 174.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.1 mt -127.4 93.2 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -174.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -67.02 162.58 21.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.818 1.247 . . . . 0.0 110.158 172.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.78 58.36 0.08 OUTLIER Glycine 0 C--N 1.337 0.615 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -169.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.8 p -135.1 153.03 52.16 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.148 0.979 . . . . 0.0 110.502 170.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 p -99.46 -34.96 10.06 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.963 1.305 . . . . 0.0 109.323 169.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.1 pp -60.72 -25.98 66.83 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.695 1.198 . . . . 0.0 112.502 177.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.94 68.6 1.36 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.53 -47.03 0.05 OUTLIER Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 178.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.03 -28.62 69.92 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 117.874 0.837 . . . . 0.0 110.737 176.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -68.84 -40.46 79.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -76.75 -37.41 55.99 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 122.72 0.408 . . . . 0.0 110.62 -179.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.58 -43.01 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 118.454 0.57 . . . . 0.0 109.474 171.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.19 93.8 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.548 0.613 . . . . 0.0 110.395 177.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.14 -42.4 99.21 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.458 0.572 . . . . 0.0 110.872 178.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -61.81 -50.41 72.41 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.704 0.802 . . . . 0.0 110.165 178.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.3 mt -62.18 -39.75 93.72 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.383 0.673 . . . . 0.0 110.655 179.216 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.96 99.3 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.952 0.501 . . . . 0.0 110.6 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.12 -43.61 94.76 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.678 0.672 . . . . 0.0 110.3 178.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -58.27 -45.99 86.84 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.914 -0.492 . . . . 0.0 110.067 175.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.6 mt -62.48 -38.83 91.35 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.996 178.027 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.22 -38.51 90.65 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.23 0.923 . . . . 0.0 110.316 177.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.05 -36.74 82.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.54 0.609 . . . . 0.0 110.756 175.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.16 -25.28 65.19 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.154 0.581 . . . . 0.0 111.898 173.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.78 0.61 17.57 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.395 1.474 . . . . 0.0 113.998 170.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -83.59 149.57 26.48 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.04 1.42 . . . . 0.0 109.91 -178.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -87.86 140.18 29.77 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 p -139.22 165.97 25.76 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.305 1.042 . . . . 0.0 109.812 -169.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -154.42 155.4 34.91 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 169.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.9 p -126.28 84.31 2.26 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -171.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.6 mt -68.12 119.98 13.58 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -174.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -75.54 92.36 2.89 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.192 0.997 . . . . 0.0 108.458 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.45 61.79 5.65 Favored Glycine 0 CA--C 1.542 1.772 0 C-N-CA 124.628 1.108 . . . . 0.0 113.929 175.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -69.06 177.47 5.07 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.973 3.115 . . . . 0.0 111.875 179.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 38.3 mt -107.49 154.21 21.7 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.828 1.251 . . . . 0.0 107.965 169.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.46 -38.83 72.2 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.924 0.889 . . . . 0.0 111.539 -177.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.09 -18.09 63.01 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -75.3 -19.43 59.68 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.601 0.637 . . . . 0.0 111.862 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.1 mt -99.9 143.09 25.83 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 123.983 0.913 . . . . 0.0 110.517 -173.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.19 163.19 38.72 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.364 2.043 . . . . 0.0 109.26 169.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.81 25.66 0.77 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.521 1.128 . . . . 0.0 111.904 -176.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.5 m -155.89 142.2 18.43 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.13 1.372 . . . . 0.0 107.907 177.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 150.46 -176.16 29.18 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 178.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -128.92 101.24 6.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 178.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -103.14 171.82 7.16 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.202 1.001 . . . . 0.0 108.981 -177.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.2 tp -148.0 117.2 6.87 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 176.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.52 135.39 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -169.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.78 119.91 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.0 m -123.04 -174.42 2.94 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.799 1.64 . . . . 0.0 107.793 -174.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -144.47 170.26 16.37 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 168.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.452 HG21 ' O ' ' A' ' 97' ' ' THR . 24.1 m -126.24 129.28 48.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -67.17 -29.75 69.53 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 117.92 0.327 . . . . 0.0 111.393 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.94 -38.95 0.32 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.692 0.663 . . . . 0.0 112.805 175.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.87 19.15 7.85 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.054 0.942 . . . . 0.0 112.732 -170.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.62 -8.07 28.08 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.266 0.936 . . . . 0.0 113.171 174.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.12 121.3 15.32 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.495 1.147 . . . . 0.0 109.834 176.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.9 mt -78.11 142.01 63.44 Favored Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 176.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.75 145.28 86.18 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.602 2.868 . . . . 0.0 112.044 176.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.49 -17.73 34.14 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.964 1.706 . . . . 0.0 114.281 -173.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -62.42 -44.8 95.56 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.502 0.721 . . . . 0.0 109.429 178.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.2 tp -120.05 -17.58 8.35 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.334 0.654 . . . . 0.0 112.329 -170.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.4 p -53.94 -32.87 12.3 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -178.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -54.69 -23.99 35.38 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.518 2.146 . . . . 0.0 114.852 171.033 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -61.23 -38.54 87.0 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.33 0.968 . . . . 0.0 110.769 177.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -66.98 -37.15 83.71 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.237 0.471 . . . . 0.0 110.474 177.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.81 -45.94 69.91 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.72 -31.19 72.04 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.764 -0.585 . . . . 0.0 112.1 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.9 mt -61.71 -60.72 3.24 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 123.45 0.7 . . . . 0.0 109.405 171.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -71.14 -26.82 63.17 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -171.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -67.69 -37.18 81.96 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.686 0.676 . . . . 0.0 110.97 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -105.95 -34.38 7.63 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.96 0.504 . . . . 0.0 111.613 -170.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.9 tttp 32.73 59.27 1.47 Allowed Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 127.759 2.424 . . . . 0.0 113.59 -174.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -69.95 159.21 54.07 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.73 1.62 . . . . 0.0 110.004 174.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -71.76 127.65 33.23 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 169.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 pp -140.54 38.36 1.86 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.862 1.265 . . . . 0.0 110.129 177.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.1 m -59.43 24.41 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.856 2.462 . . . . 0.0 115.497 170.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.73 3.51 0.97 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.311 1.445 . . . . 0.0 112.184 178.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.9 t -87.35 146.11 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 169.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -122.11 146.44 47.21 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 168.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -137.63 168.98 18.57 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -125.43 156.57 19.28 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 104.802 -3.319 . . . . 0.0 104.802 169.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.06 123.9 25.29 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.408 1.104 . . . . 0.0 109.986 -169.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.2 mt -132.7 135.48 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.14 162.16 13.65 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 169.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.5 mt -141.71 144.13 26.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -177.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 175.41 166.35 32.91 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 106.743 -2.543 . . . . 0.0 106.743 177.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.4 m -73.55 134.53 43.8 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 169.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -61.61 -15.21 37.33 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -67.73 -23.95 65.32 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.158 0.983 . . . . 0.0 111.647 173.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -62.32 143.23 57.19 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.861 0.864 . . . . 0.0 111.14 -175.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.91 -33.09 75.2 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.426 0.69 . . . . 0.0 111.518 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.452 ' O ' HG21 ' A' ' 56' ' ' THR . 24.6 m -117.21 43.61 2.28 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.68 1.592 . . . . 0.0 108.049 178.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -43.96 117.33 1.17 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.73 1.212 . . . . 0.0 110.762 175.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 64.2 m 48.46 33.07 3.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.113 1.765 . . . . 0.0 113.751 -178.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.71 -24.9 19.46 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.366 -0.686 . . . . 0.0 112.912 -175.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.416 ' HB2' HG23 ' A' ' 56' ' ' THR . . . -67.44 -21.76 65.54 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.169 1.484 . . . . 0.0 113.807 -169.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 tp -57.99 -26.66 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.497 1.119 . . . . 0.0 110.237 172.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -57.94 -38.76 76.54 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.716 -0.615 . . . . 0.0 112.119 -174.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -72.43 -41.14 66.5 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.566 -0.709 . . . . 0.0 110.416 -178.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 45.3 mt -61.39 -47.64 84.89 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.396 0.678 . . . . 0.0 109.53 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -70.31 -36.55 74.39 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.76 -178.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.72 96.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.721 -0.656 . . . . 0.0 110.87 -169.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -74.05 -25.57 59.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.159 0.89 . . . . 0.0 111.717 -175.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.1 mt -66.23 -48.35 70.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.478 1.49 . . . . 0.0 108.603 169.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -61.11 -44.31 97.55 Favored 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 123.634 0.774 . . . . 0.0 109.611 -175.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -72.99 0.31 11.68 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.035 1.734 . . . . 0.0 112.722 178.168 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.3 m -122.72 7.21 9.4 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.55 1.14 . . . . 0.0 111.838 176.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 132.43 -34.0 2.57 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 118.547 -1.141 . . . . 0.0 114.598 168.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.22 177.88 0.77 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.715 1.258 . . . . 0.0 112.211 -178.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -149.54 162.18 40.66 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 121.399 -0.813 . . . . 0.0 111.039 169.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.27 165.35 3.58 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.059 1.344 . . . . 0.0 110.119 173.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.0 m -145.58 159.69 42.75 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 174.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.78 -124.7 32.89 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -172.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -139.33 163.53 32.25 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.3 m -66.06 149.67 49.89 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.7 tp -129.56 150.62 50.82 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.426 1.091 . . . . 0.0 109.259 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.24 142.48 47.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 176.451 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.4 mt -134.75 108.97 11.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -171.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -68.15 133.19 48.51 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.85 0.86 . . . . 0.0 110.593 178.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.1 pt -125.31 16.46 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 125.537 1.535 . . . . 0.0 111.462 174.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.18 -24.15 66.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.779 0.832 . . . . 0.0 110.863 170.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -126.07 161.99 26.35 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.578 1.551 . . . . 0.0 107.972 171.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -49.68 -48.97 49.25 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 127.234 2.214 . . . . 0.0 113.26 -169.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -158.74 103.37 1.72 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.686 1.195 . . . . 0.0 107.82 -173.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.3 tp -53.36 137.7 49.78 Favored Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 125.579 1.552 . . . . 0.0 110.077 175.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -56.43 169.21 1.73 Allowed 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.701 2.934 . . . . 0.0 114.582 177.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 58.36 -166.21 0.16 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.329 1.852 . . . . 0.0 111.68 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -138.53 69.58 45.77 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.562 1.145 . . . . 0.0 109.142 -178.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.29 -23.52 51.73 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.171 1.914 . . . . 0.0 111.533 179.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.74 -46.75 88.16 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.458 0.572 . . . . 0.0 109.807 175.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -63.99 -41.31 97.54 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.596 0.635 . . . . 0.0 110.993 176.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.81 -46.29 88.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.665 0.666 . . . . 0.0 110.632 -177.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -66.32 -35.92 81.6 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 122.68 0.392 . . . . 0.0 111.035 175.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 30.2 tp -62.96 -36.21 82.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.204 177.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.62 -47.06 65.08 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 170.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.4 m -64.26 -42.86 96.27 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.43 0.615 . . . . 0.0 110.839 177.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -60.27 -52.85 63.5 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.849 178.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.2 m -65.21 -34.0 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 119.94 1.246 . . . . 0.0 110.948 -177.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.46 -40.52 95.87 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.55 0.614 . . . . 0.0 111.652 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.5 mt -85.62 -35.63 20.86 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.103 -175.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 pp -76.6 -29.35 56.51 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.421 1.01 . . . . 0.0 111.659 177.212 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? . . . . . 0 C--O 1.249 1.026 0 C-N-CA 128.823 2.849 . . . . 0.0 113.695 179.434 . . . . . . . . 0 0 . 1 stop_ save_